Citrus Sinensis ID: 004395
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 756 | 2.2.26 [Sep-21-2011] | |||||||
| P0DH62 | 567 | Inactive protein kinase S | N/A | no | 0.625 | 0.834 | 0.459 | 1e-127 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.425 | 0.454 | 0.495 | 4e-88 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.383 | 0.380 | 0.522 | 9e-88 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.414 | 0.459 | 0.496 | 1e-87 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.387 | 0.406 | 0.526 | 2e-86 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.387 | 0.412 | 0.533 | 5e-86 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.404 | 0.469 | 0.498 | 2e-85 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.404 | 0.426 | 0.501 | 7e-84 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.376 | 0.397 | 0.513 | 2e-83 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.387 | 0.571 | 0.510 | 3e-82 |
| >sp|P0DH62|Y4407_SELML Inactive protein kinase SELMODRAFT_444075 OS=Selaginella moellendorffii GN=SELMODRAFT_444075 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 455 bits (1171), Expect = e-127, Method: Compositional matrix adjust.
Identities = 265/577 (45%), Positives = 339/577 (58%), Gaps = 104/577 (18%)
Query: 106 QLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIV 165
+L ++D K++ ++I+ + G + +EAK+ +A WVVLD+ LK E K C++EL NIV
Sbjct: 5 KLRKIHDLKKVHTTLEILQFARRGVIPSEAKRFRATWVVLDRNLKSEGKLCLQELNSNIV 64
Query: 166 VMKRSQAKVLRLNLVGASKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPV--VTPI 223
V+ RS K+LRLNL +++ LP D +ES DSSS + G V P
Sbjct: 65 VVHRSNPKILRLNL---KRRD------LPYDEEESI-------DSSSVLLNGLSLSVMPK 108
Query: 224 SSPELGTPFTATEAGTSSVSSSDPGTSPFFISGINGDLKKESSVIREDRNLEDSSSDTDS 283
+L + + + SS S F +S + LK E+ S ++
Sbjct: 109 GFDQLYWESSTSSSEASSPDSRLVTAPKFELSVLEELLKNETR--------RKGPSPSEV 160
Query: 284 ENLSVSSASMRFQPWMTEFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRD 343
N + SS + + +FLR + E + R + +DR
Sbjct: 161 LNSTTSSPASHKPQVLNDFLRMKESREYTEETDTQRNVSRP---------------VDR- 204
Query: 344 AGVGMSSYRTDLEFSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELEL 403
+VR+ I L + + P PPPLCSICQHK PVFGKPPR F++AEL+L
Sbjct: 205 --------------VSSVRKQIHLRKQSSPQPPPLCSICQHKTPVFGKPPRKFTFAELQL 250
Query: 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN 463
ATGGFS NFLAEGG+GSV+RG LPDGQAVAVKQHKLAS+QGD EFC+EVEVLSCAQ RN
Sbjct: 251 ATGGFSDVNFLAEGGYGSVYRGRLPDGQAVAVKQHKLASTQGDKEFCAEVEVLSCAQQRN 310
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+VMLIG+C ED++RLLVYE++CNGSLDSHLYG R K
Sbjct: 311 LVMLIGYCAEDKKRLLVYEFVCNGSLDSHLYG---------RRSKT-------------- 347
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
VGDFGLARWQP+G++GVETRVIG FGYLAPEY Q+
Sbjct: 348 -------------------------VGDFGLARWQPNGELGVETRVIGAFGYLAPEYTQT 382
Query: 584 GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643
GQITEKADVYSFG+VL+ELV+GRKAVDL+R KG+ CL+EWARP L E ++L+D RL
Sbjct: 383 GQITEKADVYSFGIVLLELVSGRKAVDLSRNKGEMCLSEWARPFLREQKYEKLIDQRLRG 442
Query: 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680
+ +EV ML AA+LCI DP RPRMSQVLR+LEG
Sbjct: 443 RFCVNEVENMLLAATLCIDPDPLIRPRMSQVLRLLEG 479
|
Selaginella moellendorffii (taxid: 88036) |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (835), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 166/335 (49%), Positives = 217/335 (64%), Gaps = 13/335 (3%)
Query: 349 SSYRTDLEFSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGF 408
S+ R+D F + +AP G Q ++ G FSY EL AT GF
Sbjct: 325 STARSDSAF-------FRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGF 377
Query: 409 SQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
SQ N L EGGFG V++G+LPDG+ VAVKQ K+ QGD EF +EVE LS HR++V ++
Sbjct: 378 SQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIV 437
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G CI RRLL+Y+Y+ N L HL+G + L+W+ R KIA GAARGL YLHE+C
Sbjct: 438 GHCISGDRRLLIYDYVSNNDLYFHLHG-EKSVLDWATRVKIAAGAARGLAYLHEDCHP-R 495
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
I+HRD++ +NILL +F+ V DFGLAR D + + TRVIGTFGY+APEYA SG++TE
Sbjct: 496 IIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTE 555
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL----LEEYAIDELVDPRLGNH 644
K+DV+SFGVVL+EL+TGRK VD ++P G + L EWARPL +E D L DP+LG +
Sbjct: 556 KSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGN 615
Query: 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
Y E E++ M+ AA C+R RPRM Q++R E
Sbjct: 616 YVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFE 650
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 325 bits (833), Expect = 9e-88, Method: Compositional matrix adjust.
Identities = 154/295 (52%), Positives = 206/295 (69%), Gaps = 5/295 (1%)
Query: 389 FGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE 448
FG+ FSY EL +AT GFS N L EGGFG V++GVLPD + VAVKQ K+ QGD E
Sbjct: 411 FGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDRE 470
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK 508
F +EV+ +S HRN++ ++G+CI + RRLL+Y+Y+ N +L HL+ L+W+ R K
Sbjct: 471 FKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVK 530
Query: 509 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
IA GAARGL YLHE+C I+HRD++ +NILL ++F LV DFGLA+ D + + TR
Sbjct: 531 IAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHITTR 589
Query: 569 VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL 628
V+GTFGY+APEYA SG++TEK+DV+SFGVVL+EL+TGRK VD ++P G + L EWARPLL
Sbjct: 590 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 649
Query: 629 ----EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
E L DP+LG +Y E++ M+ AA+ CIR RPRMSQ++R +
Sbjct: 650 SNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFD 704
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 162/326 (49%), Positives = 219/326 (67%), Gaps = 13/326 (3%)
Query: 395 WFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVE 454
WFSY EL T GFS+ N L EGGFG V++GVL DG+ VAVKQ K+ SQG+ EF +EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 455 VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA 514
++S HR++V L+G+CI ++ RLLVY+Y+ N +L HL+ + + W R ++A GAA
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAA 445
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETRVIGT 572
RG+ YLHE+C I+HRD++ +NILL + FE LV DFGLA+ + D+ V TRV+GT
Sbjct: 446 RGIAYLHEDCHP-RIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGT 504
Query: 573 FGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL---- 628
FGY+APEYA SG+++EKADVYS+GV+L+EL+TGRK VD ++P G + L EWARPLL
Sbjct: 505 FGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAI 564
Query: 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDTVIDTYM 688
E DELVDPRLG ++ E++ M+ AA+ C+R RP+MSQV+R L DT
Sbjct: 565 ENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL------DTLE 618
Query: 689 STPGYDVGSRSGRIWVEQQQHQQQQL 714
G R G+ V + Q Q+
Sbjct: 619 EATDITNGMRPGQSQVFDSRQQSAQI 644
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 157/298 (52%), Positives = 205/298 (68%), Gaps = 5/298 (1%)
Query: 388 VFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH 447
+ G FSY EL T GF++ N L EGGFG V++G L DG+ VAVKQ K S QGD
Sbjct: 351 ILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDR 410
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
EF +EVE++S HR++V L+G+CI D+ RLL+YEY+ N +L+ HL+G LEWS R
Sbjct: 411 EFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRV 470
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
+IA+G+A+GL YLHE+C I+HRD++ NILL ++E V DFGLAR V T
Sbjct: 471 RIAIGSAKGLAYLHEDCHP-KIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVST 529
Query: 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627
RV+GTFGYLAPEYA SG++T+++DV+SFGVVL+ELVTGRK VD +P G++ L EWARPL
Sbjct: 530 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPL 589
Query: 628 L----EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681
L E + EL+D RL Y EHEV+ M+ A+ C+R RPRM QV+R L+ D
Sbjct: 590 LLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCD 647
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (818), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 160/300 (53%), Positives = 208/300 (69%), Gaps = 7/300 (2%)
Query: 388 VFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH 447
V G F+Y EL T GFS+ N L EGGFG V++G L DG+ VAVKQ K+ S QGD
Sbjct: 333 VMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDR 392
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
EF +EVE++S HR++V L+G+CI D RLL+YEY+ N +L+ HL+G + LEW+ R
Sbjct: 393 EFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRV 452
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
+IA+G+A+GL YLHE+C I+HRD++ NILL +FE V DFGLA+ V T
Sbjct: 453 RIAIGSAKGLAYLHEDCHP-KIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVST 511
Query: 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627
RV+GTFGYLAPEYAQSG++T+++DV+SFGVVL+EL+TGRK VD +P G++ L EWARPL
Sbjct: 512 RVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPL 571
Query: 628 L----EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL--EGD 681
L E ELVD RL HY E+EV+ M+ A+ C+R RPRM QV+R L EGD
Sbjct: 572 LHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGD 631
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (813), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 158/317 (49%), Positives = 212/317 (66%), Gaps = 11/317 (3%)
Query: 372 PPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQ 431
P PPP + V G F+Y EL AT GFS+AN L +GGFG VH+G+LP G+
Sbjct: 250 PVLPPPSPGL------VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGK 303
Query: 432 AVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDS 491
VAVKQ K S QG+ EF +EVE++S HR++V LIG+C+ +RLLVYE++ N +L+
Sbjct: 304 EVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEF 363
Query: 492 HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551
HL+G + +EWS R KIA+G+A+GL YLHE+C I+HRD++ +NIL+ FE V D
Sbjct: 364 HLHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPK-IIHRDIKASNILIDFKFEAKVAD 422
Query: 552 FGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDL 611
FGLA+ D + V TRV+GTFGYLAPEYA SG++TEK+DV+SFGVVL+EL+TGR+ VD
Sbjct: 423 FGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDA 482
Query: 612 NRPKGQQCLTEWARPLL----EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHS 667
N L +WARPLL EE + L D ++GN Y E+ M+ A+ C+R
Sbjct: 483 NNVYVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARR 542
Query: 668 RPRMSQVLRILEGDTVI 684
RPRMSQ++R LEG+ +
Sbjct: 543 RPRMSQIVRALEGNVSL 559
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 157/313 (50%), Positives = 213/313 (68%), Gaps = 7/313 (2%)
Query: 388 VFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH 447
V G F+Y EL T GF ++ + EGGFG V++G+L +G+ VA+KQ K S++G
Sbjct: 350 VIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYR 409
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
EF +EVE++S HR++V L+G+CI ++ R L+YE++ N +LD HL+G + LEWS R
Sbjct: 410 EFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRV 469
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
+IA+GAA+GL YLHE+C I+HRD++ +NILL +FE V DFGLAR + T
Sbjct: 470 RIAIGAAKGLAYLHEDCHP-KIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIST 528
Query: 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627
RV+GTFGYLAPEYA SG++T+++DV+SFGVVL+EL+TGRK VD ++P G++ L EWARP
Sbjct: 529 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPR 588
Query: 628 L----EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDTV 683
L E+ I E+VDPRL N Y E EVY M+ A+ C+R RPRM QV+R L DT
Sbjct: 589 LIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL--DTR 646
Query: 684 IDTYMSTPGYDVG 696
D T G VG
Sbjct: 647 DDLSDLTNGVKVG 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 149/290 (51%), Positives = 205/290 (70%), Gaps = 5/290 (1%)
Query: 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV 455
F+Y EL AT GFS+AN L +GGFG V +G+L +G+ VAVKQ K SSQG+ EF +EV +
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR 515
+S HR++V L+G+CI D +RLLVYE++ N +L+ HL+G + +EWS+R KIAVG+A+
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAK 461
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY 575
GL YLHE C I+HRD++ +NIL+ FE V DFGLA+ D + V TRV+GTFGY
Sbjct: 462 GLSYLHENCNP-KIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGY 520
Query: 576 LAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA--- 632
LAPEYA SG++TEK+DV+SFGVVL+EL+TGR+ +D+N L +WARPLL + +
Sbjct: 521 LAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSELG 580
Query: 633 -IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681
+ +VD +L N Y + E+ M+ A+ C+R RPRM QV R+LEG+
Sbjct: 581 NFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGN 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 152/298 (51%), Positives = 201/298 (67%), Gaps = 5/298 (1%)
Query: 388 VFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH 447
V G F+Y EL AT FS+AN L EGGFG V++G+L +G VAVKQ K+ S+QG+
Sbjct: 163 VLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEK 222
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
EF +EV ++S HRN+V L+G+CI +RLLVYE++ N +L+ HL+G + +EWS R
Sbjct: 223 EFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRL 282
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
KIAV +++GL YLHE C I+HRD++ NIL+ FE V DFGLA+ D + V T
Sbjct: 283 KIAVSSSKGLSYLHENCNPK-IIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVST 341
Query: 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627
RV+GTFGYLAPEYA SG++TEK+DVYSFGVVL+EL+TGR+ VD N L +WARPL
Sbjct: 342 RVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPL 401
Query: 628 ----LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681
LEE + L D +L N Y E+ M+ A+ C+R RPRM QV+R+LEG+
Sbjct: 402 LVQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGN 459
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 756 | ||||||
| 255572979 | 754 | ATP binding protein, putative [Ricinus c | 0.992 | 0.994 | 0.845 | 0.0 | |
| 225442323 | 737 | PREDICTED: inactive protein kinase SELMO | 0.972 | 0.997 | 0.812 | 0.0 | |
| 449458185 | 751 | PREDICTED: tyrosine-protein kinase Lck-l | 0.990 | 0.997 | 0.792 | 0.0 | |
| 449531434 | 751 | PREDICTED: LOW QUALITY PROTEIN: tyrosine | 0.990 | 0.997 | 0.789 | 0.0 | |
| 356526029 | 750 | PREDICTED: tyrosine-protein kinase Lck-l | 0.981 | 0.989 | 0.797 | 0.0 | |
| 356522578 | 750 | PREDICTED: inactive protein kinase SELMO | 0.981 | 0.989 | 0.793 | 0.0 | |
| 224128638 | 694 | predicted protein [Populus trichocarpa] | 0.914 | 0.995 | 0.853 | 0.0 | |
| 356550454 | 698 | PREDICTED: LOW QUALITY PROTEIN: inactive | 0.911 | 0.987 | 0.827 | 0.0 | |
| 356556706 | 699 | PREDICTED: uncharacterized protein LOC10 | 0.911 | 0.985 | 0.819 | 0.0 | |
| 15231330 | 753 | protein kinase protein with adenine nucl | 0.974 | 0.978 | 0.745 | 0.0 |
| >gi|255572979|ref|XP_002527420.1| ATP binding protein, putative [Ricinus communis] gi|223533230|gb|EEF34986.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1255 bits (3248), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 641/758 (84%), Positives = 681/758 (89%), Gaps = 8/758 (1%)
Query: 3 MSGEVKKG-KQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSH 61
MS E K+G KQEKG SDVA KVVVAVKASKEIP+TALVWALTHVVQ GDCITLLVVVPSH
Sbjct: 1 MSREQKRGGKQEKGGSDVAVKVVVAVKASKEIPKTALVWALTHVVQAGDCITLLVVVPSH 60
Query: 62 SSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIK 121
S GR+ W FPRFAGDCASGHRKS SG SEQR DITDSCSQMILQLHDVYDPNKIN KIK
Sbjct: 61 SPGRKLWGFPRFAGDCASGHRKSHSGATSEQRCDITDSCSQMILQLHDVYDPNKINVKIK 120
Query: 122 IVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVG 181
IVSGSPCG+VAAEAK+A A WVVLDKQLKHEEK CMEELQCNIVVMKR+Q KVLRLNLVG
Sbjct: 121 IVSGSPCGSVAAEAKRALANWVVLDKQLKHEEKRCMEELQCNIVVMKRTQPKVLRLNLVG 180
Query: 182 ASKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSS 241
SK EA A PLPS+ DE+ +K KNK+ SS SIRGPVVTP SSPELGTPFTATE GTSS
Sbjct: 181 TSK-EAESAIPLPSELDEAPDKQTKNKNDSSDSIRGPVVTPTSSPELGTPFTATEVGTSS 239
Query: 242 VSSSDPGTSPFFISGINGDLKKESS-VIREDRNLEDSSSDTDSENLSVSSASMRFQPWMT 300
VSS DPGTSPFFIS N DLKKE S VI+E ++++SSSDTDSE+LS +SAS+RF+PW+
Sbjct: 240 VSS-DPGTSPFFISDTNADLKKEESLVIKEHGDVDESSSDTDSEHLSTASASLRFEPWIG 298
Query: 301 EFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGN 360
E L SH QSS MEE RRT+ QASTTKALLEKFS+LDR G+GMS+YRTD + SGN
Sbjct: 299 EILSSHIQSSRHMEEGPQRRTS-MAQASTTKALLEKFSKLDRQTGIGMSNYRTDSDLSGN 357
Query: 361 VREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFG 420
VREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFG
Sbjct: 358 VREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFG 417
Query: 421 SVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480
SVHRGVLPDGQAVAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED+RRLLV
Sbjct: 418 SVHRGVLPDGQAVAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEDKRRLLV 477
Query: 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 540
YEYICNGSLDSHLYG H+EPLEWSARQ+IAVGAARGLRYLHEECRVGCIVHRDMRPNNIL
Sbjct: 478 YEYICNGSLDSHLYGRHREPLEWSARQRIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 537
Query: 541 LTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLV 600
+THDFEPLVGDFGLARWQPDGD GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLV
Sbjct: 538 ITHDFEPLVGDFGLARWQPDGDTGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLV 597
Query: 601 ELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLC 660
ELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL+DP+LGN+YSE EVYCMLHAASLC
Sbjct: 598 ELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELIDPQLGNNYSEQEVYCMLHAASLC 657
Query: 661 IRRDPHSRPRMSQVLRILEGDTVIDT-YMSTPGYDVGSRSGRIWVE-QQQHQQQQLPYSG 718
IRRDPHSRPRMSQVLRILEGD ++D+ Y STPGYDVG+RSGRIW E Q QHQ Q YSG
Sbjct: 658 IRRDPHSRPRMSQVLRILEGDMLMDSNYASTPGYDVGNRSGRIWAEQQHQHQHHQQHYSG 717
Query: 719 PLMNEALEGFGRKLPLDSLKAAFWERDKARRTSRENDL 756
PL NEALEGF KL LD+L+ AFWER+KARR S E+DL
Sbjct: 718 PLANEALEGFS-KLSLDTLRPAFWEREKARRISCEDDL 754
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225442323|ref|XP_002280107.1| PREDICTED: inactive protein kinase SELMODRAFT_444075 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1251 bits (3237), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 614/756 (81%), Positives = 671/756 (88%), Gaps = 21/756 (2%)
Query: 3 MSGEVKKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHS 62
MS + K+GKQEK SS+ AEKVVVAVKAS+EIP+TALVWALTHVVQPGDCITLLVVVP+ S
Sbjct: 1 MSKDQKRGKQEK-SSEAAEKVVVAVKASREIPKTALVWALTHVVQPGDCITLLVVVPAQS 59
Query: 63 SGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKI 122
GR+ W FPRFAGDCASGHRKS SG SEQ+ +ITDSCSQMILQLHDVYDPNKIN KIKI
Sbjct: 60 PGRKLWGFPRFAGDCASGHRKSHSGASSEQKCEITDSCSQMILQLHDVYDPNKINVKIKI 119
Query: 123 VSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGA 182
VSGSPCGAV+ EAK+ +A WVVLDKQLKHEEKCCMEELQCNIVVMKRSQ KVLRLNLVG+
Sbjct: 120 VSGSPCGAVSGEAKRTEANWVVLDKQLKHEEKCCMEELQCNIVVMKRSQPKVLRLNLVGS 179
Query: 183 SKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSV 242
K E+ A EK K K+ S SIRGPVVTP SSPELGTPFTATE GTSSV
Sbjct: 180 PKMESETAS----------EKHSKTKNDSMKSIRGPVVTPSSSPELGTPFTATEVGTSSV 229
Query: 243 SSSDPGTSPFFISGINGDLKKE-SSVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTE 301
SSSDPGTSPFF S +NGDLKKE SS +E+ +L++SSSDTD+ENLS SS S+ FQPWM
Sbjct: 230 SSSDPGTSPFFNSEVNGDLKKEESSHTKENLDLDESSSDTDNENLSPSS-SVGFQPWMAG 288
Query: 302 FLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNV 361
L SHHQSS +E+ S+++ +KTQ T+KALL+KFS++DRDA +GM +YR++L+FSGNV
Sbjct: 289 VLTSHHQSSQHIEQS-SKKSRDKTQPPTSKALLDKFSKIDRDARIGMMNYRSELDFSGNV 347
Query: 362 REAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGS 421
REAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGS
Sbjct: 348 REAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGS 407
Query: 422 VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481
VHRGVLPDGQAVAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIG+CIEDRRRLLVY
Sbjct: 408 VHRGVLPDGQAVAVKQHKLASSQGDVEFCSEVEVLSCAQHRNVVMLIGYCIEDRRRLLVY 467
Query: 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
EYICNGSLDSHLYG H++PLEWSARQK+AVGAARGLRYLHEECRVGCIVHRDMRPNNIL+
Sbjct: 468 EYICNGSLDSHLYGRHRDPLEWSARQKVAVGAARGLRYLHEECRVGCIVHRDMRPNNILI 527
Query: 542 THDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVE 601
THDFEPLVGDFGLARWQPDGD GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVE
Sbjct: 528 THDFEPLVGDFGLARWQPDGDTGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVE 587
Query: 602 LVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCI 661
LVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN YSE EVYCMLHAASLCI
Sbjct: 588 LVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNCYSEQEVYCMLHAASLCI 647
Query: 662 RRDPHSRPRMSQVLRILEGDTVIDT-YMSTPGYDVGSRSGRIWVEQQQHQQQQLPYSGPL 720
RRDPH+RPRMSQVLRILEGD V+D+ YM+TPGYDVGS+SGRIW +Q QH YSGP+
Sbjct: 648 RRDPHARPRMSQVLRILEGDMVMDSNYMATPGYDVGSQSGRIWSDQHQH------YSGPI 701
Query: 721 MNEALEGFGRKLPLDSLKAAFWERDKARRTSRENDL 756
+NEA E F KL L++L++AFWE+DK RRTS E+ L
Sbjct: 702 LNEAYEEFSGKLSLEALRSAFWEKDKGRRTSSEDKL 737
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458185|ref|XP_004146828.1| PREDICTED: tyrosine-protein kinase Lck-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1223 bits (3164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/756 (79%), Positives = 662/756 (87%), Gaps = 7/756 (0%)
Query: 3 MSGEVKKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHS 62
MS ++K+GKQ+KGS DV +KV+VAVKASKEIP+TALVWALTHVVQ GDCITLLVVVPS S
Sbjct: 1 MSRDLKRGKQDKGSDDV-QKVIVAVKASKEIPKTALVWALTHVVQIGDCITLLVVVPSQS 59
Query: 63 SGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKI 122
SGR+FW FPRFAGDCASGH+K+ SGT SE + DITDSCSQMILQLHDVYDPNKIN KIKI
Sbjct: 60 SGRKFWGFPRFAGDCASGHKKAHSGTSSELKCDITDSCSQMILQLHDVYDPNKINVKIKI 119
Query: 123 VSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGA 182
VSGSP GAVAAEAK+AQA WVVLDKQLKHEEKCCMEELQCNIVVMKRSQ KVLRLNLVG+
Sbjct: 120 VSGSPSGAVAAEAKRAQASWVVLDKQLKHEEKCCMEELQCNIVVMKRSQPKVLRLNLVGS 179
Query: 183 SKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSV 242
KKE V P PSD E E K + IRGPVVTP SSPELGTPFTATEAGTSSV
Sbjct: 180 PKKEPEVPSPSPSDIYEGSESHQKENNDPLDFIRGPVVTPSSSPELGTPFTATEAGTSSV 239
Query: 243 SSSDPGTSPFFISGINGDLKKES-SVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTE 301
SSSDPGTSPFF S +NGD KKE VI+E++ L+ +SSD+D ENLSVSSAS+RFQPWMTE
Sbjct: 240 SSSDPGTSPFFNSEMNGDTKKEELFVIKENKELDAASSDSDIENLSVSSASLRFQPWMTE 299
Query: 302 FLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNV 361
FL SH QSS + S+R +++ QAST + L K S+LDR++ +GMSS+R+D +F G+V
Sbjct: 300 FLSSHLQSSQHISGR-SQRCDDRNQASTRNSFLLKSSKLDRESSIGMSSHRSDNDFHGDV 358
Query: 362 REAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGS 421
R+A+SLSRN PPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGG+GS
Sbjct: 359 RDAVSLSRNTPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGYGS 418
Query: 422 VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481
VHRGVLPDGQ VAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIE++RRLLVY
Sbjct: 419 VHRGVLPDGQVVAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEEKRRLLVY 478
Query: 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
EYICNGSLDSHLYG QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+
Sbjct: 479 EYICNGSLDSHLYGRQQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILI 538
Query: 542 THDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVE 601
THDFEPLVGDFGLARWQPDGD GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVE
Sbjct: 539 THDFEPLVGDFGLARWQPDGDTGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVE 598
Query: 602 LVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCI 661
L+TGRKAVDL+RPKGQQCLTEWARPLL+E+ IDEL+DPRL N ++EHEVYCMLHAASLCI
Sbjct: 599 LITGRKAVDLSRPKGQQCLTEWARPLLDEFLIDELIDPRLVNSFAEHEVYCMLHAASLCI 658
Query: 662 RRDPHSRPRMSQVLRILEGDTVID-TYMSTPGYDVGSRSGRIWVEQQQHQQQQLPYSGPL 720
RRDP++RPRMSQVLRILEGD V+D Y STPGYDVG+RSGR+W EQQQ Q YSG L
Sbjct: 659 RRDPNARPRMSQVLRILEGDLVMDANYFSTPGYDVGNRSGRMWTEQQQQPQN---YSGLL 715
Query: 721 MNEALEGFGRKLPLDSLKAAFWERDKARRTSRENDL 756
+E +E F K+ ++SL+ +WERDK RRTS ++L
Sbjct: 716 SDETVERFNEKVCVESLRPGYWERDKTRRTSSGSEL 751
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449531434|ref|XP_004172691.1| PREDICTED: LOW QUALITY PROTEIN: tyrosine-protein kinase Lck-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1218 bits (3151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 597/756 (78%), Positives = 660/756 (87%), Gaps = 7/756 (0%)
Query: 3 MSGEVKKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHS 62
MS ++K+GKQ+KGS DV +KV+VAVKASKEIP+TALVWALTHVVQ GDCITLLVVVPS S
Sbjct: 1 MSRDLKRGKQDKGSDDV-QKVIVAVKASKEIPKTALVWALTHVVQIGDCITLLVVVPSQS 59
Query: 63 SGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKI 122
S R+FW FPRFAGDCASGH+K+ SGT SE + DITDSCSQMILQLHDVYDPNKIN KIKI
Sbjct: 60 SDRKFWGFPRFAGDCASGHKKAHSGTSSELKCDITDSCSQMILQLHDVYDPNKINVKIKI 119
Query: 123 VSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGA 182
VSGSP GAVAAEAK+AQA WVVLDKQLKHEEKCCMEELQCNIVVMKRSQ KVLRLNLVG+
Sbjct: 120 VSGSPSGAVAAEAKRAQASWVVLDKQLKHEEKCCMEELQCNIVVMKRSQPKVLRLNLVGS 179
Query: 183 SKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSV 242
KKE V P PSD E K K + IRGPVVTP SSPELGTPFTATEAGTSSV
Sbjct: 180 PKKEPEVPSPSPSDIYEGSXKHQKENNDPLDFIRGPVVTPSSSPELGTPFTATEAGTSSV 239
Query: 243 SSSDPGTSPFFISGINGDLKKES-SVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTE 301
SSSDPGTSPFF S +NGD KKE VI+E++ L+ +SSD+D ENLS SSAS+RFQPWMTE
Sbjct: 240 SSSDPGTSPFFNSEMNGDTKKEELFVIKENKELDAASSDSDIENLSASSASLRFQPWMTE 299
Query: 302 FLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNV 361
FL SH QSS + S+R +++ QAST + L K S+LDR++ +GMSS+R+D +F G+V
Sbjct: 300 FLSSHLQSSQHISGR-SQRCDDRNQASTRNSFLLKSSKLDRESSIGMSSHRSDNDFHGDV 358
Query: 362 REAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGS 421
R+A+SLSRN PPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGG+GS
Sbjct: 359 RDAVSLSRNTPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGYGS 418
Query: 422 VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481
VHRGVLPDGQ VAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIE++RRLLVY
Sbjct: 419 VHRGVLPDGQVVAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEEKRRLLVY 478
Query: 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
EYICNGSLDSHLYG QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+
Sbjct: 479 EYICNGSLDSHLYGRQQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILI 538
Query: 542 THDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVE 601
THDFEPLVGDFGLARWQPDGD GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVE
Sbjct: 539 THDFEPLVGDFGLARWQPDGDTGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVE 598
Query: 602 LVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCI 661
L+TGRKAVDL+RPKGQQCLTEWARPLL+E+ IDEL+DPRL N ++EHEVYCMLHAASLCI
Sbjct: 599 LITGRKAVDLSRPKGQQCLTEWARPLLDEFLIDELIDPRLVNSFAEHEVYCMLHAASLCI 658
Query: 662 RRDPHSRPRMSQVLRILEGDTVID-TYMSTPGYDVGSRSGRIWVEQQQHQQQQLPYSGPL 720
RRDP++RPRMSQVLRILEGD V+D Y STPGYDVG+RSGR+W EQQQ Q YSG L
Sbjct: 659 RRDPNARPRMSQVLRILEGDLVMDANYFSTPGYDVGNRSGRMWTEQQQQPQN---YSGLL 715
Query: 721 MNEALEGFGRKLPLDSLKAAFWERDKARRTSRENDL 756
+E +E F K+ ++SL+ +WERDK RRTS ++L
Sbjct: 716 SDETVERFNEKVCVESLRPGYWERDKTRRTSSGSEL 751
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526029|ref|XP_003531622.1| PREDICTED: tyrosine-protein kinase Lck-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1197 bits (3096), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/751 (79%), Positives = 655/751 (87%), Gaps = 9/751 (1%)
Query: 8 KKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
K+GKQEKGS D EKV+VAVKASKEIP+TALVW+L+HVVQPGDCITLLVVVPS SSGRR
Sbjct: 7 KRGKQEKGS-DGVEKVIVAVKASKEIPKTALVWSLSHVVQPGDCITLLVVVPSQSSGRRL 65
Query: 68 WVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSP 127
W FPRFAGDCASG +K GTISEQ+ DITDSCSQMILQLH+VYDPNKIN +IKIVSGSP
Sbjct: 66 WGFPRFAGDCASGIKKYPPGTISEQKSDITDSCSQMILQLHNVYDPNKINVRIKIVSGSP 125
Query: 128 CGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKEA 187
CGAVAAEAKKAQA WVVLDKQLKHEEK CMEELQCNIVVMKRSQ KVLRLNL+G KKE
Sbjct: 126 CGAVAAEAKKAQANWVVLDKQLKHEEKRCMEELQCNIVVMKRSQPKVLRLNLIGPQKKEV 185
Query: 188 GVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSVSSSDP 247
A P PS+ D+ E K K S SI+GP VTP SSPELGTPFTATEAGTSSVSSSDP
Sbjct: 186 EEAGPSPSEQDDMPENRTKIKLDSLNSIKGPAVTPTSSPELGTPFTATEAGTSSVSSSDP 245
Query: 248 GTSPFFISGINGDLKKESSVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTEFLRSHH 307
GTSPFFIS +NG+ KKE + I+E + L D++SDT+SE+LS SSASMR+QPW+TE L H
Sbjct: 246 GTSPFFISEMNGEFKKEET-IKESQELVDTNSDTESESLSTSSASMRYQPWITELLL--H 302
Query: 308 QSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAISL 367
Q S Q EE S ++ QASTT+A LEK+SRLDR AG +S+YR D++FSGN+REAI+L
Sbjct: 303 QPSTQCNEERSEMSHGMPQASTTRAFLEKYSRLDRGAGFEISTYRNDMDFSGNLREAIAL 362
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
S NAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL
Sbjct: 363 SGNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 422
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
P+GQ +AVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED+RRLLVYEYICNG
Sbjct: 423 PEGQVIAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEDKRRLLVYEYICNG 482
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
SLDSHLYG ++PLEWSARQKIAVGAARGLRYLHEECRVGCI+HRDMRPNNIL+THDFEP
Sbjct: 483 SLDSHLYGRQRDPLEWSARQKIAVGAARGLRYLHEECRVGCIIHRDMRPNNILITHDFEP 542
Query: 548 LVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK 607
LVGDFGLARWQPDGD GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK
Sbjct: 543 LVGDFGLARWQPDGDTGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK 602
Query: 608 AVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHS 667
AVDL RPKGQQCLTEWARPLLEE AI+EL+DPRLGNHYSEHEVYCMLHAASLCI+RDP
Sbjct: 603 AVDLTRPKGQQCLTEWARPLLEEDAIEELIDPRLGNHYSEHEVYCMLHAASLCIQRDPQC 662
Query: 668 RPRMSQVLRILEGDTVIDT-YMSTPGYDVGSRSGRIWVEQQQHQQQQLPYSGPLMNEALE 726
RPRMSQVLRILEGD V+D+ Y+STPGYD G+RSGR+W E Q Q YSGPL+ E+LE
Sbjct: 663 RPRMSQVLRILEGDMVMDSNYISTPGYDAGNRSGRLWSEPLQRQHH---YSGPLLEESLE 719
Query: 727 GFGRKLPLDSLKAAFW-ERDKARRTSRENDL 756
F KL LD K ++W +RDKARR S +D+
Sbjct: 720 SFSGKLSLDKYKPSYWGDRDKARRASCVDDI 750
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522578|ref|XP_003529923.1| PREDICTED: inactive protein kinase SELMODRAFT_444075-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1196 bits (3094), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 596/751 (79%), Positives = 656/751 (87%), Gaps = 9/751 (1%)
Query: 8 KKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
K+GKQEKGS D AEKV+VAVKASKEIP+TALVW+L+HVVQPGDCITLLVVVPS SSGRR
Sbjct: 7 KRGKQEKGS-DGAEKVIVAVKASKEIPKTALVWSLSHVVQPGDCITLLVVVPSQSSGRRL 65
Query: 68 WVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSP 127
W FPRFAGDCASG +K GTISEQ+ D+TDSCSQMILQLH+VYDPNKIN +IKIVSGSP
Sbjct: 66 WGFPRFAGDCASGIKKYPPGTISEQKSDLTDSCSQMILQLHNVYDPNKINVRIKIVSGSP 125
Query: 128 CGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKEA 187
CGAVAAEAKK QA WVVLDKQLKHEEK CMEELQCNIVVMKRSQ KVLRLNL+G KK+
Sbjct: 126 CGAVAAEAKKTQANWVVLDKQLKHEEKRCMEELQCNIVVMKRSQPKVLRLNLIGPQKKDV 185
Query: 188 GVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSVSSSDP 247
A P PS+ D+ E K K S SI+GP VTP SSPELGTPFTATEAGTSSVSSSDP
Sbjct: 186 EEAGPSPSEQDDMPENRTKIKLDSLNSIKGPTVTPTSSPELGTPFTATEAGTSSVSSSDP 245
Query: 248 GTSPFFISGINGDLKKESSVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTEFLRSHH 307
GTSPFFIS +NG+ KKE + I+E + L D++SDT+SE+LS SSASMR+QPW+TE L H
Sbjct: 246 GTSPFFISEMNGEFKKEET-IKESQELVDTNSDTESESLSTSSASMRYQPWITELLL--H 302
Query: 308 QSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAISL 367
Q S Q EE S ++ QASTT+A LEK+SRLDR AG +S+YR D++FSGN+REAI+L
Sbjct: 303 QQSSQRNEERSDISHGIPQASTTRAFLEKYSRLDRGAGFEISTYRNDMDFSGNLREAIAL 362
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
S NAPPGPPPLCSICQHKAPVFGKPPRWF+Y+ELELATGGFSQANFLAEGGFGSVHRGVL
Sbjct: 363 SGNAPPGPPPLCSICQHKAPVFGKPPRWFTYSELELATGGFSQANFLAEGGFGSVHRGVL 422
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
P+GQ +AVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED+RRLLVYEYICNG
Sbjct: 423 PEGQVIAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEDKRRLLVYEYICNG 482
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
SLDSHLYG ++ LEWSARQKIAVGAARGLRYLHEECRVGCI+HRDMRPNNIL+THDFEP
Sbjct: 483 SLDSHLYGRQRDTLEWSARQKIAVGAARGLRYLHEECRVGCIIHRDMRPNNILITHDFEP 542
Query: 548 LVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK 607
LVGDFGLARWQPDGD GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK
Sbjct: 543 LVGDFGLARWQPDGDTGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK 602
Query: 608 AVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHS 667
AVDL RPKGQQCLTEWARPLLEEYAI+EL+DPRLG HYSEHEVYCMLHAASLCI+RDP
Sbjct: 603 AVDLTRPKGQQCLTEWARPLLEEYAIEELIDPRLGKHYSEHEVYCMLHAASLCIQRDPQC 662
Query: 668 RPRMSQVLRILEGDTVIDT-YMSTPGYDVGSRSGRIWVEQQQHQQQQLPYSGPLMNEALE 726
RPRMSQVLRILEGD V+D+ Y+STPGYD G+RSGR+W E Q QQ YSGPL+ E+LE
Sbjct: 663 RPRMSQVLRILEGDMVMDSNYISTPGYDAGNRSGRLWSEPLQRQQH---YSGPLLEESLE 719
Query: 727 GFGRKLPLDSLKAAFW-ERDKARRTSRENDL 756
F KL LD K ++W +RDKARR S E+D+
Sbjct: 720 SFSGKLSLDKYKPSYWGDRDKARRASCEDDI 750
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128638|ref|XP_002329053.1| predicted protein [Populus trichocarpa] gi|222839724|gb|EEE78047.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1191 bits (3080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/697 (85%), Positives = 636/697 (91%), Gaps = 6/697 (0%)
Query: 8 KKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
KKGKQEKG SDVA KVVVAVKASKEIP+TALVWALTHVVQPGDCITLLVVVPSH+ GRR
Sbjct: 2 KKGKQEKGGSDVAVKVVVAVKASKEIPKTALVWALTHVVQPGDCITLLVVVPSHAPGRRL 61
Query: 68 WVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSP 127
W FPRFA DCA+GHRKS SG S+QR DITDSCSQMILQLHDVYDPNKIN KIKIVSGSP
Sbjct: 62 WGFPRFAADCANGHRKSHSGATSDQRCDITDSCSQMILQLHDVYDPNKINVKIKIVSGSP 121
Query: 128 CGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKEA 187
CGAV+AEAKKAQA WVVLDKQLKHEEK CMEELQCNIVVMKRSQAKVLRLNLVG SK E
Sbjct: 122 CGAVSAEAKKAQANWVVLDKQLKHEEKRCMEELQCNIVVMKRSQAKVLRLNLVGTSK-EP 180
Query: 188 GVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSVSSSDP 247
V P PS +E+ E+ KNK++SSGSIRGPVVTP SSPELGTPFT TEAGTSSVSS DP
Sbjct: 181 EVVGPSPSKLNEASEQHSKNKNNSSGSIRGPVVTPTSSPELGTPFTVTEAGTSSVSS-DP 239
Query: 248 GTSPFFISGINGDLKKESS-VIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTEFLRSH 306
G SPFFIS NG+LKKE VI+E+R+L++SSSDTD+E+LS++S S+RF+PW+ E L SH
Sbjct: 240 GASPFFISETNGELKKEEPLVIKENRDLDESSSDTDTEHLSLAS-SLRFEPWVGELLGSH 298
Query: 307 HQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAIS 366
+SS +EE S+R+N Q STT+ALLEKFS+LDR G+GMS+YRTDL+ S NVREAIS
Sbjct: 299 IKSSRHVEES-SQRSNCMAQTSTTEALLEKFSKLDRQTGIGMSNYRTDLDLSVNVREAIS 357
Query: 367 LSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV 426
LSRN PPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV
Sbjct: 358 LSRNTPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV 417
Query: 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486
LPDGQAVAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN
Sbjct: 418 LPDGQAVAVKQHKLASSQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 477
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
GSLDSHLYG H+EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFE
Sbjct: 478 GSLDSHLYGHHREPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFE 537
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
PLVGDFGLARWQPDGD GVETRVIGTFGYLAPEYA++GQITEKADVYSFGVVLVELVTGR
Sbjct: 538 PLVGDFGLARWQPDGDTGVETRVIGTFGYLAPEYAETGQITEKADVYSFGVVLVELVTGR 597
Query: 607 KAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPH 666
KAVDLNRPKGQQCLTEWARPLLEEYAI EL+DP+LGNHYSE EVYCMLHAAS+CIRRDPH
Sbjct: 598 KAVDLNRPKGQQCLTEWARPLLEEYAIVELIDPQLGNHYSEQEVYCMLHAASICIRRDPH 657
Query: 667 SRPRMSQVLRILEGDTVIDT-YMSTPGYDVGSRSGRI 702
SRPRMSQVLRILEGD +DT YMS PGYDVG+RSGRI
Sbjct: 658 SRPRMSQVLRILEGDMHVDTNYMSAPGYDVGNRSGRI 694
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550454|ref|XP_003543602.1| PREDICTED: LOW QUALITY PROTEIN: inactive protein kinase SELMODRAFT_444075-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1177 bits (3046), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 575/695 (82%), Positives = 626/695 (90%), Gaps = 6/695 (0%)
Query: 8 KKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
K+GKQEKGS D AEKV+VAVKASKEIP+TALVW+LTHVVQPGDCITLLVVVPS S+GRR
Sbjct: 8 KRGKQEKGS-DGAEKVIVAVKASKEIPKTALVWSLTHVVQPGDCITLLVVVPSQSAGRRL 66
Query: 68 WVFPRFAGDCASGHRKSFSGTIS-EQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGS 126
W FPRFAGDCA+G +KS SG+ S E + DITDSCSQMILQLHDVYDPNKIN KIKIVSGS
Sbjct: 67 WGFPRFAGDCANGQKKSTSGSSSSEHKSDITDSCSQMILQLHDVYDPNKINVKIKIVSGS 126
Query: 127 PCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKE 186
PCGAVAAEAKK+QA WVVLDKQLKHEEK CMEELQCNIVVMKRSQ KVLRLNLVG KK+
Sbjct: 127 PCGAVAAEAKKSQANWVVLDKQLKHEEKQCMEELQCNIVVMKRSQPKVLRLNLVGTQKKD 186
Query: 187 AGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSVSSSD 246
CPLPS+ +E K K K+ S SI+GPVVTP SSPELGTPFT TEAGTSSVSSSD
Sbjct: 187 FEELCPLPSEQNEMPGKQIKKKNDSLNSIKGPVVTPTSSPELGTPFTTTEAGTSSVSSSD 246
Query: 247 PGTSPFFISGINGDLKKESSVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTEFLRSH 306
GTSPFFIS +NG+ KKE + I+E+ L+DS SDTDSENLS SS S+RFQPW+T+ L
Sbjct: 247 QGTSPFFISEMNGESKKEET-IKENPELDDSISDTDSENLSTSSTSLRFQPWITDLLL-- 303
Query: 307 HQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAIS 366
HQ S Q +EE + R+ N+ Q+STT+ALLEKFSRLDR+A + +S+Y+TD +FSGNVREA++
Sbjct: 304 HQQSSQPKEERTERSYNRLQSSTTRALLEKFSRLDREAEIEISTYKTDYDFSGNVREAVA 363
Query: 367 LSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV 426
LSRN PPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGF +ANFLAEGGFGSVHRG+
Sbjct: 364 LSRNTPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFXKANFLAEGGFGSVHRGL 423
Query: 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486
LPDGQ +AVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED+RRLLVYEYICN
Sbjct: 424 LPDGQVIAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEDKRRLLVYEYICN 483
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
GSLDSHLYG EPLEWSARQKIAVGAARGLRYLHEECRVGCI+HRDMRPNNIL+THDFE
Sbjct: 484 GSLDSHLYGRQPEPLEWSARQKIAVGAARGLRYLHEECRVGCIIHRDMRPNNILITHDFE 543
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
PLVGDFGLARWQPDGD GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR
Sbjct: 544 PLVGDFGLARWQPDGDTGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 603
Query: 607 KAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPH 666
KAVDLNRPKGQQCLTEWARPLLEEYAI+EL+DPRLG+HYSEHEVYCMLHAASLCIRRDP+
Sbjct: 604 KAVDLNRPKGQQCLTEWARPLLEEYAIEELIDPRLGSHYSEHEVYCMLHAASLCIRRDPY 663
Query: 667 SRPRMSQVLRILEGDTVID-TYMSTPGYDVGSRSG 700
SRPRMSQVLRILEGDTV+D Y+STP YD+G RSG
Sbjct: 664 SRPRMSQVLRILEGDTVVDPNYISTPSYDLGKRSG 698
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556706|ref|XP_003546664.1| PREDICTED: uncharacterized protein LOC100804766 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1159 bits (2999), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/697 (81%), Positives = 621/697 (89%), Gaps = 8/697 (1%)
Query: 8 KKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
K+GKQEKGS D AEKV+VAVKASKEIP+TALVW+LTHVVQPGDCITLLVVVPS S+GRR
Sbjct: 7 KRGKQEKGS-DGAEKVIVAVKASKEIPKTALVWSLTHVVQPGDCITLLVVVPSQSTGRRL 65
Query: 68 WVFPRFAGDCASGHRKSFSGTIS-EQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGS 126
W FPRFAGDCA+G +KS SG+ S E + DITDSCSQMILQLHDVYDPNKIN KIKIVSGS
Sbjct: 66 WGFPRFAGDCANGQKKSTSGSSSSEHKSDITDSCSQMILQLHDVYDPNKINVKIKIVSGS 125
Query: 127 PCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKE 186
PCGAVAAEAKK+QA WVVLDKQLKHEEK CMEELQCNIVVMK SQ KVLRLNLVG KK+
Sbjct: 126 PCGAVAAEAKKSQANWVVLDKQLKHEEKQCMEELQCNIVVMKHSQPKVLRLNLVGTQKKD 185
Query: 187 AGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSVSSSD 246
CPL S+ E K K K S SI+GPVVTP SSPELGTPFT EAGTSSVSSSD
Sbjct: 186 FEELCPLLSEQIEMPGKQTKKKHDSLNSIKGPVVTPTSSPELGTPFTTIEAGTSSVSSSD 245
Query: 247 PGTSPFFISGING--DLKKESSVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTEFLR 304
GTSPFFIS +NG + KKE ++I E+ L+DS SDTDSENLS SSAS+RFQPW+T+ L
Sbjct: 246 QGTSPFFISEMNGGGESKKEETII-ENPELDDSISDTDSENLSTSSASLRFQPWITDLLL 304
Query: 305 SHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREA 364
HQ S Q +EE + R+ NK Q+ST +ALLEKFSRLDR+A + +S+Y+TD FSGNVREA
Sbjct: 305 --HQRSSQPKEERTERSYNKLQSSTARALLEKFSRLDREAEIELSTYKTDFNFSGNVREA 362
Query: 365 ISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHR 424
++LSRN PPGPPPLCSICQHKAPVFGKPP+WFSYAELELATGGFS+ANFLAEGGFGSVHR
Sbjct: 363 VALSRNTPPGPPPLCSICQHKAPVFGKPPKWFSYAELELATGGFSKANFLAEGGFGSVHR 422
Query: 425 GVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484
G+LPDGQ +AVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED+RRLLVYEYI
Sbjct: 423 GLLPDGQVIAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEDKRRLLVYEYI 482
Query: 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544
CN SLDSHLYG +EPLEW+ARQKIAVGAARGLRYLHEECRVGCI+HRDMRPNNIL+THD
Sbjct: 483 CNRSLDSHLYGRQREPLEWTARQKIAVGAARGLRYLHEECRVGCIIHRDMRPNNILITHD 542
Query: 545 FEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
FEPLVGDFGLARWQPDGD GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT
Sbjct: 543 FEPLVGDFGLARWQPDGDTGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 602
Query: 605 GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRD 664
GRKAVDLNRPKGQQCLTEWARPLLEEYAI+EL+DPRLG+HYSEHEVYCMLHAASLCIRRD
Sbjct: 603 GRKAVDLNRPKGQQCLTEWARPLLEEYAIEELIDPRLGSHYSEHEVYCMLHAASLCIRRD 662
Query: 665 PHSRPRMSQVLRILEGDTVID-TYMSTPGYDVGSRSG 700
P+SRPRMSQVLRILEGDTV+D Y+STP YDVG+R G
Sbjct: 663 PYSRPRMSQVLRILEGDTVMDPNYISTPSYDVGNRGG 699
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231330|ref|NP_187982.1| protein kinase protein with adenine nucleotide alpha hydrolases-like domain-containing protein [Arabidopsis thaliana] gi|9294015|dbj|BAB01918.1| unnamed protein product [Arabidopsis thaliana] gi|332641878|gb|AEE75399.1| protein kinase protein with adenine nucleotide alpha hydrolases-like domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1144 bits (2960), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 562/754 (74%), Positives = 637/754 (84%), Gaps = 17/754 (2%)
Query: 3 MSGEVKKGKQEKGS-SDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSH 61
MS K+GKQEK SD A+KV+VAVKAS+EIP+TAL+WALTHVVQPGDCITL+VVVPSH
Sbjct: 1 MSRLQKRGKQEKPVVSDGAQKVIVAVKASREIPKTALIWALTHVVQPGDCITLIVVVPSH 60
Query: 62 SSGRRFW----VFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKIN 117
+SGR+ W FP FAGDCASGHRKS S + E + D+TD+CSQMILQLHDVYDPNKIN
Sbjct: 61 NSGRKLWGFTKSFPMFAGDCASGHRKSHSEALPEIKSDLTDTCSQMILQLHDVYDPNKIN 120
Query: 118 FKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRL 177
KIKIVSGSPCGAVAAE+KKAQA WVV+DK LK EEK CM+ELQCNIVVMKRSQAKVLRL
Sbjct: 121 VKIKIVSGSPCGAVAAESKKAQANWVVMDKHLKQEEKRCMDELQCNIVVMKRSQAKVLRL 180
Query: 178 NLVGASKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEA 237
NLVG+ KK+AG CPLPS P+ + EK KN + RG VTP SSPELGTPFT+TEA
Sbjct: 181 NLVGSPKKDAGKECPLPSGPEAASEKHSKNTKGLLDADRGLPVTPTSSPELGTPFTSTEA 240
Query: 238 GTSSVSSSDPGTSPFFISGINGDLKKESS-VIREDRNLEDSSSDTDSENLSVSSASMRFQ 296
GTSSVSSSD GTSPFF G+NG +KK+ + VI+E+ L+DS S+T+SEN S++S SMRFQ
Sbjct: 241 GTSSVSSSDLGTSPFFTLGMNGYMKKDGALVIKENDGLDDSGSETESENQSLASTSMRFQ 300
Query: 297 PWMTEFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLE 356
PW++E++ +H SS + EE + +++ Q STTKALLEKFS+LD + G+ SS R DLE
Sbjct: 301 PWISEYIGTHRHSSQEAEESLLWKNDDRAQISTTKALLEKFSKLDVEVGLS-SSRRMDLE 359
Query: 357 FSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAE 416
FSGNVR+AISLSR+APPGPPPLCSICQHKAPVFGKPPR F+YAELELATGGFSQANFLAE
Sbjct: 360 FSGNVRDAISLSRSAPPGPPPLCSICQHKAPVFGKPPRLFTYAELELATGGFSQANFLAE 419
Query: 417 GGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476
GG+GSVHRGVLP+GQ VAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED R
Sbjct: 420 GGYGSVHRGVLPEGQVVAVKQHKLASSQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDSR 479
Query: 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536
RLLVYEYICNGSLDSHLYG +E LEW ARQKIAVGAARGLRYLHEECRVGCIVHRDMRP
Sbjct: 480 RLLVYEYICNGSLDSHLYGRQKETLEWPARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 539
Query: 537 NNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFG 596
NNIL+THD EPLVGDFGLARWQPDG+MGV+TRVIGTFGYLAPEYAQSGQITEKADVYSFG
Sbjct: 540 NNILITHDNEPLVGDFGLARWQPDGEMGVDTRVIGTFGYLAPEYAQSGQITEKADVYSFG 599
Query: 597 VVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHA 656
VVLVELVTGRKA+D+ RPKGQQCLTEWARPLLEEYAIDEL+DPRLGN + E EV CMLHA
Sbjct: 600 VVLVELVTGRKAIDITRPKGQQCLTEWARPLLEEYAIDELIDPRLGNRFVESEVICMLHA 659
Query: 657 ASLCIRRDPHSRPRMSQVLRILEGDTVID-TYMSTPGYDVGSRSGRIWVEQQQHQQQQLP 715
ASLCIRRDPH RPRMSQVLRILEGD ++D Y STPG + G+RSGR W +
Sbjct: 660 ASLCIRRDPHLRPRMSQVLRILEGDMIMDGNYASTPGSEAGNRSGRFWADH--------- 710
Query: 716 YSGPLMNEALEGFGRKLPLDSLKAAFWERDKARR 749
YSG L N+ + F +L +++ + A ER++++R
Sbjct: 711 YSGQLTNDGSDRFSERLSVETPRLALRERERSQR 744
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 756 | ||||||
| TAIR|locus:2091511 | 753 | AT3G13690 [Arabidopsis thalian | 0.974 | 0.978 | 0.698 | 1.5e-282 | |
| TAIR|locus:2165041 | 669 | AT5G56790 [Arabidopsis thalian | 0.876 | 0.991 | 0.583 | 5e-202 | |
| TAIR|locus:2035686 | 676 | AT1G55200 [Arabidopsis thalian | 0.657 | 0.735 | 0.672 | 2.1e-178 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.411 | 0.439 | 0.511 | 2.5e-83 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.395 | 0.439 | 0.516 | 8.3e-83 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.423 | 0.457 | 0.470 | 3.6e-82 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.383 | 0.380 | 0.522 | 4.5e-82 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.448 | 0.470 | 0.478 | 1.2e-81 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.387 | 0.449 | 0.516 | 5.8e-80 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.404 | 0.426 | 0.501 | 5.8e-80 |
| TAIR|locus:2091511 AT3G13690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2715 (960.8 bits), Expect = 1.5e-282, P = 1.5e-282
Identities = 527/754 (69%), Positives = 598/754 (79%)
Query: 3 MSGEVKKGKQEKGXXXXXXXXXXXXXXXXX-IPRTALVWALTHVVQPGDCITLLVVVPSH 61
MS K+GKQEK IP+TAL+WALTHVVQPGDCITL+VVVPSH
Sbjct: 1 MSRLQKRGKQEKPVVSDGAQKVIVAVKASREIPKTALIWALTHVVQPGDCITLIVVVPSH 60
Query: 62 SSGRRFW----VFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKIN 117
+SGR+ W FP FAGDCASGHRKS S + E + D+TD+CSQMILQLHDVYDPNKIN
Sbjct: 61 NSGRKLWGFTKSFPMFAGDCASGHRKSHSEALPEIKSDLTDTCSQMILQLHDVYDPNKIN 120
Query: 118 FKIKIVSGSPCGXXXXXXXXXXXGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRL 177
KIKIVSGSPCG WVV+DK LK EEK CM+ELQCNIVVMKRSQAKVLRL
Sbjct: 121 VKIKIVSGSPCGAVAAESKKAQANWVVMDKHLKQEEKRCMDELQCNIVVMKRSQAKVLRL 180
Query: 178 NLVGASKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEA 237
NLVG+ KK+AG CPLPS P+ + EK KN + RG VTP SSPELGTPFT+TEA
Sbjct: 181 NLVGSPKKDAGKECPLPSGPEAASEKHSKNTKGLLDADRGLPVTPTSSPELGTPFTSTEA 240
Query: 238 XXXXXXXXXXXXXXFFISGINGDLKKESS-VIREDRNLEDSSSDTDSENLSVSSASMRFQ 296
FF G+NG +KK+ + VI+E+ L+DS S+T+SEN S++S SMRFQ
Sbjct: 241 GTSSVSSSDLGTSPFFTLGMNGYMKKDGALVIKENDGLDDSGSETESENQSLASTSMRFQ 300
Query: 297 PWMTEFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLE 356
PW++E++ +H SS + EE + +++ Q STTKALLEKFS+LD + G+ SS R DLE
Sbjct: 301 PWISEYIGTHRHSSQEAEESLLWKNDDRAQISTTKALLEKFSKLDVEVGLS-SSRRMDLE 359
Query: 357 FSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAE 416
FSGNVR+AISLSR+APPGPPPLCSICQHKAPVFGKPPR F+YAELELATGGFSQANFLAE
Sbjct: 360 FSGNVRDAISLSRSAPPGPPPLCSICQHKAPVFGKPPRLFTYAELELATGGFSQANFLAE 419
Query: 417 GGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476
GG+GSVHRGVLP+GQ VAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED R
Sbjct: 420 GGYGSVHRGVLPEGQVVAVKQHKLASSQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDSR 479
Query: 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536
RLLVYEYICNGSLDSHLYG +E LEW ARQKIAVGAARGLRYLHEECRVGCIVHRDMRP
Sbjct: 480 RLLVYEYICNGSLDSHLYGRQKETLEWPARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 539
Query: 537 NNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFG 596
NNIL+THD EPLVGDFGLARWQPDG+MGV+TRVIGTFGYLAPEYAQSGQITEKADVYSFG
Sbjct: 540 NNILITHDNEPLVGDFGLARWQPDGEMGVDTRVIGTFGYLAPEYAQSGQITEKADVYSFG 599
Query: 597 VVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHA 656
VVLVELVTGRKA+D+ RPKGQQCLTEWARPLLEEYAIDEL+DPRLGN + E EV CMLHA
Sbjct: 600 VVLVELVTGRKAIDITRPKGQQCLTEWARPLLEEYAIDELIDPRLGNRFVESEVICMLHA 659
Query: 657 ASLCIRRDPHSRPRMSQVLRILEGDTVID-TYMSTPGYDVGSRSGRIWVEXXXXXXXXLP 715
ASLCIRRDPH RPRMSQVLRILEGD ++D Y STPG + G+RSGR W +
Sbjct: 660 ASLCIRRDPHLRPRMSQVLRILEGDMIMDGNYASTPGSEAGNRSGRFWADH--------- 710
Query: 716 YSGPLMNEALEGFGRKLPLDSLKAAFWERDKARR 749
YSG L N+ + F +L +++ + A ER++++R
Sbjct: 711 YSGQLTNDGSDRFSERLSVETPRLALRERERSQR 744
|
|
| TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1955 (693.3 bits), Expect = 5.0e-202, P = 5.0e-202
Identities = 397/680 (58%), Positives = 478/680 (70%)
Query: 8 KKGKQEKGXXXXXXXXXXXXXXXXXIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
+KG +E+G IP+ AL+W LTHVVQPGD I LLVVVPS+ + ++
Sbjct: 3 QKGFKERGVVVGKKVMVAVRASKE-IPKAALLWTLTHVVQPGDRIRLLVVVPSNYTSKKI 61
Query: 68 WVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSP 127
W F RF DCASG+ + +GT S+++ DI +SCSQM+ QLH+VYD KIN +IKIV S
Sbjct: 62 WGFSRFTSDCASGYGRFLAGTNSDRKDDIHESCSQMMFQLHNVYDAEKINVRIKIVFASL 121
Query: 128 CGXXXXXXXXXXXGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKEA 187
G WV+LD+ LK+E+KCC+E+L+CN+VV+K+SQ KVLRLNLV K A
Sbjct: 122 DGVIAAEAKKSNSNWVILDRGLKYEKKCCIEQLECNLVVIKKSQPKVLRLNLV----KNA 177
Query: 188 GVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAXXXXXXXXXX 247
P S + + + +R P VTP SSP+ + T+
Sbjct: 178 DTEHPEAISRLASKSVESRRSSRTGKKLREPFVTPASSPDQEVS-SHTDIGTSSISSSDA 236
Query: 248 XXXXFFISGINGDLKKESSVIRE-DRNLEDSSSDTDSENLS-VSSASMRFQPWMTEFLRS 305
F S + LKKE+ + + ++ +S SD+D E S +S AS P T L S
Sbjct: 237 GASPFLASRVFEGLKKENLWVNDGSKSFFESDSDSDGEKWSPLSMASSSSHPVTTADLLS 296
Query: 306 HHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAI 365
+ E R K++ + + L SR + +AG + + D + +VRE +
Sbjct: 297 PSGDLSKAHTETPR----KSRFAVLRLAL---SRKEPEAGKEIR--KPDSCLNKSVREVV 347
Query: 366 SLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRG 425
SLSR PGPPPLC+ICQHKAP FG PPRWF+Y+ELE AT GFS+ +FLAEGGFGSVH G
Sbjct: 348 SLSRKPAPGPPPLCTICQHKAPKFGNPPRWFTYSELETATKGFSKGSFLAEGGFGSVHLG 407
Query: 426 VLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485
LPDGQ +AVKQ+K+AS+QGD EFCSEVEVLSCAQHRNVVMLIG C+ED +RLLVYEYIC
Sbjct: 408 TLPDGQIIAVKQYKIASTQGDREFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEYIC 467
Query: 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545
NGSL SHLYG +EPL WSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF
Sbjct: 468 NGSLHSHLYGMGREPLGWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 527
Query: 546 EPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
EPLVGDFGLARWQP+GD GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVEL+TG
Sbjct: 528 EPLVGDFGLARWQPEGDKGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITG 587
Query: 606 RKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDP 665
RKA+D+ RPKGQQCLTEWARPLL++ AI+EL+DPRL N Y E EVYCM A LCIRRDP
Sbjct: 588 RKAMDIKRPKGQQCLTEWARPLLQKQAINELLDPRLMNCYCEQEVYCMALCAYLCIRRDP 647
Query: 666 HSRPRMSQVLRILEGDTVID 685
+SRPRMSQVLR+LEGD V++
Sbjct: 648 NSRPRMSQVLRMLEGDVVMN 667
|
|
| TAIR|locus:2035686 AT1G55200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1732 (614.8 bits), Expect = 2.1e-178, P = 2.1e-178
Identities = 347/516 (67%), Positives = 401/516 (77%)
Query: 175 LRLNLVGASKKEAGVACP--LPSDPDESFEKDPKNKDSSSGSIRGPVVT-PISSPELGTP 231
L+ N+V + EA V + S E KNK+ S++ V T P+SSPE+ T
Sbjct: 155 LQCNIVAMKRSEAKVLRLNLVGSSTKEPELASEKNKNRLLDSVKAVVTTTPMSSPEVETS 214
Query: 232 FTATEAXXXXXXXXXXXXXX-FFISGINGDLKKESSVIREDRNLEDSSSDTDSENLSVSS 290
FT TEA F + + D E+ V++E+ +S SD++SENLS+ S
Sbjct: 215 FTGTEAWTSSVSSSDLGTSSPVFTAEVRKD---ETLVVKEN----ESDSDSESENLSLPS 267
Query: 291 ASMRFQPWMTEFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSS 350
S RFQPW++E+L +H S +E +R + Q ST KALLEK S+LD MSS
Sbjct: 268 LSKRFQPWISEYLSTHCVSM----QESTRGDDKAVQVSTKKALLEKISKLDEGEEAAMSS 323
Query: 351 YRTDLE-FSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFS 409
R DLE +SG +R +LSRNAPP PPLCSICQHKAPVFGKPPR+FSY ELELAT GFS
Sbjct: 324 KRKDLEEYSGTLR---ALSRNAPPVSPPLCSICQHKAPVFGKPPRFFSYKELELATNGFS 380
Query: 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ANFLAEGGFGSVHRGVLP+GQ VAVKQHK+AS+QGD EFCSEVEVLSCAQHRNVVMLIG
Sbjct: 381 RANFLAEGGFGSVHRGVLPEGQIVAVKQHKVASTQGDVEFCSEVEVLSCAQHRNVVMLIG 440
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
FCIED RRLLVYEYICNGSLDSHLYG H++ L W ARQKIAVGAARGLRYLHEECRVGCI
Sbjct: 441 FCIEDTRRLLVYEYICNGSLDSHLYGRHKDTLGWPARQKIAVGAARGLRYLHEECRVGCI 500
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEK 589
VHRDMRPNNIL+THD+EPLVGDFGLARWQPDG++GV+TRVIGTFGYLAPEYAQSGQITEK
Sbjct: 501 VHRDMRPNNILITHDYEPLVGDFGLARWQPDGELGVDTRVIGTFGYLAPEYAQSGQITEK 560
Query: 590 ADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649
ADVYSFGVVL+EL+TGRKA+D+ RPKGQQCLTEWAR LLEEYA++ELVDPRL YSE +
Sbjct: 561 ADVYSFGVVLIELITGRKAMDIYRPKGQQCLTEWARSLLEEYAVEELVDPRLEKRYSETQ 620
Query: 650 VYCMLHAASLCIRRDPHSRPRMSQVLRILEGDTVID 685
V CM+H ASLCIRRDPH RPRMSQVLR+LEGD +++
Sbjct: 621 VICMIHTASLCIRRDPHLRPRMSQVLRLLEGDMLMN 656
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 813 (291.2 bits), Expect = 2.5e-83, Sum P(2) = 2.5e-83
Identities = 162/317 (51%), Positives = 211/317 (66%)
Query: 367 LSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV 426
+ +AP G Q ++ G FSY EL AT GFSQ N L EGGFG V++G+
Sbjct: 336 MQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGI 395
Query: 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486
LPDG+ VAVKQ K+ QGD EF +EVE LS HR++V ++G CI RRLL+Y+Y+ N
Sbjct: 396 LPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSN 455
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
L HL+G + L+W+ R KIA GAARGL YLHE+C I+HRD++ +NILL +F+
Sbjct: 456 NDLYFHLHG-EKSVLDWATRVKIAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLEDNFD 513
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
V DFGLAR D + + TRVIGTFGY+APEYA SG++TEK+DV+SFGVVL+EL+TGR
Sbjct: 514 ARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 573
Query: 607 KAVDLNRPKGQQCLTEWARPLL----EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIR 662
K VD ++P G + L EWARPL+ E D L DP+LG +Y E E++ M+ AA C+R
Sbjct: 574 KPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVR 633
Query: 663 RDPHSRPRMSQVLRILE 679
RPRM Q++R E
Sbjct: 634 HLATKRPRMGQIVRAFE 650
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 808 (289.5 bits), Expect = 8.3e-83, Sum P(2) = 8.3e-83
Identities = 159/308 (51%), Positives = 215/308 (69%)
Query: 395 WFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVE 454
WFSY EL T GFS+ N L EGGFG V++GVL DG+ VAVKQ K+ SQG+ EF +EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 455 VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA 514
++S HR++V L+G+CI ++ RLLVY+Y+ N +L HL+ + + W R ++A GAA
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAA 445
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETRVIGT 572
RG+ YLHE+C I+HRD++ +NILL + FE LV DFGLA+ + D+ V TRV+GT
Sbjct: 446 RGIAYLHEDCHPR-IIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGT 504
Query: 573 FGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL---- 628
FGY+APEYA SG+++EKADVYS+GV+L+EL+TGRK VD ++P G + L EWARPLL
Sbjct: 505 FGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAI 564
Query: 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDTVIDTYM 688
E DELVDPRLG ++ E++ M+ AA+ C+R RP+MSQV+R L DT+ +
Sbjct: 565 ENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL--DTLEEATD 622
Query: 689 STPGYDVG 696
T G G
Sbjct: 623 ITNGMRPG 630
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 3.6e-82, Sum P(3) = 3.6e-82
Identities = 157/334 (47%), Positives = 218/334 (65%)
Query: 358 SGNVREAISLSRNAPPGP--PPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLA 415
+GN + S + + P GP PP H + G F+Y EL AT GFSQ+ L
Sbjct: 291 NGNSSD-FSSNYSGPHGPSVPP-----PHPSVALGFNKSTFTYDELAAATQGFSQSRLLG 344
Query: 416 EGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475
+GGFG VH+G+LP+G+ +AVK K S QG+ EF +EV+++S HR +V L+G+CI
Sbjct: 345 QGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVDIISRVHHRFLVSLVGYCIAGG 404
Query: 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMR 535
+R+LVYE++ N +L+ HL+G + L+W R KIA+G+A+GL YLHE+C I+HRD++
Sbjct: 405 QRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIALGSAKGLAYLHEDCHPR-IIHRDIK 463
Query: 536 PNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSF 595
+NILL FE V DFGLA+ D V TR++GTFGYLAPEYA SG++T+++DV+SF
Sbjct: 464 ASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGTFGYLAPEYASSGKLTDRSDVFSF 523
Query: 596 GVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID----ELVDPRLGNHYSEHEVY 651
GV+L+ELVTGR+ VDL + L +WARP+ A D ELVDPRL N Y HE+
Sbjct: 524 GVMLLELVTGRRPVDLTGEM-EDSLVDWARPICLNAAQDGDYSELVDPRLENQYEPHEMA 582
Query: 652 CMLHAASLCIRRDPHSRPRMSQVLRILEGDTVID 685
M+ A+ +R RP+MSQ++R LEGD +D
Sbjct: 583 QMVACAAAAVRHSARRRPKMSQIVRALEGDATLD 616
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 4.5e-82, Sum P(2) = 4.5e-82
Identities = 154/295 (52%), Positives = 206/295 (69%)
Query: 389 FGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE 448
FG+ FSY EL +AT GFS N L EGGFG V++GVLPD + VAVKQ K+ QGD E
Sbjct: 411 FGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDRE 470
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK 508
F +EV+ +S HRN++ ++G+CI + RRLL+Y+Y+ N +L HL+ L+W+ R K
Sbjct: 471 FKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVK 530
Query: 509 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
IA GAARGL YLHE+C I+HRD++ +NILL ++F LV DFGLA+ D + + TR
Sbjct: 531 IAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHITTR 589
Query: 569 VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL 628
V+GTFGY+APEYA SG++TEK+DV+SFGVVL+EL+TGRK VD ++P G + L EWARPLL
Sbjct: 590 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 649
Query: 629 EEYAIDE----LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
E L DP+LG +Y E++ M+ AA+ CIR RPRMSQ++R +
Sbjct: 650 SNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFD 704
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-81, Sum P(2) = 1.2e-81
Identities = 167/349 (47%), Positives = 225/349 (64%)
Query: 342 RDAGVGMSSYRTDLEFSGNVREAISLSRN---APPGPP--PLCSICQHKAPVFGKPPRWF 396
+D G G SS ++ + ++ S+ + A G P + S + + G F
Sbjct: 300 QDPGKGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHF 359
Query: 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVL 456
SY EL T GF++ N L EGGFG V++G L DG+ VAVKQ K S QGD EF +EVE++
Sbjct: 360 SYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEII 419
Query: 457 SCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARG 516
S HR++V L+G+CI D+ RLL+YEY+ N +L+ HL+G LEWS R +IA+G+A+G
Sbjct: 420 SRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKG 479
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL 576
L YLHE+C I+HRD++ NILL ++E V DFGLAR V TRV+GTFGYL
Sbjct: 480 LAYLHEDCHPK-IIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYL 538
Query: 577 APEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL----EEYA 632
APEYA SG++T+++DV+SFGVVL+ELVTGRK VD +P G++ L EWARPLL E
Sbjct: 539 APEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGD 598
Query: 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681
+ EL+D RL Y EHEV+ M+ A+ C+R RPRM QV+R L+ D
Sbjct: 599 LSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCD 647
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 784 (281.0 bits), Expect = 5.8e-80, Sum P(2) = 5.8e-80
Identities = 154/298 (51%), Positives = 206/298 (69%)
Query: 388 VFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH 447
V G F+Y EL AT GFS+AN L +GGFG VH+G+LP G+ VAVKQ K S QG+
Sbjct: 260 VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGER 319
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
EF +EVE++S HR++V LIG+C+ +RLLVYE++ N +L+ HL+G + +EWS R
Sbjct: 320 EFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRL 379
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
KIA+G+A+GL YLHE+C I+HRD++ +NIL+ FE V DFGLA+ D + V T
Sbjct: 380 KIALGSAKGLSYLHEDCNPK-IIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVST 438
Query: 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627
RV+GTFGYLAPEYA SG++TEK+DV+SFGVVL+EL+TGR+ VD N L +WARPL
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 498
Query: 628 L----EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681
L EE + L D ++GN Y E+ M+ A+ C+R RPRMSQ++R LEG+
Sbjct: 499 LNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGN 556
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 5.8e-80, Sum P(2) = 5.8e-80
Identities = 157/313 (50%), Positives = 213/313 (68%)
Query: 388 VFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH 447
V G F+Y EL T GF ++ + EGGFG V++G+L +G+ VA+KQ K S++G
Sbjct: 350 VIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYR 409
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
EF +EVE++S HR++V L+G+CI ++ R L+YE++ N +LD HL+G + LEWS R
Sbjct: 410 EFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRV 469
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
+IA+GAA+GL YLHE+C I+HRD++ +NILL +FE V DFGLAR + T
Sbjct: 470 RIAIGAAKGLAYLHEDCHPK-IIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIST 528
Query: 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627
RV+GTFGYLAPEYA SG++T+++DV+SFGVVL+EL+TGRK VD ++P G++ L EWARP
Sbjct: 529 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPR 588
Query: 628 L----EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDTV 683
L E+ I E+VDPRL N Y E EVY M+ A+ C+R RPRM QV+R L DT
Sbjct: 589 LIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL--DTR 646
Query: 684 IDTYMSTPGYDVG 696
D T G VG
Sbjct: 647 DDLSDLTNGVKVG 659
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 756 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 6e-44
Identities = 81/271 (29%), Positives = 121/271 (44%), Gaps = 25/271 (9%)
Query: 414 LAEGGFGSVHRGVL-----PDGQAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V++G L VAVK K AS Q EF E ++ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C E+ ++V EY+ G L +L + L S A+ ARG+ YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---- 122
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT 587
+HRD+ N L+ + + DFGL+R D D ++APE + G+ T
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 588 EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647
K+DV+SFGV+L E+ T G++ + + EY P+
Sbjct: 183 SKSDVWSFGVLLWEIFTL----------GEEPYPGMSNAEVLEYLKKGYRLPKP--PNCP 230
Query: 648 HEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678
E+Y ++ C DP RP S+++ IL
Sbjct: 231 PELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 82/280 (29%), Positives = 121/280 (43%), Gaps = 44/280 (15%)
Query: 414 LAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVML 467
L EG FG V++G L VAVK K +S+ EF E ++ H NVV L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C E+ +V EY+ G L S+L ++ L S A+ ARG+ YL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESK---- 121
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT 587
+HRD+ N L+ + + DFGL+R D D + ++APE + G+ T
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 588 EKADVYSFGVVLVELVTGRKAVDLNRPKGQQ----CLTEWARPLLEEYAIDELVDPRLGN 643
K+DV+SFGV+L E+ T G+Q E L+ G
Sbjct: 182 SKSDVWSFGVLLWEIFTL----------GEQPYPGMSNEEVLEYLKN-----------GY 220
Query: 644 -----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678
E+Y ++ C DP RP S+++ IL
Sbjct: 221 RLPQPPNCPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 69/193 (35%), Positives = 98/193 (50%), Gaps = 10/193 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
L EGGFG+V+ G+ VA+K K SS E E+E+L H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
++ LV EY GSL L ++ L +I + GL YLH I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN----GIIH 115
Query: 532 RDMRPNNILLTHD-FEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE-YAQSGQITEK 589
RD++P NILL D + + DFGL++ D + ++GT Y+APE G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSK-LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 590 ADVYSFGVVLVEL 602
+D++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 87/292 (29%), Positives = 125/292 (42%), Gaps = 58/292 (19%)
Query: 414 LAEGGFGSVHRGVLPDGQ----AVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLI 468
L EG FG V++G L VAVK K +S+ + +F E V+ H NVV L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGC-HQEPLEWSAR------QKIAVGAARGLRYLH 521
G C E+ LV EY+ G L +L P + A+ A+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET-------RVIGTFG 574
+ VHRD+ N L+ D + DFGL+R D D + R
Sbjct: 123 SK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR------ 172
Query: 575 YLAPEYAQSGQITEKADVYSFGVVLVELVT-------GRKAVDLNRPKGQQCLTEWARPL 627
++APE + G T K+DV+SFGV+L E+ T G ++ + L + R
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-----LEYLRKGYRLP 227
Query: 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
EY DEL +E+ ML C + DP RP S+++ LE
Sbjct: 228 KPEYCPDEL-----------YEL--MLS----CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 75/269 (27%), Positives = 113/269 (42%), Gaps = 27/269 (10%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIG 469
L EG FG V+ G+ VA+K K + D E E+++L +H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
++ + LV EY G L L + + + + L YLH + I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLHSKG----I 118
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
VHRD++P NILL D + DFGLAR P + T +GT Y+APE +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGKGYGK 175
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRP-KGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647
D++S GV+L EL+TG+ P G L E + + + P S
Sbjct: 176 AVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKPK----PPFPPPEWDISP 225
Query: 648 HEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
E ++ + +DP R + L+
Sbjct: 226 -EAKDLI---RKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 85/276 (30%), Positives = 121/276 (43%), Gaps = 35/276 (12%)
Query: 414 LAEGGFGSVHRGVL-----PDGQAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V++G L VAVK K AS + EF E ++ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C + +V EY+ G L L H E L ++A+ A+G+ YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESK---- 121
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL-----APEYAQ 582
VHRD+ N L+T + + DFGL+R D R G G L APE +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSR---DIYEDDYYRKRGG-GKLPIKWMAPESLK 177
Query: 583 SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642
G+ T K+DV+SFGV+L E+ T G+Q + + E D PR
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL----------GEQPYPGMSNEEVLELLEDGYRLPR-- 225
Query: 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678
E+Y ++ C DP RP S+++ L
Sbjct: 226 PENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 85/271 (31%), Positives = 121/271 (44%), Gaps = 31/271 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
L G FG+V++ G+ VAVK + S+ D E+ +L H N+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 471 CIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ LV EY G L +L G PL +KIA+ RGL YLH G
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G- 118
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ-IT 587
I+HRD++P NILL + + DFGLA+ + T V GT Y+APE G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 588 EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647
K DV+S GV+L EL+TG+ P + + + + I ++ P L +
Sbjct: 178 PKVDVWSLGVILYELLTGKP------PFSGENILD------QLQLIRRILGPPLEFDEPK 225
Query: 648 HEVYCMLHAASL---CIRRDPHSRPRMSQVL 675
A L C+ +DP RP ++L
Sbjct: 226 -WSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 83/279 (29%), Positives = 124/279 (44%), Gaps = 42/279 (15%)
Query: 412 NFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLI 468
L G FGSV+ + D G+ +AVK +L+ + E+ +LS QH N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 469 GFCI-EDRRRLLVY-EYICNGSLDSHL--YGCHQEPLEWS-ARQKIAVGAARGLRYLHEE 523
G E++ L ++ EY+ GSL S L +G EP+ RQ + GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-----EGLAYLHSN 120
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-VIGTFGYLAPEYAQ 582
IVHRD++ NIL+ D + DFG A+ D + G T V GT ++APE +
Sbjct: 121 G----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 583 SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR-----PLLEEYAIDELV 637
+ AD++S G ++E+ TG+ P W+ L +
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK------PP--------WSELGNPMAALYKIGSSGEP 222
Query: 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
P + H SE C+RRDP RP ++L+
Sbjct: 223 -PEIPEHLSEE----AKDFLRKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 26/269 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLA-SSQGDHEFC-SEVEVLSCAQHRNVVMLIGF 470
+ +G FG V+ DG+ +K+ L+ S+ + E +EV++L H N++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 471 CIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
E + +V EY G L + +P V L+YLH +
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-K--- 123
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
I+HRD++P NI LT + +GDFG+++ + + V+GT YL+PE Q+
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYYLSPELCQNKPYNY 182
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEH 648
K+D++S G VL EL T + + L I + P + + YS
Sbjct: 183 KSDIWSLGCVLYELCTLKHPFEGENLLE----------LA--LKILKGQYPPIPSQYSS- 229
Query: 649 EVYCMLHAASLCIRRDPHSRPRMSQVLRI 677
E+ ++ S +++DP RP ++Q+L+
Sbjct: 230 ELRNLV---SSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 408 FSQANFLAEGGFGSVHRG-VLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
F + +GGFG V++ G+ VA+K KL S + + +E+++L +H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
G ++ +V E+ GSL L +Q L S + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ-TLTESQIAYVCKELLKGLEYLHSNG-- 118
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM---GVETRVIGTFGYLAPEYAQS 583
I+HRD++ NILLT D E + DFGL+ + ++GT ++APE
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLS-----AQLSDTKARNTMVGTPYWMAPEVING 171
Query: 584 GQITEKADVYSFGVVLVELVTGR 606
KAD++S G+ +EL G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 9e-29
Identities = 73/232 (31%), Positives = 118/232 (50%), Gaps = 17/232 (7%)
Query: 451 SEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
SE+ + QH N+V LIG C ++ L++EYI +L L L W R+KIA
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIA 786
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI 570
+G A+ LR+LH C +V ++ P I++ EP + R G + +T+
Sbjct: 787 IGIAKALRFLHCRCSPAVVVG-NLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCF 839
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630
+ Y+APE ++ ITEK+D+Y FG++L+EL+TG+ D + EWAR +
Sbjct: 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSD 898
Query: 631 YAIDELVDPRLGNHYSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLRILE 679
+D +DP + S ++ ++ +L C DP +RP + VL+ LE
Sbjct: 899 CHLDMWIDPSIRGDVSVNQNE-IVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (290), Expect = 6e-28
Identities = 84/281 (29%), Positives = 119/281 (42%), Gaps = 32/281 (11%)
Query: 413 FLAEGGFGSVHRGVLPDGQAVAVKQ--HKLASSQGDHE-FCSEVEVL-SCAQHRNVVMLI 468
L EG FG V+ D + VA+K KL S + E F E+++L S N+V L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQE-PLEWSARQKIAVGAARGLRYLHEECRVG 527
F ++ LV EY+ GSL+ L ++ PL S I L YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 528 CIVHRDMRPNNILLTHD-FEPLVGDFGLARWQPDGDMGVETR-----VIGTFGYLAPEYA 581
I+HRD++P NILL D + DFGLA+ PD +GT GY+APE
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 582 QS---GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638
+ +D++S G+ L EL+TG + + T I EL
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT--------LKIILELPT 232
Query: 639 PRLGNHYSEHEVYCMLHAA----SLCIRRDPHSRPRMSQVL 675
P L + S + AA + +DP +R S L
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 40/270 (14%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLAS-SQGDHEFC-SEVEVLSCAQHRNVVMLIGFCIE 473
G FG V++G+ L G VA+KQ L + + E+++L +H N+V IG IE
Sbjct: 11 GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS-IE 69
Query: 474 DRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAA---RGLRYLHEECRVG 527
L ++ EY NGSL + +G E L +AV +GL YLHE+
Sbjct: 70 TSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAYLHEQG--- 119
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT 587
++HRD++ NIL T D + DFG+A + + + V+GT ++APE + +
Sbjct: 120 -VIHRDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 588 EKADVYSFGVVLVELVTGRKAV-DLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646
+D++S G ++EL+TG DLN P+ + I + P L S
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLN-------------PMAALFRIVQDDHPPLPEGIS 224
Query: 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ C ++DP+ RP Q+L+
Sbjct: 225 PE----LKDFLMQCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 83/288 (28%), Positives = 122/288 (42%), Gaps = 40/288 (13%)
Query: 414 LAEGGFGSV---HRGVLPDGQA--VAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVM 466
L EG FG V L D VAVK S + H +F E+E+L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 467 LIGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
G C + R L+ EY+ +GSL +L H++ + + +G+ YL +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQ- 128
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD---MGVETRVIGTFGYLAPEYA 581
I HRD+ NIL+ + + DFGLA+ P+ E F Y APE
Sbjct: 129 --RYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 582 QSGQITEKADVYSFGVVLVELVT-GRK--------AVDLNRPKGQQCLTEWARPLLEEYA 632
++ + + +DV+SFGV L EL T G + +GQ +T LL+E
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LLKE-- 241
Query: 633 IDELVDPRLGNHYS-EHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
RL S EVY LC +P RP + ++ I++
Sbjct: 242 -----GERLPRPPSCPDEVY---DLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 74/270 (27%), Positives = 120/270 (44%), Gaps = 28/270 (10%)
Query: 413 FLAEGGFGSVHRGVL-PDGQAVAVK-QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
L +G G V++ P G+ A+K H + + E++ L + VV G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 471 CIEDRRRLLVYEYICNGSLDSHLY--GCHQEP-LEWSARQKIAVGAARGLRYLHEECRVG 527
++ +V EY+ GSL L G EP L + ARQ +GL YLH +
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQ-----ILKGLDYLHTKRH-- 120
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT 587
I+HRD++P+N+L+ E + DFG+++ + T V GT Y++PE Q +
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178
Query: 588 EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL-GNHYS 646
AD++S G+ L+E G+ P GQ E L++ P L +S
Sbjct: 179 YAADIWSLGLTLLECALGKFPFL---PPGQPSFFE----LMQAICDGPP--PSLPAEEFS 229
Query: 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
S C+++DP RP +++L+
Sbjct: 230 PE----FRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 80/288 (27%), Positives = 133/288 (46%), Gaps = 47/288 (16%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQ------HKLASSQGDHEFCSEVEVLSCAQH 461
+++ L +G +G+V+ G+ GQ +AVKQ + LA+ + + EV++L +H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRY 519
N+V +G C++D + E++ GS+ S L +G EP+ ++I G A Y
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----Y 117
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR---WQPDGDMGVETRVI----GT 572
LH C+VHRD++ NN++L + + DFG AR W G G + ++ GT
Sbjct: 118 LHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV--GLHGTHSNMLKSMHGT 171
Query: 573 FGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR--PLLEE 630
++APE K+D++S G + E+ TG+ A L
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP--------------LASMDRLAAM 217
Query: 631 YAIDELVD--PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ I PRL + +S + + C+ RD H RP Q+LR
Sbjct: 218 FYIGAHRGLMPRLPDSFSAAAI----DFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 74/272 (27%), Positives = 115/272 (42%), Gaps = 24/272 (8%)
Query: 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS-SQGDHEFC-SEVEVLSCAQHRNV 464
F N + +G FG V + V D + A+KQ L+ ++ + E E VL+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
+ ++ + +V EY NG L L PL + + GL +LH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
I+HRD++ N+ L +GD G+A+ D T ++GT YL+PE +
Sbjct: 122 ----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDK 176
Query: 585 QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644
EK+DV++ GVVL E TG+ D N Q L I V P +
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALIL---------KIIRGVFPPVSQM 224
Query: 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
YS+ + C+ +D RP Q+LR
Sbjct: 225 YSQQ----LAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 73/284 (25%), Positives = 120/284 (42%), Gaps = 46/284 (16%)
Query: 410 QANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQHRNVVM 466
+ N + G FG V+ V L G+ +AVK+ ++ + E E++VL +H N+V
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
G + + + EY G+L+ L + + GL YLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEH--VIRVYTLQLLEGLAYLHSHG-- 119
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVET--RVIGTFGYLAPEYAQS 583
IVHRD++P NI L H+ +GDFG A + + + E + GT Y+APE
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 584 GQITEK---ADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA---------RPLLEEY 631
G+ AD++S G V++E+ TG+ RP + E+ +P + +
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGK------RP-WSELDNEFQIMFHVGAGHKPPIPD- 229
Query: 632 AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVL 675
+L G + + C+ DP RP S++L
Sbjct: 230 -SLQLSP--EGKDFLDR-----------CLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 75/269 (27%), Positives = 120/269 (44%), Gaps = 29/269 (10%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLI 468
L G G V HR P G+ +AVK +L + E+++L +V
Sbjct: 9 LGAGNSGVVSKVLHR---PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G + + EY+ GSLD + Q + KIAV +GL YLHE+ +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--- 121
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
I+HRD++P+NIL+ + + DFG++ + + +GT Y+APE Q +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMAPERIQGNDYSV 178
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL-LEEYAIDELVDPRLGNH-YS 646
K+D++S G+ L+EL TGR L +Y ++E PRL + +S
Sbjct: 179 KSDIWSLGLSLIELATGRFPYP-------PENDPPDGIFELLQYIVNE-PPPRLPSGKFS 230
Query: 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVL 675
+LC+ +DP RP ++L
Sbjct: 231 PD----FQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 61/194 (31%), Positives = 99/194 (51%), Gaps = 15/194 (7%)
Query: 416 EGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475
+G FG V G GQ VAVK K S+ F +E V++ +H N+V L+G ++
Sbjct: 16 KGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQGN 73
Query: 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMR 535
+V EY+ GSL +L + + + + A+ G+ YL E+ VHRD+
Sbjct: 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLA 129
Query: 536 PNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSGQITEKADVY 593
N+L++ D V DFGLA+ + G ++ G + APE + + + K+DV+
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWTAPEALREKKFSTKSDVW 183
Query: 594 SFGVVLVELVT-GR 606
SFG++L E+ + GR
Sbjct: 184 SFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 9/195 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G FG V++GVL VAVK + F E E+L H N+V LIG C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ + +V E + GSL + L L ++++ AA G+ YL + CI HR
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CI-HR 117
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE--TRVIGTFGYLAPEYAQSGQITEKA 590
D+ N L+ + + DFG++R + G V + I + APE G+ T ++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIKWTAPEALNYGRYTSES 176
Query: 591 DVYSFGVVLVELVTG 605
DV+S+G++L E +
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 77/281 (27%), Positives = 124/281 (44%), Gaps = 44/281 (15%)
Query: 414 LAEGGFGSVHRGVL--PDGQ--AVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLI 468
+ G FG V RG L P + VA+K K SS +F +E ++ H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G + R +++ EY+ NGSLD L + + G A G++YL E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN---- 126
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG------YLAPEYAQ 582
VHRD+ NIL+ + V DFGL+R D + T+ G + APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWTAPEAIA 181
Query: 583 SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP-RL 641
+ T +DV+SFG+V+ E+++ G++ + + + I + D RL
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS----------YGERPYWDMS----NQDVIKAVEDGYRL 227
Query: 642 GNHYSEHEVYC--MLHAASL-CIRRDPHSRPRMSQVLRILE 679
+ C L+ L C ++D + RP SQ++ L+
Sbjct: 228 -----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 5/197 (2%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
F+ L G FG V G+ + VA+K K +F EV+ L +H++++ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
C ++ E + GSL + L + L ++ +A A G+ YL E+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---- 123
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT 587
+HRD+ NIL+ D V DFGLAR + + I + + APE A G +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-PYKWTAPEAASHGTFS 182
Query: 588 EKADVYSFGVVLVELVT 604
K+DV+SFG++L E+ T
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 88/291 (30%), Positives = 132/291 (45%), Gaps = 49/291 (16%)
Query: 414 LAEGGFGSVHRG----VLPDGQA--VAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVM 466
L EG FG V G + P+ VAVK K +S + F E E+L+ QH N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 467 LIGFCIEDRRRLLVYEYICNGSLD----SH------LYGCHQEPLEWSARQ--KIAVGAA 514
G C E ++V+EY+ +G L+ SH L E + Q +IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT-- 572
G+ YL + VHRD+ N L+ +D +GDFG++R D RV G
Sbjct: 133 SGMVYLASQ----HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY---YRVGGHTM 185
Query: 573 --FGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKA-VDLNRPKGQQCLTEWARPLL 628
++ PE + T ++DV+SFGVVL E+ T G++ L+ + +C+T+ LL
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ--GRLL 243
Query: 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+ PR EVY ++ C +RDP R + + L+
Sbjct: 244 QR--------PRT----CPSEVYDIMLG---CWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 63/200 (31%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 417 GGFGSV----HRGVLPDGQAVAVKQ-HK---LASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
G FG V + G+ A+K K + + +H +E +LS H +V L
Sbjct: 4 GSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ + +L LV EY G L SHL + E + A L YLH +G
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLH---SLG 113
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-VIGTFGYLAPEYAQSGQI 586
I++RD++P NILL D + DFGLA+ G T GT YLAPE
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 587 TEKADVYSFGVVLVELVTGR 606
+ D +S GV+L E++TG+
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 30/275 (10%)
Query: 407 GFSQANFLAEGGFGSVHR-GVLPDGQAVAVKQHKLAS-SQGD-HEFCSEVEVLSCAQHRN 463
F L +G +GSV++ L D Q A+K+ L S SQ + + +E+ +L+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQE--PLEWSARQKIAVGAARGLRYLH 521
++ ++ + +V EY G L + ++ + +I + RGL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA 581
E+ I+HRD++ NILL + +GD G+++ + IGT Y+APE
Sbjct: 121 EQK----ILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVW 173
Query: 582 QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE-EYAIDELVDPR 640
+ + K+D++S G +L E+ T + AR + + Y + P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSMQDLRYKVQRGKYPP 220
Query: 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVL 675
+ YS+ + + ++ P RP ++L
Sbjct: 221 IPPIYSQD----LQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVML 467
L G FG+V++GV +P+G+ VA+K + +S + + E E V++ H +VV L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C+ + L+ + + G L ++ H++ + V A+G+ YL EE R
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYL-EEKR-- 129
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG-----YLAPEYAQ 582
+VHRD+ N+L+ + DFGLA+ E G ++A E
Sbjct: 130 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD----EKEYHAEGGKVPIKWMALESIL 184
Query: 583 SGQITEKADVYSFGVVLVELVT-GRK 607
T K+DV+S+GV + EL+T G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-20
Identities = 82/280 (29%), Positives = 122/280 (43%), Gaps = 49/280 (17%)
Query: 414 LAEGGFGSVH----RGVLPDGQA--VAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V +LP+ VAVK K AS +F E E+L+ QH+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 468 IGFCIEDRRRLLVYEYICNGSL---------DSHLYGCHQE----PLEWSARQKIAVGAA 514
G C E R L+V+EY+ +G L D+ + ++ L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 515 RGLRY---LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD-MGVETRVI 570
G+ Y LH VHRD+ N L+ +GDFG++R D V R +
Sbjct: 133 SGMVYLASLH-------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKA--VDLNRPKGQQCLTEWARPLL 628
++ PE + T ++D++SFGVVL E+ T K L+ + +C+T+
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR---- 241
Query: 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSR 668
EL PR EVY ++ C +R+P R
Sbjct: 242 ------ELERPRT----CPPEVYAIMQG---CWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 78/279 (27%), Positives = 117/279 (41%), Gaps = 46/279 (16%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS-----EVEVLSCAQHRNVVM 466
L G FGSV+ G+ L DG AVK+ LA + E+ +LS QH N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPL-EWSARQKIAVGAARGLRYLHEE 523
+G E+ + E + GSL L YG EP+ RQ + GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEY-AQ 582
VHRD++ NIL+ + + DFG+A+ + G+ ++APE AQ
Sbjct: 122 N----TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA--KSFKGSPYWMAPEVIAQ 175
Query: 583 SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642
G AD++S G ++E+ TG+ P Q E A ++G
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKP------PWSQL----------EGVA----AVFKIG 215
Query: 643 NHYSEHEVYCMLHAA-----SLCIRRDPHSRPRMSQVLR 676
+ L C++RDP RP +++L
Sbjct: 216 RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 76/288 (26%), Positives = 122/288 (42%), Gaps = 42/288 (14%)
Query: 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQHRN 463
+ + L EG GSV + L + + + D + E+E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 464 VVMLIGFCIEDRRRLL--VYEYICNGSLDSHLYGCHQEPLEWSARQ------KIAVGAAR 515
+V G +++ + EY GSLDS +Y + + R KIA +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYK---KVKKRGGRIGEKVLGKIAESVLK 116
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETRVIGTF 573
GL YLH I+HRD++P+NILLT + + DFG++ G++ + GT
Sbjct: 117 GLSYLHSRK----IIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTS 167
Query: 574 GYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL-LEEYA 632
Y+APE Q + +DV+S G+ L+E+ R P+G+ L P+ L Y
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG----PIELLSYI 220
Query: 633 ID----ELVD-PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVL 675
++ EL D P G +SE C+ +DP RP +L
Sbjct: 221 VNMPNPELKDEPGNGIKWSEE----FKDFIKQCLEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 70/275 (25%), Positives = 114/275 (41%), Gaps = 44/275 (16%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVML 467
L +G FG L D V K+ L S + + +E+ +LS QH N++
Sbjct: 8 LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAV--GAARGLRYLHEE 523
++D L+ EY NG LY Q+ + + + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEY-ANGG---TLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
I+HRD++ NI LT +GDFG+++ ET V+GT Y++PE Q
Sbjct: 121 G----ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQG 175
Query: 584 GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL-G 642
+ K+D+++ G VL EL+T ++ D P LV + G
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------------------NLVVKIVQG 216
Query: 643 NHYSEHEVYC--MLHAASLCIRRDPHSRPRMSQVL 675
N+ VY ++ +++DP RP +VL
Sbjct: 217 NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 414 LAEGGFGSVHRGVLPDGQA--VAVKQ---HKLASSQGDHE-------FCSEVEVLSCA-Q 460
L G FG V++ + +A+K+ H A + E SEV ++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLR 518
H N+V +E+ R +V + I L H ++ ++ + I V LR
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGTFGYLA 577
YLH+E R IVHRD+ PNNI+L D + + DFGLA+ QP+ + T V+GT Y
Sbjct: 128 YLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSC 181
Query: 578 PEYAQSGQITEKADVYSFGVVLVELVT 604
PE ++ EKADV++FG +L ++ T
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 73/268 (27%), Positives = 112/268 (41%), Gaps = 27/268 (10%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG VH G VA+K + + D +F E +V+ H N+V L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
R +V EY+ NG L ++L + L + + YL +HRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESN----GFIHRD 125
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT---FGYLAPEYAQSGQITEKA 590
+ N L+ D V DFGLAR+ D T GT + PE + + K+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 591 DVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEV 650
DV+SFGV++ E+ + K P + +E + Y + P+L + EV
Sbjct: 183 DVWSFGVLMWEVFSEGKM-----PYERFSNSEVVESVSAGYRLYR---PKL----APTEV 230
Query: 651 YCMLHAASLCIRRDPHSRPRMSQVLRIL 678
Y +++ C P RP ++L L
Sbjct: 231 YTIMY---SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 414 LAEGGFGSVHRGV---LPDGQA---VAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVM 466
L +G FG V+ G+ + G+ VA+K +S + EF +E V+ +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWS-----ARQKI---AVGAARGLR 518
L+G + L+V E + G L S+L E QK A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-------WQPDGDMGVETRVIG 571
YL + VHRD+ N ++ D +GDFG+ R ++ G + R
Sbjct: 134 YLAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 572 TFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
++APE + G T K+DV+SFGVVL E+ T
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 56/193 (29%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ G +G V++ + G+ VA+K KL E+ +L +H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ +V EY GSL +Y + PL + +GL YLHE ++ HR
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGKI----HR 125
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ---SGQITEK 589
D++ NILLT D + + DFG++ Q + IGT ++APE A G K
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSA-QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGK 184
Query: 590 ADVYSFGVVLVEL 602
D+++ G+ +EL
Sbjct: 185 CDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 76/203 (37%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 414 LAEGGFGSVHR---GVLPD--GQAVAVK--QHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FGSV L D G+ VAVK QH A D E E+E+L QH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--REIEILKSLQHDNIVK 69
Query: 467 LIGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
G C RR LV EY+ GSL +L H+E L+ A +G+ YL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSK- 127
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG---TFGYLAPEYA 581
R VHRD+ NIL+ + +GDFGL + P + R G F Y APE
Sbjct: 128 RY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 582 QSGQITEKADVYSFGVVLVELVT 604
+ + +DV+SFGVVL EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G+ + VAVK K + +F +E +++ +H ++ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ +V E + GSL +L G L+ +A A G+ YL + +HRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN----YIHRD 128
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSGQITEKAD 591
+ N+L+ + V DFGLAR + E R F + APE A + + K+D
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIY--EAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 592 VYSFGVVLVELVT-GR 606
V+SFG++L E+VT GR
Sbjct: 187 VWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 28/225 (12%)
Query: 400 ELELATGGFSQANFLAEGGFGSVHRG--VLPDG----QAVAVKQHK-LASSQGDHEFCSE 452
E+ L+ F + L EG FG V++G P+ +VA+K K A + EF E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 453 VEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHL--------YGCH------Q 498
E++S QH N+V L+G C +++ +++EY+ +G L L G +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 499 EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558
L+ S IA+ A G+ YL VHRD+ N L+ + DFGL+R
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 559 PDGD-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVEL 602
D V+++ + ++ PE G+ T ++D++SFGVVL E+
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS-EVEVLSCAQHRNVVMLIGFCIE 473
G V+ + LP+ + VA+K+ L Q + EV+ +S H NVV +
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV 70
Query: 474 DRRRLLVYEYICNGS-LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
LV Y+ GS LD + L+ + + +GL YLH ++ HR
Sbjct: 71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI----HR 126
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPD-GDMGVETR--VIGTFGYLAPEYAQSGQ-ITE 588
D++ NILL D + DFG++ D GD + R +GT ++APE +
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF 186
Query: 589 KADVYSFGVVLVELVTGR 606
KAD++SFG+ +EL TG
Sbjct: 187 KADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 66/197 (33%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG V G VAVK K + S F E +++ +H +V L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
E+ +V EY+ GSL L + L +A A G+ YL E +HR
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ESRNY---IHR 127
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSGQITEKA 590
D+ NIL+ + + DFGLAR D + R F + APE A G+ T K+
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 591 DVYSFGVVLVELVT-GR 606
DV+SFG++L E+VT GR
Sbjct: 186 DVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 86/317 (27%), Positives = 141/317 (44%), Gaps = 57/317 (17%)
Query: 412 NFLAEGGFGSVHRG-VLPDG--QAVAVKQHKLASSQGDH-EFCSEVEVL-SCAQHRNVVM 466
+ + EG FG V + + DG A+K+ K +S+ DH +F E+EVL H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 467 LIGFCIEDRRRLLVYEYICNGSL------------DSHLYGCHQEPLEWSARQKIAVGA- 513
L+G C L EY +G+L D + S++Q + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 514 -ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
ARG+ YL ++ +HRD+ NIL+ ++ + DFGL+R G E V T
Sbjct: 133 VARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 181
Query: 573 FG-----YLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627
G ++A E T +DV+S+GV+L E+V+ P E L
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCAELYEKL 236
Query: 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVL----RILEGDTV 683
+ Y +++ ++ + EVY ++ C R P+ RP +Q+L R+LE
Sbjct: 237 PQGYRLEKPLN-------CDDEVYDLMRQ---CWREKPYERPSFAQILVSLNRMLEERK- 285
Query: 684 IDTYMSTPGYDVGSRSG 700
TY++T Y+ + +G
Sbjct: 286 --TYVNTTLYEKFTYAG 300
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 402 ELATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQGD-HEFCSEVEVL 456
E+ ++ + G FG V RG+L AVA+K K ++ +F SE ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 457 SCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV--GAA 514
H N++ L G + + +++ EY+ NG+LD +L E+S+ Q + + G A
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIA 117
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
G++YL + VHRD+ NIL+ + E V DFGL+R D G T G
Sbjct: 118 AGMKYLSDMN----YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 575 --YLAPEYAQSGQITEKADVYSFGVVLVELVT 604
+ APE + T +DV+SFG+V+ E+++
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 414 LAEGGFGSVHRGV--LPDGQ--AVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L G FGSV +GV + G+ VAVK + + G EF E V++ H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEP----LEWSARQKIAVGAARGLRYLHEEC 524
G C + +LV E G L +L + P E A A G+ YL E
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYL-ESK 114
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQ 582
VHRD+ N+LL + + + DFG++R G G + + APE
Sbjct: 115 H---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 583 SGQITEKADVYSFGVVLVELVT 604
G+ + K+DV+S+GV L E +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ EG G V++ G+ VA+K+ +L Q +E+ ++ +H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA--RGLRYLHEECRVGCIV 530
+V EY+ GSL + + + Q V +GL YLH I
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLH---SQNVI- 138
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR--VIGTFGYLAPEYAQSGQITE 588
HRD++ +NILL+ D + DFG A R V+GT ++APE +
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFA---AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 589 KADVYSFGVVLVELVTG 605
K D++S G++ +E+ G
Sbjct: 196 KVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 1e-17
Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 28/203 (13%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQ-HK---LASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L G FG V G+ A+K K + Q +H +E +L +H +V L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQSIRHPFLVNLY 67
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWS---ARQKIAVGAARGLRYLHEECR 525
G +D LV EY+ G L SHL + P + A Q + L YLH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL-----ALEYLHSL-- 120
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR---VIGTFGYLAPEYAQ 582
IV+RD++P N+LL D + DFG A+ V+ R + GT YLAPE
Sbjct: 121 --DIVYRDLKPENLLLDSDGYIKITDFGFAKR-------VKGRTYTLCGTPEYLAPEIIL 171
Query: 583 SGQITEKADVYSFGVVLVELVTG 605
S + D ++ G+++ E++ G
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 83/288 (28%), Positives = 129/288 (44%), Gaps = 52/288 (18%)
Query: 412 NFLAEGGFGSVHRGVLP-DG--QAVAVKQHKLASSQGDH-EFCSEVEVL-SCAQHRNVVM 466
+ + EG FG V R ++ DG A+K K +S+ DH +F E+EVL H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 467 LIGFCIEDRRRLLV-YEYICNGSL------------DSHLYGCHQEPLEWSARQ--KIAV 511
L+G C E+R L + EY G+L D H +++Q + A
Sbjct: 68 LLGAC-ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG 571
A G++YL E+ +HRD+ N+L+ + + DFGL+R G E V
Sbjct: 127 DVATGMQYLSEKQ----FIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKK 175
Query: 572 TFG-----YLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626
T G ++A E T K+DV+SFGV+L E+V+ P E
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLG-----GTPYCGMTCAELYEK 230
Query: 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQV 674
L + Y +++ PR + EVY ++ C R P+ RP +Q+
Sbjct: 231 LPQGYRMEK---PR----NCDDEVYELMRQ---CWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 79/269 (29%), Positives = 112/269 (41%), Gaps = 27/269 (10%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L +G FG V G VA+K K + F E +V+ +H +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ +V EY+ GSL L G + L +A A G+ Y+ R+ VHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN-YVHRD 127
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
+R NIL+ + V DFGLAR D + + APE A G+ T K+DV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 594 SFGVVLVELVT-GRKAVD--LNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEV 650
SFG++L EL T GR +NR Q + P E S H++
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP------------ESLHDL 235
Query: 651 YCMLHAASLCIRRDPHSRPRMSQVLRILE 679
C C R++P RP + LE
Sbjct: 236 MCQ------CWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 61/190 (32%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFC 471
L +G FG V +G L D VAVK K Q +F SE +L H N+V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+ + +V E + G S L ++ L+ K A+ AA G+ YL + CI H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAAGMAYLESK---NCI-H 116
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKAD 591
RD+ N L+ + + DFG++R + DG + APE G+ + ++D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 592 VYSFGVVLVE 601
V+S+G++L E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 79/267 (29%), Positives = 112/267 (41%), Gaps = 23/267 (8%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VAVK K + F E +++ +H +V L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ +V EY+ GSL L L+ +A A G+ Y+ R+ I HRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI-HRD 127
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
+R NIL+ + DFGLAR D + + APE A G+ T K+DV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 594 SFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYC 652
SFG++L ELVT GR + P R +LE+ + S HE+
Sbjct: 188 SFGILLTELVTKGR----VPYPGMNN------REVLEQVERGYRMPCPQDCPISLHEL-- 235
Query: 653 MLHAASLCIRRDPHSRPRMSQVLRILE 679
ML C ++DP RP + LE
Sbjct: 236 MLQ----CWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 38/287 (13%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNVVMLIG 469
+ EG +G V++ G+ VA+K+ KL + E+++L H N++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECR 525
+ L LV+E+ +D+ LY Q L S + +GL + H
Sbjct: 66 -VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---S 116
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE-YAQSG 584
G + HRD++P N+L+ + + DFGLAR + T + T Y APE
Sbjct: 117 HGIL-HRDLKPENLLINTEGVLKLADFGLAR-SFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 585 QITEKADVYSFGVVLVELVT------GRKAVD-LNR---------PKGQQCLTEWARPLL 628
+ D++S G + EL++ G+ +D L + P+ T AR
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVL 675
+ + + + +L + DPH R Q L
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQ---MLHYDPHKRITAEQAL 278
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 52/288 (18%)
Query: 412 NFLAEGGFGSVHRGVLP-DG--QAVAVKQHKLASSQGDH-EFCSEVEVL-SCAQHRNVVM 466
+ + EG FG V + + DG A+K+ K +S+ DH +F E+EVL H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 467 LIGFCIEDRRRLLV-YEYICNGSL------------DSHLYGCHQEPLEWSARQ--KIAV 511
L+G C E R L + EY +G+L D + S++Q A
Sbjct: 61 LLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG 571
ARG+ YL ++ +HRD+ NIL+ ++ + DFGL+R G E V
Sbjct: 120 DVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 168
Query: 572 TFG-----YLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626
T G ++A E T +DV+S+GV+L E+V+ P E
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCAELYEK 223
Query: 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQV 674
L + Y +++ P + EVY ++ C R P+ RP +Q+
Sbjct: 224 LPQGYRLEK---PL----NCDDEVYDLMRQ---CWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L EG +GSV++ + GQ VA+K + + E E+ +L +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHEECRVGCI 529
++ +V EY GS+ + ++ E ++IA +GL YLH
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTE----EEIAAILYQTLKGLEYLHSNK----K 120
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEK 589
+HRD++ NILL + + + DFG++ Q M VIGT ++APE Q K
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179
Query: 590 ADVYSFGVVLVELVTGR 606
AD++S G+ +E+ G+
Sbjct: 180 ADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 74/283 (26%), Positives = 115/283 (40%), Gaps = 45/283 (15%)
Query: 410 QANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGD-----HEFCSEVEVLSCAQHRN 463
+ L +G FG V+ D G+ +AVKQ + + E+++L QH
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 464 VVMLIGFCIEDRRRLLVY-EYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYL 520
+V G C+ D L ++ EY+ GS+ L YG E + ++I G+ YL
Sbjct: 66 IVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYL 120
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETR-VIGTFGYLAP 578
H IVHRD++ NIL +GDFG + R Q G + V GT +++P
Sbjct: 121 HSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 579 EYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI----- 633
E KADV+S G +VE++T + WA E A
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP--------------WAE--FEAMAAIFKIA 220
Query: 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ +P+L +H S + + RP ++LR
Sbjct: 221 TQPTNPQLPSHVSPDARNFL----RRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 52/217 (23%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEF----CSEVEVLSCAQHRNVVMLIGF 470
EG +G V++ G+ VA+K K+ F E+++L +H N+V L
Sbjct: 9 EGTYGQVYKARNKKTGELVALK--KIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 471 CIEDRRR--LLVYEYI---CNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GL 517
+ +V+EY+ G LDS K + GL
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDSPEV-------------KFTESQIKCYMKQLLEGL 113
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFGYL 576
+YLH I+HRD++ +NIL+ +D + DFGLAR + RVI T Y
Sbjct: 114 QYLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYR 168
Query: 577 APE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
PE Y + D++S G +L EL G+
Sbjct: 169 PPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 64/211 (30%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L G FG V+ G+ VAVK + S Q + +F E ++S H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGC-----HQEPLEWSARQKIAVGAARGLRYLH 521
LIG E R ++ E + G L S L L A A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL- 132
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLV---GDFGLAR-------WQPDGDMGVETRVIG 571
EE +HRD+ N LLT V DFG+AR ++ G R +
Sbjct: 133 EENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG------RAML 183
Query: 572 TFGYLAPEYAQSGQITEKADVYSFGVVLVEL 602
++ PE G T K DV+SFGV+L E+
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 6e-17
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 39/217 (17%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEF----CSEVEVLSCAQHR 462
+ + L EG +G V++ G+ VA+K+ +L + E+ +L +H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHP 58
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYL 520
N+V L+ +R+ LV+EY C+ L +L + P S I RGL Y
Sbjct: 59 NIVKLLDVIHTERKLYLVFEY-CDMDLKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE----TRVIGTFGYL 576
H I+HRD++P NIL+ D + DFGLAR G+ T + T Y
Sbjct: 115 HS----HRILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYR 165
Query: 577 APE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
APE Y + D++S G + E++TG+
Sbjct: 166 APEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 78/269 (28%), Positives = 116/269 (43%), Gaps = 37/269 (13%)
Query: 417 GGFGSVH--RGVLPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRNVVMLIGFC 471
G FG+V+ R V + VA+K+ + Q + + EV L +H N + G
Sbjct: 26 GSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY 84
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+ + LV EY C GS S + H++PL+ I GA +GL YLH R+ H
Sbjct: 85 LREHTAWLVMEY-CLGSA-SDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI----H 138
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEY---AQSGQITE 588
RD++ NILLT + DFG A + +GT ++APE GQ
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG-NHYSE 647
K DV+S G+ +EL RK N A L Y I + P L N +S+
Sbjct: 194 KVDVWSLGITCIELAE-RKPPLFNMN---------AMSAL--YHIAQNDSPTLSSNDWSD 241
Query: 648 HEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ C+++ P RP ++L+
Sbjct: 242 ----YFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 414 LAEGGFGSVHRGVL--PDG--QAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FGSV G L DG VAVK KL + EF SE + H NV+ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 468 IGFCIEDRRR------LLVYEYICNGSLDSHLY----GCHQEPLEWSARQKIAVGAARGL 517
IG C E +++ ++ +G L S L G E L K V A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT-FGYL 576
YL +HRD+ N +L D V DFGL++ GD + R+ ++
Sbjct: 127 EYLSNRN----FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 577 APEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636
A E T K+DV++FGV + E+ T +GQ P +E + I +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT----------RGQT-----PYPGVENHEIYDY 227
Query: 637 VDPRLGNHYSE-----HEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+ R GN + E+Y ++ C R DP RP +++ +LE
Sbjct: 228 L--RHGNRLKQPEDCLDELYDLM---YSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 83/286 (29%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 414 LAEGGFGSVHRG----VLP--DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V + P D VAVK K AS +F E E+L+ QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 468 IGFCIEDRRRLLVYEYICNGSL---------DSHLYGCHQEPLEWSARQ--KIAVGAARG 516
G C+E ++V+EY+ +G L D+ L P E + Q IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD-MGVETRVIGTFGY 575
+ YL + VHRD+ N L+ + +GDFG++R D V + +
Sbjct: 133 MVYLASQ----HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 576 LAPEYAQSGQITEKADVYSFGVVLVELVTGRKA--VDLNRPKGQQCLTEWARPLLEEYAI 633
+ PE + T ++DV+S GVVL E+ T K L+ + +C+T+ R L
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQR---- 243
Query: 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
PR EVY ++ C +R+PH R + ++ +L+
Sbjct: 244 -----PRT----CPKEVYDLMLG---CWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 59/194 (30%), Positives = 87/194 (44%), Gaps = 7/194 (3%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VA+K K S + F +E ++ QH +V L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
++ EY+ NGSL L L + +A A G+ ++ + +HRD
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN----YIHRD 127
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
+R NIL++ + DFGLAR D + + APE G T K+DV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 594 SFGVVLVELVT-GR 606
SFG++L E+VT GR
Sbjct: 188 SFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSC-AQHRNVVMLI 468
+ EG F +V + A+K +L + E EVL+ H ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIA--VGAARGLRYLHEE 523
+ +D L V EY NG L ++ YG E R A + A L YLH
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK---CTRFYAAEILLA---LEYLH-- 119
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV-------------- 569
G I+HRD++P NILL D + DFG A+ +
Sbjct: 120 -SKG-IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 570 -----IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
+GT Y++PE + +D+++ G ++ +++TG+
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 67/266 (25%), Positives = 110/266 (41%), Gaps = 23/266 (8%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ G FG V G + + VA+K + + + +F E +V+ H +V L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
LV+E++ +G L +L + + + G+ YL ++HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLES----SNVIHRD 125
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
+ N L+ + V DFG+ R+ D T + +PE + + K+DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 594 SFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEY-AIDELVDPRLGNHYSEHEVYC 652
SFGV++ E+ + K NR + ++E A L PRL S+
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSE---------VVETINAGFRLYKPRLA---SQSVYEL 233
Query: 653 MLHAASLCIRRDPHSRPRMSQVLRIL 678
M H C + P RP S +L L
Sbjct: 234 MQH----CWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 6/204 (2%)
Query: 402 ELATGGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ 460
E+ + + L G +G V+ GV VAVK K + EF E V+ +
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 60
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520
H N+V L+G C + ++ E++ G+L +L C+++ + +A + + YL
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEY 580
++ +HRD+ N L+ + V DFGL+R + APE
Sbjct: 121 EKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 581 AQSGQITEKADVYSFGVVLVELVT 604
+ + K+DV++FGV+L E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 414 LAEGGFGSVHR-GVLPDGQAVAVKQHKLASSQGD----HEFCSEVEVLSCAQHRNVVMLI 468
+ EG G V + G+ VA+K K+A + + ++ E++ L QH VV L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALK--KVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+LV EY L L + PL + + +G+ Y+H
Sbjct: 66 DVFPHGSGFVLVMEY-MPSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANG---- 119
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE--YAQSGQI 586
I+HRD++P N+L++ D + DFGLAR + + + + + T Y APE Y +
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR-KY 178
Query: 587 TEKADVYSFGVVLVELVTGR 606
D+++ G + EL+ G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 80/296 (27%), Positives = 122/296 (41%), Gaps = 56/296 (18%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDHE---FCSEVEVL-SCAQHRN 463
L EG FG V + + VAVK L + + SE+E++ +H+N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG--------------CHQEPLEWSARQKI 509
++ L+G C ++ +V EY +G+L L +E L
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
A ARG+ +L + CI HRD+ N+L+T D + DFGLAR D +T
Sbjct: 138 AYQVARGMEFLASK---KCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-- 191
Query: 570 IGTFGYL-----APEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEW 623
T G L APE T ++DV+SFGV+L E+ T G P + E
Sbjct: 192 --TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG------GSPYPGIPVEEL 243
Query: 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+ L E Y +++ P E+Y ++ C P RP Q++ L+
Sbjct: 244 FKLLKEGYRMEK---P----QNCTQELYHLMRD---CWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNV 464
F + N + EG +G V+R G+ VA+K+ ++ + + S E+ +L +H N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 465 VMLIGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
V L + LV EY C L S L P S + + + RGL+YLHE
Sbjct: 69 VELKEVVVGKHLDSIFLVMEY-CEQDLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHE 126
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW--QPDGDMGVETRVIGTFGYLAPEY 580
I+HRD++ +N+LLT + DFGLAR P M T + T Y APE
Sbjct: 127 NF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM---TPKVVTLWYRAPEL 179
Query: 581 A-QSGQITEKADVYSFGVVLVELVTGR 606
T D+++ G +L EL+ +
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 75/277 (27%), Positives = 130/277 (46%), Gaps = 39/277 (14%)
Query: 417 GGFGSVHRGVL-PDGQA---VAVKQHKLA-SSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
G FG V RG L G+ VA+K K + + +F SE ++ H N++ L G
Sbjct: 15 GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV--GAARGLRYLHEECRVGCI 529
+ R +++ E++ NG+LDS L Q +++ Q + + G A G++YL E
Sbjct: 75 TKSRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLSEM----NY 127
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIG---TFGYLAPEYAQSGQ 585
VHRD+ NIL+ + V DFGL+R+ + D T +G + APE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 586 ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645
T +DV+S+G+V+ E+++ + RP + + ++Y + +D
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGE-----RPYWDMSNQDVINAIEQDYRLPPPMD------- 235
Query: 646 SEHEVYC--MLHAASL-CIRRDPHSRPRMSQVLRILE 679
C LH L C ++D ++RP+ Q++ L+
Sbjct: 236 ------CPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 35/218 (16%)
Query: 412 NFLAEGGFGSVHRG----VLPDG---QAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRN 463
NFL G FG V+ G +L G VAVK K A+ Q EF E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEP-----LEWSARQKIAVGAARGLR 518
+V L+G C+ + + ++ E + G L S+L E L I + A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 519 YLHEECRVGCIVHRDMRPNNILLT---HDFEPLV--GDFGLAR-------WQPDGDMGVE 566
YL E+ +HRD+ N L++ +D + +V GDFGLAR ++ +G+ +
Sbjct: 121 YL-EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
R ++APE G+ T ++DV+SFGV++ E++T
Sbjct: 177 VR------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 67/267 (25%), Positives = 114/267 (42%), Gaps = 34/267 (12%)
Query: 417 GGFGSVH--RGVLPDGQAVAVKQHKLASSQGDHEFC--SEVEVLSCAQHRNVVMLIGFCI 472
G FG VH R D + V +KQ + D +E +VL H N++ +
Sbjct: 11 GAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL 69
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
ED+ ++V EY G+L ++ L+ V L ++H + I+HR
Sbjct: 70 EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL----ILHR 125
Query: 533 DMRPNNILLT-HDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKAD 591
D++ NILL H +GDFG+++ V+GT Y++PE + +K+D
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGKPYNQKSD 183
Query: 592 VYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE---H 648
+++ G VL EL + ++A + P L + P + + YS
Sbjct: 184 IWALGCVLYELASLKRAFEAAN-----------LPALVLKIMSGTFAP-ISDRYSPDLRQ 231
Query: 649 EVYCMLHAASLCIRRDPHSRPRMSQVL 675
+ ML+ DP RP++SQ++
Sbjct: 232 LILSMLNL-------DPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 35/277 (12%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRN 463
FS + G FG+V+ + + + VA+K+ + Q + + EV L +H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+ G + + LV EY C GS S L H++PL+ + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEY--- 580
++HRD++ NILL+ +GDFG A M +GT ++APE
Sbjct: 135 N----MIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAPEVILA 185
Query: 581 AQSGQITEKADVYSFGVVLVELVTGRKAV-DLNRPKGQQCLTEWARPLLEEYAIDELVDP 639
GQ K DV+S G+ +EL + + ++N + + P L+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--------- 236
Query: 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
H+SE+ + C+++ P RP +L+
Sbjct: 237 ---GHWSEY----FRNFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
L G GSV + +P G +A K H A S + E++++ + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 472 IEDRRRLLVYEYICNGSLD--SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+ + + E++ GSLD G P+ KIAV GL YL+ R I
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHR---I 125
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM--GVETRVIGTFGYLAPEYAQSGQIT 587
+HRD++P+NIL+ + + DFG++ G++ + +GT Y++PE Q G+ T
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYT 180
Query: 588 EKADVYSFGVVLVELVTGR 606
K+DV+S G+ ++EL G+
Sbjct: 181 VKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 76/292 (26%), Positives = 123/292 (42%), Gaps = 50/292 (17%)
Query: 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL--ASSQGDHEFC-SEVEVLSCAQ 460
G F + +G F V++ + L DG+ VA+K+ ++ + C E+++L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQ-------EPLEWSARQKIAVGA 513
H NV+ + IE+ +V E G L S + + E W K V
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIW----KYFVQL 115
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
L ++H + R I+HRD++P N+ +T +GD GL R+ + V GT
Sbjct: 116 CSALEHMHSK-R---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170
Query: 574 GYLAPEYAQSGQITEKADVYSFGVVLVELVT------GRKA--VDLNRPKGQQCLTEWAR 625
Y++PE K+D++S G +L E+ G K L + K ++C
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIEKC------ 223
Query: 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677
+Y P +HYSE + S CI DP RP +S VL++
Sbjct: 224 ----DYP------PLPADHYSEE----LRDLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 414 LAEGGFGSVHR----GVLPDGQ----AVAVKQHKLASSQGD-HEFCSEVEVLSC-AQHRN 463
L EG FG V R G+ VAVK K ++ D + SE+E++ +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG--------------CHQEPLEWSARQKI 509
++ L+G C ++ ++ EY G+L L +E L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET-- 567
A ARG+ YL CI HRD+ N+L+T D + DFGLAR D D +T
Sbjct: 140 AYQVARGMEYLESR---RCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 568 -RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
R+ ++APE T ++DV+SFG+++ E+ T
Sbjct: 196 GRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 15/195 (7%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ EG FG+V +G GQ VAVK K ++Q F E V++ H+N+V L+G +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ + V E + G+L + L + + + ++ A G+ YL + +VHR
Sbjct: 70 HNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK----LVHR 124
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADV 592
D+ NIL++ D V DFGLAR MGV+ + + APE + + + K+DV
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL-PVKWTAPEALKHKKFSSKSDV 180
Query: 593 YSFGVVLVELVT-GR 606
+S+GV+L E+ + GR
Sbjct: 181 WSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 67/278 (24%), Positives = 104/278 (37%), Gaps = 45/278 (16%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCSEVEVLSCAQHRNVVMLIGFCI 472
G FG+V + DG+ + K+ + + E SEV +L +H N+V I
Sbjct: 11 GSFGTVRKVRRKSDGKILVWKEIDY-GNMTEKEKQQLVSEVNILRELKHPNIVRYYDR-I 68
Query: 473 EDRRRLLVY---EYICNGSLDSHLYGCHQE--PLEWSARQKIAVGAARGLRYLH-EECRV 526
DR +Y EY G L + C +E +E +I L H
Sbjct: 69 IDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG 128
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
++HRD++P NI L + +GDFGLA+ +T V GT Y++PE
Sbjct: 129 NTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMSY 187
Query: 587 TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD-------P 639
EK+D++S G ++ EL P +L
Sbjct: 188 DEKSDIWSLGCLIYELCAL-------------------SPPFTARNQLQLASKIKEGKFR 228
Query: 640 RLGNHYSEHEVYCMLHAA-SLCIRRDPHSRPRMSQVLR 676
R+ YS L+ + DP RP ++L+
Sbjct: 229 RIPYRYSSE-----LNEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 66/206 (32%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 417 GGFGSVH---RGVLPDGQAVAV--KQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
G +G V + D A+ V K + +Q D +E ++LS AQ VV L +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL-TERDILSQAQSPYVVKLY-YS 61
Query: 472 IEDRRRL-LVYEYICNGSLDS--HLYGCHQEPLEWSARQKIA--VGAARGLRYLHEECRV 526
+ ++ L LV EY+ G L S G E AR IA V A L YLH
Sbjct: 62 FQGKKNLYLVMEYLPGGDLASLLENVGSLDED---VARIYIAEIVLA---LEYLH---SN 112
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLA------RWQPDGDMGVET-RVIGTFGYLAPE 579
G I+HRD++P+NIL+ + + DFGL+ R D E R++GT Y+APE
Sbjct: 113 G-IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 580 YAQSGQITEKADVYSFGVVLVELVTG 605
++ D +S G +L E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 35/271 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRNVVMLIG 469
+ G FG+V+ + VAVK+ + Q + + EV+ L +H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+++ LV EY C GS S L H++PL+ I GA +GL YLH +
Sbjct: 89 CYLKEHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN----M 142
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEY---AQSGQI 586
+HRD++ NILLT + + DFG A + +GT ++APE GQ
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-----SFVGTPYWMAPEVILAMDEGQY 197
Query: 587 TEKADVYSFGVVLVELVTGRKAV-DLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645
K DV+S G+ +EL + + ++N + + P L+ +E D G
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQS---NEWTDSFRG--- 251
Query: 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
C+++ P RP +++LR
Sbjct: 252 ----------FVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---------FCSEVEVLSCAQHRN 463
+ G FGSV+ G+ G+ +AVKQ +L S + E+ +L QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLH 521
+V +G ++ + EY+ GS+ + L YG +E L + ++I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYLH 123
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-----VIGTFGYL 576
I+HRD++ NIL+ + + DFG+++ + +T + G+ ++
Sbjct: 124 NRG----IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 577 APEYAQSGQITEKADVYSFGVVLVELVTGR 606
APE + T KAD++S G ++VE++TG+
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 42/286 (14%)
Query: 414 LAEGGFGSVHRGVLPDGQAVA---VKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ G FG V G G + A VK+ + +++ F EV+ H NV+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSAR----QKIAVGAARGLRYLHEECR 525
CIE LLV E+ G L ++L + + A+ Q++A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSN-RGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLA--RWQPDGDMGVETRVIGTFGYLAPEYAQS 583
+H D+ N LT D +GD+GLA ++ D + + + +LAPE +
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 584 GQ-------ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636
T+K++++S GV + EL T ++P + + ++ E I +L
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAA-----DQPYPDLSDEQVLKQVVREQDI-KL 230
Query: 637 VDPRLGNHYSE--HEV--YCMLHAASLCIRRDPHSRPRMSQVLRIL 678
P+L YS+ +EV +C L DP +RP +V +L
Sbjct: 231 PKPQLDLKYSDRWYEVMQFCWL---------DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 78/278 (28%), Positives = 113/278 (40%), Gaps = 46/278 (16%)
Query: 414 LAEGGFGSVHRG--VLPDGQ--AVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FG V RG G+ VAVK KL+ D F E ++ H N++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD--FLKEAAIMHSLDHENLIR 60
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
L G + ++V E GSL L S AV A G+RYL +
Sbjct: 61 LYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-- 117
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD----MGVETRVIGTFGYLAPEYAQ 582
+HRD+ NILL D + +GDFGL R P + M +V F + APE +
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 583 SGQITEKADVYSFGVVLVELVT-GRKA-VDLNRPKGQQCLTEWARPLLEEYAIDE----L 636
+ + +DV+ FGV L E+ T G + L+ G Q L ID+ L
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS---GSQIL----------KKIDKEGERL 220
Query: 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQV 674
P ++Y ++ C +P RP + +
Sbjct: 221 ERPE----ACPQDIYNVMLQ---CWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQA----VAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L G FG+VH+G+ +P+G + VA+K + Q E + + H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C +L V + GSL H+ H++ L+ V A+G+ YL E
Sbjct: 75 LGICPGASLQL-VTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
+VHR++ NILL D + DFG+A PD + ++A E G+
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 587 TEKADVYSFGVVLVELVT 604
T ++DV+S+GV + E+++
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 66/205 (32%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 414 LAEGGFGSV--------HRGVLPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNV 464
L EG FG V + G G+ VAVK K Q + + E+ +L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 465 VMLIGFCIE--DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
V G C E + L+ EY+ GSL +L + L + A G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG---TFGYLAPE 579
+ +HRD+ N+LL +D +GDFGLA+ P+G R G F Y A E
Sbjct: 126 QH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180
Query: 580 YAQSGQITEKADVYSFGVVLVELVT 604
+ + + +DV+SFGV L EL+T
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKL-ASSQGDHE---------FCSEVEVLSCAQHR 462
+ +G +G V+ + + G+ +AVKQ +L A+ G H+ SE+E L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYL 520
N+V +GF + + EY+ GS+ S L YG +E L +++ GL YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAYL 124
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPE 579
H + I+HRD++ +N+L+ D + DFG+++ D + + G+ ++APE
Sbjct: 125 HSKG----ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 580 YAQSGQ--ITEKADVYSFGVVLVELVTGRK 607
S + K D++S G V++E+ GR+
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 26/271 (9%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQ-AVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVV 465
F++ + +G FG V +G+ Q VA+K L ++ + E E+ VLS V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
G ++D + ++ EY+ GS L PL+ + I +GL YLH E +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
+ HRD++ N+LL+ E + DFG+A D + +GT ++APE +
Sbjct: 123 I----HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQSA 177
Query: 586 ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645
KAD++S G+ +EL G P + P+ + I + P L +Y
Sbjct: 178 YDSKADIWSLGITAIELAKGEP------PHSE------LHPMKVLFLIPKNNPPTLEGNY 225
Query: 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
S+ + C+ ++P RP ++L+
Sbjct: 226 SKP----LKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 34/221 (15%)
Query: 414 LAEGGFGSVHRGV------LPDGQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVM 466
L EG FG V + VAVK K +S + + SE +L H +V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHL-----YGC-----------------HQEPLEWS 504
L G C +D LL+ EY GSL S L G + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 505 ARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564
A +RG++YL E +VHRD+ N+L+ + + DFGL+R + D
Sbjct: 128 DLISFAWQISRGMQYLAEM----KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 565 VE-TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
V+ ++ ++A E T ++DV+SFGV+L E+VT
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 33/268 (12%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLASSQGD-HEFCSEVEVLS---CAQHRNVVMLIGFC 471
G +G+V+RG +P G+ VA+K L + D + EV +LS +Q N+ G
Sbjct: 12 GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY 71
Query: 472 IEDRRRLLVYEYICNGSLDSHLY-GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
++ R ++ EY GS+ + + G E +++ V L+Y+H +VG ++
Sbjct: 72 LKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA----LKYIH---KVG-VI 123
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE-K 589
HRD++ NIL+T+ + DFG+A + + + +GT ++APE G+ + K
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAA-LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182
Query: 590 ADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL-GNHYSEH 648
AD++S G+ + E+ TG N P + R + I + PRL N YS+
Sbjct: 183 ADIWSLGITIYEMATG------NPPYSDV---DAFRAM---MLIPKSKPPRLEDNGYSKL 230
Query: 649 EVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ + C+ +P R ++L+
Sbjct: 231 ----LREFVAACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 27/275 (9%)
Query: 414 LAEGGFGSVHRGV---LPDGQA---VAVKQHKLASSQGDHE-FCSEVEVLS-CAQHRNVV 465
L G FG V L A VAVK K + + E SE++++S H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
L+G C L++ EY C G L + L + L + A+G+ +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-- 160
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFGYLAPEYAQSG 584
CI HRD+ N+LLTH + DFGLAR D + V+ ++APE +
Sbjct: 161 -NCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218
Query: 585 QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644
T ++DV+S+G++L E+ + + N G +++ + + E Y + +
Sbjct: 219 VYTFESDVWSYGILLWEIFS----LGSNPYPGMPVDSKFYKLIKEGYRMAQPE------- 267
Query: 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
++ E+Y ++ C DP RP Q+++++
Sbjct: 268 HAPAEIYDIMKT---CWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 398 YAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKL-ASSQGDHEFCSEVEVL 456
+ E+ L Q + VAVK + AS +F EV++L
Sbjct: 18 FGEVHLCEADGLQDFSEKAFAENDNADAPV----LVAVKVLRPDASDNAREDFLKEVKIL 73
Query: 457 SCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK-------- 508
S N+ L+G C D ++ EY+ NG L+ L E + K
Sbjct: 74 SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLL 133
Query: 509 -IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD-MGVE 566
+A A G+RYL VHRD+ N L+ ++ + DFG++R D V+
Sbjct: 134 YMATQIASGMRYLESL----NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
R ++A E G+ T K+DV++FGV L E++T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 5/191 (2%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G + VAVK K + F E ++ QH +V L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ ++ EY+ GSL L + + A G+ Y+ + +HRD
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 128
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
+R N+L++ + DFGLAR D + + APE G T K+DV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 594 SFGVVLVELVT 604
SFG++L E+VT
Sbjct: 189 SFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 50/218 (22%), Positives = 79/218 (36%), Gaps = 24/218 (11%)
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
E +L H +V L + +D + LV + + G L HL + +
Sbjct: 50 ERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLS--QKVKFSEEQVKFWI 106
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI 570
L YLH + I+HRD++P+NILL + DF +A + T
Sbjct: 107 CEIVLALEYLHSKG----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--S 160
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630
GT GY+APE + D +S GV E + G++ + + + R E
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET 216
Query: 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSR 668
Y + A + + RDP R
Sbjct: 217 AD----------VLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 77/269 (28%), Positives = 115/269 (42%), Gaps = 27/269 (10%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L +G FG V G VA+K K + F E +++ +H +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ +V E++ GSL L + L+ +A A G+ Y+ R+ I HRD
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI-HRD 127
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
+R NIL+ + + DFGLAR D + + APE A G+ T K+DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 594 SFGVVLVELVT-GRKAVD--LNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEV 650
SFG++L ELVT GR +NR +Q + P + G S HE+
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQ------------GCPESLHEL 235
Query: 651 YCMLHAASLCIRRDPHSRPRMSQVLRILE 679
LC ++DP RP + LE
Sbjct: 236 ------MKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 412 NFLAEGGFGSVHRGVL--PDGQAV--AVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
+ +G FG V+ G L DGQ + AVK +++ + +F E ++ H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 467 LIGFCIEDR-RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVG--AARGLRYLHEE 523
L+G C+ L+V Y+ +G L + + P + + I G A+G+ YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP---TVKDLIGFGLQVAKGMEYLASK 117
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-------WQPDGDMGVETRVIGTFGYL 576
VHRD+ N +L F V DFGLAR + G + V ++
Sbjct: 118 K----FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV----KWM 169
Query: 577 APEYAQSGQITEKADVYSFGVVLVELVT 604
A E Q+ + T K+DV+SFGV+L EL+T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 28/207 (13%)
Query: 414 LAEGGFGSVHRGVLPDGQA-VAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G +G V+ Q +A+K+ S+ E+ + S +HRN+V +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 473 EDRRRLLVYEYICNGSLDSHL------YGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
E+ + E + GSL + L +++ + + +Q + GL+YLH+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDN--- 127
Query: 527 GCIVHRDMRPNNILL-THDFEPLVGDFG----LARWQPDGDMGVETRVIGTFGYLAPEYA 581
IVHRD++ +N+L+ T+ + DFG LA P GT Y+APE
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-----CTETFTGTLQYMAPEVI 181
Query: 582 QSGQ--ITEKADVYSFGVVLVELVTGR 606
G AD++S G +VE+ TG+
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 28/272 (10%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAV-AVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVV 465
F++ + +G FG V +G+ Q V A+K L ++ + E E+ VLS V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 466 MLIGFCIEDRRRLLVYEYICNGS-LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
G ++ + ++ EY+ GS LD G E + ++I +GL YLH E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL----KGLDYLHSEK 121
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
++ HRD++ N+LL+ + + DFG+A D + T +GT ++APE Q
Sbjct: 122 KI----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQS 176
Query: 585 QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644
KAD++S G+ +EL G P P+ + I + P L
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP------PNSDM------HPMRVLFLIPKNNPPTLTGE 224
Query: 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+S+ C+ +DP RP ++L+
Sbjct: 225 FSKP----FKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 28/200 (14%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS-EVEVLSCAQHRNVVMLIGFCIED 474
G FG V++ + Q VA+K L ++ + E E++ LS + + G ++
Sbjct: 12 GSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71
Query: 475 RRRLLVYEYICNGS-LDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHEECRVGCIV 530
+ ++ EY GS LD G E IA GL YLHEE ++
Sbjct: 72 SKLWIIMEYCGGGSCLDLLKPGKLDE-------TYIAFILREVLLGLEYLHEEGKI---- 120
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV-----IGTFGYLAPEYAQSGQ 585
HRD++ NILL+ + + + DFG++ G + T +GT ++APE +
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVS-----GQLT-STMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 586 ITEKADVYSFGVVLVELVTG 605
EKAD++S G+ +EL G
Sbjct: 175 YDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 30/273 (10%)
Query: 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVV 465
F++ + +G FG V++G+ + VA+K L ++ + E E+ VLS +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 466 MLIGFCIEDRRRLLVYEYICNGS-LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
G ++ + ++ EY+ GS LD G PLE + I +GL YLH E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER 121
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
++ HRD++ N+LL+ + + DFG+A D + T +GT ++APE +
Sbjct: 122 KI----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 176
Query: 585 QITEKADVYSFGVVLVELVTGRKA-VDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643
KAD++S G+ +EL G DL+ P+ + I + P L
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLH-------------PMRVLFLIPKNSPPTLEG 223
Query: 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
YS+ C+ +DP RP ++L+
Sbjct: 224 QYSKP----FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 35/277 (12%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRN 463
F+ + G FG+V+ + + VA+K+ + Q + + EV+ L +H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+ G + + LV EY C GS S L H++PL+ I GA +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEY--- 580
++HRD++ NILLT + + DFG A + +GT ++APE
Sbjct: 145 N----MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-----SFVGTPYWMAPEVILA 195
Query: 581 AQSGQITEKADVYSFGVVLVELVTGRKAV-DLNRPKGQQCLTEWARPLLEEYAIDELVDP 639
GQ K DV+S G+ +EL + + ++N + + P L+
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS--------- 246
Query: 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
N +S++ + C+++ P RP ++L+
Sbjct: 247 ---NEWSDY----FRNFVDSCLQKIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 77/288 (26%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 414 LAEGGFGSV------HRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V + D VAVK K + +F E E+L+ QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYG--------CHQEPLE------WSARQKIAVGA 513
G C + ++V+EY+ +G L+ L +P + S IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD-MGVETRVIGT 572
A G+ YL + VHRD+ N L+ + +GDFG++R D V +
Sbjct: 133 ASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 573 FGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKA--VDLNRPKGQQCLTEWARPLLEE 630
++ PE + T ++DV+SFGV+L E+ T K L+ + +C+T+ +LE
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR--VLER 246
Query: 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678
PR+ EVY ++ C +R+P R + ++ +IL
Sbjct: 247 --------PRV----CPKEVYDIMLG---CWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 414 LAEGGFGSVH----RGVLP---------DGQA--VAVKQHKL-ASSQGDHEFCSEVEVLS 457
L EG FG VH G+ DGQ VAVK + + ++F E++++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 458 CAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG-------CHQEPLEWSARQKI- 509
++ N++ L+G C+ D ++ EY+ NG L+ L H + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 510 --AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD-MGVE 566
AV A G++YL VHRD+ N L+ + + + DFG++R GD ++
Sbjct: 133 YMAVQIASGMKYLASL----NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
R + ++A E G+ T +DV++FGV L E+ T
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 31/272 (11%)
Query: 417 GGFGSVHRGVL--PDGQ--AVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLIGFC 471
G FG V G L P + VA+K K ++ +F SE ++ H N++ L G
Sbjct: 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV--GAARGLRYLHEECRVGCI 529
+ + ++V EY+ NGSLD+ L + +++ Q + + G A G++YL +
Sbjct: 75 TKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMKYLSDM----GY 127
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG--YLAPEYAQSGQIT 587
VHRD+ NIL+ + V DFGL+R D T G + APE + T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 588 EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647
+DV+S+G+V+ E+++ + RP + + + + E Y + +D H
Sbjct: 188 SASDVWSYGIVMWEVMSYGE-----RPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH--- 239
Query: 648 HEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
ML C ++D + RP+ Q++ IL+
Sbjct: 240 ---QLMLD----CWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 414 LAEGGFGSVHRG-VLPDGQAVAVKQHKL-ASSQGDHEFCSEVEVL-SCAQHRNVVMLIGF 470
L G G+V++ L + +AVK L + + + SE+E+L C + F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
+E+R + E++ GSLD +Y E + +IAV +GL YL I+
Sbjct: 69 FVENRISICT-EFMDGGSLD--VYRKIPEHV----LGRIAVAVVKGLTYLWSLK----IL 117
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKA 590
HRD++P+N+L+ + + DFG++ + + +GT Y+APE Q +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 591 DVYSFGVVLVELVTGRKAVDLNRPK--GQQCLTEWARPL-LEEYAIDELVDPRLGNH-YS 646
DV+S G+ +EL GR P+ Q PL L + +DE P L +S
Sbjct: 175 DVWSLGISFMELALGR----FPYPQIQKNQGSL---MPLQLLQCIVDE-DPPVLPVGQFS 226
Query: 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVL 675
E V H + C+R+ P RP ++
Sbjct: 227 EKFV----HFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 408 FSQANFLAEGGFGSVHR-GVLPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRN 463
F Q L +GGFG V V G+ A K+ ++ +G+ +E ++L R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
VV L + E + L LV + G L H+Y + E A GL LH+
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ 582
E IV+RD++P NILL + D GLA P+G ++ RV GT GY+APE +
Sbjct: 121 ER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVK 174
Query: 583 SGQITEKADVYSFGVVLVELVTGR 606
+ + T D ++ G +L E++ G+
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG V++ + G A K ++ S + +F E+++LS +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ + ++ E+ G+LDS + + L + + L +LH ++HR
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHSHK----VIHR 127
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA-----QSGQIT 587
D++ NILLT D + + DFG++ +T IGT ++APE +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPYD 186
Query: 588 EKADVYSFGVVLVELVTGR 606
KAD++S G+ L+EL
Sbjct: 187 YKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 23/200 (11%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G FG V G G VAVK K A++Q F +E V++ +H N+V L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 473 EDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
E++ L +V EY+ GSL +L + L K ++ + YL VH
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN----FVH 125
Query: 532 RDMRPNNILLTHDFEPLVGDFGLAR----WQPDGDMGVETRVIGTFGYLAPEYAQSGQIT 587
RD+ N+L++ D V DFGL + Q G + V+ + APE + + +
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEALREKKFS 177
Query: 588 EKADVYSFGVVLVELVT-GR 606
K+DV+SFG++L E+ + GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 12/204 (5%)
Query: 408 FSQANFLAEGGFGSVHR-GVLPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRN 463
F Q L +GGFG V V G+ A K + ++ +G+ +E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
VV L + E + L LV + G L H+Y E A GL LH
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ 582
E V+RD++P NILL + D GLA P+G+ + RV GT GY+APE
Sbjct: 121 EN----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLN 174
Query: 583 SGQITEKADVYSFGVVLVELVTGR 606
+ + T D + G ++ E++ G+
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 34/218 (15%)
Query: 414 LAEGGFGSVHR----GVLPDGQ--AVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVM 466
+ +G FG V + G+LP VAVK K AS+ +F E +++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK------------------ 508
L+G C + L++EY+ G L+ L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 509 --IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR--WQPDGDMG 564
IA A G+ YL E VHRD+ N L+ + + DFGL+R + D
Sbjct: 133 LCIAKQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVEL 602
E I ++ PE + T ++DV+++GVVL E+
Sbjct: 189 SENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 16/198 (8%)
Query: 416 EGGFGSVHRG-VLPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNVVMLIGFCI 472
EG +G V + G+ VA+K+ K + D + + EV+VL +H N+V L
Sbjct: 11 EGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR 70
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
R LV+EY+ L+ L L A + + + Y H I+HR
Sbjct: 71 RKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN----IIHR 124
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE----YAQSGQITE 588
D++P NIL++ + DFG AR T + T Y APE G+
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK--- 181
Query: 589 KADVYSFGVVLVELVTGR 606
DV++ G ++ EL+ G
Sbjct: 182 PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 87/319 (27%), Positives = 137/319 (42%), Gaps = 64/319 (20%)
Query: 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDG-----------QAVAVKQHKLA 441
PRW E+ L EG FG V V+ + VAVK K
Sbjct: 11 PRW------EVPRDRLVLGKPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSD 61
Query: 442 SSQGD-HEFCSEVEVLS-CAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHL------ 493
+++ D + SE+E++ +H+N++ L+G C +D ++ EY G+L +L
Sbjct: 62 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 121
Query: 494 -----YGCHQEPLEWSARQKI---AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545
Y Q P E + + + A ARG+ YL + CI HRD+ N+L+T D
Sbjct: 122 GMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCI-HRDLAARNVLVTEDN 177
Query: 546 EPLVGDFGLARWQPDGDMGVETRVIGTFG-----YLAPEYAQSGQITEKADVYSFGVVLV 600
+ DFGLAR D +T T G ++APE T ++DV+SFGV+L
Sbjct: 178 VMKIADFGLARDIHHIDYYKKT----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233
Query: 601 ELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLC 660
E+ T + P + E + L E + +D+ + +E+Y M+ C
Sbjct: 234 EIFTLGGS-----PYPGVPVEELFKLLKEGHRMDKPSN-------CTNELYMMMRD---C 278
Query: 661 IRRDPHSRPRMSQVLRILE 679
P RP Q++ L+
Sbjct: 279 WHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 402 ELATGGFSQANFLAEGGFGSVHRGVL-------PDGQAVAVKQHKLASSQGDHEFCSEVE 454
E+A + + L +G FG V+ G+ P+ + ++ AS + EF +E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 455 VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH--------QEPLEWSAR 506
V+ +VV L+G + + L++ E + G L S+L Q P
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 507 QKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566
++A A G+ YL+ VHRD+ N ++ DF +GDFG+ R + D +
Sbjct: 122 IQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 567 T-RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
+ + +++PE + G T +DV+SFGVVL E+ T
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 12/194 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VA+K K S D EF E +V+ H +V L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
R +V EY+ NG L ++L H + + S ++ G+ YL + +HRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLESK----QFIHRD 125
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT---FGYLAPEYAQSGQITEKA 590
+ N L+ V DFGL+R+ D + T +G+ + PE + + K+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 591 DVYSFGVVLVELVT 604
DV++FGV++ E+ +
Sbjct: 183 DVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 400 ELELATGGFSQANFLAEGGFGSVHRG--VLP---DGQAVAVKQHK-LASSQGDHEFCSEV 453
EL L+ F + L E FG +++G LP Q VA+K K + + Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 454 EVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHL--------YGCHQE------ 499
+++ H N+V L+G +++ +++EY+ G L L GC +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 500 -PLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558
L+ IA+ A G+ YL VH+D+ NIL+ + D GL+R
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQLHVKISDLGLSREI 174
Query: 559 PDGD-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
D V+ + + ++ PE G+ + +D++SFGVVL E+ +
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 414 LAEGGFGSVHRGVLPD---GQA---VAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FG V+ G D G+A VAVK ++ AS + EF +E V+ +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------KIAVGAARGLR 518
L+G + + L+V E + +G L S+L E R ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-------WQPDGDMGVETRVIG 571
YL+ + VHRD+ N ++ HDF +GDFG+ R ++ G + R
Sbjct: 134 YLNAKK----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 572 TFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
++APE + G T +D++SFGVVL E+ +
Sbjct: 187 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 76/284 (26%), Positives = 117/284 (41%), Gaps = 39/284 (13%)
Query: 414 LAEGGFGSVHRGVLPDGQA---VAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L EG FGSV G L + VAVK K+A + +F SE + H NV+ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 469 GFCIEDRRR------LLVYEYICNGSLDSHLY----GCHQEPLEWSARQKIAVGAARGLR 518
G C++ +++ ++ +G L S L G + L K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT-FGYLA 577
YL + +HRD+ N +L + V DFGL++ +GD + R+ ++A
Sbjct: 127 YLSSKS----FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 578 PEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637
E T K+DV+SFGV + E+ T +GQ P +E I + +
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT----------RGQT-----PYPGVENSEIYDYL 227
Query: 638 DPRLGNHYSEHE--VYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
R GN + + + S C +P RP + LE
Sbjct: 228 --RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 56/198 (28%), Positives = 85/198 (42%), Gaps = 12/198 (6%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +GGFG V + G+ A K + +L +G+ +E ++L R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ E + L LV + G L H+Y + + A GL +LH+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---- 115
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
IV+RD++P N+LL + D GLA G GT GY+APE Q
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDF 173
Query: 589 KADVYSFGVVLVELVTGR 606
D ++ G L E++ GR
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 12/230 (5%)
Query: 402 ELATGGFSQANFLAEGGFGSVHR-GVLPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCA 459
EL F + + L G G V + P G +A K H ++ E++VL
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 460 QHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRY 519
+V G D + E++ GSLD L + P E + IAV RGL Y
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAY 118
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
L E+ + I+HRD++P+NIL+ E + DFG++ D + +GT Y++PE
Sbjct: 119 LREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 172
Query: 580 YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 629
Q + ++D++S G+ LVEL GR + P ++ + RP+++
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIP--PPDAKELEAIFGRPVVD 220
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 52/221 (23%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCS--EVEVLSCAQHRNVV 465
L EG + V++ G+ VA+K+ KL + + F + E+++L +H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA----------- 514
L+ LV+E+ +++ L E + K V
Sbjct: 66 GLLDVFGHKSNINLVFEF-----METDL--------EKVIKDKSIVLTPADIKSYMLMTL 112
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW--QPDGDMGVETRVIGT 572
RGL YLH I+HRD++PNN+L+ D + DFGLAR P+ M +V+ T
Sbjct: 113 RGLEYLHSNW----ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT--HQVV-T 165
Query: 573 FGYLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
Y APE Y D++S G + EL+
Sbjct: 166 RWYRAPELLFGARHYGVG------VDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 69/285 (24%), Positives = 117/285 (41%), Gaps = 43/285 (15%)
Query: 411 ANFLAE-----GGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQH 461
ANF E G F V+R L D + VA+K+ ++ ++ + E+++L H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRY 519
NV+ + IED +V E G L + ++ R K V + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
+H ++HRD++P N+ +T +GD GL R+ + ++GT Y++PE
Sbjct: 122 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE 176
Query: 580 YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNR-------PKGQQCLTEWARPLLEEYA 632
K+D++S G +L E+ + ++ K +QC +Y
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC----------DYP 226
Query: 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677
P HYSE + S+CI DP RP + V +I
Sbjct: 227 ------PLPTEHYSEK----LRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 56/238 (23%), Positives = 89/238 (37%), Gaps = 67/238 (28%)
Query: 407 GFSQANFLAEGGFGSVHRGVL---PDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQ 460
+ + G +G V++ DG+ A+K+ K Q C E+ +L +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 461 HRNVVMLIGFCIEDRRRL--LVYEY-------ICNGSLDSHLYGCHQEPLEWSARQKIAV 511
H NVV L+ +E + L+++Y I H RQ V
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIK----FH-------------RQAKRV 103
Query: 512 GAAR------------GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLA 555
G+ YLH ++HRD++P NIL+ + +GD GLA
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
Query: 556 R--WQPDGDMGVETRVIGTFGYLAPE-------YAQSGQITEKADVYSFGVVLVELVT 604
R P + V+ T Y APE Y T+ D+++ G + EL+T
Sbjct: 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 11/194 (5%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLI 468
+ EG FG V++GV + AVAVK K +S E F E ++ H ++V LI
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G + +V E G L S+L ++ L+ ++ + + L YL +
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKR---- 127
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
VHRD+ N+L++ +GDFGL+R+ D ++ ++APE + T
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 589 KADVYSFGVVLVEL 602
+DV+ FGV + E+
Sbjct: 188 ASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 34/271 (12%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVML 467
+ EG FG + +L DG+ +K+ ++ S + E EV VLS +H N+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHEECR 525
E+ +V +Y G L + Q + + Q + V L+++H+
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDRK- 121
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
I+HRD++ NI LT D +GDFG+AR + + + IGT YL+PE ++
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICENRP 177
Query: 586 ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645
K+D+++ G VL E+ T + A + K +L+ I P + +HY
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL---------VLK---IIRGSYPPVSSHY 225
Query: 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
S Y + + S +R+P RP ++ +L
Sbjct: 226 S----YDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 412 NFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ + G +G V G+ VA+K KL+ E+ +L H NV+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDHENVIG 78
Query: 467 LIG-FCIEDRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAARGLRYLHEEC 524
L+ F Y+ + + L + L Q + RGL+Y+H
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS-- 136
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE----- 579
G I+HRD++P+NI + D E + DFGLAR D +M T + T Y APE
Sbjct: 137 -AG-IIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEM---TGYVATRWYRAPEIMLNW 190
Query: 580 --YAQSGQITEKADVYSFGVVLVELVTGR 606
Y Q+ D++S G ++ EL+TG+
Sbjct: 191 MHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 26/200 (13%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
+ G FG V G L D VAVK + +F E +L H N+V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 472 IEDRRRLLVYEYICNGSLDSHLY--GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+ + +V E + G + L G L+ ++ AA G+ YL + CI
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG--------YLAPEYA 581
HRD+ N L+T + DFG++R + DG V + G + APE
Sbjct: 117 -HRDLAARNCLVTEKNVLKISDFGMSREEEDG-------VYASTGGMKQIPVKWTAPEAL 168
Query: 582 QSGQITEKADVYSFGVVLVE 601
G+ + ++DV+SFG++L E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 66/221 (29%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--EFCSEVEVL-SCA 459
TG F + EG +G V++ GQ VA+K + D E E +L +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILRKYS 60
Query: 460 QHRNVVMLIGFCIEDRRRL------LVYEYICNGS---LDSHLYGCHQE-PLEWSARQKI 509
H N+ G I+ LV E GS L L + EW A I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--I 118
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
RGL YLHE ++HRD++ NILLT + E + DFG++ Q D +G
Sbjct: 119 LRETLRGLAYLHENK----VIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTF 173
Query: 570 IGTFGYLAPEYAQSGQ-----ITEKADVYSFGVVLVELVTG 605
IGT ++APE + ++DV+S G+ +EL G
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 44/125 (35%), Positives = 68/125 (54%), Gaps = 8/125 (6%)
Query: 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
E++ GSLD L + P + IAV RGL YL E+ + I+HRD++P+NIL+
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGKISIAV--LRGLTYLREKHK---IMHRDVKPSNILV 133
Query: 542 THDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVE 601
E + DFG++ D + +GT Y++PE Q T ++D++S G+ LVE
Sbjct: 134 NSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
Query: 602 LVTGR 606
+ GR
Sbjct: 191 MAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 408 FSQANFLAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA 459
F L G FG V H+G G+ A+K + L Q H E +L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQH-VAQEKSILMEL 75
Query: 460 QHRNVV-MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLE----WSARQKIAVGAA 514
H +V M+ F ++ R + E++ G L +HL + P + + A +A
Sbjct: 76 SHPFIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA---- 130
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
YLH + I++RD++P N+LL + V DFG A+ PD + GT
Sbjct: 131 --FEYLHSKD----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPE 180
Query: 575 YLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
YLAPE QS + D ++ GV+L E + G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 77/275 (28%), Positives = 119/275 (43%), Gaps = 35/275 (12%)
Query: 414 LAEGGFGSVHRGVL--PDGQAVAVKQHKLASSQGDHE---FCSEVEVLSCAQHRNVVMLI 468
L G FG + RG L P + + V H L + D + F +E L H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G ++V EY+ NG+LDS L H+ L + G A G++YL E +G
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSE---MG- 127
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL--APEYAQSGQI 586
VH+ + + +L+ D + F R Q D + T + G L APE Q
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 587 TEKADVYSFGVVLVELVT--GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644
+ +DV+SFG+V+ E+++ R D++ + + + R L PR +
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR----------LPAPR---N 232
Query: 645 YSEHEVYCMLHAASL-CIRRDPHSRPRMSQVLRIL 678
LH L C +++ RPR SQ+ IL
Sbjct: 233 CPNL-----LHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQHKLAS------SQGDHEFCSEVEVLSCAQHRNVVM 466
+ EG +G+V + + + VA+K+ +L S E C +L +H+N+V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKELKHKNIVR 63
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
L D++ LV+EY C+ L + C+ + + + +GL + H
Sbjct: 64 LYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAFCHSHN-- 119
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV----IGTFGYLAPEYAQ 582
++HRD++P N+L+ + E + DFGLAR G+ R + T Y P+
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVRCYSAEVVTLWYRPPDVLF 172
Query: 583 SGQI-TEKADVYSFGVVLVELVTG 605
++ + D++S G + EL
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 45/242 (18%)
Query: 393 PRW-FSYAELELATGGFSQANFLAEGGFGSV--------HRGVLPDGQAVAVKQHKLASS 443
PRW FS +L L L EG FG V + + VAVK K ++
Sbjct: 8 PRWEFSRDKLTLGKP-------LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60
Query: 444 QGD-HEFCSEVEVLS-CAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG------ 495
+ D + SE+E++ +H+N++ L+G C +D ++ EY G+L +L
Sbjct: 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120
Query: 496 --------CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
E + + ARG+ YL + CI HRD+ N+L+T +
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCI-HRDLAARNVLVTENNVM 176
Query: 548 LVGDFGLARWQPDGDMGVETRVIGTFG-----YLAPEYAQSGQITEKADVYSFGVVLVEL 602
+ DFGLAR + D +T T G ++APE T ++DV+SFGV++ E+
Sbjct: 177 KIADFGLARDVNNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
Query: 603 VT 604
T
Sbjct: 233 FT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 73/241 (30%), Positives = 110/241 (45%), Gaps = 43/241 (17%)
Query: 393 PRWFSYAELELATGGFSQANFLAEGGFGSV----HRGVLPDGQA----VAVKQHKLASSQ 444
P+W EL+ + L EG FG V G+ D VAVK K ++
Sbjct: 5 PKW------ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58
Query: 445 GD-HEFCSEVEVLS-CAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG------- 495
D + SE+E++ +H+N++ L+G C +D ++ EY G+L +L
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 496 -----CH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548
C +E L + A ARG+ YL + CI HRD+ N+L+T D
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCI-HRDLAARNVLVTEDNVMK 174
Query: 549 VGDFGLARWQPDGDMGVETRVIGTFG-----YLAPEYAQSGQITEKADVYSFGVVLVELV 603
+ DFGLAR + D +T T G ++APE T ++DV+SFGV+L E+
Sbjct: 175 IADFGLARDVHNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230
Query: 604 T 604
T
Sbjct: 231 T 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 414 LAEGGFGSVHRG-VLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA--QHRNVVMLIGF 470
+ EG FG ++ D + +K+ L + S+ EV+ A +H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHEECRVGC 528
E+ R +V EY G L + Q + +S Q ++ V + GL+++H+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRIN--RQRGVLFSEDQILSWFVQISLGLKHIHDRK---- 121
Query: 529 IVHRDMRPNNILLTHD-FEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT 587
I+HRD++ NI L+ + +GDFG+AR Q + M + +GT YL+PE Q+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQNRPYN 180
Query: 588 EKADVYSFGVVLVELVT 604
K D++S G VL EL T
Sbjct: 181 NKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQH 461
F + L G FG+V++G+ +P+G+ VA+K+ + A+S + + E E V++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG-----CHQEPLEWSARQKIAVGAARG 516
+V L+G C+ +L + + + G L ++ Q L W V A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG-- 574
+ YL E +VHRD+ N+L+ + DFGLA+ +G + + G
Sbjct: 122 MNYLEERR----LVHRDLAARNVLVKTPQHVKITDFGLAKL-----LGADEKEYHAEGGK 172
Query: 575 ----YLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVD 610
++A E T ++DV+S+GV + EL+T G K D
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 53/205 (25%), Positives = 79/205 (38%), Gaps = 18/205 (8%)
Query: 414 LAEGGFGSVHRGVLP------DGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L G FG V V VK K EF E+++ H+NVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHL-------YGCHQEPLEWSARQKIAVGAARGLRY 519
L+G C E ++ EY G L L PL + + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
L VHRD+ N L++ E V L++ + + + +LAPE
Sbjct: 133 LSN----ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 580 YAQSGQITEKADVYSFGVVLVELVT 604
Q + K+DV+SFGV++ E+ T
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 24/248 (9%)
Query: 430 GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489
G+ VAVK+ L Q +EV ++ QH NVV + + +V E++ G+L
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549
+ + +A + + + L LH + ++HRD++ ++ILLTHD +
Sbjct: 105 TDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQG----VIHRDIKSDSILLTHDGRVKL 157
Query: 550 GDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAV 609
DFG Q ++ ++GT ++APE + D++S G++++E+V G
Sbjct: 158 SDFGFCA-QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
Query: 610 DLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHA-ASLCIRRDPHSR 668
N P PL I + + P+L N H+V L + RDP R
Sbjct: 217 -FNEP-----------PLKAMKMIRDNLPPKLKN---LHKVSPSLKGFLDRLLVRDPAQR 261
Query: 669 PRMSQVLR 676
+++L+
Sbjct: 262 ATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFC 471
L EG + +V++G +G+ VA+K +L +G E +L +H N+V+L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 472 IEDRRRLLVYEYI----CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
LV+EY+ C +D H G H E ++ Q + RGL Y+H+
Sbjct: 73 HTKETLTLVFEYVHTDLCQ-YMDKHPGGLHPENVKLFLFQLL-----RGLSYIHQRY--- 123
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE-YAQSGQI 586
I+HRD++P N+L++ E + DFGLAR + V+ T Y P+ S +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 587 TEKADVYSFGVVLVELVTGRKA 608
+ D++ G + VE++ G A
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 61/249 (24%), Positives = 109/249 (43%), Gaps = 26/249 (10%)
Query: 430 GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489
G+ VAVK+ L Q +EV ++ QH N+V + + +V E++ G+L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 490 -DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548
D + E + + + L +LH + ++HRD++ ++ILLT D
Sbjct: 104 TDIVTHTRMNEE----QIATVCLAVLKALSFLHAQG----VIHRDIKSDSILLTSDGRVK 155
Query: 549 VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKA 608
+ DFG Q ++ ++GT ++APE + D++S G++++E+V G
Sbjct: 156 LSDFGFCA-QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
Query: 609 VDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHA-ASLCIRRDPHS 667
N P PL I + + P+L N H+V L + + RDP
Sbjct: 215 Y-FNEP-----------PLQAMKRIRDNLPPKLKNL---HKVSPRLRSFLDRMLVRDPAQ 259
Query: 668 RPRMSQVLR 676
R +++L
Sbjct: 260 RATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 12/204 (5%)
Query: 408 FSQANFLAEGGFGSVHR-GVLPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRN 463
F L +GGFG V V G+ A K + ++ +G+ +E ++L R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
VV L + E + L LV + G L H+Y + A GL LH
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ 582
E IV+RD++P NILL + D GLA P+G+ + RV GT GY+APE +
Sbjct: 121 ER----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVK 174
Query: 583 SGQITEKADVYSFGVVLVELVTGR 606
+ + T D + G ++ E++ G+
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKLASSQGDHEF----CSEVEVLSCAQHRNVV 465
+ EG +G V +R GQ VA+K K S+ D E+ +L +H N+V
Sbjct: 9 IGEGSYGVVFKCRNR---ETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 466 MLIGFCIEDRRRLLVYEYICNGS----LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
LI R+ LV+EY C+ + L+ + G + + +KI + + + H
Sbjct: 64 NLIEVFRRKRKLHLVFEY-CDHTVLNELEKNPRGVPEHLI-----KKIIWQTLQAVNFCH 117
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW--QPDGDMGVETRVIGTFGYLAPE 579
+ CI HRD++P NIL+T + + DFG AR P D T + T Y APE
Sbjct: 118 KH---NCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDY---TDYVATRWYRAPE 170
Query: 580 Y-AQSGQITEKADVYSFGVVLVELVTG 605
Q DV++ G V EL+TG
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 75/298 (25%), Positives = 120/298 (40%), Gaps = 60/298 (20%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQ---HRNVVML 467
L +G FGSV+ G+ VA+K+ K S E + EV S + H N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNEHPNIVKL 63
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQE-PLEWSARQKIAVGAARGLRYLHEECRV 526
E+ V+EY G+L L + P S + I +GL ++H +
Sbjct: 64 KEVFRENDELYFVFEY-MEGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KH 118
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE-----TRVIGTFGYLAPE-Y 580
G HRD++P N+L++ + DFGLAR + T + T Y APE
Sbjct: 119 G-FFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAPEIL 170
Query: 581 AQSGQITEKADVYSFGVVLVELVT------GRKAVD-LNR-------------PKGQQCL 620
+S + D+++ G ++ EL T G +D L + P+G +
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230
Query: 621 TEWAR--PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
++ P ++ +L + N E + +R DP RP SQ L+
Sbjct: 231 SKLGFRFPQFAPTSLHQL----IPNASPEA-----IDLIKDMLRWDPKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 28/175 (16%)
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG---DMG 564
K+ V + L YL E+ V +HRD++P+NILL + DFG++ G D
Sbjct: 118 KMTVAIVKALHYLKEKHGV---IHRDVKPSNILLDASGNVKLCDFGIS-----GRLVDSK 169
Query: 565 VETRVIGTFGYLAPEYAQSGQITEK----ADVYSFGVVLVELVTGRKAVDLNRPKGQQCL 620
+TR G Y+APE K ADV+S G+ LVEL TG+ C
Sbjct: 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN-------CK 222
Query: 621 TEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVL 675
TE+ +L + +E P L + +C LC+ +D RP+ ++L
Sbjct: 223 TEFE--VLTKILQEEP--PSLPPNEGFSPDFCSF--VDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 414 LAEGGFGSVHRGVLPDGQA-----------------VAVKQHKL-ASSQGDHEFCSEVEV 455
L EG FG VH + + Q VAVK + A+ ++F EV++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQE---------------- 499
LS + N++ L+G C+++ ++ EY+ NG L+ L H +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 500 -PLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558
+ +S+ +A+ A G++YL VHRD+ N L+ + + DFG++R
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL----NFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 559 PDGD-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELV 603
GD ++ R + ++A E G+ T +DV++FGV L E++
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
KIAV + L YLH + V +HRD++P+N+L+ + + + DFG++ + D + +T
Sbjct: 107 KIAVSIVKALEYLHSKLSV---IHRDVKPSNVLINRNGQVKLCDFGISGYLVD-SV-AKT 161
Query: 568 RVIGTFGYLAPEY----AQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW 623
G Y+APE K+DV+S G+ ++EL TGR D W
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SW 210
Query: 624 ARPLLEEYAIDELVDPRL-GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVL 675
P + + E P+L +S + + C++++ RP ++L
Sbjct: 211 KTPFQQLKQVVEEPSPQLPAEKFSPEFQDFV----NKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 75/286 (26%), Positives = 125/286 (43%), Gaps = 43/286 (15%)
Query: 414 LAEGGFGSVHRGVLPDGQAVA---VKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ G FG V + VA VK+ K ASS+ +EF + + QH N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSAR----QKIAVGAARGLRYLHEECR 525
C+E LLV+EY G L S+L ++ +++ Q++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYL--SQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-- 118
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGL--ARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
+H D+ N LT D VGD+G+ +R++ D + E +LAPE
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-IETEDDKCVPLRWLAPELVGE 175
Query: 584 GQ-------ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636
T+ ++V++ GV L EL +P E ++++ + +L
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAA-----QPYSHLSDREVLNHVIKDQQV-KL 229
Query: 637 VDPRLGNHYSE--HEV--YCMLHAASLCIRRDPHSRPRMSQVLRIL 678
P+L YSE +EV +C L P R +V R+L
Sbjct: 230 FKPQLELPYSERWYEVLQFCWL---------SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 414 LAEGGFGSVH----RGVLP-------------DGQAVAVKQHKL-ASSQGDHEFCSEVEV 455
L EG FG VH G+ VAVK + A+ ++F E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK------- 508
+S + N++ L+ CI ++ EY+ NG L+ L EP E + +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL--SRHEPQEAAEKADVVTISYS 130
Query: 509 ----IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD-M 563
+A A G++YL VHRD+ N L+ ++ + DFG++R GD
Sbjct: 131 TLIFMATQIASGMKYLSSL----NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
++ R + +++ E G+ T +DV++FGV L E++T
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 414 LAEGGFGSVH------RGVLPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVV 465
L EG FG V G G+ VAVK K S G+H + E+E+L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIV 69
Query: 466 MLIGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
G C ED L+ E++ +GSL +L ++ + + K AV +G+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD--GDMGVETRVIGTFGYLAPEYA 581
VHRD+ N+L+ + + +GDFGL + V+ + + APE
Sbjct: 129 Q----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 582 QSGQITEKADVYSFGVVLVELVT 604
+ +DV+SFGV L EL+T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 43/138 (31%), Positives = 64/138 (46%), Gaps = 13/138 (9%)
Query: 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538
LV EY+ G S + P +W A+Q IA G+ LH+ I+HRD++P N
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQRG----IIHRDIKPEN 127
Query: 539 ILLTHDFEPLVGDFGLARWQPDGDMGVET-RVIGTFGYLAPEYAQSGQITEKADVYSFGV 597
+L+ + DFGL+R G+E + +GT YLAPE + +D +S G
Sbjct: 128 LLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 598 VLVELVTGRKAVDLNRPK 615
V+ E + G P
Sbjct: 182 VIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 7e-12
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLS-CAQHRN 463
G F + G +G V++G + GQ A+K + + + E E+ +L + HRN
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRN 64
Query: 464 VVMLIGFCIE------DRRRLLVYEYICNGSLDSHLYGCHQEPL--EWSARQKIAVGAAR 515
+ G I+ D + LV E+ GS+ + L EW A I R
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILR 122
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY 575
GL +LH+ ++HRD++ N+LLT + E + DFG++ Q D +G IGT +
Sbjct: 123 GLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYW 177
Query: 576 LAPEYAQSGQITE-----KADVYSFGVVLVELVTG 605
+APE + + K+D++S G+ +E+ G
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 7e-12
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 42/218 (19%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ G +G V V G+ VA+K K+++ D E+++L +H N++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 467 LIG-FCIEDRRRL----LVYEYICNGSLDSHLYGCHQ-----EPLEWSARQKIAVGAARG 516
L+ +V E +++ L H+ +PL Q RG
Sbjct: 64 LLDILRPPSPEDFNDVYIVTEL-----METDL---HKVIKSPQPLTDDHIQYFLYQILRG 115
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDM------GVETRV 569
L+YLH ++HRD++P+NIL+ + + + DFGLAR PD D V TR
Sbjct: 116 LKYLHS----ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 570 IGTFGYLAPE-YAQSGQITEKADVYSFGVVLVELVTGR 606
Y APE S + T+ D++S G + EL+T +
Sbjct: 172 -----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEF-CSEVE--VLSCA-QHRNVVMLI 468
L +G FG V L Q A+K K D + C+ VE VLS A +H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 469 GFCIEDRRRLL--VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+C + L V EY+ G L H+ CH+ L + A GL++LH +
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKG-- 116
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
IV+RD++ +NILL D + DFG+ + GD T GT Y+APE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKY 173
Query: 587 TEKADVYSFGVVLVELVTGR 606
D +SFGV+L E++ G+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNVVMLIGF 470
L EG FG V++ + G+ VA+K+ + + + + E+++L +H NVV LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 471 CIE-----DRRRLLVY---EYICNGSLDSHLYGCHQEP---LEWSARQKIAVGAARGLRY 519
+E R+R VY Y +D L G + P L S + + G+ Y
Sbjct: 76 AVERPDKSKRKRGSVYMVTPY-----MDHDLSGLLENPSVKLTESQIKCYMLQLLEGINY 130
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR--------WQPDGDMGVE--TRV 569
LHE I+HRD++ NIL+ + + DFGLAR + G G T +
Sbjct: 131 LHENH----ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 570 IGTFGYLAPEY-AQSGQITEKADVYSFGVVLVELVTGR 606
+ T Y PE + T D++ G V E+ T R
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 33/271 (12%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGF 470
L G FG VH G VA+K A ++G + +F E +V+ H +V L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIK----AINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 471 CIEDRRRLLVYEYICNGSLDSHL---YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
C + + +V E++ NG L ++L G + + S Q + G+ YL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDV----CEGMEYLERN---- 119
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT 587
+HRD+ N L++ V DFG+ R+ D + + + PE + +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 588 EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647
K+DV+SFGV++ E+ T K + + + + +R L P+L +
Sbjct: 180 SKSDVWSFGVLMWEVFTEGK-MPFEKKSNYEVVEMISRG-------FRLYRPKLASMT-- 229
Query: 648 HEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678
VY ++++ C P RP +++LR +
Sbjct: 230 --VYEVMYS---CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKL--ASSQGDHEFCS---EVEVLSCAQH 461
+ + L +G FG V+ D G+ +A KQ + S + E + E+++L QH
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 462 RNVVMLIGFCIEDR--RRLLVY-EYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARG 516
+V G C+ DR + L ++ EY+ GS+ L YG E S +K G
Sbjct: 64 ERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE----SVTRKYTRQILEG 118
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETR-VIGTFG 574
+ YLH IVHRD++ NIL +GDFG + R Q G R V GT
Sbjct: 119 MSYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 575 YLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
+++PE KADV+S G +VE++T +
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK-----QHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L G FG+V++G+ +P+G+ V + ++ + + EF E +++ H ++V L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C+ +L V + + +G L +++ H++ + V A+G+ YL EE R
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYL-EERR-- 129
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSGQ 585
+VHRD+ N+L+ + DFGLAR +GD G ++A E +
Sbjct: 130 -LVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 586 ITEKADVYSFGVVLVELVT-GRKAVD 610
T ++DV+S+GV + EL+T G K D
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G G+V+ + + GQ VA+KQ L +E+ V+ +H N+V + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+V EY+ GSL + + + +A + + A L +LH ++HR
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA---LEFLHSNQ----VIHR 139
Query: 533 DMRPNNILLTHDFEPLVGDFGL-ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKAD 591
D++ +NILL D + DFG A+ P+ + ++GT ++APE K D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 592 VYSFGVVLVELVTG 605
++S G++ +E+V G
Sbjct: 198 IWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 408 FSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHK--LASSQGDHEFCSEVEVLSCAQH 461
F+ L +G FGSV L Q VAVK K + SS EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 462 RNVVMLIGFCIEDRRR------LLVYEYICNGSLDSHLYGCH--QEPLEWSARQ--KIAV 511
NV+ LIG + R + +++ ++ +G L + L +EP + + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD---MGVETR 568
A G+ YL + +HRD+ N +L + V DFGL++ GD G ++
Sbjct: 121 DIASGMEYLSSKN----FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 569 VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
+ +LA E T +DV++FGV + E++T
Sbjct: 177 L--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 54/189 (28%), Positives = 93/189 (49%), Gaps = 20/189 (10%)
Query: 430 GQAVAVKQHKL----ASSQGD--HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483
G +AVKQ +S Q + E+ +++ H +++ ++G ED L E+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 484 ICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
+ GS+ L YG +E + + +++ RGL YLHE I+HRD++ N+L+
Sbjct: 85 MAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHENQ----IIHRDVKGANLLI 136
Query: 542 THDFEPL-VGDFGLA-RWQPDGDMGVETR--VIGTFGYLAPEYAQSGQITEKADVYSFGV 597
+ L + DFG A R G E + ++GT ++APE + Q DV+S G
Sbjct: 137 DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGC 196
Query: 598 VLVELVTGR 606
V++E+ T +
Sbjct: 197 VIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 414 LAEGGFGSV-HRGVLPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +GGFG V V G+ A K+ +L G+ E E+L +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ E + L LV + G L H+Y + LE + G+ +LH +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD- 115
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
IV+RDM+P N+LL + D GLA DG T+ GT GY+APE + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSY 173
Query: 589 KADVYSFGVVLVELVTGR 606
D ++ G + E+V GR
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 408 FSQANFLAEGGFGSVHR-GVLPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRN 463
F L +GGFG V V G+ A K+ ++ +G+ +E +L R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR---GLRY 519
VV L + E + L LV + G L H+Y + Q+ AA GL
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIFYAAELCCGLED 117
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
L E IV+RD++P NILL + D GLA P+G+ V RV GT GY+APE
Sbjct: 118 LQRER----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPE 171
Query: 580 YAQSGQITEKADVYSFGVVLVELVTGR 606
+ + T D + G ++ E++ G+
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 31/210 (14%)
Query: 414 LAEGGFGSVHRGVL--PDGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIG- 469
L +G +GSV++ VL P G +A+K+ +L + ++ E+++L A +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 470 FCIEDRRRLLVY---EYICNGSLDSHLY--GCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
F IE VY EY+ GSLD LY G E + ++I +GL++L EE
Sbjct: 68 FFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM--GVETRVIGTFGYLAPEYAQ 582
I+HRD++P N+L+ + + + DFG++ G++ + IG Y+APE +
Sbjct: 123 N---IIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPERIK 174
Query: 583 SGQITE------KADVYSFGVVLVELVTGR 606
SG + ++DV+S G+ ++E+ GR
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRNVVMLIG 469
L EG + +V +G VA+K+ +L +G C+ EV +L +H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP--CTAIREVSLLKNLKHANIVTLHD 70
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV-GAARGLRYLHEECRVGC 528
+R LV+EY+ + L +L C L KI + RGL Y H+
Sbjct: 71 IIHTERCLTLVFEYL-DSDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---- 123
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE-YAQSGQIT 587
I+HRD++P N+L+ E + DFGLAR + V+ T Y P+ S + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYS 182
Query: 588 EKADVYSFGVVLVELVTGR 606
D++ G +L E+ TGR
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 28/203 (13%)
Query: 414 LAEGGFGSVHR------GVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L +G FG V++ GVL + + K S + ++ E+++L+ H N+V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKL 67
Query: 468 I-GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ F E+ +L+ E+ G++D+ + + PL + + L YLHE
Sbjct: 68 LDAFYYENNLWILI-EFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK-- 123
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR--VIGTFGYLAPEYAQSG 584
I+HRD++ NIL T D + + DFG++ ++ R IGT ++APE
Sbjct: 124 --IIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 585 QITE-----KADVYSFGVVLVEL 602
+ KADV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 417 GGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEV-----LSCAQHRNVVMLIGF 470
G +G+V++ P G VA+K ++ +++ + EV L H N+V L+
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70
Query: 471 CIEDR-----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
C R + LV+E++ + L ++L L + + RGL +LH
Sbjct: 71 CATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---- 125
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
CIVHRD++P NIL+T + + DFGLAR M + T V+ T Y APE
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLARIY-SCQMAL-TPVVVTLWYRAPEVLLQST 183
Query: 586 ITEKADVYSFGVVLVEL 602
D++S G + E+
Sbjct: 184 YATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNVV--- 465
N + EG +G V+R G+ VA+K+ K+ + S E+ +L QH N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 466 -MLIGFCIEDRRRLLVYEYICNGSLDSH----LYGCHQEPLEWSARQKIAVGAARGLRYL 520
+++G ++ +V EY+ H L ++P S + + + G+ +L
Sbjct: 71 EVVVGSNLDKI--YMVMEYV------EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQ-PDGDMGVETRVIGTFGYLAP 578
H+ I+HRD++ +N+LL + + DFGLAR + P T+++ T Y AP
Sbjct: 123 HDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY---TQLVVTLWYRAP 175
Query: 579 EYAQSGQI-TEKADVYSFGVVLVELVTGR 606
E + + D++S G + EL+T +
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFC-SEVEVLSCAQHRNVV 465
F Q L EG + +V++G G+ VA+K+ L + +G E+ ++ +H N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
L + + +LV+EY + L ++ +G + L+ + + +G+ + HE
Sbjct: 62 RLHDVIHTENKLMLVFEY-MDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG-------YL 576
++HRD++P N+L+ E + DFGLAR G+ + TF Y
Sbjct: 120 R----VLHRDLKPQNLLINKRGELKLADFGLAR-----AFGIP---VNTFSNEVVTLWYR 167
Query: 577 APE-YAQSGQITEKADVYSFGVVLVELVTGR 606
AP+ S + D++S G ++ E++TGR
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 20/199 (10%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG V++ + G A K + S + ++ E+E+L+ H +V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 473 EDRRRLLVYEYICNGSLDSHLY----GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
D + ++ E+ G++D+ + G + ++ RQ + L+YLH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSMK---- 130
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
I+HRD++ N+LLT D + + DFG++ + + IGT ++APE + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 589 -----KADVYSFGVVLVEL 602
KAD++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 412 NFLAEGGFGSVHRGVLPDG-----QAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVV 465
+ L EG FG + G+L D + V VK K +S+ E +L H+N++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 466 MLIGFCIEDRRRLLV-YEYICNGSLDSHLYGCH----QEPLEWSARQ--KIAVGAARGLR 518
++ CIED V Y Y+ G+L L C P S +Q +A+ A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR------WQPDGDMGVETRVIGT 572
YLH + G ++H+D+ N ++ + + + D L+R + GD E R +
Sbjct: 132 YLH---KRG-VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN--ENRPVK- 184
Query: 573 FGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
++A E + + + +DV+SFGV+L EL+T
Sbjct: 185 --WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 416 EGGFGSV----HRGVLPDGQAVAVKQHKLASSQGDHEF----CSEVEVLSCAQHRNVVML 467
EG +G V H+ GQ VA+K K S+ D E+ +L +H N+V L
Sbjct: 11 EGSYGMVMKCKHK---ETGQIVAIK--KFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
I +R LV+E++ + LD + L+ S +K RG+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH---- 119
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
I+HRD++P NIL++ + DFG AR G+ V T + T Y APE
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTK 177
Query: 587 TEKA-DVYSFGVVLVELVTG 605
+A D+++ G ++ E++TG
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 56/194 (28%), Positives = 82/194 (42%), Gaps = 7/194 (3%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V VAVK K S F +E V+ QH +V L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
++ E++ GSL L + A G+ ++ + +HRD
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRD 127
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
+R NIL++ + DFGLAR D + + APE G T K+DV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 594 SFGVVLVELVT-GR 606
SFG++L+E+VT GR
Sbjct: 188 SFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 8/155 (5%)
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV 511
E++VL +V G D + E++ GSLD L + P + + IAV
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG 571
+GL YL E+ + I+HRD++P+NIL+ E + DFG++ D + +G
Sbjct: 113 --IKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVG 164
Query: 572 TFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
T Y++PE Q + ++D++S G+ LVE+ GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 414 LAEGGFGSVHR-GVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L GGFG V V + A+K +H + + Q +H F E E+L H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 469 -GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL--EWSARQKIAVGAARGLRYLHEEC 524
F +D++ + ++ EY G L + L L E++AR IA YLH
Sbjct: 60 RTF--KDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIA-CVVLAFEYLHNRG 113
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR---VIGTFGYLAPEYA 581
I++RD++P N+LL + + DFG A+ + + GT Y+APE
Sbjct: 114 ----IIYRDLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTWTFCGTPEYVAPEII 164
Query: 582 QSGQITEKADVYSFGVVLVELVTGR 606
+ D +S G++L EL+TGR
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW---QPDGDMGVETRVIG 571
RGL+Y+H ++HRD++P+N+L+ D E +GDFG+AR P T +
Sbjct: 118 RGLKYIHS----ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 572 TFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAV 609
T Y APE S + T D++S G + E++ GR+ +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHR 462
+++ + EG +G V++G GQ VA+K+ +L S + S E+ +L QH
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHP 59
Query: 463 NVVMLIGFCIEDRRRLLVYEYIC---NGSLDSHLYGCHQEP-LEWSARQKIAVGAARGLR 518
N+V L +++ R L++E++ LDS G + + L S +I +G+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQI----LQGIL 115
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV----IGTFG 574
+ H RV +HRD++P N+L+ + + DFGLAR G+ RV + T
Sbjct: 116 FCHSR-RV---LHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEVVTLW 166
Query: 575 YLAPEYAQSGQ-ITEKADVYSFGVVLVELVTGR 606
Y APE + D++S G + E+ T +
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 75/271 (27%), Positives = 116/271 (42%), Gaps = 33/271 (12%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQHRNVVML 467
+ +G +G V HR DG+ +K+ L AS + E ++LS +H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 468 I-GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ ED +V + G L L + L + + V A L+YLHE+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
I+HRD++ N+ LT VGD G+AR + DM + +IGT Y++PE +
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STLIGTPYYMSPELFSNKP 178
Query: 586 ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645
K+DV++ G + E+ T + A + K L Y I E P + Y
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFN---AKDMNSLV---------YRIIEGKLPPMPKDY 226
Query: 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
S L A L + P RP + +LR
Sbjct: 227 SPELG--ELIATMLS--KRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 43/282 (15%)
Query: 411 ANFLAE-----GGFGSVHRGV-LPDGQAVAVKQHK---LASSQGDHEFCSEVEVLSCAQH 461
ANF E G F V+R L DG VA+K+ + L ++ + E+++L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRY 519
NV+ IED +V E G L + + + + K V L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
+H ++HRD++P N+ +T +GD GL R+ + ++GT Y++PE
Sbjct: 122 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE 176
Query: 580 YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNR-------PKGQQCLTEWARPLLEEYA 632
K+D++S G +L E+ + ++ K +QC +Y
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC----------DYP 226
Query: 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQV 674
P +HYSE + ++CI DP RP ++ V
Sbjct: 227 ------PLPSDHYSEE----LRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 81/319 (25%), Positives = 129/319 (40%), Gaps = 54/319 (16%)
Query: 373 PGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSV----HRGVLP 428
P P S + P S +ELE + N + G G+V HR P
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELE-------RVNRIGSGAGGTVYKVIHR---P 97
Query: 429 DGQAVAVKQHKLASSQGDHE------FCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482
G+ A+K G+HE C E+E+L H NVV + ++ E
Sbjct: 98 TGRLYALK-----VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152
Query: 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542
++ GSL+ ++ L ARQ ++ G+ YLH IVHRD++P+N+L+
Sbjct: 153 FMDGGSLEGTHIA-DEQFLADVARQILS-----GIAYLHRRH----IVHRDIKPSNLLIN 202
Query: 543 HDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS----GQITEKA-DVYSFGV 597
+ DFG++R M +GT Y++PE + G A D++S GV
Sbjct: 203 SAKNVKIADFGVSRILAQ-TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGV 261
Query: 598 VLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAA 657
++E GR + R +G +WA + P + H + C
Sbjct: 262 SILEFYLGRFPFGVGR-QG-----DWASLMCAICMSQPPEAPATASREFRHFISC----- 310
Query: 658 SLCIRRDPHSRPRMSQVLR 676
C++R+P R Q+L+
Sbjct: 311 --CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 62/289 (21%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQH-RNVVMLIG- 469
+ G FG+V++ + G +AVK+ + + + +++V+ + +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 470 --------FCIE------DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR 515
C+E D+ VYE + + + G KIAV +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILG------------KIAVATVK 118
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG---DMGVETRVIGT 572
L YL EE + I+HRD++P+NILL + + DFG++ G D +TR G
Sbjct: 119 ALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGC 170
Query: 573 FGYLAPEYAQSGQITE---KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 629
Y+APE ++DV+S G+ L E+ TG+ +W + +
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KW-NSVFD 218
Query: 630 EYAIDELVD---PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVL 675
+ + ++V P L N ++ +LC+ +D RP+ ++L
Sbjct: 219 Q--LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL-ASSQG-DHEFCSEVEVLSCAQHRNV 464
F + + EG +G V++ G+ VA+K+ +L ++G E+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
V L+ + + LV+E++ + L + + + +GL + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH- 119
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV----IGTFGYLAPEY 580
RV +HRD++P N+L+ + + DFGLAR GV R + T Y APE
Sbjct: 120 RV---LHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEVVTLWYRAPEI 171
Query: 581 AQSGQITEKA-DVYSFGVVLVELVTGRKAV 609
+ A D++S G + E+VT R+A+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 30/212 (14%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL-ASSQGDHEFC-SEVEVL---SCAQH 461
+ + + EG +G+V++ L G+ VA+K+ ++ S +G E+ +L +H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 462 RNVVMLIGFC--IEDRRRL---LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARG 516
N+V L+ C R L LV+E+ + L ++L C + L + + RG
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL 576
+ +LH IVHRD++P NIL+T D + + DFGLAR +M + T V+ T Y
Sbjct: 120 VDFLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMAL-TSVVVTLWYR 173
Query: 577 APE------YAQSGQITEKADVYSFGVVLVEL 602
APE YA D++S G + EL
Sbjct: 174 APEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 59/247 (23%), Positives = 108/247 (43%), Gaps = 24/247 (9%)
Query: 430 GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489
G+ VAVK+ L Q +EV ++ H NVV + + +V E++ G+L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549
+ + + + + R L YLH + ++HRD++ ++ILLT D +
Sbjct: 107 TDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQG----VIHRDIKSDSILLTSDGRIKL 159
Query: 550 GDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAV 609
DFG Q ++ ++GT ++APE + D++S G++++E++ G
Sbjct: 160 SDFGFCA-QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
Query: 610 DLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHA-ASLCIRRDPHSR 668
N P PL I + + PR+ + H+V +L L + R+P R
Sbjct: 219 -FNEP-----------PLQAMRRIRDNLPPRVKD---SHKVSSVLRGFLDLMLVREPSQR 263
Query: 669 PRMSQVL 675
++L
Sbjct: 264 ATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 430 GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489
G+ VAVK L Q +EV ++ QH+NVV + + ++ E++ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549
+ Q L + + L YLH + ++HRD++ ++ILLT D +
Sbjct: 106 TDIV---SQTRLNEEQIATVCESVLQALCYLHSQG----VIHRDIKSDSILLTLDGRVKL 158
Query: 550 GDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
DFG Q D+ ++GT ++APE + D++S G++++E+V G
Sbjct: 159 SDFGFCA-QISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 399 AELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLS 457
+ L G F + G +G V++G + GQ A+K + + + E E+ +L
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLK 67
Query: 458 -CAQHRNVVMLIGFCIE------DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
+ HRN+ G I+ D + LV E+ GS+ + L+ I
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI 570
RGL +LH ++HRD++ N+LLT + E + DFG++ Q D +G I
Sbjct: 128 REILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFI 182
Query: 571 GTFGYLAPEYAQSGQITE-----KADVYSFGVVLVELVTG 605
GT ++APE + + ++D++S G+ +E+ G
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 12/139 (8%)
Query: 471 CIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKI-AVGAARGLRYLHEECRVGC 528
C + + RL V EY+ G L H+ + R + A GL++LHE
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP---RARFYAAEIVLGLQFLHERG---- 116
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPEYAQSGQIT 587
I++RD++ +N+LL + + DFG+ + G GV T GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 588 EKADVYSFGVVLVELVTGR 606
D ++ GV+L E++ G+
Sbjct: 175 PAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 21/194 (10%)
Query: 430 GQAVAVKQHKLASSQGDHEFCS-EVEVLSCAQ--HRNVVMLI--GFCIEDRRRLLVYEYI 484
G VA+K + + + +H+ E CA+ H N+V L+ G V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-H 543
+L L L ++ + L H + IVHRD++P NI+++
Sbjct: 62 PGRTLREVL--AADGALPAGETGRLMLQVLDALACAHNQG----IVHRDLKPQNIMVSQT 115
Query: 544 DFEP--LVGDFGLARWQPD-GDMGV-----ETRVIGTFGYLAPEYAQSGQITEKADVYSF 595
P V DFG+ P D V T V+GT Y APE + +T +D+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 596 GVVLVELVTGRKAV 609
G++ +E +TG++ V
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 16/181 (8%)
Query: 430 GQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICN 486
GQ VA+K+ ++ E+++L +H N++ L I + V E +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-- 92
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
D H PLE Q RGL+Y+H +VHRD++P+NIL+ + +
Sbjct: 93 -GTDLHRL-LTSRPLEKQFIQYFLYQILRGLKYVHS----AGVVHRDLKPSNILINENCD 146
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ-ITEKADVYSFGVVLVELVTG 605
+ DFGLAR Q D M T + T Y APE + Q + D++S G + E++ G
Sbjct: 147 LKICDFGLARIQ-DPQM---TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 606 R 606
+
Sbjct: 203 K 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 9/93 (9%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
+GL+Y+H I+HRD++P N+ + D E + DFGLAR Q D +M T + T
Sbjct: 129 KGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEM---TGYVVTRW 180
Query: 575 YLAPEYAQSG-QITEKADVYSFGVVLVELVTGR 606
Y APE + T+ D++S G ++ E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 414 LAEGGFGSVHRG--VLPDGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRNVVMLI 468
L EG + +V++G L D VA+K+ +L +G C+ EV +L +H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLH 70
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEEC 524
++ LV+EY+ + L +L C + ++ Q + RGL Y H
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLL-----RGLNYCHRRK 124
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE-YAQS 583
++HRD++P N+L+ E + DFGLAR + V+ T Y P+ S
Sbjct: 125 ----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179
Query: 584 GQITEKADVYSFGVVLVELVTGR 606
+ + D++ G + E+ TGR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 414 LAEGGFGSVH--RGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV-----LSCAQHRNVVM 466
+ EG +G V R + G+ VA+K+ ++ + + + EV L +H NVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 467 LIGFCIEDR-----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
L C R + LV+E++ + L ++L + + + + RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA 581
RV VHRD++P NIL+T + + DFGLAR T V+ T Y APE
Sbjct: 128 SH-RV---VHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 181
Query: 582 QSGQITEKADVYSFGVVLVEL 602
D++S G + E+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 11/194 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G G+V+ + + GQ VA+KQ L +E+ V+ ++ N+V + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 473 EDRRRLLVYEYICNGSL-DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+V EY+ GSL D C E + + L +LH ++H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALDFLHSNQ----VIH 138
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKAD 591
RD++ +NILL D + DFG Q + + ++GT ++APE K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 592 VYSFGVVLVELVTG 605
++S G++ +E+V G
Sbjct: 198 IWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFC 471
L EG + +V++G+ +GQ VA+K + + +G E +L +H N+V+L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI- 71
Query: 472 IEDRRRL-LVYEYICNG---SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
I + L V+EY+ + H G H + Q + RGL Y+H +
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-----RGLAYIHGQH--- 123
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE-YAQSGQI 586
I+HRD++P N+L+++ E + DFGLAR + + V+ T Y P+ +
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDY 181
Query: 587 TEKADVYSFGVVLVELVTGRKA 608
+ D++ G + +E++ G+ A
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 58/188 (30%), Positives = 82/188 (43%), Gaps = 42/188 (22%)
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLE----WSARQKIAVGAARGLR 518
N+V L + + + LV ++ G L SH+ P E W+A +A+ A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-----QPDGDMGVETRVIGTF 573
LH E IV RD+ PNNILL + F RW DG+ VE
Sbjct: 101 -LHREG----IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGE-AVENM----- 147
Query: 574 GYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVD-----------LNRPKGQQCLTE 622
Y APE + TE D +S G +L EL+TG+ V+ LN P + ++E
Sbjct: 148 -YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIP---EWVSE 203
Query: 623 WARPLLEE 630
AR LL++
Sbjct: 204 EARSLLQQ 211
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 38/233 (16%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHE-------FCSEVEVLSCA 459
F + EG +G V++ D G+ VA+K+ +L D+E E+++L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL-----DNEKEGFPITAIREIKILRQL 63
Query: 460 QHRNVVMLIGFCIEDRRRL----------LVYEYICN---GSLDSHLYGCHQEPLEWSAR 506
HRN+V L + + L LV+EY+ + G L+S L ++ ++ +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 507 QKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGV 565
Q + GL Y H++ +HRD++ +NILL + + + DFGLAR + +
Sbjct: 124 QLL-----EGLNYCHKKN----FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 566 ETRVIGTFGYLAPEYAQSGQ-ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ 617
+VI T Y PE + DV+S G +L EL T + N+ Q
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FC----SEVEVLSCAQH 461
+ +++ EG +G V P G VA+K K+ S +H+ FC E+++L +H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KI--SPFEHQTFCQRTLREIKILRRFKH 62
Query: 462 RNVVMLIGFCIEDRRRLLVYE-----YICNGSLDSHLYGC-HQEPLEWSARQKIAVGAAR 515
N++ I D R +E YI +++ LY + L Q R
Sbjct: 63 ENII-----GILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR 117
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGD-MGVETRVIGTF 573
GL+Y+H ++HRD++P+N+LL + + + DFGLAR P+ D G T + T
Sbjct: 118 GLKYIHS----ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 574 GYLAPEYAQSGQITEKA-DVYSFGVVLVELVTGR 606
Y APE + + KA D++S G +L E+++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 414 LAEGGFGSVHRGV--LPDGQA-VAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLIG 469
L G FG V +GV + Q VA+K K + + E E E++ + +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
C E +LV E G L+ L G ++ + S ++ + G++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKN----F 116
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSGQIT 587
VHRD+ N+LL + + DFGL++ D + R G + + APE + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 588 EKADVYSFGVVLVE 601
++DV+S+G+ + E
Sbjct: 177 SRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 414 LAEGGFGSVHRGVLPDG---QAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ G FG V G + G V VK+ ++ AS Q +F E + QH N++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPL---EWSARQKIAVGAARGLRYLHEECRV 526
C E LLV E+ G L +L C + L + + Q++A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET-RVIGTFGYLAPEYAQS-- 583
+H D+ N LLT D +GD+GL+ + D V ++ ++APE
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 584 GQI-----TEKADVYSFGVVLVEL 602
G + T++++V+S GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 48/194 (24%), Positives = 88/194 (45%), Gaps = 11/194 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G G+V+ + + GQ VA++Q L +E+ V+ ++ N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 473 EDRRRLLVYEYICNGSL-DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+V EY+ GSL D C E + + L +LH ++H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSNQ----VIH 139
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKAD 591
RD++ +NILL D + DFG Q + + ++GT ++APE K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 592 VYSFGVVLVELVTG 605
++S G++ +E++ G
Sbjct: 199 IWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIGF 470
EG +G V++ G+ VA+K+ +L D S E+ +L H N+V L+
Sbjct: 9 EGTYGVVYKARDKLTGEIVALKKIRL--ETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
+ + LV+E++ + L ++ L+ + +G+ Y H R ++
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-R---VL 121
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV----IGTFGYLAPE-YAQSGQ 585
HRD++P N+L+ + + DFGLAR GV R + T Y APE S Q
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLAR-----AFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 586 ITEKADVYSFGVVLVELVTGR 606
+ D++S G + E+V R
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 39/128 (30%), Positives = 66/128 (51%), Gaps = 9/128 (7%)
Query: 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKI-AVGAARGLRYLHEECRVGCIVHRDMRPNN 538
V EY+ G L H+ + R + A GL++LH++ I++RD++ +N
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEA---RARFYAAEIICGLQFLHKKG----IIYRDLKLDN 126
Query: 539 ILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVV 598
+LL D + DFG+ + +G+ T GT Y+APE + + E D +SFGV+
Sbjct: 127 VLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKYNESVDWWSFGVL 185
Query: 599 LVELVTGR 606
L E++ G+
Sbjct: 186 LYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ G +G V++ + G+ A+K KL + E+ ++ +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 473 EDRRRLLVYEYICNGSLDS--HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
+ + E+ GSL H+ G PL S ++ +GL YLH + ++
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKGKM---- 128
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA---QSGQIT 587
HRD++ NILLT + + DFG++ Q + IGT ++APE A + G
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSA-QITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 588 EKADVYSFGVVLVEL 602
+ D+++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 451 SEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
SE+ L+ H +V D + LL+ EY G L+ + +E L + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV-- 171
Query: 511 VGAARGLRYLH-----EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG-DMG 564
GL + +E ++HRD++ NI L +GDFG ++ D +
Sbjct: 172 -----GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRP 614
V + GT YLAPE + + ++KAD++S GV+L EL+T L+RP
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT------LHRP 270
|
Length = 478 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 410 QANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCA-------QH 461
L G FG V+ D G+ +AVKQ + E EV L C +H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQ--VPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 462 RNVVMLIGFCIED--RRRLLVY-EYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARG 516
+V G C+ D ++L ++ EY+ GS+ L YG E + ++I +G
Sbjct: 64 DRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QG 118
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETR-VIGTFG 574
+ YLH IVHRD++ NIL +GDFG + R Q G + V GT
Sbjct: 119 VSYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 575 YLAPEYAQSGQITEKADVYSFGVVLVELVT 604
+++PE KADV+S +VE++T
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 54/170 (31%), Positives = 74/170 (43%), Gaps = 42/170 (24%)
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA------ 514
H+N+ L I V+ N LY ++E +E Q I G
Sbjct: 61 HKNITCLYDMDI-------VFPGNFNE-----LY-LYEELMEADLHQIIRSGQPLTDAHF 107
Query: 515 --------RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR------WQPD 560
GL+Y+H ++HRD++P N+L+ D E + DFGLAR +
Sbjct: 108 QSFIYQILCGLKYIHS----ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163
Query: 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKA-DVYSFGVVLVELVTGRKAV 609
G M T + T Y APE S Q KA DV+S G +L EL+ GRK V
Sbjct: 164 GFM---TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 72/274 (26%), Positives = 113/274 (41%), Gaps = 43/274 (15%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVKQHKLASSQGDHEFC-SEVEVLSCAQHRNVVMLI 468
+ EG FG R +L Q A+K+ +L S E E +L+ +H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 469 GFCIEDRRRLLVYEYICNGSL-------DSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
D +V EY G L L+ L+W + + V +++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP-EDTILQWFVQMCLGV------QHIH 117
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA 581
E+ RV +HRD++ NI LT + + +GDFG AR +GT Y+ PE
Sbjct: 118 EK-RV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTPYYVPPEIW 172
Query: 582 QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641
++ K+D++S G +L EL T + N W +L+ P L
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQAN---------SWKNLILK--VCQGSYKP-L 220
Query: 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVL 675
+HYS Y + +R+P SRP + +L
Sbjct: 221 PSHYS----YELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 32/214 (14%)
Query: 414 LAEGGFGSVHRGV-LPDGQ----AVAVK-QHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L G FG+V++G+ +PDG+ VA+K + S + + E E V++ V L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCH-----QEPLEWSARQKIAVGAARGLRYLHE 522
+G C+ +L V + + G L ++ Q+ L W V A+G+ YL E
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL-E 126
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG-----YLA 577
E R +VHRD+ N+L+ + DFGLAR D D ET G ++A
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL-DID---ETEYHADGGKVPIKWMA 179
Query: 578 PEYAQSGQITEKADVYSFGVVLVELVT-GRKAVD 610
E + T ++DV+S+GV + EL+T G K D
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 15/195 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ G +G V++ L G+ AVK KL E+ ++ +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 473 EDRRRLLVYEYICNGSLDS--HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
+ + EY GSL H+ G PL + +GL YLH + ++
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKGKM---- 128
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA---QSGQIT 587
HRD++ NILLT + + + DFG+A + + IGT ++APE A ++G
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 588 EKADVYSFGVVLVEL 602
+ D+++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
RGL+Y+H I+HRD++P+N+ + D E + DFGLAR D +M T + T
Sbjct: 131 RGLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEM---TGYVATRW 182
Query: 575 YLAPEYAQSG-QITEKADVYSFGVVLVELVTGR 606
Y APE + + D++S G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 38/212 (17%)
Query: 414 LAEGGFGSVHRGVL---PD------GQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRN 463
L +G F ++++GVL D GQ V+V L S D F ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV--GAARGLRYLH 521
+V L G C+ D ++V EY+ G LD L H+E S K+ V A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFL---HREKNNVSLHWKLDVAKQLASALHYLE 118
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD---GDMGVETRVIGT------ 572
++ +VH ++ NIL+ G + P D G+ V+
Sbjct: 119 DK----KLVHGNVCGKNILVARY-GLNEG------YVPFIKLSDPGIPITVLSREERVER 167
Query: 573 FGYLAPEYAQSGQ--ITEKADVYSFGVVLVEL 602
++APE ++GQ +T AD +SFG L+E+
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 9/199 (4%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
+++ + +G G+V + + GQ VA+KQ L +E+ V+ ++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ + +V EY+ GSL + + + +A + + L +LH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA---VCRECLQALEFLH----A 133
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
++HRD++ +N+LL D + DFG Q + + ++GT ++APE
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 587 TEKADVYSFGVVLVELVTG 605
K D++S G++ +E+V G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 414 LAEGGFGSVHRG--VLPDGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRNVVMLI 468
L EG + +V +G L + VA+K+ +L +G C+ EV +L +H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLH 70
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
D+ LV+EY+ + L ++ C + + RGL Y H
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---- 124
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE-YAQSGQIT 587
++HRD++P N+L+ E + DFGLAR + V+ T Y P+ S + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYS 183
Query: 588 EKADVYSFGVVLVELVTGR 606
+ D++ G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
A L +LH +G I++RD++P NILL + + DFGL++ D + + GT
Sbjct: 108 ALALDHLH---SLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTV 162
Query: 574 GYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
Y+APE T+ AD +SFGV++ E++TG
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQ-HKLASSQGDHEFCSEVE--VLSCAQHRNVVMLIG 469
L +G FG V L G+ AVK K Q D C+ E +LS A++ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 470 FCIEDRRRLL-VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
C + RL V E++ G L H+ + + + + A L +LH++
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKG---- 116
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVI-GTFGYLAPEYAQSGQI 586
I++RD++ +N+LL H+ + DFG+ + +G G T GT Y+APE Q
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 587 TEKADVYSFGVVLVELVTG 605
D ++ GV+L E++ G
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
RGL+Y+H I+HRD++P+N+ + D E + DFGLAR Q D +M T + T
Sbjct: 129 RGLKYIHS----AGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEM---TGYVATRW 180
Query: 575 YLAPEYAQSG-QITEKADVYSFGVVLVELVTGR 606
Y APE + + D++S G ++ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTF 573
RGL+YLH I+HRD++P N+L+ + + DFGLAR +PD + V+ +
Sbjct: 114 RGLKYLHS----AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 574 GYLAPE-YAQSGQITEKADVYSFGVVLVELVTGR 606
Y APE S T D++S G + EL+ R
Sbjct: 170 -YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +GGFG V + G+ A K+ +L +G E +L+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA--RGLRYLHEECRV 526
+ + + L LV + G L H+Y +E + + A GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-VIGTFGYLAPEYAQSGQ 585
I++RD++P N+LL +D + D GLA DG +T+ GT G++APE Q +
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEE 173
Query: 586 ITEKADVYSFGVVLVELVTGR 606
D ++ GV L E++ R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLI 468
+ EG +G V++ + +A+K+ +L Q D S E+ +L QH N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRL--EQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
++R LV+EY+ + L H+ + RG+ Y H RV
Sbjct: 68 DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-RV-- 123
Query: 529 IVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDGDMGVETRV----IGTFGYLAPE-YAQ 582
+HRD++P N+L+ L + DFGLAR G+ R + T Y APE
Sbjct: 124 -LHRDLKPQNLLIDRRTNALKLADFGLAR-----AFGIPVRTFTHEVVTLWYRAPEILLG 177
Query: 583 SGQITEKADVYSFGVVLVELVTGR 606
S + D++S G + E+V +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 52/231 (22%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHK----LASSQGDHEFCSEVEVLSCAQHRNVV 465
+ G FG V + GQ A+K + + +Q H +E ++L+ A +V
Sbjct: 9 IGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIV 64
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHE 522
L + +D L LV EY+ G L + L P E AR IA V A L +H
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA---LDSVH- 118
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA---RWQPDG--------------DMGV 565
++G I HRD++P+NIL+ D + DFGL D ++ V
Sbjct: 119 --KLGFI-HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 566 ETR-----------VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
R +GT Y+APE + + D +S GV+L E++ G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 413 FLAEGGFGSVHRGVLPD-GQAVAVKQHKL-----ASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FG V+ D G+ +AVKQ + +S+ + E+++L H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 467 LIGFCIEDRRRLL--VYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHE 522
G + R L E++ GS+ L YG E + ++I G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETR-VIGTFGYLAPEY 580
IVHRD++ NIL +GDFG + R Q G + V GT +++PE
Sbjct: 125 NM----IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 581 AQSGQITEKADVYSFGVVLVELVTGR 606
KAD++S G +VE++T +
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 408 FSQANFLAEGGFGSVHRGVLP-----DGQAVAVKQHK----LASSQGDHEFCSEVEVLSC 458
+ NF+ G GS R +L D VA+K+ + + Q DH F SE ++L+
Sbjct: 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNY 87
Query: 459 AQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLR 518
H V L G ++ LV E++ G + L + P + A +
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP------NDVGCFYAAQIV 141
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR---VIGTFGY 575
+ E + IV+RD++P N+LL D + DFG A+ V+TR + GT Y
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYTLCGTPEY 194
Query: 576 LAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRP 614
+APE + + AD ++ G+ + E++ G N P
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 82/282 (29%), Positives = 121/282 (42%), Gaps = 46/282 (16%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIG-F 470
+ +G +G V++ DG AVK S D E +E +L S H NVV G F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 471 CIEDR----RRLLVYEYICNG----SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
D+ + LV E +CNG L L C Q L+ + I GA GL++LH
Sbjct: 89 YKADKLVGGQLWLVLE-LCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHN 146
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ 582
I+HRD++ NNILLT + + DFG++ + T V GT ++APE
Sbjct: 147 NR----IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 201
Query: 583 SGQITE-----KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637
Q + + DV+S G+ +EL G PL + + + L
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDP------------------PLFDMHPVKTLF 243
Query: 638 D-PRLGNHYSEH-EVYC--MLHAASLCIRRDPHSRPRMSQVL 675
PR H E +C H S C+ +D +RP ++ +L
Sbjct: 244 KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 45/156 (28%), Positives = 67/156 (42%), Gaps = 16/156 (10%)
Query: 454 EVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVG 512
E + +H +V L C + + V EY G L H+ H + A
Sbjct: 54 ETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI---HTDVFSEPRAVFYAAC 109
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV--- 569
GL+YLHE IV+RD++ +N+LL + + DFGL + MG R
Sbjct: 110 VVLGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTF 161
Query: 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
GT +LAPE T D + GV++ E++ G
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 40/211 (18%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRNVVMLIG 469
L EG + +V++G GQ VA+K+ +L +G + E +L +H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP--FTAIREASLLKDLKHANIVTLHD 70
Query: 470 FCIEDRRRLLVYEYI---CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ LV+EY+ +D G + Q + RGL Y H+
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL-----RGLAYCHQRR-- 123
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV----IGTFGYLAP---- 578
++HRD++P N+L++ E + DFGLAR + V ++ + T Y P
Sbjct: 124 --VLHRDLKPQNLLISERGELKLADFGLARAK-----SVPSKTYSNEVVTLWYRPPDVLL 176
Query: 579 ---EYAQSGQITEKADVYSFGVVLVELVTGR 606
EY S + D++ G + E+ TGR
Sbjct: 177 GSTEY--STSL----DMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 73/282 (25%), Positives = 128/282 (45%), Gaps = 36/282 (12%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEF-CSEVE--VLSCAQHRNVVMLIG 469
L +G FG V L G+ AVK K D + C+ VE VL+ A + +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 470 FCIEDRRRLL-VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--GLRYLHEECRV 526
+ + L V E++ G L H+ Q+ + + A GL++LH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQFLHSKG-- 116
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
I++RD++ +N++L D + DFG+ + GD T GT Y+APE Q +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKY 173
Query: 587 TEKADVYSFGVVLVELVTGR------------KAVDLNRPKGQQCLTEWARPLLEEYAID 634
T D +SFGV+L E++ G+ +++ ++ P + +T+ ++ +LE+
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFER 233
Query: 635 ELVDP--RLG--NHYSEHEVYCMLHAASLCIRR-DPHSRPRM 671
DP RLG + H + ++ +L R DP +P++
Sbjct: 234 ---DPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKV 272
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
RGL+Y+H ++HRD++P+N+LL + + + DFGLAR T + T
Sbjct: 119 RGLKYIHS----ANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRW 173
Query: 575 YLAPE-YAQSGQITEKADVYSFGVVLVELVTGRK 607
Y APE + T DV+S G + EL+ GRK
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 34/97 (35%), Positives = 55/97 (56%), Gaps = 9/97 (9%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR----WQPDGDMGVETRVI 570
+ L+Y+H G ++HRD++P+NILL D + DFGLAR + + + V T +
Sbjct: 118 KALKYIHS----GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 571 GTFGYLAPE-YAQSGQITEKADVYSFGVVLVELVTGR 606
T Y APE S + T+ D++S G +L E++ G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 17/197 (8%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIG-F 470
G +GSV + G+ VA+K KL+ F E+ +L QH NV+ L+ F
Sbjct: 26 GAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVF 83
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
Y+ + + L PL Q + GL+Y+H I+
Sbjct: 84 TSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS----AGII 139
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG-QITEK 589
HRD++P N+ + D E + DFGLAR D +M T + T Y APE + +
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLAR-HADAEM---TGYVVTRWYRAPEVILNWMHYNQT 195
Query: 590 ADVYSFGVVLVELVTGR 606
D++S G ++ E++TG+
Sbjct: 196 VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 412 NFLAEGGFGSVHRGVLPD----GQAVAVK-QHKLASSQGDHEFCSEVE--VLSCAQHRNV 464
NFL G GS + +L + + A+K K Q D C+ VE VL+
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLH 521
+ + C + RL V EY+ G L H+ G +EP +I+VG L +LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLH 118
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM--GVETRVI-GTFGYLAP 578
I++RD++ +N++L + + DFG+ + M GV TR GT Y+AP
Sbjct: 119 RRG----IIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTFCGTPDYIAP 170
Query: 579 EYAQSGQITEKADVYSFGVVLVELVTGRKAVD 610
E + D +++GV+L E++ G+ D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 9/156 (5%)
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE--YICNGSLDSHLYGCHQEPLEWSARQKI 509
E+ +L C H+N++ L+ ++ L ++ Y+ +D++L L+ +
Sbjct: 70 ELVLLKCVNHKNIISLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
G+++LH I+HRD++P+NI++ D + DFGLAR M T
Sbjct: 129 LYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPY 182
Query: 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
+ T Y APE E D++S G ++ ELV G
Sbjct: 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 32/166 (19%)
Query: 451 SEVEVLSCAQHRNVVMLIGFCIE-DRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQK 508
+E VL H ++ L F E D+R L ++ EY+ G L S+L +
Sbjct: 50 NEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL----------RNSGR 97
Query: 509 IAVGAAR--------GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560
+ L YLH + IV+RD++P NILL + + DFG A+ D
Sbjct: 98 FSNSTGLFYASEIVCALEYLHSKE----IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153
Query: 561 GDMGVETRVI-GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
T + GT YLAPE QS + D ++ G+++ E++ G
Sbjct: 154 -----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 23/185 (12%)
Query: 436 KQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLY 494
KQ+ + +Q F E ++L+ A++ VV + E +R L +V EY+ G + L
Sbjct: 36 KQNLILRNQIQQVF-VERDILTFAENPFVVSMFC-SFETKRHLCMVMEYVEGGDCATLLK 93
Query: 495 GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554
P++ AR A L YLH IVHRD++P+N+L+T + DFGL
Sbjct: 94 NIGALPVD-MARMYFA-ETVLALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGL 147
Query: 555 ARWQ--------PDGDMGVETR------VIGTFGYLAPEYAQSGQITEKADVYSFGVVLV 600
++ +G + +TR V GT Y+APE + D ++ G++L
Sbjct: 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILY 207
Query: 601 ELVTG 605
E + G
Sbjct: 208 EFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE--YICNGSLDSHLYGCHQEPLEWSARQKI 509
E+ ++ C H+N++ L+ ++ L ++ YI +D++L Q L+ +
Sbjct: 73 ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
G+++LH I+HRD++P+NI++ D + DFGLAR M + V
Sbjct: 132 LYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYV 186
Query: 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
+ + Y APE E D++S G ++ E++ G
Sbjct: 187 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 36/185 (19%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW---QPDGDMGVETRVIG 571
GLRYLH + I+HRD++ NI + + +GD G A++ P +G+ G
Sbjct: 168 EGLRYLHAQR----IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-FLGLA----G 218
Query: 572 TFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL--- 628
T APE + KAD++S G+VL E++ + + P + + L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278
Query: 629 --------EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSR-PRMSQVLRILE 679
EE+ D RL + E Y L R P++R P +V ++
Sbjct: 279 ISTLKVHPEEFPRDP--GSRLVRGFIE---YASLE-------RQPYTRYPCFQRVNLPID 326
Query: 680 GDTVI 684
G+ ++
Sbjct: 327 GEFLV 331
|
Length = 357 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 452 EVEVLSCAQHRNVVMLIG-FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
E+ ++ C H+N++ L+ F + Y+ +D++L Q L+ +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 125
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI 570
G+++LH I+HRD++P+NI++ D + DFGLAR G + T +
Sbjct: 126 YQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 179
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELV------TGRKAVD 610
T Y APE E D++S G ++ E+V GR +D
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 38/232 (16%)
Query: 400 ELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHK-LASSQGDHEFCSE 452
E+ L+T F + L E FG V++G L QAVA+K K A EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 453 VEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEP------------ 500
+ S QH N+V L+G +++ +++ Y + L H + + P
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL--HEFLVMRSPHSDVGSTDDDKT 116
Query: 501 ----LEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
LE + I A G+ +L +VH+D+ N+L+ + D GL R
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 557 WQPDGD----MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
D MG I +++PE G+ + +D++S+GVVL E+ +
Sbjct: 173 EVYAADYYKLMGNSLLPI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 68/254 (26%), Positives = 107/254 (42%), Gaps = 38/254 (14%)
Query: 414 LAEGGFGSVHRGVLPDGQ------AVAV-KQHKLASSQGDHEFC-SEVEVLSCAQHRNVV 465
L +GG+G V + G A+ V K+ + +Q D +E +L +H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLY--GCHQEPLEWSARQKIAVGAARGLRYLHEE 523
LI + L+ EY+ G L HL G E +I++ L +LH++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHLHQQ 119
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
I++RD++P NILL + DFGL + T GT Y+APE
Sbjct: 120 G----IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILMR 174
Query: 584 GQITEKADVYSFGVVLVELVTG---------RKAVD------LNRPKGQQCLTEWARPLL 628
+ D +S G ++ +++TG +K +D LN P LT AR LL
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP---YLTPEARDLL 231
Query: 629 EEYAIDELVDPRLG 642
++ + RLG
Sbjct: 232 KKL-LKRNPSSRLG 244
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-07
Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 26/111 (23%)
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARW-------QPDGD----------MGVETRVIG 571
++HRD++P+NILL E ++ D+G A + D D M + +++G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193
Query: 572 TFGYLAPEYAQSGQITEKADVYSFGVVLVELVT---------GRKAVDLNR 613
T Y+APE +E D+Y+ GV+L +++T GRK +
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 460 QHRNVVMLIGF--CIEDRRRLL-VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARG 516
Q N L+G C + RL V EY+ G L H+ + P E + + A
Sbjct: 51 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA-- 108
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR--WQPDGDMGVETRVIGTFG 574
L YLHE I++RD++ +N+LL + + D+G+ + +P GD + GT
Sbjct: 109 LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD--TTSTFCGTPN 161
Query: 575 YLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDL 611
Y+APE + D ++ GV++ E++ GR D+
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 408 FSQANFLAEGGFGSV----HRGVLPDGQAVAVKQHKLASSQGDHEF----CSEVEVLSCA 459
F + EG +G V H+ + VA+K+ K S+ + E E+++L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKET---KEIVAIKKFK--DSEENEEVKETTLRELKMLRTL 57
Query: 460 QHRNVVMLI-GFCIEDRRR---LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR 515
+ N+V L F RRR LV+EY+ + ++ +E +K+ +
Sbjct: 58 KQENIVELKEAF----RRRGKLYLVFEYV-----EKNMLELLEEMPNGVPPEKVRSYIYQ 108
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY 575
++ +H C IVHRD++P N+L++H+ + DFG AR +G T + T Y
Sbjct: 109 LIKAIHW-CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 576 LAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
+PE + D++S G +L EL G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 67/216 (31%), Positives = 92/216 (42%), Gaps = 29/216 (13%)
Query: 432 AVAVKQHK--LASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGS 488
AV V Q K L + H +L +H +V L F + +L V +YI G
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL-HFSFQTADKLYFVLDYINGGE 82
Query: 489 LDSHLYG--CHQEPLEWSARQKI-AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545
L HL C EP R + A A L YLH IV+RD++P NILL
Sbjct: 83 LFYHLQRERCFLEP-----RARFYAAEIASALGYLHSLN----IVYRDLKPENILLDSQG 133
Query: 546 EPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
++ DFGL + + + G + GT YLAPE D + G VL E++ G
Sbjct: 134 HIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
Query: 606 ------RKAVD-----LNRP-KGQQCLTEWARPLLE 629
R + LN+P + + +T AR LLE
Sbjct: 193 LPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 467 LIGF--CIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
L+G C + RL LV EY+ G L H+ + P E + + A L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLHER 115
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
I++RD++ +N+LL D + D+G+ + + G + GT Y+APE +
Sbjct: 116 G----IIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRG 170
Query: 584 GQITEKADVYSFGVVLVELVTGRKAVDL 611
+ D ++ GV++ E++ GR D+
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 18/188 (9%)
Query: 430 GQAVAVKQ-HKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
G+ VA+K+ + + D E+++L +H ++V + + RR Y+
Sbjct: 25 GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84
Query: 488 SLDSHLYGCHQ-----EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542
++S L HQ + L Q R L+Y+H + HRD++P NIL
Sbjct: 85 LMESDL---HQVIKANDDLTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILAN 137
Query: 543 HDFEPLVGDFGLARWQ-PDGDMGV-ETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVV 598
D + + DFGLAR D + T + T Y APE S + T D++S G +
Sbjct: 138 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197
Query: 599 LVELVTGR 606
E++TG+
Sbjct: 198 FAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 12/94 (12%)
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG---VETRVIGT 572
G+++LH I+HRD++P+NI++ D + DFGLAR M V TR
Sbjct: 130 GIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--- 182
Query: 573 FGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
Y APE E D++S G ++ E++ G
Sbjct: 183 --YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 414 LAEGGFGSV---HRGVLPDGQAVAVKQHKLASSQGDHEFCSEVE--VLSCAQHRNVVMLI 468
L +G FG V R + A+ + + + D E C+ VE VL+ + + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVE-CTMVEKRVLALSGKPPFLTQL 66
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
C + RL V EY+ G L + G +EP +IA+G L +LH +
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFFLHSKG- 121
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR---WQPDGDMGVETRVI-GTFGYLAPEYA 581
I++RD++ +N++L + + DFG+ + W GV T+ GT Y+APE
Sbjct: 122 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-----GVTTKTFCGTPDYIAPEII 173
Query: 582 QSGQITEKADVYSFGVVLVELVTGRKAVD 610
+ D ++FGV+L E++ G+ +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 33/114 (28%), Positives = 53/114 (46%), Gaps = 12/114 (10%)
Query: 504 SARQKIAV--------GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+A++ IA+ R ++YLHE I+HRD++ NI + H + +GDFG A
Sbjct: 174 AAKRNIAICDILAIERSVLRAIQYLHENR----IIHRDIKAENIFINHPGDVCLGDFGAA 229
Query: 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAV 609
+ D + GT APE D++S G+VL E+ T ++
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 23/202 (11%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAV-----KQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ +G FG V + D Q + K H ++ S+ H +E VL+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTL-AERTVLAQVNCPFIVPL- 58
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLY--GCHQEPLE--WSARQKIAVGAARGLRYLHEE 523
F + +L LV +I G L HL G ++A A L LH+
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA------LENLHKF 112
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
+++RD++P NILL + + DFGL + D T GT YLAPE
Sbjct: 113 N----VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLG 167
Query: 584 GQITEKADVYSFGVVLVELVTG 605
T+ D ++ GV+L E++TG
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 39/129 (30%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538
L+ +Y+ G L +HLY +E S + L +LH+ +G I++RD++ N
Sbjct: 82 LILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQ---LG-IIYRDIKLEN 135
Query: 539 ILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI--TEKADVYSFG 596
ILL + ++ DFGL++ + GT Y+APE + G + D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 597 VVLVELVTG 605
V+ EL+TG
Sbjct: 196 VLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA-RGLRYLHEECRVGCIVHRDMRPN 537
L+ +Y+ G + +HLY Q + G L +LH ++G IV+RD++
Sbjct: 82 LILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLH---KLG-IVYRDIKLE 134
Query: 538 NILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKA-DVYSFG 596
NILL + ++ DFGL++ + GT Y+APE + KA D +S G
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLG 194
Query: 597 VVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHA 656
+++ EL+TG L + Q +E +R +L+ D +G E +LH
Sbjct: 195 ILIFELLTGASPFTLEGERNTQ--SEVSRRILK---CDPPFPSFIG-----PEAQDLLHK 244
Query: 657 ASLCIRRDPHSR 668
+R+DP R
Sbjct: 245 ---LLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 42/128 (32%), Positives = 60/128 (46%), Gaps = 8/128 (6%)
Query: 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538
LV +Y+ G L HL + E A+ IA L +LH+ IV+RD++P N
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFS-EDRAKFYIA-ELVLALEHLHKYD----IVYRDLKPEN 126
Query: 539 ILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE-YAQSGQITEKADVYSFGV 597
ILL + DFGL++ + T GT YLAPE T+ D +S GV
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185
Query: 598 VLVELVTG 605
++ E+ G
Sbjct: 186 LVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 18/197 (9%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH-----EFCSEVEVLSCAQHRNVVMLI 468
L G FG+V +G+ ++ K+ + + E E V+ + +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV--GAARGLRYLHEECRV 526
G C E +LV E G L+ L Q+ + + + + G++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSG 584
VHRD+ N+LL + DFGL++ + + + G + + APE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 585 QITEKADVYSFGVVLVE 601
+ + K+DV+SFGV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 40/129 (31%), Positives = 56/129 (43%), Gaps = 13/129 (10%)
Query: 480 VYEYICNGSLDSHLY--GCHQEPLEWSARQKI-AVGAARGLRYLHEECRVGCIVHRDMRP 536
V +Y+ G L HL EP R + A A L YLH I++RD++P
Sbjct: 74 VLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSLN----IIYRDLKP 124
Query: 537 NNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFG 596
NILL ++ DFGL + + + GT YLAPE + D + G
Sbjct: 125 ENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLG 183
Query: 597 VVLVELVTG 605
VL E++ G
Sbjct: 184 AVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLAS--SQGDH------EFCSEVEVLSCAQHRNVV 465
L +G FG+V+ ++ D +AVA ++ K+ G+ + E ++LS H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHEE 523
+E ++ EY LD L S Q + G+ Y+H+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
I+HRD++ NI L ++ +GDFG++R G + T GT Y++PE +
Sbjct: 126 R----ILHRDLKAKNIFLKNNLLK-IGDFGVSRLLM-GSCDLATTFTGTPYYMSPEALKH 179
Query: 584 GQITEKADVYSFGVVLVEL 602
K+D++S G +L E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 11/158 (6%)
Query: 451 SEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKI 509
+E VL +H + L + + + RL V EY+ G L HL +E + R +
Sbjct: 44 TESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRF 99
Query: 510 -AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
L YLH G IV+RD++ N++L D + DFGL + + D
Sbjct: 100 YGAEIVSALDYLHS----GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKT 154
Query: 569 VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
GT YLAPE + D + GVV+ E++ GR
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 44/144 (30%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 471 CIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
C + RL V EY+ G L H+ G +EP +IA+G L +LH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFLHSKG--- 121
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPEYAQSGQI 586
I++RD++ +N++L + + DFG+ + G G TR GT Y+APE
Sbjct: 122 -IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 587 TEKADVYSFGVVLVELVTGRKAVD 610
+ D ++FGV+L E++ G+ D
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILL-THDFEPLVGDFGLAR-WQPD-GDMGVETRVIG 571
RGL+Y+H ++HRD++P N+ + T D +GDFGLAR P G + +
Sbjct: 125 RGLKYIHS----ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 572 TFGYLAPEYA-QSGQITEKADVYSFGVVLVELVTGR 606
T Y +P T+ D+++ G + E++TG+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 33/221 (14%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRN----VV 465
+ GGFG V+ D G+ A+K + ++ QG+ +E +LS + V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEP-LEWSARQKIAVGAARGLRYLHE 522
M F D+ + + + G L HL +G E + + A + I GL ++H
Sbjct: 62 MTYAFHTPDKL-CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL-----GLEHMHN 115
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA----RWQPDGDMGVETRVIGTFGYLAP 578
+V+RD++P NILL + D GLA + +P +GT GY+AP
Sbjct: 116 RF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------VGTHGYMAP 164
Query: 579 EYAQSGQITE-KADVYSFGVVLVELVTGRKAVDLNRPKGQQ 618
E Q G + AD +S G +L +L+ G ++ K +
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 20/160 (12%)
Query: 460 QHRNVVMLIGF--CIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLE----WSARQKIAVG 512
N L+G C + RL V E++ G L H+ + P E +SA +A
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA-- 108
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ-PDGDMGVETRVIG 571
L +LHE I++RD++ +N+LL + + D+G+ + GD + G
Sbjct: 109 ----LNFLHE----RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCG 158
Query: 572 TFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDL 611
T Y+APE + D ++ GV++ E++ GR D+
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 21/166 (12%)
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEW----S 504
F E ++++ A VV L +DR +V EY+ G L +L + P +W +
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYT 148
Query: 505 ARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDM 563
A +A+ A + + +HRD++P+N+LL + DFG + +G +
Sbjct: 149 AEVVLALDAIHSMGF----------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 564 GVETRVIGTFGYLAPEYAQS----GQITEKADVYSFGVVLVELVTG 605
+T V GT Y++PE +S G + D +S GV L E++ G
Sbjct: 199 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 10/159 (6%)
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
D + L+ +YI G L +HL +E + Q + L +LH ++G I++RD
Sbjct: 77 DTKLHLILDYINGGELFTHL--SQRERFKEQEVQIYSGEIVLALEHLH---KLG-IIYRD 130
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT-EKA-D 591
++ NILL + ++ DFGL++ + ++ GT Y+AP+ + G +KA D
Sbjct: 131 IKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVD 190
Query: 592 VYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630
+S GV++ EL+TG ++ K Q E +R +L+
Sbjct: 191 WWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 5/85 (5%)
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPD---GDMGVETRVIGTFGYLAPEYAQSGQ 585
++HRD++ NILL + +GDFG ++ D+G GT Y+APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG--RTFCGTPYYVAPEIWRRKP 221
Query: 586 ITEKADVYSFGVVLVELVTGRKAVD 610
++KAD++S GV+L EL+T ++ D
Sbjct: 222 YSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 28/203 (13%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQHK---LASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ +GG+G V D G+ VA+K+ K L +E ++L+ + +V L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSARQKI-----AVGAARGLRYLHE 522
+ +D L L EY+ G + L + L E AR + AV A LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDA------LH- 118
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ 582
+G +HRD++P N L+ + DFGL++ G + V+G+ Y+APE +
Sbjct: 119 --ELG-YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLR 171
Query: 583 SGQITEKADVYSFGVVLVELVTG 605
D +S G +L E + G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 16/95 (16%)
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA----RWQPDGDMGVETRVIG 571
GL ++H +V+RD++P NILL + D GLA + +P +G
Sbjct: 109 GLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-------VG 157
Query: 572 TFGYLAPEYAQSGQITE-KADVYSFGVVLVELVTG 605
T GY+APE Q G + AD +S G +L +L+ G
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 34/214 (15%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVML--I 468
+ G +G V++ DG+ K++ L +G C E+ +L +H NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDE--KEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCH------QEPLEW--SARQKIAVGAARGLRYL 520
DR+ L+++Y + H+ H ++P++ S + + G+ YL
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR-----WQPDGDMGVETRVIG 571
H ++HRD++P NIL+ + + D G AR +P D+ V+
Sbjct: 125 H----ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL---DPVVV 177
Query: 572 TFGYLAPEYAQSGQITEKA-DVYSFGVVLVELVT 604
TF Y APE + KA D+++ G + EL+T
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 41/132 (31%), Positives = 59/132 (44%), Gaps = 17/132 (12%)
Query: 479 LVYEYICNGSLDSHLYG--CHQEPLEWSARQKI-AVGAARGLRYLHEECRVGCIVHRDMR 535
V +Y+ G L HL C EP R + A A + YLH I++RD++
Sbjct: 73 FVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSLN----IIYRDLK 123
Query: 536 PNNILLTHDFEPLVGDFGLAR--WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
P NILL ++ DFGL + +P+ + GT YLAPE + D +
Sbjct: 124 PENILLDSQGHVVLTDFGLCKEGVEPE---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180
Query: 594 SFGVVLVELVTG 605
G VL E++ G
Sbjct: 181 CLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 42/217 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-----FCSEVEVL-SCAQHRNVVM 466
+ EG +G V++ G+ VA+K+ +L D E E+ +L ++ +V
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEM---DEEGIPPTALREISLLQMLSESIYIVR 65
Query: 467 LIGFCIEDRRR-------LLVYEYICNGSLDSHL-------YGCHQEPLEWSARQKIAVG 512
L+ +E LV+EY LDS L PL +
Sbjct: 66 LL--DVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLAR--WQPDGDMGVETRV 569
+G+ + H+ ++HRD++P N+L+ L + D GL R P + T
Sbjct: 119 LLKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP---VKSYTHE 171
Query: 570 IGTFGYLAPE-YAQSGQITEKADVYSFGVVLVELVTG 605
I T Y APE S + D++S G + E+
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 399 AELELATGGFSQANFLAEGGFGSVHRGVLPDGQAV-AVKQ---HKLASSQGDHEFCSEVE 454
+L + F + G FG V + V A+K ++ F E +
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 455 VLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGA 513
+++ A +V L + +D + L +V EY+ G L + L + P +W+ V
Sbjct: 96 IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVL 153
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETRVIGT 572
A L +H +G +HRD++P+N+LL + DFG + +G + +T V GT
Sbjct: 154 A--LDAIH---SMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 573 FGYLAPEYAQS----GQITEKADVYSFGVVLVELVTG 605
Y++PE +S G + D +S GV L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 53/229 (23%), Positives = 88/229 (38%), Gaps = 46/229 (20%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS--------------EVEVL 456
L EG +G V + G+ VA+K+ K+ D E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 457 SCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK--IAVGAA 514
+ +H N++ L+ +E LV + + S L + + Q I +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDI-----MASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR----------------WQ 558
GL LH+ +HRD+ P NI + + DFGLAR Q
Sbjct: 130 NGLNVLHKWY----FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 559 PDGDMGVETRVIGTFGYLAPEYAQ-SGQITEKADVYSFGVVLVELVTGR 606
+M T + T Y APE + + D++S G + EL+TG+
Sbjct: 186 RREEM---TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-06
Identities = 30/80 (37%), Positives = 48/80 (60%), Gaps = 10/80 (12%)
Query: 479 LVYEYICNGSLDS--HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536
LV EY+ G + S H+YG E + A + I+ A L YLH R G I+HRD++P
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEM---AVKYIS-EVALALDYLH---RHG-IIHRDLKP 132
Query: 537 NNILLTHDFEPLVGDFGLAR 556
+N+L++++ + DFGL++
Sbjct: 133 DNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 76/297 (25%), Positives = 110/297 (37%), Gaps = 54/297 (18%)
Query: 417 GGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEV--EVLSCA--QHRNVVMLIGFCI 472
+ + P VAVK+ L S E + E+++ QH N++ + I
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 473 EDRRRLLVYEYICNGS----LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
D +V + GS L +H E L A I L Y+H + G
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHF----PEGLPELAIAFILKDVLNALDYIHSK---GF 122
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG--------YLAPEY 580
I HR ++ ++ILL+ D V GL G RV+ F +L+PE
Sbjct: 123 I-HRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 581 AQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR---PLLEEYAID 634
Q G EK+D+YS G+ EL G V Q L E R P L + +
Sbjct: 180 LQQNLQG-YNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236
Query: 635 ELVDPRLGNHYSEHEVYCML----------------HAASLCIRRDPHSRPRMSQVL 675
L + + S +E LC++RDP SRP SQ+L
Sbjct: 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 40/134 (29%), Positives = 56/134 (41%), Gaps = 13/134 (9%)
Query: 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGA--ARGLRYLHEECRVGCIVHRD 533
R V EY G L HL +S + GA L YLH +V+RD
Sbjct: 69 RLCFVMEYANGGELFFHLSRERV----FSEDRARFYGAEIVSALGYLHS----CDVVYRD 120
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPEYAQSGQITEKADV 592
++ N++L D + DFGL + G + GT YLAPE + D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 593 YSFGVVLVELVTGR 606
+ GVV+ E++ GR
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK 508
F E ++++ A VV L +D+ +V EY+ G L +L + P +W+
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYT 148
Query: 509 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
V A L +H +G ++HRD++P+N+LL + DFG + M
Sbjct: 149 AEVVLA--LDAIHS---MG-LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202
Query: 569 VIGTFGYLAPEYAQS----GQITEKADVYSFGVVLVELVTG 605
+GT Y++PE +S G + D +S GV L E++ G
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 31/173 (17%)
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGT 572
A+G+ +L + CI HRD+ NILLTH + DFGLAR + D + V+
Sbjct: 224 AKGMSFLASK---NCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 573 FGYLAPEYAQSGQITEKADVYSFGVVLVELVT------GRKAVDLNRPKGQQCLTEWARP 626
++APE + T ++DV+S+G++L E+ + VD K + + E R
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMIKEGYRM 336
Query: 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
L E A E+ D ++ + C DP RP Q+++++E
Sbjct: 337 LSPECAPSEMYD--------------IMKS---CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 42/133 (31%), Positives = 57/133 (42%), Gaps = 10/133 (7%)
Query: 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGA--ARGLRYLHEECRVGCIVHRD 533
R V EY G L HL +S + GA L YLH E V V+RD
Sbjct: 69 RLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV---VYRD 121
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
++ N++L D + DFGL + + D GT YLAPE + D +
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 594 SFGVVLVELVTGR 606
GVV+ E++ GR
Sbjct: 181 GLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 13/159 (8%)
Query: 451 SEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKI 509
+E VL +H + L + + RL V EY G L HL +E + R +
Sbjct: 44 TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARF 99
Query: 510 AVGA--ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
GA L YLH +V+RD++ N++L D + DFGL + + D
Sbjct: 100 -YGAEIVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMK 153
Query: 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
GT YLAPE + D + GVV+ E++ GR
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 33/204 (16%)
Query: 416 EGGFGSVHRG-VLPDGQAVAVKQHK--LASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFC 471
EG F V + G+ A+K K S + + E++ L + H N++ LI
Sbjct: 9 EGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPNILRLIE-V 66
Query: 472 IEDRR--RL-LVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECR 525
+ DR+ RL LV+E +D +LY + PL + + L ++H R
Sbjct: 67 LFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---R 118
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARW----QPDGDMGVETRVIGTFGYLAPE-Y 580
G I HRD++P NIL+ D L DFG R P T I T Y APE
Sbjct: 119 NG-IFHRDIKPENILIKDDILKL-ADFGSCRGIYSKPP------YTEYISTRWYRAPECL 170
Query: 581 AQSGQITEKADVYSFGVVLVELVT 604
G K D+++ G V E+++
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 54/213 (25%)
Query: 451 SEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQ 507
+E ++L+ A + VV L + +D+ L V +YI G + S L G +E L AR
Sbjct: 50 AERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARF 105
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA---RW------- 557
IA + +H ++G I HRD++P+NIL+ D + DFGL RW
Sbjct: 106 YIA-ELTCAIESVH---KMGFI-HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160
Query: 558 QPDGDMGVE---------------------------TRV-----IGTFGYLAPEYAQSGQ 585
Q + R +GT Y+APE
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220
Query: 586 ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQ 618
T+ D +S GV+L E++ G+ + P Q
Sbjct: 221 YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQ 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 25/169 (14%)
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR---WQPDGDMGVETRVI 570
ARG+ +L CI HRD+ NILL+ + + DFGLAR PD + R+
Sbjct: 183 ARGMEFLASR---KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630
++APE T ++DV+SFGV+L E+ + + + G Q E+ R L E
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQIDEEFCRRLKE- 291
Query: 631 YAIDELVDPRLGN-HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678
R+ Y+ E+Y ++ C +P RP S+++ IL
Sbjct: 292 -------GTRMRAPEYATPEIYSIMLD---CWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 46/208 (22%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 414 LAEGGFGSVHRGV---LPDGQAVAVKQHKLASSQGDHEFCSE-----VEVLSCAQHRNVV 465
L +G F + +G+ + D + + L H SE ++S H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQE-PLEWSARQKIAVGAARGLRYLHEEC 524
+ G C+ ++V EY+ GSLD++L + W + ++A A L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK- 119
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT------FGYLAP 578
+ H ++ N+LL + + G+ + D G+ V+ ++ P
Sbjct: 120 ---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLS---DPGISITVLPKEILLERIPWVPP 173
Query: 579 EYAQSGQ-ITEKADVYSFGVVLVELVTG 605
E ++ Q ++ AD +SFG L E+ +G
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 43/228 (18%)
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520
H+++V+L G C+ D ++V E++ G LD ++ + L + K+A A L YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYL 121
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG--LARWQPDGDMGVETR--VIGTFGYL 576
++ +VH ++ NILL E + G+ G + P + V +R + ++
Sbjct: 122 EDK----DLVHGNVCTKNILLAR--EGIDGECGPFIKLSDPGIPITVLSRQECVERIPWI 175
Query: 577 APEYAQ-SGQITEKADVYSFGVVLVEL-------VTGRKAVDLNRPKGQQCLTEWARPLL 628
APE + S ++ AD +SFG L E+ + + + R QC +L
Sbjct: 176 APECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC-------ML 228
Query: 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ EL D L H C+ DP+ RP ++R
Sbjct: 229 VTPSCKELAD--LMTH---------------CMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVML--I 468
+ G +G V++ DG+ + + L +G C E+ +L +H NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDD--RDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRYL 520
DR+ L+++Y + H+ H+ ++ G + G+ YL
Sbjct: 67 FLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR-----WQPDGDMGVETRVIG 571
H ++HRD++P NIL+ + + D G AR +P D+ V+
Sbjct: 125 H----ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL---DPVVV 177
Query: 572 TFGYLAPEYAQSGQITEKA-DVYSFGVVLVELVT 604
TF Y APE + KA D+++ G + EL+T
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 408 FSQANFLAEGGFGSVH---RGVLPDGQAVAV-KQHKLASSQGDHEFCSEVEVLSCAQHRN 463
F + + G FG V D A+ V K+ L + + F E ++LS +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
+ L + +D+ L LV EY G L S L +++ + Q + +H+
Sbjct: 63 IPQLQ-YAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFG-LARWQPDGDMGVETRVIGTFGYLAPEYA 581
+G VHRD++P N+L+ + DFG AR + M +GT Y+APE
Sbjct: 121 ---MG-YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVL 175
Query: 582 QSGQITEKA------DVYSFGVVLVELVTGR 606
+ K D +S GV+ E++ GR
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 42/127 (33%), Positives = 56/127 (44%), Gaps = 7/127 (5%)
Query: 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538
V +++ G L HL P E AR A A L YLH IV+RD++P N
Sbjct: 73 FVLDFVNGGELFFHLQRERSFP-EPRARFYAA-EIASALGYLHSIN----IVYRDLKPEN 126
Query: 539 ILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVV 598
ILL ++ DFGL + + T GT YLAPE + D + G V
Sbjct: 127 ILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAV 185
Query: 599 LVELVTG 605
L E++ G
Sbjct: 186 LYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 414 LAEGGFGSVHRGVL--PDGQAVAVK----QHKLASSQGDHEFCSEVEVL-SCAQHRNVVM 466
+ +G +G V + VL +G AVK H + D E +E +L + + H NVV
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDI-----DEEIEAEYNILKALSDHPNVVK 79
Query: 467 LIG-FCIEDRRR----LLVYEYICNGSLDSHLYGCHQ--EPLEWSARQKIAVGAARGLRY 519
G + +D + LV E GS+ + G + E +E I A GL++
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
LH +HRD++ NNILLT + + DFG++ + T V GT ++APE
Sbjct: 140 LHVNK----TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPE 194
Query: 580 YAQSGQ-----ITEKADVYSFGVVLVELVTG 605
Q + DV+S G+ +EL G
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 25/143 (17%)
Query: 452 EVEVLSCAQHRNVVMLIGFC-----IEDRRR---LLVYEYICNGSLDSHLYGCHQEP--- 500
E+++L +H NVV LI C +R + LV+E+ C + L G
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-C----EHDLAGLLSNKNVK 115
Query: 501 LEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR--WQ 558
S +K+ GL Y+H I+HRDM+ NIL+T D + DFGLAR
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNK----ILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 559 PDGDMG--VETRVIGTFGYLAPE 579
RV+ T Y PE
Sbjct: 172 SKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 48/217 (22%), Positives = 85/217 (39%), Gaps = 35/217 (16%)
Query: 414 LAEGGFGSV--------------HRGVLPDGQAVAVKQHKLA-----SSQGDHEFCSEVE 454
L G FG + RGV Q + +A S+ + +E+
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL 215
Query: 455 VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSAR------Q 507
L H N++ IE+ R Y+ D LY + E +W R +
Sbjct: 216 ALGRLNHENILK-----IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR 270
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
I + Y+H++ ++HRD++ NI L D + ++GDFG A +
Sbjct: 271 AIMKQLLCAVEYIHDKK----LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
+GT +PE E D++S G++L+++++
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQAV-AVK-QHKLASSQGDHEFCSEVE--VLSCAQHRNVVMLIG 469
L +G FG V L V A+K K Q D C+ E +L+ A + +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 470 FCIEDRRRLL-VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
C + + RL V EY+ G L + + + + A L +LH R G
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLH---RHG- 116
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
+++RD++ +NILL + + DFG+ + + T GT Y+APE Q +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELEYGP 175
Query: 589 KADVYSFGVVLVELVTGR 606
D ++ GV++ E++ G+
Sbjct: 176 SVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 45/187 (24%), Positives = 83/187 (44%), Gaps = 31/187 (16%)
Query: 500 PLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQ 558
PL+ + + A+G+ +L + CI HRD+ N+LLT + DFGLAR
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASK---NCI-HRDVAARNVLLTDGRVAKICDFGLARDIM 263
Query: 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRK-----AVDLN 612
D + V+ ++APE T ++DV+S+G++L E+ + G+ V+
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323
Query: 613 RPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMS 672
K + + +RP ++ E+Y ++ C +P RP S
Sbjct: 324 FYKMVKRGYQMSRP-----------------DFAPPEIYSIMKM---CWNLEPTERPTFS 363
Query: 673 QVLRILE 679
Q+ ++++
Sbjct: 364 QISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 51/172 (29%), Positives = 73/172 (42%), Gaps = 31/172 (18%)
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR---WQPDGDMGVETRVI 570
ARG+ +L CI HRD+ NILL+ + + DFGLAR PD R+
Sbjct: 184 ARGMEFLASR---KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVEL----VTGRKAVDLNRPKGQQCLTEWARP 626
++APE T ++DV+SFGV+L E+ + V +N Q+ L + R
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR-LKDGTRM 296
Query: 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678
E A E+ L C + DP RP S ++ IL
Sbjct: 297 RAPENATPEIYRIMLA-----------------CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 18/191 (9%)
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA--QHRNVVMLIGFCIEDRRRLLVYEYIC 485
P G V V+ L + +H + EV+ +H N++ ++ ++
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545
GS +S L E + + I GA RGL YLH+ G I HR+++ ++IL++ D
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYI-HRNIKASHILISGD- 137
Query: 546 EPLVGDFGLARWQPDGDMGVETRVIGTFG--------YLAPEYAQSG--QITEKADVYSF 595
LV GL+ G + +V+ F +L+PE + K+D+YS
Sbjct: 138 -GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196
Query: 596 GVVLVELVTGR 606
G+ EL TGR
Sbjct: 197 GITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 40/197 (20%), Positives = 85/197 (43%), Gaps = 23/197 (11%)
Query: 421 SVHRGVLPDGQAVAVKQHKLASSQGDHE-----FCSEVEVLSCAQHRNVVMLIGFCIEDR 475
S+++G+ + + V ++ K H+ +E++ L N++ + GF I+
Sbjct: 35 SIYKGIF-NNKEVIIRTFK--KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91
Query: 476 ----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
R L+ EY G L L ++ L + + +A+ +GL L++ +
Sbjct: 92 DDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---Y 146
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS--GQITEK 589
+++ + L+T +++ + GL + + + Y + + + T K
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPF----KNVNFMVYFSYKMLNDIFSEYTIK 202
Query: 590 ADVYSFGVVLVELVTGR 606
D+YS GVVL E+ TG+
Sbjct: 203 DDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK 508
F E +VL ++ + L ++ LV +Y G L + L E AR
Sbjct: 48 FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107
Query: 509 IA--VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG-LARWQPDGDMGV 565
+A V A + LH VHRD++P+NIL+ + + DFG + DG V
Sbjct: 108 LAEMVIAIDSVHQLH-------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--V 158
Query: 566 ETRV-IGTFGYLAPEYAQS-----GQITEKADVYSFGVVLVELVTG 605
++ V +GT Y++PE Q+ G+ + D +S GV + E++ G
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 27/82 (32%), Positives = 48/82 (58%), Gaps = 7/82 (8%)
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV-IGTFGYLAPEYAQS----- 583
VHRD++P+N+LL + + DFG + + + D V++ V +GT Y++PE Q+
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 584 GQITEKADVYSFGVVLVELVTG 605
G+ + D +S GV + E++ G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR---WQPDGDMGVETRVI 570
A+G+ +L CI HRD+ NILL+ + + DFGLAR PD + R+
Sbjct: 189 AKGMEFLASR---KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
++APE T ++DV+SFGV+L E+ +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
F E +VL R + L + +D L LV +Y G L + L E AR
Sbjct: 48 FREERDVLVNGDRRWITNL-HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF 106
Query: 508 KIA--VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG-LARWQPDGDMG 564
+A V A + L VHRD++P+N+LL + + DFG R DG
Sbjct: 107 YLAEMVLAIDSVHQLG-------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-- 157
Query: 565 VETRV-IGTFGYLAPEYAQS-----GQITEKADVYSFGVVLVELVTG 605
V++ V +GT Y++PE Q+ G+ + D +S GV + E++ G
Sbjct: 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 43/176 (24%), Positives = 56/176 (31%), Gaps = 29/176 (16%)
Query: 496 CHQEPLEWSARQKIAV--GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553
PL + + AV LR LH R + NILLT D L+ G
Sbjct: 9 VRGRPL--NEEEIWAVCLQCLGALRELH----------RQAKSGNILLTWDG--LLKLDG 54
Query: 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNR 613
E + ++APE Q TEKAD+YS G+ L E + + R
Sbjct: 55 SV-----AFKTPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108
Query: 614 PKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP 669
LL D+ D S + LC R P R
Sbjct: 109 ELSAILEI-----LLNGMPADDPRDRSNLEGVSAARSFE--DFMRLCASRLPQRRE 157
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 6e-04
Identities = 45/185 (24%), Positives = 86/185 (46%), Gaps = 36/185 (19%)
Query: 452 EVEVLSCAQHRNVVMLIG-FCIEDRRRLLVYEYICN-GSLDSHLYGCHQE--PLEWSARQ 507
EV V+ +H+N+V I F + ++L + C+ G L ++ C++ +E A
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 508 KIAVGAARGLRYLHEECRVGC----IVHRDMRPNNILLTHDFEPL--------------- 548
I L Y H + G ++HRD++P NI L+ +
Sbjct: 122 DITRQLLHALAYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 549 --VGDFGLARWQPDGDMGVETRV---IGTFGYLAPEYA--QSGQITEKADVYSFGVVLVE 601
+GDFGL++ ++G+E+ +GT Y +PE ++ +K+D+++ G ++ E
Sbjct: 181 AKIGDFGLSK-----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 602 LVTGR 606
L +G+
Sbjct: 236 LCSGK 240
|
Length = 1021 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGT 572
ARG+ +L + C VHRD+ N+LL + DFGLAR D + +
Sbjct: 247 ARGMEFLASK---NC-VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 573 FGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
++APE T +DV+S+G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 65/255 (25%), Positives = 100/255 (39%), Gaps = 68/255 (26%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAVAV-----KQHKLASSQGDHEFCSEVEVLSCAQHR 462
F + L G FG V D +A+ K+ L +Q H +E ++L+ A +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAH-VKAERDILAEADNE 61
Query: 463 NVVMLIGFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLE--WSARQKIAVGAARGL 517
VV L + +D+ L V +YI G + S L G E L + A AV + +
Sbjct: 62 WVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA---RWQPD------GD------ 562
+ +HRD++P+NIL+ D + DFGL RW D GD
Sbjct: 121 GF----------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 563 -------------------MGVETR------------VIGTFGYLAPEYAQSGQITEKAD 591
+E R ++GT Y+APE T+ D
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230
Query: 592 VYSFGVVLVELVTGR 606
+S GV+L E++ G+
Sbjct: 231 WWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 23/124 (18%), Positives = 44/124 (35%), Gaps = 25/124 (20%)
Query: 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGH 81
+++VAV S+E AL WA + G + LL VV S
Sbjct: 1 RILVAVDGSEE-SERALRWAARLARRLGAELVLLHVVDPPPSS----------------- 42
Query: 82 RKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAG 141
+E + + ++ L + + + ++ G P A+ A++ A
Sbjct: 43 -------AAELAELLEEEARALLEALREALAEAGVKVETVVLEGDPAEAILEAAEELGAD 95
Query: 142 WVVL 145
+V+
Sbjct: 96 LIVM 99
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 45/201 (22%), Positives = 69/201 (34%), Gaps = 58/201 (28%)
Query: 447 HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSAR 506
+E E+L+ H + L + LV +Y G L +
Sbjct: 46 KRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-------------FRLL 92
Query: 507 QK-----IAVGAAR--------GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553
Q+ ++ AR L YLH G IV+RD++P NILL ++ DF
Sbjct: 93 QRQPGKCLSEEVARFYAAEVLLALEYLHLL---G-IVYRDLKPENILLHESGHIMLSDFD 148
Query: 554 L-------------ARWQPDGDMGV-----ETRV----------IGTFGYLAPEYAQSGQ 585
L A + V ET +GT Y+APE
Sbjct: 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG 208
Query: 586 ITEKADVYSFGVVLVELVTGR 606
D ++ G++L E++ G
Sbjct: 209 HGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQPDGDMGVETRVIG 571
R L Y+H + I HRD++P N+L+ TH + + DFG A+ G V I
Sbjct: 181 RALAYIHSKF----ICHRDLKPQNLLIDPNTHTLK--LCDFGSAKNLLAGQRSVS--YIC 232
Query: 572 TFGYLAPEYA-QSGQITEKADVYSFGVVLVELVTG 605
+ Y APE + T D++S G ++ E++ G
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 90/366 (24%), Positives = 133/366 (36%), Gaps = 81/366 (22%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAVAV-----KQHKLASSQGDHEFCSEVEVLSCAQHR 462
F + L G FG V D A+ K+ L +Q H +E ++L+ A +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAH-VKAERDILAEADNE 61
Query: 463 NVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
VV L + +D+ L V +YI G + S L P E AR IA L
Sbjct: 62 WVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP-EVLARFYIA-----ELTLAI 114
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA---RW------------------QPD 560
E +HRD++P+NIL+ D + DFGL RW +P
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 561 -----------GD--MGVETR------------VIGTFGYLAPEYAQSGQITEKADVYSF 595
GD +E R ++GT Y+APE T+ D +S
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234
Query: 596 GVVLVELVTGRKAVDLNRPKGQQC-LTEWARPL-------LEEYAIDEL------VDPRL 641
GV+L E++ G+ P Q + W L L A+D + + RL
Sbjct: 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERL 294
Query: 642 G-NHYSEHEVYCMLHAASLC--IRRDPHS-RPRMSQVLRILEGDTVIDTYMSTPGYDVGS 697
G N + + + IR P P++S + D V + +P D
Sbjct: 295 GRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEE---ESPWNDASG 351
Query: 698 RSGRIW 703
S R W
Sbjct: 352 DSTRTW 357
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 42/157 (26%), Positives = 64/157 (40%), Gaps = 16/157 (10%)
Query: 451 SEVEVLSCAQHRNVVMLI-GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKI 509
E+++L HR ++ LI + + +++ +Y C D Y PL I
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYVDRSGPLPLEQAITI 190
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
L YLH I+HRD++ NI L ++GDFG A D +T
Sbjct: 191 QRRLLEALAYLHGRG----IIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDTPQ 243
Query: 570 ----IGTFGYLAPEYAQSGQITEKADVYSFGVVLVEL 602
GT +PE K D++S G+VL E+
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 756 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.77 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 98.76 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 98.4 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.32 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 98.27 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 98.12 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.08 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.04 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 97.98 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.97 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 97.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.88 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.8 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.75 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.75 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.73 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.68 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.56 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 97.54 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.5 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.31 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.28 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 97.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.25 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.22 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 96.88 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.86 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.46 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.43 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.39 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.38 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 96.25 | |
| PLN02236 | 344 | choline kinase | 96.24 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 96.18 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.16 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=452.19 Aligned_cols=287 Identities=57% Similarity=0.973 Sum_probs=255.6
Q ss_pred CCCCCChHHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEE
Q 004395 392 PPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471 (756)
Q Consensus 392 p~~~~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~ 471 (756)
+.+.|++.++..+|++|...+.||+|+||.||+|.+.+|+.||||++.....+...+|++|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999977755443145699999999999999999999999
Q ss_pred EecC-ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceee
Q 004395 472 IEDR-RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (756)
Q Consensus 472 ~~~~-~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~ 550 (756)
.+.+ ..+||||||++|+|.++|+.....+++|..+++||.++|+||+|||+.|.+ .|||||||++|||||+++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~-~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPP-PIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCC-CEecCCCCHHHeeECCCCCEEcc
Confidence 9999 499999999999999999864333899999999999999999999999765 59999999999999999999999
Q ss_pred ccccceecCCCCCCccccc-ccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh
Q 004395 551 DFGLARWQPDGDMGVETRV-IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 629 (756)
Q Consensus 551 DFGlA~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 629 (756)
|||+|+....... ..... .||.+|+|||++..+..+.|+||||||++|.||+||+++.+...+.....+..|..+.+.
T Consensus 220 DFGLa~~~~~~~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCcccc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999976543111 11112 799999999999999999999999999999999999999988776677779999999999
Q ss_pred hhhhhhccCCccC-CCCCh-hHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 630 EYAIDELVDPRLG-NHYSE-HEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 630 ~~~i~~l~dp~l~-~~~~~-~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+.+++|+.+. ..+.. .+...+..++.+|++.+|..||+|.||++.|+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 9899999999987 66664 678889999999999999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=401.61 Aligned_cols=252 Identities=32% Similarity=0.458 Sum_probs=208.6
Q ss_pred eEEEEecccCceEEEEEEecCCCEEEEEEecccCCcC--chhHHHHHHHHHhcCCCCeeeEEEEEEecC-ceeEEEEeec
Q 004395 409 SQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-RRLLVYEYIC 485 (756)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~--~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~-~~~LV~Ey~~ 485 (756)
.+.+.||+|+||+||+|.+.....||||++....... ...|.+|+.+|++++|||||+|+|+|.+.. ..+|||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3345599999999999999554449999887554332 458999999999999999999999999887 7999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCc-eEeeccCCCceeecCCC-cceeeccccceecCCCCC
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC-IVHRDMRPNNILLTHDF-EPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g-IiHrDLKp~NILL~~~~-~vkL~DFGlA~~~~~~~~ 563 (756)
+|+|.++++......+++..++.|+.+|++||.|||+. + ||||||||+||||+.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999999865578999999999999999999999999 8 99999999999999998 99999999998765432
Q ss_pred CcccccccCccccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 564 GVETRVIGTFGYLAPEYAQ--SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~--~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||....+ .+. ..........+.
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~----------~~~v~~~~~Rp~- 266 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQV----------ASAVVVGGLRPP- 266 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHH----------HHHHHhcCCCCC-
Confidence 2233467999999999999 56999999999999999999999999975543 110 001111112222
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+..+...+..++.+||..||+.||++.+++..|+.
T Consensus 267 ---~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~ 302 (362)
T KOG0192|consen 267 ---IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES 302 (362)
T ss_pred ---CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence 233355578999999999999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=401.75 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=213.8
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
..|...++||+|||+.||+++. .+|+.||+|++... .....+...+||+|.+.|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 89999999987643 3334567889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
|+|.+++|..++. ..+++++.+++.++.||+.||.|||++ +|||||||..|+||+++.++||+|||||..+...
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999987 678999999999999999999999999 9999999999999999999999999999987644
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
. ....+.+|||.|+|||++....++..+||||+|||||-||+|++||+....... .......+.
T Consensus 172 ~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket----------y~~Ik~~~Y----- 235 (592)
T KOG0575|consen 172 G-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET----------YNKIKLNEY----- 235 (592)
T ss_pred c-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH----------HHHHHhcCc-----
Confidence 3 245678999999999999999999999999999999999999999975532211 111111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+........+||..+|+.||.+|||+++||..
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1223445678899999999999999999999974
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=387.40 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=208.5
Q ss_pred eeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc-eeEEEEee
Q 004395 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR-RLLVYEYI 484 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~-~~LV~Ey~ 484 (756)
++.++.||+|..|+||++.+ ++++.+|+|++..... ...+++.+|+++|+..+||+||.+||.|..+.. .+|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 34467899999999999995 5799999999855433 345689999999999999999999999999994 99999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
.+|+|++++.. .+.+++...-+++.++++||.|||+ + +||||||||+||||+..|+|||||||.+..+.+.
T Consensus 161 DgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~----~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEER----KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhcc----CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999973 4789999999999999999999996 6 8999999999999999999999999999877655
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
...+++||..|||||.+.+..|+.++||||||++++|+++|+.||....+... .|+. -+..+++... .
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~----~~~~------Ll~~Iv~~pp-P 300 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL----DIFE------LLCAIVDEPP-P 300 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC----CHHH------HHHHHhcCCC-C
Confidence 45678999999999999999999999999999999999999999965411111 1111 1122333111 1
Q ss_pred CCCh-hHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 644 HYSE-HEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 644 ~~~~-~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+. .+..++.+++..||++||.+||++.|++++
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2222 255679999999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=388.80 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=207.8
Q ss_pred hhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCc-------CchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ-------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~-------~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
..+.|.+.+.||+|+||.|-+|. ..+|+.||||+++..... ......+|+++|++|+|||||+++++|....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678999999999999999999 568999999988643221 1234579999999999999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC---Ccceeecc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD---FEPLVGDF 552 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~---~~vkL~DF 552 (756)
..||||||++||+|.+++. .++.+.+..-..++.|++.||.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999997 456788888899999999999999999 99999999999999776 78999999
Q ss_pred ccceecCCCCCCcccccccCccccCccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI---TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 629 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 629 (756)
|+|+..+.+. ...+.+|||.|.|||++.+..+ ..++|+||+|||||-+|+|.+||........ +.
T Consensus 324 GlAK~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----------l~ 391 (475)
T KOG0615|consen 324 GLAKVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----------LK 391 (475)
T ss_pred chhhccccce--ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----------HH
Confidence 9999887443 5678999999999999977553 3588999999999999999999964432110 00
Q ss_pred hhhhhhccCCc--cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 EYAIDELVDPR--LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 ~~~i~~l~dp~--l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+++...+ +..........+.++||.+||..||++|||++|+|++
T Consensus 392 ----eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 392 ----EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ----HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1111111 1122344556678999999999999999999999883
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=385.55 Aligned_cols=250 Identities=27% Similarity=0.399 Sum_probs=202.3
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.++|...+.||+|+||+||+|+. .++..||||.+... .....+.+..|+.+|+.++|||||.|++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35788999999999999999994 57899999987655 3344566889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC------Ccceeeccccc
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD------FEPLVGDFGLA 555 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~------~~vkL~DFGlA 555 (756)
|||.||+|.++|+ ..+.+++..++.++.||+.||++||++ +||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998 456899999999999999999999999 99999999999999765 56899999999
Q ss_pred eecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
+.+.++. ...+.+|++.|||||++..++|+.|+|+||+|+|||+|++|+.||+...+..-.. ......
T Consensus 163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~----------~~~k~~ 230 (429)
T KOG0595|consen 163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL----------YIKKGN 230 (429)
T ss_pred hhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH----------HHhccc
Confidence 9887654 4567899999999999999999999999999999999999999998655432111 111011
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
-+-+.+ +......+.+++...++.+|.+|-++.+-+.
T Consensus 231 ~~~~~~----~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 231 EIVPVL----PAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred cccCch----hhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 111111 1111122446666677777777776666543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=396.69 Aligned_cols=260 Identities=28% Similarity=0.385 Sum_probs=222.2
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.+++..+.+.+++.||+|-||.||.|.+.....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..+..+||
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 344445556677889999999999999977779999998865 3445689999999999999999999999999889999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|||||+.|+|.++|....+..+.....+.++.|||+|++||+++ ++|||||..+||||+++..+||+|||||+...
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999876788899999999999999999999999 99999999999999999999999999999666
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
+...........+..|.|||.+..+.++.|||||||||+||||+| |+.||..... ...-+.+.
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------------~ev~~~le 418 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------------EEVLELLE 418 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------HHHHHHHh
Confidence 555544444556778999999999999999999999999999999 8888754322 11223333
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+-..+..++..+.+++..||+.+|++|||+..+...|++
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 444444566677889999999999999999999999998875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.34 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=207.0
Q ss_pred CeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEE-EEEecCc-eeEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIG-FCIEDRR-RLLVY 481 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~-~~~~~~~-~~LV~ 481 (756)
+|.+++.||+|.||.||++. ..+|..||.|.+.... .+.......|+.+|++|+|||||++++ .|.++.. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46777889999999999998 6799999999876443 334457888999999999999999998 4544444 89999
Q ss_pred EeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 482 EYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 482 Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|||.+|+|...+.. ...+.+++..+|+++.|++.||.++|..-+.+-|+||||||.||+|+.+|.+||+||||++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999843 3567899999999999999999999995444459999999999999999999999999999876
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... ......+|||.||+||.+.+.+|+.+|||||+||++|||+.-+.||.+..- .. +.+.+..
T Consensus 180 s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~----------L~~KI~q 242 (375)
T KOG0591|consen 180 SKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LS----------LCKKIEQ 242 (375)
T ss_pred chh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HH----------HHHHHHc
Confidence 533 345678999999999999999999999999999999999999999975421 11 1111111
Q ss_pred ccCCCCC-hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 640 RLGNHYS-EHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 640 ~l~~~~~-~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
.-....+ ......+..||..|+..||+.||+.-.++..+.
T Consensus 243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1111122 456678999999999999999998555554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=370.24 Aligned_cols=241 Identities=24% Similarity=0.301 Sum_probs=202.6
Q ss_pred CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.+|++++.||+|+||+||.++ .++++.||+|+++... .........|..||..++||+||+++..|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 579999999999999999999 4579999999876432 334567888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.||.|..+|. +.+.+++..+.-++.+|+.||.|||+. |||||||||+|||||.+|+++|+||||++.....
T Consensus 105 d~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 105 DYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999997 568899999999999999999999999 9999999999999999999999999999955443
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.. ...+++||+.|||||++.+..|+..+|+||||+++|||++|.+||....... +. +.+...+
T Consensus 179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~---------~~I~~~k- 241 (357)
T KOG0598|consen 179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MY---------DKILKGK- 241 (357)
T ss_pred CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HH---------HHHhcCc-
Confidence 22 3456899999999999999999999999999999999999999997544221 11 1111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCC
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRP 669 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RP 669 (756)
....+........+++..+|..||.+|.
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0112222334688999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=363.46 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=209.0
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+.|+.+..+|+|+||+||+++. .+|+.||||++.....+ ..+-.++|+++|++|+|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3577788999999999999994 57999999987644332 23458899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
||+. ++.+-|.. ....++...+.+++.|++.|+.|||++ ++|||||||+||||+.+|.+||||||+|+.+..+.
T Consensus 82 ~~dh-TvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDH-TVLHELER-YPNGVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecch-HHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9954 44444433 445688999999999999999999999 99999999999999999999999999999877422
Q ss_pred CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh--------
Q 004395 563 MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI-------- 633 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i-------- 633 (756)
...+.++.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+.|.+.....+..+.......+....+
T Consensus 156 -d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 156 -DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred -chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 35678899999999999877 78999999999999999999999999887766664433222111111111
Q ss_pred -hhccCCccC-----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 -DELVDPRLG-----NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 -~~l~dp~l~-----~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+.-|... +.--+.....+++++..||+.||++|++.+|++.+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111 11111233468899999999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.99 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=209.5
Q ss_pred hCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEeccc---CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~L 479 (756)
..+|.+++.||+|+|++||+|+ ..+++.||||++... ..........|-++|.+| .||+|++|+..|.|+..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 3578899999999999999999 568999999976532 334455677899999999 79999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|+||+++|+|.++|. .-+.|++..++.++.+|+.||+|||++ |||||||||+|||||.|+++||+|||.|+.+.
T Consensus 152 vLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999997 458899999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCCC----------cc--cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh
Q 004395 560 DGDMG----------VE--TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 560 ~~~~~----------~~--~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
+.... .. ..++||..|.+||+|..+..+..+|+|+||||||+|+.|.+||.....-
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------------ 293 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------------ 293 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------------
Confidence 42211 11 4589999999999999999999999999999999999999999644321
Q ss_pred hhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 ~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+.-..+..+ + ..+++..+....+|+.+.|..||.+|+|..||-++
T Consensus 294 liFqkI~~l-~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 LIFQKIQAL-D----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHHHh-c----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111111111 1 12333444578899999999999999999998774
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=372.25 Aligned_cols=264 Identities=22% Similarity=0.276 Sum_probs=209.4
Q ss_pred CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEec--CceeEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLV 480 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~LV 480 (756)
..|+.++.||+|.||.||+|+ ..+|+.||+|++..... .......+||.||++|.||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 346667789999999999999 67899999998876653 3445678899999999999999999998876 689999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
+||| .-+|.-++.. ..-.|++.++..++.||+.||+|||.. ||+|||||.+|||||++|.+||+|||||+++..
T Consensus 197 FeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999 6788887753 456799999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh-----
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID----- 634 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~----- 634 (756)
......+..+-|.+|.|||++.| ..|+.++|+||.||||.||++|++.|.......|.....-...-..+..+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 66555677788999999998876 679999999999999999999999998776654432211110000000011
Q ss_pred --hccCCcc------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 635 --ELVDPRL------GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 635 --~l~dp~l------~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
....+.. .+. ........++|+..+|..||.+|.|+.++|+
T Consensus 351 ~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111110 000 1123345789999999999999999999886
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.08 Aligned_cols=264 Identities=25% Similarity=0.344 Sum_probs=213.4
Q ss_pred CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcC--chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~--~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.+|...+.||+|.||.||+|. ..+|+.||||+++.....+ ....++|++.|+.++|+||+.++++|.....+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 367788899999999999999 5689999999988764332 3468899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+ .-+|+..+.+ ....|+...+..++.++++||+|||.+ .|+||||||+|+||+.+|.+||+|||+|+.+....
T Consensus 82 fm-~tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 6899998876 567899999999999999999999999 99999999999999999999999999999988655
Q ss_pred CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh--------hhh---hhh
Q 004395 563 MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA--------RPL---LEE 630 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~--------~~~---~~~ 630 (756)
... +..+-|.+|.|||.+.| ..|+..+||||.|||+.||+.|.+-|.+.....|....-.+ ++. +.+
T Consensus 156 ~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 433 23367999999998876 67999999999999999999999888776655543221111 111 111
Q ss_pred h-hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 631 Y-AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 631 ~-~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+ .+...-.+. .+.....+.....+|+..|+..||.+|+++.|++++
T Consensus 235 Y~~~~~~P~~~-~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPP-LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCc-cccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1 112111222 222333455567999999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=365.01 Aligned_cols=254 Identities=28% Similarity=0.382 Sum_probs=204.1
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC--ceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR--RRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~--~~~LV~E 482 (756)
.+|...+.||+|.||.||++... +|...|||.+........+.+.+|+.+|++|+|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35777889999999999999954 59999999877654333566899999999999999999999755444 6899999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-CCcceeeccccceecCC-
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPD- 560 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-~~~vkL~DFGlA~~~~~- 560 (756)
|+++|+|.+++..... .|++..+..++.||++||+|||++ |||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999986444 899999999999999999999999 9999999999999999 79999999999987653
Q ss_pred -CCCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 561 -GDMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 561 -~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
........+.||+.|||||++.++.. ..++|||||||++.||+||..||.... . ....+ ..+..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-~-------~~~~~------~~ig~ 237 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-E-------EAEAL------LLIGR 237 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-c-------hHHHH------HHHhc
Confidence 11222345789999999999986433 359999999999999999999996420 0 00000 00000
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
......++........+++..|+..||+.|||+.++|.+.
T Consensus 238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1111234445556789999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=363.62 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=203.5
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEEEec
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED 474 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~ 474 (756)
+..++|.+.+.||+|+||.||+|.. .++..||||+++.... .....+.+|+.+|..+ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4557899999999999999999973 2356899998864332 2235688999999999 899999999988764
Q ss_pred -CceeEEEEeecCCChhhhhhccC--------------------------------------------------------
Q 004395 475 -RRRLLVYEYICNGSLDSHLYGCH-------------------------------------------------------- 497 (756)
Q Consensus 475 -~~~~LV~Ey~~ggsL~~~L~~~~-------------------------------------------------------- 497 (756)
...++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 45899999999999999986421
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC-CcccccccC
Q 004395 498 ----QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGT 572 (756)
Q Consensus 498 ----~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt 572 (756)
..++++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....... .......++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 23588889999999999999999999 999999999999999999999999999986543221 112234467
Q ss_pred ccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHH
Q 004395 573 FGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVY 651 (756)
Q Consensus 573 ~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~ 651 (756)
+.|+|||++.+..++.++|||||||+||||++ |..||........ .... +..-... ..+.....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~------~~~~~~~----~~~~~~~~ 304 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQR------LKDGTRM----RAPENATP 304 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHH------HhcCCCC----CCCCCCCH
Confidence 88999999999999999999999999999997 9999965332110 0000 0000011 11223345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 652 CMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 652 ~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+.+++.+||+.||++|||+.+|++.|+.
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 68899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=366.21 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=208.8
Q ss_pred HhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEeccc----CC-cCchhHHHHHHHHHhcC-CCCeeeEEEEEEecC
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA----SS-QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDR 475 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~----~~-~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~ 475 (756)
...++|.+++.||+|+||+|++|. ..+|..||+|++... .. .....+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456799999999999999999998 457899999976653 12 23446778999999999 999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC-Ccceeecccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGL 554 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~-~~vkL~DFGl 554 (756)
.+|+||||+.||+|.+++.. .+++.+..+..++.|++.|++|||++ ||+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999974 67899999999999999999999999 99999999999999999 9999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ-IT-EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....... ...
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l----------~~k-- 234 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL----------YRK-- 234 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH----------HHH--
Confidence 99774 2233556789999999999999977 85 899999999999999999999986332111 000
Q ss_pred hhhccCCccCCCCChhH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 633 IDELVDPRLGNHYSEHE-VYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~-~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+.... ..++... ...+..|+.+||..||.+|+++.+++.
T Consensus 235 ---i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 ---IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11110 1112222 456889999999999999999999984
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=370.73 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=213.2
Q ss_pred hhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcC-chhHHHHHHHHHhcC-CCCeeeEEEEEEecC-ceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDR-RRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~-~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~-~~~L 479 (756)
..++|..++.||.|.||.||+|+ ..+|..||||.++..-... .-.-++|++.|++|. ||||++|.+++.+++ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 44689999999999999999999 5679999999877554332 223567999999998 999999999999988 8999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||| ..+|.+++.++ ++.|++..+..|+.||++||+|+|.+ |+.||||||+|||+..+..+||+||||||...
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEecccccccccc
Confidence 99999 78999999886 88999999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCCcccccccCccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhh--h----hhhhhhhh
Q 004395 560 DGDMGVETRVIGTFGYLAPEYA-QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW--A----RPLLEEYA 632 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~--~----~~~~~~~~ 632 (756)
... ..+.++.|.+|.|||++ +++.|+.+.|||++|||++|+.+-++.|.+....++....-- . ..+.+...
T Consensus 162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 443 45778899999999976 568899999999999999999999999987665444211100 0 00111111
Q ss_pred hhhccC--------CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 633 IDELVD--------PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 633 i~~l~d--------p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+...+. ..+....+ ....+..+++.+|+..||.+|||+.|++++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111 11111122 256678999999999999999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=348.80 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=204.0
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.|+..+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.+++.++|+||+.+++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 478899999999999999994 579999999876432 2233467899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999888654556799999999999999999999999 99999999999999999999999999998764332
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ...+... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~---------~~~~~~~--~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEV---------DRRVKED--Q 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHH---------HHHhhcc--c
Confidence 123456999999999999999999999999999999999999999754321110 000 0001010 1
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLR 676 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~ 676 (756)
..++......+.+|+.+||..||.+||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1223334456889999999999999997 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=367.39 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=215.0
Q ss_pred CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
..|.....||+|+.|.||.|. ..+++.||||.+........+.+++|+.+|+.++|+|||.+++.|...+.+|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 357777889999999999998 5678999999998887777788999999999999999999999999899999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
+||+|.+.+. ...+++.++..|+.+++.||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+.... .
T Consensus 353 ~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-S 424 (550)
T ss_pred CCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeecccccc-C
Confidence 9999999994 45699999999999999999999999 99999999999999999999999999998776543 3
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
...+.+|||.|||||+.....|++++||||||++++||+-|.+||-...+. ...+.+...-.|. ..
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------------rAlyLIa~ng~P~--lk 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------------RALYLIATNGTPK--LK 490 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------------HHHHHHhhcCCCC--cC
Confidence 567789999999999999999999999999999999999999999643321 1112222211222 22
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+......+.+++.+||..|+++|+++.|+|++
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 344556679999999999999999999999984
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=352.24 Aligned_cols=263 Identities=24% Similarity=0.334 Sum_probs=212.4
Q ss_pred hhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcC-chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~-~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
..+.|++...||.|.-++||+|+ .+.+..||||++....... ...+.+|+..++.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45689999999999999999999 6788999999998765544 478999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
.||.+|++.+++...-...+++..+..|+.++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+-.+.+.
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999766666799999999999999999999999 9999999999999999999999999998766543
Q ss_pred CCC--cc-cccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 562 DMG--VE-TRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 562 ~~~--~~-~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
... .. .+++||++|||||++.. ..|+.|+||||||++.+||.+|..||....+.... +....... ..+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-l~tLqn~p------p~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-LLTLQNDP------PTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-HHHhcCCC------CCc
Confidence 321 11 55789999999999643 67999999999999999999999999765543211 11000000 000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....+...........+..++..||..||.+|||++++++.
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00000111111222368899999999999999999999874
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.75 Aligned_cols=257 Identities=26% Similarity=0.357 Sum_probs=210.4
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+..++|++.+.||+|+||.||+|...+++.||+|.++... .....|.+|+.++++++||||+++++++...+..|+|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4557899999999999999999998777889999876443 345679999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999765556799999999999999999999999 99999999999999999999999999998775432
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
........++..|+|||++.+..++.++||||||+++|||++ |+.||........ + . .+... .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~--------~--~~~~~----~ 221 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV--L--------Q--QVDQG----Y 221 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--H--------H--HHHcC----C
Confidence 222222233467999999999999999999999999999999 9999864321100 0 0 00010 0
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
....+......+.+++.+||+.+|++||++.++++.|++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111222334578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.03 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=203.7
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999964 68899999876542 2234568899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.++.|..+.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 998877665443 345799999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hhhhhhhhhh--------hhh
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TEWARPLLEE--------YAI 633 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~~~~~~--------~~i 633 (756)
........|++.|+|||++.+..++.++|||||||++|||++|+.||........... .....+.... ...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 3233446789999999999998999999999999999999999999975432211100 0000000000 000
Q ss_pred hhccCCccCC------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DELVDPRLGN------HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~l~dp~l~~------~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.....+.... .+.......+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 011123456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.90 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=210.1
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
..++|++.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 346899999999999999999998888899999876432 2356789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.......+++..++.++.|++.||+|||+. +++||||||+|||++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999999765567789999999999999999999999 999999999999999999999999999987654332
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||........ . .. +......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~---~~------~~~~~~~--- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---M---SA------LQRGYRM--- 223 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---H---HH------HHcCCCC---
Confidence 22233446778999999998899999999999999999998 9999964322110 0 00 0110011
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.........+.+++.+||..+|++||+++++++.|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112233468899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.16 Aligned_cols=244 Identities=19% Similarity=0.276 Sum_probs=198.4
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCCcC---chhHHHHHHHHHhcCCCCeeeEEEEEEe----cCceeEEEEee
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRRLLVYEYI 484 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~---~~~f~~Ev~iL~~L~HpNIV~l~~~~~~----~~~~~LV~Ey~ 484 (756)
..||+|++|.||+|.+ +|+.||||.++...... .+.|.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 78999999887543333 3567899999999999999999999977 34689999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+|+|.+++.. .+.+++...+.++.+++.||.|||... +++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999974 457899999999999999999999742 78899999999999999999999999998654322
Q ss_pred cccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 565 VETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ... .+......
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~---------~i~~~~~~ 240 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYD---------LIINKNNS 240 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHH---------HHHhcCCC
Confidence 23458899999999976 689999999999999999999999997543211 000 00000011
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11222345578999999999999999999999999874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.33 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=204.8
Q ss_pred hhCCeeEEEEecccCceEEEEEEec----CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
..++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....|.+|+.++..++||||+++++++..+...+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3467999999999999999999842 467899998875432 22356889999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.++++|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999965 245789999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
............++..|+|||++.+..++.++|||||||++||+++ |..||....... .... +.+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~----------~~~~--~~~~~ 225 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD----------VIKA--VEDGF 225 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----------HHHH--HHCCC
Confidence 3222111122335678999999999999999999999999999775 999996443211 0000 01100
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. ...+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 226 ~----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 R----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred C----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 1 11223344568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=361.23 Aligned_cols=247 Identities=27% Similarity=0.357 Sum_probs=209.4
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|.+.+.||+|.||.||+|+. .+.+.||+|.+..... ...+.+.+|++|++.|+|||||.++++|+....+|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4688888999999999999994 4789999998764433 345679999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.| +|..+|. ..+.++++.+..++.++..||.|||++ +|+|||+||.||||+..|.+|+||||+|+.....
T Consensus 82 ~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9955 9999997 567899999999999999999999999 9999999999999999999999999999976543
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
....+.+.|||.|||||+..++.|+..+|+||+|||+||+++|++||.... ...+.... +.++.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----------i~~Lv~~I----~~d~v-- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----------ITQLVKSI----LKDPV-- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----------HHHHHHHH----hcCCC--
Confidence 345567889999999999999999999999999999999999999994221 11111111 11221
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+......+.+++...|.+||.+|.+..+++.+
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2333566788999999999999999999999864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=345.70 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=201.8
Q ss_pred hCCeeEEEEecccCceEEEEEEecC-----------------CCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPD-----------------GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVM 466 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----------------g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~ 466 (756)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+..... .....|.+|+++|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999997432 34799998875432 23457999999999999999999
Q ss_pred EEEEEEecCceeEEEEeecCCChhhhhhccC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCce
Q 004395 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCH-----------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529 (756)
Q Consensus 467 l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~-----------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gI 529 (756)
+++++.+....++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+. ||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i 159 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NF 159 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----Cc
Confidence 9999999999999999999999999885321 13478889999999999999999999 99
Q ss_pred EeeccCCCceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh--CC
Q 004395 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT--GR 606 (756)
Q Consensus 530 iHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt--G~ 606 (756)
+||||||+|||++.++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999986543321 11223446788999999998899999999999999999997 45
Q ss_pred CCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 607 KAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 607 ~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
.||...... . ............ ........+...+..+.+++.+||..||++|||+.+|.+.|+
T Consensus 240 ~p~~~~~~~--~-~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDE--Q-VIENAGEFFRDQ------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHH--H-HHHHHHHHhhhc------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 566533211 1 111111100000 000001112233457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=335.38 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=203.4
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
++|.+.+.||+|+||.||++.+.++..+|+|.+... ......|..|+++|+.++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468889999999999999999888889999987633 2334678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+|+|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.++|+|||+++.........
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999998643 34689999999999999999999999 99999999999999999999999999998654433222
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..... .....+ .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~------~~~~i------~~~~~~----~ 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE------VVEMI------SRGFRL----Y 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH------HCCCCC----C
Confidence 223345678999999998899999999999999999999 899986432110 00000 000000 0
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
.+......+.+++.+||+.+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.74 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=209.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
...+|.+.+.||+|+||.||+|... +++.||+|.+... ......+.+|++++..++||||+++++++..+...++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 3456889999999999999999954 5889999987643 3345678999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+++++|.+++.......+++..++.++.|++.||+|||+. |++||||||+|||+++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999765566799999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
........++..|+|||++.+..++.++|||||||++|||++ |..||...... ...... .. ..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~------~~----~~ 222 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELL------EK----GY 222 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH------HC----CC
Confidence 222222334678999999999999999999999999999998 99998643211 110000 11 11
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
....+...+..+.+++.+||..||++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 112223344578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.74 Aligned_cols=265 Identities=29% Similarity=0.444 Sum_probs=212.7
Q ss_pred CChHHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEe
Q 004395 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (756)
Q Consensus 396 ~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~ 473 (756)
.+..++++..+.+.+...||+|.||+||+|.|.. .||||+++..... ..+.|.+|+.+|++-+|.||+-|.|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3447788888888999999999999999999853 4999998876543 34679999999999999999999999998
Q ss_pred cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
... .||+.+|+|-+|+.+|+. ....|.....+.||.||++|+.|||.+ +|||||||..||||.+++.|||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv-~etkfdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHV-QETKFDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccc-hhhhhhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEeccc
Confidence 776 999999999999999986 446799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCC--CCCCcccccccCccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh
Q 004395 554 LARWQPD--GDMGVETRVIGTFGYLAPEYAQS---GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL 628 (756)
Q Consensus 554 lA~~~~~--~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 628 (756)
|+..-.. +... ...-.|...|||||++.. .+|++.+||||||||+|||+||..||. ....++ .+....+.++
T Consensus 534 Latvk~~w~g~~q-~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq-IifmVGrG~l 610 (678)
T KOG0193|consen 534 LATVKTRWSGEQQ-LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ-IIFMVGRGYL 610 (678)
T ss_pred ceeeeeeeccccc-cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh-eEEEeccccc
Confidence 9963221 1111 122347889999999853 578999999999999999999999998 333222 2222222111
Q ss_pred hhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 629 ~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
. .++.. ....+...|.+|+..||..++++||.+.+|+..|+..
T Consensus 611 ~----pd~s~------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 611 M----PDLSK------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred C----ccchh------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 1 11111 1123455789999999999999999999999988754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.09 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=210.6
Q ss_pred CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
+-|++++.||.|+-|.|-+|+ ..+|+.+|||++.... ......+.+|+-+|+.|.||||+.+|++++++..+|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 468889999999999999999 5689999999886542 222345788999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||++||.|.++|. ..++|++..+.+++.||+.|+.|||.. +|+||||||+|+|||..+.+||+|||+|....++
T Consensus 92 Eyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999997 578999999999999999999999999 9999999999999999999999999999876655
Q ss_pred CCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
. ...+.||+|.|.+||++.|.+| +.++||||+|||||-||||+.||+...- +.++.+..--.
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----------r~LLlKV~~G~----- 228 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----------RVLLLKVQRGV----- 228 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----------HHHHHHHHcCc-----
Confidence 4 3567799999999999999999 5899999999999999999999984321 11222111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...+.....+.++|+.+|+..||.+|.|+++|+++
T Consensus 229 --f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 --FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 11223445578999999999999999999999986
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=348.84 Aligned_cols=264 Identities=24% Similarity=0.343 Sum_probs=205.6
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
..++|++.+.||+|+||.||++... +|..||+|.+..... .....+.+|+++|+.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3578999999999999999999954 788999998875432 23456899999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 83 EHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999999963 456899999999999999999999851 6999999999999999999999999999865432
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh------------
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE------------ 629 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~------------ 629 (756)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||........... ...+...
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI--FGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--hcccccccccCCccccCcc
Confidence 2 2345699999999999999999999999999999999999999964332110000 0000000
Q ss_pred ---------------------hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 ---------------------EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 ---------------------~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
......+................+.+|+.+||+.||++|||+.+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000011234568999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=379.47 Aligned_cols=262 Identities=29% Similarity=0.406 Sum_probs=219.7
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEe
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~ 473 (756)
.++...+....+.||+|+||+||+|.. .+.+.||||.++..... ...+|.+|+++|..|+|||||+|+|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 345556777888999999999999983 24568999998876655 67799999999999999999999999999
Q ss_pred cCceeEEEEeecCCChhhhhhcc--------C----CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGC--------H----QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~--------~----~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL 541 (756)
++..|+|+|||..|||.+||..+ . ..+|+..+.+.||.|||.|++||-++ .+|||||-.+|+||
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNCLV 636 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhcee
Confidence 99999999999999999999532 1 23489999999999999999999999 89999999999999
Q ss_pred cCCCcceeeccccceecCCCCCCccc-ccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 004395 542 THDFEPLVGDFGLARWQPDGDMGVET-RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQC 619 (756)
Q Consensus 542 ~~~~~vkL~DFGlA~~~~~~~~~~~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 619 (756)
.++..|||+||||++.....++.+.. ...-..+|||||.+..++|+.+||||||||||||+++ |+.||.....
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----- 711 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----- 711 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----
Confidence 99999999999999965554443322 3345788999999999999999999999999999999 8888864432
Q ss_pred hhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcCc
Q 004395 620 LTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDT 682 (756)
Q Consensus 620 l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~~ 682 (756)
+..+..+....+ -..+..++..+..|+..||+..|++||++.||-..|+...
T Consensus 712 ----------~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 712 ----------QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred ----------HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 122223333333 4466778889999999999999999999999999998644
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=341.37 Aligned_cols=264 Identities=23% Similarity=0.296 Sum_probs=201.1
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|.+.+.||.|+||.||+|.. .+++.||+|+++.... .....+.+|+++++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5799999999999999999995 4789999998865432 2345688999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+. ++|.+++.. ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 95 599988864 344688999999999999999999999 999999999999999999999999999986543221
Q ss_pred CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh-hhh--------hhhhhhhhh
Q 004395 564 GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT-EWA--------RPLLEEYAI 633 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~--------~~~~~~~~i 633 (756)
......|++.|+|||++.+ ..++.++|||||||++|||++|+.||............ ... .........
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 2234568999999998865 56899999999999999999999999754432111000 000 000000000
Q ss_pred hhccCCccCCC----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DELVDPRLGNH----YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~l~dp~l~~~----~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.....+..... ........+.+|+.+||..||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111111000 01122346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=350.45 Aligned_cols=252 Identities=20% Similarity=0.249 Sum_probs=205.0
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+..|++++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999964 68999999886432 223456889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+++|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999996 345789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc-CCc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV-DPR 640 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~-dp~ 640 (756)
......||+.|+|||++.+..++.++|||||||++|||++|..||......... .... ...... .+.
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~---~~~~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLK---YWKETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHHH---hccccccCCC
Confidence 234467999999999999999999999999999999999999999754322110 0000 000000 111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .........+.+++.+||..+|.+||++.+++++
T Consensus 222 ~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 10 0001234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=350.64 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=202.2
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57999999999999999999954 68999999876432 233456889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+|+|.+++.. .+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999973 46789999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
. ....||+.|+|||++.+..++.++|||||||++|||++|..||....+.. .. ..+....+
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~---------~~i~~~~~ 232 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IY---------EKILAGRL 232 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HH---------HHHhcCCc
Confidence 2 24579999999999999999999999999999999999999996432210 00 00111100
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~~ 677 (756)
.++......+.+|+.+||+.||.+||+ +.+++.+
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111223346789999999999999996 6777654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.67 Aligned_cols=245 Identities=24% Similarity=0.284 Sum_probs=201.7
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++|+.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 37899999999999999999954 78999999876432 123456888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+++|+|.+++.. .+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999973 45789999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+....
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~---------~~i~~~~- 214 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IY---------EKILAGK- 214 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHhCC-
Confidence 224569999999999999999999999999999999999999996543211 00 0000000
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~~ 677 (756)
..++......+.+++.+||..||.+||+ +.+++++
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0112222346889999999999999995 8887753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=355.45 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=213.1
Q ss_pred CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
..|....+||+|.||.||+|. ..+++.||+|++...... ...++.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 356677889999999999999 567999999999876544 457899999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
|.||++.+.|. ....+.+..+.-++.+++.||.|||.. +.+|||||+.|||+..+|.+||+|||.+-.......
T Consensus 93 ~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999996 344558888889999999999999999 999999999999999999999999999987765443
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
. ..+++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+... .+.+.+-..|.+.+
T Consensus 167 r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv------------lflIpk~~PP~L~~ 233 (467)
T KOG0201|consen 167 R-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV------------LFLIPKSAPPRLDG 233 (467)
T ss_pred c-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE------------EEeccCCCCCcccc
Confidence 3 3778999999999999999999999999999999999999999975544211 12233333455544
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+ ...+.+++..||..||+.||++.++|++
T Consensus 234 ~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 DF----SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 33 3468999999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.07 Aligned_cols=236 Identities=24% Similarity=0.314 Sum_probs=200.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.+|+..+.||.|+||.|.+++. .+|..+|+|++....- ...+...+|..+|+.+.||+++++++.|.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 3677889999999999999994 4789999998765432 23345778999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||++||.|.++++ ..+++++..++.+|.||+.||+|||+. +|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999997 457899999999999999999999999 9999999999999999999999999999977543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.-+.+|||.|+|||.+.+.+|+.++|+|||||++|||+.|.+||....+... ...++...+
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i---------------Y~KI~~~~v 258 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI---------------YEKILEGKV 258 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH---------------HHHHHhCcc
Confidence 4568999999999999999999999999999999999999999976554111 111221111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCC
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSR 668 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~R 668 (756)
.++......+.+|+..+|+.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2333444568899999999999988
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.40 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=212.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
...+|.+.+.||.|+||.||+|...++..+|+|.+..........+..|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34578889999999999999999877999999998766554566799999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||+++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999865667899999999999999999999999 999999999999999999999999999987654322
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
.. ....++..|+|||++....++.++||||||+++|+|++ |+.||....... .. . .+. ....
T Consensus 160 ~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~------~~----~-----~~~-~~~~ 222 (261)
T cd05148 160 LS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE------VY----D-----QIT-AGYR 222 (261)
T ss_pred cc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH------HH----H-----HHH-hCCc
Confidence 21 23346778999999998899999999999999999998 899986433110 00 0 000 1111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+......+.+++.+||..||.+|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11223344568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=356.50 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=204.3
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccC-CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE 473 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~ 473 (756)
....++|++.+.||+|+||.||+|.+ .++..||||+++... ......+.+|+++|..+ +||||++++++|.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33456789999999999999999973 246689999886433 22345688999999999 89999999999999
Q ss_pred cCceeEEEEeecCCChhhhhhccC--------------------------------------------------------
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGCH-------------------------------------------------------- 497 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~~-------------------------------------------------------- 497 (756)
....++|||||++|+|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999999885421
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 498 -----------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 498 -----------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 12578899999999999999999999 999999999999999999999999999986644
Q ss_pred CCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 561 GDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 561 ~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||........ +..+ ..
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~----~~--------- 331 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKM----IK--------- 331 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHH----HH---------
Confidence 3211 1122345678999999999999999999999999999998 8888864322110 0000 00
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.......+......+.+|+.+||+.||++||++.+|++.|+.
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 000001111223468899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.51 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=205.2
Q ss_pred hhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
..++|.++..||+|+||.||+|. ..+|..+|+|+++... .......+.|-.+|....+|.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 34678899999999999999999 5579999999987543 2344568889999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||++||++..+|. ..+.|++..+..++.+++.||..||+. |+|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999997 578999999999999999999999999 99999999999999999999999999985211
Q ss_pred C----------------------CCCC-----c-------------------ccccccCccccCccccccCCCCchhhHH
Q 004395 560 D----------------------GDMG-----V-------------------ETRVIGTFGYLAPEYAQSGQITEKADVY 593 (756)
Q Consensus 560 ~----------------------~~~~-----~-------------------~~~~~Gt~~Y~APE~l~~~~~s~ksDVw 593 (756)
. .+.. . ....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 0000 0 1125799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcccccc-hhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC--
Q 004395 594 SFGVVLVELVTGRKAVDLNRPKGQQC-LTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR-- 670 (756)
Q Consensus 594 SlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-- 670 (756)
|||||+||||.|.+||....+..... +..|...+ ..| -......+..+||.+|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l---------~fP-----~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL---------KFP-----EEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc---------cCC-----CcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 99999999999999998776643311 11221111 111 111223578899999999 9999974
Q ss_pred -HHHHHH
Q 004395 671 -MSQVLR 676 (756)
Q Consensus 671 -~~eVL~ 676 (756)
+.||-+
T Consensus 438 G~~EIK~ 444 (550)
T KOG0605|consen 438 GAEEIKK 444 (550)
T ss_pred cHHHHhc
Confidence 666654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=347.07 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=197.6
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----cee
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RRL 478 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~-----~~~ 478 (756)
+|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++++.++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999994 478999999876432 223446889999999999999999999886433 479
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+ +++|.+++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~-~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELM-ESDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecC-CCCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999999 679998886 345799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC--CcccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hhhhh-hh-----
Q 004395 559 PDGDM--GVETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TEWAR-PL----- 627 (756)
Q Consensus 559 ~~~~~--~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~-~~----- 627 (756)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ..... +.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 12234579999999999876 6789999999999999999999999965432111000 00000 00
Q ss_pred -hhhh----hhhhccCCccCCCC---ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 -LEEY----AIDELVDPRLGNHY---SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 -~~~~----~i~~l~dp~l~~~~---~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.... .+..+.. .....+ .+.....+.+++.+||..||++|||+.++++.
T Consensus 234 ~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRK-KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcc-cCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0000000 000000 01123457899999999999999999999873
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.46 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=204.5
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
++|.+.+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|+.++..++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688999999999999999998777789999876432 334679999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+++|.+++... ...+++..++.++.||+.||+|||+. |++|+||||+|||++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999999653 34789999999999999999999999 99999999999999999999999999998765443222
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||........ . . .+...... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~-------~--~~~~~~~~----~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---V-------E--KVSQGLRL----Y 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---H-------H--HHhcCCCC----C
Confidence 222345678999999998889999999999999999998 9999864332100 0 0 00000001 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
.+......+.+++.+||+.+|.+||++.+|+..|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11123457899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=349.31 Aligned_cols=242 Identities=23% Similarity=0.261 Sum_probs=197.5
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
+.||+|+||.||++.. .+|+.||||+++... ......+.+|+++|..++||||+++++++..+...|+||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 578999999886432 223346788999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccc
Q 004395 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567 (756)
Q Consensus 488 sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~ 567 (756)
+|.+++. ..+.+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 9999986 346789999999999999999999999 99999999999999999999999999997543221 1223
Q ss_pred ccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCCh
Q 004395 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647 (756)
Q Consensus 568 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~ 647 (756)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... . ... .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----------~~~~~~-~--~~~----~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----------LFELIL-M--EEI----RFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH----------HHHHHH-c--CCC----CCCC
Confidence 4679999999999999999999999999999999999999996432110 000000 0 011 1222
Q ss_pred hHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 648 HEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 648 ~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
.....+.+++.+||..||++|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3345688999999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=338.61 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=198.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-c-CCCEEEEEEecccCCc--CchhHHHHHHHHHhc---CCCCeeeEEEEEEe-----
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-P-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCA---QHRNVVMLIGFCIE----- 473 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~-~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L---~HpNIV~l~~~~~~----- 473 (756)
.+|++.+.||+|+||.||+|.. . +|+.||+|.++..... ....+.+|+.+++.+ .||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3789999999999999999985 3 4788999987654322 234577788888776 69999999999863
Q ss_pred cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
....++||||+ +++|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 34689999998 57999999765566799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhh-hhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWAR-PLLEEY 631 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~-~~~~~~ 631 (756)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +..... +.....
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 156 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 998664332 2334568999999999998899999999999999999999999997544321100 000000 000000
Q ss_pred ----hhh-hccCCccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 632 ----AID-ELVDPRLG---NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 632 ----~i~-~l~dp~l~---~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+. ....+... ..........+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 0011123345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.70 Aligned_cols=256 Identities=26% Similarity=0.366 Sum_probs=209.1
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+..++|++.+.||+|+||.||+|...+++.||+|.+.... .....|.+|+.++++++|+||+++++++. ....+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4556899999999999999999998889999999876433 33467999999999999999999999875 457899999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++.......+++..++.++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999998765566899999999999999999999998 99999999999999999999999999998765333
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
........++..|+|||++.+..++.++||||||+++|||++ |+.||........ ... +......
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~------~~~~~~~-- 222 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV------IQN------LERGYRM-- 222 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH------HHH------HHcCCCC--
Confidence 222233446778999999998889999999999999999999 9999964332110 000 0111011
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+......+.+++.+||..+|++||++++++..|+.
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 --PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122234569999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.54 Aligned_cols=255 Identities=28% Similarity=0.394 Sum_probs=206.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
..++|.+.+.||+|+||.||+|...+...||+|.+.... .....|.+|+++++.++||||+++++++.+ ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 346799999999999999999997766789999876432 334578999999999999999999998754 568999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999999754455689999999999999999999999 999999999999999999999999999987654432
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
.......++..|+|||+..+..++.++|||||||++|||++ |..||........ ... +.. ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~----------~~~--~~~----~~~ 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------LDQ--VER----GYR 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH----------HHH--Hhc----CCC
Confidence 22233446778999999998899999999999999999999 8888864322100 000 000 000
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..........+.+++.+|++.||++||++.++++.|++
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 11223344568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.90 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=206.8
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
..++|++.+.||+|+||.||+|...++..||+|.+..... ....|.+|+.++++++|+||+++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3457888999999999999999988888899998775433 3457999999999999999999999885 4568999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999999765556789999999999999999999999 999999999999999999999999999987654332
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .... +. ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~------~~----~~~~ 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VLEQ------VE----RGYR 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHHH------HH----cCCC
Confidence 22223345678999999988899999999999999999999 888986432110 0000 00 0111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+......+.+++.+||..+|++|||+.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223344578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=358.57 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=206.1
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCc
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRR 476 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~ 476 (756)
.+...+|.++++||+|.||+|+++.. .+++.+|||.++... ..+.+..+.|.+|+.... ||.++.++..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34457899999999999999999995 478899999887553 345567888999998885 9999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
+|+||||+.||++..+. ..+.+++..+..++..|+.||.|||++ ||||||||.+|||||.+|++||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999955444 457899999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
.-.... ....+++|||.|||||++.+..|+..+|+|||||+|||||.|..||...+.+ ...+.+
T Consensus 517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------e~FdsI 580 (694)
T KOG0694|consen 517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------EVFDSI 580 (694)
T ss_pred ccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHH
Confidence 544222 2456799999999999999999999999999999999999999999765432 112222
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRM 671 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~ 671 (756)
+... ..|+.....+...++.++|.++|++|.-+
T Consensus 581 ~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2211 23455556678899999999999999865
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.07 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=205.2
Q ss_pred CCeeEEEEecccCceEEEEEEecC------CCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPD------GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~------g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
++|++.+.||+|+||.||+|.... ...||+|.+..... .....|.+|++++..++||||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998532 25799998764432 22356889999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC
Q 004395 479 LVYEYICNGSLDSHLYGCHQ--------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~--------------~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~ 544 (756)
++|||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+|||++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcCC
Confidence 99999999999999964321 5688999999999999999999999 99999999999999999
Q ss_pred CcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhh
Q 004395 545 FEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTE 622 (756)
Q Consensus 545 ~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~ 622 (756)
+.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||....... +
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~-- 235 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---V-- 235 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H--
Confidence 9999999999986543321 12233456889999999998899999999999999999998 999986433210 0
Q ss_pred hhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 623 WARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 623 ~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+........+...+..+.+|+.+||+.||++||++.+|++.|+.
T Consensus 236 -----------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 -----------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -----------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 00011111111233445679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=357.81 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=204.6
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
+....++.||+|+-|.||+|.+ .++.||||+++... ..+|+-|++|+||||+.|.|+|....-+|||||||.
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 3334466799999999999998 45889999766322 247888999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
.|-|...|. .+.++.......|..+||.|+.|||.+ .|||||||.-||||+.+..|||+|||.++.+.+. ..
T Consensus 196 ~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST 267 (904)
T KOG4721|consen 196 QGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST 267 (904)
T ss_pred cccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence 999999997 567889999999999999999999999 9999999999999999999999999999866543 33
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~ 645 (756)
...++||..|||||++...+.++|+|||||||||||||||..||...... ..-| ..-...+.-..
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIw-----------GVGsNsL~Lpv 332 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIW-----------GVGSNSLHLPV 332 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEE-----------eccCCcccccC
Confidence 45689999999999999999999999999999999999999999532110 0111 11112222334
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 646 ~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+..++..+.-|+++||+-.|..||+|.+++.+|+-
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 55667788899999999999999999999999973
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=352.78 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=200.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
..++|.+.+.||+|+||.||++.. .+++.||+|... ...+.+|+++|+.|+||||++++++|..+...++|||
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 446899999999999999999994 578999999643 2347799999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
++ +++|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+......
T Consensus 164 ~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 164 RY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred cC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 98 6789888863 45789999999999999999999999 99999999999999999999999999997544333
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-----hhhhhh---------hhh
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-----LTEWAR---------PLL 628 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-----l~~~~~---------~~~ 628 (756)
........||+.|+|||++.+..++.++|||||||++|||++|..||.......... +..... +..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 223345679999999999999999999999999999999999998874332111000 000000 000
Q ss_pred hhhhhhh---------ccCCccCCCC--ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 629 EEYAIDE---------LVDPRLGNHY--SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 629 ~~~~i~~---------l~dp~l~~~~--~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....+.. ...+...... .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 0000000000 01234468899999999999999999999873
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=347.05 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=201.2
Q ss_pred CeeEEEEecccCceEEEEEEe----cCCCEEEEEEecccC----CcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCce
Q 004395 407 GFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~~~~~~----~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~ 477 (756)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ......+..|+.+|..++ ||||+.+++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999884 368899999876321 223346788999999995 99999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999963 45799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
+............||+.|+|||++.+. .++.++|||||||++|||++|..||......... ...... +..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~------~~~- 225 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRR------ILK- 225 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHH------Hhc-
Confidence 644333333456799999999999865 4789999999999999999999999644322110 000000 000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
.++. ++......+.+++.+||+.||++|| ++.+++++
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1121 2222345688999999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=361.39 Aligned_cols=250 Identities=23% Similarity=0.279 Sum_probs=204.0
Q ss_pred CeeEEEEecccCceEEEEEEec-C-CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-D-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~-g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+|+.++|||||+++++|..++..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4999999999999999999843 3 6789999766554444456888999999999999999999999999999999999
Q ss_pred cCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 485 CNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 485 ~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
.+|+|.+++... ...++++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988542 345789999999999999999999999 99999999999999999999999999998765432
Q ss_pred C-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 563 M-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 563 ~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~-----~~~~~--- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVL-----YGKYD--- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-----hCCCC---
Confidence 1 2234567999999999999999999999999999999999999999643211 0000000 00001
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..+......+.+++.+||..||++||++.+++.
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112223456899999999999999999999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=354.34 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=203.9
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCCc-CchhHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVMLIGFCIE 473 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~ 473 (756)
....++|.+.+.||+|+||.||+|.. .++..||||.++..... ....+.+|+++|+.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 34456899999999999999999873 23457999988654322 234688999999999 89999999999999
Q ss_pred cCceeEEEEeecCCChhhhhhccC--------------------------------------------------------
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGCH-------------------------------------------------------- 497 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~~-------------------------------------------------------- 497 (756)
....|+||||+.+|+|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999885321
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC-
Q 004395 498 ------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG- 564 (756)
Q Consensus 498 ------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~- 564 (756)
..++++..+++++.||+.||+|||+. ||+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 13578899999999999999999999 9999999999999999999999999999865433211
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. .........
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~-------------~~~~~~~~~ 334 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY-------------KMVKRGYQM 334 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH-------------HHHHcccCc
Confidence 1122335678999999998999999999999999999997 9999964322110 00 000000011
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+......+.+++.+||+.||++||++.+|++.|+.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.29 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=203.3
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|+++++.++||||+++++++......|+||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577888999999999999998777789999876332 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+++|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...+.....
T Consensus 83 ~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999653 34789999999999999999999999 99999999999999999999999999998665432222
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....++..|+|||++.+..++.++||||||+++|||++ |..||........ .. .+...... .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~------~~~~~~~~----~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV------VE------SVSAGYRL----Y 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH------HH------HHHcCCcC----C
Confidence 222234567999999999999999999999999999999 8999864432110 00 01111111 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
.+......+.+++.+||..+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1222445789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=343.19 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=193.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|+.++|+||+++++++.+++..|+||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3456678899999999999995 4789999998864332 2235688999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+.. .+.+..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999987543 356778889999999999999999 99999999999999999999999999998664322
Q ss_pred CcccccccCccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 564 GVETRVIGTFGYLAPEYAQS-----GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||...... .|.... .... ....
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~~~~~-~~~~--~~~~ 293 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLM-CAIC--MSQP 293 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHH-HHHh--ccCC
Confidence 12234579999999998743 23457899999999999999999999732211 111100 0000 0001
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+ .........+.+|+.+||+.||++||++.|++++
T Consensus 294 ~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 P----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1122334568999999999999999999999884
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.73 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=199.9
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999954 789999998865432 223467889999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+ +++|.+++.. ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YV-HTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-CcCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 98 5788888864 346789999999999999999999999 99999999999999999999999999997543322
Q ss_pred CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh----hhhhhh----hhh
Q 004395 563 MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA----RPLLEE----YAI 633 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~----~~~~~~----~~i 633 (756)
.......|++.|+|||++.+ ..++.++|||||||++|||++|..||......... +.... .+.... ...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ-LERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhCCCChhhccchhhc
Confidence 12234568999999998865 45889999999999999999999999754321110 00000 000000 000
Q ss_pred hhccCCccCCCCCh---------hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DELVDPRLGNHYSE---------HEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~l~dp~l~~~~~~---------~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
............+. .....+.+|+.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000000 11245789999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=349.34 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=204.4
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||+|... +|+.||||++.... ......+..|++++..++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999954 78999999886432 233456889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.. .+.+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999974 36899999999999999999999998 9999999999999999999999999999865443
Q ss_pred C----------------------------CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004395 562 D----------------------------MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNR 613 (756)
Q Consensus 562 ~----------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 613 (756)
. ........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234579999999999999999999999999999999999999997543
Q ss_pred cccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 004395 614 PKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR-MSQVLRI 677 (756)
Q Consensus 614 ~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-~~eVL~~ 677 (756)
.... ... +.... ..+...........+.+++.+|+. ||.+||+ +.+++++
T Consensus 235 ~~~~------~~~------i~~~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET------YNK------IINWK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH------HHH------HhccC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2110 000 00000 000000011134568899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=328.42 Aligned_cols=257 Identities=28% Similarity=0.410 Sum_probs=210.2
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+..++|.+.+.||+|+||.||+|...+++.||||.+.... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4567899999999999999999998788899999877433 345679999999999999999999999999899999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+++++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999765556799999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
........++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ + .. +... .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~--------~~--~~~~----~ 221 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV--L--------EQ--VERG----Y 221 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H--------HH--HHcC----C
Confidence 222223335678999999998899999999999999999998 9999854321100 0 00 0000 0
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
....+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011112224568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=328.41 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=205.4
Q ss_pred hCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.++|.+...||+|+||.||+|....+..+|+|.+.... .....+.+|+++++.++||||+++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 35799999999999999999998777789999876432 334578899999999999999999998854 5689999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|.+++.......+++..+..++.|++.||.|||+. |++|+||||+|||++.++.++|+|||+++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999765556689999999999999999999999 9999999999999999999999999999876543322
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......++..|+|||++.+..++.++||||||+++|||++ |..||........ . .. +... ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~---~~------~~~~----~~~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---L---EQ------VERG----YRM 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---HH------HHcC----CCC
Confidence 2223446778999999998899999999999999999999 8999864322110 0 00 0000 011
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+......+.+++.+||..||++||++++|++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1222344578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.97 Aligned_cols=266 Identities=24% Similarity=0.327 Sum_probs=204.1
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
..++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|+++|+.++||||++++++|.+++..|+||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4578999999999999999999954 688999998765422 23356889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.. .+.+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999963 457899999999999999999999741 6999999999999999999999999999765332
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhh------hh-----------
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTE------WA----------- 624 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~------~~----------- 624 (756)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||............. +.
T Consensus 158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 1 234568999999999999899999999999999999999999996433211100000 00
Q ss_pred -----------hhhhhhhh-hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 625 -----------RPLLEEYA-IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 625 -----------~~~~~~~~-i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
++...... ...+................+.+|+.+||+.||++|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000 000000000000001123468899999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=350.95 Aligned_cols=252 Identities=19% Similarity=0.245 Sum_probs=200.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++|..++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999995 478999999886432 223346788999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+|+|.+++.. .+.+++..+..++.||+.||+|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999973 45799999999999999999999999 9999999999999999999999999999754321
Q ss_pred CCC-------------------------------------cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh
Q 004395 562 DMG-------------------------------------VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604 (756)
Q Consensus 562 ~~~-------------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt 604 (756)
... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 004395 605 GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR---MSQVLRI 677 (756)
Q Consensus 605 G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS---~~eVL~~ 677 (756)
|..||........ .... ... ...+...........+.+++.+|+. +|.+|++ +.+++.+
T Consensus 235 G~~Pf~~~~~~~~------~~~i------~~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQET------YRKI------INW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHH------HHHH------HcC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999975432110 0000 000 0000000111223467889999996 9999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=335.15 Aligned_cols=264 Identities=24% Similarity=0.292 Sum_probs=205.0
Q ss_pred CeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcC--chhHHHHHHHHHhcCCCCeeeEEEEEEec--CceeEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLVY 481 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~--~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~LV~ 481 (756)
.|+.++.|++|.||.||+|+ ..+++.||+|+++...... .-.-++||.+|.+++|||||.+..+.... +.+||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 46667889999999999999 4579999999988765332 23578999999999999999999887643 4699999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||| .-+|..++... .+++...++..++.|+++||+|||.+ .|+|||||++|+|+++.|.+||+|||||+.++.+
T Consensus 157 e~~-EhDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYV-EHDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHH-HhhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 998 67999999764 47899999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhh--------hhhhhhhhh
Q 004395 562 DMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW--------ARPLLEEYA 632 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~--------~~~~~~~~~ 632 (756)
. ...+..+-|.+|.|||++.+ ..|+.+.|+||+|||+.||+++++.|.+.....|....-. .++-.....
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 34567778999999998876 5689999999999999999999999987665544211100 001000000
Q ss_pred ------hhhccCCccCCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 633 ------IDELVDPRLGNHYSEH-EVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 633 ------i~~l~dp~l~~~~~~~-~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
........+...+... ....-++|+..+|..||.+|.|+.+.|..
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000000111111111 23456789999999999999999998874
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.21 Aligned_cols=250 Identities=34% Similarity=0.514 Sum_probs=195.5
Q ss_pred eEEEEecccCceEEEEEEec-----CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 409 SQANFLAEGGFGSVHRGVLP-----DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~-----~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.+.+.||.|.||.||+|.+. .+..|+||.++.... .....|.+|++++++++||||++++|++......++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999975 357899999865433 235789999999999999999999999998888999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+++|+|.++|.......+++..++.|+.||+.||.|||+. +++|+||+++|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccc
Confidence 99999999999876567899999999999999999999999 99999999999999999999999999998763222
Q ss_pred C-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 563 M-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 563 ~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
. .......+...|+|||.+.+..++.++||||||+++|||++ |+.||...... ++... +.+.
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~~~~~---------~~~~- 221 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------EIIEK---------LKQG- 221 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------HHHHH---------HHTT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc---------cccc-
Confidence 1 11223456788999999999889999999999999999999 67887543211 10011 1000
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
.....+......+.+++.+||..||++||++.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00112223445688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=334.70 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=203.7
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+|+.+++.++||||+.+++.+.++...|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488899999999999999995 4789999998764322 223457889999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+++|+|.+++.......+++..+..++.|++.||.|||+. ||+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999988754556799999999999999999999999 99999999999999999999999999998754332
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........ .. . +...+.. ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~----~------~~~~~~~-~~ 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--RE----E------VERRVKE-DQ 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HH----H------HHHHhhh-cc
Confidence 12335689999999999988999999999999999999999999975332110 00 0 0000000 01
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
..++......+.+++.+||..||++|| ++.++++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112233445688999999999999999 78888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.28 Aligned_cols=255 Identities=29% Similarity=0.409 Sum_probs=205.1
Q ss_pred hCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
..+|.+.+.||+|+||.||+|... ++..||||.++..... ....|.+|+++|+.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 346788889999999999999853 3478999988755443 346799999999999999999999999999999
Q ss_pred eEEEEeecCCChhhhhhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC
Q 004395 478 LLVYEYICNGSLDSHLYGCH------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~ 545 (756)
++||||+++++|.+++.... ...+++..+..++.|++.||.|||++ |++||||||+|||++.++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCC
Confidence 99999999999999996431 24588999999999999999999999 999999999999999999
Q ss_pred cceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhh
Q 004395 546 EPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEW 623 (756)
Q Consensus 546 ~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~ 623 (756)
.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------- 232 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------- 232 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------
Confidence 999999999986533221 11233446788999999999999999999999999999998 999986432211
Q ss_pred hhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 624 ~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
... .+... .....+......+.+++.+||..||++||++.||++.|+
T Consensus 233 ---~~~-----~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 ---VIE-----CITQG-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HHH-----HHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 000 00000 001112233456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.06 Aligned_cols=242 Identities=22% Similarity=0.266 Sum_probs=196.6
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+++++.++||||++++++|...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999995 578999999876432 223446778999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccc
Q 004395 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567 (756)
Q Consensus 488 sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~ 567 (756)
+|..++. ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 9998886 345789999999999999999999999 999999999999999999999999999875432221 223
Q ss_pred ccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCCh
Q 004395 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647 (756)
Q Consensus 568 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~ 647 (756)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.... ..++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----------~-----~~~~~~~--~~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----------F-----ELILMEE--IRFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH----------H-----HHHhcCC--CCCCC
Confidence 45799999999999999999999999999999999999999964332110 0 0000000 01122
Q ss_pred hHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 648 HEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 648 ~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
.....+.+++.+||..||++|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 3345688999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.52 Aligned_cols=249 Identities=20% Similarity=0.310 Sum_probs=212.6
Q ss_pred hhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
...+|++.+.||+|.||.|-+|+ ...|+.||||.++... .++.-.+.+|++|++.|+||||+.+|.+|+..+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 44678889999999999999999 4789999999876543 3444568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||..+|.|++++. ..+.|++..++.++.||..|+.|||.+ +++|||||.+|||||.++++||+||||+.++.
T Consensus 131 vMEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999997 457899999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
+.. ..++++|++.|.+||++.+.+| ++.+|-||||++||-|+.|..||++.+... + +.++..
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~----------l-----vrQIs~ 267 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR----------L-----VRQISR 267 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH----------H-----HHHhhc
Confidence 665 4578999999999999999999 589999999999999999999998654321 1 111111
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
... ..+..+....-||.+||..+|++|.|+.+|..+.
T Consensus 268 GaY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 268 GAY---REPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ccc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111 1122233466799999999999999999998764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.60 Aligned_cols=241 Identities=24% Similarity=0.260 Sum_probs=194.2
Q ss_pred ecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCCh
Q 004395 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 414 LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
||+|+||.||+|.. .+++.||+|++... .......+..|+.+|..++||||+++++++.+.+..|+||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999995 46889999987643 223345688899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccccc
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 569 (756)
.+++.. .+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 999963 46799999999999999999999999 99999999999999999999999999998543322 123446
Q ss_pred ccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhH
Q 004395 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649 (756)
Q Consensus 570 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~ 649 (756)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +.... ..++...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~---------~~~~~--~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRK---------ILQEP--LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHH---------HHcCC--CCCCCcC
Confidence 7999999999999999999999999999999999999999643211 11110 11100 1122233
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 650 VYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 650 ~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
...+.+++.+||..||.+||++..+.+.|
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 45688999999999999998654443433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.35 Aligned_cols=246 Identities=22% Similarity=0.253 Sum_probs=201.7
Q ss_pred hCCeeEEEEecccCceEEEEEEec-C-CCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-D-GQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~-g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.++|.+.+.||+|+||.||+|... + +..||+|.+.... ......+.+|++++..++||||+++++++.+....|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 357999999999999999999853 3 3689999875432 2334568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999973 45799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||....+... ...+...
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---------------~~~i~~~ 243 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---------------YQKILEG 243 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---------------HHHHhcC
Confidence 32 2345799999999999998899999999999999999999999965432100 0001110
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
. ..++......+.+++.+||+.||.+|+ ++.+++++
T Consensus 244 ~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 I--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 012222334678999999999999995 88888764
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=331.68 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=202.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-----cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.+|++.+.||+|+||.||+|.. .++..||+|.+..... .....|.+|+++++.++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688899999999999999983 3567899998764332 233568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC
Q 004395 480 VYEYICNGSLDSHLYGCH---------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~---------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~ 544 (756)
||||+.+++|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~ 160 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCC
Confidence 999999999999985321 23578899999999999999999999 99999999999999999
Q ss_pred CcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhh
Q 004395 545 FEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTE 622 (756)
Q Consensus 545 ~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~ 622 (756)
+.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||....+.. ..
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~- 236 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VI- 236 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH-
Confidence 9999999999986543321 11223446778999999998889999999999999999998 988985432110 00
Q ss_pred hhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 623 WARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 623 ~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+.+........+......+.+++.+||+.||++||++.+|++.|..
T Consensus 237 ------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ------------EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000000011222334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=351.17 Aligned_cols=253 Identities=19% Similarity=0.238 Sum_probs=203.1
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
...++|.+.+.||+|+||.||++.. .+++.||+|++... .......+..|+.+++.++||||+++++++.++...|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4456899999999999999999995 46899999987532 2233345788999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+|+|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999853 4688999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccCccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSG----QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---------------~~ 257 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---------------YS 257 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---------------HH
Confidence 54332233456799999999998653 478999999999999999999999975432100 01
Q ss_pred hccCCccCCCCC--hhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 004395 635 ELVDPRLGNHYS--EHEVYCMLHAASLCIRRDPHS--RPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~l~~~~~--~~~~~~l~~Li~~CL~~dP~~--RPS~~eVL~~ 677 (756)
.+........++ ......+.+++..||..+|++ ||++.+++.+
T Consensus 258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 258 KIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111100000011 123456889999999999998 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=330.50 Aligned_cols=270 Identities=27% Similarity=0.353 Sum_probs=203.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-----cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEe--cCcee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRL 478 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--~~~~~ 478 (756)
.+|++.+.||+|+||.||++.. .++..||+|.+..........|.+|+++|+.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788999999999999999974 3578999998876555555678999999999999999999998754 34689
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999964 235689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCc--ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 559 PDGDMGV--ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 559 ~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
....... .....++..|+|||++.+..++.++|||||||++|||++|..++......-................+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 5432211 11122345699999999889999999999999999999998776422110000000000000000001111
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+...............+.+++.+||..+|++|||+.+|++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 11111111223344568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=332.72 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=202.8
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
+.+++|++.+.||+|+||.||+|... ++..||+|.+..... .....|.+|+.+++.++||||+++++++.++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999998742 356799998754322 23346889999999999999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCH--------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~--------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~v 547 (756)
..++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCCE
Confidence 9999999999999999986422 23467889999999999999999998 99999999999999999999
Q ss_pred eeeccccceecCCCCCCc-ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhh
Q 004395 548 LVGDFGLARWQPDGDMGV-ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 548 kL~DFGlA~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~ 625 (756)
+|+|||+++......... .....+++.|+|||++.++.++.++|||||||++|||++ |..||........ .
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~---- 231 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---L---- 231 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----
Confidence 999999998654332211 112345778999999999899999999999999999999 7888854322100 0
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
. ....... ...+......+.+++.+||+.||++|||+.++++.|+
T Consensus 232 ---~-----~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 232 ---R-----FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---H-----HHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0 0000000 0112233456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.03 Aligned_cols=252 Identities=21% Similarity=0.230 Sum_probs=197.3
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.|..++.||+|+||.||+|.. .+++.||||++.... ......+.+|++++..++||||+++++++.+....|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 688999999999999999984 578999999886432 2234568899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+++|+|.+++.. ...+++..+..++.||+.||+|||.. ||+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999973 45789999999999999999999999 99999999999999999999999999986431100
Q ss_pred ----------------------------------------------CCcccccccCccccCccccccCCCCchhhHHHHH
Q 004395 563 ----------------------------------------------MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFG 596 (756)
Q Consensus 563 ----------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 596 (756)
.......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHH--hcccCCCCCCCHHHH
Q 004395 597 VVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASL--CIRRDPHSRPRMSQV 674 (756)
Q Consensus 597 vvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~--CL~~dP~~RPS~~eV 674 (756)
|++|||++|..||....+.... ..+... ...+...........+.+++.+ |+..+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~------------~~i~~~-~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ------------LKVINW-ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH------------HHHHcc-ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999999754322110 000000 0000000111123457778877 555666679999999
Q ss_pred HHH
Q 004395 675 LRI 677 (756)
Q Consensus 675 L~~ 677 (756)
+.+
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.26 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=206.8
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999995 4789999997754222 22346888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 482 EYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||+.+++|.+++... ....+++..++.++.|++.||.|||++ +++|+||||+|||++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999888532 335689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
.... ......|++.|+|||++.+..++.++|+||||+++|||++|+.||....... ..+.. .+.....+
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~------~~~~~~~~ 226 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQ------KIEQCDYP 226 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHH------HHhcCCCC
Confidence 4321 1223468899999999998889999999999999999999999985432110 00000 01111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
..........+.+++.+||..+|++||++.++++.|+..
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111122345689999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=342.05 Aligned_cols=242 Identities=24% Similarity=0.268 Sum_probs=197.2
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..|+||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999994 478999999886432 233456888999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccc
Q 004395 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567 (756)
Q Consensus 488 sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~ 567 (756)
+|.+++. ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 153 (328)
T cd05593 81 ELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK 153 (328)
T ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence 9998886 345799999999999999999999999 99999999999999999999999999997543221 1223
Q ss_pred ccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCCh
Q 004395 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647 (756)
Q Consensus 568 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~ 647 (756)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ... ..... .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~----~~~---~~~~~----~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------F----ELI---LMEDI----KFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------H----HHh---ccCCc----cCCC
Confidence 46799999999999999999999999999999999999999964322100 0 000 00011 1222
Q ss_pred hHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 648 HEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 648 ~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
.....+.+++.+||..||++|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3345688999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=330.38 Aligned_cols=265 Identities=26% Similarity=0.360 Sum_probs=203.3
Q ss_pred eeEEEEecccCceEEEEEEe-----cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEec--CceeE
Q 004395 408 FSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLL 479 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~L 479 (756)
|.+.+.||+|+||.||++.. .++..||+|.++.... .....|.+|+++|+.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988652 3678999998875432 2345788999999999999999999988754 35789
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+++|.+++.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++|+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999953 4699999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 560 DGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 560 ~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
..... ......++..|+|||.+.+..++.++||||||+++|||++|..||......-.. .............+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhhh
Confidence 43211 112234567799999999888999999999999999999999998643321110 000001000111111112
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+.......+......+.+++.+||+.+|++|||+++|++.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 2111222233445679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=326.60 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=204.3
Q ss_pred hCCeeEEEEecccCceEEEEEEecC----CCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.++|++.+.||+|+||.||+|.+.. ...||||.+..... .....|.+|+.+++.++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578999999999999999999642 45799998764432 234578899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+++|.+++.. ..+.+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999965 345789999999999999999999998 99999999999999999999999999999775
Q ss_pred CCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 560 DGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 560 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . .... .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~------~----~~~~-~~~~~ 226 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD------V----IKAV-EDGYR 226 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH------H----HHHH-HcCCC
Confidence 22211 1112335678999999999999999999999999999998 999985432110 0 0000 00001
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+ .+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 227 ~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 227 LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11 122334568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.62 Aligned_cols=253 Identities=21% Similarity=0.235 Sum_probs=202.8
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||++.. .+|+.||+|+++... ......+..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999995 478999999887532 223456888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNR-YEDQFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999965 245799999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCcccccccCccccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 562 DMGVETRVIGTFGYLAPEYAQ------SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...... ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~---~~~ 226 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMN---FQR 226 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHc---CCC
Confidence 332333457999999999986 45678999999999999999999999965432110 000000 000
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. ...........+.+|+..||. +|.+||++.+++.+
T Consensus 227 ~~----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FL----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cc----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 000111234568889999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=323.54 Aligned_cols=250 Identities=28% Similarity=0.388 Sum_probs=206.2
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|.+.+.||+|+||.||+|.. .+++.|++|.+.... ......+.+|+++++.++||||+++++++.+....|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478889999999999999995 468999999876432 23456788999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+++++|.+++.......+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999765567899999999999999999999998 999999999999999999999999999987654332
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....... . .. .+..-..+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~-------~~--~~~~~~~~---- 219 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---L-------IL--KIIRGVFP---- 219 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---H-------HH--HHHcCCCC----
Confidence 2234568899999999999999999999999999999999999996443110 0 00 00000011
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122334568999999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=350.40 Aligned_cols=252 Identities=21% Similarity=0.211 Sum_probs=198.0
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++|..++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999994 468999999875432 223456889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999963 45789999999999999999999999 9999999999999999999999999998532100
Q ss_pred C------------------------------------------CCcccccccCccccCccccccCCCCchhhHHHHHHHH
Q 004395 562 D------------------------------------------MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVL 599 (756)
Q Consensus 562 ~------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL 599 (756)
. .......+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 004395 600 VELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP---RMSQVLR 676 (756)
Q Consensus 600 ~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP---S~~eVL~ 676 (756)
|||++|+.||....+.... .. +... ...+...........+.+++.+|+ .+|.+|+ ++.+++.
T Consensus 235 yell~G~~Pf~~~~~~~~~------~~------i~~~-~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQ------LK------VINW-ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHH------HH------Hhcc-CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999999754432110 00 0000 000000011122345677888876 5999999 8899886
Q ss_pred H
Q 004395 677 I 677 (756)
Q Consensus 677 ~ 677 (756)
+
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=351.92 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=214.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCc-eeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR-RLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~-~~LV~ 481 (756)
++|..++.+|+|+||.+++... .++..|++|++...... ..+...+|+.++++++|||||.+++.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788889999999999999884 46789999988765432 33468899999999999999999999999988 99999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
+||+||+|.+.+....+..+++..+..|+.|++.|+.|||++ .|+|||||+.|||++.++.|+|+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999999876778899999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
. .....++||+.||.||.+.+.+|+.|+|||||||++|||++-+++|........ . ..+ ....
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L----------i-----~ki-~~~~ 222 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL----------I-----LKI-NRGL 222 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH----------H-----HHH-hhcc
Confidence 3 345678899999999999999999999999999999999999999975543210 0 111 1111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....+......+..++..||..+|..||++.++|..
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 223444556679999999999999999999999875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=339.43 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=195.6
Q ss_pred eeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHH---HhcCCCCeeeEEEEEEecCceeEE
Q 004395 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVL---SCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL---~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
|++.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|++++ +.++||||+++++++.+....|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999985 478999999886432 22334567777665 456799999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+++|..++. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999998884 45799999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+....
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~---------~~i~~~~ 217 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------F---------DSIVNDE 217 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------H---------HHHHhCC
Confidence 22 122346799999999999999999999999999999999999999965432100 0 0011100
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
..++......+.+++.+||+.||.+|| ++.++++.
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 012223345688999999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=332.85 Aligned_cols=256 Identities=27% Similarity=0.383 Sum_probs=206.4
Q ss_pred CCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
++|.+.+.||+|+||.||+|.. .++..+++|.+..........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 5688999999999999999973 2356789998765554445679999999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC
Q 004395 480 VYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~ 545 (756)
||||+.+++|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCC
Confidence 999999999999996422 24589999999999999999999999 999999999999999999
Q ss_pred cceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhh
Q 004395 546 EPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEW 623 (756)
Q Consensus 546 ~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~ 623 (756)
.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |..||........
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------ 234 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------ 234 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 999999999976543321 12233456888999999999999999999999999999999 9999865432110
Q ss_pred hhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 624 ~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.. .+.... ........+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 235 ----~~-----~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 ----IE-----CITQGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred ----HH-----HHhCCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 00 000100 0011122345688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.16 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=203.5
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc-----CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-----GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~-----~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
++|.+.+.||+|+||.||.|.. .+++.||+|.+...... ....+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4789999999999999999985 57899999987643221 23468889999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999863 45789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcc--cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 560 DGDMGVE--TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 560 ~~~~~~~--~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
....... ....|+..|+|||++.+..++.++||||||+++|||++|+.||........ .....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~~~~ 220 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---------------IFKIA 220 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---------------HHHHh
Confidence 3221111 235678899999999998899999999999999999999999864321100 00000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
........+......+.+++.+||..+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111112233344568899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=344.93 Aligned_cols=202 Identities=22% Similarity=0.309 Sum_probs=175.6
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++.+.||+|+||.||+|.. .+++.||||++.... ......+..|+.++..++||||+++++.+.+....||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999984 468999999886432 223346788999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999973 46799999999999999999999999 9999999999999999999999999999754321
Q ss_pred CC----------------------------------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 004395 562 DM----------------------------------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK 607 (756)
Q Consensus 562 ~~----------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~ 607 (756)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 004395 608 AVDLNR 613 (756)
Q Consensus 608 Pf~~~~ 613 (756)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=340.21 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=196.6
Q ss_pred EEecccCceEEEEEEe----cCCCEEEEEEecccC----CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 412 NFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~----~~g~~VAVK~~~~~~----~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+.||+|+||.||++.. .+++.||||+++... ......+..|+++|+.++||||++++++|..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999984 357899999876431 22334577899999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++. ..+.+.+..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999986 346788999999999999999999999 999999999999999999999999999985433221
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+..+.... .
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---------------~~~~~~~~~--~ 217 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---------------TIDKILKGK--L 217 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---------------HHHHHHcCC--C
Confidence 2334579999999999999889999999999999999999999996433210 001111111 1
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
..+......+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 12223345688999999999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=348.57 Aligned_cols=255 Identities=19% Similarity=0.259 Sum_probs=202.0
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
+....++|++.+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 344557899999999999999999995 46889999987532 22234468889999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+||||+.+|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999999853 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSG----QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
..............||+.|+|||++.+. .++.++|||||||+||||++|+.||........
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--------------- 255 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--------------- 255 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---------------
Confidence 7654333233456799999999998653 378999999999999999999999964432110
Q ss_pred hhhccCCccCCCCC--hhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 004395 633 IDELVDPRLGNHYS--EHEVYCMLHAASLCIRRDPHS--RPRMSQVLRI 677 (756)
Q Consensus 633 i~~l~dp~l~~~~~--~~~~~~l~~Li~~CL~~dP~~--RPS~~eVL~~ 677 (756)
...+........++ ......+.+++..|+..++.+ |+++.+++++
T Consensus 256 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 01111110000111 123446788999999855544 8899999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=326.24 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=204.0
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++......|+||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999995 57899999988765544556788899999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.. ..++++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999999863 45789999999999999999999999 99999999999999999999999999998664322
Q ss_pred CcccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 564 GVETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+..... .+. ...+..+.
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~--------~~~~~~~~ 230 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMS--------KSNFQPPK 230 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eee--------cCCCCCCC
Confidence 1223456889999999884 4557889999999999999999999985433211100 000 00001111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
... .......+.+++.+||..+|++||+++++++.|
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 110 112235688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=331.89 Aligned_cols=257 Identities=28% Similarity=0.396 Sum_probs=205.5
Q ss_pred hCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
..+|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|++++.+++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45789999999999999999983 234568999877554445567999999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcc
Q 004395 479 LVYEYICNGSLDSHLYGC-----------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~-----------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~v 547 (756)
+||||+.+++|.+++... ....+++..++.++.|++.||+|||+. |++||||||+|||++.++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcE
Confidence 999999999999998632 123589999999999999999999999 99999999999999999999
Q ss_pred eeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhh
Q 004395 548 LVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 548 kL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~ 625 (756)
+|+|||+++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--------- 230 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------- 230 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------
Confidence 9999999986543221 11223345778999999999999999999999999999998 899986443210
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.... +....... .+......+.+++.+||+.||.+|||+.+++..|+..
T Consensus 231 -~~~~--i~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 231 -VIEC--ITQGRVLQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred -HHHH--HHcCCcCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0000 00000011 1112334689999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=348.53 Aligned_cols=252 Identities=18% Similarity=0.227 Sum_probs=197.5
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||++.. .+|+.||||++.... ......+.+|++++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999984 578999999875432 223356888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+|+|.+++.. .+.+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999963 46789999999999999999999999 9999999999999999999999999999643211
Q ss_pred CC------------C----------------------------------cccccccCccccCccccccCCCCchhhHHHH
Q 004395 562 DM------------G----------------------------------VETRVIGTFGYLAPEYAQSGQITEKADVYSF 595 (756)
Q Consensus 562 ~~------------~----------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSl 595 (756)
.. . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 0012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCC---CCHH
Q 004395 596 GVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSR---PRMS 672 (756)
Q Consensus 596 GvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~R---PS~~ 672 (756)
||++|||++|..||........ +. ... ..... ..+.. .......+.+++.+||. +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~--~~----~i~---~~~~~--~~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET--YR----KII---NWRET--LYFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH--HH----HHH---ccCCc--cCCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999965432110 00 000 00000 00000 01223468899999997 77765 5999
Q ss_pred HHHHH
Q 004395 673 QVLRI 677 (756)
Q Consensus 673 eVL~~ 677 (756)
+++.+
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=348.94 Aligned_cols=250 Identities=21% Similarity=0.219 Sum_probs=195.3
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.|..++.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+++++++.++...|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999999994 578999999876432 2233568889999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
||.+|+|.+++.. .+.+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999864 35789999999999999999999999 99999999999999999999999999985321000
Q ss_pred ----------------------------------------------CCcccccccCccccCccccccCCCCchhhHHHHH
Q 004395 563 ----------------------------------------------MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFG 596 (756)
Q Consensus 563 ----------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 596 (756)
.......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC---HHH
Q 004395 597 VVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR---MSQ 673 (756)
Q Consensus 597 vvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS---~~e 673 (756)
|+||||++|+.||....+.... ..+... ...+...........+.+++.+|+ .+|.+|++ +.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~------------~~i~~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQ------------MKVINW-QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHH------------HHHHcc-CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 9999999999999754321110 000000 000000011122345677777765 59999997 777
Q ss_pred HHH
Q 004395 674 VLR 676 (756)
Q Consensus 674 VL~ 676 (756)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=338.92 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=200.9
Q ss_pred hhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCC--------------cCchhHHHHHHHHHhcCCCCeeeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--------------QGDHEFCSEVEVLSCAQHRNVVMLI 468 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~--------------~~~~~f~~Ev~iL~~L~HpNIV~l~ 468 (756)
.-++|.+++.||+|.||.|-+|+ ..+++.||||++..... ...+...+||.||++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 34689999999999999999999 45799999998753211 1124688999999999999999999
Q ss_pred EEEEec--CceeEEEEeecCCChhhhhhccCCCC-CCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC
Q 004395 469 GFCIED--RRRLLVYEYICNGSLDSHLYGCHQEP-LEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (756)
Q Consensus 469 ~~~~~~--~~~~LV~Ey~~ggsL~~~L~~~~~~~-L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~ 545 (756)
++..+. +.+|||+|||..|.+...- ..++ |++.++++++.+++.||+|||.+ |||||||||+|+||+.+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcCCC
Confidence 998764 4789999999988876544 3455 99999999999999999999999 999999999999999999
Q ss_pred cceeeccccceecCCCCC----CcccccccCccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 004395 546 EPLVGDFGLARWQPDGDM----GVETRVIGTFGYLAPEYAQSGQ----ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ 617 (756)
Q Consensus 546 ~vkL~DFGlA~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~ 617 (756)
++||+|||.+..+..+.. ......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||.....
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--- 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--- 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence 999999999987743321 1123468999999999887632 35789999999999999999999964321
Q ss_pred cchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 618 QCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 618 ~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
..+ .+.++...+.-...++....+.+||.+||.+||+.|.+..+|..+.
T Consensus 325 -------~~l-----~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 -------LEL-----FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -------HHH-----HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111 1223332222222224456789999999999999999999997664
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.80 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=200.4
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCC----EEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.+|+..+.||+|+||.||+|.+. +|. .||+|.++.... .....|..|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57999999999999999999853 344 489998764432 3345788999999999999999999999764 5789
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|+||+.+|+|.+++.. ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999975 345688999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCc-ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 560 DGDMGV-ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 560 ~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
...... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... +. ... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~~-~~~-----~~-- 226 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------IS-SIL-----EK-- 226 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HH-HHH-----hC--
Confidence 432211 112234678999999999999999999999999999998 999986432110 00 000 00
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
......+......+.+++.+||..+|++||++.+++..|..
T Consensus 227 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~ 267 (316)
T cd05108 227 --GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 267 (316)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00001112233468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.16 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=199.1
Q ss_pred EecccCceEEEEEEecCCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCChhh
Q 004395 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDS 491 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~ 491 (756)
.||+|+||.||+|...++..||+|.+...... ....|.+|+++++.++||||+++++++......++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 69999999999999888899999987654322 23468899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccccccc
Q 004395 492 HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG 571 (756)
Q Consensus 492 ~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~G 571 (756)
++.. ....+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++...............+
T Consensus 82 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 82 FLRK-KKDELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9864 345689999999999999999999999 99999999999999999999999999997654332222222344
Q ss_pred CccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHH
Q 004395 572 TFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEV 650 (756)
Q Consensus 572 t~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~ 650 (756)
+..|+|||++.+..++.++||||||+++|+|++ |..||........ . . .+.. ......+....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------~-~-----~~~~----~~~~~~~~~~~ 220 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------R-E-----QVEK----GYRMSCPQKCP 220 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------H-H-----HHHc----CCCCCCCCCCC
Confidence 678999999998899999999999999999998 9999864322100 0 0 0011 01111222344
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 651 YCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 651 ~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
..+.+++.+||..+|++||++.++++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 57899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.05 Aligned_cols=257 Identities=25% Similarity=0.357 Sum_probs=208.1
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++..++|.+.+.||+|+||.||++...++..+|+|.+.... .....|.+|+++++.++|+||+++++++.+ ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 34567899999999999999999997777889999876432 234578999999999999999999999887 7789999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.......+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999765556789999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.........++..|+|||++.+..++.++|+|||||++|+|++ |..||....... .... +.. .
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~---------~~~----~ 219 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA---------LER----G 219 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHH---------HhC----C
Confidence 3222233346678999999998889999999999999999999 899986432110 0000 000 0
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
............+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011112334568899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=356.23 Aligned_cols=260 Identities=30% Similarity=0.417 Sum_probs=210.0
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEEec--CC---CEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEE
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGVLP--DG---QAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g---~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~ 471 (756)
.+++..++-.+.+.||+|+||.||+|.+. ++ ..||||..+.. ......+|+.|+++++.++|||||+|||++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 35666677777899999999999999953 22 23899988752 244567899999999999999999999999
Q ss_pred EecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeec
Q 004395 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 472 ~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
.....++||||+|.||+|.++|... .+.++..+++.++.+.|.||+|||++ ++|||||-.+|+|++.++.+||+|
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999753 33699999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCccc-ccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhh
Q 004395 552 FGLARWQPDGDMGVET-RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLE 629 (756)
Q Consensus 552 FGlA~~~~~~~~~~~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 629 (756)
|||++.-.. ..... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||........
T Consensus 306 FGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------------ 371 (474)
T KOG0194|consen 306 FGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------------ 371 (474)
T ss_pred cccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH------------
Confidence 999875431 11111 1124678999999999999999999999999999999 8889865443200
Q ss_pred hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 630 ~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
...+......-..+...+..+..++.+||..+|++||+|.++.+.|+..
T Consensus 372 ---~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 372 ---KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred ---HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 0111122222233345566788899999999999999999999998753
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.07 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=196.1
Q ss_pred EecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCChh
Q 004395 413 FLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLD 490 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~ 490 (756)
.||+|+||.||+|.. .+++.||+|.+.... ......|.+|+++|+.++||||++++++|......++||||+.+++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 599999999999995 478999999765332 223456899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc-ccc
Q 004395 491 SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE-TRV 569 (756)
Q Consensus 491 ~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~-~~~ 569 (756)
+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++........... ...
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 82 TFLRT-EGPRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99864 345689999999999999999999999 999999999999999999999999999975443221111 111
Q ss_pred ccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChh
Q 004395 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEH 648 (756)
Q Consensus 570 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~ 648 (756)
.++..|+|||++.++.++.++|||||||++|||++ |..||........ ...+.. ......+..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~------------~~~~~~----~~~~~~~~~ 220 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT------------REAIEQ----GVRLPCPEL 220 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH------------HHHHHc----CCCCCCccc
Confidence 23457999999999999999999999999999998 8888854321100 000011 111122223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 649 EVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 649 ~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
....+.+++.+||+.+|++||++.++++.|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=348.99 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=206.0
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcC-CCCeeeEEEEEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCI 472 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~ 472 (756)
++...++|.+++.||+|+||.||+|... .+..||||++..... .....|.+|+++|..+. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3445678999999999999999999842 234799998864432 23456899999999996 999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccC-------------------------------------------------------
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCH------------------------------------------------------- 497 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~------------------------------------------------------- 497 (756)
+....|||||||.+|+|.++|..+.
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999999885421
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCc
Q 004395 498 ---------------------------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538 (756)
Q Consensus 498 ---------------------------------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~N 538 (756)
...+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~N 267 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHh
Confidence 13478888999999999999999999 99999999999
Q ss_pred eeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 004395 539 ILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKG 616 (756)
Q Consensus 539 ILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~ 616 (756)
||++.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999986543221 12223457788999999999999999999999999999997 999986432111
Q ss_pred ccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 617 ~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. + .. .+..- .....+......+.+++.+||+.||++||++.+|.+.|+.
T Consensus 348 ~--~---~~------~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 348 T--F---YN------KIKSG----YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred H--H---HH------HHhcC----CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 0 0 00 00000 0111222344578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.18 Aligned_cols=268 Identities=23% Similarity=0.292 Sum_probs=209.4
Q ss_pred HhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEec--ccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEe-----c
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHK--LASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-----D 474 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~--~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~-----~ 474 (756)
.....|...+.||+|+||.|..+. ..+|+.||||++. ....-..+...+|+++|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 345567778899999999999999 4589999999876 3344455678899999999999999999999875 3
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
+.+|+|+|+| +-+|...+. .+..|+...+..++.||++||.|+|+. +|+||||||.|+|++.+..+||+||||
T Consensus 99 ~DvYiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEeccccc
Confidence 4689999999 789999996 445599999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCC-CCCcccccccCccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 555 ARWQPDG-DMGVETRVIGTFGYLAPEYA-QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 555 A~~~~~~-~~~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
|+..... .....+.++-|.+|.|||++ ....|+...||||.||||.||++|++.|.+.....|..+.....+...+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9977532 22234677889999999977 457899999999999999999999999987665554322211111111111
Q ss_pred hhhcc-----------CCccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 633 IDELV-----------DPRLG---NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 633 i~~l~-----------dp~l~---~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+..+. ..... ...-+.......+|+.+||..||.+|+|++|+|++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11110 01111 11112344567899999999999999999999885
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.64 Aligned_cols=247 Identities=24% Similarity=0.292 Sum_probs=196.1
Q ss_pred ecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCCh
Q 004395 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 414 LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
||+|+||.||++.. .+|+.||+|.+..... .....+..|+++++.++||||+++++++.++...|+||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 4699999998754221 2234566799999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccccc
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 569 (756)
.+++.......+++..++.++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 9998765566799999999999999999999999 99999999999999999999999999998765432 22345
Q ss_pred ccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhH
Q 004395 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649 (756)
Q Consensus 570 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~ 649 (756)
.|+..|+|||++.+..++.++|||||||++|||++|+.||........ .... . .......... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~-----~----~~~~~~~~~~-~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEEL-----K----RRTLEDEVKF-EHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHH-----H----HHhhcccccc-ccccC
Confidence 689999999999988899999999999999999999999964322110 0000 0 0111111000 01123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 650 VYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 650 ~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
...+.+++.+||+.||++||++.|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 34688999999999999999998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=340.85 Aligned_cols=242 Identities=23% Similarity=0.277 Sum_probs=196.2
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
+.||+|+||.||++.. .+|+.||+|++.... ......+..|++++..++||||+++++++..+...|+||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999984 578999999886432 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 488 sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
+|..++. ....+++..+..++.||+.||.|||+ . ||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~----~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 9998886 34579999999999999999999997 6 899999999999999999999999999985432221 22
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..... ++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~----------~~~i~---~~~~~----~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------FELIL---MEEIR----FP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH----------HHHHh---cCCCC----CC
Confidence 345699999999999999999999999999999999999999964322100 00000 00111 12
Q ss_pred hhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
......+.+++.+||+.||++|+ ++.+++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 22344688999999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.82 Aligned_cols=241 Identities=22% Similarity=0.277 Sum_probs=194.8
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCC-CCeeeEEEEEEecCceeEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~H-pNIV~l~~~~~~~~~~~LV~ 481 (756)
+|.+.+.||+|+||.||+|... +++.||||++... .......+..|++++..+.| ++|+.+++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999954 6789999987643 22344568889999999976 56889999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999999863 45789999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ . ..+....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~----------~-----~~i~~~~- 217 (324)
T cd05587 155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----------F-----QSIMEHN- 217 (324)
T ss_pred CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----------H-----HHHHcCC-
Confidence 11 22345799999999999999999999999999999999999999964432100 0 0000000
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRM 671 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~ 671 (756)
..++......+.+++.+||..||.+|++.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11222334568899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=319.74 Aligned_cols=251 Identities=23% Similarity=0.395 Sum_probs=203.5
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|+++++.++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4788899999999999999998778899999876432 234579999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999864 335689999999999999999999999 99999999999999999999999999998665433222
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....++..|+|||++.++.++.++||||||+++|||++ |..||....... ........ .....+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~---~~~~~~----- 223 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINAG---FRLYKP----- 223 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHhCC---CCCCCC-----
Confidence 223335678999999998899999999999999999998 999986432110 00000000 000111
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
......+.+++.+||+.+|++||++.++++.|
T Consensus 224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11235689999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=331.54 Aligned_cols=260 Identities=27% Similarity=0.378 Sum_probs=207.2
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~ 472 (756)
+++..++|++.+.||+|+||.||++... ....+|+|.+..... .....+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4556678999999999999999999853 236899998764322 2335688999999999 7999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCc
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGC--------------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~--------------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~N 538 (756)
.+...+++|||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~N 162 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARN 162 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----Cccccccceee
Confidence 999999999999999999998542 345789999999999999999999999 99999999999
Q ss_pred eeecCCCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 004395 539 ILLTHDFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKG 616 (756)
Q Consensus 539 ILL~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~ 616 (756)
||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999999999876543221 1122335678999999998999999999999999999997 999886432110
Q ss_pred ccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 617 ~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. . . .+........+......+.+++.+||..||++|||+.++++.|+.
T Consensus 243 ~------~-~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 243 L------F-K---------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred H------H-H---------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 0 0 0 000111111222334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=358.05 Aligned_cols=258 Identities=22% Similarity=0.280 Sum_probs=206.8
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR- 475 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~- 475 (756)
..+...++|.+.+.||+|+||.||+|. ..+|+.||||++..... .....+.+|+.+|..++|+||+++++.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 344556899999999999999999998 45799999998865432 23456888999999999999999988775432
Q ss_pred -------ceeEEEEeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc
Q 004395 476 -------RRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (756)
Q Consensus 476 -------~~~LV~Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~ 546 (756)
..++||||+.+|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCC
Confidence 368999999999999998642 345799999999999999999999999 9999999999999999999
Q ss_pred ceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh
Q 004395 547 PLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 547 vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 625 (756)
+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMH 255 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHH
Confidence 99999999987653221 1233467999999999999999999999999999999999999999643211 0000
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. ...... ..+......+.+++.+||+.||.+||++.+++++
T Consensus 256 ~~-----~~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KT-----LAGRYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HH-----hcCCCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 011111 1223344578999999999999999999999874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.69 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=212.0
Q ss_pred CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+++.||.|-||.||.|+ .+++-.||+|++... ..+..+++.+|++|-+.|+||||+++|++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 568889999999999999999 457889999986532 3445678999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||..+|+|...|.......+++.....+..|+|.||.|+|.. +||||||||+|+|++.++.+||+|||.+..-.
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999877778899999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||...... ..+.++..-.
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---------------etYkrI~k~~- 238 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---------------ETYKRIRKVD- 238 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---------------HHHHHHHHcc-
Confidence 33567789999999999999999999999999999999999999999754311 0011111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
-.++........++|.+|+..+|.+|.+..|++.+
T Consensus 239 -~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 -LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11223444568899999999999999999999875
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.90 Aligned_cols=255 Identities=29% Similarity=0.394 Sum_probs=204.1
Q ss_pred hCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
..+|...+.||+|+||.||++... ++..+|+|.+..........|.+|+++++.++|+||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457888899999999999999732 35689999877655555668999999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC
Q 004395 479 LVYEYICNGSLDSHLYGCHQ-------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~-------------~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~ 545 (756)
++|||+.+++|.+++..... ..+++..++.++.|++.||+|||+. ||+||||||+|||+++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCC
Confidence 99999999999999864321 3589999999999999999999999 999999999999999999
Q ss_pred cceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhh
Q 004395 546 EPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEW 623 (756)
Q Consensus 546 ~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~ 623 (756)
.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------ 233 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------ 233 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------
Confidence 999999999986543221 11122345788999999999999999999999999999998 8999854322110
Q ss_pred hhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 624 ~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
... ....... ..+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 234 ----~~~--~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 ----IEC--ITQGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----HHH--HHcCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000 0000011 111223346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.99 Aligned_cols=256 Identities=27% Similarity=0.360 Sum_probs=202.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
.+++|.+.+.||+|+||.||+|... .+..||+|....... .....|..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567999999999999999999964 356899997764332 234569999999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC---cce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQ-----EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---EPL 548 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~-----~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~---~vk 548 (756)
.++||||+.+++|.+++..... ..+++..++.++.||+.||+|||+. +++||||||+|||++.++ .+|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceE
Confidence 9999999999999999864321 3589999999999999999999999 999999999999998765 589
Q ss_pred eeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhh
Q 004395 549 VGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARP 626 (756)
Q Consensus 549 L~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~ 626 (756)
|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||........ .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~----- 231 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---M----- 231 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H-----
Confidence 9999999865332211 1112234568999999998999999999999999999997 9999865432110 0
Q ss_pred hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
..+........+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 232 --------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 --------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000000011122233456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.21 Aligned_cols=245 Identities=23% Similarity=0.314 Sum_probs=195.9
Q ss_pred ecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCCh
Q 004395 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 414 LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
||+|+||.||++.. .+|+.||+|.+..... .....+..|+++++.++|+||+.+++++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 4789999998764322 2234677899999999999999999999999999999999999999
Q ss_pred hhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccc
Q 004395 490 DSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567 (756)
Q Consensus 490 ~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~ 567 (756)
.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 9887532 345799999999999999999999999 999999999999999999999999999986654332 223
Q ss_pred ccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCCh
Q 004395 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647 (756)
Q Consensus 568 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~ 647 (756)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .......... ..++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~---------~~~~~~~~~~--~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NK---------ELKQRILNDS--VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HH---------HHHHhhcccC--CCCcc
Confidence 45789999999999999999999999999999999999999964332110 00 0001111110 11223
Q ss_pred hHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 004395 648 HEVYCMLHAASLCIRRDPHSRP-----RMSQVLR 676 (756)
Q Consensus 648 ~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~ 676 (756)
.....+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 3445688999999999999999 6677766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.02 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=205.1
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
+..++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+|..++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 34568999999999999999999853 246899998764432 23346889999999999999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCH--------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~--------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~v 547 (756)
..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCCE
Confidence 9999999999999999986422 23478899999999999999999999 99999999999999999999
Q ss_pred eeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhh
Q 004395 548 LVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 548 kL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~ 625 (756)
||+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||....... ...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~--- 232 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLK--- 232 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHH---
Confidence 9999999986543322 12233456789999999988889999999999999999998 999986432211 000
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
.+.... ....+......+.+++.+||+.+|++|||+.+++..|+
T Consensus 233 ---------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 ---------FVIDGG-HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---------HHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000000 01112223457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=318.22 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=207.7
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++.+.||+|+||.||+|... +|+.||+|.++... ......+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999965 89999999876422 223457889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 482 EYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||+.+++|.+++... ....+++..++.++.+++.||.|||+. ||+||||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999988542 345689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
.... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ........ . .....+
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~----~~~~~~ 227 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-E----KCDYPP 227 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhh-h----cCCCCC
Confidence 3321 123356889999999999888999999999999999999999998543211 00000000 0 000111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. ........+.+++.+||..+|++||++.+|++.|+.
T Consensus 228 ~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 228 L----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred C----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 1 111334568899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=353.06 Aligned_cols=260 Identities=20% Similarity=0.286 Sum_probs=194.8
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEec--------C
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--------R 475 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--------~ 475 (756)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+|+.+|+.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 46899999999999999999995 57899999987532 22355799999999999999999887532 2
Q ss_pred ceeEEEEeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-cceeecc
Q 004395 476 RRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDF 552 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-~vkL~DF 552 (756)
.+++||||+. ++|.+++.. .....+++..++.++.||+.||+|||+. ||+||||||+||||+.++ .+||+||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeecc
Confidence 4679999995 677777642 2456799999999999999999999999 999999999999998665 7999999
Q ss_pred ccceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh----hhh
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA----RPL 627 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~----~~~ 627 (756)
|+|+.+.... ......||+.|+|||++.+ ..|+.++|||||||+||||++|.+||........ +.... .+.
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCC
Confidence 9998664432 2234578999999998865 4689999999999999999999999975433211 11100 000
Q ss_pred hhhh----------hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 LEEY----------AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 ~~~~----------~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.... .+.......+...++......+.+|+.+||..||.+|||+.|++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 0000000001111222234578899999999999999999999864
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=361.30 Aligned_cols=259 Identities=22% Similarity=0.263 Sum_probs=212.1
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEecCC-CEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEE-EEe---c
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLPDG-QAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGF-CIE---D 474 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g-~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~-~~~---~ 474 (756)
+.+...++++.+.|.+|||+.||+|....+ ..||+|++-...........+||++|+.|+ |+|||.+++. ... +
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 455667899999999999999999996554 999999887777778888999999999998 9999999993 221 1
Q ss_pred ---CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeec
Q 004395 475 ---RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 475 ---~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
-+++|.||||.||.|-++|..+....|++.++++|+.++++|+++||...+ .|||||||-+||||+.+|..||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~p--PiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKP--PIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCC--ccchhhhhhhheEEcCCCCEEeCc
Confidence 257899999999999999987666679999999999999999999998732 499999999999999999999999
Q ss_pred cccceecCCCCCC--------cccccccCccccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch
Q 004395 552 FGLARWQPDGDMG--------VETRVIGTFGYLAPEYA---QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL 620 (756)
Q Consensus 552 FGlA~~~~~~~~~--------~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l 620 (756)
||.|.-....... ......-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+..+..
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----- 264 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----- 264 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence 9999743322100 11123569999999976 5778899999999999999999999999865432
Q ss_pred hhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 621 TEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 621 ~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+++..+.-.-.+.....|.+||..||+.||.+||++-||+..+-.
T Consensus 265 --------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 --------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred --------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 2223222222224567789999999999999999999999887643
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.89 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=192.5
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.. .+++.||||.++... ......+..|..++..+ +||||+++++++..+...|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 468899999886432 22334566777777654 799999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999998863 45799999999999999999999999 99999999999999999999999999998654332 223
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +.. ..+ .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~----------~~~~--i~~-~~~----~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE----------LFDS--ILN-DRP----HFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH----------HHHH--HHc-CCC----CCC
Confidence 45679999999999999999999999999999999999999997543210 0000 000 011 122
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMS-QVLR 676 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~-eVL~ 676 (756)
......+.+++.+||..||.+||++. ++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 22344678999999999999999875 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.70 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=206.0
Q ss_pred hCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ....+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45788899999999999999987 478999998875543 4567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|.+++.......+++..++.++.|++.||.|||+. +++||||||+|||++.++.++|+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999999765555799999999999999999999999 999999999999999999999999999986643221
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
...++..|+|||++..+.++.++||||||+++|||++ |..||....... +. ..+......
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~-------------~~~~~~~~~ 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV-------------PHVEKGYRM 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH-------------HHHhcCCCC
Confidence 2234667999999998899999999999999999997 999986432110 00 000000011
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+...+..+.+++.+||..+|++||++.+++..|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1122334578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.70 Aligned_cols=261 Identities=25% Similarity=0.307 Sum_probs=196.7
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhc---CCCCeeeEEEEEEec-----C
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCA---QHRNVVMLIGFCIED-----R 475 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L---~HpNIV~l~~~~~~~-----~ 475 (756)
+|++.+.||+|+||.||+|.. .+|+.||+|.++..... ....+.+|+++++.+ .||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999995 47899999987654322 233566788887766 699999999988653 3
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..++||||+. ++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5799999995 6898888765556699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh--hhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL--LEEYAI 633 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~--~~~~~i 633 (756)
+...... ......||..|+|||++.+..++.++|||||||++|+|++|++||........ +....... ......
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhhC
Confidence 8664322 22345689999999999988999999999999999999999999964432211 00000000 000000
Q ss_pred hh-------ccCCcc---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DE-------LVDPRL---GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~-------l~dp~l---~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.. ...+.. .....+.....+.+++.+||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000 00111123446789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=339.05 Aligned_cols=248 Identities=20% Similarity=0.281 Sum_probs=195.7
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.. .+++.||+|+++... ......+..|..++..+ +||||++++++|.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999995 468999999887532 22334688899999998 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|.+++. ..+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 99998886 346799999999999999999999999 99999999999999999999999999997532221 123
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc--cchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ--QCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+....... .....+... .+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~--~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ--------VILEKQI--R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH--------HHHcCCC--C
Confidence 346799999999999999999999999999999999999999974332210 001111111 1111110 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPR------MSQVLR 676 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS------~~eVL~ 676 (756)
.+......+.+++.+||+.||.+||+ +.++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 22233456889999999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.00 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=204.8
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
+|++.+.||+|+||.||++.. .+++.||+|.++... ....+.+..|+.+++.++|+||+++++++.++...|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 588899999999999999995 478999999876432 234457888999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
++++|.+++.......+++..++.++.|++.||.|||++ ||+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999988755556789999999999999999999999 999999999999999999999999999986654322
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ . . .+.. . ....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~----~--~~~~---~-~~~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------I----L--KVCQ---G-SYKP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------H----H--HHhc---C-CCCC
Confidence 22345689999999999988899999999999999999999999964322100 0 0 0000 0 0011
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+......+.+++.+||..||++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122233468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=331.10 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=201.8
Q ss_pred CeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.|.+.+.||+|+||.||+|... +++.||+|.+...... ....|..|+.++..++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666788999999999999853 2578999988744322 23468899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC
Q 004395 480 VYEYICNGSLDSHLYGC--------------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~--------------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~ 545 (756)
++||+.+++|.+++... ....+++..++.++.|++.||+|||+. ||+||||||+|||+++++
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCCC
Confidence 99999999999998521 124588999999999999999999999 999999999999999999
Q ss_pred cceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhh
Q 004395 546 EPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEW 623 (756)
Q Consensus 546 ~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~ 623 (756)
.+||+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||...... .+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HH
Confidence 999999999886543321 11223446789999999988889999999999999999998 88888643211 00
Q ss_pred hhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 624 ~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+.... ...++......+.+++..||+.+|++||++.+|++.|+.
T Consensus 236 ---------~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 ---------IEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------HHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 01111111 112233445568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=340.84 Aligned_cols=258 Identities=26% Similarity=0.345 Sum_probs=201.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCCc-CchhHHHHHHHHHhc-CCCCeeeEEEEEEec-
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVMLIGFCIED- 474 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~- 474 (756)
..++|++.+.||+|+||.||+|.. .+++.||+|+++..... ....+..|++++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 445799999999999999999963 23578999987643322 234678899999999 799999999988654
Q ss_pred CceeEEEEeecCCChhhhhhccC---------------------------------------------------------
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCH--------------------------------------------------------- 497 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~--------------------------------------------------------- 497 (756)
...+++|||+.+++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 56889999999999999885321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC-cccccccCcc
Q 004395 498 --QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG-VETRVIGTFG 574 (756)
Q Consensus 498 --~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~ 574 (756)
..++++..+..++.||+.||+|||+. ||+||||||+|||++.++.++|+|||+++........ ......++..
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 13689999999999999999999999 9999999999999999999999999999865433221 1223456778
Q ss_pred ccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHH
Q 004395 575 YLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCM 653 (756)
Q Consensus 575 Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l 653 (756)
|+|||++.+..++.++|||||||+||||++ |..||........ + ... +...... ..+......+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~----~~~-----~~~~~~~----~~~~~~~~~~ 305 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F----CRR-----LKEGTRM----RAPEYATPEI 305 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H----HHH-----HhccCCC----CCCccCCHHH
Confidence 999999999999999999999999999998 9999864322110 0 000 0010011 1122234568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 654 LHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 654 ~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+++.+||+.+|++||++.+|+++|+.
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=322.35 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=206.7
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||+|.. .++..||||.+..... .....+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678888999999999999994 5889999997654322 22357889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 482 EYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||+.+++|.+++... ....+++..++.++.||+.||.|||+. |++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999988532 345789999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|..||........ .... .+.....+
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~------~~~~~~~~ 226 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCK------KIEQCDYP 226 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HHhh------hhhcCCCC
Confidence 4322 12335688999999999988999999999999999999999999864322100 0000 00111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. .........+.+++.+||..||++|||+.+|++.++.
T Consensus 227 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 P---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred C---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1 1112344578899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=322.89 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=203.6
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CC---CEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DG---QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g---~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
..+|+..+.||+|+||.||+|... ++ ..+|+|.+..... .....+..|+++++.++||||+++++++.+.+..|+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999964 33 3799998765422 234568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+++|.+++.. ....+++..+..++.|++.||+|||+. |++||||||+|||++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999964 346789999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCCccc--ccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 560 DGDMGVET--RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 560 ~~~~~~~~--~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
........ ....+..|+|||++.+..++.++|||||||++|||++ |..||....... ..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i------~~- 225 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAI------ND- 225 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHH------hc-
Confidence 43221111 1223457999999998889999999999999999997 999986432210 00000 00
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.............+.+++.+||+.+|++||++.+|++.|++
T Consensus 226 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 226 ---GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 01111122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.56 Aligned_cols=261 Identities=20% Similarity=0.222 Sum_probs=203.9
Q ss_pred hHHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEe
Q 004395 398 YAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (756)
Q Consensus 398 ~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~ 473 (756)
+..+....++|.+.+.||+|+||.||++.. .+++.||+|++... .......+.+|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 445566678999999999999999999995 46889999987532 22233457889999999999999999999999
Q ss_pred cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
+...|+||||+.+|+|.+++.. ..++...+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999853 4588999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSG----QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 629 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 629 (756)
+++..............||+.|+|||++.+. .++.++|||||||++|||++|..||....... .....
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i-- 259 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKI-- 259 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHH--
Confidence 9987654333233456799999999998653 37899999999999999999999997543210 00000
Q ss_pred hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 004395 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHS--RPRMSQVLRIL 678 (756)
Q Consensus 630 ~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~--RPS~~eVL~~L 678 (756)
.... ..+...........+.+++..||..++.+ |+++.+++++.
T Consensus 260 ----~~~~-~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 ----MNHK-NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ----HcCC-CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0000 00000111223456788999999844433 77999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.24 Aligned_cols=242 Identities=20% Similarity=0.296 Sum_probs=195.3
Q ss_pred EEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|... +++.||||++.... ......+..|.+++..+ +||||+.+++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999954 68899999876432 23345677899999876 799999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|..++. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 99998886 345789999999999999999999999 999999999999999999999999999986433221 22
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.... ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----------~-----~~i~~~~--~~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL----------F-----ESILHDD--VLYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH----------H-----HHHHcCC--CCCC
Confidence 345799999999999999999999999999999999999999975432110 0 0010000 0111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRP-------RMSQVLRI 677 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RP-------S~~eVL~~ 677 (756)
......+.+++..||..||++|| ++.+++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 22334688999999999999999 77887764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.10 Aligned_cols=241 Identities=20% Similarity=0.256 Sum_probs=195.0
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
+|.+.+.||+|+||.||+|... +++.||+|++.... ......+..|..++..+ +|++|+.+++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999854 67899999876432 22234567788888877 5899999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998863 45789999999999999999999999 9999999999999999999999999999854322
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~------~---------~~i~~~~- 217 (323)
T cd05616 155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------F---------QSIMEHN- 217 (323)
T ss_pred CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH------H---------HHHHhCC-
Confidence 21 22346799999999999999999999999999999999999999975432110 0 0011100
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRM 671 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~ 671 (756)
..++......+.+++.+||+.||++|++.
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11222334568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.27 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=205.9
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEEEec
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED 474 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~ 474 (756)
...++|.+.+.||+|+||.||+|.. .++..||||.++.... .....+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3445799999999999999999973 1345799998764432 2235688999999999 799999999999999
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
+..|+||||+.+|+|.+++.......+++..+..++.|++.||+|||++ +|+|+||||+|||++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999999754445589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 555 ARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 555 A~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||........ +
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~------------ 253 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--F------------ 253 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--H------------
Confidence 986543321 11122346788999999999999999999999999999998 9999864332110 0
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
............+......+.+++.+||..+|++||++.++++.|+.
T Consensus 254 -~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 254 -YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred -HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 00000111111112234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.91 Aligned_cols=265 Identities=23% Similarity=0.256 Sum_probs=204.6
Q ss_pred CeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCC-eeeEEEEEEecC------c
Q 004395 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDR------R 476 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpN-IV~l~~~~~~~~------~ 476 (756)
.|...+.||+|+||+||+|+ ..+|+.||+|++...... ......+|+.+|+.|+|+| ||.+++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45556679999999999999 558999999998876542 4456889999999999999 999999999887 7
Q ss_pred eeEEEEeecCCChhhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQ--EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~--~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
+++|+||+ .-+|..++..... ..++...+..++.||+.||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeeccch
Confidence 89999998 7899999976443 4677789999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
|+.+.-+.. ..+.-++|.+|.|||++.+. .|+...||||+|||++||++++..|.+.....+....-.......+..+
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 996653322 24556789999999999875 7899999999999999999999999766653332111100000000111
Q ss_pred hhcc---C--CccCCCC-----Ch---hHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELV---D--PRLGNHY-----SE---HEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~---d--p~l~~~~-----~~---~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.... + ..+.... .. .......+++.+||+.+|.+|.|+..++.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1100 0 0000000 01 111357889999999999999999999884
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.27 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=198.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCC----EEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
++|++.+.||+|+||.||+|.+ .+|+ .+++|.+..... ....++..|+.++..+.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 4688889999999999999995 3454 477777653322 22346777888999999999999999886 456789
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
++||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999964 345799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 560 DGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 560 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
..... ......++..|+|||++.++.++.++|||||||++|||++ |..||....+.. ..+ ..... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~-----~ 228 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPD----LLEKG-----E 228 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCC-----C
Confidence 43221 1223457788999999998999999999999999999998 999996543211 000 00000 0
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+. .+......+.+++.+||..||++|||+.++++.|..
T Consensus 229 ~~~----~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 229 RLA----QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred cCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 000 111123457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=330.45 Aligned_cols=264 Identities=20% Similarity=0.298 Sum_probs=200.1
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|.+.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+++++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999854 6889999988754332 334678899999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+. ++|.+++.. ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LD-KDLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 95 588888864 345689999999999999999999999 999999999999999999999999999986543221
Q ss_pred CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhh--hhhh-------hhhhhhh
Q 004395 564 GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTE--WARP-------LLEEYAI 633 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~--~~~~-------~~~~~~i 633 (756)
......+++.|+|||++.+ ..++.++|||||||++|||+||+.||............. ...+ .......
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223467899999998865 568999999999999999999999997544321100000 0000 0000000
Q ss_pred hhccCCccCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DELVDPRLGN----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~l~dp~l~~----~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.....+.... .........+.+++.+||..||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 001123346789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=327.55 Aligned_cols=249 Identities=20% Similarity=0.310 Sum_probs=205.0
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.+.|+||+++++++..+...|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5899999999999999999984 578999999887665555677899999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
++++|.+++. ...+++..+..++.|++.||+|||.. ||+||||||+|||++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 9999999985 34689999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||....+.... ..+ .........
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~------------~~~~~~~~~ 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLI------------ATNGTPELQ 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHH------------hcCCCCCCC
Confidence 123346889999999999888999999999999999999999999654321110 000 000000011
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+......+.+++.+||..+|++||++.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 12233456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=345.56 Aligned_cols=264 Identities=25% Similarity=0.331 Sum_probs=200.2
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----cee
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RRL 478 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~-----~~~ 478 (756)
+|++.+.||+|+||.||++.. .+|+.||||++.... ......+.+|+++|+.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999995 578999999875432 223456889999999999999999999998776 789
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+ +++|.+++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~-~~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELM-QSDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeecc-ccCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 999998 478888775 456799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh-hhh-hhhhh------
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT-EWA-RPLLE------ 629 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~-~~~~~------ 629 (756)
............+++.|+|||++.+. .++.++|||||||++|||++|+.||....+..+.... ... .+...
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 44332233345689999999998774 5799999999999999999999999765432211000 000 00000
Q ss_pred hhhhhhcc----C-CccC--CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 EYAIDELV----D-PRLG--NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 ~~~i~~l~----d-p~l~--~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
......+. . +... ..........+.+|+.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 0 0000 01112234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.01 Aligned_cols=258 Identities=27% Similarity=0.344 Sum_probs=203.9
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec--------CCCEEEEEEecccC-CcCchhHHHHHHHHHhc-CCCCeeeEEEEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP--------DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~ 472 (756)
+..++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+..|++++..+ +||||++++++|.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34468999999999999999999742 23579999887542 23345688899999999 7999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCc
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~N 538 (756)
.....|+||||+.+|+|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~N 170 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAARN 170 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHHh
Confidence 9999999999999999999996532 23589999999999999999999998 99999999999
Q ss_pred eeecCCCcceeeccccceecCCCCCCc-ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 004395 539 ILLTHDFEPLVGDFGLARWQPDGDMGV-ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKG 616 (756)
Q Consensus 539 ILL~~~~~vkL~DFGlA~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~ 616 (756)
||++.++.++|+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~- 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence 999999999999999998654322111 112234568999999998889999999999999999998 88888543211
Q ss_pred ccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 617 ~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..... +........+......+.+++.+||..+|++||++.+|++.|+.
T Consensus 250 -----~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 250 -----ELFKL----------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred -----HHHHH----------HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 00000 00001111222344578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=321.64 Aligned_cols=253 Identities=30% Similarity=0.427 Sum_probs=199.6
Q ss_pred eeEEEEecccCceEEEEEEec-C---CCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc-----
Q 004395 408 FSQANFLAEGGFGSVHRGVLP-D---GQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR----- 476 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~---g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~----- 476 (756)
|.+.+.||+|+||.||+|... + +..||+|.++.... .....+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999853 2 46899998775432 234578999999999999999999998876554
Q ss_pred -eeEEEEeecCCChhhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeec
Q 004395 477 -RLLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 477 -~~LV~Ey~~ggsL~~~L~~~----~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
.++||||+.+|+|..++... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECC
Confidence 79999999999999988532 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCcc-cccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhh
Q 004395 552 FGLARWQPDGDMGVE-TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLE 629 (756)
Q Consensus 552 FGlA~~~~~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 629 (756)
||+++.......... ....++..|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~----------~~- 225 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----------IY- 225 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----------HH-
Confidence 999987654332111 12235678999999998899999999999999999999 888886432210 00
Q ss_pred hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 630 ~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+.... ....+......+.+++.+||+.||++||++.++++.|+.
T Consensus 226 ----~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 226 ----DYLRHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred ----HHHHcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0011100 111223344578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=327.73 Aligned_cols=251 Identities=28% Similarity=0.385 Sum_probs=201.7
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.|+..+.||+|+||.||++.. .+++.||+|.+...... ....+..|+.+++.++|+||+.+++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999995 47899999987643222 23457789999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999998755556799999999999999999999998 99999999999999999999999999997654322
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ........ ... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~-----~~~-~---- 221 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLV-----KEV-Q---- 221 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhh-----hhh-h----
Confidence 12234689999999999999999999999999999999999999975322110 00000000 000 0
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLR 676 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~ 676 (756)
..+.......+.+|+..||+.||.+||| +.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1122223446889999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.27 Aligned_cols=251 Identities=26% Similarity=0.344 Sum_probs=201.1
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+++|+.++|+||+.+++++..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999985 4789999998764322 223457889999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999998765556799999999999999999999999 99999999999999999999999999997654322
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
......|+..|+|||++.+..++.++|+|||||++|||++|..||........ .... ....... .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~---------~~~~~~~--~ 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEV---------DRRVLET--E 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH---------HHhhhcc--c
Confidence 12345689999999999988999999999999999999999999964332110 0000 0000000 0
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLR 676 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~ 676 (756)
..+.......+.+|+..||+.||++||+ +.+++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1122233446789999999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=322.17 Aligned_cols=252 Identities=27% Similarity=0.373 Sum_probs=195.9
Q ss_pred eEEEEecccCceEEEEEEecC-CC--EEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEec------Cce
Q 004395 409 SQANFLAEGGFGSVHRGVLPD-GQ--AVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------RRR 477 (756)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~-g~--~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~------~~~ 477 (756)
.+.+.||+|+||.||+|.+.. +. .||+|.++... ......|..|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999643 33 68999876542 23345788999999999999999999987532 246
Q ss_pred eEEEEeecCCChhhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 478 LLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~----~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
++||||+.+|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++|+|||
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCCC
Confidence 8999999999999887421 234589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCcc-cccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVE-TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEY 631 (756)
Q Consensus 554 lA~~~~~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 631 (756)
+++.......... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~-~~-- 228 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYDY-LR-- 228 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-HH--
Confidence 9987654332111 12345678999999999999999999999999999999 88888643211 00000 00
Q ss_pred hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 632 AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 632 ~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... ...........+.+++.+||+.||++|||+.+|++.|+.
T Consensus 229 ------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 229 ------QGN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred ------cCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 000 001122334568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.45 Aligned_cols=236 Identities=22% Similarity=0.313 Sum_probs=191.4
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.. .+++.||||++... .......+..|..++..+ +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 46899999987643 223345677899998877 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 999998863 45799999999999999999999999 99999999999999999999999999987543222 122
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~---------~~i~~~~--~~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------F---------EAILNDE--VVYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------H---------HHHhcCC--CCCC
Confidence 346799999999999999999999999999999999999999975432110 0 0000000 0112
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRM 671 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~ 671 (756)
......+.+++.+||+.||.+||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2234568899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.40 Aligned_cols=243 Identities=21% Similarity=0.283 Sum_probs=191.8
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.. .+++.||+|+++... ......+..|+.++.++ +||||+++++++.+....|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999995 468899999887532 22334577899988877 799999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|..++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 99998886 346799999999999999999999999 999999999999999999999999999975432221 22
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc--cchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ--QCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.. ..+.... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~--------~~i~~~~--~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVILEKQ--IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH--------HHHhcCC--CC
Confidence 346799999999999999999999999999999999999999964322111 00001100 0111111 11
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRM 671 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~ 671 (756)
++......+.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 223334568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=319.61 Aligned_cols=248 Identities=26% Similarity=0.363 Sum_probs=200.9
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEE-ecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI-EDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~-~~~~~~LV~Ey~ 484 (756)
.+|.+.+.||+|+||.||++.. .|..||+|..... .....|.+|+.+++.++|+||+++++++. +++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4789999999999999999986 4788999987643 23457899999999999999999999764 456789999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|.+++.......+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999999765555689999999999999999999999 99999999999999999999999999998543322
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
....++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...... .. ....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------~~~~~~------~~----~~~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRV------EK----GYKM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH------hc----CCCC
Confidence 22345678999999998899999999999999999998 99998633211 100000 00 0011
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1222334578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=322.88 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=201.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEec------C
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED------R 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~------~ 475 (756)
+++.|.+.+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.++.++ +||||++++++|... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 456788889999999999999985 468899999886543 3445788999999998 699999999998753 3
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..|+||||+.+++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 579999999999999999765556799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 630 (756)
....... .......|+..|+|||++. +..++.++|||||||++|||++|..||....+....
T Consensus 159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------------ 225 (272)
T cd06637 159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------------ 225 (272)
T ss_pred eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------------
Confidence 8653321 2234467899999999986 346888999999999999999999999643221110
Q ss_pred hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 631 ~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
........+. .........+.+++.+||..+|.+|||+.++++
T Consensus 226 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 FLIPRNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHhcCCCCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000000111 111123346889999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.12 Aligned_cols=245 Identities=25% Similarity=0.358 Sum_probs=195.4
Q ss_pred EecccCceEEEEEEe---cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 413 FLAEGGFGSVHRGVL---PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~---~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
.||+|+||.||+|.+ .++..+|+|+++.... .....+..|+.++..+.||||+++++++. ....++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 3678999998764432 23457899999999999999999999985 45679999999999
Q ss_pred ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC--c
Q 004395 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--V 565 (756)
Q Consensus 488 sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~--~ 565 (756)
+|.+++.. ...+++..+..++.|++.||+|||++ ||+||||||.|||++.++.++|+|||+++........ .
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999963 45789999999999999999999999 9999999999999999999999999999866443211 1
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....++..|+|||.+....++.++|||||||++|||++ |..||....... .. . .+.......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~-------~------~i~~~~~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VT-------Q------MIESGERME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-------H------HHHCCCCCC
Confidence 122234678999999988889999999999999999998 999996432210 00 0 000111111
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+......+.+++.+||+.||++||++++|...|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 222344568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=350.34 Aligned_cols=267 Identities=18% Similarity=0.209 Sum_probs=197.2
Q ss_pred HHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC------CCeeeEEEEE
Q 004395 399 AELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH------RNVVMLIGFC 471 (756)
Q Consensus 399 ~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H------pNIV~l~~~~ 471 (756)
.++....++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+..|++++..++| .+|+.++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34556678999999999999999999985 468899999886432 223456778888887755 4588999988
Q ss_pred Eec-CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecCCC----
Q 004395 472 IED-RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDF---- 545 (756)
Q Consensus 472 ~~~-~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~~~---- 545 (756)
... ...|+|||++ +++|.+++.. .+.+++..+..++.||+.||.|||. . |||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~----gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTEL----HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEEecCCcccc
Confidence 764 4688999987 8899988863 4679999999999999999999997 5 899999999999998765
Q ss_pred ------------cceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004395 546 ------------EPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNR 613 (756)
Q Consensus 546 ------------~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 613 (756)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||+...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 489999999864322 2345679999999999999999999999999999999999999997654
Q ss_pred cccccchh-hhhhhhhhhhh-------hhhcc------CCccCC-----------CCChhHHHHHHHHHHHhcccCCCCC
Q 004395 614 PKGQQCLT-EWARPLLEEYA-------IDELV------DPRLGN-----------HYSEHEVYCMLHAASLCIRRDPHSR 668 (756)
Q Consensus 614 ~~~~~~l~-~~~~~~~~~~~-------i~~l~------dp~l~~-----------~~~~~~~~~l~~Li~~CL~~dP~~R 668 (756)
........ .....+..... ...+. .+.... .........+.+||.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 32211110 00000000000 00000 000000 0000112457799999999999999
Q ss_pred CCHHHHHHH
Q 004395 669 PRMSQVLRI 677 (756)
Q Consensus 669 PS~~eVL~~ 677 (756)
||+.|+|++
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999973
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.23 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=203.8
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEec
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~ 474 (756)
++..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345678999999999999999999743 245899998764322 2234688899999999999999999999999
Q ss_pred CceeEEEEeecCCChhhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCH--------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~--------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~ 546 (756)
...|+||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCc
Confidence 99999999999999999996421 23456788899999999999999999 9999999999999999999
Q ss_pred ceeeccccceecCCCCCCc-ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhh
Q 004395 547 PLVGDFGLARWQPDGDMGV-ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWA 624 (756)
Q Consensus 547 vkL~DFGlA~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~ 624 (756)
++|+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||...... +..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~ 231 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVL 231 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH
Confidence 9999999998654322211 122345778999999999999999999999999999998 78888542211 000
Q ss_pred hhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 625 RPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 625 ~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
..+.+... ...+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 232 ---------~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 232 ---------KFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ---------HHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 00111100 011122335789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=319.16 Aligned_cols=252 Identities=30% Similarity=0.448 Sum_probs=200.6
Q ss_pred eeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCch--hHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~--~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
|++.+.||+|+||.||++... +++.||+|++......... ....|+.+++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 788999999999999999954 5679999988765433222 3456999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|.+++. ....+++..++.++.|+++||.|||+. +|+|+||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNE 153 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTS
T ss_pred cccccccccc--ccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccc-ccc
Confidence 9889999997 456789999999999999999999999 999999999999999999999999999986422 222
Q ss_pred cccccccCccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 565 VETRVIGTFGYLAPEYAQ-SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......++..|+|||++. +..++.++||||||+++|+|++|..||............ ..... .......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~----~~~~~~~--- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EKILK----RPLPSSS--- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HHHHH----THHHHHT---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hhccc----ccccccc---
Confidence 334567899999999998 888899999999999999999999999754111111000 00000 0000000
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.........+.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011257999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=327.00 Aligned_cols=254 Identities=29% Similarity=0.381 Sum_probs=200.9
Q ss_pred CeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
+|++.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+.+|+.++||||+++++.|......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778889999999999999842 235788887764432 234568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhcc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCC
Q 004395 480 VYEYICNGSLDSHLYGC----------------------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~----------------------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~ 537 (756)
||||+.+++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~ 156 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAAR 156 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----Ceehhhhhhh
Confidence 99999999999987532 124588999999999999999999999 9999999999
Q ss_pred ceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 004395 538 NILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPK 615 (756)
Q Consensus 538 NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~ 615 (756)
|||+++++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||....+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999986543221 11122345678999999988889999999999999999998 99998643321
Q ss_pred cccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 616 GQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 616 ~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. +.. ..........+......+.+++.+||+.+|++||++.++++.|+.
T Consensus 237 ~---~~~-------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 237 R---LFN-------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred H---HHH-------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1 010 000001111122233568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=324.09 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=205.3
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecC-----CCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEe-cC
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPD-----GQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DR 475 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~-~~ 475 (756)
+..++|.+.+.||+|+||.||+|.... +..|++|.+.... ......+.+|+.+++.++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345789999999999999999999654 6889999876432 2234568899999999999999999998776 46
Q ss_pred ceeEEEEeecCCChhhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCccee
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQ------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~------~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL 549 (756)
..++++||+.+++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEE
Confidence 78999999999999999864322 4689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhh
Q 004395 550 GDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 550 ~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
+|||+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||....+.. +....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~ 232 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------MAAYL 232 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH------HHHHH
Confidence 999999865433221 1122346778999999998889999999999999999999 999996543211 10000
Q ss_pred hhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 628 ~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...... ......+..+.+++.+||..||++|||+.++++.|+.
T Consensus 233 ------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 233 ------KDGYRL----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred ------HcCCCC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 000010 1112234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=322.96 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=198.3
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
+|++.+.||+|+||.||+|.. .+++.||+|.+.... ......|.+|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999984 578999999876442 223356889999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|..+. .+++..+..++.|++.||.|||+. ||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999996542 478889999999999999999999 99999999999999999999999999998654332
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||........... + ........+......
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-----~---~~~~~~~~~~~~~~~ 220 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-----P---LQLLQCIVDEDPPVL 220 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-----h---HHHHHHHhccCCCCC
Confidence 2345789999999999999999999999999999999999999964322111100 0 000011111100000
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111123468899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=328.31 Aligned_cols=254 Identities=26% Similarity=0.345 Sum_probs=199.5
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCC--EEEEEEeccc-CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQ--AVAVKQHKLA-SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~--~VAVK~~~~~-~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV 480 (756)
++|++.+.||+|+||.||+|... ++. .+++|.++.. .......|.+|++++.++ +||||+++++++.+....|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57899999999999999999864 343 4788877642 223345788999999999 699999999999999999999
Q ss_pred EEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc
Q 004395 481 YEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~ 546 (756)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCe
Confidence 99999999999996421 13588999999999999999999998 9999999999999999999
Q ss_pred ceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhh
Q 004395 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 547 vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~ 625 (756)
+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||....... ...
T Consensus 158 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~ 229 (297)
T cd05089 158 SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYE 229 (297)
T ss_pred EEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence 9999999986432111 1111223557999999998899999999999999999997 999996433211 000
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
. +. .......+......+.+++.+||..+|.+||++.++++.|+..
T Consensus 230 ~------~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 230 K------LP----QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred H------Hh----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00 0111111223345688999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=322.14 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=203.1
Q ss_pred hCCeeEEEEecccCceEEEEEEec-C---CCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-D---GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~---g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
..+|.+.+.||+|+||.||+|... + +..+|+|.++.... .....|..|+.++..++||||+++++++..++..|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357899999999999999999853 2 34799998764332 224578999999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999965 345789999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccc--ccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 560 DGDMGVET--RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 560 ~~~~~~~~--~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
........ ...++..|+|||++.+..++.++|+|||||++||+++ |..||........ . .. +.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~---~~------~~~~ 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---I---KA------IEEG 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---H---HH------HhCC
Confidence 43322111 1223568999999998899999999999999999886 9999864332110 0 00 0000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. ...+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 226 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 226 YR----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred Cc----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 00 01112234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.23 Aligned_cols=241 Identities=25% Similarity=0.332 Sum_probs=193.1
Q ss_pred EEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|... +|+.||+|.++... ......+..|..++..+ +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999954 68999999886432 23344577788888765 899999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.++|+|||+++...... ...
T Consensus 81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 999998863 46789999999999999999999999 99999999999999999999999999987533222 123
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... ...+.+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~----------~~~~~~---~~~~~~----~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE----------LFESIR---VDTPHY----P 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----------HHHHHH---hCCCCC----C
Confidence 45679999999999999999999999999999999999999996443210 001000 001111 1
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMS-QVLR 676 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~-eVL~ 676 (756)
......+.+++.+||+.||++||++. +++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 22334688999999999999999985 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=316.39 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=202.7
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEe-cCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~-~~~~~LV~E 482 (756)
+|++.+.||.|+||.||++.. .+++.||+|.+..... .....+.+|++++++++|+||+++++.+.. +...|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 589999999999999999995 4678999998764322 334568899999999999999999998764 446799999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+++++|.+++.......+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999765566799999999999999999999999 99999999999999999999999999998664322
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ..... ..... +
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~-----~~~~~-~--- 220 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRI-----IEGKL-P--- 220 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHH-----HhcCC-C---
Confidence 22334568999999999999999999999999999999999999986432110 00000 01111 1
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 221 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 -PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1223344578999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.14 Aligned_cols=242 Identities=22% Similarity=0.313 Sum_probs=195.7
Q ss_pred EEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|... +++.||||+++... ......+..|++++..+ +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999954 68899999886432 23345677899999888 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++....... ..
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 999988863 45799999999999999999999999 999999999999999999999999999975332221 22
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... .. . .+.... ..++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~----~-----~i~~~~--~~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LF----Q-----SILEDE--VRYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HH----H-----HHHcCC--CCCC
Confidence 34569999999999999999999999999999999999999996433110 00 0 000000 0122
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRM-----SQVLRI 677 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~-----~eVL~~ 677 (756)
......+.+++.+||..||++||++ .+++..
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2334568899999999999999999 777663
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=316.54 Aligned_cols=248 Identities=32% Similarity=0.425 Sum_probs=202.8
Q ss_pred EEecccCceEEEEEEecC----CCEEEEEEecccCCcC-chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~----g~~VAVK~~~~~~~~~-~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.... +..||+|.+....... ...+.+|++++..++|+||+++++++.+....++||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999643 7899999887654433 56799999999999999999999999999999999999999
Q ss_pred CChhhhhhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 487 GSLDSHLYGCH-------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 487 gsL~~~L~~~~-------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999997531 47899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 560 DGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 560 ~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
.... .......++..|+|||.+....++.++||||||+++|||++ |..||....... ... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~---------~~~ 221 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VLE---------YLR 221 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HHH---------HHH
Confidence 4321 12234557889999999988899999999999999999999 699997542210 000 000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
. ......+......+.+++.+||..+|.+||++.++++.|+
T Consensus 222 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 K-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred c-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 0111122233457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.32 Aligned_cols=260 Identities=23% Similarity=0.290 Sum_probs=202.4
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----ceeEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RRLLV 480 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~-----~~~LV 480 (756)
.|...+++|.|.||.||.|.. .+++.||||+...... .-.+|+++|+.+.|||||+|+-+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 578889999999999999994 4679999998765433 2236999999999999999999887543 24589
Q ss_pred EEeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC-Ccceeecccccee
Q 004395 481 YEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLARW 557 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~-~~vkL~DFGlA~~ 557 (756)
|||| ..+|.+.+.. ..+..++.-.+.-++.||++||+|||+. ||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 101 leym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999 5799888863 2467788889999999999999999998 99999999999999987 9999999999998
Q ss_pred cCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhh-hhh-hhhhhh---
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTE-WAR-PLLEEY--- 631 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~-~~~-~~~~~~--- 631 (756)
...+.. ...+..|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+.....|....- ... |-.++.
T Consensus 176 L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 876653 356778999999998876 679999999999999999999999998765544422111 100 111100
Q ss_pred --hhhhccCCccC-----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 632 --AIDELVDPRLG-----NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 632 --~i~~l~dp~l~-----~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...+...|.+. ..+......+..+|+.++|..+|.+|.++.|++.+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00111122221 11334456678999999999999999999999874
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=331.38 Aligned_cols=241 Identities=25% Similarity=0.333 Sum_probs=193.2
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.. .+++.||||+++... ......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999995 468899999886532 23344567788888764 899999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999999963 45789999999999999999999999 999999999999999999999999999975432221 22
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... ...+.+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----------~~~~i~---~~~~~~----~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE----------LFQSIR---MDNPCY----P 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH----------HHHHHH---hCCCCC----C
Confidence 34679999999999999999999999999999999999999996533210 001000 011111 1
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMS-QVLR 676 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~-eVL~ 676 (756)
......+.+++.+||+.||++||++. ++++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 22334678999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=328.49 Aligned_cols=259 Identities=26% Similarity=0.351 Sum_probs=204.8
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe--------cCCCEEEEEEecccC-CcCchhHHHHHHHHHhc-CCCCeeeEEEEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL--------PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~ 472 (756)
+...+|.+.+.||+|+||.||+|.. .++..||+|...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4456899999999999999999973 134579999876432 23345788999999999 7999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCc
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~N 538 (756)
.....|+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~N 167 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAARN 167 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----Ceeecccccce
Confidence 9999999999999999999996432 24578899999999999999999999 99999999999
Q ss_pred eeecCCCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 004395 539 ILLTHDFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKG 616 (756)
Q Consensus 539 ILL~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~ 616 (756)
||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 99999999999999999876543221 1222345678999999998899999999999999999998 77887543211
Q ss_pred ccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 617 ~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.+.... .. ......+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 247 -----~~~~~~------~~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 247 -----ELFKLL------KE----GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred -----HHHHHH------Hc----CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 111100 00 000111223345688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=319.23 Aligned_cols=246 Identities=23% Similarity=0.350 Sum_probs=194.9
Q ss_pred EecccCceEEEEEEec---CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCC
Q 004395 413 FLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggs 488 (756)
.||+|+||.||+|.+. ++..||+|++...... ....|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 4557999987654332 2356899999999999999999999885 457899999999999
Q ss_pred hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc--
Q 004395 489 LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE-- 566 (756)
Q Consensus 489 L~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~-- 566 (756)
|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999864 345799999999999999999999999 999999999999999999999999999986543322111
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~ 645 (756)
....++..|+|||++....++.++|||||||++|||++ |..||........ . ..+........
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~----------~~~~~~~~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV------M----------SFIEQGKRLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH------H----------HHHHCCCCCCC
Confidence 11223578999999988889999999999999999996 9999964432110 0 00000011112
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 646 ~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+......+.+++.+||..+|++||++.+|++.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 23345678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=327.86 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=202.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|++.+.||+|+||.||++.. .++..+|+|.+..... .....+.+|++++.+++||||++++++|.+++..|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3689999999999999999995 4688999998764422 2234688999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ +++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 999999999974 367899999999999999999999732 79999999999999999999999999987654322
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh--------------
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE-------------- 629 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~-------------- 629 (756)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||....................
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 2345689999999999888899999999999999999999999864332111000000000000
Q ss_pred ---h----hhhhhccCCccCCCCC-hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 ---E----YAIDELVDPRLGNHYS-EHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 ---~----~~i~~l~dp~l~~~~~-~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. .....+.... ....+ ......+.+++.+||..+|++||++.+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 233 SPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000000000 00000 1133468899999999999999999999884
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.59 Aligned_cols=263 Identities=24% Similarity=0.298 Sum_probs=197.6
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR----- 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~----- 475 (756)
..++|.+.+.||+|+||.||++.. .+|..||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999999985 468999999876432 233456889999999999999999999986543
Q ss_pred -ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 476 -RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 476 -~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
..|+||||+. ++|.+.+. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 4799999994 56766664 2488899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc--hh-------hhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC--LT-------EWAR 625 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~--l~-------~~~~ 625 (756)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .. .+..
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 97543322 2234578999999999999999999999999999999999999997543211100 00 0000
Q ss_pred hh---hhhh----------hhhhccCCccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 PL---LEEY----------AIDELVDPRLG---NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ~~---~~~~----------~i~~l~dp~l~---~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .... ...+....... ..........+.+|+.+||..||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000 00000000000 00011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=332.73 Aligned_cols=255 Identities=20% Similarity=0.227 Sum_probs=197.8
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++.+.||+|+||.||++.. .+++.||+|++... .......|..|+.++..++|+||+.+++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999995 46899999987632 2223446888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999964 345789999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCCcccccccCccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQS-----GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
.........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +........ ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~---~~~ 226 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNH---KEH 226 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcC---CCc
Confidence 3322333569999999999863 45788999999999999999999999643221 110110000 000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHS--RPRMSQVLRI 677 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~--RPS~~eVL~~ 677 (756)
. .+. .........+.+++.+|+..++++ ||++.+++.+
T Consensus 227 ~--~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 F--QFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c--cCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 000 011113346778888877654443 7899998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=335.44 Aligned_cols=192 Identities=25% Similarity=0.341 Sum_probs=166.6
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
...+|.+.+.||+|+||.||+|... +++.||+|+... .....|+.+|++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3458999999999999999999954 578999996432 124579999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+ .++|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 98 6789888864 456799999999999999999999999 99999999999999999999999999997543221
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAV 609 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf 609 (756)
......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223456999999999999999999999999999999999966655
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=343.16 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=224.5
Q ss_pred hHHHHHhhCCeeEEEEecccCceEEEEEEecC-CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 398 YAELELATGGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 398 ~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
+..++....+......||-|.||.||.|+|+. .-.||||.++.. ....++|+.|+.+++.++|||+|+|+|+|.....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 35677777788889999999999999999864 568999988743 4557899999999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
+|||+|||++|+|.++|..+++..++.-..+.++.||..|++||..+ ++|||||...|+|+.++..+||+||||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999999888899999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
+.....+...........|.|||-+....++.|+|||+|||+||||.| |.-||.... +. ...+
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lS----------qVY~ 477 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LS----------QVYG 477 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HH----------HHHH
Confidence 887665444334445778999999999999999999999999999998 777775332 11 1122
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
++...++-..++.++..+.+|+..||+..|.+||++.|+-+.+|.+
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 3333333445566777899999999999999999999999988753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=369.45 Aligned_cols=257 Identities=29% Similarity=0.400 Sum_probs=209.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEec--CCC----EEEEEEeccc-CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP--DGQ----AVAVKQHKLA-SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~----~VAVK~~~~~-~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
...+..+.+.||+|.||.||.|... .|. .||||.++.. +.+...+|+.|..+++.+.|||||+++|+|.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3456778899999999999999943 343 4899987655 34556789999999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeec
Q 004395 477 RLLVYEYICNGSLDSHLYGC-----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~-----~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
.+|++|||+||+|..+|+.. ....|+....+.++.+||+|+.||+++ .+|||||..+|+||+....+||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999763 246789999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCccc-ccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhh
Q 004395 552 FGLARWQPDGDMGVET-RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLE 629 (756)
Q Consensus 552 FGlA~~~~~~~~~~~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 629 (756)
||+|+...+.++.... ...-...|||||.+..+.++.|+|||||||+|||++| |..||...... +.....+.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLLDVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHHHHHh
Confidence 9999954444332222 2234568999999999999999999999999999999 88898654321 11111111
Q ss_pred hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 630 ~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. +-..+..++..+.+++..||+.+|++||++..|++.+..
T Consensus 920 gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 920 GG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred CC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 11 122344566678899999999999999999999997764
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.65 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=203.5
Q ss_pred CCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
++|.+...||+|+||.||+|... +.+.||+|.+...... ....+.+|+++|++++|+||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999853 3467999977654333 3457999999999999999999999999989999
Q ss_pred EEEEeecCCChhhhhhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeec
Q 004395 479 LVYEYICNGSLDSHLYGCHQ-------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~-------~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
+||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999964331 2689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhh
Q 004395 552 FGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEE 630 (756)
Q Consensus 552 FGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 630 (756)
||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~-------~~~ 230 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---V-------LNR 230 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---H-------HHH
Confidence 99987554333223334456788999999988889999999999999999999 788885322110 0 000
Q ss_pred hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 631 ~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
..............+..+.+++.+||..+|.+||++.+++..|.
T Consensus 231 -----~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 -----LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00000111112233456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.06 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=206.8
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.++|.+.+.||.|+||.||+|.. .+++.+|+|.+..........+..|+++++.++||||+++++++.+....|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 36899999999999999999995 46789999998766555667899999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999998864 336799999999999999999999999 99999999999999999999999999997654321
Q ss_pred CcccccccCccccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 564 GVETRVIGTFGYLAPEYAQSG---QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.......++..|+|||.+.+. .++.++||||||+++|||++|..||....+.... .......+..+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~----------~~~~~~~~~~~~ 225 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL----------FLISKSNFPPPK 225 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----------HHHHhccCCCcc
Confidence 122345688899999999776 8899999999999999999999999643321110 000001111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..........+.+++.+||..+|.+|||+.+|+.
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 --LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1112233456899999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.87 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=200.7
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCC----EEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
..+|.+.+.||+|+||.||+|.+ .+|. .||+|.+..... .....+.+|+.++..++||||+.+++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 45789999999999999999984 3554 489998764432 234578899999999999999999999975 4578
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
++|||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999864 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 559 PDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 559 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
...... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... +..+ +...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~---------~~~~ 227 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL---------LEKG 227 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---------HHCC
Confidence 532211 1112235678999999998999999999999999999998 999986432210 0000 0110
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... ..+......+.+++.+||..||+.||++.+++..|+.
T Consensus 228 ~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 228 ERL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267 (279)
T ss_pred CcC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 001 1112234568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.81 Aligned_cols=253 Identities=24% Similarity=0.231 Sum_probs=213.2
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc---CchhHHHHHHHHHhcC-CCCeeeEEEEEEecCce
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~ 477 (756)
.....|.+.+.||.|.||.||++..+ +|+.+|+|.+...... ....+.+|+++|+++. |||||.++++|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34568999999999999999999954 5999999988655433 3458999999999998 99999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC----Ccceeeccc
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD----FEPLVGDFG 553 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~----~~vkL~DFG 553 (756)
++|||+|.||.|.+.+... .+++..+..++.|++.++.|||+. ||+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999764 399999999999999999999998 99999999999999643 579999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... .+
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------------~i 250 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------------AI 250 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------------HH
Confidence 9998776 335567899999999999999999999999999999999999999997554321110 00
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. ..+..+...........+.+++..|+..||.+|+|+.++|++
T Consensus 251 ~-~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 251 L-RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred H-cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 0 011123334444556678999999999999999999999995
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.19 Aligned_cols=252 Identities=25% Similarity=0.264 Sum_probs=206.6
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
+.|++++.||.|.-|+||++... ++..+|+|++...... .......|-+||+.++||.++.||..|+.+...||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 45667788999999999999965 4689999998755433 3345677999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC-
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD- 560 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~- 560 (756)
|||+||+|..+++....+.+++..++.++.+++-||+|||-. |||+|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999999988889999999999999999999999999 999999999999999999999999999752210
Q ss_pred --------------------------------C-C---------------------CCcccccccCccccCccccccCCC
Q 004395 561 --------------------------------G-D---------------------MGVETRVIGTFGYLAPEYAQSGQI 586 (756)
Q Consensus 561 --------------------------------~-~---------------------~~~~~~~~Gt~~Y~APE~l~~~~~ 586 (756)
. . ......++||-.|+|||++.+..+
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 011234689999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCC
Q 004395 587 TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPH 666 (756)
Q Consensus 587 s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~ 666 (756)
+.++|+|+|||+||||+.|..||-+...... + ..++...+.-...+.....+.+||.++|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l-------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--L-------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh--H-------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999976554321 1 112211111111224456789999999999999
Q ss_pred CCCC----HHHHHH
Q 004395 667 SRPR----MSQVLR 676 (756)
Q Consensus 667 ~RPS----~~eVL~ 676 (756)
+|.- +.||-+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9998 777765
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.51 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=198.9
Q ss_pred EecccCceEEEEEEecCCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCChhh
Q 004395 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDS 491 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~ 491 (756)
.||.|+||.||++...+++.||+|.+...... ....|..|++++++++|+||+++++++.+....++||||+.+++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 69999999999999766999999987654433 34578999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc-cccc
Q 004395 492 HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE-TRVI 570 (756)
Q Consensus 492 ~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~-~~~~ 570 (756)
++... ...+++..++.++.+++.||.|||++ +++||||||+|||++.++.++|+|||++........... ....
T Consensus 82 ~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 82 FLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99652 44688999999999999999999999 999999999999999999999999999986543221111 1123
Q ss_pred cCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhH
Q 004395 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649 (756)
Q Consensus 571 Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~ 649 (756)
++..|+|||++.++.++.++||||||+++|||++ |..||........ . ..+........+...
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~-------------~~~~~~~~~~~~~~~ 220 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---R-------------ERIESGYRMPAPQLC 220 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---H-------------HHHhcCCCCCCCccC
Confidence 4567999999998899999999999999999999 8888854432110 0 000001111122334
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 650 VYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 650 ~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
+..+.+++.+||..+|++||++.++++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.16 Aligned_cols=238 Identities=24% Similarity=0.290 Sum_probs=193.4
Q ss_pred EEecccCceEEEEEEe----cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 412 NFLAEGGFGSVHRGVL----PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~----~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|+++|++++||||+++++++.++...|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999873 3689999998864322 223457789999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+|+|.+++. ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 999999986 345799999999999999999999999 99999999999999999999999999998654332 12
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~ 645 (756)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---------------~~~i~~~~--~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---------------MTMILKAK--LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---------------HHHHHcCC--CCC
Confidence 2346799999999999988899999999999999999999999964322100 00011100 012
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHH
Q 004395 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQ 673 (756)
Q Consensus 646 ~~~~~~~l~~Li~~CL~~dP~~RPS~~e 673 (756)
+......+.+++.+||+.||.+||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2223456889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=323.27 Aligned_cols=269 Identities=24% Similarity=0.304 Sum_probs=202.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-----cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEec--Cce
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRR 477 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~ 477 (756)
..|.+.+.||+|+||.||++.. .++..||+|.++... ......+.+|+++|+.++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578889999999999999973 357899999876443 23345789999999999999999999998875 568
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+. ||+||||||+|||++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999999864 234689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 558 QPDGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 558 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
....... ......++..|+|||++.+..++.++|||||||++|||++++.|+..........................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6533211 11234567789999999888899999999999999999998876532111000000000000000000000
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+... ............+.+++.+||+.+|++||++.++++.|+.
T Consensus 239 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 239 LEEG-KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHcC-ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 0000 0111122344579999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.14 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=205.5
Q ss_pred CeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|+..+.||.|+||.||.+. ..+++.+++|.+.... ......+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999998 4578999999876442 33345788999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.......+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999764456789999999999999999999998 999999999999999999999999999987654332
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......|++.|+|||++.+..++.++||||||+++|||++|..||....... .. ..+..... .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~---------~~~~~~~~-~ 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LV---------VKIVQGNY-T 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HH---------HHHHcCCC-C
Confidence 2234568999999999988889999999999999999999999996432210 00 00000000 0
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.........+.+++.+||..+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1112334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=320.86 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=202.8
Q ss_pred hhCCeeEEEEecccCceEEEEEEecC----CCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
...+|.+.+.||+|+||.||+|...+ ...||||...... ....+.|.+|+.+++.++||||+++++++.+ ...|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34578899999999999999998533 3468999876544 2344578999999999999999999999875 5578
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.++|+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999642 34689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
............++..|+|||.+....++.++||||||+++|||++ |..||........ +. .+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~----------~~~~~~ 225 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IG----------RIENGE 225 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HH----------HHHcCC
Confidence 5443222223335568999999988889999999999999999996 9999964432110 00 000000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. ..+......+.+++.+|+..+|++|||+.+++..|+.
T Consensus 226 ~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 226 RL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 1122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=325.94 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=200.0
Q ss_pred hCCeeEEEEecccCceEEEEEEecC---------------CCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPD---------------GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLI 468 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~---------------g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~ 468 (756)
.++|++.+.||+|+||.||++.... ...||+|.+..... .....|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999987432 23589998764422 2334688999999999999999999
Q ss_pred EEEEecCceeEEEEeecCCChhhhhhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCc
Q 004395 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCH----------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538 (756)
Q Consensus 469 ~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~----------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~N 538 (756)
+++......++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+|
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~N 159 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRN 159 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChhh
Confidence 99999999999999999999999985421 12478899999999999999999999 99999999999
Q ss_pred eeecCCCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCcc
Q 004395 539 ILLTHDFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT--GRKAVDLNRPK 615 (756)
Q Consensus 539 ILL~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt--G~~Pf~~~~~~ 615 (756)
||++.++.+||+|||++......... ......++..|+|||++.++.++.++|||||||++|+|++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999999865433211 1222345778999999998899999999999999999998 55666533211
Q ss_pred cccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 616 GQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 616 ~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
...... ...... .........+...+..+.+++.+||+.||++||++++|++.|+
T Consensus 240 --~~~~~~-~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 --QVIENT-GEFFRN------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHH-HHhhhh------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 100000 000000 0000001111223357999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.05 Aligned_cols=262 Identities=27% Similarity=0.386 Sum_probs=202.8
Q ss_pred hCCeeEEEEecccCceEEEEEEecC-----------------CCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPD-----------------GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVM 466 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----------------g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~ 466 (756)
.++|++.+.||+|+||.||+|.... +..||+|.+..... .....+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999988432 24689998765432 23457889999999999999999
Q ss_pred EEEEEEecCceeEEEEeecCCChhhhhhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCC
Q 004395 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCH---------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (756)
Q Consensus 467 l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~---------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~ 537 (756)
++++|..+...++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATR 159 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----Cccccccchh
Confidence 9999999999999999999999999986432 23689999999999999999999999 9999999999
Q ss_pred ceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCc
Q 004395 538 NILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT--GRKAVDLNRP 614 (756)
Q Consensus 538 NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt--G~~Pf~~~~~ 614 (756)
|||++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999986543321 12233456788999999998889999999999999999998 6677753321
Q ss_pred ccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 615 KGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 615 ~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
. . ........... .........+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 240 ~--~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 Q--Q-VIENAGHFFRD------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H--H-HHHHHHhcccc------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 0 00000000000 0000001112223357899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=317.35 Aligned_cols=247 Identities=27% Similarity=0.396 Sum_probs=200.5
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
++|.+.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4689999999999999999975 67889999876432 345789999999999999999999998765 4799999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+++|.+++.......+++..++.++.|++.||.|||+. |++||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999999765556789999999999999999999998 99999999999999999999999999998643321
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....+..|+|||++.++.++.++|+|||||++|||++ |+.||....... .... +.. .....
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~------~~~----~~~~~ 217 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKEC------VEK----GYRME 217 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHH------HhC----CCCCC
Confidence 22334678999999998899999999999999999998 999986433211 0000 000 00111
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.....+..+.+++.+||+.+|+.||++.+++..|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122234568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=339.30 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=196.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|+..+.||+|+||.||++.. .+++.||+|++.... ......+..|+.++..++||||+++++.+.+....||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3689999999999999999995 468999999886432 233456888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+|+|.+++. ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999996 346799999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC----------------------------------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 004395 562 DM----------------------------------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK 607 (756)
Q Consensus 562 ~~----------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~ 607 (756)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00123579999999999999999999999999999999999999
Q ss_pred CCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 004395 608 AVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR---MSQVLR 676 (756)
Q Consensus 608 Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS---~~eVL~ 676 (756)
||....+... ...... . ...+..+ .. ......+.+++.+|+ .||.+|++ +.++++
T Consensus 235 Pf~~~~~~~~------~~~i~~-~-~~~~~~p---~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQET------YRKVMN-W-KETLVFP---PE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHHH------HHHHHc-C-CCceecC---CC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9975433211 000000 0 0000000 00 112345777888876 49999985 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=314.46 Aligned_cols=265 Identities=24% Similarity=0.308 Sum_probs=211.7
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC----
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR---- 475 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~---- 475 (756)
+.+..++|++.+.||+|||+.||++. ..++..||+|++.....++.+..++|++..++++||||++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 45667899999999999999999999 6789999999988877778889999999999999999999998876554
Q ss_pred -ceeEEEEeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecc
Q 004395 476 -RRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 476 -~~~LV~Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
..||+++|+..|+|.+.+... .+..+++.+++.|+.+|++||++||+..+ .++||||||.|||+.+++.++|.||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~--~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP--PYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC--cccccCCCcceeEecCCCceEEEec
Confidence 489999999999999999654 34579999999999999999999999822 3999999999999999999999999
Q ss_pred ccceecCCCCCC--------cccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 004395 553 GLARWQPDGDMG--------VETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 553 GlA~~~~~~~~~--------~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~ 621 (756)
|.++...-.-.+ ....-..|..|.|||.+. +...++++|||||||+||.|+.|.-||+.....+...-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla- 252 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA- 252 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-
Confidence 999754311100 011234689999999885 35568999999999999999999999974333222110
Q ss_pred hhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 622 EWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 622 ~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
-....+.+.-.........+.+++.+|++.||.+||++.+++..++.
T Consensus 253 ------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 253 ------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 01111111111111244579999999999999999999999998875
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=332.80 Aligned_cols=243 Identities=22% Similarity=0.277 Sum_probs=192.2
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.. .+++.||+|++.... ......+..|+.++.++ +||||+.+++++.+....|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999995 468899999887532 22334678899999888 599999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|..++. ..+.+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 99998886 345799999999999999999999999 99999999999999999999999999997533222 122
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||+||||++|+.||.............+... .+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~--~~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ--------VILEKP--IRIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH--------HHHhCC--CCCC
Confidence 346799999999999999999999999999999999999999964332211111111110 011110 1122
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRM 671 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~ 671 (756)
......+.+++.+||..||.+|+++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2233467899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.79 Aligned_cols=265 Identities=21% Similarity=0.277 Sum_probs=200.8
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999854 688999998865432 2334678899999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+. ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 95 699888864 345689999999999999999999999 999999999999999999999999999976543221
Q ss_pred CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh---------hhhhhhhhhhhh
Q 004395 564 GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT---------EWARPLLEEYAI 633 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~---------~~~~~~~~~~~i 633 (756)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||............ ............
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 1223457899999998865 45789999999999999999999999754432110000 000000000000
Q ss_pred hhccCCccCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPRLGN----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~l~~----~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.....+.... .........+.+|+.+||+.||.+|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000011100 0111234467899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=338.25 Aligned_cols=262 Identities=21% Similarity=0.202 Sum_probs=200.8
Q ss_pred hhCCeeEEEEecccCceEEEEEEec---CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
...+|.+.+.||+|+||.||++... .+..||+|.+... ..+.+|+++|+.++||||+++++++......|+|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3458999999999999999999742 4678999976532 2456899999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+ +++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++....
T Consensus 165 ~e~~-~~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKY-KCDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhc-CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9998 578888884 456899999999999999999999999 999999999999999999999999999986554
Q ss_pred CCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc-cchhhhhhh------------
Q 004395 561 GDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ-QCLTEWARP------------ 626 (756)
Q Consensus 561 ~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~-~~l~~~~~~------------ 626 (756)
.... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ..+......
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 3221 22346799999999999999999999999999999999999999965543221 001000000
Q ss_pred ---hhhhh-hhhhccCCccC--CC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 627 ---LLEEY-AIDELVDPRLG--NH-YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 627 ---~~~~~-~i~~l~dp~l~--~~-~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+.... .......+... .. ........+.++|.+||..||++||++.+++.+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000000000 00 001123467889999999999999999999884
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.35 Aligned_cols=247 Identities=28% Similarity=0.391 Sum_probs=198.6
Q ss_pred EecccCceEEEEEEecC--CC--EEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 413 FLAEGGFGSVHRGVLPD--GQ--AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~--g~--~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
.||+|+||.||+|.+.+ ++ .||||.+..... .....|.+|+.++++++||||+++++++.+ ...++||||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 58999999999998543 33 699998876554 445679999999999999999999999988 8899999999999
Q ss_pred ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC--c
Q 004395 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--V 565 (756)
Q Consensus 488 sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~--~ 565 (756)
+|.+++.......+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999764336789999999999999999999999 9999999999999999999999999999876542211 1
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....++..|+|||++.+..++.++|||||||++|||++ |..||....... ..... .. ... ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~------~~-~~~--~~~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKI------DK-EGE--RLE 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH------Hh-cCC--cCC
Confidence 123457789999999999999999999999999999998 999986432211 00000 00 000 011
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
.+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11223456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.73 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=203.1
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
++..+.++.....||+|+||.||+|.. .++..||+|.+..........+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345566666677899999999999994 4678999998776655556689999999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCC--CHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-CCcceeeccccce
Q 004395 480 VYEYICNGSLDSHLYGCHQEPL--EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLAR 556 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L--~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-~~~vkL~DFGlA~ 556 (756)
||||+.+++|.+++... ...+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 83 FMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999742 2345 8888999999999999999999 9999999999999976 6799999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQ--ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
....... ......|++.|+|||++.... ++.++||||||+++|+|++|+.||........ ..+... ..
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~------~~ 227 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVG------MF 227 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhh------hh
Confidence 6543322 122345889999999986643 78999999999999999999999864321110 000000 00
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
......+......+.+++.+||+.+|++|||+.+++..
T Consensus 228 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 -----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111223344568899999999999999999999873
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.05 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=201.4
Q ss_pred CCeeEEEEecccCceEEEEEEec-CC---CEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DG---QAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g---~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
..|++.+.||+|+||.||+|... ++ ..||||.+.... ......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45889999999999999999954 33 369999876542 22345799999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+++|.+++... .+.+++..++.++.|++.||+|||+. |++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998653 45789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCc-cc-ccc--cCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 561 GDMGV-ET-RVI--GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 561 ~~~~~-~~-~~~--Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
..... .. ... .+..|+|||++.+..++.++|||||||++|||++ |..||....... ...+ +..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~---------i~~ 226 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINA---------IEQ 226 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHH---------HHc
Confidence 32111 11 111 2457999999999999999999999999999886 999986432110 0000 000
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... ...+...+..+.+++.+||..+|++||++.+|+..|+.
T Consensus 227 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 227 DYR----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred CCc----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000 11112334568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.86 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=200.8
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcC---------chhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---------DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~---------~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
+|.+...||.|+||.||+|.. .+++.||+|.+....... ...+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477788999999999999985 468899999876543322 1458889999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.++||||+++++|.+++.. .+.+++..+..++.|++.||+|||+. |++||||+|+|||++.++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999963 46789999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC-----CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhh
Q 004395 557 WQPDGDM-----GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEY 631 (756)
Q Consensus 557 ~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 631 (756)
....... .......|+..|+|||++.+..++.++|||||||++|+|++|..||....... .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~---~ 222 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---------AI---F 222 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---------HH---H
Confidence 6652211 11123458899999999998889999999999999999999999996432110 00 0
Q ss_pred hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 632 AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 632 ~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.......+. .+......+.+++.+||+.||.+||++.++++
T Consensus 223 ~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 KIGENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHhccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011111122 22233456889999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.28 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=201.2
Q ss_pred CeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCc------CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~------~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
+|...+.||.|+||.||+|...+|+.+|+|.+...... ....+.+|+++|+.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999999888999999987654321 124588899999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+++|.+++.. ..++++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999963 35789999999999999999999999 999999999999999999999999999975432
Q ss_pred CC-----CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 561 GD-----MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 561 ~~-----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
.. ........|+..|+|||++.+..++.++||||||+++|+|++|..||........ . ..... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~----~~~~~-~~ 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----M----FYIGA-HR 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----H----HHhhh-cc
Confidence 11 1112235689999999999998999999999999999999999999964321100 0 00000 00
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
...+. .+......+.+++.+||..+|++||++.+++.
T Consensus 225 ~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111 22233456889999999999999999999976
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=332.67 Aligned_cols=237 Identities=24% Similarity=0.317 Sum_probs=189.1
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHH-HHHhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVE-VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~-iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.. .+|+.||||++.... ......+..|.. +++.++||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999995 478999999876432 122234555554 56789999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|..++. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 99999886 346789999999999999999999999 99999999999999999999999999997543222 123
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||++|||++|..||...... ... ..+..... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~---------~~i~~~~~--~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMY---------DNILNKPL--RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHH---------HHHHcCCC--CCC
Confidence 3467999999999999999999999999999999999999999643211 000 00111000 111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMS 672 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~ 672 (756)
......+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 22345688999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.36 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=198.5
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 488899999999999999995 4789999998764422 2335688999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 484 ICNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 484 ~~ggsL~~~L~~~~-~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
+. ++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 96 78988885433 36799999999999999999999999 99999999999999999999999999998654322
Q ss_pred CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc--hhhhhhhh------hh-hhh
Q 004395 563 MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC--LTEWARPL------LE-EYA 632 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~--l~~~~~~~------~~-~~~ 632 (756)
.......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||.......... +..+..+. .. ...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 12223457899999998865 457899999999999999999999997543211100 00000000 00 000
Q ss_pred hhhccCCccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 633 IDELVDPRLG---NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 633 i~~l~dp~l~---~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.......... ..........+.+++.+||..||++|||+.+|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0001123346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=319.56 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=201.5
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
++|.+.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677888999999999999984 568999999887655444556888999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|.+++. ..+.+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++....... .
T Consensus 89 ~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 89 GGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred CCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 9999999986 345799999999999999999999999 99999999999999999999999999997654322 1
Q ss_pred cccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 565 VETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
......|+..|+|||++. ...++.++|||||||++|+|++|..||....+...... ........+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~----------~~~~~~~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL----------MTKSNFQPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh----------hhccCCCCCcc
Confidence 223456899999999874 45688999999999999999999999854332111000 00000111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.. .......+.+++.+||..+|++||++.+|++
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 0012235789999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=341.81 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=205.7
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCCc-CchhHHHHHHHHHhcC-CCCeeeEEEEEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQ-HRNVVMLIGFCI 472 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~ 472 (756)
+++..++|.+.+.||+|+||.||+|.+. .+..||||+++..... ....+..|+++|.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455567888999999999999999853 3468999998754322 2346889999999997 999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccC-------------------------------------------------------
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCH------------------------------------------------------- 497 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~------------------------------------------------------- 497 (756)
.....++||||+.+|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986421
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCC
Q 004395 498 -----------------------------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (756)
Q Consensus 498 -----------------------------------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp 536 (756)
...+++..++.++.||+.||+|||+. +|+||||||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlkp 267 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLAA 267 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCCc
Confidence 12467788899999999999999998 999999999
Q ss_pred CceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 004395 537 NNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRP 614 (756)
Q Consensus 537 ~NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 614 (756)
+|||+++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986543221 11223457889999999998889999999999999999998 8889864321
Q ss_pred ccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 615 KGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 615 ~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... . ...+........+......+.+++.+||..+|.+||++.+|++.|+.
T Consensus 348 ~~~----------~-----~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 NEQ----------F-----YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred hHH----------H-----HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 110 0 00000000111222334578999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.76 Aligned_cols=250 Identities=21% Similarity=0.317 Sum_probs=205.7
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++..+...|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36899999999999999999994 57999999988765555566788999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+++++|.+++. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999985 34689999999999999999999999 999999999999999999999999999986543321
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+..... .. . .......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~-----------~--~~~~~~~ 235 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LI-----------A--TNGTPEL 235 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-ee-----------c--cCCCCCC
Confidence 1233568899999999999889999999999999999999999996543321110 00 0 0000000
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..+......+.+++.+||..+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111223345789999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.55 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=205.1
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.+|+..+.||.|+||.||+|.. .+|+.||+|.+..........+.+|+.+++.++||||+.+++++......|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5799999999999999999984 578999999887665555667899999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|..++. ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 9999999885 34689999999999999999999999 999999999999999999999999999886543321
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+.... .. +.....+.+ .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~------~~~~~~~~~--~ 236 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YL------IATNGTPEL--Q 236 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH------HHhcCCccc--C
Confidence 123346889999999999888999999999999999999999999654321110 00 000000000 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+......+.+++.+||..||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 12223346889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=330.58 Aligned_cols=242 Identities=20% Similarity=0.266 Sum_probs=194.8
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~ 481 (756)
+|...+.||+|+||.||+|.. .+|+.||+|++.... ......+..|+.++..+. |++|+.+++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999995 478999999876432 233456788999998886 578889999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+|+|.+++. ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999986 346799999999999999999999999 9999999999999999999999999999854322
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~---------~~i~~~~- 217 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL------F---------QSIMEHN- 217 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH------H---------HHHHhCC-
Confidence 21 22345699999999999999999999999999999999999999975432100 0 0011100
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMS 672 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~ 672 (756)
..++......+.+++.+||+.+|.+|++..
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 012223345678999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.82 Aligned_cols=249 Identities=27% Similarity=0.381 Sum_probs=204.5
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
++|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+|+++++.++||||+++++++.+....|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888999999999999999965 488999998765433 568999999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|.+++.. ....+++..++.++.|++.||.|||.. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999864 346789999999999999999999999 999999999999999999999999999986654321
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+.... ........+. ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------------~~~~~~~~~~--~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------------FMIPNKPPPT--LS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------------hhhccCCCCC--CC
Confidence 223345889999999999989999999999999999999999999643321110 0000000010 11
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+......+.+++.+||+.||++|||+.+++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12223356889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.36 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=202.2
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.+.|++.+.||.|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 35788999999999999999995 45899999998765555566788999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|..++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 999999888754 345789999999999999999999999 99999999999999999999999999987543321
Q ss_pred CcccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 564 GVETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.......+++.|+|||++. ...++.++|||||||++|||++|..||........ .. .+.....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----------~~~~~~~ 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL----------KIAKSEP 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HH----------HHhcCCC
Confidence 1223456889999999984 34578899999999999999999999864332100 00 0000001
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+. ...+......+.+++.+||..+|++||++.++++
T Consensus 233 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11 0112223346889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.71 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=200.0
Q ss_pred eeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
|++.+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++||||+++++++..+...|+||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999954 5788999988655545556789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
++|..++.. ...++++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++....... ...
T Consensus 87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 999988764 346799999999999999999999999 99999999999999999999999999997654322 122
Q ss_pred cccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 567 TRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
....|++.|+|||++. +..++.++|||||||++|||++|+.||........ ... +.....+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~----------~~~~~~~~~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK----------IAKSEPPTL 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH----------HhhcCCCCC
Confidence 3456899999999884 45578899999999999999999999864332110 000 000001110
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+......+.+++.+||+.||.+||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122233568899999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=323.29 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=203.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
..++|++.+.||+|+||.||+|... ++..||+|.+..... .....|.+|+.+++.++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467999999999999999999853 467899998764332 234568899999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCC
Q 004395 477 RLLVYEYICNGSLDSHLYGCH--------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~--------------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp 536 (756)
.++||||+.+++|.+++.... ...+++..++.++.|++.||+|||.. +++||||||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p 158 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLAT 158 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccH
Confidence 999999999999999996321 13578899999999999999999999 999999999
Q ss_pred CceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 004395 537 NNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRP 614 (756)
Q Consensus 537 ~NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 614 (756)
+|||++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986543221 11122335678999999998999999999999999999997 8888853321
Q ss_pred ccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 615 KGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 615 ~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
. +.. ..+.+... ...+......+.+++.+||+.||++|||+.|+++.|+
T Consensus 239 ~------~~~---------~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 E------EVI---------YYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H------HHH---------HHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 000 01111111 0112233457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.86 Aligned_cols=196 Identities=24% Similarity=0.363 Sum_probs=161.6
Q ss_pred EEEecccCceEEEEEEec---CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEe--cCceeEEEEeec
Q 004395 411 ANFLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLVYEYIC 485 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--~~~~~LV~Ey~~ 485 (756)
+..||+|+||.||+|... +++.||+|.+... .....+.+|+++|+.++||||+++++++.. +...|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 357999999999999853 5678999987643 233467899999999999999999998864 44678999998
Q ss_pred CCChhhhhhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee----cCCCcceeecccc
Q 004395 486 NGSLDSHLYGC-------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL----THDFEPLVGDFGL 554 (756)
Q Consensus 486 ggsL~~~L~~~-------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL----~~~~~vkL~DFGl 554 (756)
+++|.+++... ....+++..+..++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 57888877421 123589999999999999999999999 99999999999999 4567899999999
Q ss_pred ceecCCCCC--CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004395 555 ARWQPDGDM--GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNR 613 (756)
Q Consensus 555 A~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 613 (756)
++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 987653321 12234678999999999876 458999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=327.18 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=198.4
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCC--EEEEEEecccC-CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQ--AVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~--~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~L 479 (756)
.++|++.+.||+|+||.||+|... ++. .+|+|.+.... ......|.+|++++.++ +||||+++++++.+++..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357899999999999999999953 454 45777655322 22345788999999999 89999999999999999999
Q ss_pred EEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC
Q 004395 480 VYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~ 545 (756)
||||+.+++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCC
Confidence 999999999999996432 23688999999999999999999999 999999999999999999
Q ss_pred cceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhh
Q 004395 546 EPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWA 624 (756)
Q Consensus 546 ~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~ 624 (756)
.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||...... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~ 233 (303)
T cd05088 162 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY 233 (303)
T ss_pred cEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHH
Confidence 99999999986432111 1111224667999999988889999999999999999998 99998643211 000
Q ss_pred hhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 625 RPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 625 ~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. +.. ......+......+.+++.+||+.+|++||++.+++..|+.
T Consensus 234 ~~------~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 234 EK------LPQ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HH------Hhc----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00 000 00011112233468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.20 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=203.5
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999954 68999999886543 23345688999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.. .++++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999964 3899999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||....+... . ..+.....+.+..
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~----------~~~~~~~~~~~~~ 220 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--L----------FLIPKNNPPSLEG 220 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--H----------HHhhhcCCCCCcc
Confidence 122345688999999999988899999999999999999999999965432110 0 0001111111111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
. .....+.+++.+||..+|++||++.++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 03346889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.30 Aligned_cols=262 Identities=23% Similarity=0.386 Sum_probs=200.9
Q ss_pred hCCeeEEEEecccCceEEEEEEec-----------------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-----------------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVM 466 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-----------------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~ 466 (756)
.++|++.+.||+|+||.||++... ++..||+|.+..... .....|.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998532 244789998765432 23457899999999999999999
Q ss_pred EEEEEEecCceeEEEEeecCCChhhhhhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCC
Q 004395 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCH---------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (756)
Q Consensus 467 l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~---------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~ 537 (756)
+++++..++..++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp~ 159 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATR 159 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCChh
Confidence 9999999999999999999999999986432 13477889999999999999999999 9999999999
Q ss_pred ceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCc
Q 004395 538 NILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT--GRKAVDLNRP 614 (756)
Q Consensus 538 NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt--G~~Pf~~~~~ 614 (756)
|||++.++.++|+|||+++.+..... .......++..|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999986543221 11222345678999999888899999999999999999998 6677753322
Q ss_pred ccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 615 KGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 615 ~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
.. .... ......... .....+ .+..+...+.+++.+||+.||.+||++.+|++.|+
T Consensus 240 ~~--~~~~-~~~~~~~~~-~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQ--VIEN-TGEFFRDQG-RQVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH--HHHH-HHHHHhhcc-ccccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 0000 000000000 000001 11223457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=332.01 Aligned_cols=255 Identities=18% Similarity=0.200 Sum_probs=198.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||++.. .+++.||+|++... .......+..|+.++..++|+||+.+++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999995 46889999987542 1223345888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.||+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999974 245789999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCcccccccCccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQS-----GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
.........||+.|+|||++.+ +.++.++|||||||+||||++|+.||....... ....... ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~----~~- 224 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMN----HE- 224 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHc----CC-
Confidence 3222334579999999999875 567899999999999999999999996433210 0000000 00
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHS--RPRMSQVLRI 677 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~--RPS~~eVL~~ 677 (756)
....+. .........+.+++.+|+..++++ |+++++++++
T Consensus 225 ~~~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ERFQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CcccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000000 111123456888999999866544 4678888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.40 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=202.4
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec--------CCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP--------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~ 472 (756)
...++|.+.+.||+|+||.||+|... .+..||+|.++.... .....+..|++++..+ +||||++++++|.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34468899999999999999999731 245799998764322 2345688999999999 5999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCc
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~N 538 (756)
+....|+||||+.+|+|.+++.... ...+++..+..++.|++.||.|||++ ||+||||||+|
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~N 164 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAARN 164 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----Ceeecccccee
Confidence 9999999999999999999996422 24589999999999999999999999 99999999999
Q ss_pred eeecCCCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 004395 539 ILLTHDFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKG 616 (756)
Q Consensus 539 ILL~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~ 616 (756)
||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999865432211 1112234567999999998899999999999999999999 888885432110
Q ss_pred ccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 617 ~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... ... .. .....+......+.+++.+||..+|++||++.++++.|+.
T Consensus 245 ------~~~-~~~--------~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 245 ------LFK-LLR--------EG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred ------HHH-HHH--------cC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 000 000 00 0011122334468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.43 Aligned_cols=238 Identities=21% Similarity=0.341 Sum_probs=189.0
Q ss_pred EecccCceEEEEEEecC-------------CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 413 FLAEGGFGSVHRGVLPD-------------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~-------------g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.||+|+||.||+|.+.+ ...||+|.+..........|..|+.++..++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998432 23588898765544445578889999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc-------ceeecc
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE-------PLVGDF 552 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~-------vkL~DF 552 (756)
||||+.+++|..++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++. ++++||
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999888864 345799999999999999999999999 9999999999999987664 899999
Q ss_pred ccceecCCCCCCcccccccCccccCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcccccchhhhhhhhhhh
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQ-SGQITEKADVYSFGVVLVELV-TGRKAVDLNRPKGQQCLTEWARPLLEE 630 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELl-tG~~Pf~~~~~~~~~~l~~~~~~~~~~ 630 (756)
|++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||........
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------------- 218 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------------- 218 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------------
Confidence 998754322 2345788999999886 567899999999999999998 58888754321100
Q ss_pred hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 631 ~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
..+...... ........+.+|+.+||+.||.+||++.+|++.|
T Consensus 219 ---~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 ---ERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---HHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000000000 0111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.47 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=190.9
Q ss_pred EecccCceEEEEEEec---CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCC
Q 004395 413 FLAEGGFGSVHRGVLP---DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggs 488 (756)
.||+|+||.||+|.+. ++..+|+|.++.... .....|.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999854 345799998765432 223468889999999999999999999999999999999999999
Q ss_pred hhhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC-
Q 004395 489 LDSHLYGCH---QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG- 564 (756)
Q Consensus 489 L~~~L~~~~---~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~- 564 (756)
|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999996432 23567788889999999999999999 9999999999999999999999999999754432211
Q ss_pred cccccccCccccCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 565 VETRVIGTFGYLAPEYAQSG-------QITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
......|+..|+|||++.+. .++.++||||||+++|||++ |..||........ .. ..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~-----~~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LT-----YTVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HH-----HHhhcccCCC
Confidence 12234578889999988642 35789999999999999996 9999964332110 00 0000000111
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
..+.+. ......+.+++.+|+ .+|++|||+++|++.|+
T Consensus 231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 122211 122345778999999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=332.28 Aligned_cols=243 Identities=23% Similarity=0.281 Sum_probs=191.2
Q ss_pred EEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHH-HHHhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVE-VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~-iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|... +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999954 67899999876432 122234444544 56788999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|.+++.. ...+.+..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 999999863 45688899999999999999999999 99999999999999999999999999997543222 123
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||++|||++|..||....... ... .+.... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~---------~i~~~~--~~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYD---------NILNKP--LQLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHH---------HHHhCC--cCCC
Confidence 45679999999999999999999999999999999999999996433211 000 000000 0112
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
......+.+++.+||+.||.+||++.+.+..+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 23345688999999999999999887544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.25 Aligned_cols=250 Identities=30% Similarity=0.426 Sum_probs=200.7
Q ss_pred eEEEEecccCceEEEEEEecC-----CCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 409 SQANFLAEGGFGSVHRGVLPD-----GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~-----g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.+.+.||.|+||.||++.... +..||+|.+...... ....+..|++++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999643 488999988655433 45689999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999753333399999999999999999999999 99999999999999999999999999998765543
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
........+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ... ......
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~----~~~--~~~~~~-- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VL----EYL--KKGYRL-- 223 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HH----HHH--hcCCCC--
Confidence 222212337789999999988889999999999999999998 788886422110 00 000 000001
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
.........+.+++.+||..||++|||+.++++.|
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 --PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11122345688999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.87 Aligned_cols=262 Identities=26% Similarity=0.342 Sum_probs=204.1
Q ss_pred CChHHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEE-
Q 004395 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCI- 472 (756)
Q Consensus 396 ~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~- 472 (756)
+.+..+....++|++.+.||+|+||.||++.. .+++.+|+|++... ......+..|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34455666788999999999999999999985 46889999987542 22345688899999999 6999999999884
Q ss_pred ----ecCceeEEEEeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc
Q 004395 473 ----EDRRRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (756)
Q Consensus 473 ----~~~~~~LV~Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~ 546 (756)
.+...++||||+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCC
Confidence 345689999999999999987532 345789999999999999999999999 9999999999999999999
Q ss_pred ceeeccccceecCCCCCCcccccccCccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 004395 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS-----GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 547 vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~ 621 (756)
++|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+... +.
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~ 239 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LF 239 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hh
Confidence 99999999986643322 2233468999999998853 4578999999999999999999999864432111 00
Q ss_pred hhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 622 EWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 622 ~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. ......+.. ..+......+.+++.+||+.||++||++.+|++.
T Consensus 240 ~----------~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 K----------IPRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred h----------ccccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000000110 0111123458899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.26 Aligned_cols=255 Identities=19% Similarity=0.220 Sum_probs=197.7
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||++... +++.||+|++... .......+..|+.++..++|+||+.+++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999954 5788999987532 1222345888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999964 345789999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCcccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||....... ........ ....
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~--~~~~ 227 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNH--KERF 227 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCC--Cccc
Confidence 322233457999999999986 3568899999999999999999999996432211 00000000 0000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHS--RPRMSQVLRI 677 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~--RPS~~eVL~~ 677 (756)
..+. ........+.+++.+|+..++++ |+++.+++++
T Consensus 228 ~~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0011 11123456788899988665554 6899998875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.97 Aligned_cols=269 Identities=24% Similarity=0.343 Sum_probs=205.0
Q ss_pred CCeeEEEEecccCceEEEEEEec-----CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEe--cCce
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRR 477 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-----~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--~~~~ 477 (756)
+.|.+.+.||+|+||.||+|.+. ++..||||.+...... ....|..|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46777889999999999999853 3689999988755433 35679999999999999999999999887 5578
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. |++|+||||+|||++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999652 33699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 558 QPDGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 558 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+.................. ....+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM-IVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccc-cHHHHHH
Confidence 6532211 111233556799999998889999999999999999999999998543221110000000000 0000111
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+........+......+.+++.+||..+|++||++.+|++.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 111111111122334578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.30 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=197.8
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR----- 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~----- 475 (756)
..++|.+.+.||+|+||.||++.. .+++.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999984 4688999998764322 23356788999999999999999999886543
Q ss_pred -ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 476 -RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 476 -~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
..|+||||+. ++|.+.+. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 4699999994 57777664 2588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc--hh-------hhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC--LT-------EWAR 625 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~--l~-------~~~~ 625 (756)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .. .+..
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654322 2234578999999999999999999999999999999999999997543211100 00 0000
Q ss_pred ---hhhhhh-----hhhhccCCc-----cC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 ---PLLEEY-----AIDELVDPR-----LG---NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ---~~~~~~-----~i~~l~dp~-----l~---~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+..... ....+..+. .. ..........+.+++.+||..||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 000000000 00 00111123467899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.71 Aligned_cols=246 Identities=28% Similarity=0.379 Sum_probs=195.1
Q ss_pred EEecccCceEEEEEEec--C--CCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVLP--D--GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~--~--g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.+. + +..||+|.+...... ....+.+|+++++.+.|+||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999842 2 368999987754432 3457899999999999999999999876 4568999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
++|.+++.. ...+++..++.++.|++.||+|||.. +++||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999974 34789999999999999999999999 999999999999999999999999999987654332111
Q ss_pred --cccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 567 --TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 567 --~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||....... +..+. ..... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~---------~~~~~----~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAML---------ESGER----L 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH---------HcCCc----C
Confidence 11223567999999999999999999999999999998 999996443210 11110 00000 1
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+......+.+++.+||..+|++||++.++++.|++
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~ 254 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1122233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=343.57 Aligned_cols=266 Identities=23% Similarity=0.270 Sum_probs=209.8
Q ss_pred HHhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-C-----CCeeeEEEEEEec
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-H-----RNVVMLIGFCIED 474 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-H-----pNIV~l~~~~~~~ 474 (756)
+....+|.+.++||+|.||.|-+|. ..+++.||||+++... .-..+...|+.+|..|+ | -|||+++++|...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 3444589999999999999999999 5679999999998543 33445667999999997 4 4899999999999
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC--Ccceeecc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD--FEPLVGDF 552 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~--~~vkL~DF 552 (756)
++.|||+|++ .-+|.++|..+....|+...++.|+.||+.||.+||+. +|||+||||+||||.+- ..+||+||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCCcCceeEEec
Confidence 9999999998 89999999988888999999999999999999999999 99999999999999653 47999999
Q ss_pred ccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh-h------
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA-R------ 625 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~-~------ 625 (756)
|.|++..... ..++.+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+....++....... .
T Consensus 336 GSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 336 GSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred ccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999765432 2667899999999999999999999999999999999999888766654442211100 0
Q ss_pred --------hhhhh-hhh--------------------------hhccCC-c---cCCCCChhHHHHHHHHHHHhcccCCC
Q 004395 626 --------PLLEE-YAI--------------------------DELVDP-R---LGNHYSEHEVYCMLHAASLCIRRDPH 666 (756)
Q Consensus 626 --------~~~~~-~~i--------------------------~~l~dp-~---l~~~~~~~~~~~l~~Li~~CL~~dP~ 666 (756)
.+... ... .+...| . +...........+.+++.+||..||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 00000 000 000001 0 00001112345689999999999999
Q ss_pred CCCCHHHHHHH
Q 004395 667 SRPRMSQVLRI 677 (756)
Q Consensus 667 ~RPS~~eVL~~ 677 (756)
+|+|..|++++
T Consensus 492 ~R~tp~qal~H 502 (586)
T KOG0667|consen 492 ERITPAQALNH 502 (586)
T ss_pred hcCCHHHHhcC
Confidence 99999999985
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=322.33 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=203.4
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|...+.||+|+||.||+|... +++.||+|.+...... ....+..|+++|..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37899999999999999999954 5899999987654322 3456889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.......+++..++.++.|++.||+|||.. |++|+||||+|||++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999999755557899999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC----------------------------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004395 562 DM----------------------------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNR 613 (756)
Q Consensus 562 ~~----------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 613 (756)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10 01123468899999999998889999999999999999999999996443
Q ss_pred cccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 004395 614 PKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR----MSQVLR 676 (756)
Q Consensus 614 ~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS----~~eVL~ 676 (756)
.... +..+................+.+++.+||..||++||+ +.+++.
T Consensus 237 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET---------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH---------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2110 01111111111111114467899999999999999999 777666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=341.03 Aligned_cols=261 Identities=21% Similarity=0.242 Sum_probs=197.1
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
..+|.+.+.||+|+||.||+|... +++.||||... ...+.+|+++|++|+|+|||++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 458999999999999999999954 58899999532 23467899999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+ .++|.+++.. ....+++..++.|+.||+.||.|||+. ||+||||||+||||+.++.++|+|||+++.......
T Consensus 242 ~-~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 Y-RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred c-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 8 5789888864 345799999999999999999999999 999999999999999999999999999986643221
Q ss_pred -CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc-cc-cc---hhhhhhhh----------
Q 004395 564 -GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPK-GQ-QC---LTEWARPL---------- 627 (756)
Q Consensus 564 -~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~-~~-~~---l~~~~~~~---------- 627 (756)
.......||+.|+|||++.+..++.++|||||||+||||++|..++...... .. .. +.......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1223457999999999999999999999999999999999988765322111 00 00 00000000
Q ss_pred -----hhhhhhh--hccCCccCCCCCh---hHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 -----LEEYAID--ELVDPRLGNHYSE---HEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 -----~~~~~i~--~l~dp~l~~~~~~---~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....... ....+........ .....+.+|+.+||+.||.+|||+.|+|++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 0000000000000 112357889999999999999999999984
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.69 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=204.0
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|++.+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+++++.++||||+++++++.....+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 5677888999999999999995 468999999876543 23346789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.. .+.+++..+..++.+++.||.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999998863 457999999999999999999999731 79999999999999999999999999987543221
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... ........ ............
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~ 232 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ--DDPMGILD--LLQQIVQEPPPR 232 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh--hhhhHHHH--HHHHHhhccCCC
Confidence 224568999999999988899999999999999999999999997544321100 00000000 011111111101
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~L 678 (756)
.........+.+++.+||..||++||++.++++..
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01112345688999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.01 Aligned_cols=258 Identities=25% Similarity=0.336 Sum_probs=199.8
Q ss_pred hhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEEEec-
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED- 474 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~- 474 (756)
..++|++.+.||+|+||.||+|.. .+++.||||.++.... .....+.+|+.+|.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346899999999999999999972 3578999998875432 2334688999999999 689999999988654
Q ss_pred CceeEEEEeecCCChhhhhhccC---------------------------------------------------------
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCH--------------------------------------------------------- 497 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~--------------------------------------------------------- 497 (756)
...++||||+.+|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 46789999999999999986421
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC-Ccccc
Q 004395 498 --------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETR 568 (756)
Q Consensus 498 --------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~ 568 (756)
...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12478888999999999999999999 999999999999999999999999999986543221 11122
Q ss_pred cccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCCh
Q 004395 569 VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647 (756)
Q Consensus 569 ~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~ 647 (756)
..++..|+|||++.+..++.++||||||+++|+|++ |..||........ .... +..-..... +.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~------~~~~~~~~~----~~ 305 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRR------LKEGTRMRA----PD 305 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HHHH------HhccCCCCC----CC
Confidence 345678999999998999999999999999999997 9999864322100 0000 000000111 11
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 648 HEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 648 ~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.....+.+++..||+.||++||++.+|++.|+.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 122458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.62 Aligned_cols=265 Identities=25% Similarity=0.329 Sum_probs=203.1
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999954 68899999876432 2334678999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.++.|..++. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998776766554 345689999999999999999999999 99999999999999999999999999998765543
Q ss_pred CCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hhhhhhhhhhhh--------
Q 004395 563 MGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TEWARPLLEEYA-------- 632 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~~~~~~~~-------- 632 (756)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||........... ......+.....
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3233456788999999999887 889999999999999999999999964432111000 000000000000
Q ss_pred h--hhccCCc----cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 633 I--DELVDPR----LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 633 i--~~l~dp~----l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
. .++.... ....++......+.+++.+||..+|++||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0000000 000112223567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=332.63 Aligned_cols=240 Identities=23% Similarity=0.282 Sum_probs=190.3
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHH-HHHhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVE-VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~-iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999994 578999999876432 222334556655 46779999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (325)
T cd05604 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT 153 (325)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence 99998886 456799999999999999999999999 99999999999999999999999999997543221 123
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||++|||++|..||....... .... +..... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~---------~~~~~~--~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDN---------ILHKPL--VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHH---------HHcCCc--cCC
Confidence 45679999999999999999999999999999999999999996443210 0000 000000 111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVL 675 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~eVL 675 (756)
+.....+.+++.+|+..+|.+||++.+.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 12334678899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=330.07 Aligned_cols=237 Identities=22% Similarity=0.291 Sum_probs=188.7
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHH-HHHhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVE-VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~-iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 468999999876432 122334555554 67889999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
++|..++. ....+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99998886 346788999999999999999999999 99999999999999999999999999987543222 223
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....||+.|+|||++.+..++.++|||||||++|||++|..||...... ... ..+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~---------~~i~~~~--~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMY---------DNILHKP--LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHH---------HHHhcCC--CCCC
Confidence 4467999999999999999999999999999999999999999653211 000 0111110 1122
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMS 672 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~ 672 (756)
......+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23345688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.92 Aligned_cols=264 Identities=24% Similarity=0.285 Sum_probs=201.0
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|+....||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999965 689999998764322 223467899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+++++|..++. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999888887765 345699999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hhhhhhhhhh-------hh-
Q 004395 563 MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TEWARPLLEE-------YA- 632 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~~~~~~-------~~- 632 (756)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|..||........... .......... ..
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1 1223457889999999876 5678999999999999999999999975433211000 0000000000 00
Q ss_pred hhhccCCccCCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 633 IDELVDPRLGNHY-----SEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 633 i~~l~dp~l~~~~-----~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
......+...... .......+.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000011110000 0122356889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.79 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=202.7
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999995 478999999876543 22345789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+ +++|.+++... ...+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999998653 36799999999999999999999999 999999999999999999999999999987654432
Q ss_pred CcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hh-hhhhhh------h-hhhh
Q 004395 564 GVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TE-WARPLL------E-EYAI 633 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~-~~~~~~------~-~~~i 633 (756)
.......|+..|+|||++.+. .++.++||||||+++|||++|.++|........... .. ...+.. . ....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 223345689999999988654 468999999999999999999888864432111000 00 000000 0 0000
Q ss_pred hhccCCccC----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPRLG----NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~l~----~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+..+... ....+.....+.+++.+||..+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 00111234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=311.30 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=204.1
Q ss_pred hCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCc----Cc----hhHHHHHHHHHhcC-CCCeeeEEEEEEec
Q 004395 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ----GD----HEFCSEVEVLSCAQ-HRNVVMLIGFCIED 474 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~----~~----~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~ 474 (756)
-..|...+.||.|..+.|-++. ..+|..+|+|++...... .. +.-.+|+.||+++. ||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3467777889999999998887 457889999987644321 11 23566999999985 99999999999999
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
..+++|+|.|+.|.|.|+|. ..-.+++...++|+.|+.+|++|||.. +||||||||+|||++++.+++|+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999997 456799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQS------GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL 628 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 628 (756)
|+.+..+. .....+|||+|+|||.+.. ..|+..+|+|++|+++|-|+.|.+||-.. ..+
T Consensus 170 a~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------------kQm 234 (411)
T KOG0599|consen 170 ACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------------KQM 234 (411)
T ss_pred eeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------------HHH
Confidence 99887765 4567899999999998853 56888999999999999999999998421 111
Q ss_pred hhh-hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 629 EEY-AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 629 ~~~-~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
-.. -+.+- .-.+......+......+||.+||+.||.+|.|+.|+|++
T Consensus 235 lMLR~ImeG-kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 235 LMLRMIMEG-KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHHhc-ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 100 00000 0111222233445568899999999999999999999883
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=320.99 Aligned_cols=195 Identities=25% Similarity=0.365 Sum_probs=160.5
Q ss_pred EEEecccCceEEEEEEec---CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEe--cCceeEEEEeec
Q 004395 411 ANFLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLVYEYIC 485 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--~~~~~LV~Ey~~ 485 (756)
+..||+|+||.||+|... ++..||+|.+... .....+.+|+++|+.++||||+++++++.. +...++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA- 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee-
Confidence 357999999999999954 4578999987643 233468899999999999999999998854 45789999998
Q ss_pred CCChhhhhhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee----cCCCcceeecccc
Q 004395 486 NGSLDSHLYGC-------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL----THDFEPLVGDFGL 554 (756)
Q Consensus 486 ggsL~~~L~~~-------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL----~~~~~vkL~DFGl 554 (756)
+++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 56887776421 223588999999999999999999999 99999999999999 5667999999999
Q ss_pred ceecCCCCC--CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004395 555 ARWQPDGDM--GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLN 612 (756)
Q Consensus 555 A~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~ 612 (756)
++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 987654321 12234578999999999876 45799999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=333.47 Aligned_cols=261 Identities=24% Similarity=0.307 Sum_probs=197.0
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEec-----
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED----- 474 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~----- 474 (756)
...++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++|+.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999984 5788999998764322 2334677899999999999999999987643
Q ss_pred -CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 475 -RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 475 -~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
...|++++++ +++|.+++. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 899988874 45799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh----h--
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR----P-- 626 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----~-- 626 (756)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +..+.. +
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 237 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPSP 237 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence 99865432 234578999999999876 5689999999999999999999999965432111 000000 0
Q ss_pred -hhh---hhhhhhccC--CccCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 627 -LLE---EYAIDELVD--PRLGN----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 627 -~~~---~~~i~~l~d--p~l~~----~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
... ......... +.... .........+.+|+.+||..||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000000 00000 0000112347799999999999999999999873
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=312.97 Aligned_cols=237 Identities=24% Similarity=0.393 Sum_probs=188.9
Q ss_pred EecccCceEEEEEEecC-C----------CEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 413 FLAEGGFGSVHRGVLPD-G----------QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~-g----------~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.||+|+||.||+|...+ + ..|++|.+...... ...|.+|+.+++.++||||+++++++.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 69999999999999653 3 25788876544333 5789999999999999999999999988 7789999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-------cceeecccc
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-------EPLVGDFGL 554 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-------~vkL~DFGl 554 (756)
||+.+|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .++|+|||+
T Consensus 80 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999752 33789999999999999999999998 999999999999999888 799999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSG--QITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEY 631 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 631 (756)
+..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||........ ... .
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~------~~~----~ 219 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK------ERF----Y 219 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH------HHH----H
Confidence 986543 1234467889999999876 78999999999999999999 5777754321110 000 0
Q ss_pred hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 632 AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 632 ~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
. .. ...+......+.+++.+||..+|.+||++.++++.|+
T Consensus 220 ~-----~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 Q-----DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred h-----cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 0001111156889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.72 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=197.7
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEec------
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------ 474 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~------ 474 (756)
..++|.+.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 346899999999999999999994 468899999876432 22345688899999999999999999987643
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
...|+||||+ +++|.+.+. ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~-~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELM-DANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCC-CCCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 3579999999 467777774 2488899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc--hh-------hhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC--LT-------EWAR 625 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~--l~-------~~~~ 625 (756)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +. .+..
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98654322 2234578999999999999999999999999999999999999997543221100 00 0000
Q ss_pred hh---hhhh----------hhhhccCCcc---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 PL---LEEY----------AIDELVDPRL---GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ~~---~~~~----------~i~~l~dp~l---~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+ .... ....+..... ...........+.+++.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0000 0000000000 000111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=310.78 Aligned_cols=247 Identities=26% Similarity=0.357 Sum_probs=201.2
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-----cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-----QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-----~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
+|+..+.||+|+||.||+|... ++..|++|.+..... .....+.+|+++++.++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999965 789999998764332 2345688999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+. ||+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999963 35689999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCcccccccCccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQ-ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
.. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||....... ... .....
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~----------~~~~~--- 217 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVF----------KIGRS--- 217 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHH----------HHHhc---
Confidence 32 223456899999999987766 8999999999999999999999996433110 000 00000
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
......+......+.+++.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0011122233456889999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.37 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=203.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
++|.+.+.||.|+||.||+|.. .++..||+|.+..........|..|+++++.++||||+++++++..+...|+||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 5688889999999999999995 468999999887665555567999999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|.+++.. ....+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 85 DGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999864 345799999999999999999999999 999999999999999999999999999875543221
Q ss_pred cccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 565 VETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
......|++.|+|||++. ...++.++||||||+++|||++|+.||....... .... +.....+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~----------~~~~~~~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLK----------ILKSEPP 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHH----------HhcCCCC
Confidence 223456899999999874 3457789999999999999999999996432210 0000 0000011
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+ ..+......+.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11 1112233468899999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.32 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=204.3
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|++.+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999984 478999999876432 22345789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999999754455789999999999999999999998 999999999999999999999999999986644321
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||....... .. ....... ..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~---------~~~~~~~-~~ 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LV---------LKIIRGS-YP 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HH---------HHHhcCC-CC
Confidence 1223458899999999998889999999999999999999999986432210 00 0111100 01
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+......+.+++.+||+.+|++||++.+|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122334568999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.80 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=203.6
Q ss_pred ChHHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEe-
Q 004395 397 SYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE- 473 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~- 473 (756)
+..++....+.|++.+.||.|+||.||+|.. .+++.||+|++.... .....+..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3444555667899999999999999999995 578999999876443 2345688899999998 69999999999853
Q ss_pred -----cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcce
Q 004395 474 -----DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548 (756)
Q Consensus 474 -----~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vk 548 (756)
....|++|||+.+|+|.+++.......+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999999765556789999999999999999999999 999999999999999999999
Q ss_pred eeccccceecCCCCCCcccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhh
Q 004395 549 VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW 623 (756)
Q Consensus 549 L~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~ 623 (756)
|+|||++....... .......|++.|+|||++. ...++.++|||||||++|||++|..||....+....
T Consensus 162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 99999987553221 1223456899999999875 356788999999999999999999999643321110
Q ss_pred hhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 624 ~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..+.....+.. ........+.+++.+||..||.+||++.+|++
T Consensus 236 -------~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -------FLIPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------hhHhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00011111111 11123356899999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.73 Aligned_cols=261 Identities=28% Similarity=0.352 Sum_probs=205.0
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec--------CCCEEEEEEecccC-CcCchhHHHHHHHHHhc-CCCCeeeEEEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP--------DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGF 470 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~ 470 (756)
+++...+|.+.+.||+|+||.||+|... .+..||+|.++... ......+.+|++++.++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 4455568999999999999999999732 12368999876432 22345788999999999 79999999999
Q ss_pred EEecCceeEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCC
Q 004395 471 CIEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (756)
Q Consensus 471 ~~~~~~~~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp 536 (756)
|......+++|||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlkp 162 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLAA 162 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----Ceecccccc
Confidence 999999999999999999999986421 23588899999999999999999999 999999999
Q ss_pred CceeecCCCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 004395 537 NNILLTHDFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRP 614 (756)
Q Consensus 537 ~NILL~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 614 (756)
+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999866443211 1122334567999999999999999999999999999998 8888854321
Q ss_pred ccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 615 KGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 615 ~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
. .+..... . ......+......+.+++.+||+.+|++||++.+++..|+..
T Consensus 243 ~------~~~~~~~---------~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 243 E------ELFKLLK---------E-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred H------HHHHHHH---------c-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1 1111000 0 001111223345688999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.29 Aligned_cols=239 Identities=22% Similarity=0.355 Sum_probs=187.9
Q ss_pred EecccCceEEEEEEecC-------------------------CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeE
Q 004395 413 FLAEGGFGSVHRGVLPD-------------------------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~-------------------------g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l 467 (756)
.||+|+||.||+|.+.. ...||+|.+..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588888765444444578899999999999999999
Q ss_pred EEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC--
Q 004395 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-- 545 (756)
Q Consensus 468 ~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-- 545 (756)
+++|.++...++||||+.+|+|..++.. ..+.+++..+..++.||++||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998864 356789999999999999999999999 999999999999997654
Q ss_pred -----cceeeccccceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCccccc
Q 004395 546 -----EPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELV-TGRKAVDLNRPKGQQ 618 (756)
Q Consensus 546 -----~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELl-tG~~Pf~~~~~~~~~ 618 (756)
.++++|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||....+...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 3799999998644322 12347888999998865 56899999999999999994 69998864432111
Q ss_pred chhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 619 CLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 619 ~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
..+ ... .... +......+.+++.+||+.+|++||++.+|++.|.
T Consensus 231 --~~~---------~~~--~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ERF---------YEK--KHRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHH---------HHh--ccCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 000 000 0001 1111235889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.11 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=202.6
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|...+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+++|++++||||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999985 478899999876432 22345788999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC-CcceeeccccceecCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~-~~vkL~DFGlA~~~~~~~ 562 (756)
+.+++|.+++.......+++..+..++.|++.||.|||++ ||+|+||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999765556789999999999999999999999 99999999999999865 467999999998765432
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||........ .... .... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~-----~~~~-~---- 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKI-----MSGT-F---- 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHH-----HhcC-C----
Confidence 12235688999999999988899999999999999999999999865432110 0000 0000 0
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...+......+.+++.+||..+|++|||+.++++.
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11112234468899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=315.91 Aligned_cols=246 Identities=28% Similarity=0.376 Sum_probs=192.0
Q ss_pred EecccCceEEEEEEec-CCC--EEEEEEecccC-CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 413 FLAEGGFGSVHRGVLP-DGQ--AVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~-~g~--~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
.||+|+||.||+|... ++. .+|+|.++... ......+..|++++.++ +||||++++++|...+..|+||||+.+|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999964 444 46888766332 23345788999999999 7999999999999999999999999999
Q ss_pred ChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 488 SLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 488 sL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
+|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+|||++.++.+||+|||
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCCC
Confidence 9999986422 13588999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~----- 224 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKL----- 224 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHH-----
Confidence 986322111 1111223567999999988899999999999999999997 99999543211 000000
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. .......+......+.+++.+||..+|.+|||+.+++..|+.
T Consensus 225 -~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 225 -P----QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred -h----CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 0 000011112233468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=315.71 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=203.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
..|+..+.||.|+||.||+|.. .++..||+|.+.... ......+.+|+++++.+.||||+++++++.++...|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3577778899999999999995 468899999876443 23345788999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++. ..++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999985 35789999999999999999999999 999999999999999999999999999986644322
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......++..|+|||++.+..++.++|+|||||++|||++|..||....+.... .........
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCCCC
Confidence 123346888999999999888999999999999999999999998644321110 000111112
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.........+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2333455678899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.92 Aligned_cols=263 Identities=21% Similarity=0.295 Sum_probs=194.8
Q ss_pred EEEEeccc--CceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 410 QANFLAEG--GFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 410 ~~~~LG~G--~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
+.++||+| +||+||++.. .+|+.||+|++..... .....+.+|+++++.++||||++++++|..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34679999 7899999984 5799999998865432 22345778999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999654456699999999999999999999999 9999999999999999999999999876533221110
Q ss_pred ------cccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh---hhh--h
Q 004395 565 ------VETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL---LEE--Y 631 (756)
Q Consensus 565 ------~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~---~~~--~ 631 (756)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ......... ... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCccccccccch
Confidence 0112346788999999976 4689999999999999999999999964322110 000000000 000 0
Q ss_pred hhhhc--------cCC-----------------ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 632 AIDEL--------VDP-----------------RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 632 ~i~~l--------~dp-----------------~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...++ .+. .....+.......+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000 000 00001112234568899999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.79 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=197.7
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-----cCchhHHHHHHHHHhcCCCCeeeEEEEEEec--Cce
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-----QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRR 477 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-----~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~ 477 (756)
.+|.+.+.||+|+||.||+|.. .+|..||||.+..... .....+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4789999999999999999995 4689999998754321 1234688899999999999999999998764 467
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999863 35688999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC--CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 558 QPDGDM--GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 558 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||........ +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---------------~~~ 220 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---------------IFK 220 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---------------HHH
Confidence 542211 112234688999999999888899999999999999999999999964321100 011
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..........+......+.+++.+|+ .+|++||+++++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 221 IATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred HhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 11111111223344456788999998 499999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.88 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=200.5
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++..+...|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 355667799999999999985 468899999876443 223456889999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|.+++. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999999884 35789999999999999999999999 999999999999999999999999999986543321
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....+... . ..+.....+ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~---------~~~~~~~~~----~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L---------FLIPKNSPP----T 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H---------hhhhcCCCC----C
Confidence 12234688999999999998999999999999999999999999864322110 0 000111111 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 222334568899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.64 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=205.6
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|++.+.||.|+||.||+|.. .++..+|+|++..... .....+.+|+++|+.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4789999999999999999995 4688999998764432 2456789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 484 ICNGSLDSHLYGCHQ-EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~-~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
+.+++|.+++..... ..+++..+..++.|++.||+|||+. ||+||||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975333 5789999999999999999999999 99999999999999999999999999998665433
Q ss_pred CC---cccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 563 MG---VETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 563 ~~---~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.. ......|+..|+|||++... .++.++|+|||||++|+|++|+.||....... .+..... ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~----------~~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQ----------NDP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhc----------CCC
Confidence 22 22345689999999998776 78999999999999999999999996443211 0110000 001
Q ss_pred CccCCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHY-SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~-~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+.+.... .......+.+++.+||..||++||++.+|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111100 11334568899999999999999999999873
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=314.35 Aligned_cols=251 Identities=27% Similarity=0.356 Sum_probs=187.9
Q ss_pred EecccCceEEEEEEecC---CCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCC
Q 004395 413 FLAEGGFGSVHRGVLPD---GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~---g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggs 488 (756)
.||+|+||.||+|...+ ...+|+|.+..... .....|.+|+++++.++||||+++++++.+....|+||||+.+|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997433 35788887654322 223568899999999999999999999999999999999999999
Q ss_pred hhhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC-C
Q 004395 489 LDSHLYGCH---QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-G 564 (756)
Q Consensus 489 L~~~L~~~~---~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~-~ 564 (756)
|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999996532 23456788899999999999999999 999999999999999999999999999875433221 1
Q ss_pred cccccccCccccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 565 VETRVIGTFGYLAPEYAQS-------GQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
......++..|+|||++.. ..++.++|||||||++|||++ |..||........ +. ..... ....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~~~~-~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LK----QVVRE-QDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HH----HHhhc-cCccC
Confidence 1123346778999998743 456889999999999999999 7888854322110 00 00000 00111
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
..+. .+......+.+++..|+ .||++||++.+|++.|.
T Consensus 231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1121 22233345677888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=312.05 Aligned_cols=248 Identities=26% Similarity=0.335 Sum_probs=190.3
Q ss_pred EEecccCceEEEEEEec----CCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEE-ecCceeEEEEeec
Q 004395 412 NFLAEGGFGSVHRGVLP----DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCI-EDRRRLLVYEYIC 485 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~-~~~~~~LV~Ey~~ 485 (756)
+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999843 24579999875332 233457889999999999999999999876 4556899999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC--
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-- 563 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~-- 563 (756)
+++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999643 34567888899999999999999999 999999999999999999999999999975543211
Q ss_pred -CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 564 -GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG-RKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 564 -~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.......++..|+|||++.+..++.++|||||||++|||++| .+||...... ..... ......+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~~~~~------~~~~~~~~- 222 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------DITVY------LLQGRRLL- 222 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH------HhcCCCCC-
Confidence 111233467789999999888999999999999999999995 5555432111 00000 00000111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+...+..+.+++..||..+|++||++.+|+..|+.
T Consensus 223 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 223 ---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=317.51 Aligned_cols=262 Identities=20% Similarity=0.255 Sum_probs=197.6
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|.+.+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588899999999999999995 4789999998764322 2234678899999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+. ++|.+++.. ....+++..++.++.||++||.|||+. +|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 95 688887754 346799999999999999999999999 999999999999999999999999999986543221
Q ss_pred CcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh--hhhh---hhhhcc
Q 004395 564 GVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL--LEEY---AIDELV 637 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~--~~~~---~i~~l~ 637 (756)
......+++.|+|||++.+. .++.++|||||||++|+|+||..|+........ .+....... .... .+....
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHHhHHhhhcc
Confidence 12334578999999988764 478999999999999999999998643222111 000000000 0000 000000
Q ss_pred CCccC---------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 638 DPRLG---------NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 638 dp~l~---------~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+.... ..........+.+++.+||+.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 0111223456889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.08 Aligned_cols=247 Identities=29% Similarity=0.440 Sum_probs=195.6
Q ss_pred EecccCceEEEEEEecC-------CCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 413 FLAEGGFGSVHRGVLPD-------GQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~-------g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.||+|+||.||+|...+ ++.+|+|.+.... ......|.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 59999999999998532 2579999765432 233557899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-----cceeecccc
Q 004395 485 CNGSLDSHLYGC-----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-----EPLVGDFGL 554 (756)
Q Consensus 485 ~ggsL~~~L~~~-----~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-----~vkL~DFGl 554 (756)
.+++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+|||++.++ .++|+|||+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999643 223478999999999999999999998 999999999999999887 899999999
Q ss_pred ceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 555 ARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 555 A~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~----------~~~-- 225 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV----------LQH-- 225 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH----------HHH--
Confidence 9865433211 1122345788999999999999999999999999999998 9999864322100 000
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
+........+...+..+.+++.+||..+|++||++.+|++.|+
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 ----VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000011112233456889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.30 Aligned_cols=264 Identities=25% Similarity=0.362 Sum_probs=201.0
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+++++.++||||+++++++..+...|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999965 6899999986543222 24568899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|..+.. ....+++..++.++.|++.||+|||+. ||+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999988888765 334589999999999999999999999 99999999999999999999999999998764433
Q ss_pred CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhhhhhh-------hhh-
Q 004395 563 MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWARPLLE-------EYA- 632 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~~~~~-------~~~- 632 (756)
.......++..|+|||++.+ ..++.++||||||+++|||++|++||.......... ...+...+.. ...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22234568899999999875 457889999999999999999999986443211100 0000000000 000
Q ss_pred hhhccCCccCC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 633 IDELVDPRLGN-----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 633 i~~l~dp~l~~-----~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
......+.... ...+.....+.+++.+||..+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000010000 011123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=314.80 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=201.5
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCC----EEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
..+|++.+.||+|+||.||+|... +|. .+|+|....... .....+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 357889999999999999999853 343 589997765433 234578899999999999999999999987 7889
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999975 345699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCc-ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 559 PDGDMGV-ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 559 ~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
....... .....++..|+|||.+....++.++|+||||+++|||++ |+.||....... +.. .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~------~~~~- 226 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPD------LLEK- 226 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHH------HHhC-
Confidence 5332111 111223567999999988899999999999999999998 999996543211 000 0000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
......+......+.+++.+||..||+.||++.++++.|+.
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~ 267 (279)
T cd05057 227 ---GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267 (279)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 00011112233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=317.02 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=205.8
Q ss_pred hCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.+.|++.+.||+|.|+.||++. .++|+.+|+|+++.. ...+.+++.+|+.|-+.|+|||||+|.+.+.+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4578888899999999999988 568999999987543 2335678999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---CCcceeeccccceec
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQ 558 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~~~vkL~DFGlA~~~ 558 (756)
|+|.|++|..-+..+ .-+++..+-.++.||++||.|+|.+ +|||||+||.|+||.. ..-+||+|||+|...
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999997766532 5678888999999999999999999 9999999999999954 345899999999988
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.++. ....++|||.|||||++...+|+..+|||+.|||||-|+.|.+||...... .+. + ..... +
T Consensus 164 ~~g~--~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rly-------e-~I~~g--~ 228 (355)
T KOG0033|consen 164 NDGE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY-------E-QIKAG--A 228 (355)
T ss_pred CCcc--ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHH-------H-HHhcc--c
Confidence 7433 456788999999999999999999999999999999999999999643211 111 0 00011 1
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
-.....+..+......+|+.+||..||.+|.|+.|.|.+
T Consensus 229 yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 229 YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 111222334455578899999999999999999999874
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.00 Aligned_cols=256 Identities=22% Similarity=0.351 Sum_probs=204.3
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecc--cCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCce
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~--~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~ 477 (756)
+.+....|++++.||+||.+.||++...+.+.||+|++.. ...+....|++|++.|.+|+ |.+|++||+|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 4455678999999999999999999988889999986543 34455678999999999996 99999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|||||| -+.+|..+|.........| .+..+..|++.|+.++|.+ ||||.||||+|+|+- .|.+||+|||+|..
T Consensus 436 YmvmE~-Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMEC-GDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEEeec-ccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 999998 4789999997644433334 8889999999999999999 999999999999995 47999999999997
Q ss_pred cCCCCCC-cccccccCccccCccccccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh
Q 004395 558 QPDGDMG-VETRVIGTFGYLAPEYAQSGQ-----------ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 558 ~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~-----------~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 625 (756)
....... ....-+||+.||+||.+.... .+.++||||||||||+|+.|+.||..... .|
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~-- 579 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QI-- 579 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HH--
Confidence 7654322 233468999999999885422 56789999999999999999999963321 11
Q ss_pred hhhhhhhhhhccCCccCCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEH-EVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~-~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+..+.+|...-.|+.. ...++.+++..||++||++||++.++|+.
T Consensus 580 -----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 -----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 123444555333233322 12238999999999999999999999984
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.97 Aligned_cols=239 Identities=20% Similarity=0.354 Sum_probs=189.0
Q ss_pred EecccCceEEEEEEec-C-------CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 413 FLAEGGFGSVHRGVLP-D-------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~-~-------g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.||+|+||.||+|... . ...||+|.+..........+..|+.+++.++||||+++++++..+...++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 5999999999999853 2 2348888765444444567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc--------ceeeccccce
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE--------PLVGDFGLAR 556 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~--------vkL~DFGlA~ 556 (756)
.+|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++. ++++|||++.
T Consensus 82 ~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999753 34689999999999999999999999 9999999999999988765 5899999987
Q ss_pred ecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGR-KAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~-~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
..... ....++..|+|||++.+ ..++.++||||||+++|||++|. .||....+... .... .
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------~~~~-----~ 219 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------LQFY-----E 219 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------HHHH-----H
Confidence 54332 23457889999999976 45799999999999999999995 55543221100 0000 0
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
. . ...+......+.+++.+||+.||++|||++++++.|+
T Consensus 220 ~--~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 D--R----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c--c----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 1122223356889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=355.16 Aligned_cols=257 Identities=22% Similarity=0.295 Sum_probs=201.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....|.+|+++++.++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5899999999999999999995 46899999988643222 2346899999999999999999999999999999999
Q ss_pred EeecCCChhhhhhcc---------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecc
Q 004395 482 EYICNGSLDSHLYGC---------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~---------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
||++||+|.+++... ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.++|+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEec
Confidence 999999999988531 123466778899999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCC-----------------CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc
Q 004395 553 GLARWQPDGD-----------------MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPK 615 (756)
Q Consensus 553 GlA~~~~~~~-----------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 615 (756)
|+++...... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998652110 01112357999999999999999999999999999999999999999643211
Q ss_pred cccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhc
Q 004395 616 GQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP-RMSQVLRILEG 680 (756)
Q Consensus 616 ~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-S~~eVL~~Le~ 680 (756)
... .. ..+..+..... ....+..+.+++.+||+.||++|| +++++++.|+.
T Consensus 238 ki~----------~~---~~i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 238 KIS----------YR---DVILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhh----------hh---hhccChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 00 00011100000 012334688999999999999996 56667666654
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=312.12 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=195.0
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-----cCchhHHHHHHHHHhcCCCCeeeEEEEEEec--Cce
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-----QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRR 477 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-----~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~ 477 (756)
.+|...+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999985 4689999998764321 1234588899999999999999999998753 567
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
+++|||+.+++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999963 45689999999999999999999998 999999999999999999999999999975
Q ss_pred cCCCC--CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 558 QPDGD--MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 558 ~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||........ +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---------------~~~ 220 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---------------IFK 220 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---------------HHH
Confidence 53211 1111234588999999999988899999999999999999999999964321100 000
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..........+......+.+++ +||..+|++||++.+|++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 221 IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000001112223334566677 688889999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.11 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=202.2
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|...+.||+|+||.||+|.. .+++.||+|.+...... ....+..|+++++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588899999999999999985 47899999988765443 456789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.. ...+++..+..++.|++.||.|||+. ||+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999973 45688999999999999999999999 999999999999999999999999999987654332
Q ss_pred Ccc---cccccCccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 564 GVE---TRVIGTFGYLAPEYAQSGQ---ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 564 ~~~---~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||........ .. ..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-------~~----~~~~~~~ 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-------IM----FHVGAGH 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-------HH----HHHhcCC
Confidence 211 1356788999999998766 88999999999999999999999964321100 00 0000000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+.+.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111 1112345789999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=312.16 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=199.7
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc----------CchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ----------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~----------~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
+|...+.||.|+||.||+|.. .+|+.||+|.++..... ..+.+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578889999999999999984 46899999987542211 1235778999999999999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999974 36799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC-CcccccccCccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 556 RWQPDGDM-GVETRVIGTFGYLAPEYAQSGQ--ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 556 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
+....... .......|+..|+|||++.... ++.++|+||||+++|+|++|..||........ +.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~----~----- 224 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFK----L----- 224 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHH----h-----
Confidence 76543211 1123356889999999987654 78999999999999999999999853221100 000 0
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
......+.+...........+.+++..||..+|++||++.+|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000011111111222334578899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.29 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=201.8
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEe--cCceeEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLVY 481 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--~~~~~LV~ 481 (756)
+|++.+.||.|+||.||++.. .+|+.||+|.+..... .....+..|+++++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 488899999999999999984 5788999998764322 234568889999999999999999998764 34679999
Q ss_pred EeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 482 EYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLH-----EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH-----~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
||+.+++|.+++... ...++++..++.++.||+.||.||| +. +++|+||||+||+++.++.++|+|||+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~----~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN----TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC----cceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999998642 2467999999999999999999999 76 899999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
+........ ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...... ... .
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~----~----- 220 (265)
T cd08217 157 AKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLA----S----- 220 (265)
T ss_pred cccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHH----H-----
Confidence 987654332 123456899999999999888999999999999999999999999754311 000 0
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+........+......+.+++.+||..+|++||++.+|+++
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 -KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 001111112233444678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=311.24 Aligned_cols=253 Identities=28% Similarity=0.398 Sum_probs=201.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecC------
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDR------ 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~------ 475 (756)
.+++|++.+.||+|+||.||+|... +++.+++|++..... ....+.+|+.+++++ .|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999964 678999998765433 346789999999999 6999999999997654
Q ss_pred ceeEEEEeecCCChhhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~--~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
..|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999986433 56899999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCcccccccCccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQS-----GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL 628 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 628 (756)
++....... .......|+..|+|||++.. ..++.++|||||||++|+|++|..||........ +.
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~------- 228 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF------- 228 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH-------
Confidence 998654322 22234568999999998753 3467899999999999999999999964321100 00
Q ss_pred hhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 629 ~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+.....+.. .........+.+++.+||..||++|||+.++++
T Consensus 229 ---~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 ---KIPRNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---HhhccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0011001111 111223456889999999999999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=316.85 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=199.4
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
+|++.+.||+|+||.||++... +|..||+|.+.... ......+.+|++++.+++||||+++++++......|+||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788899999999999999964 78999999876532 223457889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 485 CNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 485 ~ggsL~~~L~~~-~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
.+++|..++... ....+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.++|+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999888642 1347999999999999999999999632 89999999999999999999999999997654322
Q ss_pred CcccccccCccccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 564 GVETRVIGTFGYLAPEYAQSG------QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
.....|++.|+|||++.+. .++.++|||||||++|+|++|..||........ .. .+....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------~~------~~~~~~ 223 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI------FA------QLSAIV 223 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH------HH------HHHHHh
Confidence 2234588899999998553 358899999999999999999999964321100 00 001111
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.. .....+......+.+++.+||..+|++||++.+++.
T Consensus 224 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11 011122334556889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.89 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=200.1
Q ss_pred CeeEEEEecccCceEEEEEEecC--CCEEEEEEecccCC----------cCchhHHHHHHHHHh-cCCCCeeeEEEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVLPD--GQAVAVKQHKLASS----------QGDHEFCSEVEVLSC-AQHRNVVMLIGFCIE 473 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~--g~~VAVK~~~~~~~----------~~~~~f~~Ev~iL~~-L~HpNIV~l~~~~~~ 473 (756)
+|++.+.||+|+||.||+|.... ++.+|+|.+..... .....+..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999654 78899997653321 122357778888875 789999999999999
Q ss_pred cCceeEEEEeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecCCCcceee
Q 004395 474 DRRRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~~~~vkL~ 550 (756)
++..++||||+++++|.+++.. .....+++..++.++.|++.||.|||. . +++|+||+|+|||++.++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK----RIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC----ceeecCCCHHHEEECCCCcEEEe
Confidence 9999999999999999998843 234679999999999999999999996 5 79999999999999999999999
Q ss_pred ccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhh
Q 004395 551 DFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630 (756)
Q Consensus 551 DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 630 (756)
|||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....... .....
T Consensus 157 dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~--- 225 (269)
T cd08528 157 DFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKI--- 225 (269)
T ss_pred cccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHH---
Confidence 999998655432 2344568999999999998889999999999999999999999986432110 00000
Q ss_pred hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 631 ~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
......+.. .......+.+++.+||+.||++||++.++..+++
T Consensus 226 --~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 --VEAVYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --hhccCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 001111111 1122346889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=311.29 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=201.6
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc------CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~------~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+++|+.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999984 67899999987643311 23568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-cceeeccccceec
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQ 558 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-~vkL~DFGlA~~~ 558 (756)
||||+.+++|.+++.. .+++++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999963 45789999999999999999999999 999999999999998776 5999999999866
Q ss_pred CCCCCC---cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 559 PDGDMG---VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 559 ~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
...... ......|+..|+|||++.+..++.++||||||+++|+|++|..||......... . . +..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~-~---------~~~ 222 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--A-L---------IFK 222 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--H-H---------HHH
Confidence 533211 122356889999999998888999999999999999999999999643221110 0 0 001
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..........+......+.+++.+||..+|++||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00001112233334457889999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.60 Aligned_cols=262 Identities=27% Similarity=0.358 Sum_probs=204.6
Q ss_pred CChHHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 004395 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE 473 (756)
Q Consensus 396 ~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~ 473 (756)
+.+.++....++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34455666788999999999999999999995 578999999876432 2345678899999999 79999999999875
Q ss_pred c-----CceeEEEEeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc
Q 004395 474 D-----RRRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (756)
Q Consensus 474 ~-----~~~~LV~Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~ 546 (756)
. ...|+||||+.+++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCC
Confidence 4 3589999999999999988532 346789999999999999999999999 9999999999999999999
Q ss_pred ceeeccccceecCCCCCCcccccccCccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 004395 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG-----QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 547 vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~ 621 (756)
++|+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||........ +.
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 999999999865433221 2234688999999988643 368899999999999999999999864322100 00
Q ss_pred hhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 622 EWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 622 ~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. +.....+.+ ..+......+.+++.+||+.+|++||++.++++.
T Consensus 244 ~----------~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 K----------IPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H----------HhcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 000001111 1112233468899999999999999999999873
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=337.09 Aligned_cols=245 Identities=28% Similarity=0.409 Sum_probs=206.5
Q ss_pred CeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcC---chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~---~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.|.-++.||.|+||.||.|+ ..+.+.||||++.....+. ..+++.|+..|.++.|||++.+.|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 45666789999999999999 4578999999987765544 4578899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|| -|+-.|++.- ..+++.+..+..|+.+.+.||+|||++ +.||||||..||||++.|.|||+|||.|....+
T Consensus 107 YC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 98 6888888854 568999999999999999999999999 999999999999999999999999999975543
Q ss_pred CCcccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 563 MGVETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
.+.++|||.|||||++. .+.|+-++||||||++..||.-.++|+..... +..-+.+...-.|
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------------MSALYHIAQNesP 243 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYHIAQNESP 243 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------------HHHHHHHHhcCCC
Confidence 45789999999999884 58899999999999999999999999743221 1122233333344
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+. ..+....+.+++..||+.-|.+|||..+++++
T Consensus 244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 443 44566789999999999999999999999764
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.34 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=206.7
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.+|++.+.||+|++|.||+|... +++.||+|++..... .....+..|+.++..++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36889999999999999999965 599999998876543 3456799999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
+.+++|.+++.. ...+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999974 3679999999999999999999999 8 99999999999999999999999999998765433
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .+ .. ..+.....
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~----~~-----~~~~~~~~- 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FE----LM-----QAICDGPP- 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HH----HH-----HHHhcCCC-
Confidence 22 2345688999999999988999999999999999999999999975542110 00 00 11111100
Q ss_pred CCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 643 NHYSEH-EVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~-~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...+.. ....+.+++.+||..+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111222 34578999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.56 Aligned_cols=255 Identities=22% Similarity=0.281 Sum_probs=201.7
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+++++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3689999999999999999995 4688999998765432 23346888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.|++|.+++.. .+.+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999964 45789999999999999999999999 9999999999999999999999999998742110
Q ss_pred C--------------CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh
Q 004395 562 D--------------MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 562 ~--------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
. ........|+..|+|||++.+..++.++|+|||||++|||++|..||....+. .+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~---- 224 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------EL---- 224 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH----
Confidence 0 00112245788999999998888999999999999999999999999643211 00
Q ss_pred hhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 628 ~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...........+... ......+.+++.+||+.||++||++..+++.|+.
T Consensus 225 ~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 225 FGQVISDDIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHhcccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000000111111111 1233468899999999999999998777777664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.78 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=198.0
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+++|.+.+.||+|+||.||+|.. .+|..||+|.+...... ....+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46899999999999999999985 46899999987654332 23467889999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+ +++|.+++.. ....+++..+..++.|++.||.|||.. ||+|+||||+|||++.++.++|+|||+++......
T Consensus 84 ~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YM-HTDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred cc-cCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 99 5788777653 335688889999999999999999999 99999999999999999999999999997543322
Q ss_pred CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh---hhhhh----hhhh
Q 004395 563 MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR---PLLEE----YAID 634 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~---~~~~~----~~i~ 634 (756)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.............|.. +.... ....
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 1 1223457899999999875 457899999999999999999999997543221110000000 00000 0000
Q ss_pred ----hccCCccCCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 635 ----ELVDPRLGNHY-----SEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 635 ----~l~dp~l~~~~-----~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
........... .......+.+++.+|+..||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000 0011346789999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.16 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=198.4
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCC----EEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
.++|+..+.||+|+||.||+|.+ .+|. .||+|.+..... .....+.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 35788889999999999999985 3454 578887764332 2233688999999999999999999998754 568
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999999864 344689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 559 PDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 559 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... .. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~------ 226 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IP----DLLEK------ 226 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHC------
Confidence 433221 1122345778999999999999999999999999999997 899986432110 00 00000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
......+......+.+++..||..+|++||++.++++.|+.
T Consensus 227 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 227 ---GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00001111233468899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.82 Aligned_cols=240 Identities=22% Similarity=0.243 Sum_probs=187.1
Q ss_pred ecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhc---CCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA---QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 414 LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L---~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
||+|+||.||+|.. .+|+.||||++.... ......+..|..++..+ .||||+.+++++.+....|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999995 468999999875322 12223455677777665 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|.+++. ..+.+++..+..++.||+.||+|||+. ||+||||||+|||++.++.++|+|||+++...... ...
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 99999886 356799999999999999999999999 99999999999999999999999999997543322 123
Q ss_pred cccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~ 645 (756)
....||+.|+|||++.+. .++.++|||||||++|||++|..||....... ......... ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----------~~~~i~~~~---~~~~~-- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----------MYRNIAFGK---VRFPK-- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----------HHHHHHcCC---CCCCC--
Confidence 456799999999998764 48999999999999999999999996432110 000000000 11111
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 004395 646 SEHEVYCMLHAASLCIRRDPHSRP----RMSQVLR 676 (756)
Q Consensus 646 ~~~~~~~l~~Li~~CL~~dP~~RP----S~~eVL~ 676 (756)
......+.+++.+||..||++|| ++.++++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11234578899999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.70 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=197.3
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|.+.+.||+|+||.||+|... +++.||||.+...... ....+.+|+++++.++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57999999999999999999954 6899999987654322 234577899999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+. ++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 96 5999988653 34789999999999999999999999 999999999999999999999999999875432211
Q ss_pred CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch--hhhh-hhhhhh----hhhhh
Q 004395 564 GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL--TEWA-RPLLEE----YAIDE 635 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l--~~~~-~~~~~~----~~i~~ 635 (756)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||........... .... .+.... .....
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122346889999998865 5588999999999999999999999964431110000 0000 000000 00000
Q ss_pred cc--------CCccCCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 636 LV--------DPRLGNHY-SEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 636 l~--------dp~l~~~~-~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.. ...+.... .......+.+++.+||+.+|.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000000 0001146789999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=358.51 Aligned_cols=258 Identities=21% Similarity=0.293 Sum_probs=199.8
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEec--C
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--R 475 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~ 475 (756)
.+...++|.+.+.||+|+||.||+|.. .++..||+|.+..... .....|..|+.+|..|+|||||+++++|.+. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 344567999999999999999999995 4678899998765422 2345688999999999999999999988653 5
Q ss_pred ceeEEEEeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcc---cCceEeeccCCCceeecC-------
Q 004395 476 RRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECR---VGCIVHRDMRPNNILLTH------- 543 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~---~~gIiHrDLKp~NILL~~------- 543 (756)
.+||||||+.+|+|.++|... ....+++..++.|+.||+.||.|||..+. ..+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999999642 23679999999999999999999998521 015999999999999964
Q ss_pred ----------CCcceeeccccceecCCCCCCcccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004395 544 ----------DFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDL 611 (756)
Q Consensus 544 ----------~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 611 (756)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||+||..||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3458999999998654332 2234579999999999854 4588999999999999999999999964
Q ss_pred CCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 612 NRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 612 ~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.... ......+ .. .+.+. .......+.+||..||..+|.+||++.|+|.
T Consensus 246 ~~~~-----~qli~~l------k~--~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNF-----SQLISEL------KR--GPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcH-----HHHHHHH------hc--CCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 3221 1111000 00 01110 0112356889999999999999999999984
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.88 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=205.0
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
++|.+.+.||+|+||.||++.. .++..||+|.+..........+.+|+.+++.++||||++++++|...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6899999999999999999984 478899999886555555567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|.+++.. ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999999853 4688999999999999999999999 999999999999999999999999999876554332
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
......|++.|+|||++....++.++||||||+++|+|++|+.||........... .. ........
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~--~~------------~~~~~~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IA------------TNGTPELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--hh------------cCCCCCCC
Confidence 22334688999999999888899999999999999999999999975433211100 00 00000011
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
........+.+++.+||..+|++||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112233468899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.05 Aligned_cols=267 Identities=26% Similarity=0.392 Sum_probs=215.5
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcC-chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~-~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.+.......+.+.||+|-||.|.++....+..||||+++...... ..+|..|+++|.+|+||||++++|+|..++.+|+
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 355667788899999999999999998788999999998766554 4789999999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|+|||++|+|.+++.......+.-..-.+|+.||+.||+||.+. ++|||||.+.|+|++.++++||+|||+++.+.
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~----nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL----NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh----chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999999764333345566678999999999999999 99999999999999999999999999999665
Q ss_pred CCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 560 DGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT--GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 560 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt--G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
.++.. ...+.+-...|||+|.+.-++++.++|||+||++|||+++ ...||....... ..+-...++....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~---- 761 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQG---- 761 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCC----
Confidence 55543 3445667889999999999999999999999999999876 677775332210 0111111111100
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.......+.-++..+.+++.+||..|-.+||+++++...|.+
T Consensus 762 --~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 762 --RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred --cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 011112234466788999999999999999999999998865
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.49 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=188.3
Q ss_pred EecccCceEEEEEEecCC---CEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCC
Q 004395 413 FLAEGGFGSVHRGVLPDG---QAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g---~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggs 488 (756)
.||+|+||.||+|...++ ..+++|.+.... ......|.+|+.+++.++||||++++++|.+....|+||||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985433 345666655433 2344679999999999999999999999999999999999999999
Q ss_pred hhhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC-CCc
Q 004395 489 LDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD-MGV 565 (756)
Q Consensus 489 L~~~L~~~~--~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~-~~~ 565 (756)
|.+++.... ...+++..++.++.||+.||+|||+. +++||||||+|||++.++.++|+|||++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999996432 24567778889999999999999999 99999999999999999999999999986432211 112
Q ss_pred ccccccCccccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 566 ETRVIGTFGYLAPEYAQS-------GQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
.....|+..|+|||++.. ..++.++|||||||++|||++ |..||....... ....... .....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHh-hcccccC
Confidence 234568899999998753 245789999999999999997 566775432210 1111111 1111222
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
++.+... ....+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333222 2345778899999 68999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.82 Aligned_cols=244 Identities=24% Similarity=0.301 Sum_probs=201.1
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4799999999999999999995 468999999876432 223456889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+. ||+|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999974 46799999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||....... .. .......
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------~~-----~~~~~~~- 214 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----------IY-----EKILEGK- 214 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----------HH-----HHHhcCC-
Confidence 234568999999999988888999999999999999999999996443110 00 0000000
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLR 676 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~ 676 (756)
..++......+.+++.+||..||.+|| ++.++++
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 112222345688999999999999999 7777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.71 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=200.0
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcC---CCCeeeEEEEEEecCceeEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~---HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++ ||||+++++++.++...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999995 578999999876542 233456889999999997 999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.. ..+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999853 4799999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.. ......|+..|+|||++.++ .++.++||||||+++|+|++|..||......... . .+.....+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~---------~~~~~~~~~ 221 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---M---------LIPKSKPPR 221 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---h---------ccccCCCCC
Confidence 32 22345689999999988654 4689999999999999999999999644321110 0 000111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+... .....+.+++.+||..||++||++.+++.
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 13356889999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.88 Aligned_cols=263 Identities=21% Similarity=0.286 Sum_probs=199.3
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|+..+.||.|+||.||+|.. .+|+.||||.+..... .....+.+|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 588899999999999999985 4789999998764332 2235688999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+ .++|.+++.......+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 L-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred c-ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 9 57899988765667899999999999999999999999 99999999999999999999999999998654322
Q ss_pred CcccccccCccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhh-------hhhhhh---
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQ-ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWAR-------PLLEEY--- 631 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~-------~~~~~~--- 631 (756)
.......+++.|+|||++.+.. ++.++||||||+++|||+||+.||.......... ...... +.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 1122345788999999887644 5889999999999999999999996543211100 000000 000000
Q ss_pred --hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 632 --AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 632 --~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.........+ ..........+.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0001112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.87 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=193.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHH-HHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEV-LSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~i-L~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|++.+.||+|+||.||+|.. .+|+.||+|.++.... .....+..|+.+ ++.++||||+++++++..+...|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4789999999999999999995 4699999998765422 233456667665 566789999999999999999999999
Q ss_pred eecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 483 YICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 483 y~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|+ .|+|.+++... ....+++..++.++.|++.||+|||+++ +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~-~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL---SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hh-cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99 57888887542 3357999999999999999999999863 799999999999999999999999999986543
Q ss_pred CCCCcccccccCccccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQS----GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
.. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||...... .... . .....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~-~------~~~~~ 223 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQL-K------QVVEE 223 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHH-H------HHHhc
Confidence 22 1233468899999998865 45688999999999999999999998532211 0000 0 00000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..+.+. .......+.+++.+||..+|++||++.+++.
T Consensus 224 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 1112346889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=324.97 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=213.1
Q ss_pred hCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcC--chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~--~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.+-|.+.+.||+|.|..|-+|+ .-+|..||||++....... ...+.+|++.++.++|||||+||++...+..+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4568888999999999999998 4589999999987554332 346888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee-cCCCcceeeccccceecCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL-THDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL-~~~~~vkL~DFGlA~~~~~ 560 (756)
|+=.+|+|.+||.. ....+.+..+.+++.||+.|+.|||.. .+|||||||+||.+ ..-|.+||+|||++..+.+
T Consensus 97 ELGD~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999976 456799999999999999999999999 89999999999877 5679999999999988876
Q ss_pred CCCCcccccccCccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQIT-EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
+. ..++.+|+..|.|||++.+..|+ +++||||||||||-|++|+.||+....... +-.++|-
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDC 234 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDC 234 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcc
Confidence 65 45678999999999999999997 789999999999999999999976543211 1223333
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. ...+.+...+..+||..||..||++|.+.++|...
T Consensus 235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2 23456777889999999999999999999998753
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=309.64 Aligned_cols=258 Identities=26% Similarity=0.314 Sum_probs=201.7
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEec--CceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~LV~ 481 (756)
++|...+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|+++++.++||||++++++|.+. ...|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4789999999999999999996 4689999998775432 3345789999999999999999999998654 3689999
Q ss_pred EeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 482 EYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 482 Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||+.+++|.+++.. .....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999988753 2346689999999999999999999999 99999999999999999999999999987554
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... .....++..|+|||.+.+..++.++|||||||++|+|++|..||......... ..+.... +.....+
T Consensus 157 ~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~------~~~~~~~ 226 (287)
T cd06621 157 NSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELLSY------IVNMPNP 226 (287)
T ss_pred ccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHHHH------HhcCCch
Confidence 322 12345788999999999999999999999999999999999999755321000 0010000 0000011
Q ss_pred ccCCCCC--hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 RLGNHYS--EHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~--~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+..... ......+.+++.+||..+|.+|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1111111 1234568899999999999999999999883
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=310.92 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=201.9
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
+|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|+++++.++||||+++++++..+...++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777788999999999999964 689999998765432 33457899999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
.+++|.+++... ...+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~----~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 82 DGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLHEKH----KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred CCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHcCCC----CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 999999999753 2689999999999999999999999 7 99999999999999999999999999987553321
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
.....++..|+|||++.+..++.++||||||+++|+|++|..||......... ..... ........ .
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~---------~~~~~~~~-~ 222 (265)
T cd06605 156 --AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELL---------QYIVNEPP-P 222 (265)
T ss_pred --hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHH---------HHHhcCCC-C
Confidence 11256889999999999999999999999999999999999999644211110 01100 11111100 0
Q ss_pred CCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 644 HYSEH-EVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 644 ~~~~~-~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..+.. ....+.++|.+||..||++|||+.+++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11111 3456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.75 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=215.5
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec---CC--CEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEec
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP---DG--QAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~---~g--~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~ 474 (756)
.++........++||+|-||.||+|++. .| -.||||..+.+. .+..+.|+.|+-+++.++||||++|+|+|.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 3444455566778999999999999943 23 358889877643 34567899999999999999999999999864
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
..|||||+++-|.|..+|.. +...|+......++.||+.||+|||+. .+|||||...|||+.....+||+||||
T Consensus 464 -P~WivmEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred -ceeEEEecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhheeecCcceeeecccch
Confidence 68999999999999999976 567899999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
+++..+..........-...|||||.+.-.+++.++|||.|||.+||++. |.+||..-....-
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---------------- 601 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---------------- 601 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------
Confidence 99998877666665556778999999999999999999999999999987 9999975543211
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
-..+...-+...++.++..|..|+.+||+.+|.+||++.++...|.+
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 11112222334566777889999999999999999999999887653
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.80 Aligned_cols=262 Identities=24% Similarity=0.292 Sum_probs=199.8
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc-----CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-----GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~-----~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
+|.+.+.||+|+||.||+|.. .+|+.||||.+...... ....+..|+++++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488889999999999999995 46899999988754332 234577899999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+ +++|.+++.... ..+++..++.++.||++||.|||++ ||+|+||||+|||++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999996432 4799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh----hhhhhh----
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR----PLLEEY---- 631 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----~~~~~~---- 631 (756)
... ......+++.|+|||++.+ ..++.++|||||||++|||++|.++|........ +..... +.....
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhcc
Confidence 322 1223356888999998865 4678999999999999999999877764332110 000000 000000
Q ss_pred hhhhccCCccCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 632 AIDELVDPRLGNH-----YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 632 ~i~~l~dp~l~~~-----~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
............. ........+.+++.+||..||++|||+.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 112234578899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=318.59 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=198.9
Q ss_pred EEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCCh
Q 004395 411 ANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
...||+|+||.||+|.. .+++.||+|.+..........+.+|+.++..++||||+++++++..+...|+||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 44699999999999985 47899999988765555556788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccccc
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 569 (756)
.+++. ...+++..++.++.|++.||.|||+. +++||||||+|||++.++.++|+|||++....... ......
T Consensus 106 ~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 177 (297)
T cd06659 106 TDIVS---QTRLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 177 (297)
T ss_pred HHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccce
Confidence 98874 35689999999999999999999999 99999999999999999999999999997554322 122345
Q ss_pred ccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhH
Q 004395 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649 (756)
Q Consensus 570 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~ 649 (756)
.|+..|+|||++.+..++.++|||||||++|||++|..||....+... +.. +.....+.. ......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~----------~~~~~~~~~--~~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKR----------LRDSPPPKL--KNAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----------HhccCCCCc--cccCCC
Confidence 689999999999988899999999999999999999999964332111 000 000000000 111122
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 650 VYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 650 ~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...+.+++.+||+.+|++||++.++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 3458899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.66 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=202.3
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|.+.+.||+|+||.||+|... +|..||+|.+.... ......+.+|+++++.++|+||+++++.+.++...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999954 68899999876532 22345688999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc-ceeeccccceecCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE-PLVGDFGLARWQPDGD 562 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~-vkL~DFGlA~~~~~~~ 562 (756)
+.+++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++. ++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999999765555689999999999999999999999 9999999999999998864 6999999998665432
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
. ......|++.|+|||++.+..++.++|+||||+++|||++|..||...... .+.... ......
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~-----~~~~~~---- 220 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKI-----CQGYFA---- 220 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHH-----hcccCC----
Confidence 1 222345899999999998888999999999999999999999998643211 111110 011111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.........+.+++.+||..+|++|||+.++++.
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112233468899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=300.50 Aligned_cols=250 Identities=29% Similarity=0.434 Sum_probs=205.1
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
.|...+.||+|++|.||++... +++.+++|++..........+.+|+++++.++|+||+++++++..+...++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999964 789999998876555456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+++|.+++... ...+++..+..++.|++.||.|||.. |++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999998642 25799999999999999999999998 999999999999999999999999999987654432
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~ 645 (756)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||......... . .......+.+..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~----------~~~~~~~~~~~~-- 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL--F----------KIATNGPPGLRN-- 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH--H----------HHHhcCCCCcCc--
Confidence 23456899999999998888999999999999999999999999644221100 0 000000111110
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 646 ~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.......+.+++.+||..||++|||+.++++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11113568899999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.12 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=200.5
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
-|...+.||+|+||.||+|.. .++..||||....... .....+.+|+.++++++||||+++++++.++...|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778899999999999985 4788999998764322 23356889999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.+++|.+++. ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999985 35689999999999999999999999 999999999999999999999999999986643321
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||........ .. .+.....+ .
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~------~~~~~~~~----~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LF------LIPKNNPP----T 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HH------HHhcCCCC----C
Confidence 12334688899999999888889999999999999999999999864321100 00 00010011 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
........+.+++.+||+.+|.+||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 222334568899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=313.73 Aligned_cols=265 Identities=22% Similarity=0.289 Sum_probs=197.7
Q ss_pred CeeEEEEecccCceEEEEEEec---CCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEec--Ccee
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP---DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRL 478 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~ 478 (756)
+|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4888999999999999999954 57899999887633 33345688899999999999999999999988 7899
Q ss_pred EEEEeecCCChhhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC----CCcceeec
Q 004395 479 LVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH----DFEPLVGD 551 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~---~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~----~~~vkL~D 551 (756)
+||||+. ++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 9999985 5777766422 224789999999999999999999999 9999999999999999 99999999
Q ss_pred cccceecCCCCC--CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-------h
Q 004395 552 FGLARWQPDGDM--GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-------T 621 (756)
Q Consensus 552 FGlA~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-------~ 621 (756)
||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999986643321 12234568899999998866 4578999999999999999999999975543321000 0
Q ss_pred hhhhh-----------hhhhhhhhhccCCccCCCCC---------h--hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 622 EWARP-----------LLEEYAIDELVDPRLGNHYS---------E--HEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 622 ~~~~~-----------~~~~~~i~~l~dp~l~~~~~---------~--~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..... ...........+......++ . .....+.+++.+||+.||++|||+.+++.
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000000000000000111 0 22346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.39 Aligned_cols=251 Identities=29% Similarity=0.392 Sum_probs=206.5
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEec--CceeEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLVY 481 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~LV~ 481 (756)
+|...+.||+|++|.||+|... +++.|++|++..... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999965 789999998765543 3456789999999999999999999999988 8899999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999999743 3899999999999999999999998 9999999999999999999999999999877654
Q ss_pred CCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 DMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ....+....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--------------ALYKIGSSG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--------------HHHhccccC
Confidence 321 12345688999999999888899999999999999999999999975431100 001111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.....+......+.+++.+|+..+|++||++.+++..
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1122333345679999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.69 Aligned_cols=245 Identities=23% Similarity=0.357 Sum_probs=198.6
Q ss_pred EEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCCh
Q 004395 411 ANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
...||+|+||.||++.. .++..||||.+..........+.+|+.+++.++|+||+++++.+..++..|+||||+.+++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 45699999999999985 46889999988665555556788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccccc
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 569 (756)
.+++. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++........ .....
T Consensus 107 ~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 178 (292)
T cd06658 107 TDIVT---HTRMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSL 178 (292)
T ss_pred HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCcee
Confidence 99884 34689999999999999999999999 999999999999999999999999999975543221 22345
Q ss_pred ccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhH
Q 004395 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649 (756)
Q Consensus 570 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~ 649 (756)
.|+..|+|||++.+..++.++||||||+++|||++|..||........ + ..+.....+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~----------~~~~~~~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--M----------RRIRDNLPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----------HHHHhcCCCcccc--cccc
Confidence 689999999999988899999999999999999999999964322100 0 0011111111111 1122
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 650 VYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 650 ~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...+.+++.+||..||.+|||+.++++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3457889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=308.47 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=196.3
Q ss_pred eeEEEEecccCceEEEEEEec----CCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 004395 408 FSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~------ 475 (756)
|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999843 46899999876542 223456889999999999999999999886542
Q ss_pred ceeEEEEeecCCChhhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeec
Q 004395 476 RRLLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~----~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
..++++||+.+|+|.+++... ....+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECc
Confidence 247899999999999887422 223578999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhh
Q 004395 552 FGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLE 629 (756)
Q Consensus 552 FGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 629 (756)
||+++....... .......+++.|++||.+....++.++|||||||++|||++ |+.||....... +..+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~------ 227 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNY------ 227 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHH------
Confidence 999986543321 11123345678999999998889999999999999999999 888885432110 0000
Q ss_pred hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 630 ~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+...... ..+......+.+++.+||+.+|++||++.++++.|++
T Consensus 228 ---~~~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 228 ---LIKGNRL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred ---HHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0000000 1112334578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=343.86 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=216.7
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEec----CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
++......+.++||.|.||.||+|.++ ....||||.++....+ ...+|+.|+.||-+++||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 344556788999999999999999954 2357999999977544 45689999999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
..||+|||++|+|+.||+.+ .+.+.+.+..-++++|+.|+.||-+. ++|||||...|||++.+-..|++||||++
T Consensus 705 vMIiTEyMENGsLDsFLR~~-DGqftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQN-DGQFTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhc-CCceEeehHHHHHHHHHHHhHHHhhc----CchhhhhhhhheeeccceEEEecccccee
Confidence 99999999999999999874 46699999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCCccccccc--CccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 557 WQPDGDMGVETRVIG--TFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 557 ~~~~~~~~~~~~~~G--t~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
.+.++.....++.-| ...|.|||.+...+++.++||||||+||||.++ |.+||-.... + ..
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----------Q----dV- 843 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------Q----DV- 843 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----------H----HH-
Confidence 876654333333333 467999999999999999999999999999887 8888743221 1 11
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
...+...++-.-+.+++..|.+|+..||++|-++||.+.||+..|+..
T Consensus 844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 111222333445667888999999999999999999999999998754
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=310.79 Aligned_cols=263 Identities=21% Similarity=0.233 Sum_probs=196.0
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCc-----
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRR----- 476 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~----- 476 (756)
++|++.+.||+|+||.||+|.. .+|+.||||....... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4789999999999999999995 4789999998765432 23456888999999995 6999999999987666
Q ss_pred eeEEEEeecCCChhhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-CCcceeecc
Q 004395 477 RLLVYEYICNGSLDSHLYGCH---QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDF 552 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~---~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-~~~vkL~DF 552 (756)
.|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.++|+||
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeec
Confidence 899999996 58988885432 34689999999999999999999999 9999999999999998 899999999
Q ss_pred ccceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh--h
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL--E 629 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~--~ 629 (756)
|+++.+.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........ +........ .
T Consensus 156 g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (295)
T cd07837 156 GLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPT 232 (295)
T ss_pred ccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence 9998654321 11223357889999998865 4578999999999999999999999965432211 000000000 0
Q ss_pred hhhhhhcc-------CCc----cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 630 EYAIDELV-------DPR----LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 630 ~~~i~~l~-------dp~----l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
........ .+. ......+.....+.++|.+||..||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000 000 000011123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.26 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=197.1
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----ce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~-----~~ 477 (756)
+++|.+.+.||+|+||.||+|.. .+|+.||||.+.... ......+..|+.+++.++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999984 578999999876432 223456888999999999999999999876543 47
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|+|+||+ .++|.+++. ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.++|+|||+++.
T Consensus 84 ~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELM-ETDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 9999998 468887774 45799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC--CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhhhhhhhhhh
Q 004395 558 QPDGDM--GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWARPLLEEYAI 633 (756)
Q Consensus 558 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~~~~~~~~i 633 (756)
...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ........ .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-SQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-CHHHH
Confidence 543221 11233568999999998754 568999999999999999999999996543211100 00000000 00000
Q ss_pred hhccCCc---------cCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPR---------LGNH-----YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~---------l~~~-----~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+.+.. .... ..+.....+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000 001123468899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=333.89 Aligned_cols=244 Identities=26% Similarity=0.350 Sum_probs=206.4
Q ss_pred EecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCChhh
Q 004395 413 FLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDS 491 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~ 491 (756)
+||+|.||+||.|+. .+...+|||.+..........+..|+.+.+.|+|.|||+++|.|.+++.+-|+||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999994 4566899998887777777788999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCC--CHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec-CCCcceeeccccceecCCCCCCcccc
Q 004395 492 HLYGCHQEPL--EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-HDFEPLVGDFGLARWQPDGDMGVETR 568 (756)
Q Consensus 492 ~L~~~~~~~L--~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~-~~~~vkL~DFGlA~~~~~~~~~~~~~ 568 (756)
+|.. .-+++ .+.++-.+..||++||.|||++ .|||||||-+||||+ -.|.+||+|||.++.+..-+. ...+
T Consensus 662 LLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TET 735 (1226)
T KOG4279|consen 662 LLRS-KWGPLKDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTET 735 (1226)
T ss_pred HHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhccCCc-cccc
Confidence 9975 56777 8888999999999999999999 999999999999995 579999999999997755443 3456
Q ss_pred cccCccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 569 VIGTFGYLAPEYAQSG--QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 569 ~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
+.||..|||||++..+ .|+.++|||||||++.||.||++||...+..... +-..-.-+.....+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------------MFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------------MFKVGMYKVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------------hhhhcceecCCCCc
Confidence 7899999999999764 5899999999999999999999999644432110 01111112234566
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+.......+|.+|+..||.+||++.++|.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 777788999999999999999999999986
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=341.00 Aligned_cols=269 Identities=20% Similarity=0.255 Sum_probs=190.1
Q ss_pred hhCCeeEEEEecccCceEEEEEEec--CCCEEEEEEec-----------------ccCCcCchhHHHHHHHHHhcCCCCe
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP--DGQAVAVKQHK-----------------LASSQGDHEFCSEVEVLSCAQHRNV 464 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~VAVK~~~-----------------~~~~~~~~~f~~Ev~iL~~L~HpNI 464 (756)
..++|.+++.||+|+||.||++... ++..+++|.+. .........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998743 22222222100 0111223458899999999999999
Q ss_pred eeEEEEEEecCceeEEEEeecCCChhhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee
Q 004395 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH---QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541 (756)
Q Consensus 465 V~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~---~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL 541 (756)
+++++++.+.+..|+|++++ +++|.+++.... ........++.++.||+.||.|||++ |||||||||+||||
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NILl 300 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENIFL 300 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEE
Confidence 99999999999999999998 677877775321 22334567788999999999999999 99999999999999
Q ss_pred cCCCcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcccccch
Q 004395 542 THDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKA-VDLNRPKGQQCL 620 (756)
Q Consensus 542 ~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~P-f~~~~~~~~~~l 620 (756)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||+||||++|..+ |..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987765443334456799999999999999999999999999999999998754 432221111111
Q ss_pred hhhhhhh---hhh-----hhhhhccCC-cc---CCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 621 TEWARPL---LEE-----YAIDELVDP-RL---GNHYS-----EHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 621 ~~~~~~~---~~~-----~~i~~l~dp-~l---~~~~~-----~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
......+ ..+ ..+...+.. .+ ....+ ......+.+++.+||+.||++|||+.|++.+
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1100000 000 000000000 00 00000 0122356778999999999999999999874
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=311.73 Aligned_cols=261 Identities=15% Similarity=0.177 Sum_probs=187.6
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecC----CCEEEEEEecccCCcCch-----------hHHHHHHHHHhcCCCCeeeE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQGDH-----------EFCSEVEVLSCAQHRNVVML 467 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~~~~~~~~~~~-----------~f~~Ev~iL~~L~HpNIV~l 467 (756)
+..++|.+.+.||+|+||.||+|...+ +..+|+|+.......... ....+...+..+.|+||+.+
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 455789999999999999999999643 456677754433221111 11223344556789999999
Q ss_pred EEEEEecC----ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC
Q 004395 468 IGFCIEDR----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (756)
Q Consensus 468 ~~~~~~~~----~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~ 543 (756)
++++.... ..++++|++ ..++.+.+.. ....++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcC
Confidence 99776543 346788876 4567666642 23467888999999999999999999 9999999999999999
Q ss_pred CCcceeeccccceecCCCCC------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 004395 544 DFEPLVGDFGLARWQPDGDM------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ 617 (756)
Q Consensus 544 ~~~vkL~DFGlA~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~ 617 (756)
++.++|+|||+|+.+..... .......||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999987643211 111234699999999999999999999999999999999999999975432211
Q ss_pred cchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 618 QCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 618 ~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
. ....... -+..+..... ........+.+++..|+..+|++||++.++++.|+
T Consensus 242 ~-~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 L-IHAAKCD-----FIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred H-HHHhHHH-----HHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 0000000 0111111111 01122356889999999999999999999998763
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.69 Aligned_cols=266 Identities=25% Similarity=0.295 Sum_probs=197.9
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEec--CceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~L 479 (756)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+...... ....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35799999999999999999995 46999999987654322 223567899999999999999999998765 46899
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+. ++|.+++.. ....+++..++.++.||+.||.|||+. |++||||||+|||++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999984 688888864 246799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhh-------hhhhhh
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWA-------RPLLEE 630 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~-------~~~~~~ 630 (756)
... .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..... .+....
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 160 LPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred Ccc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 432 12223346888999998865 567899999999999999999999997543321110 00000 000000
Q ss_pred hhhhhcc--CCccCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 631 YAIDELV--DPRLGNH---YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 631 ~~i~~l~--dp~l~~~---~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....... ....... ........+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 0000000 001123457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=311.02 Aligned_cols=266 Identities=24% Similarity=0.287 Sum_probs=195.5
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecC-------
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------- 475 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~------- 475 (756)
++|.+.+.||+|+||.||+|.. .+++.||||.+...... ....+.+|++++++++||||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 5799999999999999999995 46899999987644322 2335678999999999999999999987654
Q ss_pred -ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 476 -RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 476 -~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++ |++|+||||+|||++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFC-EHDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCC-CcCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 349999998 5688888754 334789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCC---cccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh-----
Q 004395 555 ARWQPDGDMG---VETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR----- 625 (756)
Q Consensus 555 A~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----- 625 (756)
+......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866432211 12234578899999988664 47899999999999999999999997554321111000000
Q ss_pred ---hhhhhhh-hhhccCCccC-----CCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 ---PLLEEYA-IDELVDPRLG-----NHY-SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ---~~~~~~~-i~~l~dp~l~-----~~~-~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+...... ...+..+... ... .......+.+++.+||..||.+|||+++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 0000000000 000 00112356789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.21 Aligned_cols=248 Identities=22% Similarity=0.267 Sum_probs=203.0
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+|.+.+.||.|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999964 689999998764322 335678999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++.. ..++++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999964 36899999999999999999999999 99999999999999999999999999998665432
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||........ .... . .... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~---~------~~~~-~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIR---A------KQET-AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHH---H------Hhcc-cc
Confidence 22345688999999999988899999999999999999999999975432100 0000 0 0000 11
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRM--SQVLR 676 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~--~eVL~ 676 (756)
...+......+.+++.+||..||.+||++ .+++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 12223334678899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=306.59 Aligned_cols=263 Identities=24% Similarity=0.298 Sum_probs=199.1
Q ss_pred eeEEEEecccCceEEEEEEec-CCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEec--CceeEEEE
Q 004395 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLVYE 482 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~LV~E 482 (756)
|.+.+.||+|+||.||+|... +|+.+|+|.+.... ......+.+|+++++.++|+||+++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999965 58999999887653 22345688999999999999999999999988 78999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+. ++|.+++... ...+++..++.++.||+.||+|||.. |++|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 995 5898888642 35799999999999999999999999 99999999999999999999999999998765543
Q ss_pred CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhh-------hhhhhhhh
Q 004395 563 MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWAR-------PLLEEYAI 633 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~-------~~~~~~~i 633 (756)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... +..... +.......
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 222334457889999997765 467899999999999999999999997544321100 000000 00000000
Q ss_pred hhccC------CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DELVD------PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~l~d------p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..... ..+...+...+...+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 00000011112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=299.84 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=206.2
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|.+.+.||.|+||.||++... ++..||+|++..... .....+..|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999954 689999998875433 3456788999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 484 ICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 484 ~~ggsL~~~L~~~~--~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
+++++|.+++.... ...+++..+..++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999997532 47899999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
. .......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... .... .....
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~-----~~~~~----- 219 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALK-----ILKGQ----- 219 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHH-----HhcCC-----
Confidence 3 12234568899999999998889999999999999999999999986443110 0000 00110
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....+......+.+++.+||..+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111222344568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.27 Aligned_cols=247 Identities=22% Similarity=0.334 Sum_probs=200.4
Q ss_pred eeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
|...+.||+|++|.||++.. .+++.+|+|.+..........+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999995 57899999988755544556788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
++|.+++.. ..+++..+..++.|++.||+|||++ ||+||||+|+||+++.++.++|+|||++........ ..
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 999999864 5689999999999999999999999 999999999999999999999999999875543221 12
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||....+... ... +.....+... ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~------~~~~~~~~~~--~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKR------IRDNLPPKLK--NL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHH------HHhcCCCCCc--cc
Confidence 335689999999999988899999999999999999999999864332110 000 0111111111 11
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
......+.+++.+||..+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 113346899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.15 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=195.5
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|...+.||+|+||.||++.. .+++.||+|.+..... .....+..|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 445567899999999999995 4689999998764432 23456889999999996 99999999999999999999999
Q ss_pred ecCCChhhhh---hccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 484 ICNGSLDSHL---YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 484 ~~ggsL~~~L---~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
+ +++|.++. .......+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.++|+|||+++....
T Consensus 85 ~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 M-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred c-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 8 45665543 3334567999999999999999999999742 899999999999999999999999999986543
Q ss_pred CCCCcccccccCccccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSG---QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||...... ..... ......
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~------~~~~~~ 227 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLT------QVVKGD 227 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHHh------hhcCCC
Confidence 321 2334588999999998776 6899999999999999999999999643210 00000 000001
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+.+...........+.+|+.+||+.+|++|||+.+|+..
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122222222345578999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.92 Aligned_cols=247 Identities=28% Similarity=0.395 Sum_probs=197.0
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
...|...+.||+|+||.||+|.. .+|+.||+|.+...... ....+.+|+++++.++||||++++++|.+....|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35688889999999999999995 46899999987643322 234688999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+. |+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99985 677777753 345799999999999999999999999 999999999999999999999999999975533
Q ss_pred CCCCcccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
. ....|+..|+|||++. ...++.++||||||+++|||++|..||......... ..+....
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------------~~~~~~~ 230 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------------YHIAQND 230 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------------HHHhcCC
Confidence 2 2346888999999874 456889999999999999999999998643221100 0000000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+.+ ........+.+++.+||..+|++||++.+|+.+
T Consensus 231 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0111 112234568899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=310.36 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=199.3
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEec--CceeEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLV 480 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~LV 480 (756)
++|.+.+.||.|+||.||+|... +++.+|+|.++..... ....+.+|+.++.+++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999964 6889999988654322 223577899999999999999999999877 889999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+. ++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+|||++.++.++|+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99995 6999888653 34699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-h-hhhhhhhhh------h-
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-L-TEWARPLLE------E- 630 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l-~~~~~~~~~------~- 630 (756)
... ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||.......... + ..+..+... .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 321 22334578899999988764 46899999999999999999999997543211100 0 000000000 0
Q ss_pred -----hhhhhccCCccCCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 631 -----YAIDELVDPRLGNHYSEH-EVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 631 -----~~i~~l~dp~l~~~~~~~-~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..........+...++.. ....+.+++.+||+.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000001111112221 3456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=307.99 Aligned_cols=260 Identities=23% Similarity=0.309 Sum_probs=198.3
Q ss_pred eeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
|++.+.||.|++|.||+|.. .+|..||+|++..... .....+.+|+++++.++||||+++++++.+....|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999995 4799999998765432 23356889999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
+++|.+++.......+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 57999998754445799999999999999999999999 999999999999999999999999999976543221
Q ss_pred cccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh----hhh---------hh
Q 004395 565 VETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR----PLL---------EE 630 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----~~~---------~~ 630 (756)
......++..|+|||++.+. .++.++||||||+++|+|++|..||........ +..... +.. ..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence 11223568899999988664 578999999999999999999999965432211 000000 000 00
Q ss_pred h--hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 631 Y--AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 631 ~--~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
. .......... ..........+.+++.+||+.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000000 0111223356889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=309.67 Aligned_cols=265 Identities=25% Similarity=0.285 Sum_probs=199.0
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC----
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR---- 475 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~---- 475 (756)
...++|++.+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999964 689999998865432 23346788999999999999999999987655
Q ss_pred ------ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCccee
Q 004395 476 ------RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (756)
Q Consensus 476 ------~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL 549 (756)
..++|+||+. ++|..++.. ....+++..++.++.|++.||+|||+. ||+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMD-HDLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccC-ccHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEEe
Confidence 7899999996 477777754 245799999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh-
Q 004395 550 GDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL- 627 (756)
Q Consensus 550 ~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~- 627 (756)
+|||++...............++..|+|||++.+ ..++.++|||||||++|||++|+.||........ +.......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~~~~~~~ 235 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LELISRLCG 235 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhC
Confidence 9999998765433222233456888999998865 4578999999999999999999999975432111 00000000
Q ss_pred -hhhhhhhhc--------cCC------ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 628 -LEEYAIDEL--------VDP------RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 628 -~~~~~i~~l--------~dp------~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
........+ .++ .... .....+..+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 000 0000 01112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=358.55 Aligned_cols=253 Identities=31% Similarity=0.397 Sum_probs=208.2
Q ss_pred hhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.+-+|....+||.|.||.||-|. ..+|...|+|.++... ......+.+|..+|..|.|||+|++||+=.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34477888899999999999999 5689999999776543 33456788999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
||||.+|+|.+.+. .++.+++.....+..|++.||.|||++ |||||||||+||||+.+|.+|++|||.|.....
T Consensus 1313 MEyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999997 456677778888999999999999999 999999999999999999999999999997765
Q ss_pred CCC---CcccccccCccccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 561 GDM---GVETRVIGTFGYLAPEYAQSG---QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 561 ~~~---~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
... +......||+.|||||++.+. ...-++||||||||+.||+||++||..... +| .+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~--------aIM 1451 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EW--------AIM 1451 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hh--------HHH
Confidence 431 223457899999999999763 456789999999999999999999964322 11 122
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+--.-...++......-.+++.+||..||.+|.++.|++++
T Consensus 1452 y~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 YHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2222222233444566677899999999999999999998875
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.16 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=197.7
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+++++.++||||+++++++.++...|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999954 789999998764332 233568899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-CCcceeeccccceecCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-~~~vkL~DFGlA~~~~~~ 561 (756)
|+ +++|.+++.......+++..++.++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99 56888888654445578889999999999999999999 9999999999999985 557999999999765432
Q ss_pred CCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-h-hhhhhhhhhh----hhhh
Q 004395 562 DMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-L-TEWARPLLEE----YAID 634 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l-~~~~~~~~~~----~~i~ 634 (756)
. .......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||.......... . ..+..+.... ..+.
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 1 11233457899999998866 457899999999999999999999996543211100 0 0000000000 0000
Q ss_pred hcc--CCccCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 635 ELV--DPRLGN----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 635 ~l~--dp~l~~----~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
... .+.... ...+.....+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000 011122345789999999999999999999987
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.75 Aligned_cols=250 Identities=23% Similarity=0.287 Sum_probs=199.4
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-----CcCchhHHHHHHHHHhcCCCCeeeEEEEEEec--Cce
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRR 477 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-----~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~ 477 (756)
.+|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999995 468999999865321 12234688899999999999999999998764 457
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999863 35689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC--CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 558 QPDGD--MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 558 ~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
..... ........|+..|+|||++.+..++.++|+|||||++|+|++|+.||....... .+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~~ 220 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------------AIFK 220 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---------------HHHH
Confidence 53211 111123568999999999998889999999999999999999999996432110 0111
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..........+......+.+++.+||. +|..||++.+++.+
T Consensus 221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111111122344455678999999999 57999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.84 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=204.7
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.++.|.....||+|+||.||+|... ++..||+|.+..... ....+.+|+++++.++|+||+++++++......|+|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888889999999999999965 688999998875544 45678899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++.... ..+++..++.++.|++.||.|||.. ||+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999997532 4799999999999999999999998 99999999999999999999999999987554322
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
. ......++..|+|||++.+..++.++||||||+++|+|++|..||....+... .. . +.....+..
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~----~------~~~~~~~~~- 236 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LF----L------ITTKGIPPL- 236 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HH----H------HHhcCCCCC-
Confidence 1 12334578899999999988899999999999999999999999864322110 00 0 000000000
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0111133568899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.40 Aligned_cols=242 Identities=23% Similarity=0.304 Sum_probs=196.7
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCCh
Q 004395 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 414 LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
||.|+||.||++... +++.||+|++..... .....+.+|+++++.++||||+++++++.++...|+||||+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 589999998764332 2335688999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccccc
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 569 (756)
.+++.. ...+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999974 35689999999999999999999998 99999999999999999999999999998765432 22335
Q ss_pred ccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhH
Q 004395 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649 (756)
Q Consensus 570 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~ 649 (756)
.|+..|+|||++.+..++.++|+||||+++|+|++|..||......... . ............++...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~---------~~~~~~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME----I---------YNDILKGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH----H---------HHHHhccCCCCCCCccc
Confidence 6889999999998888999999999999999999999999654321000 0 01111111112223333
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 004395 650 VYCMLHAASLCIRRDPHSRPR-----MSQVLR 676 (756)
Q Consensus 650 ~~~l~~Li~~CL~~dP~~RPS-----~~eVL~ 676 (756)
...+.+++.+||..+|++||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 567899999999999999999 777766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.83 Aligned_cols=261 Identities=22% Similarity=0.226 Sum_probs=194.2
Q ss_pred eeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcC-CCCeeeEEEEEEec--CceeEEEE
Q 004395 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIED--RRRLLVYE 482 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~--~~~~LV~E 482 (756)
|++.+.||+|+||.||+|.. .+++.||+|+++.... ........|+.++.++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67788999999999999994 4789999998765422 22234567999999886 99999999999987 88999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+. ++|.+++.. ....+++..++.++.|++.||+|||+. |++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 995 688888764 235789999999999999999999999 9999999999999999 999999999998664332
Q ss_pred CCcccccccCccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc-chhhhhhhhhh----hhh---h
Q 004395 563 MGVETRVIGTFGYLAPEYAQ-SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQ-CLTEWARPLLE----EYA---I 633 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~~~~~----~~~---i 633 (756)
. .....++..|+|||++. ++.++.++|||||||++|||++|..||......... ........... ... .
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 23356889999999764 456789999999999999999999999654322110 00000000000 000 0
Q ss_pred hhccCCccC----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPRLG----NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~l~----~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.....+... ..........+.+++.+||..+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 00011234678999999999999999999999873
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.20 Aligned_cols=244 Identities=25% Similarity=0.327 Sum_probs=194.3
Q ss_pred ecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCCh
Q 004395 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 414 LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
||+|+||.||++.. .+|+.||+|.+.... ......+..|+++|+.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 468999999876432 22344577899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccccc
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 569 (756)
.+++.......+++..++.++.|++.||.|||+. |++||||+|+|||++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 9999765555799999999999999999999999 99999999999999999999999999998654321 12234
Q ss_pred ccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhH
Q 004395 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649 (756)
Q Consensus 570 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~ 649 (756)
.++..|+|||++.+..++.++||||||+++|+|++|+.||......... . . . ...... ....++...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~----~-~-----~~~~~~-~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--E----E-L-----KRRTLE-MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--H----H-H-----Hhcccc-ccccCCccC
Confidence 5788999999998888999999999999999999999999644321110 0 0 0 000000 011122233
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 004395 650 VYCMLHAASLCIRRDPHSRP-----RMSQVLR 676 (756)
Q Consensus 650 ~~~l~~Li~~CL~~dP~~RP-----S~~eVL~ 676 (756)
...+.+++.+||+.||.+|| ++.+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 45688999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.41 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=198.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR----- 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~----- 475 (756)
..++|+..+.||+|+||.||+|.. .+|+.||||.+... .......+.+|+.++++++||||++++++|....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999994 57899999987532 2223346778999999999999999999886443
Q ss_pred -ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 476 -RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 476 -~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
..|+||||+ .++|.+.+.. .++...+..++.|++.||+|||.. ||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~-~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELM-DANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEecc-CCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 469999999 5688888753 288999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-h-h-------hhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-L-T-------EWAR 625 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l-~-------~~~~ 625 (756)
++...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||.......... + . .+..
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98664332 1234568899999999999999999999999999999999999996543211100 0 0 0000
Q ss_pred h---hhhh----------hhhhhccCCcc----CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 P---LLEE----------YAIDELVDPRL----GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ~---~~~~----------~~i~~l~dp~l----~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. .... ..+.++..... ...........+.+++.+||+.||++|||+.++|..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000 00001110000 000111234567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.98 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=198.9
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
+|++.+.||.|++|.||+|... +|..||||.+...... ....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999964 6899999988755433 3456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 485 CNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 485 ~ggsL~~~L~~~~-~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
. ++|.+++.... ...+++..+..++.|++.||.|||+. |++||||||+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 6 58888885432 35689999999999999999999999 999999999999999999999999999975543221
Q ss_pred CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhh-hhhhhhhhhhhhcc-CC
Q 004395 564 GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEW-ARPLLEEYAIDELV-DP 639 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~-~~~~~~~~~i~~l~-dp 639 (756)
......++..|++||++.+ ..++.++|||||||++|+|++|..||.......... .... ..+... ....+. .+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES--TWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh--hHHHHhcCc
Confidence 1223457889999998865 456899999999999999999999997543221100 0000 000000 000000 00
Q ss_pred ccCCC-----------CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 640 RLGNH-----------YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 640 ~l~~~-----------~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+... ..+.....+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 11122356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.24 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=203.7
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|++.+.||+|++|.||++... +++.||+|.+..... .....+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4888999999999999999854 688999998875543 3445789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999864 36799999999999999999999999 999999999999999999999999999987755432
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
. .....++..|+|||.+.+..++.++|||+||+++|+|++|..||....... ..+ .......+
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~--------~~~~~~~~---- 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALF--------RIVQDDHP---- 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHH--------HHhccCCC----
Confidence 2 233568899999999988888999999999999999999999986432110 000 00000111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..+......+.+++.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 122233456889999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=356.90 Aligned_cols=260 Identities=31% Similarity=0.546 Sum_probs=208.2
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
...|...+.||+|+||.||+|.. .+|..||||.+..... ....|++++++++|||||+++++|.+....|+||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34677788999999999999995 5789999998764322 223568899999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+++|+|.+++. .++|..+..++.|+++||+|||..|.. +|+||||||+|||++.++.+++. ||.+.....
T Consensus 765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999995 389999999999999999999955433 89999999999999999888875 666543321
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+..... ......|.+...........+++.+..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccC
Confidence 12336889999999999999999999999999999999999999643322 223445554433333344455555533
Q ss_pred C--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 644 H--YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 644 ~--~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
. ....+...+.+++.+||+.||++||+|.||++.|+..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 2 3345666788999999999999999999999999853
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.87 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=203.9
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|++.+.||+|+||.||++.. .+++.+|+|.+.... ......+..|+++++.++|+||+++++++.+....|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999984 478899999876432 22345688899999999999999999999999999999999
Q ss_pred ecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 484 ICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 484 ~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
+.+++|.+++... ....+++..++.++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998642 246789999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....... +.. ......
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----------~~~------~~~~~~ 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD----------LRY------KVQRGK 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------HHH------HHhcCC
Confidence 1223458899999999999999999999999999999999999996543210 000 000111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....+......+.+++.+||..+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112223445678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.05 Aligned_cols=242 Identities=23% Similarity=0.287 Sum_probs=188.5
Q ss_pred EecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHh---cCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 413 FLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSC---AQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~---L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
.||+|+||.||++.. .+++.||+|.+..... .....+.+|..++.. ..||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 4689999998754322 122334555554444 469999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+++|.+++. ..+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999886 345799999999999999999999999 99999999999999999999999999997554322
Q ss_pred ccccccCccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 566 ETRVIGTFGYLAPEYAQ-SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....|+..|+|||.+. +..++.++|||||||++|+|++|..||..........+ ... ...... .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--------~~~--~~~~~~----~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------DRM--TLTVNV----E 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH--------HHH--hhcCCc----C
Confidence 22346899999999886 45689999999999999999999999965432211000 000 000111 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
.+......+.+++.+||..||.+|| ++.+++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2233445788999999999999999 59988774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.58 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=208.4
Q ss_pred eeEEEEecccCceEEEEEEec--CCC--EEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 408 FSQANFLAEGGFGSVHRGVLP--DGQ--AVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~--~g~--~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
..+.++||+|.||.|++|.|. +|+ .||||.++..... ...+|++|+.+|.+|+|||+++|||+..+ ....||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344568999999999999974 454 5899998876554 56789999999999999999999999987 77899999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
+++.|+|.+.|+......|.......++.|||.||.||..+ ++|||||...|+||.....|||+||||.+.++..+
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999887778899999999999999999999999 99999999999999999999999999999877544
Q ss_pred CCc--ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 563 MGV--ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 563 ~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... .....-...|+|||.+....++.++|||+|||+||||+| |..||-+... ..+.+.+|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL~~iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQILKNIDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHHHhccc
Confidence 221 112233567999999999999999999999999999999 8889865432 122333443
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.-.-.-++.+...+++++..||..+|++||||..|.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 3333455667889999999999999999999999963
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.88 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=196.2
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.|...+.||+|+||.||+|.. .++..||+|.+...... ....+..|+++++.++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 467778899999999999995 47899999987643222 23468889999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+. |+|.+++.. ...++++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 995 688777753 356799999999999999999999999 9999999999999999999999999998754332
Q ss_pred CCcccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 563 MGVETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
....|++.|+|||++. .+.++.++|||||||++|||++|..||........ . ..+...
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~-------------~~~~~~ 239 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L-------------YHIAQN 239 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H-------------HHHHhc
Confidence 2346889999999873 46688999999999999999999999854321100 0 000000
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
.............+.+++.+||+.+|.+||++.++++.+.
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 0001111223446889999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=301.13 Aligned_cols=260 Identities=25% Similarity=0.318 Sum_probs=197.0
Q ss_pred eeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc--CchhHHHHHHHHHhc---CCCCeeeEEEEEEecCc-----
Q 004395 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCA---QHRNVVMLIGFCIEDRR----- 476 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L---~HpNIV~l~~~~~~~~~----- 476 (756)
|++.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+.++.++ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999965 5899999988643322 234566788887766 59999999999998776
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.+++|||+. ++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+|||++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999995 6899888754445799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh--hhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE--EYAID 634 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~--~~~i~ 634 (756)
.+.... ......++..|+|||++.+..++.++|||||||++|||++|..||........ +..+...... .....
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcC
Confidence 764332 12234578899999999999999999999999999999999999875432211 1110000000 00000
Q ss_pred -------hccCCccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 635 -------ELVDPRLG---NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 635 -------~l~dp~l~---~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
........ ..........+.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0011123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.59 Aligned_cols=250 Identities=25% Similarity=0.319 Sum_probs=209.4
Q ss_pred HhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecc---cCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL---ASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~---~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
+..+.|+.-++||+||||.||-+. ..+|+.||+|.+.. ....+....++|-.+|.+++.+.||.+-..|+..+.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 445678999999999999999988 45899999996543 23345566889999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
|||..|.||+|.-+|+...+..+++..++.++.+|+.||++||.. +||+|||||+|||||+.|+++|+|.|||..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999999987777899999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.++... ...+||.+|||||++.++.|+...|+|||||+||||+.|+-||.....+... ..++..+.
T Consensus 338 ~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~------------eEvdrr~~ 403 (591)
T KOG0986|consen 338 PEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR------------EEVDRRTL 403 (591)
T ss_pred CCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH------------HHHHHHHh
Confidence 876643 3448999999999999999999999999999999999999999654432110 01111111
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRM 671 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~ 671 (756)
.-...++.....+..++....|+.||.+|.-.
T Consensus 404 -~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 404 -EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred -cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 01133555566678889999999999999643
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.91 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=205.7
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
-|.++..||.|+||.||+|+.+ ++-..|-|++...+....++|+-|++||..+.||+||+|++.|...+.+||+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 4666778999999999999955 455667788887777788899999999999999999999998888899999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
||-.+..+.. -+..|.+.++..++.|++.||.|||++ +|||||||..|||++-+|.++|+|||.+..... ....
T Consensus 113 GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 113 GGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred CchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 9999888865 467899999999999999999999999 999999999999999999999999999864322 1223
Q ss_pred ccccccCccccCcccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 566 ETRVIGTFGYLAPEYA-----QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l-----~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
...++|||.|||||+. ...+|+.++||||||++|.||..+.+|.....+. +-+ ..+..--.|.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---------RVl---lKiaKSePPT 254 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---------RVL---LKIAKSEPPT 254 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---------HHH---HHHhhcCCCc
Confidence 4568899999999977 4578999999999999999999999997543321 111 1111111222
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+ ..+......+.+++.+||..||..||++.+++++
T Consensus 255 L--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 255 L--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred c--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2 1234455678999999999999999999999874
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.10 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=198.4
Q ss_pred CeeEEEEecccCceEEEEEEe----cCCCEEEEEEecccCC----cCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCce
Q 004395 407 GFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLASS----QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~~~~~~~----~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~ 477 (756)
+|++.+.||.|+||.||++.. .+|..||+|.+..... .....+..|+++|..+ +|+||+.+++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999984 4789999998764322 2235678899999999 599999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++||||+|+|||++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999964 45789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCcccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
.............|+..|+|||++.+ ..++.++||||||+++|+|++|..||........ ...+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~---------~ 223 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISR---------R 223 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHH---------H
Confidence 65433333334568999999999875 3468899999999999999999999964322111 111110 0
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLR 676 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~ 676 (756)
+... ...++......+.+++.+||..||++|| ++.+++.
T Consensus 224 ~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 224 ILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000 0112233445688999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=316.45 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=198.7
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----c
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----R 476 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~-----~ 476 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||.+... .......+.+|+.+|+.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45899999999999999999994 57899999987643 2223456788999999999999999999886543 4
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+||||+ +++|.+++. ..+.+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 84 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELM-DTDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCC-CCCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 79999998 578988886 346799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhhh-------h
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWARP-------L 627 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~~-------~ 627 (756)
...... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ....... .
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 664432 12234568899999998865 568899999999999999999999996432111000 0000000 0
Q ss_pred hhhhhhh----h---ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 LEEYAID----E---LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 ~~~~~i~----~---l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....... . ...+... ...+.....+.+++.+||+.+|++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000 0 0000000 0112234568899999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=316.54 Aligned_cols=266 Identities=22% Similarity=0.320 Sum_probs=199.5
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEe----cCce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~----~~~~ 477 (756)
..+|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36899999999999999999994 4799999998764322 234567889999999999999999998763 3468
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehh-hhhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999999 5789998863 45699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCC---cccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh-h-h---hh
Q 004395 558 QPDGDMG---VETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA-R-P---LL 628 (756)
Q Consensus 558 ~~~~~~~---~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~-~-~---~~ 628 (756)
....... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......+....... . + ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 1234578999999998865 56899999999999999999999999654322110000000 0 0 00
Q ss_pred ---hhhhhhhccC---CccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 629 ---EEYAIDELVD---PRLG---NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 629 ---~~~~i~~l~d---p~l~---~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....+.+... .... ..........+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 0000 00112234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.70 Aligned_cols=262 Identities=23% Similarity=0.256 Sum_probs=200.0
Q ss_pred eeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
|.+.+.||.|++|.||+|.. .+|+.+|+|.+...... ....+..|+++|+.++|+||+++++++.++...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678899999999999995 47899999987654332 3457888999999999999999999999999999999998
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
. ++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||.+....... .
T Consensus 81 ~-~~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 D-TDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred C-CCHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 5 5888888652 36899999999999999999999999 99999999999999999999999999998775543 1
Q ss_pred cccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch--hhhhhh------hhhh---hh
Q 004395 565 VETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL--TEWARP------LLEE---YA 632 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l--~~~~~~------~~~~---~~ 632 (756)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........... .....+ .... ..
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 22334578899999998776 789999999999999999999999965432211000 000000 0000 00
Q ss_pred hhhccCC--ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 633 IDELVDP--RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 633 i~~l~dp--~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
...+... .............+.+++.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 0000111234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.24 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=195.9
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCCh
Q 004395 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 414 LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
||.|+||.||++... +|+.||+|.+..... .....+.+|++++.+++||||+++++.+......|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 599999998765433 3345788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC------
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM------ 563 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~------ 563 (756)
.+++.. .+.+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN--VGSLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999974 34789999999999999999999999 999999999999999999999999999875443211
Q ss_pred -CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 564 -GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 564 -~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
.......++..|+|||.+....++.++||||||+++|+|++|..||........ . ..+......
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~---------~~~~~~~~~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------F---------QNILNGKIE 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------H---------HHHhcCCcC
Confidence 122345688899999999888899999999999999999999999965432110 0 000000000
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
..........+.+++.+||+.+|.+|||+..+.+.|+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000012456889999999999999999966666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.36 Aligned_cols=266 Identities=24% Similarity=0.303 Sum_probs=197.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEeccc--CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEec--Cce
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED--RRR 477 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~--~~~ 477 (756)
..++|.+.+.||+|+||.||+|... +|+.+|+|.+... .......+.+|+.++.++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999954 6889999977532 222334677899999999 999999999998654 367
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|+||||+. ++|..++.. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.++|+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999995 699988853 3789999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC----CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hhhhhh-----
Q 004395 558 QPDGDM----GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TEWARP----- 626 (756)
Q Consensus 558 ~~~~~~----~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~~----- 626 (756)
...... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||........... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 654322 12234568999999998755 5678999999999999999999999964432211000 000000
Q ss_pred ------hhhhhhhhhccCCcc--CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 627 ------LLEEYAIDELVDPRL--GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 627 ------~~~~~~i~~l~dp~l--~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
......+........ ...........+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000 000111134578999999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=303.87 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=201.4
Q ss_pred CeeEEEEecccCceEEEEEEe----cCCCEEEEEEecccC----CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCce
Q 004395 407 GFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~~~~~~----~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~ 477 (756)
+|.+.+.||+|+||.||++.. .+++.||||.++... ......+..|++++.++ +||||+.+++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488899999999999999883 357889999876322 22335688999999999 599999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|+||||+.+++|.+++.. ...+++..+..++.|+++||.|||.. +++||||||.||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999863 45789999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCCcccccccCccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQ--ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
.............|+..|+|||.+.+.. ++.++||||||+++|||++|..||........ ...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~-----~~~~~ 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISR-----RILKS 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHH-----HHHcc
Confidence 6543322233456899999999987654 78899999999999999999999964322110 011100 00000
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+ ..+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 228 --~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11 1122233468899999999999999999988887763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=299.09 Aligned_cols=244 Identities=22% Similarity=0.252 Sum_probs=189.3
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHH-HhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVL-SCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL-~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||.|+||.||+|.. .+|+.||+|.+..... .....+..|..++ ..++|+||+++++++..++..|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4699999999999985 4689999998764322 1122344555544 445899999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+|||++.++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999963 45789999999999999999999999 999999999999999999999999999875433 2
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ..... . .. .........
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~----~-~~--~~~~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNI----L-SR--RINWPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH----H-hc--ccCCCCccc
Confidence 33468899999999988889999999999999999999999996433210 00000 0 00 000011111
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
......+.+++.+||..+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 223456899999999999999997766655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.10 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=201.5
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----cee
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RRL 478 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~-----~~~ 478 (756)
+|.+.+.||.|+||.||+|... +|+.||||.+.... ......+.+|+++++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999964 58999999876543 233457889999999999999999999998775 789
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+. ++|.+++.. ..++++..++.++.||+.||+|||+. ||+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999995 689888863 44899999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCC--CcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhh-hhhh----
Q 004395 559 PDGDM--GVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWAR-PLLE---- 629 (756)
Q Consensus 559 ~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~-~~~~---- 629 (756)
..... .......++..|+|||++.+. .++.++|+||||+++|+|++|..||.......... ...... +...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 55431 122345688999999999887 78999999999999999999999997554321100 000000 0000
Q ss_pred --hhhhhhcc---CCcc---CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 --EYAIDELV---DPRL---GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 --~~~i~~l~---dp~l---~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.......+ .... ...........+.+++.+||+.+|.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 0000 000111234568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.60 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=210.0
Q ss_pred eeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
|.++..||+|+||.||+|.. .+|+.+|||.+.. ..+..++..|+.++.+++.|+||++||.|..+..+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 55677899999999999984 5799999997654 34567899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|++.+.++. .+++|++..+..++...++||+|||.. .=||||||..||||+.+|..||+|||.|-.+.+ .....
T Consensus 113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKR 186 (502)
T KOG0574|consen 113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKR 186 (502)
T ss_pred CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhh
Confidence 999999975 678999999999999999999999998 779999999999999999999999999976654 23456
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
++++|||.|||||++..-.|+.++||||||++..||.-|++||....+... -.-+.. .|...-..+
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------------IFMIPT--~PPPTF~KP 252 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------------IFMIPT--KPPPTFKKP 252 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------------eEeccC--CCCCCCCCh
Confidence 678999999999999999999999999999999999999999964433211 001111 121222234
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+.....+.+++..||-..|++|-|+.+++++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 5566789999999999999999999999875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=305.00 Aligned_cols=266 Identities=24% Similarity=0.272 Sum_probs=195.2
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~------ 475 (756)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999995 46899999987644322 2346788999999999999999999875543
Q ss_pred --ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 476 --RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 476 --~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
.+++||||+ .++|...+.. ....+++..+..++.|+++||.|||+. ||+||||||+|||++.++.++|+|||
T Consensus 87 ~~~~~lv~~~~-~~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYM-DHDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecC-CcCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCc
Confidence 469999998 4577777754 345799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCC----------cccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hh
Q 004395 554 LARWQPDGDMG----------VETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LT 621 (756)
Q Consensus 554 lA~~~~~~~~~----------~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~ 621 (756)
+++........ ..+...|++.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865432211 1123467889999998765 457899999999999999999999996543321100 00
Q ss_pred hhhhhhh-hh----hhhhhccCCccCCCCC-------hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 622 EWARPLL-EE----YAIDELVDPRLGNHYS-------EHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 622 ~~~~~~~-~~----~~i~~l~dp~l~~~~~-------~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
....... .. ..+....+.......+ ......+.+++.+||..||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 00 0000000000000000 112246889999999999999999999876
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=306.88 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=193.3
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCC
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggs 488 (756)
++.+|.|+++.||++.. +++.||||++... .......+..|+++++.++|+||+++++++.+.+..+++|||+.+++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556655555554 7899999988654 23344679999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC-----
Q 004395 489 LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM----- 563 (756)
Q Consensus 489 L~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~----- 563 (756)
|.+++.......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999765556789999999999999999999999 999999999999999999999999999875532211
Q ss_pred -CcccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh---hhhhhhh------
Q 004395 564 -GVETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA---RPLLEEY------ 631 (756)
Q Consensus 564 -~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~---~~~~~~~------ 631 (756)
.......++..|+|||++.+ ..++.++|||||||++|||++|..||........ .+.... .......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhc
Confidence 11123457888999999876 4588999999999999999999999975432111 000000 0000000
Q ss_pred -hhhh----ccCCc----cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 632 -AIDE----LVDPR----LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 632 -~i~~----l~dp~----l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.... ...+. ............+.+++.+||..||++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 0011122334568899999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.55 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=202.4
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV 480 (756)
++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++.++. ||||+++++++..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999954 79999999876422 233457889999999999 99999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+++|.+++.. ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999974 34799999999999999999999999 999999999999999999999999999986654
Q ss_pred CCC-------------------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 004395 561 GDM-------------------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 561 ~~~-------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~ 621 (756)
... .......|+..|+|||.+....++.++||||||++++++++|+.||...... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~- 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--LTF- 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--HHH-
Confidence 321 1223356789999999998888999999999999999999999999744310 000
Q ss_pred hhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 004395 622 EWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRM----SQVLR 676 (756)
Q Consensus 622 ~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~----~eVL~ 676 (756)
. .... ....++......+.+++.+||..+|++||++ .++++
T Consensus 232 -------~-----~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 -------Q-----KILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -------H-----HHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 0000 0111222234568899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=304.69 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=196.9
Q ss_pred EEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCChh
Q 004395 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLD 490 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~ 490 (756)
..||+|+||.||++.. .+|+.||||++..........+.+|+.+++.++|+||+++++++..++..++||||+.+++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4699999999999985 578999999876554445567899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcccccc
Q 004395 491 SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI 570 (756)
Q Consensus 491 ~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~ 570 (756)
+++. ...+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 106 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 106 DIVT---HTRMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 9874 34689999999999999999999999 999999999999999999999999999876543221 123356
Q ss_pred cCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHH
Q 004395 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEV 650 (756)
Q Consensus 571 Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~ 650 (756)
|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ... +.....+.+.. .....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~------~~~------~~~~~~~~~~~--~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKM------IRDNLPPKLKN--LHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH------HHhhCCcccCC--cccCC
Confidence 88999999999888899999999999999999999999864322100 000 01111111111 11223
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 651 YCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 651 ~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..+.+++.+||..+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 45788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=302.60 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=195.3
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV 480 (756)
..++|.+.+.||+|+||.||+|... +++.||||.++.... .....+..|+.++..+. ||||++++++|.+....|+|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3467899999999999999999975 489999998864432 23345677887777775 99999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+ +++|.+++.. ....+++..+..++.|++.||+|||+.+ +|+||||+|+||++++++.++|+|||++.....
T Consensus 93 ~e~~-~~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELM-STCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eecc-CcCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9998 5677777654 3458999999999999999999999731 899999999999999999999999999976543
Q ss_pred CCCCcccccccCccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQ----ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... ..+. ... ...
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~-----~~~ 235 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLT----KIL-----QEE 235 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHH----HHh-----cCC
Confidence 321 22335788999999987553 7899999999999999999999996422110 0000 000 000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+... ........+.+++.+||..||++||++.++++.
T Consensus 236 -~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 -PPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01110 011233468999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=299.97 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=187.7
Q ss_pred EecccCceEEEEEEe-cCCCEEEEEEecccCCc---CchhHHHHHHH---HHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 413 FLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEV---LSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~---~~~~f~~Ev~i---L~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
.||+|+||.||+|.. .+++.||+|.+...... ....+..|..+ ++...||||+.+++++.+....|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 46899999987643221 12234445444 444579999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
|++|.+++. ..+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999886 346799999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....|+..|+|||++.++ .++.++|||||||++|||++|+.||........... . .......+.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--------~--~~~~~~~~~---- 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------D--RMTLTMAVE---- 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--------H--HHhhccCCC----
Confidence 2234689999999998754 689999999999999999999999965422111000 0 000001111
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLR 676 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~ 676 (756)
.+......+.+++.+||..+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1222345688999999999999999 9999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.19 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=196.1
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEec---------
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--------- 474 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--------- 474 (756)
.++|.+.+.||.|+||.||+|.. .+|+.||+|.+..........+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 47899999999999999999995 57899999988766655566788999999999999999999876544
Q ss_pred -----CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-CCcce
Q 004395 475 -----RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPL 548 (756)
Q Consensus 475 -----~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-~~~vk 548 (756)
...|+||||+. ++|.+++. ...+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEE
Confidence 35789999995 68988884 34689999999999999999999999 9999999999999974 56789
Q ss_pred eeccccceecCCCCC--CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh
Q 004395 549 VGDFGLARWQPDGDM--GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 549 L~DFGlA~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 625 (756)
|+|||+++....... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+...........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999986533211 11123457889999997654 567899999999999999999999996543221100000000
Q ss_pred hhhhhh-------hhhhccC-CccCC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 PLLEEY-------AIDELVD-PRLGN-----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ~~~~~~-------~i~~l~d-p~l~~-----~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+..... .+..... ..... .........+.+++.+||..||.+|||+.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000 0000000 00000 0011233567899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=308.20 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=192.7
Q ss_pred Eeccc--CceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 413 FLAEG--GFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 413 ~LG~G--~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
.||.| +||+||++.. .+|+.||+|++...... ..+.+.+|+.+++.++||||++++++|..+...++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999995 57999999987654322 2356888999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC---
Q 004395 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--- 564 (756)
Q Consensus 488 sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~--- 564 (756)
+|.+++.......+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++++||+.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999998765555789999999999999999999998 9999999999999999999999999865432211100
Q ss_pred ---cccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh-hh----h----hhh
Q 004395 565 ---VETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA-RP----L----LEE 630 (756)
Q Consensus 565 ---~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~-~~----~----~~~ 630 (756)
......++..|+|||++.+ ..++.++|||||||++|||++|..||........ ..... .+ . ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccch
Confidence 0011235667999999976 3478999999999999999999999965432111 00000 00 0 000
Q ss_pred -------------hhhh----------hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 631 -------------YAID----------ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 631 -------------~~i~----------~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+. ..................+.+|+.+||..||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 0001111111223455678999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=308.49 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=199.5
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEe-cCc
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRR 476 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~-~~~ 476 (756)
+...+++|.+.+.||.|+||.||+|.. .+|+.||+|++.... ......+..|+++++.++||||++++++|.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 344678999999999999999999984 479999999875322 2234568899999999999999999999875 557
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+||||+ +++|.+++. ..++++..+..++.|++.||.|||+. +|+||||+|+|||++.++.++|+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 89999998 778988884 35688999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhh--------hhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEW--------ARP 626 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~--------~~~ 626 (756)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.+. ...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 133467889999998766 568999999999999999999999996543211100 0000 000
Q ss_pred hhhhhhhhhccCCccCCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 627 LLEEYAIDELVDPRLGNHY-----SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~-----~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
........-+..-...... .+.....+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000011 11234578899999999999999999999774
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=307.49 Aligned_cols=263 Identities=22% Similarity=0.261 Sum_probs=195.6
Q ss_pred CCee-EEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcC--------------chhHHHHHHHHHhcCCCCeeeEEE
Q 004395 406 GGFS-QANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG--------------DHEFCSEVEVLSCAQHRNVVMLIG 469 (756)
Q Consensus 406 ~~y~-~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~--------------~~~f~~Ev~iL~~L~HpNIV~l~~ 469 (756)
++|. +.+.||.|+||.||+|.. .+++.||||++....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 457799999999999995 478999999876432221 124788999999999999999999
Q ss_pred EEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCccee
Q 004395 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (756)
Q Consensus 470 ~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL 549 (756)
++...+..++||||+. ++|.+++. ....+++.....++.|++.||.|||+. ||+|+||+|+|||++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEEE
Confidence 9999999999999995 79999886 345689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCC-------------CCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcc
Q 004395 550 GDFGLARWQPDGD-------------MGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPK 615 (756)
Q Consensus 550 ~DFGlA~~~~~~~-------------~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 615 (756)
+|||++....... ........+++.|+|||++.+. .++.++|||||||++|||++|..||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998665111 0111223468889999998764 4689999999999999999999999755432
Q ss_pred cccc-hhhhhhhhhhhhhhhhc------------cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 616 GQQC-LTEWARPLLEEYAIDEL------------VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 616 ~~~~-l~~~~~~~~~~~~i~~l------------~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.... ........ ....+... ..+... .........+.+++.+||..+|++||++.+++..
T Consensus 241 ~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQLGRIFELLGTP-NEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHhCCC-chhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1100 00000000 00000000 000000 0011224568899999999999999999999873
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=295.80 Aligned_cols=247 Identities=19% Similarity=0.220 Sum_probs=191.1
Q ss_pred HHHhhCCeeEEEEe--cccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCc
Q 004395 401 LELATGGFSQANFL--AEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 401 l~~~~~~y~~~~~L--G~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~ 476 (756)
.....++|.+.+.+ |+|+||.||++.. .++..+|+|.+....... .|+.+...+ +||||++++++|...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33344567776666 9999999999994 578899999876432211 133333323 69999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-cceeeccccc
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLA 555 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-~vkL~DFGlA 555 (756)
.|+||||+++++|.+++.. ...+++..++.++.|+++||.|||+. |++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999964 34899999999999999999999999 999999999999999998 9999999999
Q ss_pred eecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
...... ....|+..|+|||++.+..++.++||||||+++|||++|..||........ ....+. .
T Consensus 158 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~----------~ 221 (267)
T PHA03390 158 KIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLL----------K 221 (267)
T ss_pred eecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHH----------H
Confidence 865432 234588999999999998999999999999999999999999974322110 001110 0
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR-MSQVLR 676 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-~~eVL~ 676 (756)
..... ..........+.+++.+||+.+|.+||+ ++++++
T Consensus 222 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 222 RQQKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00000 0111234456899999999999999995 698875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=311.32 Aligned_cols=269 Identities=22% Similarity=0.253 Sum_probs=200.7
Q ss_pred ChHHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEe
Q 004395 397 SYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~ 473 (756)
...++....++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|++++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3455666789999999999999999999984 5789999998764322 223568889999999999999999998864
Q ss_pred c------CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcc
Q 004395 474 D------RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (756)
Q Consensus 474 ~------~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~v 547 (756)
. ...|++++++ +++|.+++. ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCCE
Confidence 3 3468888886 899988874 34699999999999999999999999 99999999999999999999
Q ss_pred eeeccccceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhh
Q 004395 548 LVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWAR 625 (756)
Q Consensus 548 kL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~ 625 (756)
+|+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.......... ......
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999999854322 234568899999998866 568899999999999999999999996433211100 000000
Q ss_pred ----hh---hhhh---hhhhccCCccCC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 ----PL---LEEY---AIDELVDPRLGN---HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ----~~---~~~~---~i~~l~dp~l~~---~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .... .....+...... .........+.+++.+||+.||.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0000 000000000000 0001123468899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=339.58 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=193.2
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEec-------
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------- 474 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~------- 474 (756)
...+|+.+.+||+||||.||+++.+ ||+.||||++.... ......+.+|+.+|++|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3456777889999999999999954 89999999887653 22345688999999999999999998654320
Q ss_pred --------------------------------------------------------------------------------
Q 004395 475 -------------------------------------------------------------------------------- 474 (756)
Q Consensus 475 -------------------------------------------------------------------------------- 474 (756)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 004395 475 --------------------------------RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522 (756)
Q Consensus 475 --------------------------------~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~ 522 (756)
..+||-||||+.-+|.+++..+.... .....|+++.+|++||.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 12588999998888888886432211 467889999999999999999
Q ss_pred hcccCceEeeccCCCceeecCCCcceeeccccceecC-----------------CCCCCcccccccCccccCccccccC-
Q 004395 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP-----------------DGDMGVETRVIGTFGYLAPEYAQSG- 584 (756)
Q Consensus 523 ~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~-----------------~~~~~~~~~~~Gt~~Y~APE~l~~~- 584 (756)
. |||||||||.||+|+.++.|||+|||+|+... .......+..+||.-|+|||++.+.
T Consensus 716 ~----giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 716 Q----GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred C----ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9 99999999999999999999999999998611 0112244667899999999999764
Q ss_pred --CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC--CChhHHHHHHHHHHHh
Q 004395 585 --QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH--YSEHEVYCMLHAASLC 660 (756)
Q Consensus 585 --~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~--~~~~~~~~l~~Li~~C 660 (756)
.|+.|+|+||||+||+||+. ||..... ....+..+.++.+... +.......-..+|.+|
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--------------Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSME--------------RASILTNLRKGSIPEPADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHH--------------HHHHHHhcccCCCCCCcccccccchHHHHHHHHH
Confidence 59999999999999999996 5653321 1122233333333222 2333344567899999
Q ss_pred cccCCCCCCCHHHHHH
Q 004395 661 IRRDPHSRPRMSQVLR 676 (756)
Q Consensus 661 L~~dP~~RPS~~eVL~ 676 (756)
++.||.+|||+.|+|.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999987
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=299.67 Aligned_cols=262 Identities=26% Similarity=0.320 Sum_probs=198.0
Q ss_pred eeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc-CchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEEee
Q 004395 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
|.+.+.||+|+||.||+|... +++.||||.+...... ......+|+..+.+++ |+||+++++++.++...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677889999999999999964 5889999987644322 2234567999999999 999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
+|+|.+++.......+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 89999988754446789999999999999999999999 99999999999999999999999999998664432
Q ss_pred cccccccCccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhhh-----hhhhhhhhhcc
Q 004395 565 VETRVIGTFGYLAPEYAQ-SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWARP-----LLEEYAIDELV 637 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~~-----~~~~~~i~~l~ 637 (756)
......++..|+|||++. ...++.++|+||||+++|||++|+.||.......... ...+... ......+....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 123456889999999875 4557899999999999999999999996543321100 0000000 00000000000
Q ss_pred CCccC-------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 638 DPRLG-------NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 638 dp~l~-------~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
...+. ..........+.+++.+||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000 0001112356889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=318.97 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=208.4
Q ss_pred hhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcC--chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~--~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
..+.|.+...||+|.|+.|.+|+ ..++..||||++....... ...+.+|++++..|.|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 45789999999999999999999 4579999999887554332 24588999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+|.+.+++. ..+...+..+..++.|+.+|++|||.+ +|+|||||.+||||+.+.++||+|||++.++..
T Consensus 134 ~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999997 456677799999999999999999999 999999999999999999999999999998875
Q ss_pred CCCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
+. ...+++|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++..-..- ..+
T Consensus 208 ~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------------r~r 266 (596)
T KOG0586|consen 208 GL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------------RPR 266 (596)
T ss_pred cc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------------cch
Confidence 44 4567899999999999999888 5899999999999999999999986543211 111
Q ss_pred ccCCC--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 RLGNH--YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~l~~~--~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+.+. .+........++++++|-++|.+|++++++...
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111 111222346789999999999999999999764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=309.74 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=197.6
Q ss_pred HHhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC---
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR--- 475 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~--- 475 (756)
....++|.+.+.||+|+||.||+|. ..+|..||||++..... .....+.+|+++|+.++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3356789999999999999999998 45799999998754322 22346889999999999999999999987654
Q ss_pred ---ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecc
Q 004395 476 ---RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 476 ---~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
..++||||+ +++|.+++. ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 889988884 35799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhhh----
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWARP---- 626 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~~---- 626 (756)
|++...... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.......... .......
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999865332 233467899999998876 458899999999999999999999997543211100 0000000
Q ss_pred hhh---hhhhhhccC--CccC----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 627 LLE---EYAIDELVD--PRLG----NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 627 ~~~---~~~i~~l~d--p~l~----~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+.. ......... +... ..........+.+++.+|++.||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000000 0000 0011223345889999999999999999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=301.82 Aligned_cols=244 Identities=29% Similarity=0.407 Sum_probs=193.5
Q ss_pred eeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
|...+.||+|+||.||+|.. .+|+.||+|.+...... ....+..|+++++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56667899999999999995 46899999987643322 234678899999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+ .++|.+++.. ...++++..++.++.||+.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~-~~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 C-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred C-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 9 5678777754 346799999999999999999999999 999999999999999999999999999864322
Q ss_pred CcccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 564 GVETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||......... . .......+.
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~----------~--~~~~~~~~~ 239 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------Y--HIAQNDSPT 239 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH----------H--HHHhcCCCC
Confidence 23456889999999984 466889999999999999999999998643321110 0 000000111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. ........+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 L---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 111223458899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.08 Aligned_cols=260 Identities=23% Similarity=0.311 Sum_probs=193.2
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~------ 475 (756)
..+|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999995 478999999876432 222346889999999999999999999987543
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..|+|+||+. .+|..++ ...+++..+..++.|++.||+|||.. +|+||||||+|||++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4699999984 5776655 24689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh-------
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL------- 627 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~------- 627 (756)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..................
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 754322 234567899999999876 46889999999999999999999999754321110000000000
Q ss_pred -hhhhhhhhccC--CccC-CC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 -LEEYAIDELVD--PRLG-NH---YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 -~~~~~i~~l~d--p~l~-~~---~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
........... +... .. ..+.....+.+++.+||+.||++||++.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 0000 00 001123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=305.87 Aligned_cols=262 Identities=24% Similarity=0.300 Sum_probs=193.4
Q ss_pred CeeEEEEecccCceEEEEEEec-C--CCEEEEEEecccCC--cCchhHHHHHHHHHhc-CCCCeeeEEEEEEec----Cc
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-D--GQAVAVKQHKLASS--QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED----RR 476 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~--g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~----~~ 476 (756)
+|.+.+.||+|+||.||++... + +..||+|.+..... .....+.+|++++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999953 4 78999998764322 2245678899999999 599999999975433 35
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+++||+ +++|.+++. ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.++|+|||+++
T Consensus 81 ~~~~~e~~-~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELM-EADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEecc-cCCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 78889987 579998886 456799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCC---cccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc-------------c
Q 004395 557 WQPDGDMG---VETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQ-------------C 619 (756)
Q Consensus 557 ~~~~~~~~---~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~-------------~ 619 (756)
........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||......... .
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 66532211 1234578999999998765 56899999999999999999999999754321100 0
Q ss_pred hhhhhhhhhhhhhhhhc--cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 620 LTEWARPLLEEYAIDEL--VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 620 l~~~~~~~~~~~~i~~l--~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+..+..+..... .... ................+.+++.+||+.||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNY-IRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHH-HHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 0000 0000000011112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.87 Aligned_cols=245 Identities=29% Similarity=0.421 Sum_probs=194.2
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.|...+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 466677899999999999995 4688999998764322 223467889999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+. |+|.+++.. ...++++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 995 688777753 345689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 563 MGVETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
....|++.|+|||++. ...++.++|||||||++|+|++|..||........ . ..+.....+
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~----------~~~~~~~~~ 232 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----------YHIAQNESP 232 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--H----------HHHhhcCCC
Confidence 2346889999999874 35678899999999999999999999854321100 0 000010011
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. ........+.+++.+||..+|++||++.+++..
T Consensus 233 ~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 233 AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred Cc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11 112234568899999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.02 Aligned_cols=249 Identities=23% Similarity=0.273 Sum_probs=195.9
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC-----CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS-----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~-----~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
+|.+.+.||+|+||.||++... .+..+++|.++... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999853 34556666544321 12234577899999999999999999999999999999
Q ss_pred EEeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 481 YEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
|||+.+++|.+++.. .....+++..++.++.|++.||.|||+. |++|+||||+||+++. +.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999998853 2346799999999999999999999999 9999999999999975 56999999999876
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
..... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... .... .......
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~------~~~~~~~ 222 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVL------RIVEGPT 222 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH------HHHcCCC
Confidence 44321 223456889999999998888999999999999999999999998532210 0000 0001011
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+ ..+......+.+++.+||..+|++||++.++++.
T Consensus 223 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 P----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1 1233444578899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.36 Aligned_cols=248 Identities=25% Similarity=0.294 Sum_probs=200.9
Q ss_pred hCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|..+++||+|.||.|.+++ ..+|+.||+|+++..-- .....-+.|-++|...+||.+..|...|..++++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3567778899999999999998 55899999998875422 2233456799999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||..||.|.-+|. ....+++...+.+...|+.||.|||+. +||+||||.+|+|||.||++||+||||++.-..
T Consensus 247 MeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999996 467799999999999999999999999 999999999999999999999999999984322
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.. ....+++|||.|+|||++....|+.++|+|.+|||+|||++|+.||...... .+.+-.-..++.
T Consensus 321 ~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----------kLFeLIl~ed~k--- 386 (516)
T KOG0690|consen 321 YG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----------KLFELILMEDLK--- 386 (516)
T ss_pred cc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh----------HHHHHHHhhhcc---
Confidence 11 2345789999999999999999999999999999999999999999533211 111111112221
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~ 676 (756)
++....++...|+.-+|..||.+|. .+.||.+
T Consensus 387 ----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 387 ----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 2223334577888999999999995 4555544
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=309.55 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=197.7
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc----
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR---- 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~---- 476 (756)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+.||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999964 68899999876432 2233567789999999999999999988776554
Q ss_pred --eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 477 --RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 477 --~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
.++|+||+ +++|.+++. ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 789999885 35799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc-chhhhhhhhhh---
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQ-CLTEWARPLLE--- 629 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~-~l~~~~~~~~~--- 629 (756)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .+.........
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 9865432 234467889999998865 46789999999999999999999999644321110 00000000000
Q ss_pred ----hhhhhhccC---CccCCCC---ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 ----EYAIDELVD---PRLGNHY---SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 ----~~~i~~l~d---p~l~~~~---~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
......++. ......+ .......+.+++.+||..||++|||+.+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000 0000000 01124578899999999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=292.96 Aligned_cols=262 Identities=26% Similarity=0.335 Sum_probs=198.3
Q ss_pred eeEEEEecccCceEEEEEEec-CCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+..|+++++.++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999954 59999999887653 233456888999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
. ++|.+++... ...+++..++.++.|++.||.|||+. ||+||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 6 6999999753 25799999999999999999999999 999999999999999999999999999986644321
Q ss_pred cccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhhhhh-hhhhhh-hhhhc----
Q 004395 565 VETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LTEWAR-PLLEEY-AIDEL---- 636 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~~~~~-~~~~~~-~i~~l---- 636 (756)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||.......... ...... +..... .+..+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 12233467889999998776 78999999999999999999999996543211100 000000 000000 00000
Q ss_pred -cCCccCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 637 -VDPRLGN----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 637 -~dp~l~~----~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.-+.... ...+.....+.+++..||..||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000112456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=318.74 Aligned_cols=240 Identities=24% Similarity=0.354 Sum_probs=192.5
Q ss_pred EEEecccCceEEEEEEe-cCCCEEE---EEEeccc-CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc--eeEEEEe
Q 004395 411 ANFLAEGGFGSVHRGVL-PDGQAVA---VKQHKLA-SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR--RLLVYEY 483 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~-~~g~~VA---VK~~~~~-~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~--~~LV~Ey 483 (756)
...||+|+|-+||+|.. .+|-.|| ||.-+.. .......|..|+++|+.|+||||+++|+++.+... +-+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 44699999999999995 3576666 3322221 22334679999999999999999999999987665 7799999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-CCcceeeccccceecCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-~~~vkL~DFGlA~~~~~~~ 562 (756)
+..|+|..|+. ..+.++...+..|++||++||.|||++.+ .|||||||.+||+|+. -|.|||+|+|||.......
T Consensus 125 ~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~P--PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDP--PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCC--CccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999997 45678889999999999999999999854 6999999999999976 4999999999999765443
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh---hhhhhhhccCC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL---EEYAIDELVDP 639 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~---~~~~i~~l~dp 639 (756)
...++|||.|||||... ..|++.+||||||+.++||+|+..||.......+ .++... ....+..+-
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-----IYKKV~SGiKP~sl~kV~-- 269 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-----IYKKVTSGIKPAALSKVK-- 269 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-----HHHHHHcCCCHHHhhccC--
Confidence 34578999999999988 8899999999999999999999999976654322 111111 111112221
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..++.++|.+||.. ..+|||+.|+|.
T Consensus 270 ----------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 ----------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 23588999999999 999999999997
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=296.16 Aligned_cols=267 Identities=24% Similarity=0.304 Sum_probs=199.4
Q ss_pred CCeeEEEEecccCceEEEEEEec---C--CCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEe-cCce
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP---D--GQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRRR 477 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~---~--g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~-~~~~ 477 (756)
..|+.+..||+|.||.||+|+.. + ...+|||.++..... .....++|+.+++.|+||||+.|..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46899999999999999999732 2 237999988755332 23468999999999999999999999887 7789
Q ss_pred eEEEEeecCCChhhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC----Ccceee
Q 004395 478 LLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD----FEPLVG 550 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~---~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~----~~vkL~ 550 (756)
+|++||. .-+|...|+.. ..+.++...+..|++||+.|+.|||++ -|+||||||+|||+..+ |.|||+
T Consensus 104 ~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 104 WLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeEee
Confidence 9999997 67888888532 346799999999999999999999999 99999999999999888 999999
Q ss_pred ccccceecCCCCC--CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc----hhhh
Q 004395 551 DFGLARWQPDGDM--GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC----LTEW 623 (756)
Q Consensus 551 DFGlA~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~----l~~~ 623 (756)
|||+|+.+.++-. .....++-|.+|.|||++.+ ..|+.+.|||++|||+.||+|-.+.|.....+.... ..+.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 9999998876532 23445778999999999877 568999999999999999999988885433221110 0000
Q ss_pred -------------hhhhhhhhh-----hhhccCCccCCCCChh--------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 624 -------------ARPLLEEYA-----IDELVDPRLGNHYSEH--------EVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 624 -------------~~~~~~~~~-----i~~l~dp~l~~~~~~~--------~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.++.+.... +..+... ........ -....++|+..+|..||-+|.|+.++++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~-~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRH-YYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHh-hcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 011111110 0000000 00000000 11126789999999999999999999885
Q ss_pred h
Q 004395 678 L 678 (756)
Q Consensus 678 L 678 (756)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 4
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=327.34 Aligned_cols=145 Identities=28% Similarity=0.349 Sum_probs=131.1
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||+|... +++.||||+++..... ....+..|+.++..++||||+++++++......||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 7899999988654322 2356888999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
||+.+++|.+++.. .+.+++..++.|+.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999963 45689999999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=289.51 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=194.3
Q ss_pred EEEEecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEEeecC
Q 004395 410 QANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
.+..||.|..|.|+++.. .+|...|||.+.... ....+.++..+.++...+ .|.||+++|||..+...++.||.| .
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 345699999999999994 579999999876543 334456777777766554 899999999999999999999987 3
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
--++.++. +..+++++..+-++...+.+||.||-++ -+|||||+||+|||+|+.|++||||||++-++.+.. ..
T Consensus 175 ~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeK---H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ah 248 (391)
T KOG0983|consen 175 TCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AH 248 (391)
T ss_pred HHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHh---cceeecccCccceEEccCCCEEeecccccceeeccc--cc
Confidence 44444443 3567899999999999999999999876 289999999999999999999999999998776554 34
Q ss_pred cccccCccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 567 TRVIGTFGYLAPEYAQS---GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
++..|.+.|||||.+.. ..|+.++||||||+.|+||.||+.||.....+-. .... +..-..|.+..
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-----~ltk------vln~ePP~L~~ 317 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-----VLTK------VLNEEPPLLPG 317 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-----HHHH------HHhcCCCCCCc
Confidence 55679999999999854 5789999999999999999999999976543211 0000 11111233322
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. ......+.+++..||.+|+.+||.+.++|++
T Consensus 318 ~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 H--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred c--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 1245578999999999999999999999874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=288.32 Aligned_cols=254 Identities=22% Similarity=0.241 Sum_probs=197.9
Q ss_pred hhCCeeEE-EEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEec----Cc
Q 004395 404 ATGGFSQA-NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED----RR 476 (756)
Q Consensus 404 ~~~~y~~~-~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~----~~ 476 (756)
.+++|.+. ++||-|-.|.|-.++ ..+|+.+|+|++.. ....++|+++.-.. .|||||.++++|... ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667654 479999999999988 45899999997652 23467888876555 599999999998643 34
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---CCcceeeccc
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFG 553 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~~~vkL~DFG 553 (756)
+.+|||.|+||.|...+.++....+++.++-.|+.||+.|+.|||+. +|.||||||+|+|.+. |..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhheeeecCCCCcceEecccc
Confidence 67899999999999999988888999999999999999999999999 9999999999999964 5678999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
+|+..... ....+-+.||.|.|||++...+|+..+|+||+||++|-|++|.+||....- ..+..-.+...... .
T Consensus 210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~g-q 283 (400)
T KOG0604|consen 210 FAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTG-Q 283 (400)
T ss_pred cccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhcc-C
Confidence 99865432 234556789999999999999999999999999999999999999964321 11111111110000 0
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
- .+.............++|+.+|..+|.+|.|+.+++..
T Consensus 284 y-----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 Y-----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0 01111122334456789999999999999999999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=284.43 Aligned_cols=236 Identities=27% Similarity=0.304 Sum_probs=192.6
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCCh
Q 004395 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 414 LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
||.|+||.||++... +++.+|+|.+...... ....+..|+++++.++||||+++++.+..+...|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 5899999987654322 345788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccccc
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 569 (756)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999964 34689999999999999999999998 999999999999999999999999999987654321 22345
Q ss_pred ccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhH
Q 004395 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649 (756)
Q Consensus 570 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~ 649 (756)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ... ..+... ...++...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------~~~-----~~~~~~--~~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----------EIY-----EKILKD--PLRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----------HHH-----HHHhcC--CCCCCCCC
Confidence 6889999999998888899999999999999999999999644320 000 001110 11122223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHH
Q 004395 650 VYCMLHAASLCIRRDPHSRPRMSQ 673 (756)
Q Consensus 650 ~~~l~~Li~~CL~~dP~~RPS~~e 673 (756)
...+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 456889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=329.59 Aligned_cols=259 Identities=20% Similarity=0.244 Sum_probs=209.1
Q ss_pred ChHHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecc---cCCcCchhHHHHHHHHHhcCCCCeeeEEEEEE
Q 004395 397 SYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKL---ASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~---~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~ 472 (756)
....+.....+|.++++||+|+||.|.+++. .+++.||+|+++. .......-|..|-.+|..-..+=|+.+...|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 3455667778999999999999999999994 5799999998764 23444556899999999888999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecc
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
++.++|+|||||+||+|-.+|.. ..++++..++.++..|..||.-||+. |+|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~m----gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHSM----GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHhc----cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999964 23899999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCcccccccCccccCccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQ----S-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~----~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
|.+-.....+.-.....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||.... +..-+..
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~K- 292 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGK- 292 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHH-
Confidence 999877755555556678999999999984 3 679999999999999999999999995332 1111111
Q ss_pred hhhhhhhhccCCccCCCCC--hhHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 004395 628 LEEYAIDELVDPRLGNHYS--EHEVYCMLHAASLCIRRDPHSRPR---MSQVLRI 677 (756)
Q Consensus 628 ~~~~~i~~l~dp~l~~~~~--~~~~~~l~~Li~~CL~~dP~~RPS---~~eVL~~ 677 (756)
+++-.-.-.+| ...+....+||...+ -+|+.|.. +.++-.+
T Consensus 293 --------Im~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 293 --------IMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred --------HhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 11110011112 224456778888877 47888887 8888664
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=283.49 Aligned_cols=220 Identities=23% Similarity=0.193 Sum_probs=177.3
Q ss_pred cCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCChhhhhhc
Q 004395 417 GGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG 495 (756)
Q Consensus 417 G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~ 495 (756)
|.||.||++.. .+++.||+|.+.... .+..|...+....||||+++++++.+....++||||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999994 578999999876432 234555556666799999999999999999999999999999999864
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcccccccCccc
Q 004395 496 CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY 575 (756)
Q Consensus 496 ~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y 575 (756)
...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++....... ....++..|
T Consensus 79 --~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 --FLNIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 34699999999999999999999999 99999999999999999999999999886554321 223457789
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHH
Q 004395 576 LAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLH 655 (756)
Q Consensus 576 ~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~ 655 (756)
+|||++.+..++.++||||+|+++|||++|..|+....... ...... ..+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTL----NIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------cccccc----CCcccCCHHHHH
Confidence 99999988889999999999999999999998875321110 000000 111223346889
Q ss_pred HHHHhcccCCCCCCCHH
Q 004395 656 AASLCIRRDPHSRPRMS 672 (756)
Q Consensus 656 Li~~CL~~dP~~RPS~~ 672 (756)
++.+||+.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=313.02 Aligned_cols=200 Identities=34% Similarity=0.431 Sum_probs=172.5
Q ss_pred CeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC------cee
Q 004395 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------RRL 478 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~------~~~ 478 (756)
.|...+.||+||||.||+|+ ..+|+.||||.++... ....+..++|+++|++|+|+|||+++++=++.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45666789999999999999 5689999999877543 334567899999999999999999999755433 458
Q ss_pred EEEEeecCCChhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec--CCC--cceeeccc
Q 004395 479 LVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT--HDF--EPLVGDFG 553 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~-~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~--~~~--~vkL~DFG 553 (756)
+|||||.||||...|..- +...|++...+.++..+..||.|||++ ||+||||||.||++- .+| ..||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999999653 345799999999999999999999999 999999999999983 223 47899999
Q ss_pred cceecCCCCCCcccccccCccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQ-SGQITEKADVYSFGVVLVELVTGRKAVDLN 612 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~ 612 (756)
.|+...++. ....++||..|++||.+. .+.|+.-+|.|||||++|+++||..||...
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 999887655 567789999999999998 588999999999999999999999999643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=320.45 Aligned_cols=261 Identities=30% Similarity=0.411 Sum_probs=210.2
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec----C----CCEEEEEEecccCC-cCchhHHHHHHHHHhcC-CCCeeeEEEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP----D----GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNVVMLIGF 470 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~----g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~-HpNIV~l~~~ 470 (756)
+++..++..+.+.||+|.||.|++|... . ...||||.++.... .....+..|+++|..+. |+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 5556666677779999999999999832 1 45799998775433 34567999999999995 9999999999
Q ss_pred EEecCceeEEEEeecCCChhhhhhccC------------C--CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCC
Q 004395 471 CIEDRRRLLVYEYICNGSLDSHLYGCH------------Q--EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (756)
Q Consensus 471 ~~~~~~~~LV~Ey~~ggsL~~~L~~~~------------~--~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp 536 (756)
|...+..++|+||++.|+|..+|..+. . ..|+....+.++.||+.|++||++. .+|||||-.
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLAa 446 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLAA 446 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----Cccchhhhh
Confidence 999999999999999999999997543 0 2388999999999999999999999 899999999
Q ss_pred CceeecCCCcceeeccccceecCCCCCCccccccc--CccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 004395 537 NNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG--TFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNR 613 (756)
Q Consensus 537 ~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~G--t~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~ 613 (756)
+|||++.+..+||+|||+|+...+........-.| ...|||||.+....|+.++||||||++||||+| |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999665544333222222 445999999999999999999999999999999 778885421
Q ss_pred cccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 614 PKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 614 ~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. .+ +-+.+........+..+...+.+++..||+.+|++||++.++.+.|+.
T Consensus 527 ~~-----~~----------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 527 PT-----EE----------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred cH-----HH----------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 10 00 111223333334455566789999999999999999999999999986
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-33 Score=267.16 Aligned_cols=264 Identities=22% Similarity=0.264 Sum_probs=204.0
Q ss_pred CeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|...+.||+|.||+||+|+ +.+++.||+|.++..... .....++|+-+|+.++|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45666789999999999999 567999999988765433 345789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
| ..+|..+... -++.++.+.+..++.|+++||.|+|++ +++||||||.|+||+.+|++||+|||+|+.++-+..
T Consensus 83 c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred h-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 8 7889888865 467899999999999999999999999 999999999999999999999999999998765432
Q ss_pred CcccccccCccccCccccccCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhh---hhccC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQ-ITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAI---DELVD 638 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i---~~l~d 638 (756)
... .-+-|.+|.+|.++.+.+ |+...|+||.||++.|+.. |++.|.......+....-|......+..+ ..+.|
T Consensus 157 cys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 CYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 222 234689999999998754 7899999999999999987 66667666555443222222222222221 22222
Q ss_pred CccCCCCChh-----HH----HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEH-----EV----YCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~-----~~----~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
-.....|+.. .+ ..-.+++...+.-+|..|.++++.++.
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2222222221 11 123578888889999999999998874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=309.28 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=217.1
Q ss_pred CChHHHHHhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 004395 396 FSYAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIE 473 (756)
Q Consensus 396 ~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~ 473 (756)
..++.+...+.-|++...||.|.+|.||++. .++|+.+|+|++.... ...+++..|.++|+.+. |||++.++|+|..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 4455555667789999999999999999999 5689999999887654 44557888999999885 9999999999864
Q ss_pred -----cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcce
Q 004395 474 -----DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548 (756)
Q Consensus 474 -----~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vk 548 (756)
++.+|||||||.+|+.-|++....+..+.|..+..|+..++.||.+||.+ .+||||||-.|||++.++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcEE
Confidence 56899999999999999999877788999999999999999999999999 899999999999999999999
Q ss_pred eeccccceecCCCCCCcccccccCccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhh
Q 004395 549 VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS-----GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW 623 (756)
Q Consensus 549 L~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~ 623 (756)
|+|||++..+.. ..+...+.+|||.|||||++.. ..|+.++|+||||++..||.-|.+|+-..-+
T Consensus 164 LvDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------- 233 (953)
T KOG0587|consen 164 LVDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------- 233 (953)
T ss_pred Eeeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------
Confidence 999999986643 3445667889999999999854 3478899999999999999999999854322
Q ss_pred hhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 624 ~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
......+.. +|...-..+......+.++|..||..|..+||++.+++++
T Consensus 234 ---mraLF~IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 234 ---MRALFLIPR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---hhhhccCCC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111112222 2333333455667789999999999999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-33 Score=286.38 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=203.0
Q ss_pred hHHHHHhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecC
Q 004395 398 YAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDR 475 (756)
Q Consensus 398 ~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~ 475 (756)
|.++...++ +.||+|+|+.|--++ +.+|..||||++............+|++++...+ |+||++|++||+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 555555553 479999999999988 7899999999988776666778889999999986 999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc---ceeecc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDF 552 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~---vkL~DF 552 (756)
++|||||-|.||.|..+|+ ....+++.++.++..+|+.||.|||.+ ||.||||||+|||-.+-.. +|||||
T Consensus 150 ~FYLVfEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999998 456799999999999999999999999 9999999999999976554 799999
Q ss_pred ccceecCCCCC------CcccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 004395 553 GLARWQPDGDM------GVETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 553 GlA~~~~~~~~------~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~ 621 (756)
.|..-...... ....+.+|+..|||||+.. ...|+.++|.||||+|||-||.|.+||.+.--.. +-
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--CG- 300 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--CG- 300 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--CC-
Confidence 99864322111 1123457889999999762 3568999999999999999999999996543221 11
Q ss_pred hhhhhhh----hhhhhhhccCCc--cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 622 EWARPLL----EEYAIDELVDPR--LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 622 ~~~~~~~----~~~~i~~l~dp~--l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
|.+.-. .+.-+..+-+.. +...-..+......++++.++..|+.+|.++.+++.
T Consensus 301 -WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 -WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111100 000011111110 111112234556788999999999999999999887
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=302.21 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=201.6
Q ss_pred EEEecccCceEEEEEE-ecCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 411 ANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
.+.||+|.||+||-|. .++|+.||||++.... ......+++|+.||..++||+||.|-..|+..++.++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 4689999999999999 5689999999876432 334467999999999999999999999999999999999998 67
Q ss_pred ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC---CcceeeccccceecCCCCCC
Q 004395 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD---FEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 488 sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~---~~vkL~DFGlA~~~~~~~~~ 564 (756)
++.+.|.....++|++.....+..||+.||+|||.+ +|+|+||||+||||... ..+||||||+|++.++..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 777777666889999999999999999999999999 99999999999999654 468999999999987654
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc-CCccCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV-DPRLGN 643 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~-dp~l~~ 643 (756)
....++|||.|+|||++....|...-|+||.|||+|--+.|..||........+. .-..++ .+..+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI------------QNAaFMyPp~PW- 788 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI------------QNAAFMYPPNPW- 788 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh------------hccccccCCCch-
Confidence 3456899999999999999999999999999999999999999997544322210 001111 12222
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+......+||...|+..-.+|.+.++.+.+
T Consensus 789 ---~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 789 ---SEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ---hhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 2333457789999999999999999887653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=292.15 Aligned_cols=243 Identities=21% Similarity=0.277 Sum_probs=198.2
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCce
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~ 477 (756)
+-..+|.++.+||.|+||.|.+|..+ +.+.||||+++..- ..+.+--+.|-++|.... -|.++++..+|..-+++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34467999999999999999999854 57789999887542 222333456778877664 68999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|+||||+.||+|--+++ .-+.+.+..+..+|..|+-||-|||++ |||+||||.+||||+.+|++||+|||+++.
T Consensus 426 yFVMEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999997 457788899999999999999999999 999999999999999999999999999984
Q ss_pred cCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
-.-+.. ...+++|||.|+|||++..++|+..+|+|||||+||||+.|++||+...... ....+.
T Consensus 500 ni~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---------------lF~aI~ 563 (683)
T KOG0696|consen 500 NIFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---------------LFQAIM 563 (683)
T ss_pred cccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHH
Confidence 332222 3456899999999999999999999999999999999999999998664321 111111
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCC
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP 669 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP 669 (756)
+.. -.|+.....+...+....|...|.+|.
T Consensus 564 ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred Hcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 111 235556666778888889999999995
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=305.77 Aligned_cols=240 Identities=25% Similarity=0.286 Sum_probs=194.4
Q ss_pred hCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+..|.+...+|.|+|+.|-.+. ..+++..++|++.... .+-..|+.++... +||||+++.+.+.++...|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5678888889999999999988 5678999999887552 2334577666655 69999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee-cCCCcceeeccccceecCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL-THDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL-~~~~~vkL~DFGlA~~~~~~ 561 (756)
++.|+-|.+.+.. .+.....+..|+.+|+.|+.|||++ |||||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~---~~~~~~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---KPEFCSEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---cchhHHHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988888853 2333377888999999999999999 99999999999999 68999999999999876544
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
..+-+-|..|.|||++....|++++||||||++||+||+|+.||...... .. ....+..+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~e-------------i~~~i~~~-- 529 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IE-------------IHTRIQMP-- 529 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HH-------------HHHhhcCC--
Confidence 22334688999999999999999999999999999999999999754322 00 01111122
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+.........+|+.+||+.||.+||+|.+++..
T Consensus 530 --~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 --KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2224455678999999999999999999999763
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=295.54 Aligned_cols=266 Identities=22% Similarity=0.266 Sum_probs=206.1
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC--C----CeeeEEEEEEec
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH--R----NVVMLIGFCIED 474 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H--p----NIV~l~~~~~~~ 474 (756)
...+++|.+...||+|.||.|-.+.. ..+..||||+++.... -.+..+-|+++|.++.+ | -+|.+.++|.-.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 44578999999999999999999883 4578999998875432 23346679999999942 3 378899999999
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-----------
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH----------- 543 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~----------- 543 (756)
+..|||+|.+ |.++.++|..++-.+++...++.|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEEEeccCC
Confidence 9999999998 88999999888888999999999999999999999999 9999999999999932
Q ss_pred ---------CCcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 004395 544 ---------DFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRP 614 (756)
Q Consensus 544 ---------~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 614 (756)
+..++|+|||.|++-.... ..++.|..|.|||++.+-.++.++||||+||||+||.||...|+....
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 3458899999998654432 567889999999999999999999999999999999999999987664
Q ss_pred ccccchhhhh-hhhh----hh-----hhhhhccC----------------CccC---CCCChhHHHHHHHHHHHhcccCC
Q 004395 615 KGQQCLTEWA-RPLL----EE-----YAIDELVD----------------PRLG---NHYSEHEVYCMLHAASLCIRRDP 665 (756)
Q Consensus 615 ~~~~~l~~~~-~~~~----~~-----~~i~~l~d----------------p~l~---~~~~~~~~~~l~~Li~~CL~~dP 665 (756)
.......+.. .|.. .. +-...-++ +... -.....+...|++|+.+||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 3321111111 1110 00 00000000 0000 01122355679999999999999
Q ss_pred CCCCCHHHHHHH
Q 004395 666 HSRPRMSQVLRI 677 (756)
Q Consensus 666 ~~RPS~~eVL~~ 677 (756)
.+|+|+.|+|.+
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999873
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=295.32 Aligned_cols=265 Identities=28% Similarity=0.421 Sum_probs=200.9
Q ss_pred EEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhc--CCCCeeeEEEEEEecC----ceeEEEEe
Q 004395 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA--QHRNVVMLIGFCIEDR----RRLLVYEY 483 (756)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L--~HpNIV~l~~~~~~~~----~~~LV~Ey 483 (756)
+.++||+|.||.||+|.+ +++.||||++.. +....|.+|-+|++.. +|+||++|++.-.... .++||++|
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 345799999999999998 459999998874 3455788999988854 7999999999865544 78999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhccc-----CceEeeccCCCceeecCCCcceeeccccceec
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV-----GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~-----~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
.+.|+|.++|. ...++|....+|+..+++||+|||+.-+. ++|+|||||..||||.+|++..|+|||||..+
T Consensus 290 h~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 290 HPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred ccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 99999999994 56899999999999999999999976442 26999999999999999999999999999987
Q ss_pred CCCC-CCcccccccCccccCccccccCC-CC-----chhhHHHHHHHHHHHHhCCCCCCCCC-cccccchhhhh--hhhh
Q 004395 559 PDGD-MGVETRVIGTFGYLAPEYAQSGQ-IT-----EKADVYSFGVVLVELVTGRKAVDLNR-PKGQQCLTEWA--RPLL 628 (756)
Q Consensus 559 ~~~~-~~~~~~~~Gt~~Y~APE~l~~~~-~s-----~ksDVwSlGvvL~ELltG~~Pf~~~~-~~~~~~l~~~~--~~~~ 628 (756)
..+. .+....-+||.+|||||++.+.- +. .+.||||+|.|||||+++..-++... +..+.-+.... +|-+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 6433 22333468999999999997632 22 36899999999999999887664222 22221111111 1111
Q ss_pred ---hhhhhhhccCCccCCCCCh-hHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 629 ---EEYAIDELVDPRLGNHYSE-HEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 629 ---~~~~i~~l~dp~l~~~~~~-~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.+....+...|.+....-. .....+.+.+..||..||+.|.|+.=+-+.+...
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 1223344444544433222 2345678999999999999999999888777653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=269.27 Aligned_cols=237 Identities=28% Similarity=0.343 Sum_probs=192.9
Q ss_pred CceEEEEEEec-CCCEEEEEEecccCCcC-chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCChhhhhhc
Q 004395 418 GFGSVHRGVLP-DGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG 495 (756)
Q Consensus 418 ~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~-~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~ 495 (756)
+||.||+|... +|+.+|+|++....... ...+.+|++.+++++|+||+++++++......+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999975 58999999987655444 67899999999999999999999999999999999999999999999864
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcccccccCccc
Q 004395 496 CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY 575 (756)
Q Consensus 496 ~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y 575 (756)
. ..+++..++.++.+++.+|.|||.. +++|+||+|+||+++.++.++|+|||++....... ......++..|
T Consensus 81 ~--~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 R--GRLSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 2 2389999999999999999999999 99999999999999999999999999998765442 22345688999
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC-CCCChhHHHHHH
Q 004395 576 LAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG-NHYSEHEVYCML 654 (756)
Q Consensus 576 ~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~-~~~~~~~~~~l~ 654 (756)
++||.+.+..++.++|||+||+++|+|++|..||....... ... ..+...... ..........+.
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~------------~~~~~~~~~~~~~~~~~~~~~~ 218 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELF------------KKIGKPKPPFPPPEWKISPEAK 218 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHH------------HHHhccCCCCccccccCCHHHH
Confidence 99999998889999999999999999999999996531110 000 000000000 000000335688
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 004395 655 HAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 655 ~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+++.+||..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=284.89 Aligned_cols=266 Identities=24% Similarity=0.330 Sum_probs=200.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEec--------
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-------- 474 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~-------- 474 (756)
+.|....+||+|.||.||+|+. .+|+.||+|++-... ..-....++|+++|..|+|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3466667899999999999994 568889998654432 22334678999999999999999999887532
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
..+||||.+| .-+|.-+|.. ....++...+.+++.++..||.|+|.. .|+|||+|++|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~c-ehDLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFC-EHDLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHh-hhhHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeecccc
Confidence 3589999998 5788888853 446799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCC---CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh--------h
Q 004395 555 ARWQPDGD---MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT--------E 622 (756)
Q Consensus 555 A~~~~~~~---~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~--------~ 622 (756)
|+.+.... ....+..+-|.+|.+||.+.+ ..|+++.|||..|||+.||+||.+.|.......+..+. .
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98664322 122345567999999998876 67899999999999999999999999876654332221 1
Q ss_pred hhhhhhhhhhhhhcc--CCccCCCCCh--h------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 623 WARPLLEEYAIDELV--DPRLGNHYSE--H------EVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 623 ~~~~~~~~~~i~~l~--dp~l~~~~~~--~------~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+|...+..+.+.+ .|...+.+.. + -.+..++|+..++..||.+|+++++++.+
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 122322222222222 1111111110 0 11357899999999999999999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-33 Score=295.03 Aligned_cols=259 Identities=26% Similarity=0.358 Sum_probs=199.7
Q ss_pred HhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcC-------chhHHHHHHHHHhcCCCCeeeEEEEEE-e
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG-------DHEFCSEVEVLSCAQHRNVVMLIGFCI-E 473 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~-------~~~f~~Ev~iL~~L~HpNIV~l~~~~~-~ 473 (756)
.+.++|-++.+||+|||+.||+|. +...+.||||+...+.... .+..++|..|.+.|.||.||++|+||. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 345678888999999999999999 5567889999876543221 135889999999999999999999986 5
Q ss_pred cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec---CCCcceee
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT---HDFEPLVG 550 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~---~~~~vkL~ 550 (756)
.+.+|-|+|||+|.+|+-+|. ..+.+++..++.|+.||+.||.||.+..+ .|||-||||.||||- ..|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikp--PIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKP--PIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCC--CeeeeccCCccEEEecCcccceeEee
Confidence 668999999999999999997 56789999999999999999999998844 699999999999994 45889999
Q ss_pred ccccceecCCCCCC------cccccccCccccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch
Q 004395 551 DFGLARWQPDGDMG------VETRVIGTFGYLAPEYAQS----GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL 620 (756)
Q Consensus 551 DFGlA~~~~~~~~~------~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l 620 (756)
||||++...+.... ......||.+|++||.+.- ..++.|+||||+|||+|..+.|++||..... ++-+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHH
Confidence 99999987654322 3344689999999997742 4578999999999999999999999974322 1111
Q ss_pred hhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 621 TEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 621 ~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+.+..+.....-.+ ..-+....+...+|.+||+..-++|....++..
T Consensus 694 -------LqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 -------LQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------HhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111111100000 011223446788999999999999988777643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=285.01 Aligned_cols=265 Identities=25% Similarity=0.345 Sum_probs=200.8
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHh--cCCCCeeeEEEEEEecC----c
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSC--AQHRNVVMLIGFCIEDR----R 476 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~--L~HpNIV~l~~~~~~~~----~ 476 (756)
-..++..+.+.||+|.||.||+|.| .|..||||++... +...+.+|.+|+.. |+|+||+.|++.-..++ +
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3456888999999999999999999 6789999998743 34567889998875 59999999998765443 5
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc----ccCceEeeccCCCceeecCCCcceeecc
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~----~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
+|||++|.+.|||.|+|. ...++....++++..+|.||+|||-.- .-+.|.|||||..|||+..++...|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~---r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLN---RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHh---hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 799999999999999995 478999999999999999999999542 1226999999999999999999999999
Q ss_pred ccceecCCCC---CCcccccccCccccCccccccC----CC--CchhhHHHHHHHHHHHHhCC----------CCCCCCC
Q 004395 553 GLARWQPDGD---MGVETRVIGTFGYLAPEYAQSG----QI--TEKADVYSFGVVLVELVTGR----------KAVDLNR 613 (756)
Q Consensus 553 GlA~~~~~~~---~~~~~~~~Gt~~Y~APE~l~~~----~~--s~ksDVwSlGvvL~ELltG~----------~Pf~~~~ 613 (756)
|||....... ....+..+||..|||||++... .+ -..+||||||.|+||++... .||....
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9998765432 1234457899999999999652 12 24699999999999998632 3443222
Q ss_pred cccccchhhhhhhhhhhhhhhhccCCccCCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 614 PKGQQCLTEWARPLLEEYAIDELVDPRLGNH-YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 614 ~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~-~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+.+... . .+.+..-.+.+.|.+.+. .+.+....+.++++.||..+|..|-|+--+-+.|..
T Consensus 441 p~DPs~-e-----eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 441 PSDPSF-E-----EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred CCCCCH-H-----HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 221110 0 000011112223333333 344677889999999999999999999888877754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=285.73 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=193.9
Q ss_pred eEEEEecccCceEEEEEE-ecCCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEeec
Q 004395 409 SQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
+-+..||.|+||+|++-. .+.|+..|||.+..... .....|+.|.++..+- ..||||++||.+..++..|+.||+|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 334579999999999988 56899999998876544 4456788888876555 5899999999999999999999998
Q ss_pred CCChhhhh---hccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 486 NGSLDSHL---YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 486 ggsL~~~L---~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
..+|+.+. +......+++...-+|+.....||.||-+.. .|||||+||+||||+..|.+||||||++-.+.++-
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l---kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL---KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh---hhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 67775443 4446678999999999999999999998763 79999999999999999999999999987554322
Q ss_pred CCcccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC-C
Q 004395 563 MGVETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD-P 639 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d-p 639 (756)
..+.-.|...|||||.+.. ..|+.+|||||||++|||+.||..|+..... . ++.....-.-+ |
T Consensus 223 --AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----------v-feql~~Vv~gdpp 288 (361)
T KOG1006|consen 223 --AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----------V-FEQLCQVVIGDPP 288 (361)
T ss_pred --HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----------H-HHHHHHHHcCCCC
Confidence 2334568999999998854 4589999999999999999999999864321 1 11111000111 1
Q ss_pred ccC-CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 RLG-NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~l~-~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+. .....+....|..+|..||.+|-.+||.+.+++.+
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 11122345578999999999999999999998763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=294.88 Aligned_cols=214 Identities=24% Similarity=0.328 Sum_probs=181.8
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
.-.....-|..++.||-|+||.|.++. .++...||+|.+.... .........|-.||.....+=||+||..|.+.+
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 334455678899999999999999998 5567789999775432 223345677999999999999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
.+|+||+|++||++-.+|. .-+.|++..++.++.++..|+++.|.. |+|||||||+|||||.+|++||+||||+
T Consensus 703 nLYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred ceEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeecccc
Confidence 9999999999999999997 457899999999999999999999999 9999999999999999999999999998
Q ss_pred ee---------cCCCCCC--------------------------------cccccccCccccCccccccCCCCchhhHHH
Q 004395 556 RW---------QPDGDMG--------------------------------VETRVIGTFGYLAPEYAQSGQITEKADVYS 594 (756)
Q Consensus 556 ~~---------~~~~~~~--------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwS 594 (756)
.- +..++.. .....+||+.|+|||++....|+..+|+||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 52 2211100 012357999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcccccc
Q 004395 595 FGVVLVELVTGRKAVDLNRPKGQQC 619 (756)
Q Consensus 595 lGvvL~ELltG~~Pf~~~~~~~~~~ 619 (756)
.|||||||+.|+.||....+.+.+.
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCccee
Confidence 9999999999999998887766543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=306.89 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=207.6
Q ss_pred eeEEEEecccCceEEEEEEe-cCCC----EEEEEEeccc-CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 408 FSQANFLAEGGFGSVHRGVL-PDGQ----AVAVKQHKLA-SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~----~VAVK~~~~~-~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
....++||+|+||+||+|.| +.|+ +||||++... ..+...+|+.|+-+|.+|+|||+++|+++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34567899999999999984 5554 6899977544 3345678999999999999999999999998765 88999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
+|++.|+|.++++. ++.++-....+.|..||++||.|||++ .++||||-.+|||+..-..+||.|||+|+.....
T Consensus 777 q~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999986 677899999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCccc-ccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 562 DMGVET-RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 562 ~~~~~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
...... ...-.+.|||-|.+....|+.++|||||||++||++| |..|++..... .+..++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----------------eI~dlle~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----------------EIPDLLEK 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------------HhhHHHhc
Confidence 432222 1223567999999999999999999999999999999 99998755432 22333333
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+-..++.+...+..++.+||..|++.||+++++...+..
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 33334566677789999999999999999999999877654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=307.08 Aligned_cols=259 Identities=21% Similarity=0.210 Sum_probs=171.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-C----CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEE------EE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-D----GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF------CI 472 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~----g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~------~~ 472 (756)
..++|.+.+.||+|+||.||+|... + +..||||++..... .+.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999954 5 78999997653221 1111111 1222223333322221 24
Q ss_pred ecCceeEEEEeecCCChhhhhhccCC------------------CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeecc
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCHQ------------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDM 534 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~~------------------~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDL 534 (756)
.....+|||||+.+++|.+++..... .......+..++.||+.||.|||+. +|+||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDL 281 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDV 281 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcC
Confidence 55678999999999999998864211 0112334668999999999999999 9999999
Q ss_pred CCCceeecC-CCcceeeccccceecCCCCCCcccccccCccccCccccccC----------------------CCCchhh
Q 004395 535 RPNNILLTH-DFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG----------------------QITEKAD 591 (756)
Q Consensus 535 Kp~NILL~~-~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------------------~~s~ksD 591 (756)
||+|||++. ++.+||+|||+|+....+.........|++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 58999999999986654433334557799999999965322 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh----hhhhhhccCCccCCC----C--ChhHHHHHHHHHHHhc
Q 004395 592 VYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE----EYAIDELVDPRLGNH----Y--SEHEVYCMLHAASLCI 661 (756)
Q Consensus 592 VwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~----~~~i~~l~dp~l~~~----~--~~~~~~~l~~Li~~CL 661 (756)
||||||+||||+++..+++.. +..+...+.. ...+.....+..... + .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999977665321 0111110000 000111111110000 0 0001123458999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 004395 662 RRDPHSRPRMSQVLRI 677 (756)
Q Consensus 662 ~~dP~~RPS~~eVL~~ 677 (756)
+.||++|||+.+++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=295.94 Aligned_cols=266 Identities=20% Similarity=0.223 Sum_probs=182.2
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-----------------cCCCEEEEEEecccCCcCch--------------hHHHH
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-----------------PDGQAVAVKQHKLASSQGDH--------------EFCSE 452 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-----------------~~g~~VAVK~~~~~~~~~~~--------------~f~~E 452 (756)
..++|.+.++||+|+||.||+|.. ..++.||||.+......... .+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 23568999988654332222 34457
Q ss_pred HHHHHhcCCCCe-----eeEEEEEEe--------cCceeEEEEeecCCChhhhhhccC----------------------
Q 004395 453 VEVLSCAQHRNV-----VMLIGFCIE--------DRRRLLVYEYICNGSLDSHLYGCH---------------------- 497 (756)
Q Consensus 453 v~iL~~L~HpNI-----V~l~~~~~~--------~~~~~LV~Ey~~ggsL~~~L~~~~---------------------- 497 (756)
+.++.+++|.++ ++++++|.. ....+|||||+.+++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 677787753 346899999999999999986421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcccccccCccccC
Q 004395 498 QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLA 577 (756)
Q Consensus 498 ~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~A 577 (756)
...+++..++.++.|++.||.|||.. +|+||||||+|||++.++.+||+|||+++....+.........+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12346778899999999999999999 99999999999999999999999999997654332211122335889999
Q ss_pred ccccccCC--------------------CC--chhhHHHHHHHHHHHHhCCC-CCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 578 PEYAQSGQ--------------------IT--EKADVYSFGVVLVELVTGRK-AVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 578 PE~l~~~~--------------------~s--~ksDVwSlGvvL~ELltG~~-Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
||.+.... |+ .+.||||+||++|+|++|.. ||......... +..+ ...... +.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~-~~~~~~--~r 454 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQY-DNDLNR--WR 454 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhhc-cchHHH--HH
Confidence 99875422 11 34799999999999999875 66422111000 0000 000000 00
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDP---HSRPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP---~~RPS~~eVL~~ 677 (756)
........-...........+|+.+||..+| .+|+|+.|+|++
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000011001112234567899999999866 689999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=271.82 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=198.8
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV 480 (756)
.+|.++++||+|+|.+|.++.+ ++.+.||+|+++.. ..++....+.|-.+..+. +||.+|.+..+|....++++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5788999999999999999984 57899999987643 344555677888888887 499999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
.||+.||+|--+++ ....|+++.++.+...|..||.|||+. |||+||||.+|+|||..|++||+|+|+++.-..
T Consensus 330 ieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999998887 457899999999999999999999999 999999999999999999999999999985332
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hhhhhhhhhhhhhhhccCC
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~~~~~~~~i~~l~dp 639 (756)
+. ....+++|||.|+|||.+.+..|+..+|+|+||++++||+.|+-||+..+..+.... .++..+. ++..
T Consensus 404 ~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------ilek 474 (593)
T KOG0695|consen 404 PG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------ILEK 474 (593)
T ss_pred CC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hhhh
Confidence 22 234578999999999999999999999999999999999999999986654433211 1111111 1111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCC
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRP 669 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP 669 (756)
.+. .+.........++..-|..||.+|.
T Consensus 475 qir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 QIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 111 1112223455677888999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=295.22 Aligned_cols=242 Identities=21% Similarity=0.269 Sum_probs=197.7
Q ss_pred CCeeEEEEecccCceEEEEEEecC-CCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.++..+..||-||||.|=++.... ...+|+|+++.. .....+....|-.||..++.|.||++|-.|.++...|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 345566779999999999988543 334888876543 3334456788999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
|-|-||.|+..|. .++.+...++..++..+++|++|||.+ |||+|||||+|+||+.+|-+||.|||+|+....+
T Consensus 500 EaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999997 567899999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
. ..-+++|||.|.|||++.+..++.++|.||||+++|||++|.+||...++.... ... + ..++.+-
T Consensus 574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY-----n~I-L--kGid~i~---- 639 (732)
T KOG0614|consen 574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY-----NLI-L--KGIDKIE---- 639 (732)
T ss_pred C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH-----HHH-H--hhhhhhh----
Confidence 4 445789999999999999999999999999999999999999999866543111 000 0 1111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPR 670 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS 670 (756)
++........+|+.++...+|.+|.-
T Consensus 640 ---~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 ---FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---cccccchhHHHHHHHHHhcCcHhhhc
Confidence 22223345678888888999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=240.78 Aligned_cols=210 Identities=33% Similarity=0.501 Sum_probs=183.6
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCChhh
Q 004395 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDS 491 (756)
Q Consensus 414 LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~ 491 (756)
||+|.+|.||++... +++.+++|++...... ....+.+|+++++.++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999964 4899999988755432 34679999999999999999999999999899999999998899999
Q ss_pred hhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-CCcceeeccccceecCCCCCCcccccc
Q 004395 492 HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPDGDMGVETRVI 570 (756)
Q Consensus 492 ~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-~~~vkL~DFGlA~~~~~~~~~~~~~~~ 570 (756)
++.... ..+++..++.++.+++.+|.|||+. |++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 986422 4789999999999999999999999 9999999999999999 89999999999987654321 123355
Q ss_pred cCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhH
Q 004395 571 GTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649 (756)
Q Consensus 571 Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~ 649 (756)
+...|++||.+... .++.++|+|+||+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999877 788999999999999998
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 650 VYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 650 ~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+.+++..|+..+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357889999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=266.23 Aligned_cols=132 Identities=27% Similarity=0.378 Sum_probs=116.0
Q ss_pred hCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-----C---CCeeeEEEEEEe--
Q 004395 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-----H---RNVVMLIGFCIE-- 473 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-----H---pNIV~l~~~~~~-- 473 (756)
.++|.+.++||.|-|++||++. ..+.+.||+|+.+.... -.+..+.||++|++++ | ..||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4799999999999999999999 55778999999885432 2345778999999984 3 369999999975
Q ss_pred --cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee
Q 004395 474 --DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541 (756)
Q Consensus 474 --~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL 541 (756)
+.++|||+|++ |-+|..+|....-+.++...+..|+.||+.||.|||..| ||||-||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeee
Confidence 45799999998 899999998777888999999999999999999999999 99999999999999
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=249.68 Aligned_cols=208 Identities=24% Similarity=0.375 Sum_probs=170.6
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEeccc-CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCce
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA-SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~-~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~ 477 (756)
+++..+....+..||+|++|.|=+-+ ..+|+..|+|.+... ..+..+..++|+.+..+. .+|.+|.|||.+......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 44455555666789999999997777 568999999987654 234455677888876654 589999999999889999
Q ss_pred eEEEEeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 478 LLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
++.||.| .-+|+.+-.. ..++.+++...-+|+..+.+||.|||++. .+||||+||+||||+.+|++|+||||++
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL---~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL---SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh---hhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999998 6788766532 25678999999999999999999999985 7999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQS----GQITEKADVYSFGVVLVELVTGRKAVDLNRP 614 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 614 (756)
-++.++- ..+--.|...|||||.+.. ..|+.++||||||+.++||.+++.||+....
T Consensus 197 G~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 197 GYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 8775542 1122458899999998843 4799999999999999999999999975443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=250.63 Aligned_cols=270 Identities=19% Similarity=0.345 Sum_probs=205.4
Q ss_pred CCCCCCChHHHHHhh---CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCee
Q 004395 391 KPPRWFSYAELELAT---GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVV 465 (756)
Q Consensus 391 ~p~~~~s~~~l~~~~---~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV 465 (756)
+|...+.|+...+.. ++|++.+.+|+|.|+.||.|. ..+++.++||+++... .+.+.+|+.||..|. ||||+
T Consensus 20 rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi 96 (338)
T KOG0668|consen 20 RPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNII 96 (338)
T ss_pred CchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCee
Confidence 455566666654433 579999999999999999999 5678899999988543 456889999999997 99999
Q ss_pred eEEEEEEecC--ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC
Q 004395 466 MLIGFCIEDR--RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (756)
Q Consensus 466 ~l~~~~~~~~--~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~ 543 (756)
.|+++..+.. ...||+||+.+.+...+. ..|+...+..++.++++||.|||+. ||+|||+||.|++||+
T Consensus 97 ~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~----GImHRDVKPhNvmIdh 167 (338)
T KOG0668|consen 97 KLLDIVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM----GIMHRDVKPHNVMIDH 167 (338)
T ss_pred ehhhhhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc----CcccccCCcceeeech
Confidence 9999987654 568999999888877655 3578888999999999999999999 9999999999999987
Q ss_pred C-CcceeeccccceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 004395 544 D-FEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 544 ~-~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~ 621 (756)
. ..++|+|+|||.++..+.. .+-.+.+..|--||++-. ..|+..-|+|||||+|..|+..+.||........+ +.
T Consensus 168 ~~rkLrlIDWGLAEFYHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LV 244 (338)
T KOG0668|consen 168 ELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LV 244 (338)
T ss_pred hhceeeeeecchHhhcCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HH
Confidence 5 5689999999998876542 223346778889998855 67899999999999999999999999644433222 22
Q ss_pred hhhhh--------hhhhhhhhhccCCccCC-----------C----CChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 622 EWARP--------LLEEYAIDELVDPRLGN-----------H----YSEH-EVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 622 ~~~~~--------~~~~~~i~~l~dp~l~~-----------~----~~~~-~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+.- .+..+.+. ++|.+.+ . -..+ ..++..+++...|..|-++|+|+.|++.+
T Consensus 245 kIakVLGt~el~~Yl~KY~i~--Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 245 KIAKVLGTDELYAYLNKYQID--LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHhChHHHHHHHHHHccC--CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 22221 11111111 2222111 0 0111 12568899999999999999999998763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=287.71 Aligned_cols=243 Identities=26% Similarity=0.325 Sum_probs=185.5
Q ss_pred EEEEecccCceE-EEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 410 QANFLAEGGFGS-VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 410 ~~~~LG~G~fG~-Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
-.+.+|.|.-|+ ||+|.. .|+.||||.+.... ..-..+|+..|..-+ |||||++++.-.+.+..||..|.| .-
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~ 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC 587 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence 345688888875 799998 67899999765332 234678999998885 999999999988899999999998 78
Q ss_pred Chhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---C--CcceeeccccceecCC
Q 004395 488 SLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---D--FEPLVGDFGLARWQPD 560 (756)
Q Consensus 488 sL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~--~~vkL~DFGlA~~~~~ 560 (756)
+|.+++... ......-...+.++.|+++||++||+. +||||||||.||||+. + ..++|+|||+++.+..
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl----~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL----KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc----ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 999999752 111111134578899999999999998 9999999999999976 3 4578999999998765
Q ss_pred CCC--CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 561 GDM--GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG-RKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 561 ~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
+.. .......||-+|+|||++....-+.++||||||||+|+.++| ..||+....... ..+.....+..+.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-------NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-------NILTGNYTLVHLE 736 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-------hhhcCccceeeec
Confidence 442 233456799999999999998888899999999999999996 899974422111 1111111111111
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. ..++ ...+||.+|++.+|..||++.+||.+
T Consensus 737 ~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 737 P-------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred c-------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 0111 57899999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=239.65 Aligned_cols=199 Identities=34% Similarity=0.408 Sum_probs=173.4
Q ss_pred eeEEEEecccCceEEEEEEecC-CCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
|.+.+.||+|++|.||++.... ++.+|+|.+...... ....+.+|++.+..++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999654 899999988765544 56688999999999999999999999999899999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+++|.+++.... ..+++..++.++.+++.+|.|||.. +++|+||+|.||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKG-GKLSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999996422 1289999999999999999999999 99999999999999999999999999998776543112
Q ss_pred ccccccCccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004395 566 ETRVIGTFGYLAPEYA-QSGQITEKADVYSFGVVLVELVTGRKAVDL 611 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 611 (756)
.....++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2345678899999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-30 Score=260.63 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=198.2
Q ss_pred eEEEEecccCceEEEEEEe-cCCCEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----ceeEE
Q 004395 409 SQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RRLLV 480 (756)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~-----~~~LV 480 (756)
+..+.||-|+||.||.+.. .+|+.||+|++... .....+.+.+|+++|..++|.|++..+++..-.. .+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3456799999999999985 47999999976532 2223457889999999999999999888765432 56889
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
+|+| ..+|...+. ....|+...+.-+..||++||.|||+. +|+||||||.|+|++.+..+||||||||+....
T Consensus 136 TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEecccccccccch
Confidence 9998 788988886 577899999999999999999999999 999999999999999999999999999996554
Q ss_pred CCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh-hhhh-hhhh------hh
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT-EWAR-PLLE------EY 631 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~~-~~~~------~~ 631 (756)
.+....+.-+-|-.|.|||++.+ ..|+.+.||||.|||+.||+..+..|+...+..+..+. +... +..+ ++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 33333344456889999999987 56899999999999999999999999877766543221 1111 1111 11
Q ss_pred hhhhccC-----CccCCCC----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 632 AIDELVD-----PRLGNHY----SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 632 ~i~~l~d-----p~l~~~~----~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
.-..++. |.+...| +.+.......+...++..||++|.+..+.+..+.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111111 1111111 1122234567788899999999999999987653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=258.96 Aligned_cols=264 Identities=24% Similarity=0.307 Sum_probs=210.5
Q ss_pred ChHHHHHhhCCeeEEEEecccCceEEEEEEecC------CCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEE
Q 004395 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLPD------GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIG 469 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~ 469 (756)
...++.+...+++...++-+|.||.||.|.|.+ .+.|-+|.++....+ ....|+.|.-+|..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 345666777889999999999999999997543 344666766544332 3456888999999999999999999
Q ss_pred EEEec-CceeEEEEeecCCChhhhhhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec
Q 004395 470 FCIED-RRRLLVYEYICNGSLDSHLYGC------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (756)
Q Consensus 470 ~~~~~-~~~~LV~Ey~~ggsL~~~L~~~------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~ 542 (756)
++.+. ...+.+|.++.-|+|..+|..+ ..+.++..+...++.|++.|++|||.+ ||||.||..+|++||
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVID 430 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----Ccccchhhhhcceeh
Confidence 88764 4678899999889999999732 234577778889999999999999999 999999999999999
Q ss_pred CCCcceeeccccceecCCCCCCccc-ccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccch
Q 004395 543 HDFEPLVGDFGLARWQPDGDMGVET-RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCL 620 (756)
Q Consensus 543 ~~~~vkL~DFGlA~~~~~~~~~~~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l 620 (756)
+.-.+||+|=.|++.+.+.++.-.. .-..+..||+||.+....|+.++||||||++||||+| |+.|+...+|.+.
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--- 507 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--- 507 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH---
Confidence 9999999999999977666543222 2234678999999999999999999999999999999 8888865544322
Q ss_pred hhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 621 TEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 621 ~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+....+-..+.+++++|+.++..||+.+|++||+++|+..-|.+
T Consensus 508 -------------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 -------------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 12222222333455677889999999999999999999999987764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=268.92 Aligned_cols=196 Identities=22% Similarity=0.334 Sum_probs=170.5
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC--------CcCchhHHHHHHHHHhcC---CCCeeeEEEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--------SQGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIE 473 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~--------~~~~~~f~~Ev~iL~~L~---HpNIV~l~~~~~~ 473 (756)
..|..++.||+|+||.|++|..+ +...|+||.+.... ....-..-.|++||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999954 56788889654321 111124667999999997 9999999999999
Q ss_pred cCceeEEEEee-cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecc
Q 004395 474 DRRRLLVYEYI-CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 474 ~~~~~LV~Ey~-~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
++.+||+||-. +|.+|.++|. ....+++..+..|+.|++.|+++||+. ||||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEeec
Confidence 99999999986 5668999997 456799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVD 610 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~ 610 (756)
|.|.+...+. ...++||..|.|||++.+.+| +..-|||++|++||-++....||.
T Consensus 715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998776654 346789999999999999888 688999999999999999988873
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=267.55 Aligned_cols=275 Identities=21% Similarity=0.218 Sum_probs=210.4
Q ss_pred CCCChHHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC------CCeee
Q 004395 394 RWFSYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH------RNVVM 466 (756)
Q Consensus 394 ~~~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H------pNIV~ 466 (756)
.++.+.-.+++.++|.+....|+|-|++|-+|.. ..|+.||||++..+... .+.=+.|++||++|.. -|+++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 3456666788999999999999999999999984 45889999999865432 2345679999999952 48999
Q ss_pred EEEEEEecCceeEEEEeecCCChhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC-
Q 004395 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD- 544 (756)
Q Consensus 467 l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~-~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~- 544 (756)
|+-.|...+++|||+|-+ ..+|.+.|... .+-.|....+..++.|+.-||..|-.. ||+|.||||+|||+++.
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEeccCc
Confidence 999999999999999987 78999999542 345688889999999999999999887 99999999999999875
Q ss_pred CcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh
Q 004395 545 FEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA 624 (756)
Q Consensus 545 ~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 624 (756)
..+||||||.|....+... +.+.-+..|.|||++.|-+|+...|+||.||+||||.||+..|.+.....+..+....
T Consensus 574 ~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred ceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 5679999999987766543 3344566799999999999999999999999999999999999766554332211100
Q ss_pred -h----hhhhhhhh---------------------------hhccCC------ccC--CCCCh---hHHHHHHHHHHHhc
Q 004395 625 -R----PLLEEYAI---------------------------DELVDP------RLG--NHYSE---HEVYCMLHAASLCI 661 (756)
Q Consensus 625 -~----~~~~~~~i---------------------------~~l~dp------~l~--~~~~~---~~~~~l~~Li~~CL 661 (756)
. .++....+ ...+.| .+. ..++. .....|.+|+..||
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 0 01111000 001111 000 11222 24456889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 004395 662 RRDPHSRPRMSQVLRI 677 (756)
Q Consensus 662 ~~dP~~RPS~~eVL~~ 677 (756)
.+||++|.|..|+|.+
T Consensus 731 ~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 731 ILDPEKRITVNQALKH 746 (752)
T ss_pred ccChhhcCCHHHHhcC
Confidence 9999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=274.70 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=207.3
Q ss_pred hCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
..+|.....+|+|.||.||+++ ..+++..|+|+++.....+...+..|+-+++..+|||||.+++.+......+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4578899999999999999999 568999999999998888888899999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
|.||+|.+.-+ -.+++++.++...++..++||+|||+. |=+|||||-.|||+++.|.+|++|||.+-.+.. ..
T Consensus 94 cgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti 166 (829)
T KOG0576|consen 94 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TI 166 (829)
T ss_pred cCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhhh-hh
Confidence 99999999876 578999999999999999999999999 889999999999999999999999999875543 23
Q ss_pred CcccccccCccccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 564 GVETRVIGTFGYLAPEYA---QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.+...+.||+.|||||+. ..+.|...+|||++|+...|+---++|.....+. +.+ .+... ...-.|.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l-----~LmTk---S~~qpp~ 236 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RAL-----FLMTK---SGFQPPT 236 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHH-----HHhhc---cCCCCCc
Confidence 345678899999999976 4678999999999999999998877775322111 100 00000 1111122
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+.+. ......+.++++.|+..+|++||++..+|.
T Consensus 237 lkDk--~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCC--ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2111 122345788999999999999999998765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=246.86 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=193.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC------c
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------R 476 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~------~ 476 (756)
.+|..+..+|.|.- .|-.+.. -.++.||+|++... .....+...+|..++..+.|+||++++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777888999988 5555552 36889999975433 2334456788999999999999999999987443 5
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+||||| ..+|...+. -.++-..+..|..|++.|++|||+. ||+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchhhc
Confidence 79999999 789988886 2466678889999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh---------
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL--------- 627 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~--------- 627 (756)
.-... -..+.++.|..|.|||++.+..|.+.+||||+||++.||++|.-.|.+..- +.+|..-.
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHhcCCCHH
Confidence 54332 356678899999999999998899999999999999999999998864332 22222110
Q ss_pred ------------hh---h---hhhhhccCCccCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 ------------LE---E---YAIDELVDPRLGNH---YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 ------------~~---~---~~i~~l~dp~l~~~---~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+ . ....+++....... .+......+.+++.+||..||++|.+++++|++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 0 01111111111100 011123346789999999999999999999985
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=232.02 Aligned_cols=261 Identities=18% Similarity=0.222 Sum_probs=209.7
Q ss_pred HhhCCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC-CCeeeEEEEEEecCceeEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H-pNIV~l~~~~~~~~~~~LV 480 (756)
+..+.|.+++.||+|+||.+|.|. ..+|..||||.-... ..-..+..|..+...|++ .+|+.+..|+.+...-.||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 445789999999999999999999 678999999975432 233468889999999985 8899999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec---CCCcceeecccccee
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT---HDFEPLVGDFGLARW 557 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~---~~~~vkL~DFGlA~~ 557 (756)
|+++ |.+|++++.-+ ...++..+++-++.|++.-++|+|.+ ++|||||||+|+|+. ....+.|+|||||+.
T Consensus 90 MdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchhh
Confidence 9998 99999999764 45689999999999999999999999 999999999999995 345688999999998
Q ss_pred cCCCCC------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhh
Q 004395 558 QPDGDM------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEY 631 (756)
Q Consensus 558 ~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 631 (756)
+.+... .......||..|.+-..+.+...+.+.|+-|+|.+|.++.-|..||+...+....-.. .
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy---------E 234 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY---------E 234 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH---------H
Confidence 765432 2334578999999999888888899999999999999999999999876654332111 1
Q ss_pred hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 632 AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 632 ~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+.+.......+..+...+.++.-.+..|-....++-|++..+.+.+.-
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 1222222222223344455678888999999999999999988777653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=280.49 Aligned_cols=196 Identities=18% Similarity=0.216 Sum_probs=142.5
Q ss_pred hcCC-CCeeeEEEEE-------EecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCce
Q 004395 458 CAQH-RNVVMLIGFC-------IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529 (756)
Q Consensus 458 ~L~H-pNIV~l~~~~-------~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gI 529 (756)
.++| +||+.++++| .+...++++|||+ +++|.++|.. ....+++..++.++.||++||.|||++ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQ----GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhC----Ce
Confidence 4556 6888888887 3334678889987 7899999964 346699999999999999999999999 99
Q ss_pred EeeccCCCceeecC-------------------CCcceeeccccceecCCCC---------------CCcccccccCccc
Q 004395 530 VHRDMRPNNILLTH-------------------DFEPLVGDFGLARWQPDGD---------------MGVETRVIGTFGY 575 (756)
Q Consensus 530 iHrDLKp~NILL~~-------------------~~~vkL~DFGlA~~~~~~~---------------~~~~~~~~Gt~~Y 575 (756)
+||||||+||||+. ++.+||+|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4556677777776421100 0001124689999
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHH
Q 004395 576 LAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLH 655 (756)
Q Consensus 576 ~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~ 655 (756)
||||++.+..|+.++|||||||+||||++|..|+..... ... .+ . .....+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~----~~----~-~~~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMS----SL----R-HRVLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHH----HH----H-HhhcChhh-----hhcCHHHHH
Confidence 999999999999999999999999999999887642110 000 00 0 01111111 011234567
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 004395 656 AASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 656 Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
++.+||+.+|.+||++.|+++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8889999999999999999874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=237.13 Aligned_cols=259 Identities=18% Similarity=0.199 Sum_probs=198.5
Q ss_pred CeeEEEEecccCceEEEEEEecC--CCEEEEEEecccCCcCchhHHHHHHHHHhcCC----CCeeeEEEEE-EecCceeE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLPD--GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH----RNVVMLIGFC-IEDRRRLL 479 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~--g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H----pNIV~l~~~~-~~~~~~~L 479 (756)
+|.+.+.||+|+||.||.+.... ...+|+|............+..|..+|..+.. +++..+++.+ ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999544 35799997765543333378889999999973 6999999999 47778899
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC-----Ccceeecccc
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-----FEPLVGDFGL 554 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~-----~~vkL~DFGl 554 (756)
||+.+ |.+|.++......+.++..+++.++.|++.+|++||+. |++||||||+|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99997 99999988655568899999999999999999999999 99999999999999765 4689999999
Q ss_pred ce--ecCCCCC----Cc---ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh
Q 004395 555 AR--WQPDGDM----GV---ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 555 A~--~~~~~~~----~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 625 (756)
|+ .+..... .. ...+.||..|+++..+.+...+.+.|+||+++++.||+.|..||........ .
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-------~ 246 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-------K 246 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-------H
Confidence 99 3322211 01 1235699999999999999999999999999999999999999954432211 0
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcCc
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDT 682 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~~ 682 (756)
.............. .....+..+..+...+-..+...+|.+..+...|....
T Consensus 247 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 00011111111111 11222334666666677799999999999999876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=231.31 Aligned_cols=258 Identities=18% Similarity=0.218 Sum_probs=205.9
Q ss_pred CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
-+|++++.||+|.||..|.|+ +-+++.||||.-... ....++..|.+.++.|. .++|+..|.|..++-.-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 379999999999999999999 568999999954332 33456888999998885 69999999999999899999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-----CCcceeeccccceec
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-----DFEPLVGDFGLARWQ 558 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-----~~~vkL~DFGlA~~~ 558 (756)
+ |.+|+|++.-+ +..|+..++..+|.|++.-++|+|++ .+|+|||||+|+||.. ...+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 99999998654 56799999999999999999999999 9999999999999954 345789999999998
Q ss_pred CCCCCCc------ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 559 PDGDMGV------ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 559 ~~~~~~~------~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
.++.... .....||..||+-..+.+...+.+.|+-|||-|++++|-|..||+...........+-
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK--------- 250 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK--------- 250 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH---------
Confidence 8765332 2346799999999999999999999999999999999999999987655432211111
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+-+..........+...+.++...+...-.++..+-|.++-+...+.+
T Consensus 251 IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 251 IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 111111111112233345567778888888999999999988776654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-26 Score=242.59 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=196.2
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec----CCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecC
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDR 475 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~ 475 (756)
+....+.|..+++||+|.|++||++... ..+.||+|.+...+ ....+..|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445567899999999999999999832 46789999766543 3456889999999996 899999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC-Ccceeecccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGL 554 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~-~~vkL~DFGl 554 (756)
..++|+||++.-+..+++. .++...+..+++.++.||.|+|.+ |||||||||.|+|.+.. +.-.|+||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechh
Confidence 9999999999999888885 367899999999999999999999 99999999999999754 6678999999
Q ss_pred ceecCC-------------------CC---------------C---------CcccccccCccccCcccccc-CCCCchh
Q 004395 555 ARWQPD-------------------GD---------------M---------GVETRVIGTFGYLAPEYAQS-GQITEKA 590 (756)
Q Consensus 555 A~~~~~-------------------~~---------------~---------~~~~~~~Gt~~Y~APE~l~~-~~~s~ks 590 (756)
|..+.. +. . ...-...||++|.|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 972110 00 0 00112579999999998865 5568999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhh-------------------------hhhhh--hhhhc----cCC
Q 004395 591 DVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP-------------------------LLEEY--AIDEL----VDP 639 (756)
Q Consensus 591 DVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~-------------------------~~~~~--~i~~l----~dp 639 (756)
||||.|+|++-+++++.||.....+.. .+.+.+.. ...+. .+..+ +.+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred ceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 999999999999999999964443221 11111000 00000 00000 000
Q ss_pred --c---cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 --R---LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 --~---l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. .........+..+++++.+|+..||.+|.|++++|.+
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 0000111223367899999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=231.56 Aligned_cols=252 Identities=18% Similarity=0.270 Sum_probs=184.6
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEE-EEecCceeEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGF-CIEDRRRLLVY 481 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~-~~~~~~~~LV~ 481 (756)
.+.|.+.+.||+|.||.+-++.. .+.+.+++|.+... .....+|.+|..---.|. |.||+.-|++ |+..+.+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 35788999999999999999994 56788999976533 334568999987655554 8999988874 56667788999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec--CCCcceeeccccceecC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT--HDFEPLVGDFGLARWQP 559 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~--~~~~vkL~DFGlA~~~~ 559 (756)
||++.|+|.+-+. ...+.+....+++.|+++||.|+|+. ++||||||.+||||- +...+||||||+.+..+
T Consensus 102 E~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999998884 35678888899999999999999999 999999999999993 34579999999987543
Q ss_pred CCCCCcccccccCccccCcccccc---CC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQS---GQ--ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~---~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
..- ...--+..|.+||.... +. ..+.+|+|.||+++|.++||..||+...... ....+|.......
T Consensus 175 ~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~~rk---- 245 (378)
T KOG1345|consen 175 TTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWLKRK---- 245 (378)
T ss_pred cee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHhccc----
Confidence 211 12234667999997643 33 3678999999999999999999998433222 2233332221111
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...-|+....+++ .++.+..+-|..+|++|--..++-+.
T Consensus 246 ~~~~P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 246 NPALPKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred CccCchhhcccCH----HHHHHHHHhcCCcccccchhHHHHHH
Confidence 0112333333443 46777888899999999655555443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=212.74 Aligned_cols=165 Identities=26% Similarity=0.276 Sum_probs=125.1
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|+|.+++.. .+.++++..++.++.|++.||.|||+. + ||+|||++.++.+++ ||+++......
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeecccc----
Confidence 789999964 356799999999999999999999998 5 999999999999999 99998764422
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
..||+.|+|||++.+..++.++|||||||++|||+||+.||........ ........ .... .+. .....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-----~~~~~~~~--~~~~-~~~-~~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-----ILEILLNG--MPAD-DPR-DRSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-----HHHHHHHH--hccC-Ccc-ccccH
Confidence 2589999999999999999999999999999999999999964322111 01111000 0000 000 00111
Q ss_pred hhHHH--HHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 647 EHEVY--CMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 647 ~~~~~--~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
..... .+.+++.+||..+|.+||++.++++.+.
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 12222 5899999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-22 Score=210.01 Aligned_cols=260 Identities=28% Similarity=0.382 Sum_probs=196.8
Q ss_pred eeEEEEecccCceEEEEEEecCCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCC-CeeeEEEEEEecCceeEEEEe
Q 004395 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHR-NVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~Hp-NIV~l~~~~~~~~~~~LV~Ey 483 (756)
|.....||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +|+.+++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 678889999999999999975 78899987655433 356799999999999988 799999999777778999999
Q ss_pred ecCCChhhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-cceeeccccceecCCC
Q 004395 484 ICNGSLDSHLYGCHQ-EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQPDG 561 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~-~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-~vkL~DFGlA~~~~~~ 561 (756)
+.+++|.+++..... ..+.......++.|++.+|.|+|.. +++|||+||+|||++..+ .++++|||+++.+...
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999976653211 2789999999999999999999999 999999999999999988 7999999999866544
Q ss_pred CCC-----cccccccCccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 562 DMG-----VETRVIGTFGYLAPEYAQS---GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 562 ~~~-----~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~ 232 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPT 232 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCC
Confidence 322 2356789999999999987 57889999999999999999999997644321 000000000000000
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. .................+.+++..|+..+|..|.+..+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000001122467889999999999999998887653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=230.17 Aligned_cols=165 Identities=24% Similarity=0.240 Sum_probs=130.1
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec--CCCEEEEEEecccC-----CcCchhHHHHHHHHHhcCCCCeee-EEEEEEec
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP--DGQAVAVKQHKLAS-----SQGDHEFCSEVEVLSCAQHRNVVM-LIGFCIED 474 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~VAVK~~~~~~-----~~~~~~f~~Ev~iL~~L~HpNIV~-l~~~~~~~ 474 (756)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......|.+|+++|..++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 35578999999999999999999853 57888999765321 112346899999999999999985 5432
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeecc-CCCceeecCCCcceeeccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDM-RPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDL-Kp~NILL~~~~~vkL~DFG 553 (756)
+..||||||++|++|.. +. .. . ...++.|+++||.|||+. ||+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~--~~---~---~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR--PH---G---DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC--cc---c---hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 45799999999999963 21 11 1 146789999999999999 9999999 9999999999999999999
Q ss_pred cceecCCCCCC-------cccccccCccccCccccccC
Q 004395 554 LARWQPDGDMG-------VETRVIGTFGYLAPEYAQSG 584 (756)
Q Consensus 554 lA~~~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~ 584 (756)
+|+.+...... ..+...+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99976543211 11356789999999999653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-23 Score=241.07 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=186.3
Q ss_pred EEEEecccCceEEEEEEe-cCCCEEEEEEeccc--CCcCch----hHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 410 QANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA--SSQGDH----EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~--~~~~~~----~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
....+|.|++|.|+.... ......+.|..... ...... .+..|+.+-..|.|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 456799999998887773 33444555533211 111111 24557777778899999988887777776677799
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
||++ +|..++.. ...+....+..++.|++.|+.|+|.. ||.|||||++|++++.+|.+||+|||.+..+.-+.
T Consensus 402 ~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9998 99999963 35788999999999999999999999 99999999999999999999999999998665332
Q ss_pred ---CCcccccccCccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 563 ---MGVETRVIGTFGYLAPEYAQSGQIT-EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 563 ---~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
......++|+..|+|||++.+..|+ ...||||.|++++.|++|+.||.......++.. ......+...
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--------~~~~~~~~~~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--------TNNYSDQRNI 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--------hhcccccccc
Confidence 2455678899999999999999997 568999999999999999999965443322210 0000000000
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..-........+.....++.+||+.||.+|.|+.+|++
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00001111223345678999999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=198.80 Aligned_cols=174 Identities=11% Similarity=0.082 Sum_probs=137.3
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchh---------HHHHHHHHHhcCCCCeeeEEEEEE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE---------FCSEVEVLSCAQHRNVVMLIGFCI 472 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~---------f~~Ev~iL~~L~HpNIV~l~~~~~ 472 (756)
....++|+..++||.|+||.||++.. ++..+|||++.......... +.+|+..+.++.|+||..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45789999999999999999999765 57789999987544333222 678999999999999999998866
Q ss_pred ec--------CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC
Q 004395 473 ED--------RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (756)
Q Consensus 473 ~~--------~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~ 544 (756)
.. ...+|||||++|.+|.++.. ++. ....+++.+|..||.. |++|||+||+||+++.+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCC
Confidence 43 35789999999999987742 222 3466999999999999 99999999999999999
Q ss_pred CcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh
Q 004395 545 FEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604 (756)
Q Consensus 545 ~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt 604 (756)
| ++|+|||.......... . ..++....|+.++|+|+||+.+..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a---~----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKA---K----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhh---H----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 99999999875532110 0 013445567789999999999876643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=7e-21 Score=192.07 Aligned_cols=138 Identities=18% Similarity=0.207 Sum_probs=108.8
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCCcC---------chhH-----------------HHHHHHHHhcCCCCee
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG---------DHEF-----------------CSEVEVLSCAQHRNVV 465 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~---------~~~f-----------------~~Ev~iL~~L~HpNIV 465 (756)
..||+|+||.||+|...+|+.||||+++...... ...| ..|+++|..+.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 5799999999999998789999999987542211 1122 3499999999887764
Q ss_pred eEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhhcccCceEeeccCCCceeecCC
Q 004395 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL-HEECRVGCIVHRDMRPNNILLTHD 544 (756)
Q Consensus 466 ~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yL-H~~~~~~gIiHrDLKp~NILL~~~ 544 (756)
....+.. ...+|||||+.|++|...+. ...+++...+..++.|++.+|.|| |.. ||+||||||+|||++ +
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli~-~ 153 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEE-C
Confidence 4333222 23489999998877765533 345789999999999999999999 688 999999999999998 4
Q ss_pred Ccceeeccccceec
Q 004395 545 FEPLVGDFGLARWQ 558 (756)
Q Consensus 545 ~~vkL~DFGlA~~~ 558 (756)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-21 Score=198.76 Aligned_cols=245 Identities=21% Similarity=0.292 Sum_probs=190.2
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCC
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggs 488 (756)
..+|.+...|..|+|+|+.+.. +.|+++.. .....++|..|.-.|+.+.||||+.+++.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgndi-vakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDI-VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCcch-hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 3468899999999999976554 44665433 22334679999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCccee--eccccceecCCCCCCcc
Q 004395 489 LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV--GDFGLARWQPDGDMGVE 566 (756)
Q Consensus 489 L~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL--~DFGlA~~~~~~~~~~~ 566 (756)
|...|++...-..+-.++.+++.++++|++|||+.-+ -|.---|....++||++.+.+| +|--++...
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsfqe-------- 343 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-------- 343 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeeeec--------
Confidence 9999987666677888999999999999999998743 2444568899999999988876 443322211
Q ss_pred cccccCccccCccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQIT---EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s---~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
....-.|.||+||.+...+-+ .++|+|||.++||||.|...||....+...- ..+.-..+..
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv 408 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRV 408 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccccc
Confidence 112247889999999765543 5799999999999999999999755443221 1122233444
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
..++.....+..|+.-|+..||.+||.++.|+-.||..
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 55666667799999999999999999999999998853
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.1e-20 Score=183.98 Aligned_cols=141 Identities=21% Similarity=0.186 Sum_probs=111.6
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCcC--------------------------chhHHHHHHHHHhcCCCCe
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--------------------------DHEFCSEVEVLSCAQHRNV 464 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~--------------------------~~~f~~Ev~iL~~L~HpNI 464 (756)
...||+|+||.||+|...+|+.||||+++...... ...+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 45799999999999997789999999887542210 1123578999999999988
Q ss_pred eeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecC
Q 004395 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTH 543 (756)
Q Consensus 465 V~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~ 543 (756)
.....+... ..||||||+.|+++..... ....++...+..++.|++.+|.+||. . ||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEEEE-
Confidence 544443332 2489999998876544322 23567888999999999999999999 8 999999999999999
Q ss_pred CCcceeeccccceecCC
Q 004395 544 DFEPLVGDFGLARWQPD 560 (756)
Q Consensus 544 ~~~vkL~DFGlA~~~~~ 560 (756)
++.++|+|||+|.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-21 Score=222.78 Aligned_cols=250 Identities=23% Similarity=0.241 Sum_probs=185.9
Q ss_pred CeeEEEEecccCceEEEEEEecCCCEEEEEEecccC-CcCchhHHHHHHH--HHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS-SQGDHEFCSEVEV--LSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~-~~~~~~f~~Ev~i--L~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+|...+.||++.|=+|.+|..+.|. |+||++.... .-..+.|.++++- ...++|||++.+.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6788899999999999999988887 8889865443 3344555554433 4456899999999888888888999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee--cCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW--QPDG 561 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~--~~~~ 561 (756)
+ .-+|.|.|. .+.-|...+...|+.|++.||..+|.. ||+|||||.+||||+.=+-+.|+||...+- +++.
T Consensus 103 v-khnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 V-KHNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred H-hhhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 8 679999995 334467778889999999999999999 999999999999999999999999987762 3333
Q ss_pred CCCccccc----ccCccccCccccccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhh
Q 004395 562 DMGVETRV----IGTFGYLAPEYAQSG----------Q-ITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 562 ~~~~~~~~----~Gt~~Y~APE~l~~~----------~-~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~ 625 (756)
+....+.+ ..-.+|+|||.+... . .+++-||||+||+++||++ |++||.... .+.....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAYRSG 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhHhcc
Confidence 32222222 223479999977431 2 5788999999999999999 688886321 1111111
Q ss_pred -hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 626 -PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 626 -~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
....+..+.++-|. .+.+++..|+++||.+|.++++.|+.-.+.
T Consensus 251 ~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred CccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 12222233333333 378899999999999999999999976553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=180.20 Aligned_cols=185 Identities=17% Similarity=0.069 Sum_probs=139.5
Q ss_pred EEEEecccCceEEEEEEecCCCEEEEEEecccCCcC----chhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEEee
Q 004395 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG----DHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~----~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
....|++|+||+||.+.. .+.+++.+.+.....-. ...|.+|+++|.+|. |++|+.++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997776 67778877655433211 124789999999995 5889999986 3469999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeecc-CCCceeecCCCcceeeccccceecCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDM-RPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDL-Kp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
.|.+|...+.. . ...++.|++.+|.++|+. ||+|||| ||+|||++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~~---~------~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPPR---G------DLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhhh---h------hHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99998754421 1 135788999999999999 9999999 79999999999999999999986543221
Q ss_pred -----Cc-------ccccccCccccCccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 004395 564 -----GV-------ETRVIGTFGYLAPEYAQSG-QIT-EKADVYSFGVVLVELVTGRKAVDLN 612 (756)
Q Consensus 564 -----~~-------~~~~~Gt~~Y~APE~l~~~-~~s-~ksDVwSlGvvL~ELltG~~Pf~~~ 612 (756)
.. ......++.|+.|+...-. ..+ ...++++.|+-+|.++||+.+.-..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 00 0112357788888754322 233 6789999999999999999886543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-20 Score=209.80 Aligned_cols=232 Identities=23% Similarity=0.243 Sum_probs=184.1
Q ss_pred ecccCceEEEEEE----ecCCCEEEEEEecccCCc--CchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEEeecC
Q 004395 414 LAEGGFGSVHRGV----LPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 414 LG~G~fG~Vy~a~----~~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+|.|.||.|+++. ...|..+|+|+.+..... .......|..++..++ ||.+|++...+..+...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999876 345788999976644321 1124566888888887 99999999999999999999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
|.|...+. ....+.+.....+...++-|++++|.. +|+|||+|++||+++.+|++++.|||+++..-+....
T Consensus 82 g~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 82 GDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred chhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99998886 445677778888899999999999999 9999999999999999999999999999876554322
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCC
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~ 646 (756)
+||..|||||++. .+...+|.||||++++||+||..||... ... .++. .....+
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----------~~~---------~Il~--~~~~~p 207 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----------TMK---------RILK--AELEMP 207 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----------HHH---------HHhh--hccCCc
Confidence 8999999999998 6688999999999999999999999640 111 1111 111234
Q ss_pred hhHHHHHHHHHHHhcccCCCCCCCH--HHHHHHhh
Q 004395 647 EHEVYCMLHAASLCIRRDPHSRPRM--SQVLRILE 679 (756)
Q Consensus 647 ~~~~~~l~~Li~~CL~~dP~~RPS~--~eVL~~Le 679 (756)
........+++..++..+|..|.-. .-+.+.++
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 4455667888999999999999744 34444443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=185.39 Aligned_cols=232 Identities=21% Similarity=0.313 Sum_probs=150.2
Q ss_pred CeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc---CchhHHHHHHHHHhcCC----------CCeeeEEEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQH----------RNVVMLIGFCI 472 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~H----------pNIV~l~~~~~ 472 (756)
.+.....||.|+|+.||.+... +|+.+|||+....... ..+.+.+|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4677889999999999999964 6999999987554422 23456555544433222 11222222111
Q ss_pred ---------ec---C-----ceeEEEEeecCCChhhhhh---ccC--CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceE
Q 004395 473 ---------ED---R-----RRLLVYEYICNGSLDSHLY---GCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530 (756)
Q Consensus 473 ---------~~---~-----~~~LV~Ey~~ggsL~~~L~---~~~--~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIi 530 (756)
.. . ..+++|+-+ -++|.+++. ... ...+....++.+..|+++.+++||.. |++
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~----GlV 167 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY----GLV 167 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc----ceE
Confidence 11 1 346778876 788888763 211 12345556678889999999999999 999
Q ss_pred eeccCCCceeecCCCcceeeccccceecCCCCCCcccccccCccccCcccccc--------CCCCchhhHHHHHHHHHHH
Q 004395 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS--------GQITEKADVYSFGVVLVEL 602 (756)
Q Consensus 531 HrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDVwSlGvvL~EL 602 (756)
|+||||+|+|++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999999876543211 1234578999997743 2478899999999999999
Q ss_pred HhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCC
Q 004395 603 VTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSR 668 (756)
Q Consensus 603 ltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~R 668 (756)
++|+.||+...+.... .+ .+ ..+. +.+..+..||..+|+.+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~---~~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADP---EW----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTS---GG----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccc---cc----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999865432110 00 12 2233 677789999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=205.35 Aligned_cols=206 Identities=22% Similarity=0.267 Sum_probs=167.1
Q ss_pred CCCCCCChHHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC---CCCeeeE
Q 004395 391 KPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ---HRNVVML 467 (756)
Q Consensus 391 ~p~~~~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~---HpNIV~l 467 (756)
..+..-...++++....|.+.+.||+|+||.||+|...+|+.||+|+-+..... +|.-=.+++.+|+ -+.|..+
T Consensus 683 ~~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~ 759 (974)
T KOG1166|consen 683 RVPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHI 759 (974)
T ss_pred cccccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHH
Confidence 334444556778888899999999999999999999777999999987654432 2222344555665 2445555
Q ss_pred EEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC----
Q 004395 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---- 543 (756)
Q Consensus 468 ~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---- 543 (756)
...+.-.+.-+||+||.+.|+|.+++. ..+.+++..+..++.|++..+++||.. +|||+||||+|+||..
T Consensus 760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 760 SSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred HHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCC
Confidence 555556677899999999999999997 678899999999999999999999999 9999999999999942
Q ss_pred ---CCcceeeccccceec---CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 004395 544 ---DFEPLVGDFGLARWQ---PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK 607 (756)
Q Consensus 544 ---~~~vkL~DFGlA~~~---~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~ 607 (756)
...++|+|||-+... .++ ......++|-.+-.+|...|..++..+|.|.|..+++-||.|+.
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCcccceEEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 456899999998633 333 24455678999999999999999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=175.84 Aligned_cols=135 Identities=19% Similarity=0.163 Sum_probs=106.3
Q ss_pred EEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhc-----CCCCeeeEEEEEEecC---c-eeEE
Q 004395 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-----QHRNVVMLIGFCIEDR---R-RLLV 480 (756)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-----~HpNIV~l~~~~~~~~---~-~~LV 480 (756)
-...||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. . +.+|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 346899999999996 3234444 69987765445567899999999999 5799999999998874 3 3378
Q ss_pred EEe--ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHH-HHHHhhcccCceEeeccCCCceeecC----CCcceeeccc
Q 004395 481 YEY--ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGL-RYLHEECRVGCIVHRDMRPNNILLTH----DFEPLVGDFG 553 (756)
Q Consensus 481 ~Ey--~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL-~yLH~~~~~~gIiHrDLKp~NILL~~----~~~vkL~DFG 553 (756)
+|| +.+++|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 457999999953 346555 35678888888 999999 9999999999999974 3479999954
Q ss_pred cc
Q 004395 554 LA 555 (756)
Q Consensus 554 lA 555 (756)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-18 Score=193.41 Aligned_cols=215 Identities=22% Similarity=0.337 Sum_probs=162.4
Q ss_pred HHhcCCCCeeeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCce-Eeecc
Q 004395 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI-VHRDM 534 (756)
Q Consensus 456 L~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gI-iHrDL 534 (756)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....+..+|+.||+|||.. .| .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s----~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS----PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC----cceeeeee
Confidence 3568899999999999999999999999999999999975 567799999999999999999999987 33 99999
Q ss_pred CCCceeecCCCcceeeccccceecCCC-CCCcccccccCccccCccccccC---C----CCchhhHHHHHHHHHHHHhCC
Q 004395 535 RPNNILLTHDFEPLVGDFGLARWQPDG-DMGVETRVIGTFGYLAPEYAQSG---Q----ITEKADVYSFGVVLVELVTGR 606 (756)
Q Consensus 535 Kp~NILL~~~~~vkL~DFGlA~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~---~----~s~ksDVwSlGvvL~ELltG~ 606 (756)
+..|++++....+||+|||+....... .........-...|.|||.+.+. . .+.+.||||||++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998866431 11111222345679999998763 1 467899999999999999999
Q ss_pred CCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 607 KAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 607 ~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.||+........ .+.... +.. .......|.+.... +....+..++..||..+|..||++.++...++..
T Consensus 156 ~~~~~~~~~~~~--~eii~~-~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDP--DEIILR-VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCCh--HHHHHH-HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999764332221 111111 111 11122223222111 2333688999999999999999999999888753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=173.70 Aligned_cols=142 Identities=20% Similarity=0.139 Sum_probs=113.0
Q ss_pred CeeEEEEecccCceEEEEEE--ecCCCEEEEEEecccCCcC------------------------chhHHHHHHHHHhcC
Q 004395 407 GFSQANFLAEGGFGSVHRGV--LPDGQAVAVKQHKLASSQG------------------------DHEFCSEVEVLSCAQ 460 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~--~~~g~~VAVK~~~~~~~~~------------------------~~~f~~Ev~iL~~L~ 460 (756)
.|.+.+.||+|+||.||+|. ..+|+.||||+++...... ...+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 5689999999876542110 012567999999997
Q ss_pred CC--CeeeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCc-eEeeccCCC
Q 004395 461 HR--NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC-IVHRDMRPN 537 (756)
Q Consensus 461 Hp--NIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g-IiHrDLKp~ 537 (756)
+. .++.++++ ...+|||||+.|++|...+. ....+....+..++.|++.+|.|||.. | |+||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE----GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCChh
Confidence 53 34455543 23589999998888876553 234566667789999999999999999 9 999999999
Q ss_pred ceeecCCCcceeeccccceecC
Q 004395 538 NILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 538 NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|||++ ++.++|+|||++....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=167.66 Aligned_cols=134 Identities=19% Similarity=0.276 Sum_probs=113.6
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCCcC--------chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--------DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~--------~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
+.||+|++|.||+|.. .|..+++|+........ ...+.+|++++..+.|+||+....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 67789999765432211 13577899999999999998877777777888999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
++|++|.+++... .+ .+..++.+++.+|.++|.. +++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998532 12 7889999999999999999 999999999999999 78999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-17 Score=164.57 Aligned_cols=130 Identities=23% Similarity=0.317 Sum_probs=106.6
Q ss_pred EecccCceEEEEEEecCCCEEEEEEecccCCcC--------chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--------DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~--------~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
+||+|+||.||+|.+ +|..|++|......... ...+.+|++++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 67889999755332111 245678999999999887665555556667789999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
+|++|.+++... .. .++.+++.+|.+||.. |++|+|++|.|||++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~--~~-------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG--ND-------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc--HH-------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887531 11 7899999999999999 999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.3e-18 Score=190.65 Aligned_cols=239 Identities=20% Similarity=0.251 Sum_probs=156.9
Q ss_pred eEEEEecccCceEEEEEEecC----CCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEE------EEEEe----
Q 004395 409 SQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLI------GFCIE---- 473 (756)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~------~~~~~---- 473 (756)
.+.+..+..++|.++...... ...++-+..+...........+++-.+... .|++.+..- ..+..
T Consensus 247 ~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~ 326 (516)
T KOG1033|consen 247 SISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVG 326 (516)
T ss_pred cccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccc
Confidence 334456666666666655222 234444444443322222333344333333 344433221 11111
Q ss_pred -cCceeEEEEeecCCChhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeec
Q 004395 474 -DRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 474 -~~~~~LV~Ey~~ggsL~~~L~~-~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
...+|+.|++|...+|.++|.. +.....++...+.++.|++.|+.| + +.+|||+||.||+...+..+||.|
T Consensus 327 ~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 327 KKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred cccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhhh
Confidence 2247899999999999999963 344567888999999999999999 5 899999999999999999999999
Q ss_pred cccceecCCCC-----CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhh
Q 004395 552 FGLARWQPDGD-----MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 552 FGlA~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~ 625 (756)
||+........ ....+..+||..||+||.+.+..|+.++||||||++|+|++. =...+..
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------------- 465 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-------------- 465 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH--------------
Confidence 99998765443 223455789999999999999999999999999999999998 1111110
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHH
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQ 673 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~e 673 (756)
.-.....-+..++|.+...++ +-..|+.+++...|.+||++.+
T Consensus 466 ~~t~~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHhhhhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 000000011122222222233 2356889999999999994444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.6e-18 Score=197.56 Aligned_cols=207 Identities=25% Similarity=0.337 Sum_probs=144.8
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.+|..+++|..|+||.||....+ +.+.+|+|+-+.. .+++- +|.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee-------------------
Confidence 57889999999999999999854 5788998643211 11111 33333444444
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC----
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD---- 560 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~---- 560 (756)
|+=...+. .-++++... +.+++|||.. ||+|||+||+|.||+.-|++|++|||+.+....
T Consensus 136 --gDc~tllk--~~g~lPvdm--------vla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLK--NIGPLPVDM--------VLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcc--cCCCCcchh--------hHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 33334443 223444332 7899999999 999999999999999999999999999874221
Q ss_pred ----CCC------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhh
Q 004395 561 ----GDM------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630 (756)
Q Consensus 561 ----~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 630 (756)
+.. .....++||+.|+|||++.-..|+..+|+|++|+|+||++-|..||+...+... + ..++.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--f----g~vis- 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--F----GQVIS- 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--H----hhhhh-
Confidence 111 112346899999999999999999999999999999999999999987755321 1 11111
Q ss_pred hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCC
Q 004395 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP 669 (756)
Q Consensus 631 ~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP 669 (756)
+++.- ..-++....+.++++.++|+.+|..|-
T Consensus 273 ---d~i~w----pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 ---DDIEW----PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ---hhccc----cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 11110 111222334688999999999999996
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=162.09 Aligned_cols=138 Identities=22% Similarity=0.179 Sum_probs=110.6
Q ss_pred CeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCc----------------------CchhHHHHHHHHHhcCCC--
Q 004395 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ----------------------GDHEFCSEVEVLSCAQHR-- 462 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~----------------------~~~~f~~Ev~iL~~L~Hp-- 462 (756)
.|.+.+.||+|+||.||++...+|+.||||++...... ....+..|..++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 38888999999999999999888999999986643210 011256788899999877
Q ss_pred CeeeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec
Q 004395 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (756)
Q Consensus 463 NIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~ 542 (756)
.++..++. ...++||||+.|++|...... .....++.+++.++.++|.. ||+||||||+||+++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~Nill~ 159 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH----GIIHGDLSEFNILVD 159 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCcccEEEc
Confidence 44555543 356999999999998765421 34567899999999999998 999999999999999
Q ss_pred CCCcceeeccccceecCC
Q 004395 543 HDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 543 ~~~~vkL~DFGlA~~~~~ 560 (756)
.++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=170.01 Aligned_cols=196 Identities=22% Similarity=0.262 Sum_probs=140.6
Q ss_pred CCCCeeeEEEEEEec---------------------------CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHH
Q 004395 460 QHRNVVMLIGFCIED---------------------------RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVG 512 (756)
Q Consensus 460 ~HpNIV~l~~~~~~~---------------------------~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~q 512 (756)
+|||||.+.++|.+. ..+|+||.-+ ..+|..++.. ...+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHH
Confidence 599999999988652 3578999887 6899999953 45667778889999
Q ss_pred HHHHHHHHHhhcccCceEeeccCCCceee--cCCCc--ceeeccccceecCCCC-----CCcccccccCccccCcccccc
Q 004395 513 AARGLRYLHEECRVGCIVHRDMRPNNILL--THDFE--PLVGDFGLARWQPDGD-----MGVETRVIGTFGYLAPEYAQS 583 (756)
Q Consensus 513 Ia~aL~yLH~~~~~~gIiHrDLKp~NILL--~~~~~--vkL~DFGlA~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~ 583 (756)
+++|+.|||.+ ||.|||||.+|||| ++|+. +.|+|||.+-.-..-. ........|...-||||+...
T Consensus 350 lLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 350 LLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 99999999999998 44544 5689999875322100 111223457888999998864
Q ss_pred CC-----C-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHH
Q 004395 584 GQ-----I-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAA 657 (756)
Q Consensus 584 ~~-----~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li 657 (756)
.+ . -.|+|.|+.|.+.||+++...||...+...- +...+.+---|.+ +..++..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----------~~r~Yqe~qLPal----p~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----------DTRTYQESQLPAL----PSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-----------chhhhhhhhCCCC----cccCChHHHHHH
Confidence 22 1 2589999999999999999999965322110 1111111112222 233444688999
Q ss_pred HHhcccCCCCCCCHHHHHHHh
Q 004395 658 SLCIRRDPHSRPRMSQVLRIL 678 (756)
Q Consensus 658 ~~CL~~dP~~RPS~~eVL~~L 678 (756)
...|+.||.+|++..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999877655544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=184.73 Aligned_cols=138 Identities=19% Similarity=0.287 Sum_probs=112.3
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEeccc--CCc------CchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLA--SSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~--~~~------~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
....|...+.||+|+||.||+|.+... .+++|+.... ... ....+.+|++++..++|+||+..+.++.+..
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344556788999999999999987543 3444432211 111 1245888999999999999998888888777
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..++||||++|++|.+++. ....++.+++.+|.|||+. ||+||||||+|||+ .++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 8899999999999998884 3567999999999999999 99999999999999 6789999999999
Q ss_pred ee
Q 004395 556 RW 557 (756)
Q Consensus 556 ~~ 557 (756)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 74
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.3e-15 Score=149.92 Aligned_cols=137 Identities=22% Similarity=0.203 Sum_probs=99.8
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCc--CchhH----------------------HHHHHHHHhcCCC--Ce
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEF----------------------CSEVEVLSCAQHR--NV 464 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~--~~~~f----------------------~~Ev~iL~~L~Hp--NI 464 (756)
.+.||+|+||.||+|...+|+.||||++...... ....+ ..|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4579999999999999878999999987643221 11111 3466666666543 34
Q ss_pred eeEEEEEEecCceeEEEEeecCCChhhh-hhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeec
Q 004395 465 VMLIGFCIEDRRRLLVYEYICNGSLDSH-LYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLT 542 (756)
Q Consensus 465 V~l~~~~~~~~~~~LV~Ey~~ggsL~~~-L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~ 542 (756)
++.+++ ...++||||+.++++... +.... .. ..+..++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~----~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA----GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc----CcCcCCCChhhEEEE
Confidence 555543 246999999988554322 21100 11 5678899999999999999 7 999999999999999
Q ss_pred CCCcceeeccccceecCC
Q 004395 543 HDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 543 ~~~~vkL~DFGlA~~~~~ 560 (756)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.1e-15 Score=139.40 Aligned_cols=135 Identities=21% Similarity=0.167 Sum_probs=113.6
Q ss_pred EEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC--CCeeeEEEEEEecCceeEEEEeecCC
Q 004395 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H--pNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+.++..++| .+++++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999744 7899998754432 4578999999999986 59999999988888899999999888
Q ss_pred ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 488 sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
.+..+ +......++.+++.+|+++|.... .+++|+||+|+|||++..+.++++|||+++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~-~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPL-LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCc-eEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77644 556777889999999999998521 2699999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=151.65 Aligned_cols=135 Identities=17% Similarity=0.158 Sum_probs=104.6
Q ss_pred EEec-ccCceEEEEEEecCCCEEEEEEecccC-------------CcCchhHHHHHHHHHhcCCCCe--eeEEEEEEecC
Q 004395 412 NFLA-EGGFGSVHRGVLPDGQAVAVKQHKLAS-------------SQGDHEFCSEVEVLSCAQHRNV--VMLIGFCIEDR 475 (756)
Q Consensus 412 ~~LG-~G~fG~Vy~a~~~~g~~VAVK~~~~~~-------------~~~~~~f~~Ev~iL~~L~HpNI--V~l~~~~~~~~ 475 (756)
..|| .||.|+||.+... +..++||.+.... ......+.+|++++..|.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4587 8999999998874 6778998764311 1122457889999999998875 67777654332
Q ss_pred c----eeEEEEeecC-CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceee
Q 004395 476 R----RLLVYEYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (756)
Q Consensus 476 ~----~~LV~Ey~~g-gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~ 550 (756)
. .++||||++| .+|.+++.. .+++.. .+.+|+.+|.+||+. ||+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA----GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999987 689888743 345543 367899999999999 99999999999999999999999
Q ss_pred ccccceec
Q 004395 551 DFGLARWQ 558 (756)
Q Consensus 551 DFGlA~~~ 558 (756)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-16 Score=184.32 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=187.2
Q ss_pred CeeEEEEecccCceEEEEEEec--CCCEEEEEEecccC--CcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP--DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~--~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.|.+.+.||+|.|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4566667999999999887743 34456666554433 111223334666666676 999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hhcccCceEeeccCCCceeecCCC-cceeeccccceecC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH-EECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQP 559 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH-~~~~~~gIiHrDLKp~NILL~~~~-~vkL~DFGlA~~~~ 559 (756)
+|..|+++.+.+........+...+-.++.|+..+|.|+| .. ++.||||||+|.+++..+ .++++|||+|..+.
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999998883222225666778889999999999999 77 999999999999999999 99999999999776
Q ss_pred C--CCCCccccccc-CccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 560 D--GDMGVETRVIG-TFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 560 ~--~~~~~~~~~~G-t~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
. +........+| ++.|+|||.+.+. ......|+||.|+++.-+++|..||+........ ...|...-
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~-------- 247 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK-------- 247 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc--------
Confidence 6 33334455678 9999999999885 4468899999999999999999999755443221 11111110
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
................+++..++..+|..|.+..++-.
T Consensus 248 ---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 ---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00011112222334667788888899999999888743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.6e-13 Score=151.79 Aligned_cols=140 Identities=25% Similarity=0.243 Sum_probs=99.9
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCCcCc----------------------------------------hhHHH
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD----------------------------------------HEFCS 451 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~----------------------------------------~~f~~ 451 (756)
+.||+|++|.||+|++.+|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999998754321100 13555
Q ss_pred HHHHHHhcC----CCCeeeEEEEE-EecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHH-HHHHHHhhcc
Q 004395 452 EVEVLSCAQ----HRNVVMLIGFC-IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR-GLRYLHEECR 525 (756)
Q Consensus 452 Ev~iL~~L~----HpNIV~l~~~~-~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~-aL~yLH~~~~ 525 (756)
|++.+.++. |.+-+.+-.++ ......+|||||++|++|.++...... .+ ....++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC--
Confidence 666666552 32223322222 223457999999999999887643111 12 23456666666 47888988
Q ss_pred cCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 526 ~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|++|+|++|.||+++.++.++|+|||++..+.
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.9e-13 Score=150.37 Aligned_cols=247 Identities=23% Similarity=0.234 Sum_probs=184.6
Q ss_pred CeeEEEEecc--cCceEEEEEEe---cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCcee
Q 004395 407 GFSQANFLAE--GGFGSVHRGVL---PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 407 ~y~~~~~LG~--G~fG~Vy~a~~---~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~ 478 (756)
.|.+...+|. |.+|.||.+.. .++..+|+|.-+.... .....=.+|+....+++ |+|.++.+..+...+..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999885 4688999996333222 22333345666666664 999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHH----HHHHHHhhcccCceEeeccCCCceeecCC-Ccceeeccc
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR----GLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFG 553 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~----aL~yLH~~~~~~gIiHrDLKp~NILL~~~-~~vkL~DFG 553 (756)
+-+|+| +.+|..+.+. ...-++....+....+... ||.++|.. +++|-|+||+||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC----cccccccchhheecccccceeecCCcc
Confidence 999997 7888888864 2334777888888888888 99999999 99999999999999999 889999999
Q ss_pred cceecCCCCCCcc----cccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh
Q 004395 554 LARWQPDGDMGVE----TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 629 (756)
Q Consensus 554 lA~~~~~~~~~~~----~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 629 (756)
+...+.++..... .+..|...|++||.+. +-++..+|+|++|.++.+-.+|..+...... ..|..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~---- 337 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ---- 337 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc----
Confidence 9998877664322 2235788899999887 4568899999999999999998876543211 11111
Q ss_pred hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 630 ~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+..-.+...+.......+...+.+|++.+|-.|++.+.+..
T Consensus 338 ------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111222233333345566889999999999999988765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.2e-12 Score=122.00 Aligned_cols=131 Identities=20% Similarity=0.081 Sum_probs=97.6
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCe-eeEEEEEEecCceeEEEEeecCCCh
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNI-V~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
.+.|+.|.++.||++... +..|++|....... ....+..|+.++..+.+.++ ++++.+.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 457899999999999874 77899997654322 23357889999999876554 45555443 345899999999888
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcc-cCceEeeccCCCceeecCCCcceeeccccce
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR-VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~-~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.... .....++.+++++|+.||.... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6431 1123457889999999998821 12369999999999999 6789999999986
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.6e-11 Score=141.61 Aligned_cols=145 Identities=18% Similarity=0.164 Sum_probs=97.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEecC-CCEEEEEEecccCCcC----------------------------------c--
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQG----------------------------------D-- 446 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~~~~~~~~~----------------------------------~-- 446 (756)
....|.. +.||+|++|.||+|++.+ |+.||||+.+..-... .
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3445666 789999999999999876 9999999886431100 0
Q ss_pred ----hhHHHHHHHHHhcC----CCCeeeEEEEEEe-cCceeEEEEeecCCChhhhhhccCCC----CCCHHHHHHHHHHH
Q 004395 447 ----HEFCSEVEVLSCAQ----HRNVVMLIGFCIE-DRRRLLVYEYICNGSLDSHLYGCHQE----PLEWSARQKIAVGA 513 (756)
Q Consensus 447 ----~~f~~Ev~iL~~L~----HpNIV~l~~~~~~-~~~~~LV~Ey~~ggsL~~~L~~~~~~----~L~~~~~~~ia~qI 513 (756)
-+|.+|+..+.++. +.+.+.+-.++.+ ....+|||||+.|+.|.++..-...+ .+....+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 12555665555553 4444444343332 44678999999999998743211111 23333333444444
Q ss_pred HHHHHHHHhhcccCceEeeccCCCceeecCCC----cceeeccccceecCC
Q 004395 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFGLARWQPD 560 (756)
Q Consensus 514 a~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~----~vkL~DFGlA~~~~~ 560 (756)
... |++|+|+||.||+++.++ .++++|||++..+..
T Consensus 277 -------f~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -------FRD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HhC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999988 999999999986643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-10 Score=116.77 Aligned_cols=137 Identities=16% Similarity=0.130 Sum_probs=100.2
Q ss_pred EEecccCceEEEEEEecC-------CCEEEEEEecccCC----------------------cCchhHH----HHHHHHHh
Q 004395 412 NFLAEGGFGSVHRGVLPD-------GQAVAVKQHKLASS----------------------QGDHEFC----SEVEVLSC 458 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~-------g~~VAVK~~~~~~~----------------------~~~~~f~----~Ev~iL~~ 458 (756)
..||.|--+.||.|...+ +..+|||+.+.... .....+. .|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47999997653210 0011223 79999999
Q ss_pred cCC--CCeeeEEEEEEecCceeEEEEeecCCChhh-hhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhhcccCceEeecc
Q 004395 459 AQH--RNVVMLIGFCIEDRRRLLVYEYICNGSLDS-HLYGCHQEPLEWSARQKIAVGAARGLRYL-HEECRVGCIVHRDM 534 (756)
Q Consensus 459 L~H--pNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~-~L~~~~~~~L~~~~~~~ia~qIa~aL~yL-H~~~~~~gIiHrDL 534 (756)
+.. -+++..+++ ...+|||||+.+..+.. .+. ...++......+..+++.+|.+| |.. ||||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~----glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKEC----NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhC----CeecCCC
Confidence 863 567777765 45689999996544422 221 22455566778889999999999 787 9999999
Q ss_pred CCCceeecCCCcceeeccccceecCC
Q 004395 535 RPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 535 Kp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
++.|||++ ++.++|+|||.+.....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 46899999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-10 Score=116.76 Aligned_cols=142 Identities=21% Similarity=0.209 Sum_probs=112.4
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCC--CCeeeEEEEEEecC---ceeEEEEeec
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDR---RRLLVYEYIC 485 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~H--pNIV~l~~~~~~~~---~~~LV~Ey~~ 485 (756)
+.|+.|.++.||++...+|..+++|....... .....+..|++++..+.+ .++++++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999986778999998654332 235578999999999975 44677888776543 5689999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc-----------------------------------------
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----------------------------------------- 524 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~----------------------------------------- 524 (756)
|.+|.+.+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876631 45778888889999999999998531
Q ss_pred -----------ccCceEeeccCCCceeecC--CCcceeeccccce
Q 004395 525 -----------RVGCIVHRDMRPNNILLTH--DFEPLVGDFGLAR 556 (756)
Q Consensus 525 -----------~~~gIiHrDLKp~NILL~~--~~~vkL~DFGlA~ 556 (756)
...+++|+|+.|.|||++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 0236899999999999998 6678899999886
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-11 Score=139.29 Aligned_cols=249 Identities=19% Similarity=0.159 Sum_probs=177.8
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEe--cCCCEEEEEEecccCCcCc--hhHHHHHHHHHhcC-CCCeeeEEEEEEecCc
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVL--PDGQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRR 476 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~~VAVK~~~~~~~~~~--~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~ 476 (756)
.....+|..+..||.|.|+.||.... .++..|++|.+........ ..-+.|+.+...+. |.+++.+...+...+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34556899999999999999999874 3678999997665433322 22345676666664 8999998888888888
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC-Ccceeeccccc
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLA 555 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~-~~vkL~DFGlA 555 (756)
.|+=.|||+++++...+. ....+....++++..|++.++.++|+. .++|+|+||+||++.++ +.-++.|||.+
T Consensus 341 ~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhccccccc
Confidence 899999999999876662 345677888999999999999999999 99999999999999886 77889999998
Q ss_pred eecCCCCCCcccccccCccc-cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGY-LAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y-~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
..+.-.. ......+..| .+++......+..+.|+||||..+.+.++|...-. .. ..|....
T Consensus 415 t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~-------~~~~~i~------- 476 (524)
T KOG0601|consen 415 TRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SG-------VQSLTIR------- 476 (524)
T ss_pred cccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCc-cc-------ccceeee-------
Confidence 6422111 0111123334 35666667788899999999999999999865321 11 1111110
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
.-.-+. .+. ....++.+...++..++..||.+.++..+.+
T Consensus 477 ~~~~p~----~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 477 SGDTPN----LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccccC----CCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 000111 111 1145677788899999999999988766543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.3e-10 Score=127.90 Aligned_cols=166 Identities=19% Similarity=0.218 Sum_probs=126.7
Q ss_pred ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHH
Q 004395 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSAR 506 (756)
Q Consensus 427 ~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~ 506 (756)
..++.+|.|...+...........+-++-|+.++||||+++++.++.....|||+|-+ --|..++.. +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHH
Confidence 4467888888777665533445777888999999999999999999999999999987 466666653 335566
Q ss_pred HHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcccccccCccccCccccccCCC
Q 004395 507 QKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586 (756)
Q Consensus 507 ~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~ 586 (756)
..-+.||+.||.|||..| +++|++|.-+-|+++..|..||++|-++.....-.. ......---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 778899999999999876 899999999999999999999999999864432211 111111223456666544322
Q ss_pred CchhhHHHHHHHHHHHHhC
Q 004395 587 TEKADVYSFGVVLVELVTG 605 (756)
Q Consensus 587 s~ksDVwSlGvvL~ELltG 605 (756)
-..|.|.|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 356999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2e-11 Score=128.78 Aligned_cols=201 Identities=20% Similarity=0.261 Sum_probs=137.7
Q ss_pred HHHhcCCCCeeeEEEEEEecC-----ceeEEEEeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccC
Q 004395 455 VLSCAQHRNVVMLIGFCIEDR-----RRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVG 527 (756)
Q Consensus 455 iL~~L~HpNIV~l~~~~~~~~-----~~~LV~Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~ 527 (756)
-|-++.|.|||+++.|+.+.. +..++.||+.-|+|..+|... ....+....-.+|+.||+.||.|||+..+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P-- 197 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP-- 197 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC--
Confidence 444567999999999887543 578999999999999999643 34567777778999999999999998643
Q ss_pred ceEeeccCCCceeecCCCcceeeccccceecCCC----CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHH
Q 004395 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG----DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELV 603 (756)
Q Consensus 528 gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~----~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELl 603 (756)
.|+|+++..+-|++..+|.+|++-- ........ .........+-++|.+||+-.....+-++|||+||+...||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 5999999999999999999987421 11111000 000111234678999999888778888999999999999998
Q ss_pred hCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 604 TGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 604 tG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.|..--.... ..... .......+..+-++. -..++..|+...|+.||+|.+++.+
T Consensus 277 ilEiq~tnse---S~~~~----ee~ia~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSE---SKVEV----EENIANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCc---ceeeh----hhhhhhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence 8753211000 00000 000000111111111 1346778999999999999998775
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.8e-11 Score=143.14 Aligned_cols=246 Identities=22% Similarity=0.247 Sum_probs=173.0
Q ss_pred CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
..+.+.+-+-+|.|+.++.+. ...|...++|..... .....+...++-.++-...+|-++....-+......+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 345566678889999998877 234544555543322 1222333444444444445677776665555667889999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
+|+.+++|...|+. .+..+..-+..+...+..+++|||.. .++|||++|.|+|+..++..+++|||+....+.-
T Consensus 884 ~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred HHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999974 34566667777888889999999997 6899999999999999999999999854321100
Q ss_pred -------------------------CC-----CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004395 562 -------------------------DM-----GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDL 611 (756)
Q Consensus 562 -------------------------~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 611 (756)
.. .......||+.|.+||.+.+......+|+|++|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 00 112346799999999999999999999999999999999999999976
Q ss_pred CCcccccchhhhhhhhhhhhhhhhccCC-ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 004395 612 NRPKGQQCLTEWARPLLEEYAIDELVDP-RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMS 672 (756)
Q Consensus 612 ~~~~~~~~l~~~~~~~~~~~~i~~l~dp-~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~ 672 (756)
..+... + ..+... ..+...+....+...+++...+..+|.+|-.+.
T Consensus 1038 ~tpq~~--f-------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQI--F-------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhh--h-------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 543211 1 111111 111122334445678889999999999998776
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=108.32 Aligned_cols=130 Identities=25% Similarity=0.316 Sum_probs=99.8
Q ss_pred EecccCceEEEEEEecCCCEEEEEEecccCCc--C-c-----hhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--G-D-----HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~--~-~-----~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.+++|+-+.+|.+.+. |..+.+|.-.....- . . ..-.+|+.+|.++.--.|..-+-+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999873 445677743222111 1 1 23566999999997666665555566777789999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
+|..|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++..++ ++++||||+.+
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999899642 256778888888999999 999999999999998775 99999999873
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.8e-09 Score=104.38 Aligned_cols=142 Identities=20% Similarity=0.286 Sum_probs=107.1
Q ss_pred EEEEecccCceEEEEEEecCCCEEEEEEecccCC--------cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--------QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~--------~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
...+|-+|+-+.|+++.+ .|+.+.||.-..... -....-.+|+++|.++.--+|.--.-++.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456899999999999988 678888884322111 11235677999999987667665555677777889999
Q ss_pred EeecC-CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc---ceeeccccce
Q 004395 482 EYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDFGLAR 556 (756)
Q Consensus 482 Ey~~g-gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~---vkL~DFGlA~ 556 (756)
||++| .++.+++...-...........++..|-+.|.-||.+ +|||+||..+||+|..++. +.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99965 3788888643333333334478899999999999999 9999999999999966544 4799999985
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-08 Score=103.25 Aligned_cols=126 Identities=24% Similarity=0.222 Sum_probs=83.7
Q ss_pred EEEEEEecCCCEEEEEEecccCCc---------------------Cc-----hhHHHHHHHHHhcCCC--CeeeEEEEEE
Q 004395 421 SVHRGVLPDGQAVAVKQHKLASSQ---------------------GD-----HEFCSEVEVLSCAQHR--NVVMLIGFCI 472 (756)
Q Consensus 421 ~Vy~a~~~~g~~VAVK~~~~~~~~---------------------~~-----~~f~~Ev~iL~~L~Hp--NIV~l~~~~~ 472 (756)
.||.|...+|..+|||+.+..... .. ....+|.+.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999889999999986543110 00 1366799999999865 567777653
Q ss_pred ecCceeEEEEeec--CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhhcccCceEeeccCCCceeecCCCccee
Q 004395 473 EDRRRLLVYEYIC--NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL-HEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (756)
Q Consensus 473 ~~~~~~LV~Ey~~--ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yL-H~~~~~~gIiHrDLKp~NILL~~~~~vkL 549 (756)
..+|||||+. |..+..+... .++......++.+++..+..+ |.. ||+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~----givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKA----GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCT----TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhc----CceecCCChhhEEeecc-eEEE
Confidence 4589999997 5455443321 111344566778888866664 677 99999999999999888 9999
Q ss_pred eccccceecC
Q 004395 550 GDFGLARWQP 559 (756)
Q Consensus 550 ~DFGlA~~~~ 559 (756)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999997554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-08 Score=107.24 Aligned_cols=140 Identities=19% Similarity=0.121 Sum_probs=101.7
Q ss_pred EecccCceEEEEEEecCCCEEEEEEecccCC-----------cCchhHHHHHHHHHhcCCCCe--eeEEEEEEe-----c
Q 004395 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASS-----------QGDHEFCSEVEVLSCAQHRNV--VMLIGFCIE-----D 474 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~-----------~~~~~f~~Ev~iL~~L~HpNI--V~l~~~~~~-----~ 474 (756)
.+-+.....|++..+ +|+.|.||....... .....+.+|...+.+|...+| +..+++++. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 444444455667666 678899996532221 111247899999988854443 445555543 2
Q ss_pred CceeEEEEeecCC-ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-------CCc
Q 004395 475 RRRLLVYEYICNG-SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-------DFE 546 (756)
Q Consensus 475 ~~~~LV~Ey~~gg-sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-------~~~ 546 (756)
...+||||++++. +|.+++......+.+...+..++.+++..+..||.. ||+|+||++.|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCCCCCce
Confidence 3578999999775 799888533344566778889999999999999999 9999999999999975 467
Q ss_pred ceeecccccee
Q 004395 547 PLVGDFGLARW 557 (756)
Q Consensus 547 vkL~DFGlA~~ 557 (756)
+.|+||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998863
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3e-08 Score=103.75 Aligned_cols=136 Identities=26% Similarity=0.209 Sum_probs=101.3
Q ss_pred eeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcC----------------------chhHHHHHHHHHhcCCC--C
Q 004395 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG----------------------DHEFCSEVEVLSCAQHR--N 463 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~----------------------~~~f~~Ev~iL~~L~Hp--N 463 (756)
+.++..||.|--+.||.|..+.|.++|||..+.....- .....+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 56678999999999999999999999999655332110 12366799999999744 7
Q ss_pred eeeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC
Q 004395 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (756)
Q Consensus 464 IV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~ 543 (756)
|++.+++ ++..+||||++|--|...- +.....-.++..|+.-+.-+-.. ||||+|+.+-|||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc----CccccCCchheEEEec
Confidence 7777765 4568999999886664332 12333444555555555555565 9999999999999999
Q ss_pred CCcceeeccccceec
Q 004395 544 DFEPLVGDFGLARWQ 558 (756)
Q Consensus 544 ~~~vkL~DFGlA~~~ 558 (756)
||.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999877543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.2e-07 Score=103.92 Aligned_cols=167 Identities=19% Similarity=0.210 Sum_probs=128.8
Q ss_pred ceEEEEEE-ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEE----ecCceeEEEEeecC-CChhhh
Q 004395 419 FGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI----EDRRRLLVYEYICN-GSLDSH 492 (756)
Q Consensus 419 fG~Vy~a~-~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~----~~~~~~LV~Ey~~g-gsL~~~ 492 (756)
-.+.|++. ..||..|++|+++....+....-..-+++++++.|+|||+|.++|. .+..++|||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35678888 4589999999885544444444456788999999999999999887 34568999999864 577766
Q ss_pred hhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 493 LYGC-------------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 493 L~~~-------------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
-... .+...++...|.++.|+..||.++|+. |+.-+-|.|.+||++.+..++|...|+.....
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5321 233577899999999999999999999 99999999999999999999998888776543
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK 607 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~ 607 (756)
... + |-+.+ -.+-|.=.||.+++-|.||..
T Consensus 445 ~d~--------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDP--------T-------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC--------C-------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 322 0 11111 246788899999999999964
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.3e-08 Score=93.87 Aligned_cols=132 Identities=18% Similarity=0.276 Sum_probs=96.7
Q ss_pred EEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhHH
Q 004395 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCS 101 (756)
Q Consensus 22 ~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 101 (756)
+|+|++|.|.. +..||.||+...-..|+.|+||+|++..... .++ .+ .. ....+...+..+...
T Consensus 1 ~ILVavD~S~~-s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~---~~~---~~-----~~----~~~~~~~~~~~~~~~ 64 (146)
T cd01989 1 SVAVAVDKDKK-SKNALKWALDNLATKGQTIVLVHVHPPITSI---PSS---SG-----KL----EVASAYKQEEDKEAK 64 (146)
T ss_pred CEEEEecCccc-cHHHHHHHHHhccCCCCcEEEEEeccCcccC---CCC---cc-----ch----HHHHHHHHHHHHHHH
Confidence 48999999854 9999999999888889999999998764222 000 00 00 000111122233345
Q ss_pred HHHHHHhhhcCCCCceEEEEEEeC-CCCchhhHHhhhccceEEEeccccch----------hhhhhhhccc--eeEEEEe
Q 004395 102 QMILQLHDVYDPNKINFKIKIVSG-SPCGAVAAEAKKAQAGWVVLDKQLKH----------EEKCCMEELQ--CNIVVMK 168 (756)
Q Consensus 102 ~~~~~l~~~~~~~~v~~~~~v~~g-~~~~~v~~eak~~~a~wvVld~~~k~----------~~~~~~~~l~--C~i~~~~ 168 (756)
+.+.+....|+..+++++..++.| .|...|+.+|++.+|..|||++|=+. --.+++++.+ |-|.+++
T Consensus 65 ~~l~~~~~~~~~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~ 144 (146)
T cd01989 65 ELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVS 144 (146)
T ss_pred HHHHHHHHHHhhcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEe
Confidence 677777788888899999999986 77778888899999999999998333 2348999999 9999988
Q ss_pred c
Q 004395 169 R 169 (756)
Q Consensus 169 ~ 169 (756)
+
T Consensus 145 ~ 145 (146)
T cd01989 145 K 145 (146)
T ss_pred C
Confidence 5
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.3e-08 Score=115.10 Aligned_cols=150 Identities=20% Similarity=0.300 Sum_probs=106.5
Q ss_pred HHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC--------CcccccccCccccCccccc
Q 004395 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM--------GVETRVIGTFGYLAPEYAQ 582 (756)
Q Consensus 511 ~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~--------~~~~~~~Gt~~Y~APE~l~ 582 (756)
.+++.||.|+|... ++||++|.|++|.++..+..||+.|+++.....+.. ...--..-...|.|||++.
T Consensus 106 ~~v~dgl~flh~sA---k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA---KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCc---ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34459999999873 899999999999999999999999999865433111 0001122355799999999
Q ss_pred cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhc
Q 004395 583 SGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCI 661 (756)
Q Consensus 583 ~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL 661 (756)
+...+.++|+||||+++|.+.. |+.-+...+.. ..+......+......++...+.++.+-+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-------------~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-------------LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCc-------------chhhhhhcccccccccccccCcHHHHHHHHHHh
Confidence 9888999999999999999995 44444322111 112222222222233444556677888889999
Q ss_pred ccCCCCCCCHHHHHH
Q 004395 662 RRDPHSRPRMSQVLR 676 (756)
Q Consensus 662 ~~dP~~RPS~~eVL~ 676 (756)
..++.-||++.+++.
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998888755
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.3e-07 Score=91.73 Aligned_cols=107 Identities=22% Similarity=0.251 Sum_probs=85.1
Q ss_pred chhHHHHHHHHHhcCCCC--eeeEEEEEEecC----ceeEEEEeecCC-ChhhhhhccCCCCCCHHHHHHHHHHHHHHHH
Q 004395 446 DHEFCSEVEVLSCAQHRN--VVMLIGFCIEDR----RRLLVYEYICNG-SLDSHLYGCHQEPLEWSARQKIAVGAARGLR 518 (756)
Q Consensus 446 ~~~f~~Ev~iL~~L~HpN--IV~l~~~~~~~~----~~~LV~Ey~~gg-sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~ 518 (756)
...+.+|...+..|...+ +++.+++..... ..+||+|++++. +|.+++.... .++......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 346788888888886433 456666665532 458999999874 7999886422 2667778899999999999
Q ss_pred HHHhhcccCceEeeccCCCceeecCCC---cceeeccccceec
Q 004395 519 YLHEECRVGCIVHRDMRPNNILLTHDF---EPLVGDFGLARWQ 558 (756)
Q Consensus 519 yLH~~~~~~gIiHrDLKp~NILL~~~~---~vkL~DFGlA~~~ 558 (756)
-||.. ||+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 133 ~lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999887 7899999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.3e-06 Score=89.33 Aligned_cols=138 Identities=19% Similarity=0.156 Sum_probs=104.0
Q ss_pred ecccCceEEEEEEecCCCEEEEEEecccC------CcCchhHHHHHHHHHhcCCC--CeeeEEEEEE-e----cCceeEE
Q 004395 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLAS------SQGDHEFCSEVEVLSCAQHR--NVVMLIGFCI-E----DRRRLLV 480 (756)
Q Consensus 414 LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~------~~~~~~f~~Ev~iL~~L~Hp--NIV~l~~~~~-~----~~~~~LV 480 (756)
-|+||-+-|+.... +|+.+-+|.-...- ..+...|.+|...|..|..- .+++.. ++. . ....+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56789999999776 44578888643111 23556899999999998633 245555 332 1 1246899
Q ss_pred EEeecC-CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc--ceeecccccee
Q 004395 481 YEYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE--PLVGDFGLARW 557 (756)
Q Consensus 481 ~Ey~~g-gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~--vkL~DFGlA~~ 557 (756)
+|-+.| .+|.+++......+.+......++.+++..|+-||.. |+.|+|+-+.|||++.++. +.++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998743 5888888654445668888899999999999999999 9999999999999986677 88999987763
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.7e-06 Score=82.40 Aligned_cols=132 Identities=12% Similarity=0.259 Sum_probs=93.5
Q ss_pred cEEEEEEeCCCC-cchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhh
Q 004395 21 EKVVVAVKASKE-IPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (756)
Q Consensus 21 ~~v~v~~d~~~~-~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (756)
++++|++|.|.. .+..|+.||+.-.-+.|..|+||+|++....... .++ ... ... ....+..+.
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~-~~~---------~~~----~~~-~~~~~~~~~ 67 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYAS-LGL---------AYS----AEL-PAMDDLKAE 67 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCccccc-ccc---------ccc----ccc-hHHHHHHHH
Confidence 579999999975 2578999999987788999999999975322100 111 000 000 001122222
Q ss_pred HHHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccchh---------hhhhhhccceeEEEEe
Q 004395 100 CSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVMK 168 (756)
Q Consensus 100 ~~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~---------~~~~~~~l~C~i~~~~ 168 (756)
..+.+.++.+.+...++.++..+..|.|...|+..|++.++..||++.| +.. -.+++++.+|-|.+++
T Consensus 68 ~~~~l~~~~~~~~~~~~~~~~~v~~G~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~~llGS~a~~vl~~a~cpVlvVr 144 (144)
T PRK15005 68 AKSQLEEIIKKFKLPTDRVHVHVEEGSPKDRILELAKKIPADMIIIASH-RPDITTYLLGSNAAAVVRHAECSVLVVR 144 (144)
T ss_pred HHHHHHHHHHHhCCCCCceEEEEeCCCHHHHHHHHHHHcCCCEEEEeCC-CCCchheeecchHHHHHHhCCCCEEEeC
Confidence 2345566666666688889999999999888888899999999999988 442 4489999999998875
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.2e-06 Score=101.03 Aligned_cols=141 Identities=23% Similarity=0.261 Sum_probs=93.0
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCCcCc----------------------------------------hhHHH
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD----------------------------------------HEFCS 451 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~----------------------------------------~~f~~ 451 (756)
..|+.++-|.||+|++++|+.||||+.+.+-.... -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999999999999997653321100 12555
Q ss_pred HHHHHHhcC-----CCCeeeEEEEE-EecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcc
Q 004395 452 EVEVLSCAQ-----HRNVVMLIGFC-IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525 (756)
Q Consensus 452 Ev~iL~~L~-----HpNIV~l~~~~-~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~ 525 (756)
|+.-+.++. .++| .+-.+| .-.....|+|||+.|..+.+...-.. ..++...+.....++. +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc--
Confidence 666666553 2333 222222 23456799999999999988853212 3344333222222221 2222234
Q ss_pred cCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 526 ~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|+.|.|..|.||+++.+|.+.+.|||+.....+
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999875543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.4e-06 Score=90.99 Aligned_cols=257 Identities=14% Similarity=0.111 Sum_probs=148.5
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEE------EEe-cCceeEEEE
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGF------CIE-DRRRLLVYE 482 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~------~~~-~~~~~LV~E 482 (756)
++.||+|+-+.+|-.-.-. ..| -|+.......... ..++.|... .||-+-.-+.+ .-+ +...-++|.
T Consensus 16 gr~LgqGgea~ly~l~e~~-d~V-AKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVR-DQV-AKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchhh-chh-heeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4569999999999644211 123 3555433322221 122233332 35543321111 111 223567788
Q ss_pred eecCCC-hhhhhh----ccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 483 YICNGS-LDSHLY----GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 483 y~~ggs-L~~~L~----~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
.+.+.. +..++. ...-....|...++.+..++.+.+-||+. |.+-+|+.++|+|+.+++.+.|.|=.....
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~----Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH----GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc----CCcccccCccceeeecCceEEEEcccceee
Confidence 876542 222221 11234578999999999999999999999 889999999999999999999987544332
Q ss_pred cCCCCCCcccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCccccc--chh-hhhhhhh
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTG-RKAVDLNRPKGQQ--CLT-EWARPLL 628 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~~~--~l~-~~~~~~~ 628 (756)
..++. ....-+|...|.+||.-. +-.-+...|.|.||+++++++.| +.||.+....... -+. ..+....
T Consensus 167 ~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 NANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred ccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 22221 122346889999999654 33456789999999999999997 9999643322110 000 1111000
Q ss_pred hhh--hhhhccCCccCCCCChhHHHHHHHHHHHhcccC--CCCCCCHHHHHHHhh
Q 004395 629 EEY--AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRD--PHSRPRMSQVLRILE 679 (756)
Q Consensus 629 ~~~--~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~d--P~~RPS~~eVL~~Le 679 (756)
... .-... .+.....-..-....+..+..+|+... +.-|||++..+..|.
T Consensus 245 ~ya~~~~~g~-~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~ 298 (637)
T COG4248 245 AYASDQRRGL-KPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD 298 (637)
T ss_pred eechhccCCC-CCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence 000 00000 011111111112345667777887543 568999998877654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.2e-06 Score=85.32 Aligned_cols=152 Identities=25% Similarity=0.221 Sum_probs=103.5
Q ss_pred ChHHHHHhhCCeeEEEE---ecccCceEEEEEEecCCCEEEEEEecccCCcCc-------------------h-----hH
Q 004395 397 SYAELELATGGFSQANF---LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD-------------------H-----EF 449 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~---LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~-------------------~-----~f 449 (756)
++..+..+.++..+... |..|--+.||+|...++..+|||+.+....... + ..
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 33444444455554444 556777789999987899999998764432111 0 13
Q ss_pred HHHHHHHHhcC--CCCeeeEEEEEEecCceeEEEEeecCC-ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhccc
Q 004395 450 CSEVEVLSCAQ--HRNVVMLIGFCIEDRRRLLVYEYICNG-SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526 (756)
Q Consensus 450 ~~Ev~iL~~L~--HpNIV~l~~~~~~~~~~~LV~Ey~~gg-sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~ 526 (756)
..|+.-|.++. +=.+++-+++. .-.|||||+... .-.-.| ..-++....+..+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 34777777774 45566777665 348999999433 111122 2233444467788888888888887743
Q ss_pred CceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 527 ~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
++||+||+.-|||+. ++.+.|+|||-|....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 899999999999999 8899999999997554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.1e-06 Score=83.47 Aligned_cols=143 Identities=22% Similarity=0.166 Sum_probs=85.8
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCC--CeeeEEEEEEe---cCceeEEEEeec
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR--NVVMLIGFCIE---DRRRLLVYEYIC 485 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~Hp--NIV~l~~~~~~---~~~~~LV~Ey~~ 485 (756)
++.|+.|..+.||+....+ ..+++|..... .....+..|+.+++.+... .++.++.++.. ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999866 58999976543 3455788899999888533 35677765433 234689999999
Q ss_pred CCChhh----------------hh---hcc--CCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 004395 486 NGSLDS----------------HL---YGC--HQEPLEWSAR---------QKI------------AVGAAR-GLRYLHE 522 (756)
Q Consensus 486 ggsL~~----------------~L---~~~--~~~~L~~~~~---------~~i------------a~qIa~-aL~yLH~ 522 (756)
|..+.. .+ +.. ...++..... ... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 888877 11 111 1111111110 000 112222 3444443
Q ss_pred hc---ccCceEeeccCCCceeec-CCCcceeeccccce
Q 004395 523 EC---RVGCIVHRDMRPNNILLT-HDFEPLVGDFGLAR 556 (756)
Q Consensus 523 ~~---~~~gIiHrDLKp~NILL~-~~~~vkL~DFGlA~ 556 (756)
.. ...+++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 123799999999999999 66666899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.4e-06 Score=79.87 Aligned_cols=131 Identities=17% Similarity=0.219 Sum_probs=91.7
Q ss_pred cEEEEEEeCCC-CcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhh
Q 004395 21 EKVVVAVKASK-EIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (756)
Q Consensus 21 ~~v~v~~d~~~-~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (756)
++|+|++|.|. +.+..|+.||+.-. +.+..|.||+|++..... ....+ . . ...+......+.
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~la-~~~~~l~llhv~~~~~~~-~~~~~---~-------~-----~~~~~~~~~~~~ 65 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFLA-QDDGVIHLLHVLPGSASL-SLHRF---A-------A-----DVRRFEEHLQHE 65 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHHH-hcCCeEEEEEEecCcccc-ccccc---c-------c-----chhhHHHHHHHH
Confidence 68999999995 67999999999864 445689999998764221 00000 0 0 000111122232
Q ss_pred HHHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch--------hhhhhhhccceeEEEEe
Q 004395 100 CSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH--------EEKCCMEELQCNIVVMK 168 (756)
Q Consensus 100 ~~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~--------~~~~~~~~l~C~i~~~~ 168 (756)
..+.+.++.+.++..+++++..+..|.|...|...|++.+|..||++.|-+. .-.+.+++..|.|.++|
T Consensus 66 ~~~~l~~~~~~~~~~~~~v~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~llGS~a~~v~~~a~~pVLvV~ 142 (142)
T PRK15456 66 AEERLQTMVSHFTIDPSRIKQHVRFGSVRDEVNELAEELGADVVVIGSRNPSISTHLLGSNASSVIRHANLPVLVVR 142 (142)
T ss_pred HHHHHHHHHHHhCCCCcceEEEEcCCChHHHHHHHHhhcCCCEEEEcCCCCCccceecCccHHHHHHcCCCCEEEeC
Confidence 3355666666666678899999999999888887799999999999999432 23388999999998875
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.9e-05 Score=81.28 Aligned_cols=139 Identities=14% Similarity=0.147 Sum_probs=94.2
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchh---------HHHHHHHHHhcCC---CCeeeEEE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE---------FCSEVEVLSCAQH---RNVVMLIG 469 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~---------f~~Ev~iL~~L~H---pNIV~l~~ 469 (756)
.+..++|...+.+-......|.+-.. +|..+.+|..+.......+. ..+++..+..+.. -.++.++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45678999999999988888877766 67889999765433222222 2234443444432 22223222
Q ss_pred EEE-----ecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC
Q 004395 470 FCI-----EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (756)
Q Consensus 470 ~~~-----~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~ 544 (756)
+.. -....+|+|||++|..|.++.. ++. .++..+..+|.-||.. |+.|+|..|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~----G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH----GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc----CCccCCCCcCcEEEECC
Confidence 222 1234568999999988876542 222 3556677889999999 99999999999999865
Q ss_pred Ccceeeccccce
Q 004395 545 FEPLVGDFGLAR 556 (756)
Q Consensus 545 ~~vkL~DFGlA~ 556 (756)
.++++||+..+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 48999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.5e-05 Score=82.99 Aligned_cols=139 Identities=14% Similarity=0.103 Sum_probs=86.0
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC--eeeEEEEEEecCceeEEEEeecCCC-
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIGFCIEDRRRLLVYEYICNGS- 488 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN--IV~l~~~~~~~~~~~LV~Ey~~ggs- 488 (756)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-+ +++.++++.+.+...+|||++.|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24467788765422 3345788999999986443 4778888888888899999998863
Q ss_pred hhhhh---------------------hccCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhhcccCceEeeccC
Q 004395 489 LDSHL---------------------YGCHQEPLEWSARQ-KIAV----------GAAR-GLRYLHEECRVGCIVHRDMR 535 (756)
Q Consensus 489 L~~~L---------------------~~~~~~~L~~~~~~-~ia~----------qIa~-aL~yLH~~~~~~gIiHrDLK 535 (756)
+...+ +............. .+.. .+.. ...+|...-....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 11000111111111 0100 0111 12222222112257999999
Q ss_pred CCceeecCCCcceeeccccce
Q 004395 536 PNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 536 p~NILL~~~~~vkL~DFGlA~ 556 (756)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.7e-05 Score=76.17 Aligned_cols=128 Identities=13% Similarity=0.129 Sum_probs=88.1
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++++|++|.|.. |..|+.||+...-+.|-.|+||+|++..... + .+. ... ...+....+.+..
T Consensus 4 k~ILvavD~S~~-s~~al~~A~~lA~~~~a~l~llhV~~~~~~~-----~---~~~---~~~-----~~~~~~~~~~~~~ 66 (142)
T PRK09982 4 KHIGVAISGNEE-DALLVNKALELARHNDAHLTLIHIDDGLSEL-----Y---PGI---YFP-----ATEDILQLLKNKS 66 (142)
T ss_pred eEEEEEecCCcc-hHHHHHHHHHHHHHhCCeEEEEEEccCcchh-----c---hhh---hcc-----chHHHHHHHHHHH
Confidence 689999999866 8999999999888899999999998753211 0 000 000 0011112222222
Q ss_pred HHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccchhhh-------hhhhccceeEEEEe
Q 004395 101 SQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEK-------CCMEELQCNIVVMK 168 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~~~-------~~~~~l~C~i~~~~ 168 (756)
...+..+...++. ..++..++.|.|...|+..|++.+|..||++.| ++..+ ..+.+..|-|.+++
T Consensus 67 ~~~l~~~~~~~~~--~~~~~~v~~G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~~va~~V~~~s~~pVLvv~ 138 (142)
T PRK09982 67 DNKLYKLTKNIQW--PKTKLRIERGEMPETLLEIMQKEQCDLLVCGHH-HSFINRLMPAYRGMINKMSADLLIVP 138 (142)
T ss_pred HHHHHHHHHhcCC--CcceEEEEecCHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHHHHHHHHHhcCCCCEEEec
Confidence 3445555544433 357788888999999998899999999999998 66544 55788888888876
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.8e-05 Score=81.06 Aligned_cols=139 Identities=18% Similarity=0.071 Sum_probs=85.6
Q ss_pred ecccCc-eEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEEeecCCChhh
Q 004395 414 LAEGGF-GSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYICNGSLDS 491 (756)
Q Consensus 414 LG~G~f-G~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~ 491 (756)
|..|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+++++++...++..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 788998764 4678888765432 345778999998885 4446688888877667899999999887764
Q ss_pred hh-------------------hccC--CCCCCHH--HHHHHHH--------------------HHHHHHHHHHhhc---c
Q 004395 492 HL-------------------YGCH--QEPLEWS--ARQKIAV--------------------GAARGLRYLHEEC---R 525 (756)
Q Consensus 492 ~L-------------------~~~~--~~~L~~~--~~~~ia~--------------------qIa~aL~yLH~~~---~ 525 (756)
.. +... ..++... ....... .+...+..|-... .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 1100 0011100 0000000 0111122221111 1
Q ss_pred cCceEeeccCCCceeecCCCcceeeccccce
Q 004395 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 526 ~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
...++|+|+.|.|||+++++.+.|+||+.|.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2369999999999999998878899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.08 E-value=0.0001 Score=75.11 Aligned_cols=125 Identities=23% Similarity=0.371 Sum_probs=91.1
Q ss_pred CCeeEEEEecccCc-eEEEEEEecCCCEEEEEEecc---cCC------------------cCchhHHHHHHHHHhcC---
Q 004395 406 GGFSQANFLAEGGF-GSVHRGVLPDGQAVAVKQHKL---ASS------------------QGDHEFCSEVEVLSCAQ--- 460 (756)
Q Consensus 406 ~~y~~~~~LG~G~f-G~Vy~a~~~~g~~VAVK~~~~---~~~------------------~~~~~f~~Ev~iL~~L~--- 460 (756)
..++.++.||.|.- |.||++.+ +|+.||+|.++. ... .-...|..|-+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999998 678999998321 110 01124788988888885
Q ss_pred CCCe--eeEEEEEEecC------------------ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHH
Q 004395 461 HRNV--VMLIGFCIEDR------------------RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520 (756)
Q Consensus 461 HpNI--V~l~~~~~~~~------------------~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yL 520 (756)
+.++ |+++||..-.. ...||.||+.... .+. ..-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence 4566 99999874321 2356777764432 122 23356777788899
Q ss_pred HhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 521 H~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~----gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL----GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC----CeeeccCcccccc-----CCEEEecccC
Confidence 999 9999999999988 4579999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.7e-05 Score=91.36 Aligned_cols=139 Identities=22% Similarity=0.187 Sum_probs=92.5
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCCcC-------------------------------------chhHHHHHH
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-------------------------------------DHEFCSEVE 454 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~-------------------------------------~~~f~~Ev~ 454 (756)
+.||....|.||+|++++|+.||||+-+..-... .-+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999755332111 013555555
Q ss_pred HHHh----cCCCC------eeeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc
Q 004395 455 VLSC----AQHRN------VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524 (756)
Q Consensus 455 iL~~----L~HpN------IV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~ 524 (756)
-..+ +.|-+ |++++..+ .....|+||||.|..+.|.-.- ....++...+..-+.++..-+-+. .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~~qIf~--~- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYLEQIFK--T- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHHHHHHh--c-
Confidence 3333 34555 55555444 3467999999999988776432 233455554444443332222222 2
Q ss_pred ccCceEeeccCCCceeec----CCCcceeeccccceecC
Q 004395 525 RVGCIVHRDMRPNNILLT----HDFEPLVGDFGLARWQP 559 (756)
Q Consensus 525 ~~~gIiHrDLKp~NILL~----~~~~vkL~DFGlA~~~~ 559 (756)
|++|+|-.|.|||++ .++.+.+.|||+.....
T Consensus 321 ---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 ---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 899999999999998 36788999999987543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.1e-05 Score=91.43 Aligned_cols=147 Identities=16% Similarity=0.215 Sum_probs=93.2
Q ss_pred EEEecccCceEEEEEEecCC---CEEEEEEecccCC-cCchhHHHHHHHHHhcC-CCCe--eeEEEEEEec---CceeEE
Q 004395 411 ANFLAEGGFGSVHRGVLPDG---QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNV--VMLIGFCIED---RRRLLV 480 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g---~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~-HpNI--V~l~~~~~~~---~~~~LV 480 (756)
...|+.|.+..+|+....++ ..+++|+...... .....+.+|+++|+.|. |.+| ++++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999886553 3677776543221 23357889999999996 6665 7888888764 467899
Q ss_pred EEeecCCChhhh-----------------------hhccCC---------CCCCH--HHHHHHHH---------------
Q 004395 481 YEYICNGSLDSH-----------------------LYGCHQ---------EPLEW--SARQKIAV--------------- 511 (756)
Q Consensus 481 ~Ey~~ggsL~~~-----------------------L~~~~~---------~~L~~--~~~~~ia~--------------- 511 (756)
|||++|..+.+. |+.... .+..+ .++..+..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999987654321 111100 01111 11111111
Q ss_pred HHHHHHHHHHhhccc-------CceEeeccCCCceeecCC-Cc-ceeecccccee
Q 004395 512 GAARGLRYLHEECRV-------GCIVHRDMRPNNILLTHD-FE-PLVGDFGLARW 557 (756)
Q Consensus 512 qIa~aL~yLH~~~~~-------~gIiHrDLKp~NILL~~~-~~-vkL~DFGlA~~ 557 (756)
.+...+.+|..+.+. .++||+|+++.|||++.+ +. +-|.||.++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 123346677655442 359999999999999753 33 46899998863
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.4e-05 Score=73.96 Aligned_cols=129 Identities=21% Similarity=0.281 Sum_probs=88.1
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++|+|++|.+.. +..|+.||+...-+.|+.|++|+|++....... +. ..............
T Consensus 3 ~~Ilv~~d~~~~-~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~--~~----------------~~~~~~~~~~~~~~ 63 (140)
T PF00582_consen 3 KRILVAIDGSEE-SRRALRFALELAKRSGAEITLLHVIPPPPQYSF--SA----------------AEDEESEEEAEEEE 63 (140)
T ss_dssp SEEEEEESSSHH-HHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHH--HH----------------HHHHHHHHHHHHHH
T ss_pred CEEEEEECCCHH-HHHHHHHHHHHHHhhCCeEEEEEeecccccccc--cc----------------ccccccccccchhh
Confidence 789999998765 889999999998889999999999997432200 00 00000000000000
Q ss_pred HHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEEe
Q 004395 101 SQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMK 168 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~ 168 (756)
..............++...+.+..|.+...|+.+++..++.-||++++-+. -.++++.+.+|-|.+++
T Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~~pVlvv~ 140 (140)
T PF00582_consen 64 QARQAEAEEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAPCPVLVVP 140 (140)
T ss_dssp HHHHHHHHHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTSSEEEEEE
T ss_pred hhhhHHHHHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCCCCEEEeC
Confidence 011111012233367888899999998888998999999999999999422 35699999999998875
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.0001 Score=75.27 Aligned_cols=132 Identities=21% Similarity=0.272 Sum_probs=94.2
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccC----------------CcCchhHHHHHHHHHhcC------CCCeeeEE
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS----------------SQGDHEFCSEVEVLSCAQ------HRNVVMLI 468 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~----------------~~~~~~f~~Ev~iL~~L~------HpNIV~l~ 468 (756)
...||+|+.-.||. .++.....||+..... .....++.+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999886 4455667888876554 223456778888777776 78999999
Q ss_pred EEEEecCceeEEEEeecCC------ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec
Q 004395 469 GFCIEDRRRLLVYEYICNG------SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (756)
Q Consensus 469 ~~~~~~~~~~LV~Ey~~gg------sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~ 542 (756)
|+.+.+...-+|+|.+.+. +|.+++. .+.++. . +...+-+-..||-++ .|+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~---~~~~L~~f~~~l~~~----~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-E---LRQALDEFKRYLLDH----HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-H---HHHHHHHHHHHHHHc----CCeecCCCcccEEEE
Confidence 9999999999999998542 5777773 344554 3 333333445677777 899999999999995
Q ss_pred CCC----cceeec-cccc
Q 004395 543 HDF----EPLVGD-FGLA 555 (756)
Q Consensus 543 ~~~----~vkL~D-FGlA 555 (756)
... .+.|+| ||-.
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 432 466777 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=97.96 E-value=3.7e-05 Score=73.46 Aligned_cols=127 Identities=13% Similarity=0.145 Sum_probs=85.5
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++++|++|.|.. +..||.||+.-.-..|..|+||+|.+..... +. +. . .....+......
T Consensus 4 ~~ILvavD~S~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~---~~-----~~-~-------~~~~~~~~~~~~--- 63 (144)
T PRK15118 4 KHILIAVDLSPE-SKVLVEKAVSMARPYNAKVSLIHVDVNYSDL---YT-----GL-I-------DVNLGDMQKRIS--- 63 (144)
T ss_pred eEEEEEccCChh-HHHHHHHHHHHHHhhCCEEEEEEEccChhhh---hh-----hh-h-------hcchHHHHHHHH---
Confidence 689999999976 8999999999765678899999994321111 00 00 0 000011111111
Q ss_pred HHHHHHHhhhcCCCCceEEE-EEEeCCCCchhhHHhhhccceEEEeccccchh-------hhhhhhccceeEEEEe
Q 004395 101 SQMILQLHDVYDPNKINFKI-KIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE-------EKCCMEELQCNIVVMK 168 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~~~~-~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~-------~~~~~~~l~C~i~~~~ 168 (756)
.+....|..+.+..++.+.. .+..|.|...|+..|++.+|..||++.| .+- -.+.+.+.+|-|.+++
T Consensus 64 ~~~~~~l~~~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~lgSva~~v~~~a~~pVLvv~ 138 (144)
T PRK15118 64 EETHHALTELSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHH-QDFWSKLMSSARQLINTVHVDMLIVP 138 (144)
T ss_pred HHHHHHHHHHHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCc-ccHHHHHHHHHHHHHhhCCCCEEEec
Confidence 22334455555667887643 4457999888998899999999999999 442 2378999999999987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=2.8e-06 Score=97.35 Aligned_cols=181 Identities=20% Similarity=0.123 Sum_probs=130.9
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC-eeeEEEEEEecCceeEEEEeecCC-Ch
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDRRRLLVYEYICNG-SL 489 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN-IV~l~~~~~~~~~~~LV~Ey~~gg-sL 489 (756)
.-+++|+++++|+.+-.-.+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 347889999999987211122224433322 34566899999999999 777777777777889999999766 22
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCccccc
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 569 (756)
...+.. ..-.+...+...+...-+++|+|+|+. -=+||| |||..+ +..+..||+.+..+.... .....
T Consensus 323 ~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~----~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~ 390 (829)
T KOG0576|consen 323 ALEMTV-SEIALEQYQFAYPLRKETRPLAELHSS----YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTA 390 (829)
T ss_pred cccCCh-hhHhhhhhhhhhhhhhhcccccccccc----cccCcc----cccccc-cccccccccCCcccCccc--ccccC
Confidence 221110 122344445556677778899999987 448898 888766 688999999987665432 34567
Q ss_pred ccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004395 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAV 609 (756)
Q Consensus 570 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf 609 (756)
.+++.++|||+.....+....|+|++|.--.++.-|-+|-
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 7999999999999999999999999998777887777664
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00011 Score=67.14 Aligned_cols=119 Identities=21% Similarity=0.362 Sum_probs=86.9
Q ss_pred EEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhHH
Q 004395 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCS 101 (756)
Q Consensus 22 ~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 101 (756)
+|+|++|.+.. +..+|.||+.-.-+.+..|++|+|.+..... +. +..........
T Consensus 1 ~ilv~i~~~~~-~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~---~~---------------------~~~~~~~~~~~ 55 (130)
T cd00293 1 RILVAVDGSEE-SERALRWAARLARRLGAELVLLHVVDPPPSS---AA---------------------ELAELLEEEAR 55 (130)
T ss_pred CEEEEeCCCHH-HHHHHHHHHHHHHhcCCEEEEEEEecCCCCc---ch---------------------hHHHHHHHHHH
Confidence 48999998544 8999999999988889999999997753322 00 11111222334
Q ss_pred HHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccchhh----------hhhhhccceeEEE
Q 004395 102 QMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEE----------KCCMEELQCNIVV 166 (756)
Q Consensus 102 ~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~~----------~~~~~~l~C~i~~ 166 (756)
+.+.++...|+..++.+...+..|.+...|+.+++..++..||++.+ ++.. .+.+++..|.+.+
T Consensus 56 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dlvvig~~-~~~~~~~~~~~~~~~~ll~~~~~pvli 129 (130)
T cd00293 56 ALLEALREALAEAGVKVETVVLEGDPAEAILEAAEELGADLIVMGSR-GRSGLRRLLLGSVAERVLRHAPCPVLV 129 (130)
T ss_pred HHHHHHHHHHhcCCCceEEEEecCCCHHHHHHHHHHcCCCEEEEcCC-CCCccceeeeccHHHHHHhCCCCCEEe
Confidence 67788887787889999999999998778888899999999999987 3332 2455555565543
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00011 Score=76.42 Aligned_cols=73 Identities=15% Similarity=0.118 Sum_probs=47.1
Q ss_pred EEecccCceE-EEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCC---CeeeEEEEEEecC---ceeEEEEee
Q 004395 412 NFLAEGGFGS-VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR---NVVMLIGFCIEDR---RRLLVYEYI 484 (756)
Q Consensus 412 ~~LG~G~fG~-Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~Hp---NIV~l~~~~~~~~---~~~LV~Ey~ 484 (756)
+.|+.||... ||+. +..+.+|.... ......+.+|+++|..|... -++.+++.....+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 4577777774 8875 23467776443 22345788999999888632 3455555443322 348899999
Q ss_pred cCCChh
Q 004395 485 CNGSLD 490 (756)
Q Consensus 485 ~ggsL~ 490 (756)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00012 Score=74.17 Aligned_cols=103 Identities=24% Similarity=0.194 Sum_probs=81.2
Q ss_pred HHHHHHHHhcCC-CCeeeEEEEEEecCceeEEEEeecCCChhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccC
Q 004395 450 CSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527 (756)
Q Consensus 450 ~~Ev~iL~~L~H-pNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~-~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~ 527 (756)
..|.-+|..+++ +++++++|+|- .++|.||+..+++...-.. ..-...+|..+.+||.++++.+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~- 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG- 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC-
Confidence 357788888886 69999999993 4789999977766421100 0123468999999999999999999986333
Q ss_pred ceEeeccCCCceeecCCCcceeecccccee
Q 004395 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 528 gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
.+...|++++|+-++++|.+|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 478899999999999999999999988753
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00012 Score=72.64 Aligned_cols=130 Identities=21% Similarity=0.218 Sum_probs=91.5
Q ss_pred eeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCee-eEEEEEEecCceeEEEEeecC
Q 004395 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVV-MLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV-~l~~~~~~~~~~~LV~Ey~~g 486 (756)
....+.||+|.+|.||++.+. |..+|+|+-+.. .....+..|+++|..+.--++. ++|.|..+ ++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 345678999999999999984 458899965533 3456789999999999876664 56665433 556999988
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccC-CCceeecCCCcceeecccccee
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMR-PNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLK-p~NILL~~~~~vkL~DFGlA~~ 557 (756)
..|.+.-... +. +-...+++.---|-.. ||-|..|. |..++|.+++.+.|+||.-|+.
T Consensus 97 ~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~~----GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG-----DR----KHLLRVLEKAYKLDRL----GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc-----cH----HHHHHHHHHHHHHHHh----ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8887766421 22 2233444543334444 89999987 5555666666999999999874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00055 Score=74.16 Aligned_cols=79 Identities=13% Similarity=0.066 Sum_probs=58.7
Q ss_pred eeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC---CCeeeEEEEEEec---CceeEEE
Q 004395 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH---RNVVMLIGFCIED---RRRLLVY 481 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H---pNIV~l~~~~~~~---~~~~LV~ 481 (756)
..-.+.||.|..+.||+....+++ +.+|..+. ......|..|.+.|+.|.- -.+++++++|... +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344567999999999998765564 66676432 1133578999999999853 3688899887643 5689999
Q ss_pred EeecCCCh
Q 004395 482 EYICNGSL 489 (756)
Q Consensus 482 Ey~~ggsL 489 (756)
|+++|+++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99988765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00064 Score=70.29 Aligned_cols=141 Identities=16% Similarity=0.111 Sum_probs=83.0
Q ss_pred EEEecccCceEEEEEEecC--CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC-eeeEEEEEEecCceeEEEEeecCC
Q 004395 411 ANFLAEGGFGSVHRGVLPD--GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~--g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN-IV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
.+.|..|-...+|+....+ +..|++|+..... .......+|+.++..+...+ .+++++.+. -.+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567888888999998654 6789999765332 22223457999999885433 445554432 24899999887
Q ss_pred Chhhh-----------------hhccC-CC--------CCC-HHHHHHHHHH----------------------HHHHHH
Q 004395 488 SLDSH-----------------LYGCH-QE--------PLE-WSARQKIAVG----------------------AARGLR 518 (756)
Q Consensus 488 sL~~~-----------------L~~~~-~~--------~L~-~~~~~~ia~q----------------------Ia~aL~ 518 (756)
++... ++... .. ... +..+..+... +...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76321 01110 00 111 2222222111 111111
Q ss_pred HH----HhhcccCceEeeccCCCceeecC-CCcceeeccccce
Q 004395 519 YL----HEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLAR 556 (756)
Q Consensus 519 yL----H~~~~~~gIiHrDLKp~NILL~~-~~~vkL~DFGlA~ 556 (756)
.| -......+++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 22 11111236999999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00035 Score=64.77 Aligned_cols=113 Identities=8% Similarity=0.076 Sum_probs=79.1
Q ss_pred EEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhHH
Q 004395 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCS 101 (756)
Q Consensus 22 ~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 101 (756)
+|+|++|.+.. ++.||.||....-+.+..|+||+|.+.... ...+. -.
T Consensus 1 ~Ilv~vd~s~~-s~~al~~a~~la~~~~~~l~ll~v~~~~~~------------------------~~~~~-------~~ 48 (124)
T cd01987 1 RILVCISGGPN-AERLIRRAARLADRLKAPWYVVYVETPRLN------------------------RLSEA-------ER 48 (124)
T ss_pred CEEEEECCCcc-hHHHHHHHHHHHHHhCCCEEEEEEecCccc------------------------cCCHH-------HH
Confidence 58999999865 899999999988888999999999874211 00011 12
Q ss_pred HHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhcc-ceeEEEE
Q 004395 102 QMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEEL-QCNIVVM 167 (756)
Q Consensus 102 ~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l-~C~i~~~ 167 (756)
+.++.+.+.++..++.+. .+..|.+...|..+|+..++..||++.|-+. .-.+.+.+. .|-|.++
T Consensus 49 ~~l~~~~~~~~~~~~~~~-~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a~~~~v~v~ 123 (124)
T cd01987 49 RRLAEALRLAEELGAEVV-TLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRAGNIDVHIV 123 (124)
T ss_pred HHHHHHHHHHHHcCCEEE-EEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhCCCCeEEEe
Confidence 445555555555566443 2344677677888899999999999999432 234777777 8877653
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00035 Score=74.95 Aligned_cols=142 Identities=16% Similarity=0.048 Sum_probs=85.9
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC--eeeEEEE------EEecCceeEEEE
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIGF------CIEDRRRLLVYE 482 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN--IV~l~~~------~~~~~~~~LV~E 482 (756)
.+.|..|....+|+....+ ..+++|+... .....+..|++++..|.+.+ +++++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 5567888888999987644 4688887653 23445677888888885333 4454432 233456789999
Q ss_pred eecCCChhh----h----------hhccC----C-----CCCCHHHHH----------HHHHHHHHHHHHHHhh---ccc
Q 004395 483 YICNGSLDS----H----------LYGCH----Q-----EPLEWSARQ----------KIAVGAARGLRYLHEE---CRV 526 (756)
Q Consensus 483 y~~ggsL~~----~----------L~~~~----~-----~~L~~~~~~----------~ia~qIa~aL~yLH~~---~~~ 526 (756)
|++|..+.. . ++... . ....|.... .....+..++.++... ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998877532 0 01100 0 011111110 0111233444555431 112
Q ss_pred CceEeeccCCCceeecCCCcceeeccccce
Q 004395 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 527 ~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999998778899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00051 Score=72.36 Aligned_cols=137 Identities=15% Similarity=0.066 Sum_probs=79.6
Q ss_pred ecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCe-eeEEEEEEecCceeEEEEeecCCChhhh
Q 004395 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYICNGSLDSH 492 (756)
Q Consensus 414 LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNI-V~l~~~~~~~~~~~LV~Ey~~ggsL~~~ 492 (756)
+..|-...+|+... ++..+++|..........-...+|.++|+.+...++ ++++..+. -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 567788886543322221246789999999864433 45554432 3799999988766421
Q ss_pred -----------------hhccC--CCCCCHHHH-HHHHHHH---------HHHHHHHHhh----cccCceEeeccCCCce
Q 004395 493 -----------------LYGCH--QEPLEWSAR-QKIAVGA---------ARGLRYLHEE----CRVGCIVHRDMRPNNI 539 (756)
Q Consensus 493 -----------------L~~~~--~~~L~~~~~-~~ia~qI---------a~aL~yLH~~----~~~~gIiHrDLKp~NI 539 (756)
|+... ..+++.... ..+..++ ...+..+-.. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 112222211 1211111 1112222111 0122689999999999
Q ss_pred eecCCCcceeeccccce
Q 004395 540 LLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 540 LL~~~~~vkL~DFGlA~ 556 (756)
++++++ +.|+||..|.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999877 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00055 Score=63.63 Aligned_cols=122 Identities=16% Similarity=0.152 Sum_probs=90.4
Q ss_pred EEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhHH
Q 004395 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCS 101 (756)
Q Consensus 22 ~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 101 (756)
+|+|.+|.+. -+..+|.+|..-.-+.+-.|+||+|++..... .+ ....+..+...
T Consensus 1 ~ILv~vd~s~-~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~----~~--------------------~~~~~~~~~~~ 55 (132)
T cd01988 1 RILVPVANPN-TARDLLELAAALARAQNGEIIPLNVIEVPNHS----SP--------------------SQLEVNVQRAR 55 (132)
T ss_pred CEEEecCCch-hHHHHHHHHHHHhhcCCCeEEEEEEEecCCCC----Cc--------------------chhHHHHHHHH
Confidence 5899999884 48999999999877778899999998863321 11 00001122335
Q ss_pred HHHHHHhhhcCCCCceEEEEEEe-CCCCchhhHHhhhccceEEEeccccchh---------hhhhhhccceeEEEEe
Q 004395 102 QMILQLHDVYDPNKINFKIKIVS-GSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVMK 168 (756)
Q Consensus 102 ~~~~~l~~~~~~~~v~~~~~v~~-g~~~~~v~~eak~~~a~wvVld~~~k~~---------~~~~~~~l~C~i~~~~ 168 (756)
+.+..+.+.++..++.++..+.. |.+.+.|+..|+..++..||++.+-+.. -.+.+.+.+|-+.++|
T Consensus 56 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~~pvlvv~ 132 (132)
T cd01988 56 KLLRQAERIAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAPCDVAVVK 132 (132)
T ss_pred HHHHHHHHHhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCCCCEEEeC
Confidence 77888888888889999988865 7777778877999999999999994322 3467888899888764
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00029 Score=86.04 Aligned_cols=196 Identities=19% Similarity=0.184 Sum_probs=138.9
Q ss_pred HHHHHHHHHhcCCCCeeeEEEEEEecCce----eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc
Q 004395 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524 (756)
Q Consensus 449 f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~----~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~ 524 (756)
..-|.+.+..+.|+|++.++.|..+.... .+..|+|..-++...+. .-+.++....+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 33466778888999999999987765432 35567888888888887 457789999999999999999999998
Q ss_pred ccCceEeeccCCC---ceeecCCCcceee--ccccceecCCCCCCcccccccCccccCccccccCCCCc--hhhHHHHHH
Q 004395 525 RVGCIVHRDMRPN---NILLTHDFEPLVG--DFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE--KADVYSFGV 597 (756)
Q Consensus 525 ~~~gIiHrDLKp~---NILL~~~~~vkL~--DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~--ksDVwSlGv 597 (756)
...|.-|..+ +-..+..+.+.++ ||+....+.+... .....-+..|.++|......+.. ..|+|.+|.
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 5556555554 5556667777766 9998886655432 22233466788888887666554 479999999
Q ss_pred HHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 598 VLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 598 vL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+..+..|..+-.... ....+++.. .. ..+.+....|+..++++|+++.+++..
T Consensus 381 l~~~~~~~~~i~~~~~------------------~~~~~l~~~----~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA------------------VPVSLLDVL----ST----SELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCccccccc------------------chhhhhccc----cc----hhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999998865432110 001111111 00 136677889999999999999999885
Q ss_pred h
Q 004395 678 L 678 (756)
Q Consensus 678 L 678 (756)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00063 Score=64.62 Aligned_cols=127 Identities=13% Similarity=0.158 Sum_probs=86.4
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++++|++|.+.. +..||.+|+.---+-|..|+||++++..... .++ . .....+......
T Consensus 4 ~~ILv~~D~s~~-s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~---~~~---~-----------~~~~~~~~~~~~--- 62 (142)
T PRK10116 4 SNILVAVAVTPE-SQQLLAKAVSIARPVNGKISLITLASDPEMY---NQF---A-----------APMLEDLRSVMQ--- 62 (142)
T ss_pred ceEEEEccCCcc-hHHHHHHHHHHHHHhCCEEEEEEEccCcccc---hhh---h-----------HHHHHHHHHHHH---
Confidence 689999999876 7889999998766668899999997653211 111 0 000111111111
Q ss_pred HHHHHHHhhhcCCCCceEE-EEEEeCCCCchhhHHhhhccceEEEeccccchh-------hhhhhhccceeEEEEe
Q 004395 101 SQMILQLHDVYDPNKINFK-IKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE-------EKCCMEELQCNIVVMK 168 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~~~-~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~-------~~~~~~~l~C~i~~~~ 168 (756)
.+....|..+.+..++.+. +.+..|.+...|+..|++.++..||++.|-+.. -.+++.+..|-|.+++
T Consensus 63 ~~~~~~l~~~~~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~s~a~~v~~~~~~pVLvv~ 138 (142)
T PRK10116 63 EETQSFLDKLIQDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRASCSAKRVIASSEVDVLLVP 138 (142)
T ss_pred HHHHHHHHHHHHhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 2333445555566677654 666679998888888999999999999993322 2488899999999887
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0037 Score=70.45 Aligned_cols=76 Identities=20% Similarity=0.145 Sum_probs=54.8
Q ss_pred EEEecccCceEEEEEEecCC-CEEEEEEeccc-----C--CcCchhHHHHHHHHHhcC---CCCeeeEEEEEEecCceeE
Q 004395 411 ANFLAEGGFGSVHRGVLPDG-QAVAVKQHKLA-----S--SQGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g-~~VAVK~~~~~-----~--~~~~~~f~~Ev~iL~~L~---HpNIV~l~~~~~~~~~~~L 479 (756)
.+.||.|.+..||++...+| +.|.||.-... . .-....+..|.+.|..+. -.++++++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 35799999999999998776 48999974311 1 123455777888888863 24678888774 455789
Q ss_pred EEEeecCCC
Q 004395 480 VYEYICNGS 488 (756)
Q Consensus 480 V~Ey~~ggs 488 (756)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.002 Score=69.50 Aligned_cols=140 Identities=22% Similarity=0.219 Sum_probs=84.2
Q ss_pred EEecccCceEEEEEEecC-------CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC-eeeEEEEEEecCceeEEEEe
Q 004395 412 NFLAEGGFGSVHRGVLPD-------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~-------g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN-IV~l~~~~~~~~~~~LV~Ey 483 (756)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+...+ .+++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899988654 5789999865433 23345678999998886433 3456665532 468999
Q ss_pred ecCCChhhh-----------------hhccCCC-------CCC--HHHHHH--------------------------HHH
Q 004395 484 ICNGSLDSH-----------------LYGCHQE-------PLE--WSARQK--------------------------IAV 511 (756)
Q Consensus 484 ~~ggsL~~~-----------------L~~~~~~-------~L~--~~~~~~--------------------------ia~ 511 (756)
++|..+... ++..... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776431 1111100 111 111111 111
Q ss_pred HHHHHHHHHHhh-----cccCceEeeccCCCceeecCC----Ccceeeccccce
Q 004395 512 GAARGLRYLHEE-----CRVGCIVHRDMRPNNILLTHD----FEPLVGDFGLAR 556 (756)
Q Consensus 512 qIa~aL~yLH~~-----~~~~gIiHrDLKp~NILL~~~----~~vkL~DFGlA~ 556 (756)
.+...+.+|-.. ....+++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 222233344321 122379999999999999985 889999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0012 Score=71.03 Aligned_cols=134 Identities=16% Similarity=0.221 Sum_probs=89.9
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++++|++|.|.. +..|+.||+.---+-+..|+||+|++...... .++ ... ....+.+....+..
T Consensus 4 ~~ILv~~D~s~~-~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~--~~~--~~~-----------~~~~~~~~~~~~~~ 67 (305)
T PRK11175 4 QNILVVIDPNQD-DQPALRRAVYLAQRNGGKITAFLPIYDFSYEM--TTL--LSP-----------DEREAMRQGVISQR 67 (305)
T ss_pred ceEEEEcCCCcc-ccHHHHHHHHHHHhcCCCEEEEEeccCchhhh--hcc--cch-----------hHHHHHHHHHHHHH
Confidence 689999999976 89999999997666777899998876432210 010 000 00001111111112
Q ss_pred HHHHHHHhhhcCCCCceEEEEEE-eCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEEecC
Q 004395 101 SQMILQLHDVYDPNKINFKIKIV-SGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMKRS 170 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~~~~~v~-~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~~~ 170 (756)
.+.+..+...+...++.++..++ .|.|...|...|++.++..||++.|-+. .-.+.+.+..|-+.+++..
T Consensus 68 ~~~l~~~~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~~pvlvv~~~ 147 (305)
T PRK11175 68 TAWIREQAKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCPCPVLMVKDQ 147 (305)
T ss_pred HHHHHHHHHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCCCCEEEeccc
Confidence 23344444555567899999888 4888778888899999999999998432 1247899999999999853
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0019 Score=69.95 Aligned_cols=143 Identities=17% Similarity=0.094 Sum_probs=83.1
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC--eeeEEEE------EEecCceeEEEE
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIGF------CIEDRRRLLVYE 482 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN--IV~l~~~------~~~~~~~~LV~E 482 (756)
.+.++.|....+|+....+| .+++|+..... .......|++++..|...+ +++++.. ...++..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876555 57788765421 2345567778887774322 4444432 122456789999
Q ss_pred eecCCChhhh--------------hhccCCC---C-------CCHHHHH------------HHHHHHHHHHHHHHhh---
Q 004395 483 YICNGSLDSH--------------LYGCHQE---P-------LEWSARQ------------KIAVGAARGLRYLHEE--- 523 (756)
Q Consensus 483 y~~ggsL~~~--------------L~~~~~~---~-------L~~~~~~------------~ia~qIa~aL~yLH~~--- 523 (756)
|++|..+... ++....+ + -.|.... .....+...++++...
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988654211 1110000 0 0111100 0111233445555421
Q ss_pred cccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 524 ~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112389999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00017 Score=77.63 Aligned_cols=136 Identities=17% Similarity=0.073 Sum_probs=97.0
Q ss_pred CeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcC-----------------c-----hhHHHHHHHHHhcCC--C
Q 004395 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-----------------D-----HEFCSEVEVLSCAQH--R 462 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~-----------------~-----~~f~~Ev~iL~~L~H--p 462 (756)
-+.+++.||-|.-+.||.+....|+..++|..+.....- . -....|...|+.|.. =
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 367889999999999999999899999999644332110 0 124458888888853 2
Q ss_pred CeeeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec
Q 004395 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (756)
Q Consensus 463 NIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~ 542 (756)
-|++.+++ ++.++|||++.|-.|...-+ .....+ +...+..-+--|..+ |+||+|..--||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~~---ly~~lm~~Iv~la~~----GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPPT---LYDDLMGLIVRLANH----GLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee-----cCChHH---HHHHHHHHHHHHHHc----CceecccchheeEEe
Confidence 35566655 45699999998888865442 122223 333444445566677 999999999999999
Q ss_pred CCCcceeeccccceec
Q 004395 543 HDFEPLVGDFGLARWQ 558 (756)
Q Consensus 543 ~~~~vkL~DFGlA~~~ 558 (756)
+++.++++||--....
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999876543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0034 Score=68.23 Aligned_cols=142 Identities=15% Similarity=0.097 Sum_probs=77.5
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC--eeeEEE------EEEecCceeEEEE
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIG------FCIEDRRRLLVYE 482 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN--IV~l~~------~~~~~~~~~LV~E 482 (756)
.+.|+.|....+|+....+| .+++|+.. . .....+..|+.++..|...+ +++.+. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34566777789999886555 68888765 1 12234445666666653222 334332 1223456789999
Q ss_pred eecCCChhh-----------hh---hccCC---------CCCCH-HHHHH------------HHHH-HHHHHHHHHhh--
Q 004395 483 YICNGSLDS-----------HL---YGCHQ---------EPLEW-SARQK------------IAVG-AARGLRYLHEE-- 523 (756)
Q Consensus 483 y~~ggsL~~-----------~L---~~~~~---------~~L~~-~~~~~------------ia~q-Ia~aL~yLH~~-- 523 (756)
|++|..+.. .| +.... ..+.| ..... ...+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998875421 11 11000 01111 11111 1111 11122222211
Q ss_pred -cccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 524 -CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 524 -~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.-+.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 012379999999999999977666899999875
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.003 Score=70.01 Aligned_cols=103 Identities=15% Similarity=0.210 Sum_probs=73.5
Q ss_pred CccEEEEEEeCCCCcchhhHhHHhhhccCC--CCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccch
Q 004395 19 VAEKVVVAVKASKEIPRTALVWALTHVVQP--GDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDI 96 (756)
Q Consensus 19 ~~~~v~v~~d~~~~~~~~a~~wal~~~~~~--gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (756)
.-++++|++|.|.. |..|+.-|+...-.. +..|+||+|++..... .+ . .+.
T Consensus 4 ~ykkILVavDGSe~-S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~---~~------------~-----------~~~ 56 (357)
T PRK12652 4 AANRLLVPVADSVT-VRQTVAYAVESAEEAAETPTVHLVAAASGRAVD---PE------------G-----------QDE 56 (357)
T ss_pred ccCeEEEEeCCCHH-HHHHHHHHHHHHHhcCCCCEEEEEEEecCcccc---cc------------h-----------hHH
Confidence 34899999999965 899999999876553 5899999999853211 00 0 011
Q ss_pred hhhHHHHHHHHhhhcCC------CCceEEEEEEe--------CCCCchhhHHhhhccceEEEeccc
Q 004395 97 TDSCSQMILQLHDVYDP------NKINFKIKIVS--------GSPCGAVAAEAKKAQAGWVVLDKQ 148 (756)
Q Consensus 97 ~~~~~~~~~~l~~~~~~------~~v~~~~~v~~--------g~~~~~v~~eak~~~a~wvVld~~ 148 (756)
....++.+.++.+..+. .+|.++..|+. |.|...|+..|++.++..||+|..
T Consensus 57 ~~~~eelle~~~~~~~~~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~ 122 (357)
T PRK12652 57 LAAAEELLERVEVWATEDLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPE 122 (357)
T ss_pred HHHHHHHHHHHHHHHHHhhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCC
Confidence 11112344444444433 69999999987 788888988899999999999998
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.011 Score=63.95 Aligned_cols=76 Identities=22% Similarity=0.263 Sum_probs=50.3
Q ss_pred eeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC---CCCeeeEEEEEEecCceeEEEEee
Q 004395 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~---HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
....+.|+.|....+|+.. .+++.+.||+.. ......|..|++-|+.|. --.+++.+++....+..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3456679999999999987 577889999755 334457889999999884 346789999988877889999999
Q ss_pred cCC
Q 004395 485 CNG 487 (756)
Q Consensus 485 ~gg 487 (756)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0059 Score=67.08 Aligned_cols=137 Identities=20% Similarity=0.234 Sum_probs=96.6
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCC---------cCc-----------------hhHHHHHHHHHhcCCCCee
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS---------QGD-----------------HEFCSEVEVLSCAQHRNVV 465 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~---------~~~-----------------~~f~~Ev~iL~~L~HpNIV 465 (756)
..|..|--+-||.|...+|..+|||+++..-. .+. -....|++-|.+|...+|+
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 46778999999999988999999997652110 000 0133477777777655543
Q ss_pred eEEEEEEecCceeEEEEeecCCChh--hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC
Q 004395 466 MLIGFCIEDRRRLLVYEYICNGSLD--SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (756)
Q Consensus 466 ~l~~~~~~~~~~~LV~Ey~~ggsL~--~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~ 543 (756)
----+.. ....|||+|+ |.+=+ -.| ....++...+..+-.+++.-+.-|...| ++||.||.--|+|+ .
T Consensus 230 ~PePIlL--k~hVLVM~Fl-Grdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c---~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFL-GRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC---RLVHADLSEFNLLY-H 299 (520)
T ss_pred CCCceee--ecceEeeeec-cCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh---ceeccchhhhhheE-E
Confidence 2211111 1347999998 33321 122 3456778889999999999999999998 79999999999998 6
Q ss_pred CCcceeeccccceec
Q 004395 544 DFEPLVGDFGLARWQ 558 (756)
Q Consensus 544 ~~~vkL~DFGlA~~~ 558 (756)
+|.++|+|-+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 679999999887643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.02 Score=63.55 Aligned_cols=73 Identities=18% Similarity=0.131 Sum_probs=48.6
Q ss_pred EecccCceEEEEEEecCC-CEEEEEEe----cc---cCCcCchhHHHHHHHHHhcC--CC-CeeeEEEEEEecCceeEEE
Q 004395 413 FLAEGGFGSVHRGVLPDG-QAVAVKQH----KL---ASSQGDHEFCSEVEVLSCAQ--HR-NVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g-~~VAVK~~----~~---~~~~~~~~f~~Ev~iL~~L~--Hp-NIV~l~~~~~~~~~~~LV~ 481 (756)
.||.|....||++..++| +.|+||.- +. ...-.......|.+.|.... -| .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997654 58999952 21 11223345567888887764 24 45566655 445567999
Q ss_pred EeecCC
Q 004395 482 EYICNG 487 (756)
Q Consensus 482 Ey~~gg 487 (756)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.029 Score=61.34 Aligned_cols=128 Identities=22% Similarity=0.233 Sum_probs=76.6
Q ss_pred EEEEEEecCCCEEEEEEecc--cCCcCchhHHHHHHHHHhcCC--CCeeeEEEEEEecC--ceeEEEEeecCCChhhhhh
Q 004395 421 SVHRGVLPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDR--RRLLVYEYICNGSLDSHLY 494 (756)
Q Consensus 421 ~Vy~a~~~~g~~VAVK~~~~--~~~~~~~~f~~Ev~iL~~L~H--pNIV~l~~~~~~~~--~~~LV~Ey~~ggsL~~~L~ 494 (756)
.+|.... +++.+.+. ... ..........+|.+++..+.- --+...+++|.++. ..|.||+|++|..+.+.+.
T Consensus 40 ~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 3444433 37777777 221 122334456678888887752 23445667776665 6799999998855443331
Q ss_pred ccCCCCCCHHHHHHHH-HHHHHH--------------------------------------------------HHHHHhh
Q 004395 495 GCHQEPLEWSARQKIA-VGAARG--------------------------------------------------LRYLHEE 523 (756)
Q Consensus 495 ~~~~~~L~~~~~~~ia-~qIa~a--------------------------------------------------L~yLH~~ 523 (756)
.. ... .+++ ..+++. ..||+.+
T Consensus 118 ~~---~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 118 PE---SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred cc---cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 10 000 1111 133333 3444433
Q ss_pred cc----cCceEeeccCCCceeecCCCcceeecccccee
Q 004395 524 CR----VGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 524 ~~----~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
-+ ...++|+|+.+.||+++.++-+=|.||+++..
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 22 23699999999999999998888999999863
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.00062 Score=84.77 Aligned_cols=160 Identities=13% Similarity=0.053 Sum_probs=114.6
Q ss_pred HHHHHHHHHhcCCCCeeeEEEEEEe--cCceeEEEEeecCCChhhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhhc
Q 004395 449 FCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLVYEYICNGSLDSHLYGCHQ--EPLEWSARQKIAVGAARGLRYLHEEC 524 (756)
Q Consensus 449 f~~Ev~iL~~L~HpNIV~l~~~~~~--~~~~~LV~Ey~~ggsL~~~L~~~~~--~~L~~~~~~~ia~qIa~aL~yLH~~~ 524 (756)
...|..-++...|+++...+.-... +...|.+++|+.+|.+.+.|..... .++...-+.....+...+..-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4445556666789988877665433 3456899999999999999864322 23333333333334355555555442
Q ss_pred ccC-ceEeeccCCCceeecCCCcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHH
Q 004395 525 RVG-CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELV 603 (756)
Q Consensus 525 ~~~-gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELl 603 (756)
..+ -.+|++||+-|.+|..+..+|++++|+.+...+ .........+++.|+.|++...-.++.++|+|..|+.+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 111 268999999999999999999999999984332 222334567888999999998888999999999999999998
Q ss_pred hCCCCC
Q 004395 604 TGRKAV 609 (756)
Q Consensus 604 tG~~Pf 609 (756)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.019 Score=61.54 Aligned_cols=29 Identities=31% Similarity=0.518 Sum_probs=24.9
Q ss_pred ceEeeccCCCceeecCCCc-ceeeccccce
Q 004395 528 CIVHRDMRPNNILLTHDFE-PLVGDFGLAR 556 (756)
Q Consensus 528 gIiHrDLKp~NILL~~~~~-vkL~DFGlA~ 556 (756)
.++|+|+.|.|||+++++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 5899999999999997555 4599999885
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.021 Score=61.56 Aligned_cols=133 Identities=17% Similarity=0.227 Sum_probs=83.2
Q ss_pred ccEEEEEEeCCCCc------chhhHhHHhhhccCC-CCeEEEEEEecCCCCCCcccccccccccccCCcccccccccccc
Q 004395 20 AEKVVVAVKASKEI------PRTALVWALTHVVQP-GDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQ 92 (756)
Q Consensus 20 ~~~v~v~~d~~~~~------~~~a~~wal~~~~~~-gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (756)
.++|+|++|.+.+. +..||.+|+.=.-.- +-.|+||+|++..... .+. .. ... ...+.
T Consensus 152 ~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~--~~~------~~-~~~------~~~~~ 216 (305)
T PRK11175 152 GGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPIN--IAI------EL-PEF------DPSVY 216 (305)
T ss_pred CCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchh--ccc------cc-ccc------chhhH
Confidence 58999999987653 356889888644333 6789999997643221 000 00 000 00111
Q ss_pred ccchhhhHHHHHHHHhhhcCCCCceE-EEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccce
Q 004395 93 RGDITDSCSQMILQLHDVYDPNKINF-KIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQC 162 (756)
Q Consensus 93 ~~~~~~~~~~~~~~l~~~~~~~~v~~-~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C 162 (756)
...+.+ +....|.++.+..++.. .+.|..|.|...|...|++.+|..||++.|-+. .-.+.+.+++|
T Consensus 217 ~~~~~~---~~~~~l~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~~ 293 (305)
T PRK11175 217 NDAIRG---QHLLAMKALRQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLNC 293 (305)
T ss_pred HHHHHH---HHHHHHHHHHHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCCC
Confidence 111111 22223333333335543 466778998878887799999999999998443 35588999999
Q ss_pred eEEEEecC
Q 004395 163 NIVVMKRS 170 (756)
Q Consensus 163 ~i~~~~~~ 170 (756)
.|.++|..
T Consensus 294 pVLvv~~~ 301 (305)
T PRK11175 294 DLLAIKPD 301 (305)
T ss_pred CEEEEcCC
Confidence 99999843
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.059 Score=59.71 Aligned_cols=141 Identities=18% Similarity=0.180 Sum_probs=83.3
Q ss_pred EEEecccCceEEEEEEecC-----CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCe-eeEEEEEEecCceeEEEEee
Q 004395 411 ANFLAEGGFGSVHRGVLPD-----GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~-----g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNI-V~l~~~~~~~~~~~LV~Ey~ 484 (756)
...|-.|-.-.+|+..+.+ ++.|.+|+...... ..-.-.+|..++..+..-++ +++++++..+ .|++|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3455558888999987532 36788997654432 22234679999998865444 3566665332 589999
Q ss_pred cCCChhhh-----------------hhccC----CCCCCHHHHHHHHHHH-----------------HHHHHHHHhh---
Q 004395 485 CNGSLDSH-----------------LYGCH----QEPLEWSARQKIAVGA-----------------ARGLRYLHEE--- 523 (756)
Q Consensus 485 ~ggsL~~~-----------------L~~~~----~~~L~~~~~~~ia~qI-----------------a~aL~yLH~~--- 523 (756)
.+.+|... ++... .....+..+..+..++ ...+..|...
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87776421 11111 0112233333332221 1122222221
Q ss_pred -cccCceEeeccCCCceeecC-CCcceeeccccce
Q 004395 524 -CRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLAR 556 (756)
Q Consensus 524 -~~~~gIiHrDLKp~NILL~~-~~~vkL~DFGlA~ 556 (756)
.....++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22236899999999999986 4689999998875
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.039 Score=52.07 Aligned_cols=136 Identities=19% Similarity=0.289 Sum_probs=92.9
Q ss_pred CccEEEEEEe-CCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchh
Q 004395 19 VAEKVVVAVK-ASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDIT 97 (756)
Q Consensus 19 ~~~~v~v~~d-~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (756)
..+++++++| .+ +.+..|+.+|+......+..+.++.|+...........+..... ......+..
T Consensus 4 ~~~~il~~~d~~s-~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~ 69 (154)
T COG0589 4 MYKKILVAVDVGS-EAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAP-------------IPLSEEELE 69 (154)
T ss_pred ccceEEEEeCCCC-HHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccch-------------hhhhHHHHH
Confidence 3478999999 65 44899999999998888888888888776432211111000000 001111112
Q ss_pred hhHHHHHHHHhhhcCCCCce-EEEEEEeCCCC-chhhHHhhhccceEEEeccccch----------hhhhhhhccceeEE
Q 004395 98 DSCSQMILQLHDVYDPNKIN-FKIKIVSGSPC-GAVAAEAKKAQAGWVVLDKQLKH----------EEKCCMEELQCNIV 165 (756)
Q Consensus 98 ~~~~~~~~~l~~~~~~~~v~-~~~~v~~g~~~-~~v~~eak~~~a~wvVld~~~k~----------~~~~~~~~l~C~i~ 165 (756)
....+.+..+....+..++. +...+..|.|. ..|...|...+|..||++.+ ++ --.+.+.+.+|.+.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~-g~~~l~~~llGsvs~~v~~~~~~pVl 148 (154)
T COG0589 70 EEAEELLAEAKALAEAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSR-GRSGLSRLLLGSVAEKVLRHAPCPVL 148 (154)
T ss_pred HHHHHHHHHHHHHHHHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCC-CCccccceeeehhHHHHHhcCCCCEE
Confidence 22246677777777777888 59999999995 56666788889999999997 32 24489999999999
Q ss_pred EEec
Q 004395 166 VMKR 169 (756)
Q Consensus 166 ~~~~ 169 (756)
+++.
T Consensus 149 vv~~ 152 (154)
T COG0589 149 VVRS 152 (154)
T ss_pred EEcc
Confidence 9874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.08 Score=59.83 Aligned_cols=73 Identities=15% Similarity=0.066 Sum_probs=50.3
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecc----cCC---cCchhHHHHHHHHHhcC---CCCeeeEEEEEEecCceeEE
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKL----ASS---QGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~----~~~---~~~~~f~~Ev~iL~~L~---HpNIV~l~~~~~~~~~~~LV 480 (756)
.+.||.|..-.||+.... +..|+||.-.. ... -....-..|++.|..+. -.++++++.++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 567899999999998864 45688996431 111 12333445677776664 2578899998874 46889
Q ss_pred EEeecC
Q 004395 481 YEYICN 486 (756)
Q Consensus 481 ~Ey~~g 486 (756)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 756 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-67 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-66 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-36 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 502 bits (1294), Expect = e-174
Identities = 136/298 (45%), Positives = 193/298 (64%), Gaps = 6/298 (2%)
Query: 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-DHEFCS 451
+ FS EL++A+ FS N L GGFG V++G L DG VAVK+ K +QG + +F +
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKI 509
EVE++S A HRN++ L GFC+ RLLVY Y+ NGS+ S L Q PL+W RQ+I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
A+G+ARGL YLH+ C I+HRD++ NILL +FE +VGDFGLA+ D V T V
Sbjct: 137 ALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195
Query: 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQ--CLTEWARPL 627
GT G++APEY +G+ +EK DV+ +GV+L+EL+TG++A DL R L +W + L
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDTVID 685
L+E ++ LVD L +Y + EV ++ A LC + P RP+MS+V+R+LEGD + +
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 442 bits (1139), Expect = e-151
Identities = 114/295 (38%), Positives = 160/295 (54%), Gaps = 7/295 (2%)
Query: 394 RWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEV 453
+LE AT F + G FG V++GVL DG VA+K+ SSQG EF +E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 454 EVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAV 511
E LS +H ++V LIGFC E +L+Y+Y+ NG+L HLYG + W R +I +
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG-VETRVI 570
GAARGL YLH I+HRD++ NILL +F P + DFG+++ + D + T V
Sbjct: 147 GAARGLHYLHT----RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630
GT GY+ PEY G++TEK+DVYSFGVVL E++ R A+ + P+ L EWA
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDTVID 685
++++VDP L + + A C+ RP M VL LE +
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 425 bits (1095), Expect = e-145
Identities = 107/304 (35%), Positives = 161/304 (52%), Gaps = 22/304 (7%)
Query: 393 PRWFSYAELELATGGFSQ------ANFLAEGGFGSVHRGVLPDGQAVAVKQ----HKLAS 442
FS+ EL+ T F + N + EGGFG V++G + + VAVK+ + +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 443 SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH-QEPL 501
+ +F E++V++ QH N+V L+GF + LVY Y+ NGSL L PL
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 502 EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
W R KIA GAA G+ +LHE +HRD++ NILL F + DFGLAR
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 562 DMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL 620
+ +R++GT Y+APE G+IT K+D+YSFGVVL+E++TG AVD +R Q L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLL 243
Query: 621 TEWARPLL-EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+ + EE I++ +D ++ + V M AS C+ + RP + +V ++L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 680 GDTV 683
T
Sbjct: 303 EMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 4e-79
Identities = 74/308 (24%), Positives = 114/308 (37%), Gaps = 31/308 (10%)
Query: 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV 455
L + A G FG V + + VAVK Q + +E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVK--IF-PIQDKQSWQNEYEV 69
Query: 456 --LSCAQHRNVVMLIGFCIEDR----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKI 509
L +H N++ IG L+ + GSL L + W+ I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHI 126
Query: 510 AVGAARGLRYLHEECRVG------CIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGD 562
A ARGL YLHE+ I HRD++ N+LL ++ + DFGLA ++
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 563 MGVETRVIGTFGYLAPEYAQSG-----QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ 617
G +GT Y+APE + + D+Y+ G+VL EL + A D +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 618 QCLTE--WARPLLEE---YAIDELVDPRLGNHYSEHEVY-CMLHAASLCIRRDPHSRPRM 671
E P LE+ + + P L +++ +H + C D +R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 672 SQVLRILE 679
V +
Sbjct: 307 GCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 7e-60
Identities = 69/319 (21%), Positives = 118/319 (36%), Gaps = 42/319 (13%)
Query: 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV 455
+ +E L + G +G+V++G L D + VAVK + S F +E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVK---VFSFANRQNFINEKNI 58
Query: 456 --LSCAQHRNVVMLIGFCIED-----RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK 508
+ +H N+ I LLV EY NGSL +L +W + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCR 115
Query: 509 IAVGAARGLRYLHEECRVG-----CIVHRDMRPNNILLTHDFEPLVGDFGLAR------- 556
+A RGL YLH E G I HRD+ N+L+ +D ++ DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 557 WQPDGDMGVETRVIGTFGYLAPEYAQS-------GQITEKADVYSFGVVLVELVTGRKAV 609
+P + +GT Y+APE + ++ D+Y+ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 610 --DLNRPKGQQCLTEWARPLLEEYAIDELVD-----PRLGNHYSEHEVYCMLHA--ASLC 660
+ P+ Q + LV P+ + E+ + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 661 IRRDPHSRPRMSQVLRILE 679
+D +R +
Sbjct: 296 WDQDAEARLTAQXAEERMA 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-56
Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 38/274 (13%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ G FG V + + VA+K ++ S F E+ LS H N+V L G C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEP-LEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
LV EY GSL + L+G P + + ++G+ YLH ++HR
Sbjct: 73 PV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LIHR 129
Query: 533 DMRPNNILLTHDFEPL-VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKAD 591
D++P N+LL L + DFG A M T G+ ++APE + +EK D
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDI-QTHM---TNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 592 VYSFGVVLVELVTGRKA-VDLNRPKGQ--QCLTEWARPLLEEYAIDELVDPRLGNHYSEH 648
V+S+G++L E++T RK ++ P + + RP + + + +
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-----PLIKNLPKPI------- 233
Query: 649 EVYCMLHAASL---CIRRDPHSRPRMSQVLRILE 679
SL C +DP RP M ++++I+
Sbjct: 234 --------ESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 7e-55
Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 52/284 (18%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFC 471
+ G FG+VHR G VAVK + EF EV ++ +H N+V+ +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQ-EPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
+ +V EY+ GSL L+ E L+ R +A A+G+ YLH IV
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP--IV 161
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKA 590
HR+++ N+L+ + V DFGL+R + + GT ++APE + EK+
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 591 DVYSFGVVLVELVTGRK------------AVDLN--RPK-GQQCLTEWARPLLEEYAIDE 635
DVYSFGV+L EL T ++ AV R + + + A ++E
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA-IIEG----- 274
Query: 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
C +P RP + ++ +L
Sbjct: 275 ------------------------CWTNEPWKRPSFATIMDLLR 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 78/293 (26%), Positives = 120/293 (40%), Gaps = 65/293 (22%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ GGFG V+R G VAVK SQ E ++ + +H N++ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
C+++ LV E+ G L+ L + + AV ARG+ YLH+E V I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVP-I 129
Query: 530 VHRDMRPNNILLTHDFEPL--------VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA 581
+HRD++ +NIL+ E + DFGLAR G + ++APE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVI 186
Query: 582 QSGQITEKADVYSFGVVLVELVTGRK------------AVDLN--RPK-GQQCLTEWARP 626
++ ++ +DV+S+GV+L EL+TG V +N C +A+
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAK- 245
Query: 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
L+E+ C DPHSRP + +L L
Sbjct: 246 LMED-----------------------------CWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-54
Identities = 84/292 (28%), Positives = 126/292 (43%), Gaps = 59/292 (20%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH-------EFCSEVEVLSCAQHRNVV 465
+ +GGFG VH+G + D VA+K L S+G+ EF EV ++S H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
L G R +V E++ G L L P++WS + ++ + A G+ Y+ +
Sbjct: 87 KLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQ--NQ 141
Query: 526 VGCIVHRDMRPNNILLTHDFEPL-----VGDFGLARWQPDGDMGVETRVIGTFGYLAPE- 579
IVHRD+R NI L E V DFGL++ G+ +G F ++APE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL----LGNFQWMAPET 197
Query: 580 -YAQSGQITEKADVYSFGVVLVELVTGRK--------AVDLNRPKGQQCLTEWARPLLEE 630
A+ TEKAD YSF ++L ++TG + ++ L RP
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----RP---- 249
Query: 631 YAIDELVDPRLGNHYSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLRILE 679
I E PRL ++ C DP RP S +++ L
Sbjct: 250 -TIPEDCPPRL---------------RNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-52
Identities = 72/283 (25%), Positives = 109/283 (38%), Gaps = 39/283 (13%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG + G+ + +K+ + F EV+V+ C +H NV+ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+D+R + EYI G+L + WS R A A G+ YLH I+HR
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSM----NIIHR 132
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-------------VIGTFGYLAPE 579
D+ +N L+ + +V DFGLAR D E V+G ++APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 580 YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639
EK DV+SFG+VL E++ A P ++ ++
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNA------------DPDYLPRTMDFGLNVRGFL 240
Query: 640 RLGNHYSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLRILE 679
C + C DP RP ++ LE
Sbjct: 241 DR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-51
Identities = 71/293 (24%), Positives = 113/293 (38%), Gaps = 37/293 (12%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV--LSCAQHRNVVMLIGFC 471
+ +G +G V G G+ VAVK + + + + E E+ +H N++ I
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVK---VFFTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 472 IEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
I+ L+ +Y NGSL +L L+ + K+A + GL +LH E
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 528 ----CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE---TRVIGTFGYLAPE- 579
I HRD++ NIL+ + + D GLA V+ +GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 580 -----YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634
Q AD+YSFG++L E+ R + Q + +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 635 ELVD-----PRLGNHYSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLRILE 679
E+V P N +S E + L C +P SR +V + L
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQM--GKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-51
Identities = 61/278 (21%), Positives = 103/278 (37%), Gaps = 41/278 (14%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFC 471
L E G + +G G + VK K+ +F E L H NV+ ++G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 472 IE--DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
L+ ++ GSL + L+ ++ S K A+ ARG+ +LH + I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL--I 134
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE---YAQSGQI 586
+ ++++ D + + + ++APE
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 587 TEKADVYSFGVVLVELVTGRKA-VDLNRPK-GQQCLTEWARPLLEEYAIDELVDPRLGNH 644
AD++SF V+L ELVT DL+ + G + E RP I + P +
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-----TIPPGISPHV--- 240
Query: 645 YSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLRILE 679
+ L C+ DP RP+ ++ ILE
Sbjct: 241 ------------SKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 9e-50
Identities = 66/293 (22%), Positives = 116/293 (39%), Gaps = 37/293 (12%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV--LSCAQHRNVVMLIGFC 471
+ +G +G V RG G+ VAVK SS+ + + E E+ +H N++ I
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 472 IEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ R L+ Y GSL +L L+ + +I + A GL +LH E
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 528 ----CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE---TRVIGTFGYLAPE- 579
I HRD++ NIL+ + + + D GLA ++ +GT Y+APE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 580 -----YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634
++ D+++FG+VL E+ R + + + +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 635 ELVD-----PRLGNHYSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLRILE 679
++V P + N + L A L C ++P +R ++ + L
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSL--AKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 37/293 (12%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV--LSCAQHRNVVMLIGFC 471
+ +G FG V RG G+ VAVK + SS+ + + E E+ +H N++ I
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 472 IEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+D LV +Y +GSL +L ++ + K+A+ A GL +LH E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 528 ----CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE---TRVIGTFGYLAPE- 579
I HRD++ NIL+ + + D GLA ++ +GT Y+APE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 580 -----YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634
+ + ++AD+Y+ G+V E+ R ++ Q + +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 635 ELVD-----PRLGNHYSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLRILE 679
++V P + N + E ++ A + C + +R ++ + L
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVM--AKIMRECWYANGAARLTALRIKKTLS 332
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-48
Identities = 73/275 (26%), Positives = 120/275 (43%), Gaps = 31/275 (11%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFC 471
+ G FG+V++G G VAVK + + F +EV VL +H N+++ +G+
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+ +V ++ SL HL+ + E IA ARG+ YLH + I+H
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS----IIH 143
Query: 532 RDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFGYLAPE---YAQSGQIT 587
RD++ NNI L D +GDFGLA ++ G+ ++APE S +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 588 EKADVYSFGVVLVELVTGRKAVDLNRPKGQ---QCLTEWARPLLEEYAIDELVDPRLGNH 644
++DVY+FG+VL EL+TG+ + Q P L + + R+
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK--VRSNCPKRMKR- 260
Query: 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
M C+++ RP ++L +E
Sbjct: 261 -------LMAE----CLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 59/288 (20%), Positives = 111/288 (38%), Gaps = 52/288 (18%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFC 471
+ +G FG V+ G G+ VA++ + D F EV +H NVV+ +G C
Sbjct: 41 IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+ ++ +L S + + L+ + ++IA +G+ YLH + I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK----GILH 153
Query: 532 RDMRPNNILLTHDFEPLVGDFGLAR----WQPDGDMGVETRVIGTFGYLAPEYAQSGQI- 586
+D++ N+ + + ++ DFGL Q G +LAPE +
Sbjct: 154 KDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 587 --------TEKADVYSFGVVLVELVTGRKAVDLNRP-KGQQCLT-EWA-----RPLLEEY 631
++ +DV++ G + EL P K Q W +P L +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREW------PFKTQPAEAIIWQMGTGMKPNLSQI 266
Query: 632 AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+ + E+ +L C + RP ++++ +LE
Sbjct: 267 GMGK-------------EISDILLF---CWAFEQEERPTFTKLMDMLE 298
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 60/243 (24%), Positives = 91/243 (37%), Gaps = 24/243 (9%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
P + P +W L + G FG V G L
Sbjct: 86 LSTQQPLTKKSGVVLHRAVP----KDKW------VLNHEDLVLGEQIGRGNFGEVFSGRL 135
Query: 428 -PDGQAVAVKQHK-LASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485
D VAVK + +F E +L H N+V LIG C + + +V E +
Sbjct: 136 RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195
Query: 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545
G + L L ++ AA G+ YL + C +HRD+ N L+T
Sbjct: 196 GGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKN 250
Query: 546 EPLVGDFGLARWQPDGDMGVETRVIGTFGY----LAPEYAQSGQITEKADVYSFGVVLVE 601
+ DFG++R + DG G APE G+ + ++DV+SFG++L E
Sbjct: 251 VLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307
Query: 602 LVT 604
+
Sbjct: 308 TFS 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 63/268 (23%), Positives = 109/268 (40%), Gaps = 24/268 (8%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
G F V+R L DG VA+K+ L ++ + E+++L H NV+
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101
Query: 472 IEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
IED +V E G L + + + + K V L ++H +
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR----V 157
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEK 589
+HRD++P N+ +T +GD GL R ++GT Y++PE K
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 216
Query: 590 ADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649
+D++S G +L E+ + ++ L + P +HYSE E
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYGDKMNLYS---------LCKKIEQCDYPPLPSDHYSE-E 266
Query: 650 VYCMLHAASLCIRRDPHSRPRMSQVLRI 677
+ ++ ++CI DP RP ++ V +
Sbjct: 267 LRQLV---NMCINPDPEKRPDVTYVYDV 291
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-34
Identities = 68/237 (28%), Positives = 99/237 (41%), Gaps = 10/237 (4%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
S++A L ++C P + + E+ L +G FG V G
Sbjct: 150 SKHADGLCHRLTTVCPTSKP----QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
VA+K K + F E +V+ +H +V L E+ +V EY+ G
Sbjct: 206 NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKG 263
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
SL L G + L +A A G+ Y+ VHRD+R NIL+ +
Sbjct: 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVC 319
Query: 548 LVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
V DFGLAR D + + APE A G+ T K+DV+SFG++L EL T
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 69/308 (22%), Positives = 115/308 (37%), Gaps = 36/308 (11%)
Query: 390 GKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE 448
G+ +F + + + L EGGF V L DG A+K+ Q E
Sbjct: 13 GRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE 72
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWS 504
E ++ H N++ L+ +C+ +R L+ + G+L + + + +
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 505 ARQ--KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
Q + +G RGL +H + HRD++P NILL + +P++ D G
Sbjct: 133 EDQILWLLLGICRGLEAIHAKG----YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188
Query: 563 MGVETRVI--------GTFGYLAPEYAQS---GQITEKADVYSFGVVLVELVTGRKAVDL 611
G + T Y APE I E+ DV+S G VL ++ G D+
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 612 NRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRM 671
KG A+ + +S + + + DPH RP +
Sbjct: 249 VFQKGD----------SVALAVQNQLSIPQSPRHSS----ALWQLLNSMMTVDPHQRPHI 294
Query: 672 SQVLRILE 679
+L LE
Sbjct: 295 PLLLSQLE 302
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 68/264 (25%), Positives = 111/264 (42%), Gaps = 24/264 (9%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLAS-SQGDHEFC-SEVEVLSCAQHRNVVMLIGFCI 472
EG FG DG+ +K+ ++ S + E EV VL+ +H N+V
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
E+ +V +Y G L + + V L+++H+ I+HR
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----ILHR 149
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADV 592
D++ NI LT D +GDFG+AR + + + IGT YL+PE ++ K+D+
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYYLSPEICENKPYNNKSDI 208
Query: 593 YSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYC 652
++ G VL EL T + A + K L+ I P + HYS
Sbjct: 209 WALGCVLYELCTLKHAFEAGSMKN----------LV--LKIISGSFPPVSLHYSYD---- 252
Query: 653 MLHAASLCIRRDPHSRPRMSQVLR 676
+ S +R+P RP ++ +L
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILE 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 22/279 (7%)
Query: 414 LAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L +G FGSV G+ VAVK+ + ++ + +F E+E+L QH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 469 GFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
G C RR L+ EY+ GSL +L H+E ++ + +G+ YL R
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-GTKR- 134
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSG 584
+HRD+ NIL+ ++ +GDFGL + P + + G + APE
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 585 QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP--RLG 642
+ + +DV+SFGVVL EL T + + + + + + + + EL+ RL
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252
Query: 643 N-HYSEHEVYC-MLHAASLCIRRDPHSRPRMSQVLRILE 679
E+Y M C + + RP + ++
Sbjct: 253 RPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVD 287
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-33
Identities = 68/237 (28%), Positives = 99/237 (41%), Gaps = 10/237 (4%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
S++A L ++C P + + E+ L +G FG V G
Sbjct: 233 SKHADGLCHRLTTVCPTSKP----QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 288
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
VA+K K + F E +V+ +H +V L E+ +V EY+ G
Sbjct: 289 NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKG 346
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
SL L G + L +A A G+ Y+ VHRD+R NIL+ +
Sbjct: 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVC 402
Query: 548 LVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
V DFGLAR D + + APE A G+ T K+DV+SFG++L EL T
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-33
Identities = 56/238 (23%), Positives = 101/238 (42%), Gaps = 7/238 (2%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
S A L + +Y + E+ + + L G +G V+ GV
Sbjct: 183 STVADGLITTLHYPAPKRNKPTIYGVSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVW 241
Query: 428 -PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486
VAVK K + + + EF E V+ +H N+V L+G C + ++ E++
Sbjct: 242 KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
G+L +L C+++ + +A + + YL ++ +HR++ N L+ +
Sbjct: 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHL 356
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604
V DFGL+R + APE + + K+DV++FGV+L E+ T
Sbjct: 357 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-33
Identities = 72/279 (25%), Positives = 122/279 (43%), Gaps = 22/279 (7%)
Query: 414 LAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L +G FGSV G+ VAVK+ + ++ + +F E+E+L QH N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 469 GFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
G C RR L+ EY+ GSL +L H+E ++ + +G+ YL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSG 584
+HRD+ NIL+ ++ +GDFGL + P + + G + APE
Sbjct: 165 -RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223
Query: 585 QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP--RLG 642
+ + +DV+SFGVVL EL T + + + + + + + + EL+ RL
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 283
Query: 643 N-HYSEHEVYC-MLHAASLCIRRDPHSRPRMSQVLRILE 679
E+Y M C + + RP + ++
Sbjct: 284 RPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVD 318
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 70/280 (25%), Positives = 109/280 (38%), Gaps = 24/280 (8%)
Query: 414 LAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVML 467
L EG FG V G+ VAVK K S + E+E+L H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 468 IGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
G C ED L+ E++ +GSL +L ++ + + K AV +G+ YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYL-GSRQ 146
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQS 583
VHRD+ N+L+ + + +GDFGL + + + APE
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 584 GQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD-PRL 641
+ +DV+SFGV L EL+T + + + ++ L + RL
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-LVNTLKEGKRL 262
Query: 642 GN-HYSEHEVYC-MLHAASLCIRRDPHSRPRMSQVLRILE 679
EVY M C P +R ++ E
Sbjct: 263 PCPPNCPDEVYQLMRK----CWEFQPSNRTSFQNLIEGFE 298
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 60/283 (21%), Positives = 110/283 (38%), Gaps = 50/283 (17%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ GGFG V + DG+ +K+ K + + EV+ L+ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 72
Query: 471 CIEDRRRL----------------LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA 514
+ E+ G+L+ + E L+ ++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGTF 573
+G+ Y+H + +++RD++P+NI L + +GDFGL + DG TR GT
Sbjct: 133 KGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTL 185
Query: 574 GYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633
Y++PE S ++ D+Y+ G++L EL+
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKF------------F 228
Query: 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+L D + + + + E + + + P RP S++LR
Sbjct: 229 TDLRDGIISDIFDKKEKTLL----QKLLSKKPEDRPNTSEILR 267
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 61/239 (25%), Positives = 92/239 (38%), Gaps = 15/239 (6%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
+ L C KP + + E+ L G FG V
Sbjct: 155 KKGNDGLCQKLSVPCMSS-----KPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATY 209
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
VAVK K S + F +E V+ QH +V L ++ ++ E++ G
Sbjct: 210 NKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKG 267
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
SL L + A G+ ++ + +HRD+R NIL++
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRDLRAANILVSASLVC 323
Query: 548 LVGDFGLARWQPDGDMGVETRVIGTFGY--LAPEYAQSGQITEKADVYSFGVVLVELVT 604
+ DFGLAR D + R F APE G T K+DV+SFG++L+E+VT
Sbjct: 324 KIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 61/270 (22%), Positives = 104/270 (38%), Gaps = 27/270 (10%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLAS-SQGDHEFC-SEVEVLSCAQHRNVVMLIG-FC 471
G +G + DG+ + K+ S ++ + + SEV +L +H N+V
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 472 IEDRRRL-LVYEYICNGSLDSHLYGCHQ--EPLEWSARQKIAVGAARGLRYLHEECRVGC 528
L +V EY G L S + + + L+ ++ L+ H G
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 529 -IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT 587
++HRD++P N+ L +GDFGLAR + D +GT Y++PE
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFVGTPYYMSPEQMNRMSYN 194
Query: 588 EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE-EYAIDELVDPRLGNHYS 646
EK+D++S G +L EL A E I E R+ YS
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFT-------------AFSQKELAGKIREGKFRRIPYRYS 241
Query: 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ + + + + RP + ++L
Sbjct: 242 DE----LNEIITRMLNLKDYHRPSVEEILE 267
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 78/280 (27%), Positives = 113/280 (40%), Gaps = 25/280 (8%)
Query: 414 LAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L +G FGSV G VAVKQ + + +F E+++L +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 469 GFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
G R+ LV EY+ +G L L H+ L+ S + +G+ YL R
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL-GSRR- 147
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSG 584
VHRD+ NIL+ + + DFGLA+ P R G + APE
Sbjct: 148 --CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 585 QITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP--RL 641
+ ++DV+SFGVVL EL T K+ + + E P L + EL++ RL
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR--LLELLEEGQRL 263
Query: 642 GN-HYSEHEVYC-MLHAASLCIRRDPHSRPRMSQVLRILE 679
EV+ M C P RP S + L+
Sbjct: 264 PAPPACPAEVHELMKL----CWAPSPQDRPSFSALGPQLD 299
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV 455
Y E+ + L G FG V G VA+K K S D EF E +V
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKV 72
Query: 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR 515
+ H +V L G C + R ++ EY+ NG L ++L + + ++
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCE 131
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY 575
+ YL E + +HRD+ N L+ V DFGL+R+ D + T +G
Sbjct: 132 AMEYL-ESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVG--SK 182
Query: 576 L-----APEYAQSGQITEKADVYSFGVVLVELVT 604
PE + + K+D+++FGV++ E+ +
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 48/283 (16%)
Query: 414 LAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVML 467
L G FG+V++G+ P+G+ VA+K+ + A+S E E V++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C+ L+ + + G L ++ H++ + V A+G+ YL E+ R
Sbjct: 83 LGICLTSTV-QLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYL-EDRR-- 137
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT---FGYLAPEYAQSG 584
+VHRD+ N+L+ + DFGLA+ + E G ++A E
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 585 QITEKADVYSFGVVLVELVT-GRKAVDLNRP----KGQQCLTEWARPLLEE-YAIDELVD 638
T ++DV+S+GV + EL+T G +P + + +LE+
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGS------KPYDGIPASEISS-----ILEKGE------- 236
Query: 639 PRLGN-HYSEHEVYC-MLHAASLCIRRDPHSRPRMSQVLRILE 679
RL +VY M C D SRP+ +++
Sbjct: 237 -RLPQPPICTIDVYMIMRK----CWMIDADSRPKFRELIIEFS 274
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 62/193 (32%), Positives = 88/193 (45%), Gaps = 10/193 (5%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VAVK K S D F +E ++ QH+ +V L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ ++ EY+ NGSL L L + +A A G+ ++ E +HRD
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY--LAPEYAQSGQITEKAD 591
+R NIL++ + DFGLAR D + R F APE G T K+D
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 592 VYSFGVVLVELVT 604
V+SFG++L E+VT
Sbjct: 193 VWSFGILLTEIVT 205
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQ---AVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLIG 469
L G FGSV +GV + VA+K K + + D E E +++ + +V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
C + +LV E G L L G +E + S ++ + G++YL EE
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYL-EEKN---F 131
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSGQIT 587
VHRD+ N+LL + + DFGL++ D R G + + APE + +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 588 EKADVYSFGVVLVELVT-GRK 607
++DV+S+GV + E ++ G+K
Sbjct: 192 SRSDVWSYGVTMWEALSYGQK 212
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VAVK K S D EF E + + H +V G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ +V EYI NG L ++L H + LE S ++ G+ +L E + +HRD
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFL-ESHQF---IHRD 129
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT---FGYLAPEYAQSGQITEKA 590
+ N L+ D V DFG+ R+ D +GT + APE + + K+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 591 DVYSFGVVLVELVT-GRK 607
DV++FG+++ E+ + G+
Sbjct: 187 DVWAFGILMWEVFSLGKM 204
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 414 LAEGGFGSVHRGVL--PDGQA---VAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVML 467
+ G FG V++G+L G+ VA+K K + + +F E ++ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
G + + +++ EY+ NG+LD L + G A G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYL-ANMN-- 167
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY--LAPEYAQSGQ 585
VHRD+ NIL+ + V DFGL+R D T G APE +
Sbjct: 168 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 586 ITEKADVYSFGVVLVELVT-GRK 607
T +DV+SFG+V+ E++T G +
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGER 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 18/240 (7%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
+ +A L + V + F + L + +G FG V G
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDE--FYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICN 486
G VAVK K ++ F +E V++ +H N+V L+G +E++ L +V EY+
Sbjct: 215 -RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
GSL +L + L K ++ + YL VHRD+ N+L++ D
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNV 327
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFGY--LAPEYAQSGQITEKADVYSFGVVLVELVT 604
V DFGL + G APE + + + K+DV+SFG++L E+ +
Sbjct: 328 AKVSDFGLTKEASSTQDT------GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 10/194 (5%)
Query: 414 LAEGGFGSVHRGVLPDG-QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G +G V+ GV VAVK K + + + EF E V+ +H N+V L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ ++ E++ G+L +L C+++ + +A + + YL ++ +HR
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHR 135
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY--LAPEYAQSGQITEKA 590
D+ N L+ + V DFGL+R F APE + + K+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 591 DVYSFGVVLVELVT 604
DV++FGV+L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 414 LAEGGFGSVHRGVLP----DGQAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ G FG V G L +VA+K K+ + + +F E ++ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHEECRV 526
G + + ++V EY+ NGSLDS L + +++ Q + G A G++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYL-SDMGY 168
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL--APEYAQSG 584
VHRD+ NIL+ + V DFGL R D T G +PE
Sbjct: 169 ---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 585 QITEKADVYSFGVVLVELVT-GRK 607
+ T +DV+S+G+VL E+++ G +
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGER 249
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 65/290 (22%), Positives = 105/290 (36%), Gaps = 48/290 (16%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFC-SEVEVLSCAQHRNVVMLIGF 470
L GGFG V D A+K+ +L + + E EV+ L+ +H +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 471 CIED---------RRRLLVY---EYICNGSLDSHL-YGCHQEPLEWSARQKIAVGAARGL 517
+E ++ +Y + +L + C E E S I + A +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-----------WQPDGDMGVE 566
+LH + ++HRD++P+NI T D VGDFGL P
Sbjct: 132 EFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626
T +GT Y++PE + K D++S G++L EL+ P T+ R
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------P----FSTQMERV 234
Query: 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ L P L E + + P RP ++
Sbjct: 235 RTLT-DVRNLKFPPLFTQKYPCEYVMV----QDMLSPSPMERPEAINIIE 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ G FG VH G + VA+K + + + +F E EV+ H +V L G C+E
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
LV E++ +G L +L + + + G+ YL EE V +HRD
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYL-EEACV---IHRD 129
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY--LAPEYAQSGQITEKAD 591
+ N L+ + V DFG+ R+ D + F +PE + + K+D
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 592 VYSFGVVLVELVT-GRK 607
V+SFGV++ E+ + G+
Sbjct: 188 VWSFGVLMWEVFSEGKI 204
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ G G V G L VA+K K + + +F SE ++ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHEECRV 526
G R ++V EY+ NGSLD+ L +++ Q + G G+RYL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYL-SDLGY 172
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL--APEYAQSG 584
VHRD+ N+L+ + V DFGL+R D T G APE
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 585 QITEKADVYSFGVVLVELVT-GRK 607
+ +DV+SFGVV+ E++ G +
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGER 253
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 72/281 (25%), Positives = 113/281 (40%), Gaps = 28/281 (9%)
Query: 414 LAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVML 467
L EG FG V G+ VAVK K + + E+++L H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 468 IGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
G C + LV EY+ GSL +L + + + A G+ YL
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYL-HAQH 154
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQS 583
+HRD+ N+LL +D +GDFGLA+ P+G R G + APE +
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 584 GQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP--R 640
+ +DV+SFGV L EL+T + + + + + EL++ R
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR--LTELLERGER 269
Query: 641 LGN-HYSEHEVYC-MLHAASLCIRRDPHSRPRMSQVLRILE 679
L EVY M + C + RP ++ IL+
Sbjct: 270 LPRPDKCPAEVYHLMKN----CWETEASFRPTFENLIPILK 306
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 65/215 (30%), Positives = 92/215 (42%), Gaps = 32/215 (14%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V + VAVK K AS +F E E+L+ QH+++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ-------------KIAVGAA 514
G C E R L+V+EY+ +G L+ L + + + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
G+ YL VHRD+ N L+ +GDFG++R D RV G
Sbjct: 169 AGMVYLAGL----HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRV-GGRT 220
Query: 575 YL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
L PE + T ++DV+SFGVVL E+ T
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 23/201 (11%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ +G FG V G G VAVK K ++ F +E V++ +H N+V L+G +E
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 474 DRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
++ L +V EY+ GSL +L + L K ++ + YL VHR
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHR 141
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL-----APEYAQSGQIT 587
D+ N+L++ D V DFGL + G L APE + + +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---------GKLPVKWTAPEALREKKFS 192
Query: 588 EKADVYSFGVVLVELVT-GRK 607
K+DV+SFG++L E+ + GR
Sbjct: 193 TKSDVWSFGILLWEIYSFGRV 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 64/204 (31%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 414 LAEGGFGSVHRGVL--PDGQA--VAVKQHK---LASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FG V RG P G+ VAVK K L+ + +F EV + HRN++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
L G + +V E GSL L HQ + AV A G+ YL E R
Sbjct: 86 LYGVVLTPPM-KMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYL-ESKR- 141
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY--LAPEYAQSG 584
+HRD+ N+LL +GDFGL R P D + + APE ++
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 585 QITEKADVYSFGVVLVELVT-GRK 607
+ +D + FGV L E+ T G++
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQE 223
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 28/212 (13%)
Query: 414 LAEGGFGSVHRGVL--------PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVV 465
L +G F + +GV V +K A F ++S H+++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
+ G C+ +LV E++ GSLD++L ++ + + ++A A + +L EE
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFL-EENT 133
Query: 526 VGCIVHRDMRPNNILLTHDFEPL--------VGDFGLARWQPDGDMGVETRVIGTFGYLA 577
+ +H ++ NILL + + + D G++ D+ E R+
Sbjct: 134 L---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-RIPWV----P 185
Query: 578 PEYAQSGQI-TEKADVYSFGVVLVELVT-GRK 607
PE ++ + D +SFG L E+ + G K
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 62/211 (29%), Positives = 86/211 (40%), Gaps = 28/211 (13%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVM 466
L G FG V+ G + P VAVK S+ D +F E ++S H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQ--KIAVGAARGLRYLH 521
IG ++ R ++ E + G L S L +P + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLV---GDFGLARWQPDGDMGVETRVIGTFGYL-- 576
E +HRD+ N LLT V GDFG+AR G L
Sbjct: 158 EN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAMLPV 209
Query: 577 ---APEYAQSGQITEKADVYSFGVVLVELVT 604
PE G T K D +SFGV+L E+ +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 61/211 (28%), Positives = 85/211 (40%), Gaps = 28/211 (13%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVM 466
L G FG V+ G + VAVK S+ D +F E ++S H+N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQ--KIAVGAARGLRYLH 521
IG ++ R ++ E + G L S L +P + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLV---GDFGLARWQPDGDMGVETRVIGTFGYL-- 576
E +HRD+ N LLT V GDFG+AR G L
Sbjct: 199 EN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAMLPV 250
Query: 577 ---APEYAQSGQITEKADVYSFGVVLVELVT 604
PE G T K D +SFGV+L E+ +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 60/285 (21%), Positives = 114/285 (40%), Gaps = 46/285 (16%)
Query: 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQH--RNVVML 467
+ GG V + + Q A+K L A +Q + +E+ L+ Q ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPL-EWSAR---QKIAVGAARGLRYLHEE 523
+ I D+ +V E N L+S L ++ + W + + + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNML----EAVHTIHQH 127
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGTFGYLAPE--- 579
IVH D++P N L+ + DFG+A QPD V+ +GT Y+ PE
Sbjct: 128 G----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 580 --------YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEY 631
+I+ K+DV+S G +L + G+ T + + + +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--------------TPFQQIINQIS 228
Query: 632 AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ ++DP + + + C++RDP R + ++L
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 60/297 (20%), Positives = 114/297 (38%), Gaps = 50/297 (16%)
Query: 392 PPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--E 448
R+ + + G F +V++G+ VA + +
Sbjct: 24 DGRFLKFDIE------------IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR 71
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCI---EDRRRLLVY-EYICNGSLDSHL--YGCHQEPLE 502
F E E+L QH N+V + ++ +++ E + +G+L ++L + ++
Sbjct: 72 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMK 127
Query: 503 WSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPDG 561
+ +GL++LH R I+HRD++ +NI +T +GD GLA +
Sbjct: 128 IKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
Query: 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT 621
VIGT ++APE + E DVY+FG+ ++E+ T +C
Sbjct: 186 FA---KAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATS-------EYPYSEC-- 232
Query: 622 EWARPLLEEYAI--DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ + Y + EV ++ CIR++ R + +L
Sbjct: 233 ---QNAAQIYRRVTSGVKPASFDKVAIP-EVKEII---EGCIRQNKDERYSIKDLLN 282
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 414 LAEGGFGSVHRGVLPDGQA---VAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLI 468
L G FG+V +G + VAVK K ++ E +E V+ + +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G C + +LV E G L+ +L ++ ++ + G++YL EE
Sbjct: 85 GICEAESW-MLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYL-EESN--- 137
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSGQI 586
VHRD+ N+LL + DFGL++ + + + G + + APE +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 587 TEKADVYSFGVVLVELVT-GRK 607
+ K+DV+SFGV++ E + G+K
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQK 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 28/211 (13%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FGSV G L VAVK KL +S + EF SE + H NV+ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 468 IGFCIEDR-----RRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQ--KIAVGAARGLR 518
+G CIE + +++ ++ G L ++L P + K V A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL-- 576
YL +HRD+ N +L D V DFGL++ GD R G +
Sbjct: 162 YLSNRN----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YYRQ-GRIAKMPV 213
Query: 577 ---APEYAQSGQITEKADVYSFGVVLVELVT 604
A E T K+DV++FGV + E+ T
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V + VAVK K + +F E E+L+ QH ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------------KIAVGA 513
G C + ++V+EY+ +G L+ L + + Q IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
A G+ YL VHRD+ N L+ + +GDFG++R D RV G
Sbjct: 143 ASGMVYL-ASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD---YYRV-GGH 194
Query: 574 GYL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
L PE + T ++DV+SFGV+L E+ T
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 414 LAEGGFGSVHRGVL--PDGQ--AVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ EG FG VH+G+ P+ AVA+K K S +F E + H ++V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G E+ ++ E G L S L + L+ ++ A + L YL E R
Sbjct: 83 GVITENPV-WIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL-ESKR--- 136
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT---FGYLAPEYAQSGQ 585
VHRD+ N+L++ + +GDFGL+R+ D + ++APE +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFRR 193
Query: 586 ITEKADVYSFGVVLVELVT-GRK 607
T +DV+ FGV + E++ G K
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVK 216
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVM 466
L +G FG V+ GV VA+K A+S + EF +E V+ +VV
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------KIAVGAARGLR 518
L+G + + L++ E + G L S+L ++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL-- 576
YL+ VHRD+ N ++ DF +GDFG+ R + D G G L
Sbjct: 153 YLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPV 204
Query: 577 ---APEYAQSGQITEKADVYSFGVVLVELVT 604
+PE + G T +DV+SFGVVL E+ T
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 66/270 (24%), Positives = 96/270 (35%), Gaps = 37/270 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLA--SSQGDHEFCSEVEVL-SCAQHRNVVMLIG 469
L G +G V + DG+ AVK+ + +EV QH V L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 470 FCIEDRRRLLVYEYICNGSLDSHL--YGCH-QEPLEWSARQKIAVGAARGLRYLHEECRV 526
E L E C SL H +G E W L +LH +
Sbjct: 125 AWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLHSQG-- 177
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
+VH D++P NI L +GDFGL + E G Y+APE Q G
Sbjct: 178 --LVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEV-QEGDPRYMAPELLQ-GSY 232
Query: 587 TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYS 646
ADV+S G+ ++E+ + P G + + L + Y + P S
Sbjct: 233 GTAADVFSLGLTILEVACNMEL-----PHGGEGW----QQLRQGY-----LPPEFTAGLS 278
Query: 647 EHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
E+ +L + + DP R +L
Sbjct: 279 S-ELRSVL---VMMLEPDPKLRATAEALLA 304
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 67/290 (23%), Positives = 109/290 (37%), Gaps = 44/290 (15%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSC-AQHRN 463
F + + G FGSV + V DG A+K+ K A S + EV + QH +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLH 521
VV ED L+ EY GSL + + + + + + RGLRY+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD--------GDMGVETR----- 568
+VH D++P+NI ++ P GD+G TR
Sbjct: 133 SMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 569 -VIGTFGYLAPE-YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626
G +LA E ++ KAD+++ + +V P+ +W
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-----PRNGD---QW--- 237
Query: 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ I + PR+ S+ E +L + I DP RP +++
Sbjct: 238 ----HEIRQGRLPRIPQVLSQ-EFTELL---KVMIHPDPERRPSAMALVK 279
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 414 LAEGGFGSVHRGVLPDG---QAVAVKQHKLASSQGDH-EFCSEVEVLS-CAQHRNVVMLI 468
+ EG FG V + + A+K+ K +S+ DH +F E+EVL H N++ L+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHL------------YGCHQEPLEWSARQ--KIAVGAA 514
G C L EY +G+L L + S++Q A A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
RG+ YL ++ I HRD+ NIL+ ++ + DFGL+R + V T G
Sbjct: 153 RGMDYLSQK---QFI-HRDLAARNILVGENYVAKIADFGLSR---GQE----VYVKKTMG 201
Query: 575 YL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
L A E T +DV+S+GV+L E+V+
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLI 468
+ G FG V+ G L D AVK + G+ +F +E ++ H NV+ L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 469 GFCIEDRR-RLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHEECR 525
G C+ L+V Y+ +G L + + E + + + A+G++YL +
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL------APE 579
VHRD+ N +L F V DFGLAR D + V G A E
Sbjct: 148 -KF-VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY---YSVHNKTGAKLPVKWMALE 202
Query: 580 YAQSGQITEKADVYSFGVVLVELVT 604
Q+ + T K+DV+SFGV+L EL+T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLI 468
+ +G FG V+ G D A+K + F E ++ H NV+ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 469 GFCIEDR-RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHEECR 525
G + ++ Y+C+G L + + P + + + ARG+ YL E +
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP---TVKDLISFGLQVARGMEYL-AEQK 144
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTF--GYLAPEYAQ 582
VHRD+ N +L F V DFGLAR D + V+ + A E Q
Sbjct: 145 ---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 583 SGQITEKADVYSFGVVLVELVT 604
+ + T K+DV+SFGV+L EL+T
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLT 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 414 LAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVML 467
L G FG+V++G+ P+G+ VA+K+ + A+S E E V++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C+ L+ + + G L ++ H++ + V A+G+ YL E+ R
Sbjct: 83 LGICLTSTV-QLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYL-EDRR-- 137
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT---FGYLAPEYAQSG 584
+VHRD+ N+L+ + DFGLA+ + E G ++A E
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESILHR 194
Query: 585 QITEKADVYSFGVVLVELVT-GRK 607
T ++DV+S+GV + EL+T G K
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 58/285 (20%), Positives = 113/285 (39%), Gaps = 46/285 (16%)
Query: 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQHRN--VVML 467
+ GG V + + Q A+K L + + +E+ L+ Q + ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPL-EWSAR---QKIAVGAARGLRYLHEE 523
+ I D+ +V E N L+S L ++ + W + + + + +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNML----EAVHTIHQH 146
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGTFGYLAPE--- 579
IVH D++P N L+ + DFG+A QPD V+ +GT Y+ PE
Sbjct: 147 G----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 580 --------YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEY 631
+I+ K+DV+S G +L + G+ T + + + +
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--------------TPFQQIINQIS 247
Query: 632 AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ ++DP + + + C++RDP R + ++L
Sbjct: 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQA---VAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLIG 469
L G FGSV +GV + VA+K K + + D E E +++ + +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
C + +LV E G L L G +E + S ++ + G++YL EE
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYL-EEKN---F 457
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY--LAPEYAQSGQIT 587
VHR++ N+LL + + DFGL++ D R G + APE + +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 588 EKADVYSFGVVLVELVT-GRK 607
++DV+S+GV + E ++ G+K
Sbjct: 518 SRSDVWSYGVTMWEALSYGQK 538
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 414 LAEGGFGSVHRGVL-PDGQA----VAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVML 467
L G FG+VH+GV P+G++ V +K + S + + + H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C LV +Y+ GSL H+ H+ L V A+G+ YL EE
Sbjct: 81 LGLCPGSSL-QLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYL-EEHG-- 135
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT---FGYLAPEYAQSG 584
+VHR++ N+LL + V DFG+A P D + ++A E G
Sbjct: 136 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD--KQLLYSEAKTPIKWMALESIHFG 192
Query: 585 QITEKADVYSFGVVLVELVT-GRK 607
+ T ++DV+S+GV + EL+T G +
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAE 216
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 66/297 (22%), Positives = 111/297 (37%), Gaps = 61/297 (20%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG V + D + A+K+ + + SEV +L+ H+ VV +
Sbjct: 14 LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL-SEVMLLASLNHQYVVRYYAAWL 72
Query: 473 EDRRRL-------------LVYEYICNGSLDSHL--YGCHQEPLE-WSARQKIAVGAARG 516
E R + + EY NG+L + +Q+ E W ++I
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----EA 128
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-------------WQPDGDM 563
L Y+H + I+HRD++P NI + +GDFGLA+ G
Sbjct: 129 LSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 564 GVETRVIGTFGYLAPE-YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTE 622
T IGT Y+A E +G EK D+YS G++ E++ G + +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-------FSTGMERVNI 237
Query: 623 WARPLLEEYAIDELVDPRLGNHYSEHE---VYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ P ++ + E + ++ DP+ RP +L
Sbjct: 238 LKKLRSVSIEF----PPDFDDNKMKVEKKIIRLLI-------DHDPNKRPGARTLLN 283
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 414 LAEGGFGSVHRGVLPD---GQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQ--HRNVVM 466
L GG +V+ D VA+K + E E EV + +Q H+N+V
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+I ED LV EYI +L ++ PL G+++ H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
IVHRD++P NIL+ + + DFG+A+ + + V+GT Y +PE A+
Sbjct: 131 R-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 587 TEKADVYSFGVVLVELVTGR 606
E D+YS G+VL E++ G
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 57/212 (26%), Positives = 85/212 (40%), Gaps = 29/212 (13%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKL-ASSQGDHE-FCSEVEVLSCAQHRNVVML 467
L +G FGSV L VAVK K + D E F E + H +V L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 468 IGFCIEDRRR------LLVYEYICNGSLDSHLYGC--HQEPLEWSARQ--KIAVGAARGL 517
+G + R + +++ ++ +G L + L + P + + V A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL- 576
YL +HRD+ N +L D V DFGL+R GD R G L
Sbjct: 151 EYL-SSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQ-GCASKLP 202
Query: 577 ----APEYAQSGQITEKADVYSFGVVLVELVT 604
A E T +DV++FGV + E++T
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 67/280 (23%), Positives = 112/280 (40%), Gaps = 46/280 (16%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
L +G +G V+ G L + +A+K+ S+ E+ + +H+N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWS-------ARQKIAVGAARGLRYLHEEC 524
E+ + E + GSL S L PL+ + +Q + GL+YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN- 141
Query: 525 RVGCIVHRDMRPNNILL-THDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
IVHRD++ +N+L+ T+ + DFG ++ + G GT Y+APE
Sbjct: 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 584 GQI--TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI-----DEL 636
G + AD++S G ++E+ TG+ P + L E A
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK------PP--------FYE-LGEPQAAMFKVGMFK 242
Query: 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
V P + S C DP R + +L
Sbjct: 243 VHPEIPESMSAE----AKAFILKCFEPDPDKRACANDLLV 278
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 414 LAEGGFGSVHRGVL--PDGQ--AVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLI 468
L EG FG V+ GV G+ VAVK K + + +F SE ++ H ++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G E+ ++ E G L +L ++ L+ ++ + + YL E
Sbjct: 80 GIIEEEPT-WIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYL-ESINC-- 134
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT---FGYLAPEYAQSGQ 585
VHRD+ NIL+ +GDFGL+R+ D D + T +++PE +
Sbjct: 135 -VHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPESINFRR 190
Query: 586 ITEKADVYSFGVVLVELVT-GRK 607
T +DV+ F V + E+++ G++
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQ 213
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 54/201 (26%), Positives = 82/201 (40%), Gaps = 18/201 (8%)
Query: 414 LAEGGFGSVHRG---VLPDGQAVAVKQHKLASS-QGDHEFCS--EVEVLSCA--QHRNVV 465
+ GG G V+ V + VA+K ++ + D F + + E + Q +VV
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKL--MSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
+ F D + + I L + L Q PL I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAH---A 152
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
G HRD++P NIL++ D + DFG+A D + +GT Y+APE
Sbjct: 153 AG-ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 586 ITEKADVYSFGVVLVELVTGR 606
T +AD+Y+ VL E +TG
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLI 468
+ G FG V+ G L D AVK + G+ +F +E ++ H NV+ L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 469 GFCIEDRR-RLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHEECR 525
G C+ L+V Y+ +G L + + E + + + A+G+++L +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL-ASKK 212
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL-----APEY 580
VHRD+ N +L F V DFGLAR D + T L A E
Sbjct: 213 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALES 267
Query: 581 AQSGQITEKADVYSFGVVLVELVT 604
Q+ + T K+DV+SFGV+L EL+T
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 57/284 (20%), Positives = 98/284 (34%), Gaps = 49/284 (17%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
+ + G FG VHR G AVK+ +L + + E+ + +V
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVP 114
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPL-EWSARQKIAVGAARGLRYLHEE 523
L G E + E + GSL + GC E + Q A GL YLH
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ-----ALEGLEYLHTR 169
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPL-VGDFG----LARWQPDGDMGVETRVIGTFGYLAP 578
I+H D++ +N+LL+ D + DFG L + + GT ++AP
Sbjct: 170 R----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 579 EYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI----- 633
E K D++S +++ ++ G P W + +
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGC------HP--------WTQ--YFRGPLCLKIA 269
Query: 634 -DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ + + A +R++P R ++ R
Sbjct: 270 SEPPPIREIPPSCAPL----TAQAIQEGLRKEPVHRASAMELRR 309
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 56/217 (25%), Positives = 85/217 (39%), Gaps = 34/217 (15%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHK-LASSQGDHEFCSEVEVLSCAQHRNVVM 466
L E FG V++G L QAVA+K K A EF E + + QH NVV
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------------KIAVG 512
L+G +D+ +++ Y +G L L S +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
A G+ YL +VH+D+ N+L+ + D GL R D +
Sbjct: 137 IAAGMEYL-SSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD----YYKLLG 188
Query: 573 FGYL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
L APE G+ + +D++S+GVVL E+ +
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +G FG+V+ +A+K + +L + +H+ EVE+ S +H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ D R+ L+ EY G++ L + E A L Y H +
Sbjct: 77 Y-FHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTA-TYITELANALSYCHSKR---- 129
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR--VIGTFGYLAPEYAQSGQI 586
++HRD++P N+LL E + DFG + P R + GT YL PE +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTDLCGTLDYLPPEMIEGRMH 184
Query: 587 TEKADVYSFGVVLVELVTGR 606
EK D++S GV+ E + G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 414 LAEGGFGSVHRGVL--PDGQA--VAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ EG FG VH+G+ P+ A VA+K K S +F E + H ++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G E+ ++ E G L S L + L+ ++ A + L YL E R
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL-ESKR--- 511
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF--GYLAPEYAQSGQI 586
VHRD+ N+L++ + +GDFGL+R+ D G ++APE +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRF 569
Query: 587 TEKADVYSFGVVLVELVT 604
T +DV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEILM 587
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L +G F V+R + G VA+K + + + +EV++ +H +++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
ED + LV E NG ++ +L + E AR + G+ YLH
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHSHG--- 132
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
I+HRD+ +N+LLT + + DFGLA + + + T + GT Y++PE A
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYT-LCGTPNYISPEIATRSAH 189
Query: 587 TEKADVYSFGVVLVELVTGR 606
++DV+S G + L+ GR
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 60/285 (21%), Positives = 114/285 (40%), Gaps = 46/285 (16%)
Query: 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQH--RNVVML 467
+ GG V + + Q A+K L A +Q + +E+ L+ Q ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPL-EWSAR---QKIAVGAARGLRYLHEE 523
+ I D+ +V E N L+S L ++ + W + + + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNML----EAVHTIHQH 174
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGTFGYLAPE--- 579
IVH D++P N L+ D + DFG+A QPD V+ +G Y+ PE
Sbjct: 175 G----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 580 --------YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEY 631
+I+ K+DV+S G +L + G+ T + + + +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--------------TPFQQIINQIS 275
Query: 632 AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ ++DP + + + C++RDP R + ++L
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 51/217 (23%), Positives = 84/217 (38%), Gaps = 26/217 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFC 471
LAEGGF V+ + G+ A+K+ + + EV + + H N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 472 IEDRRR-------LLVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEE 523
+ L+ +C G L L + PL KI R ++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-- 153
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR---------WQPDGDMGVETRV--IGT 572
+ I+HRD++ N+LL++ + DFG A W VE + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 573 FGYLAPE---YAQSGQITEKADVYSFGVVLVELVTGR 606
Y PE + I EK D+++ G +L L +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 78/301 (25%), Positives = 124/301 (41%), Gaps = 50/301 (16%)
Query: 334 LEKFSRLDRDAGVGMSSYRTDLEFSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPP 393
L K L R V S + + VR I+ ++ P L + +++ P + P
Sbjct: 20 LTKRIPLRRQVTVSAESSSSMNSNTPLVR--ITTRLSSTADTPMLAGVSEYELP---EDP 74
Query: 394 RW-FSYAELELATGGFSQANFLAEGGFGSVHRGVL--------PDGQAVAVKQHK-LASS 443
+W F +L L L EG FG V + VAVK K A+
Sbjct: 75 KWEFPRDKLTLG-------KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE 127
Query: 444 QGDHEFCSEVEVLSC-AQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLE 502
+ + SE+E++ +H+N++ L+G C +D ++ EY G+L +L +E
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 503 WSARQ--------------KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548
+S ARG+ YL + +HRD+ N+L+T +
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYL-ASQK---CIHRDLAARNVLVTENNVMK 243
Query: 549 VGDFGLARWQPDGDMGVETRVIGTFGYL-----APEYAQSGQITEKADVYSFGVVLVELV 603
+ DFGLAR + D T G L APE T ++DV+SFGV++ E+
Sbjct: 244 IADFGLARDINNID----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
Query: 604 T 604
T
Sbjct: 300 T 300
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 65/275 (23%), Positives = 108/275 (39%), Gaps = 35/275 (12%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLS-CAQHRNVVMLIGFC 471
L G G++ + D + VAVK+ S D E V++L +H NV+
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE----VQLLRESDEHPNVIRYFCTE 87
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+ + + + E C +L ++ L + GL +LH IVH
Sbjct: 88 KDRQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSLN----IVH 141
Query: 532 RDMRPNNILLTHDFE-----PLVGDFGLARWQPDGDMGVETR--VIGTFGYLAPEY---A 581
RD++P+NIL++ ++ DFGL + G R V GT G++APE
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 582 QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641
T D++S G V +++ P G+ + A LL ++D L +
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQ-ANILLGACSLDCLHPEKH 255
Query: 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ + + M+ DP RP VL+
Sbjct: 256 EDVIARELIEKMIA-------MDPQKRPSAKHVLK 283
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 58/246 (23%), Positives = 94/246 (38%), Gaps = 20/246 (8%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV- 426
P AP + P + + + FL +GGF
Sbjct: 6 DPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISD 62
Query: 427 LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYE 482
+ A K + L + E+ + H++VV G ED + +V E
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLE 121
Query: 483 YICNGSLDSHLYGCHQEPL-EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
SL ++ L E AR G +YLH ++HRD++ N+ L
Sbjct: 122 LCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLHRNR----VIHRDLKLGNLFL 174
Query: 542 THDFEPLVGDFGLA-RWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLV 600
D E +GDFGLA + + DG+ + + GT Y+APE + + DV+S G ++
Sbjct: 175 NEDLEVKIGDFGLATKVEYDGER-KKV-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 232
Query: 601 ELVTGR 606
L+ G+
Sbjct: 233 TLLVGK 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 414 LAEGGFGSVHRGVLPD------GQAVAVKQHK-LASSQGDHEFCSEVEVLSC-AQHRNVV 465
L G FG V VAVK K A + SE++++S QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHL----------YGCHQEPLEWSARQ--KIAVGA 513
L+G C L++ EY C G L + L S R +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
A+G+ +L + CI HRD+ N+LLT+ +GDFGLAR + ++
Sbjct: 174 AQGMAFLASK---NCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDS----NYIVKGN 225
Query: 574 GYL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
L APE T ++DV+S+G++L E+ +
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 62/220 (28%), Positives = 89/220 (40%), Gaps = 37/220 (16%)
Query: 414 LAEGGFGSVHRGVLPD------GQAVAVKQHKLASSQGD-HEFCSEVEVLSC-AQHRNVV 465
L G FG V VAVK K ++ + SE++VLS H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHL--------------YGCHQEPLEWSARQ--KI 509
L+G C L++ EY C G L + L + L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
+ A+G+ +L + CI HRD+ NILLTH + DFGLAR + V
Sbjct: 151 SYQVAKGMAFLASK---NCI-HRDLAARNILLTHGRITKICDFGLARDIKNDS----NYV 202
Query: 570 IGTFGYL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
+ L APE + T ++DV+S+G+ L EL +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 45/201 (22%), Positives = 79/201 (39%), Gaps = 23/201 (11%)
Query: 414 LAEGGFGSVHRGV--LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
+A GG G ++ + +G+ V +K + +E + L+ H ++V + F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 471 CIEDRRRL-----LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
R +V EY+ SL + L + + L YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH---S 200
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
+G +V+ D++P NI+LT + + + D G + + GT G+ APE +
Sbjct: 201 IG-LVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINSFGYLYGTPGFQAPEIVR-TG 252
Query: 586 ITEKADVYSFGVVLVELVTGR 606
T D+Y+ G L L
Sbjct: 253 PTVATDIYTVGRTLAALTLDL 273
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 65/220 (29%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 414 LAEGGFGSVHRGVLPD--------GQAVAVKQHK-LASSQGDHEFCSEVEVLSC-AQHRN 463
L EG FG V VAVK K A+ + + SE+E++ +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------------KI 509
++ L+G C +D ++ EY G+L +L LE+S
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
A ARG+ YL + +HRD+ N+L+T D + DFGLAR D
Sbjct: 197 AYQVARGMEYL-ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YYK 248
Query: 570 IGTFGYL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
T G L APE T ++DV+SFGV+L E+ T
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-27
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGFC 471
L GGFG V R + G+ VA+KQ + S + E +C E++++ H NVV
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 80
Query: 472 IEDRRRL-------LVYEYICNGSLDSHL--YGCHQEPLEWSAR---QKIAVGAARGLRY 519
+ ++L L EY G L +L + E R I+ LRY
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS----SALRY 136
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPL---VGDFGLARWQPDGDMGVETRVIGTFGYL 576
LHE I+HRD++P NI+L + L + D G A+ G++ V GT YL
Sbjct: 137 LHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEFV-GTLQYL 190
Query: 577 APEYAQSGQITEKADVYSFGVVLVELVTGR 606
APE + + T D +SFG + E +TG
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 50/215 (23%), Positives = 78/215 (36%), Gaps = 33/215 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
L +G +V RG G A+K + ++ + E EVL H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI- 75
Query: 472 IEDRRRLLVY---EYICNGSLDSHL--YGCHQEPLEWSAR---QKIAVGAARGLRYLHEE 523
E+ E+ GSL + L E + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV----GGMNHLREN 131
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
IVHR+++P NI+ + + DFG AR D + + GT YL P+
Sbjct: 132 G----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY-GTEEYLHPD 185
Query: 580 --------YAQSGQITEKADVYSFGVVLVELVTGR 606
+ D++S GV TG
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 54/202 (26%), Positives = 84/202 (41%), Gaps = 19/202 (9%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
FL +GGF + A K + L + E+ + H++VV
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
G ED + +V E SL EP AR G +YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---AR-YYLRQIVLGCQYLHRNR- 135
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
++HRD++ N+ L D E +GDFGLA + + DG+ + + GT Y+APE
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKV-LCGTPNYIAPEVLSKK 190
Query: 585 QITEKADVYSFGVVLVELVTGR 606
+ + DV+S G ++ L+ G+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 414 LAEGGFGSVHRGVLPD--------GQAVAVKQHK-LASSQGDHEFCSEVEVLSC-AQHRN 463
L EG FG V VAVK K A+ + + SE+E++ +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------------KI 509
++ L+G C +D ++ EY G+L +L +E+S
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
ARG+ YL + +HRD+ N+L+T + + DFGLAR + D
Sbjct: 163 TYQLARGMEYL-ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNID----YYK 214
Query: 570 IGTFGYL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
T G L APE T ++DV+SFGV++ E+ T
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 414 LAEGGFGSVHRGVLPD---GQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQ--HRNVVM 466
L GG VH D + VAVK + A D F E + A H +V
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 467 L--IGFCIEDRRRL--LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
+ G L +V EY+ +L ++ + P+ ++ A + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH- 133
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR---VIGTFGYLAPE 579
+ G I+HRD++P NI+++ V DFG+AR D V T+ VIGT YL+PE
Sbjct: 134 --QNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGTAQYLSPE 189
Query: 580 YAQSGQITEKADVYSFGVVLVELVTGR 606
A+ + ++DVYS G VL E++TG
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 8e-27
Identities = 36/302 (11%), Positives = 65/302 (21%), Gaps = 58/302 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L G V + + A+K S + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 470 FC--------------------------IEDRRRLLVYEYICNGSLDS-----HLYGCHQ 498
LL+ + L+ +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVFR 188
Query: 499 EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558
A + R L + +VH P+N+ + D ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALW-- 242
Query: 559 PDGDMGVETRVIGTFGYLAPEYAQSG--QITEKADVYSFGVVLVELVTGRKAVDLNRPKG 616
G G Y E+ + T + + G+ + + L P
Sbjct: 243 KVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE--VYCMLHAASLCIRRDPHSRPRMSQV 674
+ W RP L D L + + L D R +
Sbjct: 301 KG---SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL-------NFDRRRRLLPLEA 350
Query: 675 LR 676
+
Sbjct: 351 ME 352
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 43/219 (19%), Positives = 86/219 (39%), Gaps = 34/219 (15%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVK-----------------QHKLASSQGDHEFCSEVEVL 456
L +G F + D + A+K K++ +F +E++++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 457 SCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGA-- 513
+ ++ + G I + + ++YEY+ N S+ ++ I V
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 514 ----ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
Y+H E I HRD++P+NIL+ + + DFG + + D + +
Sbjct: 157 IKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGSR 211
Query: 570 IGTFGYLAPE--YAQSGQITEKADVYSFGVVLVELVTGR 606
GT+ ++ PE +S K D++S G+ L +
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 46/227 (20%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHK-LASSQGDHEFCSEVEVLSCAQHRNVVM 466
+ EG FG V + P VAVK K AS+ +F E +++ + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ------------------- 507
L+G C + L++EY+ G L+ L + +
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 508 ---KIAVGAARGLRYLHEECRVGCIVHRDM--RPNNILLTHDFEPLVGDFGLARWQPDGD 562
IA A G+ YL E VHRD+ R N L+ + + DFGL+R D
Sbjct: 175 EQLCIARQVAAGMAYLSER----KFVHRDLATR--NCLVGENMVVKIADFGLSRNIYSAD 228
Query: 563 MGVETRVIGTFGYL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
+ PE + T ++DV+++GVVL E+ +
Sbjct: 229 ----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 71/264 (26%), Positives = 100/264 (37%), Gaps = 53/264 (20%)
Query: 376 PPLCSICQHKAPVFGKPPRW-FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDG---- 430
P S+ K P+W F L L L EG FG V +
Sbjct: 2 PLSLSVDAFKILE---DPKWEFPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRA 51
Query: 431 --QAVAVKQHK-LASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
VAVK K AS + SE VL H +V+ L G C +D LL+ EY G
Sbjct: 52 GYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 488 SLDSHLYGCHQEPLEWSARQ----------------------KIAVGAARGLRYLHEECR 525
SL L + + A ++G++YL
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEM 169
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL-----APEY 580
+VHRD+ NIL+ + + DFGL+R + D + V + G + A E
Sbjct: 170 --KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED----SYVKRSQGRIPVKWMAIES 223
Query: 581 AQSGQITEKADVYSFGVVLVELVT 604
T ++DV+SFGV+L E+VT
Sbjct: 224 LFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 55/219 (25%), Positives = 84/219 (38%), Gaps = 36/219 (16%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQHK-LASSQGDHEFCSEVEVLS-CAQHRNVV 465
L G FG V + VAVK K A+ SE+++L H NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 466 MLIGFC-IEDRRRLLVYEYICNGSLDSHL------------YGCHQEPLEWSARQ--KIA 510
L+G C +++ E+ G+L ++L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI 570
A+G+ +L + +HRD+ NILL+ + DFGLAR V
Sbjct: 155 FQVAKGMEFL-ASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----DYVR 206
Query: 571 GTFGYL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
L APE T ++DV+SFGV+L E+ +
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 70/274 (25%), Positives = 115/274 (41%), Gaps = 44/274 (16%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFC 471
+ +G FG V +G+ + VA+K L ++ + + E+ VLS V G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHEECRVGC 528
++D + ++ EY+ GS L PL+ +IA +GL YLH E
Sbjct: 90 LKDTKLWIIMEYLGGGSA-LDLL--EPGPLD---ETQIATILREILKGLDYLHSE---KK 140
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
I HRD++ N+LL+ E + DFG+A Q +GT ++APE +
Sbjct: 141 I-HRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE------YAIDELVDPRLG 642
KAD++S G+ +EL G P P E + I + P L
Sbjct: 199 KADIWSLGITAIELARG-------EP-----------PHSELHPMKVLFLIPKNNPPTLE 240
Query: 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+YS+ + C+ ++P RP ++L+
Sbjct: 241 GNYSKP----LKEFVEACLNKEPSFRPTAKELLK 270
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +G FG+V+ + +A+K + +L +H+ E+E+ S +H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ DR+R+ L+ E+ G L L + E + + A L Y HE
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFME-ELADALHYCHERK---- 134
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPEYAQSGQIT 587
++HRD++P N+L+ + E + DFG + P R + GT YL PE +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHD 190
Query: 588 EKADVYSFGVVLVELVTGR 606
EK D++ GV+ E + G
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 70/343 (20%), Positives = 110/343 (32%), Gaps = 99/343 (28%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVV 465
F + GGFG V D A+K+ +L + + E EV+ L+ +H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 466 MLIGFCIEDRRRLLVYE-----------------------------------------YI 484
+E E +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 485 CNGSLDSHLY----GCHQEPL-EWSARQK------------IAVGAARGLRYLHEECRVG 527
S +LY C +E L +W R+ I + A + +LH +
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---- 183
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR-----------WQPDGDMGVETRVIGTFGYL 576
++HRD++P+NI T D VGDFGL P T +GT Y+
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 577 APEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636
+PE + K D++S G++L EL+ T+ R + + L
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLYS-------------FSTQMERVRIIT-DVRNL 289
Query: 637 VDPRLGNHYSEHE---VYCMLHAASLCIRRDPHSRPRMSQVLR 676
P L E V ML P RP + ++
Sbjct: 290 KFPLLFTQKYPQEHMMVQDMLS-------PSPTERPEATDIIE 325
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 50/215 (23%), Positives = 79/215 (36%), Gaps = 33/215 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
L +G +V RG G A+K + ++ + E EVL H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI- 75
Query: 472 IEDRRRLLVY---EYICNGSLDSHL--YGCHQEPLEWSAR---QKIAVGAARGLRYLHEE 523
E+ E+ GSL + L E + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV----GGMNHLREN 131
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
IVHR+++P NI+ + + DFG AR D + + GT YL P+
Sbjct: 132 G----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY-GTEEYLHPD 185
Query: 580 YAQSGQI--------TEKADVYSFGVVLVELVTGR 606
+ + D++S GV TG
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 61/225 (27%), Positives = 89/225 (39%), Gaps = 42/225 (18%)
Query: 414 LAEGGFGSVHRGVLPDGQA------VAVKQHK-LASSQGDHEFCSEVEVLSC-AQHRNVV 465
L G FG V VAVK K A S SE+++++ H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ------------------ 507
L+G C L++EY C G L ++L ++ E
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 508 ---KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564
A A+G+ +L E VHRD+ N+L+TH + DFGLAR
Sbjct: 173 DLLCFAYQVAKGMEFL-EFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-- 226
Query: 565 VETRVIGTFGYL-----APEYAQSGQITEKADVYSFGVVLVELVT 604
V+ L APE G T K+DV+S+G++L E+ +
Sbjct: 227 --NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 57/273 (20%), Positives = 111/273 (40%), Gaps = 31/273 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEV-LSCAQHRNVVMLIGF 470
L G +G V + +P GQ +AVK+ +SQ ++++ + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 471 CIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ + E + SLD + + KIAV + L +LH +
Sbjct: 75 LFREGDVWICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--- 130
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE----YAQSG 584
++HRD++P+N+L+ + + DFG++ D+ + G Y+APE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDI-DAGCKPYMAPERINPELNQK 188
Query: 585 QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL-GN 643
+ K+D++S G+ ++EL R W P + + E P+L +
Sbjct: 189 GYSVKSDIWSLGITMIELAIL-------RF----PYDSWGTPFQQLKQVVEEPSPQLPAD 237
Query: 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+S + S C++++ RP ++++
Sbjct: 238 KFSAE----FVDFTSQCLKKNSKERPTYPELMQ 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 67/296 (22%), Positives = 112/296 (37%), Gaps = 56/296 (18%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLS-CAQHRNVVMLIGFCI 472
L G G+V G+ VAVK+ + E+++L+ H NV+
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCS-E 78
Query: 473 EDRRRL-LVYEYICNGSLD-----SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
R L + E CN +L ++ + + + + A G+ +LH
Sbjct: 79 TTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-- 135
Query: 527 GCIVHRDMRPNNILLTH-------------DFEPLVGDFGLARWQPDGDMGVETR---VI 570
I+HRD++P NIL++ + L+ DFGL + G T
Sbjct: 136 --IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 571 GTFGYLAPE-------YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW 623
GT G+ APE ++T D++S G V +++ K P G + E
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-----HPFGDKYSRE- 247
Query: 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLR 676
+ + +++DE+ + +E A L I DP RP +VLR
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAE--------ATDLISQMIDHDPLKRPTAMKVLR 295
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 41/273 (15%), Positives = 88/273 (32%), Gaps = 35/273 (12%)
Query: 357 FSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAE 416
+ + + LS + P + + + + P E +L + + L E
Sbjct: 22 WDDKLIFKL-LSGLSKP-VSSYPNTFEWQCKL----PAIKPKTEFQLGSKLVYVHHLLGE 75
Query: 417 GGFGSVHRGV------LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
G F V+ + Q +K K A+ + +E L + +
Sbjct: 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135
Query: 471 CIEDRRRLLVYEYICNGSLDSHL---YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ +LV E G+L + + ++ + A+ + +H+
Sbjct: 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD----C 191
Query: 528 CIVHRDMRPNNILLTHDFEPLVG-----------DFGLA---RWQPDGDMGVETRVIGTF 573
I+H D++P+N +L + F D G + + P G + T T
Sbjct: 192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI--FTAKCETS 249
Query: 574 GYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
G+ E + + D + + ++ G
Sbjct: 250 GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 29/233 (12%), Positives = 60/233 (25%), Gaps = 44/233 (18%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE------------------------ 448
L + + G++ V +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 449 ----FCSEVEVLSCAQHRNVVMLIG----FCIEDRRRLLVYEYICNGSLDSHL--YGCHQ 498
F +++ Q + ++ + + R L + L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 499 EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558
+ L AR ++ + R L LH +VH +RP +I+L + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 559 PDGDMGVETRVIGTFGYLAPEYAQSGQ-----ITEKADVYSFGVVLVELVTGR 606
+ R A GQ +T D ++ G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 40/205 (19%), Positives = 72/205 (35%), Gaps = 23/205 (11%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFCIE 473
+V+ P G+ V V++ L + + E+ V H N+V I
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHEECRVGCIV 530
D +V ++ GS + + + IA G + L Y+H G +
Sbjct: 98 DNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVLKALDYIHHM---GYV- 150
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-------GVETRVIGTFGYLAPEYAQS 583
HR ++ ++IL++ D + + + +L+PE Q
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNL-SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 584 GQI--TEKADVYSFGVVLVELVTGR 606
K+D+YS G+ EL G
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGH 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 67/286 (23%), Positives = 118/286 (41%), Gaps = 54/286 (18%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLS-CAQHRNVVMLIG-- 469
+ G +G V++G + GQ A+K + + + E E+ +L + HRN+ G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 470 ----FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHE 522
D + LV E+ GS+ + L+ + IA RGL +LH+
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYICREILRGLSHLHQ 147
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ 582
++HRD++ N+LLT + E + DFG++ Q D +G IGT ++APE
Sbjct: 148 HK----VIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 583 SGQITE-----KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE------Y 631
+ + K+D++S G+ +E+ G P PL + +
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEG-------AP-----------PLCDMHPMRALF 244
Query: 632 AIDELVDPRL-GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
I PRL +S+ C+ ++ RP Q+++
Sbjct: 245 LIPRNPAPRLKSKKWSKK----FQSFIESCLVKNHSQRPATEQLMK 286
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 75/287 (26%), Positives = 116/287 (40%), Gaps = 50/287 (17%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFCIE 473
G V P + VA+K+ L Q E E++ +S H N+V +
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSAR----QKIAV---GAARGLRYLHEECRV 526
LV + + GS+ + E + IA GL YLH+
Sbjct: 85 KDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN--- 140
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR----VIGTFGYLAPE-YA 581
G I HRD++ NILL D + DFG++ + G + +GT ++APE
Sbjct: 141 GQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 582 QSGQITEKADVYSFGVVLVELVTGR---------KAVDL---NRPKGQQCLTEWARPLLE 629
Q KAD++SFG+ +EL TG K + L N P P LE
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-----------PSLE 248
Query: 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
D+ + + G + + M+ SLC+++DP RP +++LR
Sbjct: 249 TGVQDKEMLKKYGKSFRK-----MI---SLCLQKDPEKRPTAAELLR 287
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEV-LSCAQHRNVVMLIGF 470
+ G +GSV++ V P GQ +AVK+ + + + + +++V + + +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 471 CIEDRRRLLVYEYICNGSLDS---HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ + E + S D ++Y + + KI + + L +L E +
Sbjct: 90 LFREGDCWICMEL-MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI- 586
I+HRD++P+NILL + DFG++ Q + +TR G Y+APE
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISG-QLVDSIA-KTRDAGCRPYMAPERIDPSASR 203
Query: 587 ---TEKADVYSFGVVLVELVTGR 606
++DV+S G+ L EL TGR
Sbjct: 204 QGYDVRSDVWSLGITLYELATGR 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 60/277 (21%), Positives = 112/277 (40%), Gaps = 42/277 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG V++ G A K + S + ++ E+E+L+ H +V L+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
D + ++ E+ G++D+ + L Q + L +LH + I HR
Sbjct: 87 HDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RII-HR 141
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE-----YAQSGQIT 587
D++ N+L+T + + + DFG++ + + IGT ++APE +
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 200
Query: 588 EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE------YAIDELVDPRL 641
KAD++S G+ L+E+ P P E I + P L
Sbjct: 201 YKADIWSLGITLIEMAQI-------EP-----------PHHELNPMRVLLKIAKSDPPTL 242
Query: 642 --GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ +S + + ++P +RP +Q+L
Sbjct: 243 LTPSKWSVE----FRDFLKIALDKNPETRPSAAQLLE 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 59/272 (21%), Positives = 108/272 (39%), Gaps = 39/272 (14%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G G+V+ + + GQ VA++Q L +E+ V+ ++ N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+V EY+ GSL + + ++ + + L +LH ++HR
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ----VIHR 140
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADV 592
D++ +NILL D + DFG Q + + ++GT ++APE K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 593 YSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE------YAIDELVDPRLGN--H 644
+S G++ +E++ G P P L E Y I P L N
Sbjct: 200 WSLGIMAIEMIEG-------EP-----------PYLNENPLRALYLIATNGTPELQNPEK 241
Query: 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
S + C+ D R ++L+
Sbjct: 242 LSAI----FRDFLNRCLEMDVEKRGSAKELLQ 269
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 79/286 (27%), Positives = 122/286 (42%), Gaps = 53/286 (18%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRN 463
FS + G FG+V+ + + + VA+K+ + Q + ++ EV L +H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYL 520
+ G + + LV EY C GS S L H++PL+ +IA GA +GL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEY-CLGSA-SDLLEVHKKPLQ---EVEIAAVTHGALQGLAYL 170
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE- 579
H ++HRD++ NILL+ +GDFG A M +GT ++APE
Sbjct: 171 HSHN----MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEV 221
Query: 580 --YAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE------Y 631
GQ K DV+S G+ +EL +P PL Y
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAER-------KP-----------PLFNMNAMSALY 263
Query: 632 AIDELVDPRL-GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
I + P L H+SE+ + C+++ P RP +L+
Sbjct: 264 HIAQNESPALQSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLK 305
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 61/203 (30%), Positives = 84/203 (41%), Gaps = 22/203 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +G FG V GQ AVK ++ EV++L H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
F ED+ LV E G L + E +I G+ Y+H+
Sbjct: 94 FF-EDKGYFYLVGEVYTGGELFDEIISRKRFSE----VDAARIIRQVLSGITYMHKNK-- 146
Query: 527 GCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
IVHRD++P N+LL D + DFGL+ IGT Y+APE
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPE-VLH 201
Query: 584 GQITEKADVYSFGVVLVELVTGR 606
G EK DV+S GV+L L++G
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGC 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 7e-23
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFC 471
L G G V + P G +A K L ++ E++VL +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
D + E++ GSLD L + P + K+++ +GL YL E+ + I+H
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHK---IMH 155
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR---VIGTFGYLAPEYAQSGQITE 588
RD++P+NIL+ E + DFG++ G + +++ +GT Y++PE Q +
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVS-----GQL-IDSMANSFVGTRSYMSPERLQGTHYSV 209
Query: 589 KADVYSFGVVLVELVTGR 606
++D++S G+ LVE+ GR
Sbjct: 210 QSDIWSMGLSLVEMAVGR 227
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 9/193 (4%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ EG G V G+ VAVK L Q +EV ++ QH NVV + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
++ E++ G+L + Q L + + L YLH + ++HR
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQ----GVIHR 165
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADV 592
D++ ++ILLT D + DFG Q D+ ++GT ++APE + D+
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCA-QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224
Query: 593 YSFGVVLVELVTG 605
+S G++++E+V G
Sbjct: 225 WSLGIMVIEMVDG 237
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 1e-22
Identities = 28/240 (11%), Positives = 61/240 (25%), Gaps = 55/240 (22%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVK----------------------------QHKLASS 443
L + + G++ V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 444 QGDHEFCSEVEVLSCAQHRNVVMLIG-FCIEDRRRLLVYEYICNGSLDSHL-----YGCH 497
+ F +++ Q + ++ + +L + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 498 QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557
+ L AR ++ + R L LH +VH +RP +I+L + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 558 QPDGDMGVETRVIGTFGYLAPEYAQS-----------GQITEKADVYSFGVVLVELVTGR 606
G + G+ PE +T D ++ G+V+ +
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 62/201 (30%), Positives = 85/201 (42%), Gaps = 19/201 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L G +G V A+K K + S + EV VL H N++ L F
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 471 CIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSARQKIAVGAARGLRYLHEECRVGC 528
ED+R LV E G L + H+ E A I G+ YLH+
Sbjct: 105 F-EDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAA-VIIKQVLSGVTYLHKHN---- 156
Query: 529 IVHRDMRPNNILLT---HDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
IVHRD++P N+LL D + DFGL+ + +GT Y+APE +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPE-VLRKK 213
Query: 586 ITEKADVYSFGVVLVELVTGR 606
EK DV+S GV+L L+ G
Sbjct: 214 YDEKCDVWSIGVILFILLAGY 234
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 68/281 (24%), Positives = 109/281 (38%), Gaps = 45/281 (16%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
F L EG +GSV++ + GQ VA+KQ + E E+ ++ +VV
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHEE 523
G ++ +V EY GS+ + + L +IA +GL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLT---EDEIATILQSTLKGLEYLHFM 144
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
+HRD++ NILL + + DFG+A Q M VIGT ++APE Q
Sbjct: 145 R----KIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 584 GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE------YAIDELV 637
AD++S G+ +E+ G +P P + + I
Sbjct: 200 IGYNCVADIWSLGITAIEMAEG-------KP-----------PYADIHPMRAIFMIPTNP 241
Query: 638 DPRLGN--HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
P +S+ C+ + P R +Q+L+
Sbjct: 242 PPTFRKPELWSD----NFTDFVKQCLVKSPEQRATATQLLQ 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 67/315 (21%), Positives = 114/315 (36%), Gaps = 48/315 (15%)
Query: 306 HHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAI 365
HH H + + + + + + A+
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSAL 62
Query: 366 SLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRG 425
++ APP P + + V Y S+ L G FG VH+
Sbjct: 63 AVDIPAPPAPFDHRIVTAKQGAVNSF------YT--------VSKTEILGGGRFGQVHKC 108
Query: 426 V-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEY 483
G +A K K + E +E+ V++ H N++ L E + + LV EY
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEY 167
Query: 484 ICNGSL------DSHLYGCHQEPLEWSA----RQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ G L +S+ E +Q G+R++H+ I+H D
Sbjct: 168 VDGGELFDRIIDESYNLT------ELDTILFMKQ-----ICEGIRHMHQM----YILHLD 212
Query: 534 MRPNNILLTHDFEPLV--GDFGLAR-WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKA 590
++P NIL + + DFGLAR ++P + V GT +LAPE ++
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPT 269
Query: 591 DVYSFGVVLVELVTG 605
D++S GV+ L++G
Sbjct: 270 DMWSVGVIAYMLLSG 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 27/197 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G F V G+ A+K K + + D +E+ VL +H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-Y 75
Query: 473 EDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
E LV + + G L D E A I ++YLHE
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYT-------EKDASLVIQQ-VLSAVKYLHENG- 126
Query: 526 VGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ 582
IVHRD++P N+L E + + DFGL++ + +G M + GT GY+APE
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVLA 180
Query: 583 SGQITEKADVYSFGVVL 599
++ D +S GV+
Sbjct: 181 QKPYSKAVDCWSIGVIT 197
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 64/273 (23%), Positives = 116/273 (42%), Gaps = 32/273 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVL-SCAQHRNVVMLIGF 470
+ G G V + G +AVKQ + + ++ +++ +++V+ +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
I + + E + L Q P+ K+ V + L YL E+ ++
Sbjct: 93 FITNTDVFIAMEL-MGTCAEK-LKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VI 147
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE-- 588
HRD++P+NILL + + DFG++ + D + R G Y+APE T+
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISG-RLVDDKA-KDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 589 ---KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH- 644
+ADV+S G+ LVEL TG + + C T++ +L + + P L H
Sbjct: 206 YDIRADVWSLGISLVELATG-------QFPYKNCKTDFE--VLT--KVLQEEPPLLPGHM 254
Query: 645 -YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+S C+ +D RP+ +++L
Sbjct: 255 GFSGD----FQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 53/213 (24%), Positives = 82/213 (38%), Gaps = 32/213 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCS----------EVEVLSCA 459
L G +G V A+K + + + + E+ +L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 460 QHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARG 516
H N++ L ED++ LV E+ G L + E I G
Sbjct: 104 DHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDE----CDAANIMKQILSG 158
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
+ YLH+ IVHRD++P NILL + + DFGL+ + +GT
Sbjct: 159 ICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTA 212
Query: 574 GYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
Y+APE + EK DV+S GV++ L+ G
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 48/207 (23%), Positives = 81/207 (39%), Gaps = 34/207 (16%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG VHR V G+ K + +E+ +++ H ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-F 117
Query: 473 EDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR----GLRYLH 521
ED+ + L+ E++ G L + + + + R GL+++H
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMS-----------EAEVINYMRQACEGLKHMH 166
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLV--GDFGLAR-WQPDGDMGVETRVIGTFGYLAP 578
E IVH D++P NI+ V DFGLA PD + T + AP
Sbjct: 167 EH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAP 219
Query: 579 EYAQSGQITEKADVYSFGVVLVELVTG 605
E + D+++ GV+ L++G
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 9e-21
Identities = 62/202 (30%), Positives = 86/202 (42%), Gaps = 21/202 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L +G FG V + Q AVK +K ++ D EVE+L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 471 CIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
ED +V E G L + E +I G+ Y+H+
Sbjct: 90 L-EDSSSFYIVGELYTGGELFDEIIKRKRFSE----HDAARIIKQVFSGITYMHKHN--- 141
Query: 528 CIVHRDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
IVHRD++P NILL D + + DFGL+ IGT Y+APE G
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPE-VLRG 197
Query: 585 QITEKADVYSFGVVLVELVTGR 606
EK DV+S GV+L L++G
Sbjct: 198 TYDEKCDVWSAGVILYILLSGT 219
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 62/200 (31%), Positives = 87/200 (43%), Gaps = 31/200 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L +G FG V + Q AVK +K ++ D EVE+L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 471 CIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
ED +V E G L E A +I G+ Y+H+
Sbjct: 90 L-EDSSSFYIVGELYTGGELFDEIIKRKRFS-------EHDAA-RIIKQVFSGITYMHKH 140
Query: 524 CRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLAR-WQPDGDMGVETRVIGTFGYLAPE 579
IVHRD++P NILL + + + DFGL+ +Q + M IGT Y+APE
Sbjct: 141 N----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPE 193
Query: 580 YAQSGQITEKADVYSFGVVL 599
+ G EK DV+S GV+L
Sbjct: 194 VLR-GTYDEKCDVWSAGVIL 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 51/245 (20%), Positives = 80/245 (32%), Gaps = 57/245 (23%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHK----LASSQGDHE-FCSEVEVLSCAQHRNVVML 467
+ +G +G V + A+K + D E +EV ++ H N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 468 IGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVG-------- 512
ED + + LV E G L +
Sbjct: 94 YE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 513 -----------------AAR-------GLRYLHEECRVGCIVHRDMRPNNILLTHD--FE 546
+ L YLH + G I HRD++P N L + + FE
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---G-ICHRDIKPENFLFSTNKSFE 208
Query: 547 PLVGDFGLARWQPDGDMGVETR---VIGTFGYLAPE--YAQSGQITEKADVYSFGVVLVE 601
+ DFGL++ + G GT ++APE + K D +S GV+L
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 602 LVTGR 606
L+ G
Sbjct: 269 LLMGA 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 53/202 (26%), Positives = 75/202 (37%), Gaps = 32/202 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGFC 471
L G FG VH G +K SQ E +E+EVL H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 472 IEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR----GLRYL 520
ED + +V E G L E + L Y
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSE--------GYVAELMKQMMNALAYF 140
Query: 521 HEECRVGCIVHRDMRPNNILLT---HDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLA 577
H + +VH+D++P NIL + DFGLA + T GT Y+A
Sbjct: 141 HSQ---H-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMA 194
Query: 578 PEYAQSGQITEKADVYSFGVVL 599
PE + +T K D++S GVV+
Sbjct: 195 PEVFK-RDVTFKCDIWSAGVVM 215
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 43/215 (20%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGD---HEFCSEVEVLSCAQHRNVVM 466
L G F V + G A K + +S+ E EV +L H NV+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 467 LIGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR---- 515
L E+R + L+ E + G L L ++ A +
Sbjct: 80 LHDV-YENRTDVVLILELVSGGELFDFLAQKESL------------SEEEATSFIKQILD 126
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR-WQPDGDMGVETRVI 570
G+ YLH + I H D++P NI+L P+ + DFGLA + + +
Sbjct: 127 GVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF 179
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
GT ++APE + +AD++S GV+ L++G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 43/215 (20%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK-----QHKLASSQGDHE-FCSEVEVLSCAQHRNVVM 466
L G F V + G+ A K + + E EV +L +H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 467 LIGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR---- 515
L E++ + L+ E + G L L + A +
Sbjct: 73 LHDIF-ENKTDVVLILELVSGGELFDFLAEKESLT------------EDEATQFLKQILD 119
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR-WQPDGDMGVETRVI 570
G+ YLH + I H D++P NI+L P + DFG+A + + +
Sbjct: 120 GVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF 172
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
GT ++APE + +AD++S GV+ L++G
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 43/215 (20%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFC-----SEVEVLSCAQHRNVVM 466
L G F V + G A K K S C EV +L H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 467 LIGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR---- 515
L E+R + L+ E + G L L ++ A +
Sbjct: 80 LHDV-YENRTDVVLILELVSGGELFDFLAQKESLS------------EEEATSFIKQILD 126
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR-WQPDGDMGVETRVI 570
G+ YLH + I H D++P NI+L P+ + DFGLA + + +
Sbjct: 127 GVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF 179
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
GT ++APE + +AD++S GV+ L++G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 47/216 (21%), Positives = 82/216 (37%), Gaps = 42/216 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGD-----HEFCSEVEVLSCAQHRNV 464
L G G V + VA++ K A +E+E+L H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEW-SARQKIAVGAAR-------- 515
+ + F + +V E + G L + +++ +
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGEL-----------FDKVVGNKRLKEATCKLYFYQMLL 250
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL---VGDFGLARWQPDGDMGVETRVIGT 572
++YLHE I+HRD++P N+LL+ E + DFG ++ + + + T GT
Sbjct: 251 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GT 304
Query: 573 FGYLAPE---YAQSGQITEKADVYSFGVVLVELVTG 605
YLAPE + D +S GV+L ++G
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 53/215 (24%), Positives = 82/215 (38%), Gaps = 43/215 (20%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK-----QHKLASSQGDHE-FCSEVEVLSCAQHRNVVM 466
L G F V + G A K + K + E EV +L QH NV+
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 467 LIGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR---- 515
L E++ + L+ E + G L L ++ A +
Sbjct: 79 LHEV-YENKTDVILILELVAGGELFDFLAEKESLT------------EEEATEFLKQILN 125
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR-WQPDGDMGVETRVI 570
G+ YLH I H D++P NI+L P + DFGLA + +
Sbjct: 126 GVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF 178
Query: 571 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG 605
GT ++APE + +AD++S GV+ L++G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-19
Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 28/204 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG VHR G A K E++ +S +H +V L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 473 EDRRRL-LVYEYICNGSL-D--SHLYGCHQEPLEWSARQKIAVGAAR----GLRYLHEEC 524
ED + ++YE++ G L + + + E AV R GL ++HE
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSE--------DEAVEYMRQVCKGLCHMHENN 275
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLV--GDFGLAR-WQPDGDMGVETRVIGTFGYLAPEYA 581
VH D++P NI+ T + DFGL P + V GT + APE A
Sbjct: 276 ----YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVA 328
Query: 582 QSGQITEKADVYSFGVVLVELVTG 605
+ + D++S GV+ L++G
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 49/210 (23%), Positives = 81/210 (38%), Gaps = 42/210 (20%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHE-----FCSEVEVLSCAQHRNV 464
L G G V + VA+K K A +E+E+L H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSL------DSHLYGCHQEPLEWSAR---QKIAVGAAR 515
+ + F + +V E + G L + L E + + ++
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLK-------EATCKLYFYQML----L 125
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL---VGDFGLARWQPDGDMGVETRVIGT 572
++YLHE I+HRD++P N+LL+ E + DFG ++ + + + T GT
Sbjct: 126 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GT 179
Query: 573 FGYLAPE---YAQSGQITEKADVYSFGVVL 599
YLAPE + D +S GV+L
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 42/212 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ +G F V + G+ VA+K + +L + F EV ++ H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRYL 520
IE + L L+ EY G + +L A ++ AR ++Y
Sbjct: 82 -VIETEKTLYLIMEYASGGEVFDYL----------VAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE- 579
H++ IVHRD++ N+LL D + DFG + G ++ G Y APE
Sbjct: 131 HQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFC-GAPPYAAPEL 184
Query: 580 -----YAQSGQITEKADVYSFGVVLVELVTGR 606
Y + DV+S GV+L LV+G
Sbjct: 185 FQGKKYDGP-----EVDVWSLGVILYTLVSGS 211
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 46/213 (21%), Positives = 79/213 (37%), Gaps = 36/213 (16%)
Query: 407 GFSQANF---------LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL 456
G ++ + + G +G V V A K+ + F E+E++
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 457 SCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSL-DSHL-YGCHQEPLEWSARQKIAVGA 513
H N++ L ED + LV E G L + + +E A
Sbjct: 61 KSLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRVFRE--------SDAARI 111
Query: 514 AR----GLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMGVE 566
+ + Y H+ + HRD++P N L D + DFGLA G +
Sbjct: 112 MKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MM 165
Query: 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVL 599
+GT Y++P+ + G + D +S GV++
Sbjct: 166 RTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMM 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 34/206 (16%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQG-DHE-FCSEVEVLSCAQHRNVVML 467
+ +G F V R + GQ AVK K SS G E E + +H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 468 IGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR----G 516
+ L +V+E++ L + + E +A R
Sbjct: 92 LETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--------AVASHYMRQILEA 142
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTF 573
LRY H+ I+HRD++P+ +LL P+ +G FG+A + + RV GT
Sbjct: 143 LRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTP 197
Query: 574 GYLAPEYAQSGQITEKADVYSFGVVL 599
++APE + + DV+ GV+L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHR 462
F Q L G + +V++G+ G VA+K+ KL S +G S E+ ++ +H
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHE 63
Query: 463 NVVMLIGFCIEDRRRLLVYEYICN---GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRY 519
N+V L + + LV+E++ N +DS G LE + + +GL +
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-----VIGTFG 574
HE I+HRD++P N+L+ + +GDFGLAR G+ V+ T
Sbjct: 124 CHE----NKILHRDLKPQNLLINKRGQLKLGDFGLARA-----FGIPVNTFSSEVV-TLW 173
Query: 575 YLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
Y AP+ Y + D++S G +L E++TG+
Sbjct: 174 YRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-19
Identities = 48/201 (23%), Positives = 81/201 (40%), Gaps = 31/201 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQH-KLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L +G F V R V + GQ A S DH+ E + +H N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 471 CIEDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSARQ--KIAVGAARGLRYLH 521
I + L+++ + G L + + E A + + A + + H
Sbjct: 79 -ISEEGHHYLIFDLVTGGELFEDIVAREYYS-------EADASHCIQQILEA---VLHCH 127
Query: 522 EECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFGYLAP 578
+ +VHR+++P N+LL + + + DFGLA GT GYL+P
Sbjct: 128 QMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSP 182
Query: 579 EYAQSGQITEKADVYSFGVVL 599
E + + D+++ GV+L
Sbjct: 183 EVLRKDPYGKPVDLWACGVIL 203
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 50/212 (23%), Positives = 80/212 (37%), Gaps = 33/212 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCS---EVEVL----SCAQHR 462
L +GGFG+V G L D VA+K +++ + + EV +L + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 463 NVVMLIGFCIEDRRRL-LVYEYICNGS-----LDSHLYGCHQEPLEWSARQKIAVGAARG 516
V+ L+ + E + LV E + G E +R
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGP---SR-CFFGQVVAA 151
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDGDMGVETRVIGTFGY 575
+++ H +VHRD++ NIL+ + DFG D GT Y
Sbjct: 152 IQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFD-GTRVY 204
Query: 576 LAPEYAQSGQIT-EKADVYSFGVVLVELVTGR 606
PE+ Q A V+S G++L ++V G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-18
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQ-HKLASSQGDHEFCSEVE--VLSCAQHRNVVM 466
L GGFG V + G+ A K+ +K + + VE +L+ R +V
Sbjct: 193 LGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 467 LIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGA--ARGLRYLHEE 523
L + E + L LV + G + H+Y ++ + + I A GL +LH+
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
I++RD++P N+LL D + D GLA G + GT G++APE
Sbjct: 309 N----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLG 363
Query: 584 GQITEKADVYSFGVVLVELVTGR 606
+ D ++ GV L E++ R
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 33/209 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHR-NVVMLIG 469
L G F V + + GQ A K K Q E+ VL A+ V+ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 470 FCIEDRRRL-LVYEYICNGSL----DSHLYGCHQEPLEWSARQKIAVGAAR----GLRYL 520
E+ + L+ EY G + L E + + G+ YL
Sbjct: 97 V-YENTSEIILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYL 147
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLAR-WQPDGDMGVETRVIGTFGYL 576
H+ IVH D++P NILL+ + + + DFG++R ++ ++GT YL
Sbjct: 148 HQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYL 200
Query: 577 APEYAQSGQITEKADVYSFGVVLVELVTG 605
APE IT D+++ G++ L+T
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 51/201 (25%), Positives = 82/201 (40%), Gaps = 32/201 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L +G F V R V G A K + S D + E + QH N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 471 CIEDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSARQ--KIAVGAARGLRYLH 521
I++ LV++ + G L + E A + + + + Y H
Sbjct: 97 -IQEESFHYLVFDLVTGGELFEDIVAREFYS-------EADASHCIQQILES---IAYCH 145
Query: 522 EECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFGYLAP 578
IVHR+++P N+LL + + + DFGLA D + GT GYL+P
Sbjct: 146 SNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSP 199
Query: 579 EYAQSGQITEKADVYSFGVVL 599
E + ++ D+++ GV+L
Sbjct: 200 EVLKKDPYSKPVDIWACGVIL 220
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 56/198 (28%), Positives = 86/198 (43%), Gaps = 29/198 (14%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVL-SCAQHRNVVMLI 468
L EG F + V QA AVK A++Q E+ L C H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKLH 72
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSARQ--KIAVGAARGLRYLHEEC 524
D+ LV E + G L + ++ E A + V A + ++H+
Sbjct: 73 EVF-HDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSA---VSHMHDVG 126
Query: 525 RVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA 581
+VHRD++P N+L T + + + + DFG AR +P + ++T T Y APE
Sbjct: 127 ----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 582 QSGQITEKADVYSFGVVL 599
E D++S GV+L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 27/199 (13%), Positives = 48/199 (24%), Gaps = 44/199 (22%)
Query: 414 LAEGGFGSVHRGVLPD---GQAVAVKQ--HKLASSQGDHE-FCSEVEVLSCAQHRNVVML 467
+ + D + VA+ + + S LS V +
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ L+V E+I GSL + A H R G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT 587
+ P+ + ++ D G V+ +
Sbjct: 150 -VALSIDHPSRVRVSID--------GDV-------------VLAYPATMPDA-------N 180
Query: 588 EKADVYSFGVVLVELVTGR 606
+ D+ G L L+ R
Sbjct: 181 PQDDIRGIGASLYALLVNR 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 34/208 (16%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFC 471
L EG V + L Q AVK + EVE+L C HRNV+ LI F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 472 IEDRRRLLVYEYICNGSLDSHLY--GCHQEPLEWSARQKIAVGAAR----GLRYLHEECR 525
E+ R LV+E + GS+ SH++ E A + L +LH +
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNE--------LEASVVVQDVASALDFLHNK-- 130
Query: 526 VGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETR------VIGTFGYL 576
I HRD++P NIL H + P+ + DF L G+ Y+
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 577 APE--YAQSGQIT---EKADVYSFGVVL 599
APE A S + + ++ D++S GV+L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 27/203 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFC-SEVEVLSCAQHRNVVMLIGFC 471
L G FG VHR V + K + D E+ +L+ A+HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKF--VKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 472 IEDRRRL-LVYEYICNGSL-DSHLYGCHQEPLEWSARQKIAVGAAR----GLRYLHEECR 525
E L +++E+I + + + E + R+ V L++LH
Sbjct: 71 -ESMEELVMIFEFISGLDIFER----INTSAFELNERE--IVSYVHQVCEALQFLHSH-- 121
Query: 526 VGCIVHRDMRPNNILLTHDFEPLV--GDFGLAR-WQPDGDMGVETRVIGTFGYLAPEYAQ 582
I H D+RP NI+ + +FG AR +P + + Y APE Q
Sbjct: 122 -N-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQ 176
Query: 583 SGQITEKADVYSFGVVLVELVTG 605
++ D++S G ++ L++G
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L EG F +V + A+K +H + ++ + E +V+S H V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLDHPFFVKLY 96
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIA-VGAARGLRYLHEEC 524
F +D +L Y NG L ++ G E R A + +A L YLH +
Sbjct: 97 -FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSA--LEYLHGKG 150
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPEYAQS 583
I+HRD++P NILL D + DFG A+ GT Y++PE
Sbjct: 151 ----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 584 GQITEKADVYSFGVVLVELVTGR 606
+ +D+++ G ++ +LV G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGL 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 45/217 (20%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK--------QHKLASSQGDHEFCSEVEVLSCAQHRNV 464
L G FG V V + V VK + + E+ +LS +H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGS-----LDSHLYGCHQEPLEWSAR---QKIAVGAAR 515
+ ++ E++ LV E +G +D H EPL A +++
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPL---ASYIFRQLV----S 141
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY 575
+ YL I+HRD++ NI++ DF + DFG A + G + T GT Y
Sbjct: 142 AVGYLRL----KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-FYTFC-GTIEY 195
Query: 576 LAPE------YAQSGQITEKADVYSFGVVLVELVTGR 606
APE Y + +++S GV L LV
Sbjct: 196 CAPEVLMGNPYRGP-----ELEMWSLGVTLYTLVFEE 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 25/208 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCS-EVEVLSCAQHRNVVMLI 468
L EG +G V + AVK + KL E+++L +H+NV+ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 469 G-FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSAR----QKIAVGAARGLRYLHE 522
E+++++ +V EY G + + A Q I GL YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-----GLEYLHS 127
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETRVIGTFGYLAPEY 580
+ IVH+D++P N+LLT + G+A T G+ + PE
Sbjct: 128 QG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEI 182
Query: 581 AQSGQITE--KADVYSFGVVLVELVTGR 606
A K D++S GV L + TG
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 53/202 (26%), Positives = 82/202 (40%), Gaps = 34/202 (16%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L +G F V R V G A K + S D + E + QH N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 471 CIEDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSAR---QKIAVGAARGLRYL 520
I++ LV++ + G L + E A Q+I + Y
Sbjct: 74 -IQEESFHYLVFDLVTGGELFEDIVAREFYS-------EADASHCIQQIL----ESIAYC 121
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFGYLA 577
H IVHR+++P N+LL + + + DFGLA D + GT GYL+
Sbjct: 122 HSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLS 175
Query: 578 PEYAQSGQITEKADVYSFGVVL 599
PE + ++ D+++ GV+L
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 56/243 (23%), Positives = 90/243 (37%), Gaps = 28/243 (11%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV- 426
+ N + P W + + + F + L G V+R
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYIC 485
+ A+K L + +E+ VL H N++ L E + LV E +
Sbjct: 75 KGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVT 131
Query: 486 NGSLDSHL--YGCHQEPLEWSARQKIAVGAAR----GLRYLHEECRVGCIVHRDMRPNNI 539
G L + G + E + A A + + YLHE IVHRD++P N+
Sbjct: 132 GGELFDRIVEKGYYSE--------RDAADAVKQILEAVAYLHENG----IVHRDLKPENL 179
Query: 540 LLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFG 596
L PL + DFGL++ + V GT GY APE + + D++S G
Sbjct: 180 LYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237
Query: 597 VVL 599
++
Sbjct: 238 IIT 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 41/212 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L G FG V G G VAVK + K+ S + E++ L +H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRYL 520
I +V EY+ G L ++ ++ AR + Y
Sbjct: 79 -VISTPTDFFMVMEYVSGGELFDYI----------CKHGRVEEMEARRLFQQILSAVDYC 127
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE- 579
H +VHRD++P N+LL + DFGL+ DG+ + T G+ Y APE
Sbjct: 128 HRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSC-GSPNYAAPEV 181
Query: 580 -----YAQSGQITEKADVYSFGVVLVELVTGR 606
YA + D++S GV+L L+ G
Sbjct: 182 ISGRLYAGP-----EVDIWSCGVILYALLCGT 208
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 53/234 (22%), Positives = 90/234 (38%), Gaps = 58/234 (24%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCS------------------ 451
+ +G +G V D A+K + KL G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 452 -----EVEVLSCAQHRNVVMLIGFCIED--RRRL-LVYEYICNGSLDSHLYGCHQEPLEW 503
E+ +L H NVV L+ ++D L +V+E + G + +E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPV-----------MEV 128
Query: 504 SARQKIAVGAAR--------GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+ ++ AR G+ YLH + I+HRD++P+N+L+ D + DFG++
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT---EKADVYSFGVVLVELVTGR 606
D + V GT ++APE + + DV++ GV L V G+
Sbjct: 185 NEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 44/219 (20%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHR 462
+ + + L EG + +V++G VA+K+ +L +G EV +L +H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHA 60
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRY 519
N+V L ++ LV+EY LD L + + RGL Y
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-----VIGTFG 574
H + ++HRD++P N+L+ E + DFGLAR + T+ V+ T
Sbjct: 116 CHRQK----VLHRDLKPQNLLINERGELKLADFGLARA-----KSIPTKTYDNEVV-TLW 165
Query: 575 YLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
Y P+ Y S QI D++ G + E+ TGR
Sbjct: 166 YRPPDILLGSTDY--STQI----DMWGVGCIFYEMATGR 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 48/221 (21%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCAQ 460
+ + + EG +G V++ G+ VA+K+ +L D E S E+ +L
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL-----DAEDEGIPSTAIREISLLKELH 77
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGL 517
H N+V LI +R LV+E+ ++ L ++ L+ S + RG+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-----VIGT 572
+ H+ I+HRD++P N+L+ D + DFGLAR G+ R V+ T
Sbjct: 133 AHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLARA-----FGIPVRSYTHEVV-T 182
Query: 573 FGYLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
Y AP+ Y + D++S G + E++TG+
Sbjct: 183 LWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 54/210 (25%), Positives = 78/210 (37%), Gaps = 39/210 (18%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---------QHKLASSQGDHEFCSEVEVL-SCAQHR 462
L G V R + P + AVK + EV++L + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 463 NVVMLIGFCIEDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSARQKIAVGAAR 515
N++ L E LV++ + G L D L E R KI
Sbjct: 85 NIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLS-------EKETR-KIMRALLE 135
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGY 575
+ LH+ IVHRD++P NILL D + DFG + G+ V GT Y
Sbjct: 136 VICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSY 189
Query: 576 LAPE------YAQSGQITEKADVYSFGVVL 599
LAPE ++ D++S GV++
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 61/277 (22%), Positives = 96/277 (34%), Gaps = 49/277 (17%)
Query: 348 MSSYRTDLEFSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGG 407
M S S + S + + K P+ + Y L
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQ------YQVGPL---- 50
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCS---EVEVLSCAQ 460
L GGFGSV+ G+ + D VA+K +++ EV +L
Sbjct: 51 ------LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 461 HR--NVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLY------GCHQEPLEWSARQKIAV 511
V+ L+ + E L+ E D L+ G QE L AR
Sbjct: 105 SGFSGVIRLLDW-FERPDSFVLILER-PEPVQD--LFDFITERGALQEEL---AR-SFFW 156
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDGDMGVETRVI 570
+R+ H ++HRD++ NIL+ + L + DFG D
Sbjct: 157 QVLEAVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD- 209
Query: 571 GTFGYLAPEYAQSGQIT-EKADVYSFGVVLVELVTGR 606
GT Y PE+ + + A V+S G++L ++V G
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 5e-17
Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 49/224 (21%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCA 459
+ + + EG +G+V + + VA+K+ +L D + S E+ +L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICLLKEL 58
Query: 460 QHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARG 516
+H+N+V L D++ LV+E+ D L L+ + +G
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-----VIG 571
L + H ++HRD++P N+L+ + E + +FGLAR G+ R V+
Sbjct: 114 LGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLARA-----FGIPVRCYSAEVV- 163
Query: 572 TFGYLAPE-------YAQSGQITEKADVYSFGVVLVELVTGRKA 608
T Y P+ Y + D++S G + EL +
Sbjct: 164 TLWYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRP 201
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 58/211 (27%), Positives = 84/211 (39%), Gaps = 38/211 (18%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L EG +G V V +AVAVK + + + E+ + H NVV G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSAR----QKIAVGAARGLRYLHEE 523
+ L EY G L + + E A+ Q +A G+ YLH
Sbjct: 73 -HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMA-----GVVYLH-- 122
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETRVIGTFGYLAPE-- 579
+G I HRD++P N+LL + DFGLA + + GT Y+APE
Sbjct: 123 -GIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 580 ----YAQSGQITEKADVYSFGVVLVELVTGR 606
+ E DV+S G+VL ++ G
Sbjct: 180 KRREFH--A---EPVDVWSCGIVLTAMLAGE 205
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 27/198 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGF 470
L G G V GQ A+K + ++ EV+ + ++V ++
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR------QEVDHHWQASGGPHIVCILDV 90
Query: 471 CIEDRRR-----LLVYEYICNGSL-DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
E+ L++ E + G L Q E A + + +++LH
Sbjct: 91 Y-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD-IGTAIQFLHSHN 148
Query: 525 RVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA 581
I HRD++P N+L T + L + DFG A+ + T Y+APE
Sbjct: 149 ----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---QTPCYTPYYVAPEVL 201
Query: 582 QSGQITEKADVYSFGVVL 599
+ + D++S GV++
Sbjct: 202 GPEKYDKSCDMWSLGVIM 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 6e-17
Identities = 67/208 (32%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 408 FSQANFLAEGGFGSV----HRGVLPDGQAVAVKQ-HKLASSQGDHEFCSEVE--VLSCAQ 460
F Q L +GGFG V R G+ A K+ K + E + E +L
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 461 HRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSARQKIAVGAARGLR 518
R VV L + E + L LV + G L H+Y Q E A A GL
Sbjct: 243 SRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLE 300
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAP 578
LH E IV+RD++P NILL + D GLA P+G ++ RV GT GY+AP
Sbjct: 301 DLHRER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAP 354
Query: 579 EYAQSGQITEKADVYSFGVVLVELVTGR 606
E ++ + T D ++ G +L E++ G+
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 6e-17
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 48/221 (21%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCAQ 460
+ + EG +G V++ G+ A+K+ +L + E S E+ +L +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKELK 58
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGL 517
H N+V L +R +LV+E+ LD L + LE + + G+
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-----VIGT 572
Y H+ ++HRD++P N+L+ + E + DFGLAR G+ R ++ T
Sbjct: 114 AYCHDRR----VLHRDLKPQNLLINREGELKIADFGLARA-----FGIPVRKYTHEIV-T 163
Query: 573 FGYLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
Y AP+ Y + D++S G + E+V G
Sbjct: 164 LWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 59/222 (26%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ-GDHEFCS----EVEVL---SC 458
+ + G +G+V++ G VA+K ++ + G EV +L
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 459 AQHRNVVMLIGFCIEDRRRL-----LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGA 513
+H NVV L+ C R LV+E+ + L ++L L + +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE---TRVI 570
RGL +LH C IVHRD++P NIL+T + DFGLAR + T V+
Sbjct: 130 LRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARI-----YSYQMALTPVV 180
Query: 571 GTFGYLAPE------YAQSGQITEKADVYSFGVVLVELVTGR 606
T Y APE YA D++S G + E+ +
Sbjct: 181 VTLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRRK 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 21/194 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFC 471
+ G + R + AVK + S+ D E+E+L QH N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKI--IDKSKRDPT--EEIEILLRYGQHPNIITLKDVY 85
Query: 472 IEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSARQKIAVGAARGLRYLHEECRVGCI 529
+D + + +V E + G L + Q+ E A + + + YLH + +
Sbjct: 86 -DDGKYVYVVTELMKGGELLDKI--LRQKFFSEREAS-AVLFTITKTVEYLHAQG----V 137
Query: 530 VHRDMRPNNILLTH---DFEPL-VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
VHRD++P+NIL + E + + DFG A+ + + T T ++APE +
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLERQG 196
Query: 586 ITEKADVYSFGVVL 599
D++S GV+L
Sbjct: 197 YDAACDIWSLGVLL 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCS----EVEVLSCAQH 461
+ + +FL EG F +V++ Q VA+K+ KL + E+++L H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
N++ L+ LV+++ L+ + L S + + +GL YLH
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDF-METDLEVIIKDNSL-VLTPSHIKAYMLMTLQGLEYLH 129
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-----VIGTFGYL 576
+ I+HRD++PNN+LL + + DFGLA+ G R V+ T Y
Sbjct: 130 QHW----ILHRDLKPNNLLLDENGVLKLADFGLAKS-----FGSPNRAYTHQVV-TRWYR 179
Query: 577 APE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
APE Y + D+++ G +L EL+
Sbjct: 180 APELLFGARMY--GVGV----DMWAVGCILAELLLRV 210
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 67/264 (25%), Positives = 95/264 (35%), Gaps = 55/264 (20%)
Query: 417 GGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
G F V + GQ A+K L + F E +VL R + L
Sbjct: 72 GAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQLH 127
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHEECR 525
F +D L LV EY G L + L + AR +A V A + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA---IDSVHRLG- 182
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
VHRD++P+NILL + DFG + + DG + V GT YL+PE Q+
Sbjct: 183 ---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAV 238
Query: 585 QITEKADVY-------SFGVVLVELVTGR-----------------KAVDLNRPKGQQCL 620
Y + GV E+ G+ L+ P + +
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
Query: 621 TEWARPLLEEYAIDELVDP--RLG 642
E AR ++ L P RLG
Sbjct: 299 PEEARDFIQRL----LCPPETRLG 318
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 54/209 (25%), Positives = 79/209 (37%), Gaps = 38/209 (18%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHE-----FCSEVEVL-SCAQHRN 463
+ G V R V G AVK S E E +L A H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSARQKIAVGAARG 516
++ LI E + LV++ + G L D L E R I
Sbjct: 162 IITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALS-------EKETR-SIMRSLLEA 212
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL 576
+ +LH IVHRD++P NILL + + + DFG + G+ + GT GYL
Sbjct: 213 VSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYL 266
Query: 577 APE------YAQSGQITEKADVYSFGVVL 599
APE ++ D+++ GV+L
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 42/212 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L EG FG V Q VA+K + L S E+ L +H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRYL 520
I + +V EY G L ++ ++++ R + Y
Sbjct: 77 V-ITTPTDIVMVIEY-AGGELFDYI----------VEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE- 579
H IVHRD++P N+LL + + DFGL+ DG+ ++T G+ Y APE
Sbjct: 125 HRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTSC-GSPNYAAPEV 178
Query: 580 -----YAQSGQITEKADVYSFGVVLVELVTGR 606
YA + DV+S G+VL ++ GR
Sbjct: 179 INGKLYAGP-----EVDVWSCGIVLYVMLVGR 205
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 50/204 (24%), Positives = 85/204 (41%), Gaps = 20/204 (9%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ G G V + VA+K KL+ + E+ ++ C H+N++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 467 LIG-FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
L+ F + Y+ +D++L Q L+ + G+++LH
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS--- 182
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG---VETRVIGTFGYLAPEYAQ 582
I+HRD++P+NI++ D + DFGLAR M V TR Y APE
Sbjct: 183 -AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVIL 236
Query: 583 SGQITEKADVYSFGVVLVELVTGR 606
E D++S G ++ E+V +
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 57/211 (27%), Positives = 83/211 (39%), Gaps = 38/211 (18%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L EG +G V V +AVAVK + + + E+ + H NVV G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSAR----QKIAVGAARGLRYLHEE 523
+ L EY G L + + E A+ Q +A G+ YLH
Sbjct: 73 -HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMA-----GVVYLH-- 122
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV--ETRVIGTFGYLAPE-- 579
+G I HRD++P N+LL + DFGLA + GT Y+APE
Sbjct: 123 -GIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 580 ----YAQSGQITEKADVYSFGVVLVELVTGR 606
+ + DV+S G+VL ++ G
Sbjct: 180 KRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 41/212 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L G FG V G G VAVK + K+ S + E++ L +H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRYL 520
I + +V EY+ G L ++ ++ +R G+ Y
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYI----------CKNGRLDEKESRRLFQQILSGVDYC 132
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE- 579
H +VHRD++P N+LL + DFGL+ DG+ + T G+ Y APE
Sbjct: 133 HRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSC-GSPNYAAPEV 186
Query: 580 -----YAQSGQITEKADVYSFGVVLVELVTGR 606
YA + D++S GV+L L+ G
Sbjct: 187 ISGRLYAGP-----EVDIWSSGVILYALLCGT 213
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 20/208 (9%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHR 462
+ + G G V + VA+K KL+ + E+ ++ C H+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 463 NVVMLIG-FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
N++ L+ F + YI +D++L Q L+ + G+++LH
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG---VETRVIGTFGYLAP 578
I+HRD++P+NI++ D + DFGLAR M V TR Y AP
Sbjct: 145 S----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAP 195
Query: 579 EYAQSGQITEKADVYSFGVVLVELVTGR 606
E E D++S G ++ E++ G
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 39/217 (17%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRN 463
+ + + EG +G V + GQ VA+K+ S E+ +L +H N
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE-SEDDPVIKKIALREIRMLKQLKHPN 63
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYL 520
+V L+ RR LV+EY D + +Q + + I + + +
Sbjct: 64 LVNLLEVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV----IGTFGYL 576
H+ +HRD++P NIL+T + DFG AR + + + T Y
Sbjct: 119 HKHN----CIHRDVKPENILITKHSVIKLCDFGFAR-----LLTGPSDYYDDEVATRWYR 169
Query: 577 APE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
+PE Y DV++ G V EL++G
Sbjct: 170 SPELLVGDTQYGPP------VDVWAIGCVFAELLSGV 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 53/226 (23%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCA 459
+ + L EG +G V++ + + VA+K+ +L +HE EV +L
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-----EHEEEGVPGTAIREVSLLKEL 90
Query: 460 QHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGL 517
QHRN++ L + R L++EY ++ L + + G+
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG-----DFGLARWQPDGDMGVETR---- 568
+ H +HRD++P N+LL+ DFGLAR G+ R
Sbjct: 146 NFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA-----FGIPIRQFTH 196
Query: 569 -VIGTFGYLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
+I T Y PE Y + D++S + E++
Sbjct: 197 EII-TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 61/262 (23%), Positives = 100/262 (38%), Gaps = 47/262 (17%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAV----KQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ G FG V L + + A+ K L ++ F E +VL + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSKWITTLH 140
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHEECR 525
+ +D L LV +Y G L + L E AR +A V A + +H+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA---IDSVHQLH- 195
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
VHRD++P+NIL+ + + DFG + DG + V GT Y++PE Q+
Sbjct: 196 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAM 251
Query: 585 QITEK-----ADVYSFGVVLVELVTGR-----------------KAVDLNRPKGQQCLTE 622
+ + D +S GV + E++ G P ++E
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 623 WARPLLEEYAIDELVDP--RLG 642
A+ L+ + RLG
Sbjct: 312 NAKDLIRRL----ICSREHRLG 329
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 41/216 (18%)
Query: 416 EGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCS-------------EVEVLSCAQHR 462
G +G+V GV +G VA+K ++ ++ D + E+ +L+ H
Sbjct: 32 SGSYGAVCAGVDSEGIPVAIK--RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 463 NVVMLIGFCIEDRRRL-----LVYEYICNGSLDSHLY---GCHQEPLEWSARQKIAVGAA 514
N++ L + LV E + + L + + Q
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMG--VETRVIG 571
GL LHE +VHRD+ P NILL + + + DF LAR D + V R
Sbjct: 145 LGLHVLHE----AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-- 198
Query: 572 TFGYLAPEY-AQSGQITEKADVYSFGVVLVELVTGR 606
Y APE Q T+ D++S G V+ E+ +
Sbjct: 199 ---YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/211 (25%), Positives = 78/211 (36%), Gaps = 41/211 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ G FG + VAVK + E+ +H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFKE 83
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSAR----QKIAVGAARGLRYLHEE 523
I L ++ EY G L + C+ E AR Q ++ G+ Y H
Sbjct: 84 -VILTPTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLS-----GVSYCHSM 135
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPL--VGDFGLARWQPDGDMGVETRVIGTFGYLAPE-- 579
I HRD++ N LL P + DFG ++ ++ V GT Y+APE
Sbjct: 136 Q----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV-GTPAYIAPEVL 189
Query: 580 ----YAQSGQITEKADVYSFGVVLVELVTGR 606
Y G+ ADV+S GV L ++ G
Sbjct: 190 LRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 46/222 (20%)
Query: 414 LAEGGFGSVHRGV---LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ G +G V++ D + A+K ++ + C E+ +L +H NV+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 471 CIE--DRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAA----------RGL 517
+ DR+ L+++Y + L+ + ++ + + G+
Sbjct: 87 FLSHADRKVWLLFDY-----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR--WQPDGDMGVETRVIG 571
YLH ++HRD++P NIL+ + + D G AR P + V+
Sbjct: 142 HYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 572 TFGYLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
TF Y APE Y T+ D+++ G + EL+T
Sbjct: 198 TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 31/209 (14%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ G +GSV + G+ VA+K KL+ F E+ +L QH NV+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 467 LIGFCIEDRRRL------LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520
L+ LV + + + L Q + +GL+Y+
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYI 142
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETRVIGTFGYLAP 578
H +VHRD++P N+ + D E + DFGLAR D +M V TR Y AP
Sbjct: 143 HS----AGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTRW-----YRAP 192
Query: 579 EYA-QSGQITEKADVYSFGVVLVELVTGR 606
E + D++S G ++ E++TG+
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 56/248 (22%), Positives = 95/248 (38%), Gaps = 35/248 (14%)
Query: 371 APPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQ-----ANFLAEGGFGSVHRG 425
PP P Q P + P++ + L++ + L G G V +
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 426 V-LPDGQAVAVKQHKLASSQGDHEFCS-EVEVL-SCAQHRNVVMLIGFCIEDRRR----- 477
+ A+K + D EVE+ +Q ++V ++ E+
Sbjct: 82 FNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIVDVY-ENLYAGRKCL 134
Query: 478 LLVYEYICNGSLDSHLYGCHQEPL-EWSARQ--KIAVGAARGLRYLHEECRVGCIVHRDM 534
L+V E + G L S + + E A + K A ++YLH I HRD+
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHSIN----IAHRDV 187
Query: 535 RPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKAD 591
+P N+L T L + DFG A+ + + T T Y+APE + + D
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPC-YTPYYVAPEVLGPEKYDKSCD 245
Query: 592 VYSFGVVL 599
++S GV++
Sbjct: 246 MWSLGVIM 253
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 35/219 (15%)
Query: 408 FSQANFLAEGGFGSVHRG--VLPDGQAVAVKQHKLASSQGDHE---FCS----EVEVL-- 456
+ + EG +G V + + G+ VA+K+ ++ EV VL
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRH 67
Query: 457 -SCAQHRNVVMLIGFCIEDRRRL-----LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
+H NVV L C R LV+E+ + L ++L + + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE---T 567
RGL +LH +VHRD++P NIL+T + + DFGLAR + T
Sbjct: 127 FQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARI-----YSFQMALT 177
Query: 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
V+ T Y APE D++S G + E+ +
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 5e-15
Identities = 57/208 (27%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQ-HKLASSQGDHEFCSEVE--VL---SCAQ 460
FS + GGFG V+ D G+ A+K K E + E +L S
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 461 HRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRY 519
+V + + +L + + + G L HL E R A GL +
Sbjct: 251 CPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAA-EIILGLEH 307
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
+H +V+RD++P NILL + D GLA V GT GY+APE
Sbjct: 308 MHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASV-GTHGYMAPE 360
Query: 580 YAQSGQI-TEKADVYSFGVVLVELVTGR 606
Q G AD +S G +L +L+ G
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 41/210 (19%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIGF 470
EG +G V + G+ VA+K+ S D E+++L +H N+V L+
Sbjct: 35 EGSYGMVMKCRNKDTGRIVAIKKFLE--SDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
C + +R LV+E+ +D + L++ QK G+ + H
Sbjct: 93 CKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV----IGTFGYLAPE---- 579
I+HRD++P NIL++ + DFG AR + V + T Y APE
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYDDEVATRWYRAPELLVG 198
Query: 580 ---YAQSGQITEKADVYSFGVVLVELVTGR 606
Y ++ DV++ G ++ E+ G
Sbjct: 199 DVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 55/229 (24%), Positives = 88/229 (38%), Gaps = 51/229 (22%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCA 459
+ + + +G FG V + GQ VA+K+ + ++E F E+++L
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-----ENEKEGFPITALREIKILQLL 73
Query: 460 QHRNVVMLIGFCIEDRRRL--------LVYEYICNGSLDSHLYG---CHQEPLEWSARQK 508
+H NVV LI C LV+++ + L G S ++
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFTLSEIKR 128
Query: 509 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW--QPDGDMGVE 566
+ GL Y+H I+HRDM+ N+L+T D + DFGLAR
Sbjct: 129 VMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 567 --TRVIGTFGYLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
RV+ T Y PE Y D++ G ++ E+ T
Sbjct: 185 YTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 43/212 (20%)
Query: 417 GGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
G FG V H+ + A+K + S F E ++++ A VV L
Sbjct: 80 GAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQLF 135
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRY 519
+ +D R L +V EY+ G L + + + AR L
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWARFYTAEVVLALDA 183
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETRVIGTFGYLAP 578
+H +HRD++P+N+LL + DFG + +G + +T V GT Y++P
Sbjct: 184 IHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 238
Query: 579 EYAQS----GQITEKADVYSFGVVLVELVTGR 606
E +S G + D +S GV L E++ G
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLI 468
+ G +G+V V G VA+K KL F E+ +L +H NV+ L+
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 469 GFCIEDRRRL------LVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAARGLRYLH 521
D LV + + + L E L Q + +GLRY+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA 581
I+HRD++P N+ + D E + DFGLAR Q D +M T + T Y APE
Sbjct: 146 A----AGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEM---TGYVVTRWYRAPEVI 197
Query: 582 -QSGQITEKADVYSFGVVLVELVTGR 606
+ T+ D++S G ++ E++TG+
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 55/201 (27%), Positives = 82/201 (40%), Gaps = 22/201 (10%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L G FG V G A+K Q + Q +H +E +L +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNFPFLVKLE 107
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA-VGAARGLRYLHEECRV 526
F +D L +V EY+ G + SHL + E AR A + YLH
Sbjct: 108 -FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLT--FEYLHSLD-- 161
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPEYAQSGQ 585
+++RD++P N+L+ V DFG A+ T + GT LAPE S
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKG 214
Query: 586 ITEKADVYSFGVVLVELVTGR 606
+ D ++ GV++ E+ G
Sbjct: 215 YNKAVDWWALGVLIYEMAAGY 235
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 27/203 (13%)
Query: 417 GGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
G FG V + A+K Q + ++ + F E++++ +H +V L
Sbjct: 26 GSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVF-KELQIMQGLEHPFLVNLW 81
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA-VGAARGLRYLHEECRV 526
+ +D + +V + + G L HL E + + I + A L YL +
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETVKLFICELVMA--LDYLQNQR-- 135
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
I+HRDM+P+NILL + DF +A P T + GT Y+APE S +
Sbjct: 136 --IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEMFSSRKG 191
Query: 587 ---TEKADVYSFGVVLVELVTGR 606
+ D +S GV EL+ GR
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR 214
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 40/211 (18%)
Query: 416 EGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCS-EVEVLSCAQHRNVVMLIGFCIE 473
G FG V++ L G+ VA+K+ D F + E++++ H N+V L F
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYS 118
Query: 474 DRRRL------LVYEYI-CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ LV +Y+ + Y ++ L + R L Y+H
Sbjct: 119 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---- 174
Query: 527 GCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDGDMGVE---TRVIGTFGYLAPE--- 579
I HRD++P N+LL D L + DFG A+ G+ V +R Y APE
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIF 229
Query: 580 ----YAQSGQITEKADVYSFGVVLVELVTGR 606
Y T DV+S G VL EL+ G+
Sbjct: 230 GATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 49/223 (21%), Positives = 78/223 (34%), Gaps = 58/223 (26%)
Query: 416 EGGFGSVHRGVL-PDGQAVAVK---QHKLASSQGDHEFC----SEVEVLSCAQHRNVVML 467
+G FG+V G G +VA+K Q F ++ L+ H N+V L
Sbjct: 33 QGTFGTVQLGKEKSTGMSVAIKKVIQDP--------RFRNRELQIMQDLAVLHHPNIVQL 84
Query: 468 IGFCIEDRRR-------LLVYEYICNGSLDSH----LYGCHQEPLEWSARQKIAVGAARG 516
+ R +V EY+ H Y Q + R
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYV---PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141
Query: 517 LRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQPDGDMGVE---TRVI 570
+ LH + HRD++P+N+L+ + + DFG A+ + V +R
Sbjct: 142 IGCLHLPSV--NVCHRDIKPHNVLVNEADGTLK--LCDFGSAKKLSPSEPNVAYICSRY- 196
Query: 571 GTFGYLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
Y APE Y T D++S G + E++ G
Sbjct: 197 ----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 28/208 (13%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ + G +GSV G VAVK KL+ E+ +L +H NV+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 467 LIGFCIEDRRRL------LVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRY 519
L+ R LV + + L + L Q + RGL+Y
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
+H I+HRD++P+N+ + D E + DFGLAR +M T + T Y APE
Sbjct: 148 IHS----ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM---TGYVATRWYRAPE 199
Query: 580 YA-QSGQITEKADVYSFGVVLVELVTGR 606
+ D++S G ++ EL+TGR
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 57/219 (26%)
Query: 416 EGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCS-EVEVLSCAQHRNVVMLIGFCIED 474
G FG V + L + VA+K+ D F + E++++ +H NVV L F +
Sbjct: 50 NGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSN 104
Query: 475 RRRL------LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA----------RGLR 518
+ LV EY + +Y A+ K + R L
Sbjct: 105 GDKKDEVFLNLVLEY-----VPETVY----RASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDGDMGVE---TRVIGTFG 574
Y+H +G I HRD++P N+LL L + DFG A+ G+ V +R
Sbjct: 156 YIH---SIG-ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY----- 206
Query: 575 YLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
Y APE Y T D++S G V+ EL+ G+
Sbjct: 207 YRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 65/261 (24%), Positives = 96/261 (36%), Gaps = 29/261 (11%)
Query: 363 EAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGG--FSQANF-----LA 415
E + + G + E+ LA + F L
Sbjct: 98 EWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLG 157
Query: 416 EGGFGSV----HRGVLPDGQAVAVKQHK----LASSQGDHEFCSEVEVLSCAQHRNVVML 467
+G FG V + G+ A+K K +A + H E VL ++H + L
Sbjct: 158 KGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLT-ENRVLQNSRHPFLTAL 213
Query: 468 IGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ + RL V EY G L HL E AR A + L YLH E
Sbjct: 214 K-YSFQTHDRLCFVMEYANGGELFFHLSRERVFS-EDRARFYGAEIVS-ALDYLHSEKN- 269
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPEYAQSGQ 585
+V+RD++ N++L D + DFGL + G + GT YLAPE +
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 586 ITEKADVYSFGVVLVELVTGR 606
D + GVV+ E++ GR
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGR 346
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 42/211 (19%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVV 465
L G FG VH L +G+ A+K + + Q +H E +LS H ++
Sbjct: 14 LGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN-DERLMLSIVTHPFII 69
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLY--GCHQEPLEWSARQKIA-VGAARGLRYLH 521
+ +D +++ ++ +YI G L S L P+ A+ A V A L YLH
Sbjct: 70 RMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV---AKFYAAEVCLA--LEYLH 123
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVG-----DFGLARWQPDGDMGVETRVI-GTFGY 575
+ I++RD++P NILL + G DFG A++ PD T + GT Y
Sbjct: 124 SKD----IIYRDLKPENILLDKN-----GHIKITDFGFAKYVPD-----VTYTLCGTPDY 169
Query: 576 LAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
+APE + + D +SFG+++ E++ G
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 55/241 (22%), Positives = 89/241 (36%), Gaps = 35/241 (14%)
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
+ V + R + + + + + + + +++ L
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
+ A+G+ +L R CI HRD+ NILL+ + DFGLAR
Sbjct: 197 CYSFQVAKGMEFL--ASR-KCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDP----D 248
Query: 568 RVIGTFGYL-----APEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRP-KGQQCL 620
V L APE T ++DV+SFGV+L E+ + G P G +
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPYPGVKID 302
Query: 621 TEWARPLLEEYAIDELVDPRLGN-HYSEHEVY-CMLHAASLCIRRDPHSRPRMSQVLRIL 678
E+ R L E R+ Y+ E+Y ML C +P RP S+++ L
Sbjct: 303 EEFCRRLKEGT--------RMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 350
Query: 679 E 679
Sbjct: 351 G 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 27/89 (30%), Positives = 41/89 (46%), Gaps = 9/89 (10%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDH-EFCSEVEVLSCA-QHRNVV 465
L G FG V + VAVK K ++ +H SE+++L H NVV
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 466 MLIGFCIEDRRRLLV-YEYICNGSLDSHL 493
L+G C + L+V E+ G+L ++L
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+++ EG +G V + VA+K K++ + +C E+++L +H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFE-HQTYCQRTLREIKILLRFRHENIIG 89
Query: 467 LIG-FCIEDRRRL----LVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYL 520
+ ++ +V + +++ LY + L RGL+Y+
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW--QPDGDMGVETRVIGTFGYLAP 578
H ++HRD++P+N+LL + + DFGLAR G T + T Y AP
Sbjct: 145 HS----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 579 EYA-QSGQITEKADVYSFGVVLVELVTGR 606
E S T+ D++S G +L E+++ R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 31/208 (14%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKLAS-SQGDHEFC-SEVEVLSCAQHRNVVML 467
L +G FG V Q A+K K A+ D E ++L H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 468 IGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLR 518
+ + +L L+ +++ G L + L E + L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED----------VKFYLAELALALD 140
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAP 578
+LH I++RD++P NILL + + DFGL++ D + + GT Y+AP
Sbjct: 141 HLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 195
Query: 579 EYAQSGQITEKADVYSFGVVLVELVTGR 606
E T+ AD +SFGV++ E++TG
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 33/210 (15%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKLAS--SQGDHEFCSEVE--VLSCAQHRNVV 465
L +GG+G V G+ A+K K A ++ E +L +H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------G 516
LI + + +L L+ EY+ G L L + A
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT----------ACFYLAEISMA 133
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYL 576
L +LH++ I++RD++P NI+L H + DFGL + T GT Y+
Sbjct: 134 LGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYM 188
Query: 577 APEYAQSGQITEKADVYSFGVVLVELVTGR 606
APE D +S G ++ +++TG
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 37/215 (17%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIGF 470
GG G V V + VA+K K+ + D + E++++ H N+V +
Sbjct: 21 CGGNGLVFSAVDNDCDKRVAIK--KIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 471 CIEDRRRL--------------LVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAAR 515
+L +V EY +++ L Q PL + R
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILL-THDFEPLVGDFGLARW--QPDGDMGVETRVIGT 572
GL+Y+H ++HRD++P N+ + T D +GDFGLAR G + + T
Sbjct: 132 GLKYIHS----ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 573 FGYLAPE-YAQSGQITEKADVYSFGVVLVELVTGR 606
Y +P T+ D+++ G + E++TG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 45/218 (20%), Positives = 85/218 (38%), Gaps = 37/218 (16%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSC----------- 458
L G F +V + + VA+K K+ + + E +++L
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKEDS 82
Query: 459 AQHRNVVMLIG-FCIEDRRRL---LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA 514
+++ L+ F + + +V+E + +L + + + ++I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL------VGDFGLARWQPDGDMGVETR 568
GL Y+H C I+H D++P N+L+ P + D G A W + T
Sbjct: 142 LGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTN 194
Query: 569 VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
I T Y +PE AD++S ++ EL+TG
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 43/209 (20%), Positives = 83/209 (39%), Gaps = 42/209 (20%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFCI- 472
G + V + + + + V VK K + + E+++L + N++ L I
Sbjct: 46 RGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLA--DIV 100
Query: 473 ---EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
R LV+E++ N + L + + L Y H I
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS----MGI 151
Query: 530 VHRDMRPNNILLTHDFEPL-VGDFGLAR-WQPDGDMGVE--TRVIGTFGYLAPE------ 579
+HRD++P+N+++ H+ L + D+GLA + P + V +R + PE
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVDYQ 206
Query: 580 -YAQSGQITEKADVYSFGVVLVELVTGRK 607
Y S D++S G +L ++ ++
Sbjct: 207 MYDYS------LDMWSLGCMLASMIFRKE 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 14/102 (13%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR---------WQPDGDMGV 565
R ++ LH ++HRD++P+N+L+ + + V DFGLAR +P G
Sbjct: 123 RAVKVLHG----SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 566 ETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGR 606
+ T Y APE + + DV+S G +L EL R
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 53/266 (19%), Positives = 86/266 (32%), Gaps = 57/266 (21%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIGF 470
G +G V+ + VA+K K+ D C E+ +L+ + ++ L
Sbjct: 36 RGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 471 CIEDRRRL-----LVYEYICNGSLDSHLYGCHQ-----EPLEWSARQKIAVGAARGLRYL 520
I D +V E DS L + L + I G ++
Sbjct: 94 IIPDDLLKFDELYIVLEI-----ADSDL---KKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFGYLAPE 579
HE I+HRD++P N LL D V DFGLAR + D + +
Sbjct: 146 HE----SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 580 YAQSGQITE--------------------KA-DVYSFGVVLVELVTGRKAVDLN----RP 614
Q+T K+ D++S G + EL+ ++ + P
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
Query: 615 --KGQQCLTEWARPLLEEYAIDELVD 638
G C ++ D
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 45/218 (20%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKLAS--SQGDHEFCSEVE--VLSCAQHRN-V 464
L G +G V G+ A+K K A+ + + E VL + +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR-------- 515
V L + + +L L+ +YI G L +HL + +
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----------VQIYVGEIVL 170
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF-G 574
L +LH+ G I++RD++ NILL + ++ DFGL++ + ET F G
Sbjct: 171 ALEHLHKL---G-IIYRDIKLENILLDSNGHVVLTDFGLSK----EFVADETERAYDFCG 222
Query: 575 ---YLAPE---YAQSGQITEKADVYSFGVVLVELVTGR 606
Y+AP+ SG + D +S GV++ EL+TG
Sbjct: 223 TIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGA 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 41/221 (18%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSC-AQHRNVVMLIG 469
+G +G V + + G+ VAVK K+ + + E+ +L+ + H N+V L+
Sbjct: 19 KGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 470 -FCIEDRRRL-LVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRV 526
++ R + LV++Y +++ L+ LE +Q + + ++YLH
Sbjct: 77 VLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS---- 127
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
G ++HRDM+P+NILL + V DFGL+R + + +
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 587 TE--------------------KA-DVYSFGVVLVELVTGR 606
T+ K D++S G +L E++ G+
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 55/204 (26%), Positives = 81/204 (39%), Gaps = 25/204 (12%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVV 465
L +G FG V + G+ A+K + +A + H E VL +H +
Sbjct: 13 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPFLT 68
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKI-AVGAARGLRYLHEE 523
L + + RL V EY G L HL E R + L YLH
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVSALEYLHSR 124
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPEYAQ 582
+V+RD++ N++L D + DFGL + G + GT YLAPE +
Sbjct: 125 D----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLE 178
Query: 583 SGQITEKADVYSFGVVLVELVTGR 606
D + GVV+ E++ GR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 1e-09
Identities = 38/238 (15%), Positives = 65/238 (27%), Gaps = 63/238 (26%)
Query: 380 SICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVK--- 436
C K PV FS+ L T + + EG FG V + + D VA+K
Sbjct: 3 GECSQKGPV------PFSHC---LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIA 52
Query: 437 -----QHKLASSQGDHEFCSEVEVL---------SCAQHRNVVMLIGFCI---------- 472
+ + E E+ + C + + L
Sbjct: 53 IEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLL 112
Query: 473 --------------------EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVG 512
+D + +V E+ G +D L + + + I
Sbjct: 113 KAWDHYNSTKGSANDRPDFFKDDQLFIVLEF-EFGGID--LEQMRTKLSSLATAKSILHQ 169
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI 570
L R HRD+ N+LL + + G++ +I
Sbjct: 170 LTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA-QHRNV 464
L +G FG V +G + AVK + + E VL+ + +
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMV-EKRVLALPGKPPFL 83
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
L C + RL V EY+ G L H+ + A A A GL +L +
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAA-EIAIGLFFLQSK 140
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
I++RD++ +N++L + + DFG+ + + +T GT Y+APE
Sbjct: 141 G----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAY 195
Query: 584 GQITEKADVYSFGVVLVELVTGR 606
+ D ++FGV+L E++ G+
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 60/206 (29%), Positives = 83/206 (40%), Gaps = 28/206 (13%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLS-CAQHRNV 464
+ +G FG V H+ + AVK + L + H E VL +H +
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMS-ERNVLLKNVKHPFL 101
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSAR---QKIAVGAARGLRYL 520
V L F + +L V +YI G L HL AR +IA L YL
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASA----LGYL 155
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEY 580
H IV+RD++P NILL ++ DFGL + + + T GT YLAPE
Sbjct: 156 HSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEV 210
Query: 581 AQSGQITEKADVYSFGVVLVELVTGR 606
D + G VL E++ G
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 20/202 (9%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAV----KQHKLASSQGDHEFCSEVEVLSCAQHRNVV 465
L +G FG V +G + AV K + + E VL+ +
Sbjct: 349 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMV-EKRVLALPGKPPFL 404
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
+ C + RL V EY+ G L H+ + A A A GL +L +
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAA-EIAIGLFFLQSKG 462
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
I++RD++ +N++L + + DFG+ + + +T GT Y+APE
Sbjct: 463 ----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQ 517
Query: 585 QITEKADVYSFGVVLVELVTGR 606
+ D ++FGV+L E++ G+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 48/244 (19%), Positives = 75/244 (30%), Gaps = 56/244 (22%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIGF 470
G +G V + + VA+K K+ D C E+ +L+ H +VV ++
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 471 CIEDRRRL-----LVYEYICNGSLDSHLYGCHQ-----EPLEWSARQKIAVGAARGLRYL 520
I +V E DS + L + + G++Y+
Sbjct: 121 VIPKDVEKFDELYVVLEI-----ADSDF---KKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR------WQPDGDMGVETRVIGTFG 574
H I+HRD++P N L+ D V DFGLAR
Sbjct: 173 HS----AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 575 YLAPEYAQSGQITE--------------------KA-DVYSFGVVLVELVTGRKAVDLNR 613
Q+T +A DV+S G + EL+ K
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 614 PKGQ 617
Sbjct: 289 ADRG 292
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 29/103 (28%), Positives = 44/103 (42%), Gaps = 26/103 (25%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDGDMGVE---TRVI 570
R + ++H I HRD++P N+L+ L + DFG A+ + V +R
Sbjct: 152 RAVGFIHS----LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF- 206
Query: 571 GTFGYLAPE-------YAQSGQITEKADVYSFGVVLVELVTGR 606
Y APE Y T D++S G V EL+ G+
Sbjct: 207 ----YRAPELMLGATEY------TPSIDLWSIGCVFGELILGK 239
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 38/211 (18%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA-QHRNV 464
L +G FG V + Q A+K L + E VLS A +H +
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMV-EKRVLSLAWEHPFL 80
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+ + + L V EY+ G L H+ CH+ L A A GL++LH +
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR-ATFYAA-EIILGLQFLHSK 137
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVG-----DFGLARWQPDGDMGVETRVI---GTFGY 575
IV+RD++ +NILL D G DFG+ + +M + + GT Y
Sbjct: 138 G----IVYRDLKLDNILLDKD-----GHIKIADFGMCK----ENMLGDAKTNTFCGTPDY 184
Query: 576 LAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
+APE + D +SFGV+L E++ G+
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 53/255 (20%), Positives = 80/255 (31%), Gaps = 71/255 (27%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSC--------AQHRNV 464
L G F +V + + VA+K K A + E+ +L V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 465 VMLIG-FCIE---DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520
V L+ F I +V+E + L + + + L +KI +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 521 HEECRVGCIVHRDMRPNNILLT-------------------------------------- 542
H +CR I+H D++P NILL+
Sbjct: 163 HTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 543 -----------HDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKAD 591
+ + D G A W T I T Y + E AD
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 592 VYSFGVVLVELVTGR 606
++S + EL TG
Sbjct: 276 IWSTACMAFELATGD 290
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 42/200 (21%), Positives = 68/200 (34%), Gaps = 51/200 (25%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLS-CAQHRNVVMLIGF 470
L G G V + + A+K ++ EVE+ +Q ++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVRIVDV 79
Query: 471 CIEDRRRLLVYEYI----CNGS--LDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHE 522
E+ I +G Q E A + K A ++YLH
Sbjct: 80 Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHS 135
Query: 523 ECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFGYLAPE 579
I HRD++P N+L T L + DFG A+ E G Y
Sbjct: 136 I---N-IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---------E--TTGE-KY---- 175
Query: 580 YAQSGQITEKADVYSFGVVL 599
+ D++S GV++
Sbjct: 176 -------DKSCDMWSLGVIM 188
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 52/201 (25%), Positives = 82/201 (40%), Gaps = 24/201 (11%)
Query: 417 GGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA-QHRNVVML 467
G + V + + A+K + D E V A H +V L
Sbjct: 20 GSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQT-EKHVFEQASNHPFLVGL 75
Query: 468 IGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
C + RL V EY+ G L H+ + P E AR A + L YLHE
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLALNYLHERG-- 130
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPEYAQSGQ 585
I++RD++ +N+LL + + D+G+ + G T GT Y+APE +
Sbjct: 131 --IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGED 186
Query: 586 ITEKADVYSFGVVLVELVTGR 606
D ++ GV++ E++ GR
Sbjct: 187 YGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 24/204 (11%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA-QHRNV 464
+ G + V + + A++ + D E V A H +
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQT-EKHVFEQASNHPFL 115
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
V L C + RL V EY+ G L H+ + P E AR A + L YLHE
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLALNYLHER 172
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLAPEYAQ 582
I++RD++ +N+LL + + D+G+ + G T GT Y+APE +
Sbjct: 173 G----IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 583 SGQITEKADVYSFGVVLVELVTGR 606
D ++ GV++ E++ GR
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 27/209 (12%)
Query: 412 NFLA---EGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA- 459
F+ +G FG V + G AVK L + E +LS A
Sbjct: 26 EFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMT-EKRILSLAR 81
Query: 460 QHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLR 518
H + L C + RL V E++ G L H+ + AR A L
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-ARFYAA-EIISALM 138
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI-GTFGYLA 577
+LH++ I++RD++ +N+LL H+ + DFG+ + GV T GT Y+A
Sbjct: 139 FLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIA 192
Query: 578 PEYAQSGQITEKADVYSFGVVLVELVTGR 606
PE Q D ++ GV+L E++ G
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 52/218 (23%), Positives = 79/218 (36%), Gaps = 49/218 (22%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSC------AQHR 462
+ +G FG V + Q VA+K K Q E+ +L
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159
Query: 463 NVVMLIGF-------CI--EDRRRLL---VYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
NV+ ++ C+ E LL +YE I + +K A
Sbjct: 160 NVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKF---------QGFSLPLVRKFA 206
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL--VGDFGLARWQPDGDMGVETR 568
+ L LH+ R I+H D++P NILL V DFG + ++
Sbjct: 207 HSILQCLDALHK-NR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYT 258
Query: 569 VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
I + Y APE + D++S G +L EL+TG
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 50/235 (21%), Positives = 82/235 (34%), Gaps = 59/235 (25%)
Query: 402 ELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLS 457
E + + + +G FG V + + + VA+K K +Q EV +L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLE 105
Query: 458 CAQHR------NVVMLIGF-------CIEDRRRLLVYEYICNGSLDSHLY----GCHQEP 500
+V L C+ V+E L +LY +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCL-------VFE-----MLSYNLYDLLRNTNFRG 153
Query: 501 LEWSARQKIAVGAARGLRYLH-EECRVGCIVHRDMRPNNILLTHDFEPL--VGDFGLARW 557
+ + +K A L +L E I+H D++P NILL + + DFG +
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210
Query: 558 QPDGDMGVETRVIGTFGYLAPE------YAQSGQITEKADVYSFGVVLVELVTGR 606
+ I + Y +PE Y D++S G +LVE+ TG
Sbjct: 211 LGQ----RIYQYIQSRFYRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 47/241 (19%), Positives = 75/241 (31%), Gaps = 75/241 (31%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSC-----AQHRN 463
+ +G FG V + + + AVK K + E ++L + N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 464 VVMLIGF-------CIEDRRRLLVYEYICNGSLDSHLY----GCHQEPLEWSARQKIAVG 512
+V G C+ ++E L LY + + +
Sbjct: 98 IVKYHGKFMYYDHMCL-------IFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET----- 567
+ L YL + + H D++P NILL + T
Sbjct: 146 ILKALNYLRK-MS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 568 RVIGTFG-----------------YLAPE------YAQSGQITEKADVYSFGVVLVELVT 604
++I FG Y APE + S +D++SFG VL EL T
Sbjct: 202 KLI-DFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVS------SDMWSFGCVLAELYT 254
Query: 605 G 605
G
Sbjct: 255 G 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 48/212 (22%), Positives = 83/212 (39%), Gaps = 35/212 (16%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIG 469
+ G FG ++ G + G+ VA+K K Q E ++ Q + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE----SKIYKMMQGGVGIPTIRW 72
Query: 470 FCIEDRRRLLVYEYICNG-SLDSHLYGCHQE-PLE---WSARQKIAVGAARGLRYLHEEC 524
E ++V E + G SL+ C ++ L+ A Q I+ + Y+H +
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISR-----IEYIHSKN 125
Query: 525 RVGCIVHRDMRPNNILL---THDFEPLVGDFGLAR--WQPDGDMGVETR----VIGTFGY 575
+HRD++P+N L+ + DFGLA+ + R + GT Y
Sbjct: 126 ----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 576 LAPEYAQSG-QITEKADVYSFGVVLVELVTGR 606
A G + + + D+ S G VL+ G
Sbjct: 182 -ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 31/153 (20%), Positives = 58/153 (37%), Gaps = 21/153 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQH-RNVVMLIGF 470
+ G FG + G L + VA+K L + E + + F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 471 CIEDRRRLLVYEYICNG-SLDSHLYGCHQE-PLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ +V E + G SL+ C + L+ IA+ + Y+H +
Sbjct: 74 GPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLM--IAIQLISRMEYVHSKN---- 125
Query: 529 IVHRDMRPNNILL----THDFEPL-VGDFGLAR 556
+++RD++P N L+ + + + DF LA+
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 30/149 (20%), Positives = 50/149 (33%), Gaps = 44/149 (29%)
Query: 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 539
+E++ + +P + +A LR+LHE + + H D++P NI
Sbjct: 108 TFEFLKENNF---------QPYPLPHVRHMAYQLCHALRFLHE-NQ---LTHTDLKPENI 154
Query: 540 LLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG-----------------YLAPE--- 579
L + + + + + RV FG Y PE
Sbjct: 155 LFVNSEFETLYNEHKSCEEKS-VKNTSIRVA-DFGSATFDHEHHTTIVATRHYRPPEVIL 212
Query: 580 ---YAQSGQITEKADVYSFGVVLVELVTG 605
+AQ DV+S G +L E G
Sbjct: 213 ELGWAQP------CDVWSIGCILFEYYRG 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 62/458 (13%), Positives = 113/458 (24%), Gaps = 148/458 (32%)
Query: 33 IPRTALVWALTHVV---QPGDCITL----------LVV-------VPSHSSGRRFWVFPR 72
+ R L + +P + + + + V + FW+
Sbjct: 131 VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL--N 188
Query: 73 FAGDCASGH-------------------RKSFSGTISEQRGDITDSCSQMILQ------- 106
+C S R S I + I +++
Sbjct: 189 L-KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 107 --LHDVYDPNKIN-FKI--KIVSGSPCGAVAAEAKKAQAGWVVLDKQ---LKHEEKCCME 158
L +V + N F + KI+ + V A + LD L +E ++
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE---VK 304
Query: 159 ELQCNIVVMK----RSQAKV---LRLNLVGASKKEAGVACPLPSDPDESFEKDPKNK--D 209
L + + + RL+++ S ++ D + D +
Sbjct: 305 SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG----LATWDNWKHVNCDKLTTIIE 360
Query: 210 SS-----SGSIRG--------PVVTPISSPELG----------TPFTATEAGTSSVSSSD 246
SS R P I + L + S+
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 247 PGTSPFFISGINGDLKKESSVIREDRNLEDSSSDT-------DSENLSVSSASMRFQPWM 299
P S I I +LK + + + L S D DS++L F
Sbjct: 421 PKESTISIPSIYLELKVK---LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF---- 473
Query: 300 TEFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSG 359
+ HH + + E + F + + D F
Sbjct: 474 YSHI-GHHLKNIEHPER-----------------MTLFRMV----------F-LDFRFLE 504
Query: 360 NVREAISLSRNAPPGPPPLCS--------ICQHKAPVF 389
S + NA IC + P +
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDND-PKY 541
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 26/120 (21%), Positives = 46/120 (38%), Gaps = 31/120 (25%)
Query: 507 QKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG----- 561
+K+A + + +LH + + H D++P NIL + + R +
Sbjct: 121 RKMAYQICKSVNFLHS-NK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 562 ---DMG-------VETRVIGTFGYLAPE------YAQSGQITEKADVYSFGVVLVELVTG 605
D G + ++ T Y APE ++Q DV+S G +L+E G
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQP------CDVWSIGCILIEYYLG 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 44/209 (21%), Positives = 81/209 (38%), Gaps = 27/209 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIGFC 471
+ EG FG + G L + Q VA+K S + E + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 472 IEDRRRLLVYEYICNG-SLDSHLYGCHQE-PLEWSARQKIAVGAARGLRYLHEECRVGCI 529
E +LV + + G SL+ L C ++ ++ A A ++ +HE+ +
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIHEKS----L 127
Query: 530 VHRDMRPNNILLTHDFEP-----LVGDFGLARWQPDGDMGV------ETRVIGTFGYLAP 578
V+RD++P+N L+ V DFG+ ++ D + + GT Y
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY-MS 186
Query: 579 EYAQSG-QITEKADVYSFGVVLVELVTGR 606
G + + + D+ + G V + + G
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 756 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.59 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.39 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 98.39 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 98.38 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 98.35 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 98.26 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 98.25 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 98.24 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 98.22 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 98.21 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 98.16 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.12 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 98.09 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 98.09 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 97.74 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.66 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.57 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 97.56 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 97.42 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 97.38 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 97.37 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 97.29 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.2 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 97.12 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.99 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.65 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 96.38 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.25 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.14 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.93 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.29 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=453.90 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=212.1
Q ss_pred hCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.......+.|.+|+++|++|+|||||+++|+|.+++..|
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 468999999999999999999853 47889999998666556678999999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcc
Q 004395 479 LVYEYICNGSLDSHLYGC-----------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~-----------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~v 547 (756)
||||||++|+|.++|... ....++|..++.|+.||+.||+|||++ +||||||||+||||+.++.+
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCCcE
Confidence 999999999999999642 245799999999999999999999999 99999999999999999999
Q ss_pred eeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhh
Q 004395 548 LVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 548 kL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~ 625 (756)
||+|||+|+........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||....... ...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~------~~~ 241 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIE 241 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence 99999999866543322 2234569999999999999999999999999999999999 899997543210 000
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. . ... . ...+..++..+.+|+.+||+.||++||||.+|++.|+.
T Consensus 242 ~i-~----~~~-~----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 242 CI-T----QGR-V----LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HH-H----HTC-C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH-H----cCC-C----CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 00 0 000 1 11233445678999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=454.42 Aligned_cols=256 Identities=29% Similarity=0.389 Sum_probs=206.6
Q ss_pred hCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.......+.|.+|+++|++|+|||||+++|+|.+.+..|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 457889999999999999999853 47899999998666566678999999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC
Q 004395 479 LVYEYICNGSLDSHLYGCH-------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~-------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~ 545 (756)
||||||++|+|.++|.... ..+++|..++.|+.||+.||+|||+. +||||||||+||||++++
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTT
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCCC
Confidence 9999999999999996432 35799999999999999999999999 999999999999999999
Q ss_pred cceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhh
Q 004395 546 EPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEW 623 (756)
Q Consensus 546 ~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~ 623 (756)
.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||....... .
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------~ 269 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------A 269 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH------H
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH------H
Confidence 999999999987654332 23345679999999999999999999999999999999999 899996543210 0
Q ss_pred hhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 624 ~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... +..-..+ ..+..++..+.+|+.+||+.||++||||.||++.|+.
T Consensus 270 ~~~------i~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 270 IDC------ITQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHH------HHHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHH------HHcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 000 0110111 1233445678999999999999999999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=451.06 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=211.1
Q ss_pred hCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
...+++.+.||+|+||.||+|.+ .+++.||||+++.... ...+.|.+|+.+|++|+|||||+++|+|.+++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 35688899999999999999985 2568999999875433 3346799999999999999999999999999999
Q ss_pred eEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC
Q 004395 478 LLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~ 543 (756)
|||||||++|+|.++|.... ...+++..++.|+.||+.||+|||++ +||||||||+||||++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLVYD 180 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEECC
Confidence 99999999999999996432 24699999999999999999999999 9999999999999999
Q ss_pred CCcceeeccccceecCCCC-CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchh
Q 004395 544 DFEPLVGDFGLARWQPDGD-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 544 ~~~vkL~DFGlA~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~ 621 (756)
++.+||+|||+|+...... ........||+.|||||++.++.|+.++|||||||+||||+| |+.||.......
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~----- 255 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----- 255 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-----
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 9999999999998664332 223345679999999999999999999999999999999998 899997543211
Q ss_pred hhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 622 EWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 622 ~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. . .+ ........+..++..+.+|+.+||+.||++||||.||++.|+.
T Consensus 256 -~~----~-----~i-~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 256 -VV----E-----MI-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -HH----H-----HH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -HH----H-----HH-HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 00 0 00 0111112344455678999999999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=446.70 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=206.4
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
+++..++|.+.+.||+|+||+||+|.+.+ .||||+++.... ...+.|.+|+++|++++|||||+++++|.+ +.+|
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 35566789999999999999999999743 599998875432 234579999999999999999999999865 5689
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
||||||+||+|.++|.. ...++++..++.|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+..
T Consensus 108 iVmEy~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999975 356799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CCcccccccCccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 559 PDGD-MGVETRVIGTFGYLAPEYAQS---GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 559 ~~~~-~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
.... .......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||........ +. .. ...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~----~~----~~~ 252 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--II----FM----VGR 252 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH----HH----HHT
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HH----HH----Hhc
Confidence 4322 223345689999999999864 4689999999999999999999999975432111 00 00 011
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
....|.+ ...+..++..+.+|+.+||+.||++||||.||++.|+.
T Consensus 253 ~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 253 GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122221 12333455678999999999999999999999998873
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=449.99 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=211.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
..|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4699999999999999999995 579999999997766666778999999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
+||+|.+++.. +.+++..+..++.||+.||+|||++ |||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 225 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 225 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-C
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-C
Confidence 99999999963 4699999999999999999999999 99999999999999999999999999999775432 2
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||........ + . .+.....+.+ .
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~----~------~i~~~~~~~~--~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--M----K------MIRDNLPPRL--K 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----H------HHHHSSCCCC--S
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--H----H------HHHcCCCCCC--C
Confidence 34567899999999999999999999999999999999999999965432110 0 0 0111111111 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
........+.+||.+||..||++|||+.|+++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22334567899999999999999999999977
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=456.26 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=205.0
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|++++.||+|+||.||+|.. .+|+.||||++..... .....|.+|+++|++|+|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999995 5799999999865432 234579999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
||+||+|.++|.......+++..++.|+.||+.||+|||++ |||||||||+||||+.+|.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999766667789999999999999999999999 99999999999999999999999999998664321
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
......+||+.|||||++.+..|+.++|||||||+||||+||+.||....... ...... ..- .+.
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~-----~~~-~~~-- 244 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKII-----SGS-FPP-- 244 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHH-----HTC-CCC--
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHH-----cCC-CCC--
Confidence 12345789999999999999999999999999999999999999997543211 000000 110 111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+......+.+||.+||+.||++|||+.|++++
T Consensus 245 --~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 --VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 223344568999999999999999999999873
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=452.45 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=211.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
+.|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++|+.|+|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999995 579999999998776666778999999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
.||+|.+++.. +.+++..+..|+.||+.||+|||++ |||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 231 ~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 302 (423)
T 4fie_A 231 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 302 (423)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred CCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence 99999999953 4699999999999999999999999 99999999999999999999999999999775433 2
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||........ + ..+.....+.+ .
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~----------~~i~~~~~~~~--~ 368 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--M----------KMIRDNLPPRL--K 368 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----------HHHHHSCCCCC--S
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--H----------HHHHcCCCCCC--c
Confidence 34567899999999999999999999999999999999999999965432110 0 01111111111 1
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
........+.+||.+||..||++|||+.|+|+
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12233456899999999999999999999987
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=443.98 Aligned_cols=251 Identities=22% Similarity=0.231 Sum_probs=205.6
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.+.|.+.+.||+|+||.||+|.. .+|+.||||+++... .+.+|+.+|+.|+|||||+++++|.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35689999999999999999995 579999999987532 235799999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-cceeeccccceecCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQPDGD 562 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-~vkL~DFGlA~~~~~~~ 562 (756)
|+||+|.++|.. .+.+++..++.|+.||+.||+|||++ |||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999974 46799999999999999999999999 999999999999999988 69999999999775433
Q ss_pred CC----cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 563 MG----VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 563 ~~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.. ....++||+.|||||++.+..|+.++|||||||+||||+||+.||........ +.... . .
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~----~-----~--- 271 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKIA----S-----E--- 271 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHHHH----H-----S---
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHHH----c-----C---
Confidence 21 12346799999999999999999999999999999999999999975443211 11100 0 0
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+......++.....+.++|.+||+.||++|||+.|+++.|..
T Consensus 272 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 000011233445578999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=433.33 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=197.7
Q ss_pred eeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEe----cCceeEE
Q 004395 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRRLLV 480 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~----~~~~~LV 480 (756)
|++.+.||+|+||.||+|.. .++..||+|++.... ......|.+|+++|++|+|||||+++++|.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36778899999999999995 478999999886432 2234579999999999999999999999875 3458999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCc--eEeeccCCCceeecC-CCcceeecccccee
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLTH-DFEPLVGDFGLARW 557 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g--IiHrDLKp~NILL~~-~~~vkL~DFGlA~~ 557 (756)
||||+||+|.+++.. .+.+++..+..|+.||+.||+|||++ + ||||||||+||||+. +|.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~----~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999974 46799999999999999999999998 7 999999999999985 79999999999986
Q ss_pred cCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
.... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||........ ..... .....
T Consensus 182 ~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-----~~~~i-----~~~~~ 247 (290)
T 3fpq_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRV-----TSGVK 247 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHH-----TTTCC
T ss_pred CCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-----HHHHH-----HcCCC
Confidence 4332 3456789999999999875 699999999999999999999999964332111 00000 00001
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+. ++......+.+||.+||+.||++|||+.|+++
T Consensus 248 ~~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 PAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 11222346889999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=440.94 Aligned_cols=248 Identities=20% Similarity=0.265 Sum_probs=209.1
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++++.||+|+||+||+|.. .+|+.||||++... .......+.+|+++|+.|+|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999994 57999999988643 2344567999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
|||+||+|.+++.. .+.+++..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999974 46799999999999999999999999 9999999999999999999999999999987543
Q ss_pred C-CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 D-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
. .......+||+.|||||++.+..|+.++|||||||+||||+||+.||....... ...... .. ...
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~-----~~--~~~ 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IFAKII-----KL--EYD 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-----HT--CCC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-----cC--CCC
Confidence 2 334456789999999999999999999999999999999999999996543210 000000 00 111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
++......+.+||.+||..||++|||+.|++.
T Consensus 253 ----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 253 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ----CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 22233456889999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=424.17 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=191.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++|+.++|||||++++++.+.+..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999994 579999999886432 233457999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||| +|+|.+++.. .+++++..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 998 7899999974 46799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
. .....+||+.|||||++.+..| +.++|||||||+||||+||+.||...... ....... .. ...
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~i~-----~~--~~~ 230 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKNIS-----NG--VYT 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----HT--CCC
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-----cC--CCC
Confidence 3 3345789999999999998876 58999999999999999999999653211 0000000 00 111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
++......+.+|+.+||+.||++|||+.|+++
T Consensus 231 ----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 ----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22233456889999999999999999999988
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=439.61 Aligned_cols=265 Identities=24% Similarity=0.300 Sum_probs=215.4
Q ss_pred ChHHHHHhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCC-CCeeeEE
Q 004395 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQH-RNVVMLI 468 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~H-pNIV~l~ 468 (756)
....+++..++|++.+.||+|+||.||+|.+. .++.||||.++..... ..+.|.+|+++|.++.| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34567888899999999999999999999853 2468999988754432 34579999999999965 9999999
Q ss_pred EEEEec-CceeEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeec
Q 004395 469 GFCIED-RRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533 (756)
Q Consensus 469 ~~~~~~-~~~~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrD 533 (756)
|+|.+. ..+|||||||++|+|.++|.... ...+++..++.++.|||.||+|||++ +|||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHRD 210 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRD 210 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecCc
Confidence 999764 56899999999999999996431 35689999999999999999999999 999999
Q ss_pred cCCCceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 004395 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDL 611 (756)
Q Consensus 534 LKp~NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~ 611 (756)
|||+||||++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997654332 23345779999999999999999999999999999999998 9999975
Q ss_pred CCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 612 NRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 612 ~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...... ..... ..-..+ ..+......+.+++.+||+.||++||||.||+++|+.
T Consensus 291 ~~~~~~------~~~~i-----~~g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VKIDEE------FCRRL-----KEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CCCSHH------HHHHH-----HHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHH------HHHHH-----HcCCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 432211 00111 111111 1223344578999999999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=428.97 Aligned_cols=267 Identities=23% Similarity=0.316 Sum_probs=201.5
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHH--HHHHHHhcCCCCeeeEEEEEEecC----ceeE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNVVMLIGFCIEDR----RRLL 479 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~--Ev~iL~~L~HpNIV~l~~~~~~~~----~~~L 479 (756)
++|.+.+.||+|+||.||+|.+ +|+.||||+++... ...+.. |+..+.+++|||||+++++|.+++ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4689999999999999999998 68999999886432 233444 555556789999999999998764 5799
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcc----cCceEeeccCCCceeecCCCcceeeccccc
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR----VGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~----~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
|||||++|+|.++|.. .++++..+++++.|++.||+|||+++. ..+||||||||+||||+.++.+||+|||+|
T Consensus 79 V~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999964 469999999999999999999998631 237999999999999999999999999999
Q ss_pred eecCCCCCC---cccccccCccccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhh---
Q 004395 556 RWQPDGDMG---VETRVIGTFGYLAPEYAQSG------QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW--- 623 (756)
Q Consensus 556 ~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~--- 623 (756)
+........ .....+||+.|||||++.+. .|+.++|||||||+||||+||..||......... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-~~~~~~~ 234 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLVPS 234 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTSCS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-chhcccc
Confidence 876543321 22346799999999999764 4678999999999999999999887543322111 1110
Q ss_pred --hhhhhhhhhhhhccCCccCCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 624 --ARPLLEEYAIDELVDPRLGNHY-SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 624 --~~~~~~~~~i~~l~dp~l~~~~-~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..............+|.+.... .......+.+|+.+||+.||++||||.||++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0011111111222233332221 23456678999999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=431.33 Aligned_cols=247 Identities=24% Similarity=0.282 Sum_probs=197.5
Q ss_pred CCeeEEEEecccCceEEEEEEe----cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
++|++++.||+|+||.||+|+. .+++.||||+++... ......+.+|+++|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4799999999999999999984 257899999886432 2233468899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|||||+||+|.+++.. .+.+++..+..++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999974 46799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||........ ..... .. ..
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~-----~~--~~ 243 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------MTMIL-----KA--KL 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-----HC--CC
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH------HHHHH-----cC--CC
Confidence 432 233457899999999999999999999999999999999999999975432110 00000 00 11
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRM-----SQVLR 676 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~-----~eVL~ 676 (756)
.++......+.+|+.+||+.||++|||+ +|+++
T Consensus 244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1223344578999999999999999984 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=416.98 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=187.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCc-------
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR------- 476 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~------- 476 (756)
++|++++.||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+++|++|+|||||+++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3699999999999999999995 57999999988754432 34578999999999999999999999976553
Q ss_pred -----eeEEEEeecCCChhhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceee
Q 004395 477 -----RLLVYEYICNGSLDSHLYGCHQ-EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (756)
Q Consensus 477 -----~~LV~Ey~~ggsL~~~L~~~~~-~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~ 550 (756)
+|||||||.+|+|.+++..... ...++..++.++.||+.||+|||++ |||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEc
Confidence 6999999999999999974322 3456777899999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCC-----------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 004395 551 DFGLARWQPDGDM-----------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC 619 (756)
Q Consensus 551 DFGlA~~~~~~~~-----------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~ 619 (756)
|||+|+....... ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||.....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----- 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----- 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----
Confidence 9999987654321 12234679999999999999999999999999999999996 6642110
Q ss_pred hhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 620 LTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 620 l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
... .+..+..... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ---~~~------~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 ---RVR------TLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HHH------HHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHH------HHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 0011111100 0011122345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=424.93 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=202.5
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEec------C
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------R 475 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~------~ 475 (756)
.++|.+++.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+++|+.|+|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999995 5799999999865432 2235688999999999999999999997643 5
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
.+||||||| +|+|.+++. ..+++++..+..++.||+.||.|||++ |||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~-~g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLM-ESDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECC-SEEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCC-CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeeccee
Confidence 789999999 578999997 457899999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC---CCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh-hhhh-hh--
Q 004395 556 RWQPDGD---MGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT-EWAR-PL-- 627 (756)
Q Consensus 556 ~~~~~~~---~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~~-~~-- 627 (756)
+.+.... .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.......+.... .... +.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764322 2234567899999999998875 5699999999999999999999999765432221100 0000 00
Q ss_pred ----hhhhhh---hhccCCccCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 ----LEEYAI---DELVDPRLGNH---YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 ----~~~~~i---~~l~dp~l~~~---~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...... .....+..... ..+.....+.+||.+||..||++|||+.|+|++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00000000000 011223467899999999999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=408.48 Aligned_cols=201 Identities=23% Similarity=0.315 Sum_probs=173.1
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEe----cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCc
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~ 476 (756)
....++|++.+.||+|+||.||+|+. .+++.||||.+... .....+.+|+++|..+ +|||||+++++|.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 34567899999999999999999984 25789999987543 3345688999999998 59999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC-Ccceeeccccc
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLA 555 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~-~~vkL~DFGlA 555 (756)
+|||||||+||+|.+++. .+++..+..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999983 489999999999999999999999 99999999999999877 89999999999
Q ss_pred eecCCCCC---------------------------CcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCC
Q 004395 556 RWQPDGDM---------------------------GVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRK 607 (756)
Q Consensus 556 ~~~~~~~~---------------------------~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~ 607 (756)
+...+... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86544321 112345799999999999775 58999999999999999999999
Q ss_pred CCCCCC
Q 004395 608 AVDLNR 613 (756)
Q Consensus 608 Pf~~~~ 613 (756)
||....
T Consensus 246 Pf~~~~ 251 (361)
T 4f9c_A 246 PFYKAS 251 (361)
T ss_dssp SSSCCS
T ss_pred CCCCCC
Confidence 996443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=397.62 Aligned_cols=281 Identities=41% Similarity=0.694 Sum_probs=240.6
Q ss_pred CChHHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 396 ~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
+++.+++..+++|.+.+.||+|+||.||+|...+|+.||||++..........+.+|+++++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445566788999999999999999999998889999999887666666678999999999999999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~--~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
..++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999996532 24699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC-CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 554 LARWQPDGD-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 554 lA~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 998754322 2223345689999999999999999999999999999999999999987665554444555444444445
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+...+++.+...........+.+++.+||+.||++|||+.++++.|+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 566667777777788888999999999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=397.79 Aligned_cols=290 Identities=47% Similarity=0.817 Sum_probs=246.7
Q ss_pred CCCCChHHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEE
Q 004395 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFC 471 (756)
Q Consensus 393 ~~~~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~ 471 (756)
...+++.++....++|.+.+.||+|+||.||+|...+|+.||||++...... ....+.+|+++++.++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4568899999999999999999999999999999888999999988754432 334789999999999999999999999
Q ss_pred EecCceeEEEEeecCCChhhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCccee
Q 004395 472 IEDRRRLLVYEYICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (756)
Q Consensus 472 ~~~~~~~LV~Ey~~ggsL~~~L~~~~--~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL 549 (756)
.+....++||||+.+|+|.+++.... ..++++..++.++.|++.||.|||+.+.. ||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSS-CEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999997542 34599999999999999999999998543 7999999999999999999999
Q ss_pred eccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cccccchhhhhhhh
Q 004395 550 GDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNR--PKGQQCLTEWARPL 627 (756)
Q Consensus 550 ~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~--~~~~~~l~~~~~~~ 627 (756)
+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||+... .........|....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999999776554444555679999999999999999999999999999999999999996221 11223345555555
Q ss_pred hhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcCcC
Q 004395 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDTV 683 (756)
Q Consensus 628 ~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~~~ 683 (756)
.....+..+.+......+.......+.+++.+||+.||.+|||+.+|++.|++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 55556666777777777888888999999999999999999999999999997544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=430.01 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=210.8
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++..........+.+|+++|+.|+|||||+++++|.+...+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 35899999999999999999995 57999999998766555566789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC--CcceeeccccceecCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD--FEPLVGDFGLARWQPDG 561 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~--~~vkL~DFGlA~~~~~~ 561 (756)
|.||+|.++|.. ..+.+++..+..++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999964 346799999999999999999999999 99999999999999864 89999999999987543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
. .....+||+.|||||++.+..|+.++|||||||+||||++|..||........ +. . +.. .+..+
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~--~~----~------i~~-~~~~~ 375 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LR----N------VKS-CDWNM 375 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH----H------HHT-TCCCC
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HH----H------HHh-CCCCC
Confidence 3 34457899999999999999999999999999999999999999975432211 00 0 000 00111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...........+.+||.+||..||.+|||+.|+|++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112234568899999999999999999999884
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=424.25 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=201.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHH---HHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSE---VEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~E---v~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
++|.+++.||+|+||.||+|.. .+|+.||||++... .......+.+| +.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999995 57999999988532 12233334444 55666778999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
||||||.||+|.++|.. .+.+++..+..++.||+.||+|||++ |||||||||+||||+.+|.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999974 46799999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
.... ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......... . +... ... .
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~----i~~~-i~~--~ 409 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E----IDRM-TLT--M 409 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---H----HHHH-HHH--C
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---H----HHHh-hcC--C
Confidence 5433 345789999999999964 57999999999999999999999999643222110 0 0000 000 0
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~~ 677 (756)
.. .++......+.+||.+||..||.+|++ +.||+++
T Consensus 410 ~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 410 AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11 123334456899999999999999998 6888764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=375.95 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=211.4
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..........|.+|+++|++++||||+++++++.++...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46899999999999999999995 46999999988665555667899999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+++|.+++.. ....+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999975 356799999999999999999999999 999999999999999999999999999987654322
Q ss_pred Cc-------------ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhh
Q 004395 564 GV-------------ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630 (756)
Q Consensus 564 ~~-------------~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 630 (756)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..||.............. ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~---- 238 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RG---- 238 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HH----
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hc----
Confidence 11 1145799999999999999999999999999999999999999875443322111100 00
Q ss_pred hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 631 ~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..... . +...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 239 -~~~~~----~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~ 279 (310)
T 3s95_A 239 -FLDRY----C----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279 (310)
T ss_dssp -HHHHT----C----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -ccccc----C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00111 1 11222358899999999999999999999998874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=374.88 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=210.5
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45899999999999999999994 57999999998776666677899999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.+|+|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999964 3699999999999999999999999 999999999999999999999999999987654332
Q ss_pred CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. +.....+ ..
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~------~~~~~~~--~~ 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YL------IATNGTP--EL 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HH------HHHHCSC--CC
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH------HHhCCCC--CC
Confidence 334567999999999999999999999999999999999999999654321110 00 0000011 11
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 122334456889999999999999999999987
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=367.40 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=212.6
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+..++|.+.+.||+|+||.||+|...+++.||+|++.... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3456899999999999999999998888999999987543 345679999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 86 FMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred eCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999964 456799999999999999999999999 99999999999999999999999999998665433
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ ... +.....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~------~~~------~~~~~~--- 225 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VED------ISTGFR--- 225 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHH------HHTTCC---
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH------HHH------HhcCcc---
Confidence 222334557888999999999999999999999999999999 9999965432110 000 011111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+......+.+++.+||+.||.+||++.++++.|+.
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 226 -LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 11122234568899999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=365.67 Aligned_cols=258 Identities=26% Similarity=0.356 Sum_probs=213.9
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++..++|.+.+.||+|+||.||+|...++..||+|++.... .....+.+|++++..++||||+++++++.+....++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 34567899999999999999999998888899999987543 34467999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 83 EYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp ECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EccCCCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999965 244699999999999999999999999 9999999999999999999999999999877655
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ . . .+......
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~----~--~~~~~~~~- 224 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------V----L--KVSQGHRL- 224 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------H----H--HHHTTCCC-
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------H----H--HHHcCCCC-
Confidence 4333334556788999999999899999999999999999999 9999965432110 0 0 00110011
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
..+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 225 ---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp ---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred ---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11122234688999999999999999999999999853
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=374.17 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=203.4
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
.+++..++|.+.+.||+|+||.||+|.. +|+.||||++...... ....|.+|+++|++++||||+++++++.+....
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3445567899999999999999999987 6889999988654322 235689999999999999999999999999999
Q ss_pred eEEEEeecCCChhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhcccCc--eEeeccCCCceeecCCCcceeecccc
Q 004395 478 LLVYEYICNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~-~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g--IiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
++||||+.+|+|.+++.... ...+++..++.++.||+.||+|||+. | |+||||||+|||++.++.+||+|||+
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999997422 12499999999999999999999999 8 99999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~----------~~~~~-~ 253 (309)
T 3p86_A 186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV----------VAAVG-F 253 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH----------HHHHH-H
T ss_pred Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHHH-h
Confidence 98554322 223446799999999999999999999999999999999999999975432110 00000 0
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. .....+......+.+++.+||..||.+|||+.++++.|+.
T Consensus 254 ~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 254 KC----KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp SC----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cC----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 1112233344578999999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=382.44 Aligned_cols=257 Identities=26% Similarity=0.356 Sum_probs=210.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEe--------cCCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL--------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE 473 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~ 473 (756)
..++|.+.+.||+|+||.||+|.. .++..||||+++.... .....+.+|+++|+.+ +||||++++++|.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 457899999999999999999984 2456899999875432 2345789999999999 89999999999999
Q ss_pred cCceeEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCce
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 539 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NI 539 (756)
.+..|+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NI 234 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNV 234 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchhhE
Confidence 999999999999999999997532 24689999999999999999999999 999999999999
Q ss_pred eecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 004395 540 LLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQ 617 (756)
Q Consensus 540 LL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~ 617 (756)
||+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999997654332 22234567889999999999999999999999999999999 9999975432110
Q ss_pred cchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 618 QCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 618 ~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. . +... .....+......+.+++.+||+.||.+||++.|+++.|+.
T Consensus 315 ------~~-~-----~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 315 ------FK-L-----LKEG----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp ------HH-H-----HHTT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------HH-H-----HhcC----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00 0 0110 1111223344578999999999999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=374.32 Aligned_cols=273 Identities=24% Similarity=0.343 Sum_probs=208.2
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-----cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEec--C
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--R 475 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~ 475 (756)
+..++|++.+.||+|+||.||+|.+ .+++.||||++..........|.+|+++|..++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3457899999999999999999983 36889999998765555556799999999999999999999998654 4
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..++||||+.+|+|.+++.. ....+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHH-CGGGCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHh-cccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 58999999999999999975 344699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC--CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 556 RWQPDGDM--GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 556 ~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
+....... .......++..|+|||++.+..++.++||||||+++|||++|..||........................
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87654321 1222345778899999999999999999999999999999999998532211000000000000000011
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+.+........+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 11111111222334455679999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=369.05 Aligned_cols=261 Identities=23% Similarity=0.318 Sum_probs=216.7
Q ss_pred CCChHHHHHhhCC----------eeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC
Q 004395 395 WFSYAELELATGG----------FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN 463 (756)
Q Consensus 395 ~~s~~~l~~~~~~----------y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN 463 (756)
.+++.++..+++. |...+.||+|+||.||+|... +|+.||||++..........+.+|+.+++.++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4677777766653 888899999999999999965 79999999988766666778999999999999999
Q ss_pred eeeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC
Q 004395 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (756)
Q Consensus 464 IV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~ 543 (756)
|+++++++......++||||+.+++|.+++. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECC
Confidence 9999999999999999999999999999985 45799999999999999999999999 9999999999999999
Q ss_pred CCcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhh
Q 004395 544 DFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW 623 (756)
Q Consensus 544 ~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~ 623 (756)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~------ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------ 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------
Confidence 99999999999987654322 23456799999999999999999999999999999999999999965432110
Q ss_pred hhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 624 ~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .+.....+.+ .........+.+++.+||+.||++|||+.++++.
T Consensus 250 ~~------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MK------RLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HH------HHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH------HHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0111111111 1112234568899999999999999999999873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=375.76 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=208.2
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec----CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
+..++|.+.+.||+|+||.||+|... .+..||||+++.... .....|.+|+++|+.++||||+++++++.+....
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34578999999999999999999963 345699999875432 3345799999999999999999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999964 346799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 558 QPDGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 558 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||........ .. .+.
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------~~--~~~ 268 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV----------IS--SVE 268 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH----------HH--HHH
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH----------HH--HHH
Confidence 7543221 1223446788999999999999999999999999999999 9999964332110 00 001
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. .....+......+.+++.+||..||.+|||+.+|++.|+.
T Consensus 269 ~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 269 EG----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp TT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cC----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11 1111233344578999999999999999999999999985
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=376.62 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=208.1
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
...++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|+.++||||+++++++.+.+..|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457899999999999999999995 6899999998865422 234568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+|+|.+++.. .+.+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999974 35799999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCCcccccccCccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQIT-EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
... .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||....... .... +..
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~---------i~~ 228 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRER---------VLR 228 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH---------HHH
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHH---------HHh
Confidence 432 34557899999999999888875 89999999999999999999997543211 0000 000
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. ...+......+.+|+.+||..||.+|||+.|++++
T Consensus 229 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 229 GK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 01222334568899999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=366.87 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=206.3
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcC---chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~---~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
..++|++.+.||+|+||.||+|.. .+++.||+|.+....... ...|.+|+.++..++||||+++++++.+++..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 457899999999999999999994 478999999876543322 3568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+++|.+++.. .+++++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 89 v~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999974 35799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
...........||+.|+|||++.+..++.++||||||+++|||++|+.||......... .. .+... .+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~-----~~~~~-~~ 230 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IK-----HIQDS-VP 230 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HH-----HHSSC-CC
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HH-----Hhhcc-CC
Confidence 44433344567999999999999999999999999999999999999999754321100 00 00000 00
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhcC
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRP-RMSQVLRILEGD 681 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-S~~eVL~~Le~~ 681 (756)
..........+..+.+++.+||+.||.+|| ++.++.+.|+..
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 010111223345689999999999999998 999999998853
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=370.26 Aligned_cols=260 Identities=17% Similarity=0.195 Sum_probs=209.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+++++.+ +||||+++++++.+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 357899999999999999999994 579999999876543 344689999999999 8999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc-----ceeeccccce
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE-----PLVGDFGLAR 556 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~-----vkL~DFGlA~ 556 (756)
||+ +++|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++. +||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999 99999999753 56899999999999999999999999 9999999999999999887 9999999999
Q ss_pred ecCCCCCC------cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhh
Q 004395 557 WQPDGDMG------VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630 (756)
Q Consensus 557 ~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 630 (756)
.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 76543321 124567999999999999999999999999999999999999999765432211111000000000
Q ss_pred hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 631 ~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.....+ ....+ .+.+++.+||..||.+||++.+|++.|+..
T Consensus 239 ~~~~~~---------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPIEVL---------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCHHHH---------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCHHHH---------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000000 01122 689999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=367.79 Aligned_cols=257 Identities=22% Similarity=0.334 Sum_probs=210.1
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++..++|.+.+.||+|+||.||+|...++..||||++.... .....+.+|++++..++||||+++++++.+....++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 45567899999999999999999998888899999987543 33567999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999964 245699999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........ . ..+......
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~------~------~~~~~~~~~- 240 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------A------EHIAQGLRL- 240 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------H------HHHHTTCCC-
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH------H------HHHhcccCC-
Confidence 2222233457888999999999999999999999999999998 9999965432110 0 001111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 241 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 241 ---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1122233568899999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=366.26 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=217.9
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
.+++..++|.+.+.||+|+||.||+|... ++..||+|++... ......+.+|+++++.++||||+++++++.+....|
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 34566789999999999999999999964 5889999988743 334567999999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999999876677899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
............+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ . . .+...
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~---~------~~~~~- 228 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y---E------LLEKD- 228 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H---H------HHHTT-
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---H------HHhcc-
Confidence 6544333445567889999999999999999999999999999999 9999965432110 0 0 00111
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.....+......+.+++.+||..||.+|||+.++++.|+.
T Consensus 229 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 229 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 1111223334578999999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=396.22 Aligned_cols=259 Identities=25% Similarity=0.354 Sum_probs=213.8
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
+++..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|+.++||||+++++++. ....|+|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 456678999999999999999999998888999999987543 45678999999999999999999999986 5678999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999754445789999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
..........+++.|+|||++....++.++|||||||+||||+| |+.||....... ..... . ...
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i-~----~~~--- 402 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRAL-E----RGY--- 402 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHH-H----HTC---
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-H----cCC---
Confidence 32212223446788999999999999999999999999999999 999996543211 00000 0 011
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
....+...+..+.+++.+||..||++|||+.+|++.|+..
T Consensus 403 --~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 403 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1112233445789999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=362.65 Aligned_cols=260 Identities=22% Similarity=0.375 Sum_probs=203.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHh--cCCCCeeeEEEEEEec----Cce
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSC--AQHRNVVMLIGFCIED----RRR 477 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~--L~HpNIV~l~~~~~~~----~~~ 477 (756)
..++|.+.+.||+|+||.||+|.. +|+.||||++... ....+..|.+++.. ++||||+++++++.+. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999987 7899999987642 34567778888887 7899999999987653 458
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hhcccCceEeeccCCCceeecCCCccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH--------EECRVGCIVHRDMRPNNILLTHDFEPLV 549 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH--------~~~~~~gIiHrDLKp~NILL~~~~~vkL 549 (756)
|+||||+.+|+|.+++. ...+++..++.++.||+.||+||| +. +|+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP----AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC----EEECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC----CeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999994 457999999999999999999999 77 9999999999999999999999
Q ss_pred eccccceecCCCCCCc---ccccccCccccCccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCC
Q 004395 550 GDFGLARWQPDGDMGV---ETRVIGTFGYLAPEYAQSG------QITEKADVYSFGVVLVELVTG----------RKAVD 610 (756)
Q Consensus 550 ~DFGlA~~~~~~~~~~---~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSlGvvL~ELltG----------~~Pf~ 610 (756)
+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998665433211 2234799999999999876 455799999999999999999 67765
Q ss_pred CCCcccccchhhhhhhhhhhhhhhhccCCccC-CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 611 LNRPKGQQCLTEWARPLLEEYAIDELVDPRLG-NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 611 ~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~-~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
........ ... ...........+.+. ..+.......+.+++.+||+.||++|||+.+|++.|+.
T Consensus 235 ~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 235 DVVPNDPS-FED-----MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTSCSSCC-HHH-----HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCcc-hhh-----hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 43222111 000 000000111111111 11233466789999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.15 Aligned_cols=262 Identities=16% Similarity=0.175 Sum_probs=211.3
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV 480 (756)
+..++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+|+.++..+ +|+||+.+++++.+....++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3567899999999999999999994 67999999987643 3345689999999999 799999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc-----ceeeccccc
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE-----PLVGDFGLA 555 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~-----vkL~DFGlA 555 (756)
|||+ +++|.+++.. ...++++..++.++.||+.||+|||+. ||+||||||+|||++.++. +||+|||++
T Consensus 85 ~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 85 IDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999 9999999975 345799999999999999999999999 9999999999999987776 999999999
Q ss_pred eecCCCCC------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh
Q 004395 556 RWQPDGDM------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 629 (756)
Q Consensus 556 ~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 629 (756)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87654322 123456799999999999999999999999999999999999999976543222111110000000
Q ss_pred hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 630 ~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
......+ .. ..+..+.+++.+||+.||++||++.+|++.|+..
T Consensus 239 ~~~~~~~-----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 239 STPLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HSCHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CccHHHH-----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0000111 11 2234688999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=376.20 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=207.1
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc------CchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~------~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|+.+|..++||||++++++|.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 356899999999999999999995 47999999988754322 23578999999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC----cceeecc
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDF 552 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~----~vkL~DF 552 (756)
.|+||||+.||+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999996 456799999999999999999999999 999999999999998877 7999999
Q ss_pred ccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
|+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||........ +..
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--~~~---------- 229 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN---------- 229 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH----------
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----------
Confidence 9998775533 23456799999999999999999999999999999999999999965432110 000
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+... ...+...+.......+.+||.+||..||.+|||+.|++++
T Consensus 230 i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 230 ITAV-SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHTT-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhc-CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 0000000011223468899999999999999999999873
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=378.20 Aligned_cols=266 Identities=24% Similarity=0.313 Sum_probs=214.1
Q ss_pred CChHHHHHhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeE
Q 004395 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVML 467 (756)
Q Consensus 396 ~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l 467 (756)
+....+++..++|.+.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+++|.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45677888899999999999999999999973 3468999999875432 2335699999999999 79999999
Q ss_pred EEEEEecCc-eeEEEEeecCCChhhhhhccCC------------------------------------------------
Q 004395 468 IGFCIEDRR-RLLVYEYICNGSLDSHLYGCHQ------------------------------------------------ 498 (756)
Q Consensus 468 ~~~~~~~~~-~~LV~Ey~~ggsL~~~L~~~~~------------------------------------------------ 498 (756)
+++|.+.+. .++||||+.+|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999975322
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 499 ----------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 499 ----------------~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1289999999999999999999999 99999999999999999999999999998664432
Q ss_pred -CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 563 -MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 563 -~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
........||+.|+|||++.+..++.++|||||||++|||++ |..||........ .... +......
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~-----~~~~~~~- 315 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRR-----LKEGTRM- 315 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHH-----HHHTCCC-
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHH-----HHcCCCC-
Confidence 223344678999999999999999999999999999999998 9999965432211 0000 0111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+......+.+++.+||+.||.+|||+.+|+++|+.
T Consensus 316 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 316 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1222234568999999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=390.59 Aligned_cols=259 Identities=28% Similarity=0.379 Sum_probs=208.6
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
+++..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..|+|
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 455667899999999999999999998888889999987543 345679999999999999999999999876 678999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999999754446799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
..........+++.|+|||++.+..++.++|||||||+||||++ |+.||....... .... +..
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~------i~~---- 396 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQ------VER---- 396 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHH------HHT----
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHH------HHc----
Confidence 43333334557889999999999999999999999999999999 999996443211 0000 000
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
......+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 397 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111122334456789999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=372.54 Aligned_cols=274 Identities=26% Similarity=0.343 Sum_probs=209.9
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc----e
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR----R 477 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~----~ 477 (756)
.+..++|++.+.||+|+||.||+|... ++.||||++.... .....+..|+.+|.+++||||+++++++.+... .
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 345578999999999999999999874 7899999986432 223356678889999999999999999988553 6
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc------ccCceEeeccCCCceeecCCCcceeec
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC------RVGCIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~------~~~gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
|+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ +..||+||||||+|||++.++.+||+|
T Consensus 98 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999999964 45999999999999999999999862 223799999999999999999999999
Q ss_pred cccceecCCCCC-CcccccccCccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh
Q 004395 552 FGLARWQPDGDM-GVETRVIGTFGYLAPEYAQS-----GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 552 FGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 625 (756)
||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||................
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987654332 22334679999999999986 355678999999999999999999997654432221111111
Q ss_pred hh--h---hhhhhhhccCCccCCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 626 PL--L---EEYAIDELVDPRLGNHY-SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 626 ~~--~---~~~~i~~l~dp~l~~~~-~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. . ..........+.+...+ .......+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 0 01111111122211111 12345679999999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=369.67 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=204.4
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999954 799999998865433 234578999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+|+|.+++. ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999996 456799999999999999999999999 99999999999999999999999999998654322
Q ss_pred -CCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 563 -MGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 563 -~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...+. ...
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~-------------~~~ 225 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-------------EKK 225 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH-------------TTC
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh-------------ccc
Confidence 122335679999999999987775 78999999999999999999999754332111 11100 000
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
............+.+|+.+||..||.+|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0001112334568899999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.64 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=198.6
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--------------------------cCchhHHHHHHHH
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--------------------------QGDHEFCSEVEVL 456 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--------------------------~~~~~f~~Ev~iL 456 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 347899999999999999999995 5789999998764321 1235689999999
Q ss_pred HhcCCCCeeeEEEEEEe--cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeecc
Q 004395 457 SCAQHRNVVMLIGFCIE--DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDM 534 (756)
Q Consensus 457 ~~L~HpNIV~l~~~~~~--~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDL 534 (756)
+.++||||+++++++.+ ....|+||||+.+++|.+++ ...++++..++.++.||+.||+|||+. ||+||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dl 163 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDI 163 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCC
Confidence 99999999999999987 56789999999999999876 346799999999999999999999999 9999999
Q ss_pred CCCceeecCCCcceeeccccceecCCCCCCcccccccCccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCC
Q 004395 535 RPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ---ITEKADVYSFGVVLVELVTGRKAVDL 611 (756)
Q Consensus 535 Kp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSlGvvL~ELltG~~Pf~~ 611 (756)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654322 234467999999999998765 37899999999999999999999964
Q ss_pred CCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 612 NRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 612 ~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.... ...... . ..... ..........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~------~~~~~~----~-~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIM------CLHSKI----K-SQALE----FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHH------HHHHHH----H-HCCCC----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHH------HHHHHH----h-cccCC----CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 3211 000000 0 00000 0011223356899999999999999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=359.07 Aligned_cols=279 Identities=37% Similarity=0.612 Sum_probs=226.3
Q ss_pred CCCCChHHHHHhhCCeeEE------EEecccCceEEEEEEecCCCEEEEEEecccC----CcCchhHHHHHHHHHhcCCC
Q 004395 393 PRWFSYAELELATGGFSQA------NFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQHR 462 (756)
Q Consensus 393 ~~~~s~~~l~~~~~~y~~~------~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~----~~~~~~f~~Ev~iL~~L~Hp 462 (756)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ......|.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4557899999999998877 8999999999999987 68899999876432 22345788999999999999
Q ss_pred CeeeEEEEEEecCceeEEEEeecCCChhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee
Q 004395 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541 (756)
Q Consensus 463 NIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~-~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL 541 (756)
||+++++++.+.+..++||||+++++|.+++... ...++++..++.++.||+.||.|||+. ||+||||||+|||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998643 345799999999999999999999999 99999999999999
Q ss_pred cCCCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch
Q 004395 542 THDFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL 620 (756)
Q Consensus 542 ~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l 620 (756)
+.++.+||+|||+++........ ......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... .+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence 99999999999999876543221 2234579999999998865 58999999999999999999999997544321 12
Q ss_pred hhhhhhhhh-hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 621 TEWARPLLE-EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 621 ~~~~~~~~~-~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+...... ...+...+++.+ ...+......+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 222111111 112233334333 33456677889999999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=396.48 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=217.5
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
+++...+|.+.+.||+|+||.||+|.+. ++..||||+++... .....|.+|+++|++++||||++++++|.+....||
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 4556678999999999999999999965 48899999987543 346789999999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999876667899999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
...........+++.|+|||++.+..++.++|||||||+||||++ |..||........ . +.+.
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~------~----------~~~~ 433 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------Y----------ELLE 433 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------H----------HHHH
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH------H----------HHHH
Confidence 443222334456789999999999999999999999999999999 9999975432110 0 0001
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.......+......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1111122334456789999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=357.30 Aligned_cols=251 Identities=28% Similarity=0.431 Sum_probs=197.6
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCC----cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS----QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~----~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
..++|.+.+.||+|+||.||+|.. .|+.||||++..... .....+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 457899999999999999999997 488999998765432 234578999999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCc---eEeeccCCCceeecC--------CCcce
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC---IVHRDMRPNNILLTH--------DFEPL 548 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g---IiHrDLKp~NILL~~--------~~~vk 548 (756)
||||+.+++|.+++. ...+++..++.++.|++.||.|||+. | |+||||||+|||++. ++.+|
T Consensus 84 v~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~----~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDE----AIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHS----SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CCCceeecCCchHHEEEecccccccccCcceE
Confidence 999999999999984 46799999999999999999999999 7 999999999999986 77899
Q ss_pred eeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh
Q 004395 549 VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL 628 (756)
Q Consensus 549 L~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 628 (756)
|+|||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------- 222 (271)
T 3dtc_A 157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV----------- 222 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----------
T ss_pred EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------
Confidence 99999998654432 2345699999999999999999999999999999999999999964332110
Q ss_pred hhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 629 ~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.............+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 223 ----AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 001111111122233344578999999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=361.66 Aligned_cols=259 Identities=27% Similarity=0.379 Sum_probs=213.0
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
++++..++|.+.+.||+|+||.||+|...++..||||.+.... .....+.+|+++|+.++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3556678999999999999999999998888899999887543 34567999999999999999999999986 456899
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999643334799999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
...........+++.|+|||++.+..++.++||||||+++|||++ |+.||....... .... +.....
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~------~~~~~~ 228 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQN------LERGYR 228 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHH------HHTTCC
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHH------HhcccC
Confidence 543333334557889999999998999999999999999999999 999996543211 0000 011011
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+......+.+++.+||..||++|||+.++++.|+.
T Consensus 229 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 11222334578999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=372.44 Aligned_cols=264 Identities=26% Similarity=0.371 Sum_probs=213.6
Q ss_pred hHHHHHhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEE
Q 004395 398 YAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGF 470 (756)
Q Consensus 398 ~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~ 470 (756)
+..++...++|.+.+.||+|+||.||+|... +++.||||+++.... .....|.+|+.+++.++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455667789999999999999999999963 358999999875432 234578999999999999999999999
Q ss_pred EEecCceeEEEEeecCCChhhhhhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCc
Q 004395 471 CIEDRRRLLVYEYICNGSLDSHLYGCH----------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGC 528 (756)
Q Consensus 471 ~~~~~~~~LV~Ey~~ggsL~~~L~~~~----------------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g 528 (756)
+.+....|+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~ 194 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----K 194 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----C
Confidence 999999999999999999999997532 26799999999999999999999999 9
Q ss_pred eEeeccCCCceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CC
Q 004395 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GR 606 (756)
Q Consensus 529 IiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~ 606 (756)
|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999986543221 12234568999999999999999999999999999999999 99
Q ss_pred CCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 607 KAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 607 ~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.||....... .. ..+.... ....+......+.+++.+||+.||++||++.++++.|+..
T Consensus 275 ~p~~~~~~~~------~~---------~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 275 QPYYGMAHEE------VI---------YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp CTTTTSCHHH------HH---------HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CcCCCCChHH------HH---------HHHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 9996433210 00 0000000 0112233445789999999999999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=368.53 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=206.1
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc------CchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~------~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|+.+|+.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45799999999999999999995 46899999988654322 245789999999999999999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC----cceeeccc
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFG 553 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~----~vkL~DFG 553 (756)
++||||+.+++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999996 356799999999999999999999999 999999999999999887 79999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ +. . +
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~--------~--~ 229 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA--------N--V 229 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH--------H--H
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HH--------H--H
Confidence 998765432 22346799999999999999999999999999999999999999964332110 00 0 0
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
... ...............+.+++.+||..||++|||+.+++++
T Consensus 230 ~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 230 SAV-NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHT-CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred Hhc-CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0000000011223468899999999999999999999883
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=362.06 Aligned_cols=269 Identities=22% Similarity=0.222 Sum_probs=212.8
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC--ceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR--RRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~--~~~LV 480 (756)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+++|+.++||||+++++++.... ..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 468999999999999999999954 58999999987543 234567889999999999999999999998765 67999
Q ss_pred EEeecCCChhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee----cCCCcceeeccccc
Q 004395 481 YEYICNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL----THDFEPLVGDFGLA 555 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~-~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL----~~~~~vkL~DFGlA 555 (756)
|||+.+++|.+++.... ...+++..++.++.||+.||+|||+. ||+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997532 23499999999999999999999999 99999999999999 78888999999999
Q ss_pred eecCCCCCCcccccccCccccCccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQ--------SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~--------~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
+...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||......... .......
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~ 239 (319)
T 4euu_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (319)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHH
T ss_pred eecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHH
Confidence 8775543 223467999999999886 578899999999999999999999999643322111 1111111
Q ss_pred hhhhh---hhhc-----------cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 628 LEEYA---IDEL-----------VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 628 ~~~~~---i~~l-----------~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
..... +..+ ........+.......+.+++.+||+.||++|||+.|+++...+.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 10000 0000 001111234566777899999999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=363.28 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=197.5
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEec----CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
++..++|.+.+.||+|+||.||+|... .+..||+|.+..... .....|.+|+.+++.++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 455679999999999999999999853 245799998765432 23456899999999999999999999985 567
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+||||+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECcccccc
Confidence 8999999999999999975 345799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
..............+|+.|+|||++.+..++.++||||||+++|||++ |..||........ . . .+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~------~----~--~i~~ 232 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------I----G--RIEN 232 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------H----H--HHHT
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH------H----H--HHHc
Confidence 765543333344557889999999999999999999999999999997 9999975432211 0 0 0000
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... ...+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 233 ~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 233 GER----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp TCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 001 11223344578899999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=368.05 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=207.1
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||+|.+.... .....+.+|+++|+.++||||+++++++.+....|+|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 357899999999999999999995 468999999887432 334568899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC--CCcceeeccccceecCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH--DFEPLVGDFGLARWQPD 560 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~--~~~vkL~DFGlA~~~~~ 560 (756)
|+.+|+|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999964 345799999999999999999999999 9999999999999987 78999999999997754
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ + .... .....
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~----~~i~-----~~~~~-- 221 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--I----ENIM-----NAEYT-- 221 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H----HHHH-----HTCCC--
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH--H----HHHH-----cCCCC--
Confidence 33 23456799999999999998899999999999999999999999965432110 0 0000 00000
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+...........+.+++.+||..||.+|||+.|++++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000001223468899999999999999999999984
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=370.37 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=207.2
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.. .......+.+|+.+|..++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 36899999999999999999995 47999999988643 233456788999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.||+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999974 45799999999999999999999999 999999999999999999999999999986433
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... . .. ..
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i----~-~~--~~- 222 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELI----L-ME--EI- 222 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH----H-HC--CC-
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHHHH----H-cC--CC-
Confidence 22 22345689999999999999999999999999999999999999996432210 00000 0 00 11
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
.++......+.+++.+||+.||++|| ++.+++++
T Consensus 223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 12223345689999999999999999 89999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=383.55 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=210.0
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
++..++|.+.+.||+|+||.||+|... +++.||||.++.... .....|.+|+++|+.++||||++++++|.+.+..|+
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 345678999999999999999999975 789999998874422 223568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 190 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999964 345689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcc-cccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 560 DGDMGVE-TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 560 ~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
....... ....+++.|+|||++.++.++.++|||||||++|||++ |..||........ ... +
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~---------~ 328 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REF---------V 328 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHH---------H
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH---------H
Confidence 3321111 12235778999999999999999999999999999998 9999965432100 000 0
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
........+...+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus 329 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 329 EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 0011111223344578899999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.55 Aligned_cols=253 Identities=31% Similarity=0.522 Sum_probs=205.3
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCc-------hhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGD-------HEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~-------~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
..++|.+.+.||+|+||.||+|.. .+++.||||++........ ..+.+|+++++.++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 347899999999999999999995 5799999998865443222 57899999999999999999999986554
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCc--eEeeccCCCceeecCCCc-----ce
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLTHDFE-----PL 548 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g--IiHrDLKp~NILL~~~~~-----vk 548 (756)
++||||+.+|+|.+++.. ....+++..++.++.|++.||+|||+. | |+||||||+|||++.++. +|
T Consensus 97 --~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred --eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 799999999999998865 456799999999999999999999999 8 999999999999988776 99
Q ss_pred eeccccceecCCCCCCcccccccCccccCcccc--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhh
Q 004395 549 VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA--QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626 (756)
Q Consensus 549 L~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l--~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 626 (756)
|+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||...........
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~------ 239 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI------ 239 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH------
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH------
Confidence 999999985433 23456799999999998 455678999999999999999999999975433211000
Q ss_pred hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
............+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 240 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 240 -------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 00001111122333445678999999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=364.36 Aligned_cols=265 Identities=22% Similarity=0.258 Sum_probs=203.9
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
...++|++.+.||+|+||.||+|...+|+.||+|++...... ....+.+|+++|+.++||||+++++++.+....++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 345789999999999999999999888999999988654322 235688999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+. ++|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCS-EEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCC-CCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99996 688888864 445699999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh----hhhhh----h
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR----PLLEE----Y 631 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----~~~~~----~ 631 (756)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ..... +.... .
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHHHHHCCCCTTTSGGGT
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHHCCCChHHhhhhh
Confidence 322 2344578999999999876 56899999999999999999999999755433221 11000 00000 0
Q ss_pred hhhhccCCcc--CCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 632 AIDELVDPRL--GNH-----YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 632 ~i~~l~dp~l--~~~-----~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.......... ... ..+.....+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000 000 01122346889999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=357.74 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=211.5
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+..++|.+.+.||+|+||.||+|...+++.||+|++.... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3456899999999999999999998888999999987543 234679999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 84 FMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CCTTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999975 346799999999999999999999999 99999999999999999999999999998664432
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
........|++.|+|||++.+..++.++||||||+++|+|++ |+.||....... .... +......
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~------i~~~~~~-- 224 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVED------ISTGFRL-- 224 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHH------HHTTCCC--
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHH------HhcCCcC--
Confidence 222233457889999999999999999999999999999999 899996533210 0000 0110011
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+......+.+++.+||..||++||++.++++.|+.
T Consensus 225 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 225 --YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1122234568899999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=364.02 Aligned_cols=261 Identities=28% Similarity=0.386 Sum_probs=212.9
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~ 472 (756)
+++..++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++|.++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 455667999999999999999999984 3578999999875433 2346789999999999 8999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccCC----------------CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCC
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCHQ----------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~~----------------~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp 536 (756)
+.+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+. ||+||||||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp 173 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAA 173 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCcc
Confidence 99999999999999999999975432 2599999999999999999999999 999999999
Q ss_pred CceeecCCCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 004395 537 NNILLTHDFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRP 614 (756)
Q Consensus 537 ~NILL~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 614 (756)
+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999999876543321 2234557889999999999999999999999999999999 9999965432
Q ss_pred ccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 615 KGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 615 ~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... .... +...... ..+......+.+++.+||..||.+|||+.++++.|+.
T Consensus 254 ~~~------~~~~-----~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 254 DSK------FYKM-----IKEGFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp SHH------HHHH-----HHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhH------HHHH-----hccCCCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 211 0000 0111111 1122334568999999999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=369.92 Aligned_cols=261 Identities=25% Similarity=0.343 Sum_probs=210.1
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccC-CcCchhHHHHHHHHHhc-CCCCeeeEEEEEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~ 472 (756)
+++..++|.+.+.||+|+||.||+|.. .++..||||++.... ......+.+|+.+|.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445668999999999999999999995 245689999987542 33456799999999999 8999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEe
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCHQ---------------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~~---------------------~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiH 531 (756)
..+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+. ||+|
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH 195 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVH 195 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEE
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----Cccc
Confidence 99999999999999999999975322 3489999999999999999999999 9999
Q ss_pred eccCCCceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 004395 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAV 609 (756)
Q Consensus 532 rDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf 609 (756)
|||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986643322 12334567889999999999999999999999999999998 99999
Q ss_pred CCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 610 DLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 610 ~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
........ +. ... .. ......+......+.+++.+||..||.+|||+.+|++.|+.
T Consensus 276 ~~~~~~~~--~~----~~~-----~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 276 PGIPVDAN--FY----KLI-----QN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp TTCCCSHH--HH----HHH-----HT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCcHHH--HH----HHH-----hc----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 75432211 00 000 11 11111222334578999999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=365.51 Aligned_cols=260 Identities=28% Similarity=0.356 Sum_probs=211.6
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEe
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~ 473 (756)
++...++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++|+.++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 344567899999999999999999984 3458899998875432 234578899999999999999999999999
Q ss_pred cCceeEEEEeecCCChhhhhhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEe
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGCHQ----------------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~~~----------------------~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiH 531 (756)
.+..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||++ ||+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH 173 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KLVH 173 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TEEC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CCcc
Confidence 9999999999999999999975322 3489999999999999999999999 9999
Q ss_pred eccCCCceeecCCCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 004395 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAV 609 (756)
Q Consensus 532 rDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf 609 (756)
|||||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999876543221 2233457889999999999999999999999999999999 99999
Q ss_pred CCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 610 DLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 610 ~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
........ . .. +..... ...+......+.+++.+||+.||++||++.++++.|+.
T Consensus 254 ~~~~~~~~---~----~~-----~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 254 PGIPPERL---F----NL-----LKTGHR----MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp TTCCGGGH---H----HH-----HHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCHHHH---H----HH-----hhcCCc----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 75432211 0 00 011011 11223344578999999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=372.40 Aligned_cols=209 Identities=25% Similarity=0.303 Sum_probs=184.5
Q ss_pred CCChHHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-----CCCeeeEE
Q 004395 395 WFSYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-----HRNVVMLI 468 (756)
Q Consensus 395 ~~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-----HpNIV~l~ 468 (756)
.+++.+.....++|.+.+.||+|+||.||+|.. .+++.||||++... ......+..|+++++.+. ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 345566677789999999999999999999995 57899999988632 233456788999999997 99999999
Q ss_pred EEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-----
Q 004395 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH----- 543 (756)
Q Consensus 469 ~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~----- 543 (756)
+++...+..|+||||+ +++|.+++.......+++..++.++.||+.||+|||+. ||+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEccccccc
Confidence 9999999999999999 99999999876666799999999999999999999999 9999999999999975
Q ss_pred --------------------CCcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHH
Q 004395 544 --------------------DFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELV 603 (756)
Q Consensus 544 --------------------~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELl 603 (756)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 889999999999875442 23467999999999999999999999999999999999
Q ss_pred hCCCCCCCCC
Q 004395 604 TGRKAVDLNR 613 (756)
Q Consensus 604 tG~~Pf~~~~ 613 (756)
+|+.||....
T Consensus 254 ~g~~pf~~~~ 263 (360)
T 3llt_A 254 TGSLLFRTHE 263 (360)
T ss_dssp HSSCSCCCSS
T ss_pred HCCCCCCCCc
Confidence 9999997543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=375.39 Aligned_cols=260 Identities=27% Similarity=0.342 Sum_probs=212.0
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEe--------cCCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVL--------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~ 471 (756)
++..++|.+.+.||+|+||.||+|.. ..+..||||+++.... .....+.+|+++++.+ +||||++++++|
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 44567999999999999999999984 2245799998875432 2335789999999999 899999999999
Q ss_pred EecCceeEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCC
Q 004395 472 IEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (756)
Q Consensus 472 ~~~~~~~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~ 537 (756)
.+.+..++||||+.+|+|.+++.... ...+++..++.++.||+.||+|||+. ||+||||||+
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~ 220 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAAR 220 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCcc
Confidence 99999999999999999999997543 24699999999999999999999999 9999999999
Q ss_pred ceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 004395 538 NILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPK 615 (756)
Q Consensus 538 NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~ 615 (756)
||||+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654322 22334567899999999999999999999999999999999 99999644321
Q ss_pred cccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 616 GQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 616 ~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
. .... +... .....+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 301 ~------~~~~------~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 301 E------LFKL------LKEG----HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp H------HHHH------HHTT----CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H------HHHH------HHcC----CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0000 0111 11112223445789999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=382.93 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=208.9
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-ceeEE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-RRLLV 480 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~-~~~LV 480 (756)
++..++|.+.+.||+|+||.||+|.+. |+.||||+++... ....|.+|+++|++++||||+++++++.+.. ..|+|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 445678999999999999999999974 7899999987543 5568999999999999999999999987765 78999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999865555689999999999999999999999 999999999999999999999999999985533
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
.. ....+++.|+|||++.+..++.++|||||||+||||++ |+.||........ ... . ..
T Consensus 342 ~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------~~~-i-----~~---- 401 (450)
T 1k9a_A 342 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPR-V-----EK---- 401 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH------HHH-H-----HT----
T ss_pred cc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHH-H-----Hc----
Confidence 21 22357889999999999999999999999999999998 9999975432211 000 0 00
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
......+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus 402 ~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 402 GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 01112233445678999999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=367.75 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=200.8
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCE----EEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQA----VAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~----VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
.++|++.+.||+|+||.||+|.. .+|+. ||+|.+.... ......|.+|+.++++++||||++++++|.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 46899999999999999999994 34543 5888765432 344567999999999999999999999998754 78
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999975 356799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 559 PDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 559 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
...... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||........ ...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------~~~ 231 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------SSI 231 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------------HHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH----------------HHH
Confidence 543321 2233457889999999999999999999999999999999 9999975432211 001
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+........+......+.+++.+||+.||.+||++.++++.|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 11111112233345578999999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=369.77 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=201.7
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCC--CCeeeEEEEEEecCcee
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~H--pNIV~l~~~~~~~~~~~ 478 (756)
+..++|.+.+.||+|+||.||++...+++.||||++..... .....+.+|+++|..++| |||+++++++.+....|
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 45678999999999999999999988899999998875432 233578999999999986 99999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+|||| .+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ ++.+||+|||+++..
T Consensus 86 lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99995 68999999974 46799999999999999999999999 999999999999997 678999999999876
Q ss_pred CCCCCC-cccccccCccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhh
Q 004395 559 PDGDMG-VETRVIGTFGYLAPEYAQS-----------GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626 (756)
Q Consensus 559 ~~~~~~-~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 626 (756)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------- 226 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------- 226 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----------
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----------
Confidence 543221 2335679999999999865 67899999999999999999999999643211
Q ss_pred hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...+...+++.....++......+.+++.+||+.||.+|||+.+++++
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 ---ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 011122222222233333334568899999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=377.37 Aligned_cols=257 Identities=26% Similarity=0.345 Sum_probs=207.3
Q ss_pred hhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
..++|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3568999999999999999999842 46789999886432 2334568899999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC---cce
Q 004395 477 RLLVYEYICNGSLDSHLYGCH-----QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---EPL 548 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~-----~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~---~vk 548 (756)
.|+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||+. ||+||||||+||||+.++ .+|
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCceEE
Confidence 999999999999999997532 24699999999999999999999999 999999999999999555 599
Q ss_pred eeccccceecCCC-CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhh
Q 004395 549 VGDFGLARWQPDG-DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARP 626 (756)
Q Consensus 549 L~DFGlA~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~ 626 (756)
|+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--------- 295 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------- 295 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---------
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---------
Confidence 9999999854321 1122334568999999999999999999999999999999998 9999965432110
Q ss_pred hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... +.. ......+......+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 296 -~~~--i~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 296 -LEF--VTS----GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp -HHH--HHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHH--HHc----CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 000 000 00111222334568899999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=375.12 Aligned_cols=253 Identities=20% Similarity=0.220 Sum_probs=194.1
Q ss_pred hCCeeEE-EEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHh-cCCCCeeeEEEEEEe----cCce
Q 004395 405 TGGFSQA-NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSC-AQHRNVVMLIGFCIE----DRRR 477 (756)
Q Consensus 405 ~~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~-L~HpNIV~l~~~~~~----~~~~ 477 (756)
.++|.+. +.||+|+||.||+|.. .+|+.||||++.. ...+.+|++++.+ ++||||++++++|.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 7899999999999995 4789999998862 3467889998754 579999999999876 5678
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---CCcceeecccc
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGL 554 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~~~vkL~DFGl 554 (756)
|||||||.||+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999999865556799999999999999999999999 9999999999999998 78999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... . .........
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~---~~~~~i~~~ 282 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---P---GMKTRIRMG 282 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC---C---SHHHHHHHT
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc---H---HHHHHHHcC
Confidence 98765332 234567999999999999999999999999999999999999999754322110 0 000000000
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....+ ..........+.+||.+||..||++|||+.+++++
T Consensus 283 ~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10001 11112334568999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=379.04 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=197.7
Q ss_pred hhCCeeEEEEecccCceEEEEEEec----CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
..++|.+.+.||+|+||.||+|... ++..||||+++.... .....|.+|+.+|.+++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 4468999999999999999999854 577899999875432 23457999999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999974 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCc--ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 559 PDGDMGV--ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 559 ~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~------~~~---------- 261 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIK---------- 261 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH------HHH----------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH----------
Confidence 5432111 112345778999999999999999999999999999998 999996443210 000
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+........+......+.+++.+||+.||.+||++.+|++.|+.
T Consensus 262 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~ 306 (373)
T 2qol_A 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306 (373)
T ss_dssp HHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence 000111111222344578999999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.73 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=201.5
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|.+.+.||+|+||.||+|...+|+.||+|++..... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999988899999998865432 2346788999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+. ++|.+++.. ..+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LD-QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CS-EEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 95 599998864 346799999999999999999999999 99999999999999999999999999998664322
Q ss_pred CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh----hhhh-hhhh--
Q 004395 564 GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL----LEEY-AIDE-- 635 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~----~~~~-~i~~-- 635 (756)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +....... .... ...+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhccc
Confidence 12234568999999999876 4589999999999999999999999975432211 11000000 0000 0000
Q ss_pred ccCCcc-------CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 636 LVDPRL-------GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 636 l~dp~l-------~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..++.+ ...+.......+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001100 00111223456889999999999999999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.73 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=198.0
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc------
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR------ 476 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~------ 476 (756)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|+++|++++||||++++++|.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357999999999999999999965 799999999875443 334679999999999999999999999876542
Q ss_pred ---------------------------------------------------eeEEEEeecCCChhhhhhccC-CCCCCHH
Q 004395 477 ---------------------------------------------------RLLVYEYICNGSLDSHLYGCH-QEPLEWS 504 (756)
Q Consensus 477 ---------------------------------------------------~~LV~Ey~~ggsL~~~L~~~~-~~~L~~~ 504 (756)
.++|||||.+++|.+++.... ....++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 799999999999999997532 2346677
Q ss_pred HHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC-----------CcccccccCc
Q 004395 505 ARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-----------GVETRVIGTF 573 (756)
Q Consensus 505 ~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~-----------~~~~~~~Gt~ 573 (756)
.++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 8999999999999999999 999999999999999999999999999987654321 1223457999
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHH
Q 004395 574 GYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCM 653 (756)
Q Consensus 574 ~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l 653 (756)
.|+|||++.+..++.++|||||||++|||++|..|+... . .. ......... ..........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~-------~~-----~~~~~~~~~-~~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----V-------RI-----ITDVRNLKF-PLLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----H-------HH-----HHHHHTTCC-CHHHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----H-------HH-----HHHhhccCC-CcccccCChhH
Confidence 999999999999999999999999999999987654210 0 00 000000000 00112233467
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 004395 654 LHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 654 ~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+++.+||+.||++|||+.++++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 899999999999999999999873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.74 Aligned_cols=270 Identities=24% Similarity=0.301 Sum_probs=208.7
Q ss_pred hCCeeEEEEecccCceEEEEEEe-----cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEec--Cc
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RR 476 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~ 476 (756)
.+.|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+++|+.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35699999999999999999983 468999999987543 23446799999999999999999999999876 66
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.++||||+.+++|.+++.. ....+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999999999999964 345799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC--CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 557 WQPDGDM--GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 557 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
....... .......||..|+|||++.+..++.++||||||+++|+|++|..|+................. .....+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ-MTVTRLV 253 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG-GHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc-cCHHHHH
Confidence 7754432 122345688899999999999999999999999999999999998642211000000000000 0001111
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+........+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111111222334445679999999999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=371.24 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=206.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+++|+.++||||+++++++.+....|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356899999999999999999995 4789999999875432 2335688999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC---Ccceeecccccee
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD---FEPLVGDFGLARW 557 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~---~~vkL~DFGlA~~ 557 (756)
|||+.+|+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999986 346799999999999999999999999 99999999999999865 4599999999987
Q ss_pred cCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
..... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||....... ..... . ....
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------~~~~i-~----~~~~ 247 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQI-K----AGAY 247 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-H----HTCC
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-H----hCCC
Confidence 65432 2345679999999999999999999999999999999999999996432210 00000 0 0000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+...........+.+|+.+||..||++||++.+++++
T Consensus 248 --~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 --DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00011112334568899999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=383.11 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=210.5
Q ss_pred HHHHHhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEec
Q 004395 399 AELELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (756)
Q Consensus 399 ~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~ 474 (756)
.++....++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++..++||||++++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 445566789999999999999999999954 6899999987542 223445688999999999999999999999999
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
...|||||||.||+|.+++.. ..+++..++.++.||+.||+|||+. ||+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999964 4689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ----ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 630 (756)
|+.............+||+.|+|||++.+.. |+.++|||||||+||||++|+.||........ .......
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~ 288 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNH 288 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HHHHHhc
Confidence 9877554433334678999999999997655 78999999999999999999999975432111 0111000
Q ss_pred hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 004395 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHS--RPRMSQVLRI 677 (756)
Q Consensus 631 ~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~--RPS~~eVL~~ 677 (756)
. ..+..+. .......+.+||.+||..+|.+ ||++.+|+++
T Consensus 289 ~--~~~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 289 K--NSLTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp H--HHCCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred c--ccccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 0011111 1123356889999999999988 9999999885
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=384.11 Aligned_cols=264 Identities=19% Similarity=0.228 Sum_probs=213.5
Q ss_pred ChHHHHHhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEE
Q 004395 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~ 472 (756)
.+.++....++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+|..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 44566677889999999999999999999964 5889999988642 2233445899999999999999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecc
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
+....|||||||.||+|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999974 356799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCcccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
|+|+.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||........ ....
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~i 293 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKI 293 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHhh
Confidence 999877654433344568999999999987 56789999999999999999999999975432111 0011
Q ss_pred hhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 004395 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHS--RPRMSQVLRI 677 (756)
Q Consensus 628 ~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~--RPS~~eVL~~ 677 (756)
.... ..+..|... ......+.+||.+||..+|++ ||++.+++++
T Consensus 294 ~~~~--~~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHK--ERFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHH--HHCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhcc--ccccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000 011111111 123346889999999988888 9999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=373.50 Aligned_cols=253 Identities=19% Similarity=0.256 Sum_probs=208.0
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++..........+.+|+++|+.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 35899999999999999999995 47899999988765444456789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC--CCcceeeccccceecCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH--DFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~--~~~vkL~DFGlA~~~~~~ 561 (756)
+.+|+|.+++.. ....+++..++.++.||+.||+|||+. ||+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999964 345799999999999999999999999 9999999999999974 577999999999976543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||........ + .. +.. ....+
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~--------~~--i~~-~~~~~ 269 (387)
T 1kob_A 205 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--L--------QN--VKR-CDWEF 269 (387)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--H--------HH--HHH-CCCCC
T ss_pred c--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--H--------HH--HHh-CCCCC
Confidence 3 23445799999999999999999999999999999999999999975432100 0 00 000 00011
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...........+.++|.+||..||++|||+.++++.
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111122334568999999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=373.65 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=201.6
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCce
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~ 477 (756)
...++|.+.+.||+|+||.||+|.. .+|+.||||+++.. .......+..|..+|..+ +||||+++++++.+....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3457899999999999999999995 46899999988643 223445688899999998 699999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
||||||+.||+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+|+.
T Consensus 100 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999974 35799999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ . . .+.
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~----~-----~i~ 237 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------F----E-----AIL 237 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H----H-----HHH
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------H----H-----HHH
Confidence 43322 233456899999999999999999999999999999999999999975432110 0 0 000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRM------SQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~------~eVL~~ 677 (756)
... ..++......+.+++.+||..||.+||++ .+++++
T Consensus 238 ~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 238 NDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred cCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 000 11222334568899999999999999998 777663
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=354.77 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=202.8
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999995 47899999988754432 23578899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+. ++|.+.+.. ..+.+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCD-QDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCC-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 995 566666654 456799999999999999999999999 99999999999999999999999999998765332
Q ss_pred CCcccccccCccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh----hhhh-hhhhc
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQ-ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL----LEEY-AIDEL 636 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~----~~~~-~i~~l 636 (756)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||........ .+....... .... .....
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhccc
Confidence 2234457899999999997765 79999999999999999999888643322111 111100000 0000 00000
Q ss_pred cC---------CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 637 VD---------PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 637 ~d---------p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+ ..............+.+|+.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000011122344578899999999999999999999873
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.04 Aligned_cols=265 Identities=26% Similarity=0.315 Sum_probs=202.5
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-----cCchhHHHHHHHHHhcC---CCCeeeEEEEEEe
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-----QGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIE 473 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-----~~~~~f~~Ev~iL~~L~---HpNIV~l~~~~~~ 473 (756)
...++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++++.++ ||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567999999999999999999994 5799999998764322 22346778888887775 9999999999987
Q ss_pred cC-----ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcce
Q 004395 474 DR-----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548 (756)
Q Consensus 474 ~~-----~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vk 548 (756)
.. ..++||||+. ++|.+++.......+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEE
Confidence 65 4799999995 7999999865556699999999999999999999999 999999999999999999999
Q ss_pred eeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh-
Q 004395 549 VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL- 627 (756)
Q Consensus 549 L~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~- 627 (756)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.......
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~ 236 (308)
T 3g33_A 161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIG 236 (308)
T ss_dssp ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--HHHHHHHHC
T ss_pred EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhC
Confidence 99999998664332 23556799999999999999999999999999999999999999975443211 00000000
Q ss_pred -hhhhhhhh-------ccCCccC---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 628 -LEEYAIDE-------LVDPRLG---NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 628 -~~~~~i~~-------l~dp~l~---~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.....+.. ...+... ....+.....+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000000 0000000 0001123456889999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=370.75 Aligned_cols=268 Identities=15% Similarity=0.158 Sum_probs=204.0
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecC------CCEEEEEEecccCCcC-----------chhHHHHHHHHHhcCCCCee
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPD------GQAVAVKQHKLASSQG-----------DHEFCSEVEVLSCAQHRNVV 465 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~VAVK~~~~~~~~~-----------~~~f~~Ev~iL~~L~HpNIV 465 (756)
...++|.+.+.||+|+||.||+|.... ++.||||++....... ...+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 345689999999999999999998644 4789999876443211 11234455566677899999
Q ss_pred eEEEEEEec----CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee
Q 004395 466 MLIGFCIED----RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541 (756)
Q Consensus 466 ~l~~~~~~~----~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL 541 (756)
++++++... ...||||||+ +++|.+++.. ....+++..++.++.||+.||+|||+. ||+||||||+||||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill 185 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLL 185 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEE
Confidence 999999875 4589999999 9999999975 456799999999999999999999999 99999999999999
Q ss_pred c--CCCcceeeccccceecCCCCCC------cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004395 542 T--HDFEPLVGDFGLARWQPDGDMG------VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNR 613 (756)
Q Consensus 542 ~--~~~~vkL~DFGlA~~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 613 (756)
+ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999876533211 1234569999999999999999999999999999999999999997432
Q ss_pred cccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcCc
Q 004395 614 PKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDT 682 (756)
Q Consensus 614 ~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~~ 682 (756)
.... ........ ....+..++++.+.. ...+..+.+++..||..||.+||++.+|++.|+...
T Consensus 266 ~~~~--~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 266 KDPK--YVRDSKIR-YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp TCHH--HHHHHHHH-HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCHH--HHHHHHHH-hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 2211 11111100 011122222222211 122346889999999999999999999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=351.76 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=205.2
Q ss_pred hCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEec--CceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|.. +|+.||||++..... .....|.+|+.+++.++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46899999999999999999998 488999999875432 2345799999999999999999999999887 788999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCc--eEeeccCCCceeecCCCcceeeccccceec
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g--IiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
|||+++|+|.+++.......+++..++.++.||+.||.|||+. + |+||||||+|||++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999865555799999999999999999999998 8 999999999999999999999999887643
Q ss_pred CCCCCCcccccccCccccCccccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITE---KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~---ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
.. ....||+.|+|||++.+..++. ++|||||||++|||++|+.||........ . ......
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~-----~~~~~~ 226 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------G-----MKVALE 226 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------H-----HHHHHS
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------H-----HHHHhc
Confidence 22 2346899999999998765544 89999999999999999999964432110 0 000111
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+ ..+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 227 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 227 GLRP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp CCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111 2233344578999999999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=369.21 Aligned_cols=253 Identities=19% Similarity=0.221 Sum_probs=195.4
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.++|.+.+.||+|+||.||++... +++.||||++.... .....+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999954 79999999887543 3346789999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc--ceeeccccceecCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE--PLVGDFGLARWQPDG 561 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~--vkL~DFGlA~~~~~~ 561 (756)
+.+|+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999964 35799999999999999999999999 9999999999999987766 999999999744322
Q ss_pred CCCcccccccCccccCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEK-ADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~k-sDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ..... ..+....
T Consensus 172 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~---------~~~~~~~ 238 (361)
T 3uc3_A 172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTI---------QRILSVK 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHH---------HHHHTTC
T ss_pred C--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHH---------HHHhcCC
Confidence 2 2234579999999999988888655 9999999999999999999975432211 11100 1111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
............+.+|+.+||..||++|||+.|++++
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1111111233568899999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=367.98 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=205.7
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+|+.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999995 67999999987643 223345789999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+ +|+|.+++.. .+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 8999998864 35799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
+. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..+...
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~ 223 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSC 223 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSS
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcC
Confidence 43 2345679999999999988776 78999999999999999999999754322110 000000
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....+......+.+|+.+||..||.+|||+.|+++.
T Consensus 224 --~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 --VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011222334568899999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.42 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=202.9
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCE----EEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQA----VAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~----VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
.++|++.+.||+|+||.||+|.. .+++. ||+|.+.... ......+.+|+.++..++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 46899999999999999999995 34554 7888765433 334457889999999999999999999986 56789
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999974 345799999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 559 PDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 559 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......... .. +...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~-----~~~~ 233 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DL-----LEKG 233 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HH-----HHTT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-------HH-----HHcC
Confidence 54432 22344568889999999999999999999999999999999 99999754322110 00 0000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
... ..+......+.+++.+||..||.+||++.++++.|+..
T Consensus 234 ~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 234 ERL----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp CBC----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred CCC----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011 11112223478899999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=365.34 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=204.6
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-----CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-----~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45799999999999999999995 479999999875321 223567999999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc---ceeeccc
Q 004395 479 LVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDFG 553 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~---vkL~DFG 553 (756)
+|||||.+++|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999998888542 345689999999999999999999999 9999999999999987655 9999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ... ..... ..
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~----~~i~~-~~- 248 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLF----EGIIK-GK- 248 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHH----HHHHH-TC-
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHH----HHHHc-CC-
Confidence 9987765332 23446799999999999999999999999999999999999999964311 000 00000 00
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....+... ......+.+|+.+||..||++|||+.+++++
T Consensus 249 -~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 249 -YKMNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -CCCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -CCCCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000000 1123468899999999999999999999873
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.98 Aligned_cols=246 Identities=23% Similarity=0.243 Sum_probs=194.7
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc--CchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~L 479 (756)
..++|++.+.||+|+||.||+|... +|+.||||++...... ....+..|+..+..+ +||||++++++|.+....|+
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3468999999999999999999965 7999999987643322 223455666666555 89999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+ +++|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 135 v~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 88999988753 45799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... + ..+...
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~----------~~~~~~ 267 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------W----------QQLRQG 267 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------H----------HHHTTT
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------H----------HHHhcc
Confidence 432 2334569999999999876 789999999999999999999776632110 0 000010
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.....+.......+.+++.+||+.||++|||+.++++
T Consensus 268 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0000111123356899999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=393.62 Aligned_cols=262 Identities=27% Similarity=0.372 Sum_probs=215.0
Q ss_pred hHHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 398 YAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 398 ~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
...+++..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|+.++||||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 344566778999999999999999999998888889999987543 345689999999999999999999999876 678
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
||||||+.+|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999999754446799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
.............++..|+|||++.+..++.++|||||||+||||++ |+.||....... .... +..
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~------~~~~------i~~- 479 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQ------VER- 479 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH------HHHH------HHT-
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH------HHc-
Confidence 54322112223456789999999999999999999999999999999 999996433210 0000 000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
......+..+...+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 480 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 480 ---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011112233445789999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=368.58 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=191.8
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
...++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+|+++|.+++||||++++++|.+....++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 45678999999999999999999964 68899999887442 3456889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---CCcceeeccccceec
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQ 558 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~~~vkL~DFGlA~~~ 558 (756)
||+.+++|.+++. ..+.+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999996 346799999999999999999999999 9999999999999975 899999999999865
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ .+ .... .. .
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~----~~i~-----~~--~ 267 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MF----RRIL-----NC--E 267 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HH----HHHH-----TT--C
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HH----HHHH-----hC--C
Confidence 4332 23446799999999999999999999999999999999999999964432110 00 0000 00 0
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..............+.+|+.+||..||++|||+.++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111122344568899999999999999999999883
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=365.47 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=194.9
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEecC-C---CEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEec
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLPD-G---QAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g---~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~ 474 (756)
+.+..++|.+.+.||+|+||.||+|.... + ..||||+++.. .......+.+|+++++.++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 44566789999999999999999999543 3 27999988654 233456799999999999999999999999887
Q ss_pred Cce------eEEEEeecCCChhhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC
Q 004395 475 RRR------LLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (756)
Q Consensus 475 ~~~------~LV~Ey~~ggsL~~~L~~~----~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~ 544 (756)
... ++||||+.+|+|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||++.+
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCMLAED 173 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTT
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEEcCC
Confidence 655 9999999999999999542 223699999999999999999999999 99999999999999999
Q ss_pred CcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhh
Q 004395 545 FEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTE 622 (756)
Q Consensus 545 ~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~ 622 (756)
+.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----- 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI----- 248 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-----
Confidence 9999999999987654332 12223457889999999999999999999999999999999 9999975432211
Q ss_pred hhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 623 WARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 623 ~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.... ... .....+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 249 -~~~~------~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 295 (323)
T 3qup_A 249 -YNYL------IGG----NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295 (323)
T ss_dssp -HHHH------HTT----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHH------hcC----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0000 000 0111223344578999999999999999999999999885
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=362.71 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=205.8
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||+|+++.. .......+.+|+.+|+.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 35799999999999999999995 47999999988643 223455788999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999974 45799999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .+....
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~---------~i~~~~ 219 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYE---------KILNAE 219 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH---------HHHHCC
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHH---------HHHhCC
Confidence 2 235679999999999999999999999999999999999999996432210 000 011100
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
..++......+.+++.+||..||.+|| ++.+++++
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 012223345688999999999999999 88888763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=369.32 Aligned_cols=267 Identities=20% Similarity=0.278 Sum_probs=206.1
Q ss_pred hCCeeEEEEeccc--CceEEEEEEec-CCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEG--GFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G--~fG~Vy~a~~~-~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.++|++.+.||+| +||.||+|... +|+.||||++..... .....+.+|+.+|+.++||||+++++++.+.+..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999964 799999999875432 233568889999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+|+|.+++.......+++..++.++.||+.||+|||+. ||+||||||+||||+.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999866567899999999999999999999999 99999999999999999999999999987543
Q ss_pred CCC------CCcccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh--
Q 004395 560 DGD------MGVETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE-- 629 (756)
Q Consensus 560 ~~~------~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~-- 629 (756)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcc
Confidence 211 111223478999999999987 6789999999999999999999999975433221 1100000000
Q ss_pred --hh------------------hhhhccC---C------ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 --EY------------------AIDELVD---P------RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 --~~------------------~i~~l~d---p------~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .+..... + .....+.......+.+|+.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0000000 0 00001222334568999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=371.93 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=206.1
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+++|..++||||++++++|.+....|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46899999999999999999995 46899999987543 233456788999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.||+|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+||||+.+|.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999997 456799999999999999999999999 999999999999999999999999999997654
Q ss_pred CCCCcccccccCccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQS---GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..........+. .. +.. .
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-------~~--~~~-~ 235 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-------HT--FET-T 235 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH-------HH--HHH-C
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH-------HH--Hhh-c
Confidence 32 3355789999999999964 45899999999999999999999999754332111000 00 000 0
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR-MSQVLR 676 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-~~eVL~ 676 (756)
. ..++......+.+|+.+||..||.+||+ +.+|++
T Consensus 236 ~----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 V----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred c----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1 1122334457899999999999999998 777765
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=355.91 Aligned_cols=266 Identities=23% Similarity=0.280 Sum_probs=200.2
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.++|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+|+++++.++||||+++++++.+....++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999964 6999999987654322 2356889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998886 456799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhh-hhhhhhh----hhh---
Q 004395 562 DMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTE-WARPLLE----EYA--- 632 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~-~~~~~~~----~~~--- 632 (756)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||............. ....... ...
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22 2334578999999999876 678999999999999999999999997654322211000 0000000 000
Q ss_pred -hhhccCCccCCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 633 -IDELVDPRLGNHY-----SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 633 -i~~l~dp~l~~~~-----~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
......+...... .......+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000 01234468899999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=378.76 Aligned_cols=254 Identities=20% Similarity=0.242 Sum_probs=205.6
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+++|+.++||||+++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456899999999999999999984 5799999998865432 2335688999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec---CCCcceeecccccee
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT---HDFEPLVGDFGLARW 557 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~---~~~~vkL~DFGlA~~ 557 (756)
|||+.||+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999974 46799999999999999999999999 999999999999998 468899999999987
Q ss_pred cCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||....... ...... ....
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~----------~~~~i~-~~~~ 230 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR----------LYQQIK-AGAY 230 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----------HHHHHH-HTCC
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH----------HHHHHH-hCCC
Confidence 654332 2345679999999999999999999999999999999999999996432210 000000 0000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+...........+.+|+.+||+.||++|||+.|++++
T Consensus 231 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 --DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01111112334568899999999999999999999884
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.07 Aligned_cols=261 Identities=18% Similarity=0.229 Sum_probs=202.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEE-EecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC-IEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~-~~~~~~~LV~ 481 (756)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+|++++..++|+|++..+.++ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999994 678999999865433 234688999999999987766665554 6677789999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee---cCCCcceeeccccceec
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQ 558 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL---~~~~~vkL~DFGlA~~~ 558 (756)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999964 345799999999999999999999999 99999999999999 78999999999999876
Q ss_pred CCCCC------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 559 PDGDM------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 559 ~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 54332 122356799999999999999999999999999999999999999976443322111110000000000
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.. ..... .+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 239 ~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 IE-----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HH-----HHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hh-----hhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00 00111 234689999999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.74 Aligned_cols=271 Identities=25% Similarity=0.288 Sum_probs=213.1
Q ss_pred hCCeeEEEEecccCceEEEEEEe-----cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEE--ecCce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI--EDRRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~--~~~~~ 477 (756)
.++|++.+.||+|+||.||+|.+ .+++.||||++..........+.+|+++|++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999983 468899999987665555567999999999999999999999987 45568
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|+||||+.+++|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999999652 34699999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 558 QPDGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 558 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .............+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHHH
Confidence 6543321 223356888899999999999999999999999999999999998532211000 0000000000011111
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.+........+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1122222233444556789999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=371.50 Aligned_cols=257 Identities=20% Similarity=0.268 Sum_probs=203.6
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~L 479 (756)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... ......+..|..+|.++ +||||++++++|.+....||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 45899999999999999999995 468899999886542 23345688999999887 79999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.||+|.+++.. .+.+++..++.++.||+.||+|||+. ||+||||||+||||+.++.+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999974 35799999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||............ ...... ..+...
T Consensus 205 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~--~~~~~~----~~i~~~ 277 (396)
T 4dc2_A 205 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--TEDYLF----QVILEK 277 (396)
T ss_dssp CTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C--CHHHHH----HHHHHC
T ss_pred cCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh--hHHHHH----HHHhcc
Confidence 222 2345578999999999999999999999999999999999999999644322110000 000000 001111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRM------SQVLR 676 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~------~eVL~ 676 (756)
. ..++......+.+||.+||+.||.+||++ .+|++
T Consensus 278 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 278 Q--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred c--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 0 11223344568899999999999999985 56655
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=347.94 Aligned_cols=261 Identities=18% Similarity=0.229 Sum_probs=205.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEE-EecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC-IEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~-~~~~~~~LV~ 481 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++..++|++++..+.++ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999995 689999999876543 335689999999999988766555544 6667789999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee---cCCCcceeeccccceec
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQ 558 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL---~~~~~vkL~DFGlA~~~ 558 (756)
||+ +++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 9999999964 346799999999999999999999999 99999999999999 48899999999999876
Q ss_pred CCCCCC------cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 559 PDGDMG------VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 559 ~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 544321 12456799999999999999999999999999999999999999976443222111110000000000
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.. .+.. ..+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 239 ~~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 239 IE-----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HH-----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hH-----HHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 00 0111 1234688999999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=355.16 Aligned_cols=262 Identities=28% Similarity=0.445 Sum_probs=198.0
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
.++..++|.+.+.||+|+||.||+|... ..||||+++..... ....|.+|+++|+.++||||+.+++++ .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 3566789999999999999999999853 35999988754332 335689999999999999999999975 456789
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999999964 456799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC-CCcccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 559 PDGD-MGVETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 559 ~~~~-~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
.... ........||+.|+|||++. +..++.++||||||+++|+|++|+.||........ ...... .
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~----~ 240 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVG----R 240 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHH----H
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhc----c
Confidence 4321 12233467999999999986 66789999999999999999999999975432211 000001 1
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
....+.+ .......+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 241 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 241 GSLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp TSCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111111 112233446789999999999999999999999999853
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=361.03 Aligned_cols=266 Identities=27% Similarity=0.351 Sum_probs=208.4
Q ss_pred CeeEEEEecccCceEEEEEEe-----cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEec--Ccee
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRL 478 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~--~~~~ 478 (756)
.|++.+.||+|+||.||++.+ .+|+.||||++..... .....+.+|+++|+.++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 359999999999999999863 2688999999875432 2345689999999999999999999999874 5789
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 112 lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999964 3599999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCC--CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 559 PDGDM--GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 559 ~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
..... .......||..|+|||++.+..++.++||||||+++|+|++|..||........ ....+.........+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHH
Confidence 65432 122345688899999999999999999999999999999999999864221100 000111111111112222
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+........+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 22222223344455679999999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=358.86 Aligned_cols=265 Identities=25% Similarity=0.311 Sum_probs=200.7
Q ss_pred hCCeeEE-EEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEE
Q 004395 405 TGGFSQA-NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 405 ~~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.+.|.+. +.||+|+||.||+|.. .+++.||||++..........+.+|+++|.++ +||||+++++++.+.+..|+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3578884 7899999999999994 57999999998766555667899999999985 7999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc---ceeeccccceec
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDFGLARWQ 558 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~---vkL~DFGlA~~~ 558 (756)
||+.+++|.+++.. ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999974 35799999999999999999999999 9999999999999998776 999999999865
Q ss_pred CCCCC------CcccccccCccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh
Q 004395 559 PDGDM------GVETRVIGTFGYLAPEYAQS-----GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 559 ~~~~~------~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||................+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11223569999999999875 56889999999999999999999999765432211100000000
Q ss_pred hhhhhhhhccCCccCCCCCh----hHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 LEEYAIDELVDPRLGNHYSE----HEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 ~~~~~i~~l~dp~l~~~~~~----~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
........+..... .++. .....+.+|+.+||..||++|||+.++++.
T Consensus 245 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000011111100 1111 123568899999999999999999999883
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=362.80 Aligned_cols=260 Identities=21% Similarity=0.195 Sum_probs=202.2
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc-----CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEec
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA-----SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~-----~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~ 474 (756)
+....++|.+.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+++|+.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 556678999999999999999999995 57889999987543 233456799999999999999999999999999
Q ss_pred CceeEEEEeecCCChhhhhhcc--------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 004395 475 RRRLLVYEYICNGSLDSHLYGC--------------------------------------HQEPLEWSARQKIAVGAARG 516 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~--------------------------------------~~~~L~~~~~~~ia~qIa~a 516 (756)
+..++||||+.+|+|.+++... ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988421 01234677888999999999
Q ss_pred HHHHHhhcccCceEeeccCCCceeecCCC--cceeeccccceecCCCC---CCcccccccCccccCcccccc--CCCCch
Q 004395 517 LRYLHEECRVGCIVHRDMRPNNILLTHDF--EPLVGDFGLARWQPDGD---MGVETRVIGTFGYLAPEYAQS--GQITEK 589 (756)
Q Consensus 517 L~yLH~~~~~~gIiHrDLKp~NILL~~~~--~vkL~DFGlA~~~~~~~---~~~~~~~~Gt~~Y~APE~l~~--~~~s~k 589 (756)
|+|||+. ||+||||||+|||++.++ .+||+|||+++.+.... ........||+.|+|||++.+ ..++.+
T Consensus 181 l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 181 LHYLHNQ----GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHT----TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHC----CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999 999999999999998776 89999999998654322 112345679999999999865 678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCC
Q 004395 590 ADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP 669 (756)
Q Consensus 590 sDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP 669 (756)
+|||||||++|||++|+.||........ ..... ... ..+...........+.+++.+||..||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~-----~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVL-----NKK--LCFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-----HCC--CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHH-----hcc--cccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999965432111 00000 000 0000011112345688999999999999999
Q ss_pred CHHHHHHH
Q 004395 670 RMSQVLRI 677 (756)
Q Consensus 670 S~~eVL~~ 677 (756)
++.++++.
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999883
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=358.32 Aligned_cols=252 Identities=24% Similarity=0.308 Sum_probs=206.2
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc------CchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~------~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
.++|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+|+.+|..++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457999999999999999999954 6899999988654322 245699999999999999999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC----cceeeccc
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFG 553 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~----~vkL~DFG 553 (756)
++||||+.+++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997 356799999999999999999999999 999999999999999888 79999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ +.. +
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----------i 230 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN----------I 230 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH----------H
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--HHH----------H
Confidence 998765433 22445799999999999999999999999999999999999999965432110 000 0
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
... ...............+.+++.+||..||++|||+.+++++
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 231 TSV-SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HTT-CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred Hhc-ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000001223468899999999999999999999883
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=353.87 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=203.2
Q ss_pred hhCCeeEEEEecccCceEEEEEEecC----CCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
..++|.+.+.||+|+||.||+|.... +..||+|.+..... .....|.+|+.+++.++||||+++++++.+ +..|
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998532 34699998775432 334678999999999999999999999865 4579
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999965 345699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
............+++.|+|||++.+..++.++||||||+++|||++ |+.||........ . .. +....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~---~~------~~~~~ 231 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---I---GV------LEKGD 231 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---H---HH------HHHTC
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---H---HH------HhcCC
Confidence 5543333344567889999999999999999999999999999998 9999964432211 0 00 00000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. ..+......+.+++.+||..||++||++.++++.|+.
T Consensus 232 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 232 RL----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 11 1122234568899999999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=349.34 Aligned_cols=250 Identities=20% Similarity=0.240 Sum_probs=205.2
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.++|.+.+.||+|+||.||+|... ++..||+|++..........+.+|+++++.++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457999999999999999999954 5789999998766666677899999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee---cCCCcceeeccccceecCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL---~~~~~vkL~DFGlA~~~~~ 560 (756)
+.+++|.+++.. ...+++..++.++.|++.||+|||+. ||+||||||+|||+ +.++.++|+|||++.....
T Consensus 88 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999874 45699999999999999999999999 99999999999999 7889999999999987654
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.. ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||........ . .. +... ...
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~--------~~--~~~~-~~~ 225 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--M--------LK--IREG-TFT 225 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H--------HH--HHHC-CCC
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--H--------HH--HHhC-CCC
Confidence 33 23445799999999998754 89999999999999999999999965432110 0 00 0000 000
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
............+.+++.+||+.||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000012356889999999999999999999976
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.87 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=205.6
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+++++.++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 357899999999999999999995 4689999998865432 2335688999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc---ceeecccccee
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDFGLARW 557 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~---vkL~DFGlA~~ 557 (756)
|||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988864 35799999999999999999999999 9999999999999987655 99999999987
Q ss_pred cCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .........
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----------~~~~~~~~~- 224 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL----------YAQIKAGAY- 224 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHHHTCC-
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH----------HHHHHhccc-
Confidence 65433 22346799999999999999999999999999999999999999964332110 000000000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.............+.+++.+||+.||++|||+.++++.
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 225 --DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00111112234568899999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=363.61 Aligned_cols=261 Identities=25% Similarity=0.358 Sum_probs=210.0
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec-CC-----CEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP-DG-----QAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g-----~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~ 472 (756)
++...++|.+.+.||+|+||.||+|... ++ ..||+|.+..... .....+.+|+.+|+.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4556689999999999999999999953 23 4899998875432 2345689999999999 8999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCcee
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCH------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 540 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NIL 540 (756)
+.+..|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+|||
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNVL 196 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGCE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceEE
Confidence 9999999999999999999996431 35689999999999999999999999 9999999999999
Q ss_pred ecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccccc
Q 004395 541 LTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQ 618 (756)
Q Consensus 541 L~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~ 618 (756)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 99999999999999986543321 12234557889999999999999999999999999999998 9999965432111
Q ss_pred chhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 619 CLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 619 ~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+ .... ...... ..+......+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 276 -~----~~~~-----~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 276 -F----YKLV-----KDGYQM----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp -H----HHHH-----HHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -H----HHHH-----hcCCCC----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 0 0000 111111 1122234568899999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=366.00 Aligned_cols=245 Identities=21% Similarity=0.243 Sum_probs=205.5
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+|..++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999995 47999999987543 2234567889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+|+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999974 35699999999999999999999999 9999999999999999999999999999876442
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ... .+....
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~---------~i~~~~- 254 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYE---------KIVSGK- 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHHCC-
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHH---------HHHcCC-
Confidence 235679999999999999999999999999999999999999996543210 000 000000
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~~ 677 (756)
..++......+.+++.+||+.||.+||+ +.+|+++
T Consensus 255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0122233456899999999999999998 8888763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=360.97 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=196.7
Q ss_pred hhCCeeEEEEecccCceEEEEEEe----cCCCEEEEEEecccC----CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~~~~~~----~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|+.+|+.++||||+++++++.+.+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 346899999999999999999985 478999999887542 223456888999999999999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..|+||||+.+++|.+++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999974 35789999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... ..
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~-----~~ 236 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDKIL-----KC 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHH-----HT
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-----hC
Confidence 8543322 12344679999999999999999999999999999999999999996543210 000000 00
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
.. .++......+.+++.+||..||.+|| ++.+++++
T Consensus 237 --~~----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 237 --KL----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --CC----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --CC----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 01 12223345688999999999999999 77888773
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=378.32 Aligned_cols=263 Identities=21% Similarity=0.216 Sum_probs=210.4
Q ss_pred ChHHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEE
Q 004395 397 SYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~ 472 (756)
.+.++....++|.+.+.||+|+||.||+|.. .+|+.||||+++.. .......+.+|..+|..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3455666778999999999999999999996 47999999988642 1223456889999999999999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecc
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
+.+..||||||+.||+|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+||||+.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999742 35799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCcccccccCccccCccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQ-------SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~-------~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 625 (756)
|+++.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||........ ..
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~ 280 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------YG 280 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------HH
Confidence 999877554332334568999999999987 45789999999999999999999999965432111 00
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSR---PRMSQVLRI 677 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~R---PS~~eVL~~ 677 (756)
..... ...+..+.. .......+.+||.+||. +|.+| |++.+++++
T Consensus 281 ~i~~~--~~~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIVHY--KEHLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHTH--HHHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhc--ccCcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 10000 001111211 12233468899999999 99998 589999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.67 Aligned_cols=251 Identities=20% Similarity=0.318 Sum_probs=203.6
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CC-------CEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DG-------QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g-------~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
..++|.+.+.||+|+||.||+|... ++ ..||+|++..........+.+|+++++.++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3568999999999999999999843 33 479999987666566678999999999999999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc--------c
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE--------P 547 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~--------v 547 (756)
..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999975 334599999999999999999999999 9999999999999998887 9
Q ss_pred eeeccccceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhh
Q 004395 548 LVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626 (756)
Q Consensus 548 kL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 626 (756)
||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+........ .. .
T Consensus 161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~----~ 229 (289)
T 4fvq_A 161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KL----Q 229 (289)
T ss_dssp EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH----H
T ss_pred eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HH----H
Confidence 9999999864432 234568999999999987 7789999999999999999996554432211100 00 0
Q ss_pred hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.. .. ...+.... ...+.+++.+||+.||++|||+.++++.|+..
T Consensus 230 ~~-----~~--~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 230 FY-----ED--RHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp HH-----HT--TCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred Hh-----hc--cCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 00 00 11111111 23478999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=369.80 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=200.2
Q ss_pred hCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCC--cCchhHHHHHHHHHhcC--CCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQ--HRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~--HpNIV~l~~~~~~~~~~~LV 480 (756)
..+|.+.+.||+|+||.||+|...+++.||||++..... .....+.+|+++|..++ ||||+++++++......|||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 356999999999999999999987899999998865432 23467899999999996 59999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|| +.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 568999999974 35789999999999999999999999 999999999999995 58999999999987654
Q ss_pred CCCC-cccccccCccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh
Q 004395 561 GDMG-VETRVIGTFGYLAPEYAQS-----------GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL 628 (756)
Q Consensus 561 ~~~~-~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 628 (756)
.... .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------------ 274 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------------ 274 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH------------
Confidence 3221 2345679999999999865 468999999999999999999999996432110
Q ss_pred hhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 629 ~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+..++++.....++......+.+|+.+||..||.+|||+.++++.
T Consensus 275 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 275 --SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 01112222222222233334568899999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=350.09 Aligned_cols=246 Identities=24% Similarity=0.392 Sum_probs=205.7
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEe---------
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--------- 473 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--------- 473 (756)
..++|.+.+.||+|+||.||+|... +|+.||+|++.... ..+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467999999999999999999965 79999999887542 467899999999999999999998864
Q ss_pred -------cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc
Q 004395 474 -------DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (756)
Q Consensus 474 -------~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~ 546 (756)
....++||||+.+++|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCCCC
Confidence 44589999999999999999765567899999999999999999999999 9999999999999999999
Q ss_pred ceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhh
Q 004395 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626 (756)
Q Consensus 547 vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 626 (756)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+... ..
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~---- 226 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK---- 226 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH----
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH----
Confidence 9999999998765433 223456999999999999999999999999999999999999886311 00
Q ss_pred hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. ...+....+... ....+.+++.+||..||.+|||+.++++.|+.
T Consensus 227 ~-----~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 227 F-----FTDLRDGIISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp H-----HHHHHTTCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H-----HHHhhccccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0 011111112122 23458899999999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=369.49 Aligned_cols=248 Identities=24% Similarity=0.281 Sum_probs=198.4
Q ss_pred eEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecCC
Q 004395 409 SQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (756)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~gg 487 (756)
...+.||+|+||.||+|.. .+|+.||+|+++.........+.+|+++|.+++||||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3467899999999999995 579999999988665555678999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee--cCCCcceeeccccceecCCCCCCc
Q 004395 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL--THDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 488 sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL--~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+|.+++.. ....+++..++.++.||+.||+|||+. ||+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 172 ~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 172 ELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp EEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 99998864 345699999999999999999999999 99999999999999 567889999999999775433 2
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~ 645 (756)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.. .. .... .+....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~----i~-----~~~~--~~~~~~ 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNN----IL-----ACRW--DLEDEE 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHH----HH-----HTCC--CSCSGG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HH-----hccC--CCChhh
Confidence 2345699999999999999999999999999999999999999965432110 000 00 0000 000001
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 646 ~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.......+.+|+.+||+.||.+|||+.++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1123356899999999999999999999988
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=352.86 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=207.5
Q ss_pred hhCCeeEEE-EecccCceEEEEEEec---CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 404 ATGGFSQAN-FLAEGGFGSVHRGVLP---DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 404 ~~~~y~~~~-~LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
..++|.+.. .||+|+||.||+|... ++..||||+++.... .....+.+|++++..++||||+++++++ ..+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 346787777 9999999999999843 678899999876432 3345789999999999999999999999 556789
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 86 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999999964 456799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 559 PDGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 559 ~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
...... ......||+.|+|||++.+..++.++||||||+++|||++ |+.||........ . . .+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~-~-----~i~~ 228 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------M-A-----FIEQ 228 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH------H-H-----HHHT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH------H-H-----HHhc
Confidence 543221 1223456889999999998899999999999999999998 9999965432110 0 0 0011
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... ...+......+.+++.+||..||.+||++.++++.|+.
T Consensus 229 ~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 229 GKR----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp TCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCc----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011 12233445678999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=358.32 Aligned_cols=266 Identities=24% Similarity=0.327 Sum_probs=213.5
Q ss_pred CChHHHHHhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCCc-CchhHHHHHHHHHhc-CCCCeeeE
Q 004395 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVML 467 (756)
Q Consensus 396 ~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L-~HpNIV~l 467 (756)
+....++...++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+++|..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 35566777889999999999999999999983 35689999998754332 335688999999999 69999999
Q ss_pred EEEEEecC-ceeEEEEeecCCChhhhhhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEee
Q 004395 468 IGFCIEDR-RRLLVYEYICNGSLDSHLYGCHQ--------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532 (756)
Q Consensus 468 ~~~~~~~~-~~~LV~Ey~~ggsL~~~L~~~~~--------------~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHr 532 (756)
++++...+ ..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||+. ||+||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~ 172 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHR 172 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCCS
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----Ccccc
Confidence 99988755 48999999999999999975332 2389999999999999999999999 99999
Q ss_pred ccCCCceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 004395 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVD 610 (756)
Q Consensus 533 DLKp~NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~ 610 (756)
||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986654322 22334568899999999999999999999999999999998 999996
Q ss_pred CCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 611 LNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 611 ~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
....... .. .. +....... .+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 253 ~~~~~~~-----~~-~~-----~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 253 GVKIDEE-----FC-RR-----LKEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp TCCCSHH-----HH-HH-----HHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccchhHH-----HH-HH-----hccCccCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 5432211 00 00 01101111 122233568899999999999999999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=361.84 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=208.3
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe--------cCCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL--------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~ 472 (756)
+..++|.+.+.||+|+||.||+|.. .++..||||++..... .....+.+|++++..+ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3457899999999999999999985 3577899998875432 2345688999999999 8999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCc
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~N 538 (756)
+.+..|+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+|
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~N 187 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARN 187 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGG
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCccce
Confidence 9999999999999999999997532 23589999999999999999999999 99999999999
Q ss_pred eeecCCCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 004395 539 ILLTHDFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKG 616 (756)
Q Consensus 539 ILL~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~ 616 (756)
||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 99999999999999999876543221 1233457889999999999999999999999999999999 999996543210
Q ss_pred ccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 617 ~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.... +...... ..+......+.+++.+||..||.+|||+.++++.|+..
T Consensus 268 ------~~~~------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 268 ------LFKL------LKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ------HHHH------HHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHH------HhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000 0110111 12223345689999999999999999999999999853
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=359.00 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=191.1
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+++|+.++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 36899999999999999999995 4789999998875543 344678999999999999999999999999999999999
Q ss_pred eecCCChhhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 483 YICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 483 y~~ggsL~~~L~~~----~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
|+. ++|.+++... ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 996 6999988542 235699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hhhhhh----hhhhh-
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TEWARP----LLEEY- 631 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~~----~~~~~- 631 (756)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ...... .....
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 53321 2234578999999999976 4689999999999999999999999975443211100 000000 00000
Q ss_pred hhhhccCCccCC------------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 632 AIDELVDPRLGN------------HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 632 ~i~~l~dp~l~~------------~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.... ..+.+.. .........+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPK-YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTT-CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhh-cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000 0000000 0011223468899999999999999999999873
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=366.26 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=205.2
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCc
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~ 476 (756)
....++|.+.+.||+|+||.||+|.. .+|+.||||+++... ......+..|..+|..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 44567999999999999999999996 468999999886432 33455688899999887 89999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+||||+.||+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999974 35799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... .
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------~~~~i~--~- 232 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----------LFHSIR--M- 232 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------HHHHHH--H-
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH----------HHHHHH--h-
Confidence 643322 22345789999999999999999999999999999999999999996543211 000000 0
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMS-QVLR 676 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~-eVL~ 676 (756)
..+. ++......+.+++.+||..||.+||++. +|++
T Consensus 233 ~~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 233 DNPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CCCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 0111 2223345688999999999999999997 6544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=361.99 Aligned_cols=272 Identities=24% Similarity=0.332 Sum_probs=210.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-----cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC--c
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR--R 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~--~ 476 (756)
..++|++.+.||+|+||.||+|.+ .+|+.||||++..........+.+|+++|+.++||||+++++++.... .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 346799999999999999999983 468999999987665555668999999999999999999999987654 6
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 8999999999999999975 345699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 557 WQPDGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 557 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
........ ......++..|+|||++.+..++.++||||||+++|||+||..||.......................+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 76543321 1223457788999999999899999999999999999999999885321000000000000000000111
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+.+........+......+.+++.+||..||++|||+.+|++.|+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111111112233445678999999999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.83 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=195.7
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcC---chhHHHHHHHHHhcCCCCeeeEEEEEEecCce--
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR-- 477 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~---~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~-- 477 (756)
..++|.+.+.||+|+||.||+|.. .+++.||||++....... ...|.+|++++..++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999994 678999999987643332 34688999999999999999999998876544
Q ss_pred --eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 478 --LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 478 --~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
|+||||+.+++|.+++.. .+++++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999999999974 35799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC--CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 556 RWQPDGDM--GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 556 ~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~---- 233 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVR---- 233 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHH----
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhc----
Confidence 86654321 122345799999999999999999999999999999999999999975432111 000000
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.....+ ..........+.+++.+||+.||++||++.+++.
T Consensus 234 ~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 234 EDPIPP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCCCH---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCCCc---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 000000 0001122346889999999999999997777664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=363.69 Aligned_cols=257 Identities=20% Similarity=0.266 Sum_probs=203.7
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc---CchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~L 479 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+|..+ +||||+++++++.+....|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 35799999999999999999995 46899999998754322 234588899999988 89999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+|+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999974 35799999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...... ..+...
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~----~~i~~~ 234 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--TEDYLF----QVILEK 234 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------CHHHHH----HHHHHC
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc--cHHHHH----HHHHcC
Confidence 322 2234568999999999999999999999999999999999999999643221110000 000000 000011
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRM------SQVLR 676 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~------~eVL~ 676 (756)
. ..++......+.+++.+||..||.+||++ .++++
T Consensus 235 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 235 Q--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred C--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 0 11223344568899999999999999995 56654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=354.65 Aligned_cols=269 Identities=25% Similarity=0.318 Sum_probs=202.9
Q ss_pred HHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhc--CCCCeeeEEEEEEec--
Q 004395 399 AELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA--QHRNVVMLIGFCIED-- 474 (756)
Q Consensus 399 ~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L--~HpNIV~l~~~~~~~-- 474 (756)
.......++|.+.+.||+|+||.||+|... |+.||||++... ....+..|.+++..+ +||||+++++++.+.
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334556679999999999999999999874 899999987532 234566677776655 899999999999887
Q ss_pred --CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc----ccCceEeeccCCCceeecCCCcce
Q 004395 475 --RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILLTHDFEPL 548 (756)
Q Consensus 475 --~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~----~~~gIiHrDLKp~NILL~~~~~vk 548 (756)
...|+||||+.+|+|.+++.. ..+++..++.++.|++.||.|||+.+ ...||+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 678999999999999999964 46999999999999999999999762 112799999999999999999999
Q ss_pred eeccccceecCCCCCCc---ccccccCccccCccccccCCCCch------hhHHHHHHHHHHHHhC----------CCCC
Q 004395 549 VGDFGLARWQPDGDMGV---ETRVIGTFGYLAPEYAQSGQITEK------ADVYSFGVVLVELVTG----------RKAV 609 (756)
Q Consensus 549 L~DFGlA~~~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~k------sDVwSlGvvL~ELltG----------~~Pf 609 (756)
|+|||+++......... .....||+.|+|||++.+..++.. +|||||||++|||++| ..||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999998765433211 124579999999999987766654 9999999999999999 4444
Q ss_pred CCCCcccccchhhhhhhhhhhhhhhhccCCccCCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 610 DLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH-YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 610 ~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~-~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
......... ..............+.+... ........+.+++.+||+.||++|||+.+|++.|+.
T Consensus 263 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 263 HDLVPSDPS------YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TTTSCSSCC------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhhcCCCCc------hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 332221110 00000001111111211111 122567789999999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=361.43 Aligned_cols=243 Identities=22% Similarity=0.264 Sum_probs=203.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--------CchhHHHHHHHHHhcCCCCeeeEEEEEEec
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--------GDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--------~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~ 474 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+++|+.++||||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346899999999999999999994 57899999988754321 234678899999999999999999999999
Q ss_pred CceeEEEEeecCC-ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 475 RRRLLVYEYICNG-SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 475 ~~~~LV~Ey~~gg-sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
+..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999766 9999997 455799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
+++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|..||......
T Consensus 176 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 176 SAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp TCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred cceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 998775543 2345679999999999988776 88999999999999999999999531100
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...... .+......+.+|+.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhhccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 111123468899999999999999999999984
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=360.42 Aligned_cols=263 Identities=26% Similarity=0.385 Sum_probs=212.2
Q ss_pred HHHHHhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEE
Q 004395 399 AELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFC 471 (756)
Q Consensus 399 ~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~ 471 (756)
.++++..++|.+.+.||+|+||.||+|... +++.||||.+..... .....|.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 345677789999999999999999999843 478899998864432 2334688999999999999999999999
Q ss_pred EecCceeEEEEeecCCChhhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC
Q 004395 472 IEDRRRLLVYEYICNGSLDSHLYGCH--------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (756)
Q Consensus 472 ~~~~~~~LV~Ey~~ggsL~~~L~~~~--------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~ 543 (756)
.+....++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAE 173 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEEEcC
Confidence 99999999999999999999996421 25679999999999999999999999 9999999999999999
Q ss_pred CCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchh
Q 004395 544 DFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 544 ~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~ 621 (756)
++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----- 248 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----- 248 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-----
Confidence 99999999999986543221 12223457889999999999999999999999999999999 899986432210
Q ss_pred hhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 622 EWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 622 ~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
... .+.... ....+......+.+++.+||..||.+|||+.++++.|+..
T Consensus 249 -~~~---------~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 249 -VLR---------FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp -HHH---------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -HHH---------HHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 000 000000 0111223345688999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.77 Aligned_cols=261 Identities=22% Similarity=0.269 Sum_probs=207.9
Q ss_pred hHHHHHhhCCeeEE-EEecccCceEEEEEEec-CCCEEEEEEecccCC--cCchhHHHHHHHHHhcC-CCCeeeEEEEEE
Q 004395 398 YAELELATGGFSQA-NFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCI 472 (756)
Q Consensus 398 ~~~l~~~~~~y~~~-~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~ 472 (756)
+...+...++|.+. +.||+|+||.||+|... +|+.||||++..... .....+.+|+.++..+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33455667788887 89999999999999954 699999998865432 33467899999999995 699999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---CCccee
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLV 549 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~~~vkL 549 (756)
+....|+||||+.+|+|.+++.......+++..++.++.||+.||+|||+. ||+||||||+|||++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999999765567899999999999999999999999 9999999999999988 789999
Q ss_pred eccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhh
Q 004395 550 GDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 629 (756)
Q Consensus 550 ~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~ 629 (756)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ . .
T Consensus 176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~--------~ 243 (327)
T 3lm5_A 176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--Y--------L 243 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H--------H
T ss_pred eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--H--------H
Confidence 9999998765432 22346799999999999999999999999999999999999999965432111 0 0
Q ss_pred hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 ~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+... ...............+.+++.+||+.||++|||+.++++.
T Consensus 244 --~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 244 --NISQV-NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --HHHHT-CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --HHHhc-ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00110 1111111222334568899999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=345.51 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=205.2
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357999999999999999999964 789999998865432 334678999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999996 346799999999999999999999999 99999999999999999999999999998654322
Q ss_pred -CCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 563 -MGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 563 -~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...+.. ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~-------------~~ 225 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE-------------KK 225 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHT-------------TC
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhh-------------cc
Confidence 112334678999999999987665 78999999999999999999999754332111 111100 00
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
............+.+++.+||..||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000111223456889999999999999999999977
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=369.98 Aligned_cols=267 Identities=24% Similarity=0.320 Sum_probs=192.8
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecC--c
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDR--R 476 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~--~ 476 (756)
...++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+|..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457999999999999999999994 579999999875432 233456889999999997 999999999997544 6
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+|||||. ++|..++.. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999995 799998864 4799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC--------------------CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc
Q 004395 557 WQPDGD--------------------MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPK 615 (756)
Q Consensus 557 ~~~~~~--------------------~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 615 (756)
.+.... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 754311 112344689999999999876 67899999999999999999999999755432
Q ss_pred cccchh-hh----------------hhhhhhhhhhh-hccCCccCCCC------------ChhHHHHHHHHHHHhcccCC
Q 004395 616 GQQCLT-EW----------------ARPLLEEYAID-ELVDPRLGNHY------------SEHEVYCMLHAASLCIRRDP 665 (756)
Q Consensus 616 ~~~~l~-~~----------------~~~~~~~~~i~-~l~dp~l~~~~------------~~~~~~~l~~Li~~CL~~dP 665 (756)
.+.... .. ........... ..........+ .......+.+|+.+||..||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 211000 00 00000000000 00000000000 00223468899999999999
Q ss_pred CCCCCHHHHHHH
Q 004395 666 HSRPRMSQVLRI 677 (756)
Q Consensus 666 ~~RPS~~eVL~~ 677 (756)
++|||+.|++++
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=351.12 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=204.7
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++..........+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 346899999999999999999995 4799999999876554455678999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee---cCCCcceeeccccceecC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQP 559 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL---~~~~~vkL~DFGlA~~~~ 559 (756)
|+.+++|.+++.. .+.+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999864 35799999999999999999999999 99999999999999 788999999999997543
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... ....
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~-----~~~~-- 224 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFEKIK-----EGYY-- 224 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-----HCCC--
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-----cCCC--
Confidence 32 2344579999999999999999999999999999999999999996533210 000000 0000
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.............+.+++.+||..||++|||+.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111222334578999999999999999999999873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=378.14 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=196.6
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+|..++||||++++++|.+.+..|||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46899999999999999999994 57999999988643 233445688899999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|||+.+|+|.+++.. ...+++..++.++.||+.||+|||+ . ||+||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC----CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999964 4579999999999999999999998 7 99999999999999999999999999998543
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ ....... ..
T Consensus 301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------~~~i~~~---~~ 366 (446)
T 4ejn_A 301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------FELILME---EI 366 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHHHC---CC
T ss_pred CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----------HHHHHhC---CC
Confidence 322 223456799999999999999999999999999999999999999964332100 0000000 11
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
.++......+.+|+.+||+.||.+|| ++.+++++
T Consensus 367 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 ----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 12223345689999999999999999 99999873
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=364.92 Aligned_cols=250 Identities=20% Similarity=0.237 Sum_probs=204.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEeccc---CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCcee
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~ 478 (756)
..++|.+.+.||+|+||.||+|... +|+.||||+++.. .......+..|..+|..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999964 5889999988643 223455688899999988 7999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.||+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999974 35799999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .+..
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~---------~i~~ 235 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQ---------SIME 235 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHH
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HHH---------HHHh
Confidence 3222 12345689999999999999999999999999999999999999996543210 000 0000
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~~ 677 (756)
.. ..++......+.+|+.+||..||.+||+ +.+|+++
T Consensus 236 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 236 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 1122334457899999999999999995 5677653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.58 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=196.8
Q ss_pred hCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
.++|.+.+.||+|+||.||+|.. .++.||||.+.. ......|.+|+++|++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 46899999999999999999997 478899998763 234567999999999999999999999886 3589999999
Q ss_pred cCCChhhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc-ceeeccccceecCCCC
Q 004395 485 CNGSLDSHLYGCHQ-EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE-PLVGDFGLARWQPDGD 562 (756)
Q Consensus 485 ~ggsL~~~L~~~~~-~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~-vkL~DFGlA~~~~~~~ 562 (756)
++++|.+++..... ..+++..++.++.|++.||+|||+... .||+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP-KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSS-SCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCC-CCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999975332 257899999999999999999999210 18999999999999998886 799999999755432
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ... .......+..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~------~~~~~~~~~~- 225 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMW------AVHNGTRPPL- 225 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHH------HHHTTCCCCC-
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHH------HHhcCCCCCc-
Confidence 23346999999999999999999999999999999999999999744321110 000 0011111111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.......+.+++.+||+.||++|||+.++++.|+..
T Consensus 226 ---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 226 ---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp ---BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 222335688999999999999999999999999853
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=355.81 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=206.0
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEe----cCce
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRR 477 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~----~~~~ 477 (756)
+..++|.+.+.||+|+||.||++.. .+|+.||||++..........+.+|+++++.++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4457899999999999999999995 6799999998876555556779999999999999999999999873 3478
Q ss_pred eEEEEeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 478 LLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
|+||||+.+|+|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 9999999999999998642 356799999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCC--------cccccccCccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh
Q 004395 556 RWQPDGDMG--------VETRVIGTFGYLAPEYAQSGQ---ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA 624 (756)
Q Consensus 556 ~~~~~~~~~--------~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 624 (756)
......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.......... .
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~--- 257 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-A--- 257 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-H---
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-h---
Confidence 865421111 012345799999999987654 6899999999999999999999985311110000 0
Q ss_pred hhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 625 RPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 625 ~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
..... .............+.+++.+||+.||.+|||+.++++.|+..
T Consensus 258 ------~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 258 ------LAVQN----QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp ------HHHHC----C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ------HHhhc----cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 00000 000111123345689999999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.21 Aligned_cols=258 Identities=23% Similarity=0.344 Sum_probs=197.3
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999995 5799999998875332 2345688999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 481 YEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
|||+.+++|.+++.. .....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999854 2456799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ..... .+.....
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~------~~~~~~~ 255 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK------KIEQCDY 255 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHH------HHHTTCS
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHH------HhhcccC
Confidence 43321 2234568999999999999999999999999999999999999996432210 00000 0011101
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+. .........+.+++.+||..||++|||+.+|++.|+.
T Consensus 256 ~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 256 PP---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp CC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC---CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 11 1112234568899999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.66 Aligned_cols=257 Identities=21% Similarity=0.246 Sum_probs=198.5
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcC---chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~---~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|... +++.||||++....... ...+.+|+.++..++||||+++++++.+++..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999954 78999999987543322 35688999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999974 35799999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
..........|++.|+|||++.+..++.++||||||+++|||++|+.||...... .... .+......
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~-----~~~~~~~~- 253 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGA-----HINQAIPR- 253 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHH-----HHHSCCCC-
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHH-----HhccCCCC-
Confidence 4433344567999999999999999999999999999999999999999643211 0000 00000000
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhcC
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRP-RMSQVLRILEGD 681 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-S~~eVL~~Le~~ 681 (756)
........+..+.+++.+||..||++|| ++.++++.|+..
T Consensus 254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 0011222334688999999999999999 999999999853
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=353.94 Aligned_cols=267 Identities=24% Similarity=0.331 Sum_probs=209.5
Q ss_pred ChHHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHh--cCCCCeeeEEEEEEec
Q 004395 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSC--AQHRNVVMLIGFCIED 474 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~--L~HpNIV~l~~~~~~~ 474 (756)
++.......++|.+.+.||+|+||.||+|.. +|+.||||++... ....+.+|++++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3444556678999999999999999999998 5899999988632 34568889999988 7899999999999887
Q ss_pred C----ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hhcccCceEeeccCCCceeec
Q 004395 475 R----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH--------EECRVGCIVHRDMRPNNILLT 542 (756)
Q Consensus 475 ~----~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH--------~~~~~~gIiHrDLKp~NILL~ 542 (756)
. ..|+||||+.+|+|.+++.. ..+++..++.++.|++.||.||| +. +|+||||||+|||++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----AIAHRDLKSKNILVK 181 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC----EEECSCCSGGGEEEC
T ss_pred CCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC----CeeeCCCCHHHEEEC
Confidence 6 78999999999999999964 46999999999999999999999 77 999999999999999
Q ss_pred CCCcceeeccccceecCCCCCC---cccccccCccccCccccccC------CCCchhhHHHHHHHHHHHHhC--------
Q 004395 543 HDFEPLVGDFGLARWQPDGDMG---VETRVIGTFGYLAPEYAQSG------QITEKADVYSFGVVLVELVTG-------- 605 (756)
Q Consensus 543 ~~~~vkL~DFGlA~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSlGvvL~ELltG-------- 605 (756)
.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999876543321 12345799999999999765 234789999999999999999
Q ss_pred --CCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 606 --RKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH-YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 606 --~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~-~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..||......... ...+ ..........+.+... ........+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 262 ~~~~p~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPS-VEEM-----RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCTTTTTSCSSCC-HHHH-----HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCccccCcCccc-HHHH-----HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 6676543221110 0000 0001111112222111 123566789999999999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.10 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=198.4
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|.+.+.||+|+||.||+|.. .++..||+|++..... .....+.+|+++|+.++||||+++++++.+....|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5799999999999999999995 4789999998865443 3456799999999999999999999999999999999999
Q ss_pred ecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee---cCCCcceeeccccceec
Q 004395 484 ICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQ 558 (756)
Q Consensus 484 ~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL---~~~~~vkL~DFGlA~~~ 558 (756)
+.+|+|.+++... ....+++..++.++.||+.||+|||+. ||+||||||+|||+ +.++.+||+|||+++..
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999998542 346799999999999999999999999 99999999999999 55688999999999865
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.... ......||+.|+|||++. +.++.++||||||+++|||++|+.||........ ....... .
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~---~ 241 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV----------QQKATYK---E 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHHHC---C
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH----------HhhhccC---C
Confidence 4432 234567999999999886 5689999999999999999999999965432110 0000000 1
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+.... ........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11100 01112346889999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=359.74 Aligned_cols=256 Identities=22% Similarity=0.245 Sum_probs=190.3
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEE------
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCI------ 472 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~------ 472 (756)
+++...+|++.+.||+|+||.||+|.. .+|+.||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 455567899999999999999999995 478999999886655555667899999999996 999999999994
Q ss_pred --ecCceeEEEEeecCCChhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCc--eEeeccCCCceeecCCCcc
Q 004395 473 --EDRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLTHDFEP 547 (756)
Q Consensus 473 --~~~~~~LV~Ey~~ggsL~~~L~~-~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g--IiHrDLKp~NILL~~~~~v 547 (756)
.....++||||+ +|+|.+++.. ...+++++..++.++.||+.||.|||+. | |+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 103 DTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTSCE
T ss_pred ccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCCCE
Confidence 334579999998 5899998854 2456799999999999999999999999 8 9999999999999999999
Q ss_pred eeeccccceecCCCCCC-----------cccccccCccccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004395 548 LVGDFGLARWQPDGDMG-----------VETRVIGTFGYLAPEYA---QSGQITEKADVYSFGVVLVELVTGRKAVDLNR 613 (756)
Q Consensus 548 kL~DFGlA~~~~~~~~~-----------~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 613 (756)
||+|||+++........ ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999876542211 11245689999999998 56778999999999999999999999996432
Q ss_pred cccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 614 PKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 614 ~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.... ........ ........+.+++.+||+.||.+|||+.++++.|+.
T Consensus 258 ~~~~---------------~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 258 KLRI---------------VNGKYSIP----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp -----------------------CCCC----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHh---------------hcCcccCC----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 2100 00000101 111112347889999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.59 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=199.5
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCE----EEEEEeccc-CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQA----VAVKQHKLA-SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~----VAVK~~~~~-~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
.++|++.+.||+|+||.||+|.. .+++. ||+|.+... .......+.+|+.+++.++||||++++++|..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 46899999999999999999994 35554 577766543 3344567999999999999999999999998754 88
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999975 356799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 559 PDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 559 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||........ ...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------~~~ 231 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------SSI 231 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------------HHH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH----------------HHH
Confidence 44321 12223457889999999999999999999999999999999 9999975432211 000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+........+......+.+++.+||..||.+||++.++++.|+.
T Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 275 (327)
T 3lzb_A 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 00111111223344568999999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=359.95 Aligned_cols=265 Identities=15% Similarity=0.168 Sum_probs=200.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEec----CCCEEEEEEecccCCc-----------CchhHHHHHHHHHhcCCCCeeeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQ-----------GDHEFCSEVEVLSCAQHRNVVMLI 468 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~~~-----------~~~~f~~Ev~iL~~L~HpNIV~l~ 468 (756)
..++|.+.+.||+|+||.||+|... ++..||||+....... ....+.+|+.++..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3478999999999999999999964 6789999987654321 123467788899999999999999
Q ss_pred EEEEe----cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC
Q 004395 469 GFCIE----DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (756)
Q Consensus 469 ~~~~~----~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~ 544 (756)
+++.+ ....|+||||+ +++|.+++... +.+++..++.++.||+.||+|||+. ||+||||||+|||++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEESS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEccC
Confidence 99988 67899999999 99999999743 3899999999999999999999999 99999999999999988
Q ss_pred C--cceeeccccceecCCCCC------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004395 545 F--EPLVGDFGLARWQPDGDM------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKG 616 (756)
Q Consensus 545 ~--~vkL~DFGlA~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 616 (756)
+ .+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999987643211 11244679999999999999999999999999999999999999996322111
Q ss_pred ccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 617 ~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
.. .......... .+......... .......+.+++.+||..||++||++.+|++.|+..
T Consensus 268 ~~-~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VA-VQTAKTNLLD--ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HH-HHHHHHHHHH--TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HH-HHHHHHhhcc--cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 10 0000000000 00000000000 012234689999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.08 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=185.4
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++..++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999995 579999999876432 22346789999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+++|.+++.. ...++++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999974 346799999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .......
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~ 228 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhcc
Confidence 321 223457899999999999999999999999999999999999999754322110 0000000
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
...+......+.+++.+||+.||++|||+.++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0112223456889999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.74 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=202.0
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc------CchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~------~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
.++|.+.+.||+|+||.||+|... +|+.||+|+++..... ....+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 457999999999999999999965 7899999987654321 246799999999999999999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC----cceeeccc
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFG 553 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~----~vkL~DFG 553 (756)
++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999964 45799999999999999999999999 999999999999998877 79999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ +.. +
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~----------~ 223 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LTN----------I 223 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHH----------H
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HHH----------h
Confidence 998765432 22345699999999999999999999999999999999999999965432110 000 0
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
... ...............+.+++.+||..||++||++.++++
T Consensus 224 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 224 SAV-NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HTT-CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Hhc-ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 000000001122346889999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.39 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=205.0
Q ss_pred HHhhCCeeEEE-EecccCceEEEEEEe---cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 402 ELATGGFSQAN-FLAEGGFGSVHRGVL---PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 402 ~~~~~~y~~~~-~LG~G~fG~Vy~a~~---~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
.+..++|.+.+ .||+|+||.||+|.. .+++.||||++...... ....+.+|+++++.++||||+++++++ +.+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 44557899988 999999999999963 35789999988754322 245799999999999999999999999 567
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 78999999999999999974 45699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCc--ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 556 RWQPDGDMGV--ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 556 ~~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||........ . ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~----- 232 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---T----AM----- 232 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H----HH-----
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HH-----
Confidence 8765433211 122346788999999998889999999999999999999 9999975432110 0 00
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+..... ...+......+.+++.+||+.||++||++.++++.|+.
T Consensus 233 ~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 233 LEKGER----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp HHTTCC----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011011 11223344578999999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=365.43 Aligned_cols=261 Identities=16% Similarity=0.185 Sum_probs=204.8
Q ss_pred hCCeeEEEEecccCceEEEEEEec---------CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeee---------
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP---------DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM--------- 466 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~---------~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~--------- 466 (756)
.++|.+.+.||+|+||.||+|... +++.||||++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 468999999999999999999965 3789999987643 46889999999999999887
Q ss_pred ------EEEEEEe-cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCce
Q 004395 467 ------LIGFCIE-DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 539 (756)
Q Consensus 467 ------l~~~~~~-~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NI 539 (756)
+++++.. +...|+||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHE
Confidence 6778776 67889999999 99999999865457899999999999999999999999 999999999999
Q ss_pred eecCCC--cceeeccccceecCCCCC------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004395 540 LLTHDF--EPLVGDFGLARWQPDGDM------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDL 611 (756)
Q Consensus 540 LL~~~~--~vkL~DFGlA~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 611 (756)
|++.++ .+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 899999999986653221 112345799999999999999999999999999999999999999975
Q ss_pred CCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 612 NRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 612 ~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
....... +....... ......+..... ........+.+++.+||..||++||++.+|++.|+..
T Consensus 271 ~~~~~~~-~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNTED-IMKQKQKF--VDKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCHHH-HHHHHHHH--HHSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCHHH-HHHHHHhc--cCChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 4322111 11000000 000011111100 0112235689999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=360.62 Aligned_cols=265 Identities=20% Similarity=0.276 Sum_probs=196.9
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|+++|+.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999964 7899999988654332 223566899999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+. |+|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 95 699998875 355799999999999999999999999 999999999999999999999999999986543321
Q ss_pred CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh-hhh--------hhhhhhhhh
Q 004395 564 GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT-EWA--------RPLLEEYAI 633 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~--------~~~~~~~~i 633 (756)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ... .........
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 2334578999999999876 66899999999999999999999999765432211000 000 000000000
Q ss_pred hhccCCccCCC----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDPRLGNH----YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp~l~~~----~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.....+..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000100000 011233468899999999999999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=350.33 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=199.3
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEec-CceeEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-RRRLLVY 481 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~-~~~~LV~ 481 (756)
+..++|.+.+.||+|+||.||+|.. +|+.||||++... ...+.+.+|+++++.++||||+++++++.+. +..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3457899999999999999999987 5889999987643 3456799999999999999999999997654 4789999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999754334589999999999999999999999 9999999999999999999999999999855432
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
. ....+++.|+|||++.+..++.++||||||+++|||++ |+.||........ ... +.. .
T Consensus 171 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~------~~~------~~~----~ 230 (278)
T 1byg_A 171 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPR------VEK----G 230 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH------HHH------HTT----T
T ss_pred c----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHH------Hhc----C
Confidence 2 23457889999999999999999999999999999998 9999965432110 000 001 0
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.....+......+.+++.+||+.||.+||++.++++.|+.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 1112223344578999999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=364.20 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=205.8
Q ss_pred hCCeeEEEEecccCceEEEEEEe----cCCCEEEEEEecccC----CcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecC
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDR 475 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~~~~~~----~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~ 475 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+++|..+ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35899999999999999999996 478999999876432 23345678899999999 6999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..||||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999974 35799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
+.+............||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~------ 278 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRI------ 278 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHH------
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHH------
Confidence 8765443333445679999999999986 3478999999999999999999999975433211 11111110
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRIL 678 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~L 678 (756)
.. ..+ .++......+.+|+.+||..||.+|| ++.++++..
T Consensus 279 ~~-~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 279 LK-SEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HH-CCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred hc-cCC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00 011 12333445688999999999999999 999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=346.54 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=202.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 346899999999999999999985 467899999875432 2334578899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999999974 35699999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........ . . .+.. ...
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~----~--~~~~-~~~ 224 (279)
T 3fdn_A 161 SSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------Y----K--RISR-VEF 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H----H--HHHH-TCC
T ss_pred ccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------H----H--HHHh-CCC
Confidence 322 2445799999999999999999999999999999999999999964332110 0 0 0011 011
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.++......+.+++.+||+.||.+|||+.+++++
T Consensus 225 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1222234568899999999999999999999984
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=360.98 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=202.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... .+.+|+++|.++ +||||+++++++.+....|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 346799999999999999999995 4789999999865432 345789999888 7999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC----Ccceeecccccee
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD----FEPLVGDFGLARW 557 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~----~~vkL~DFGlA~~ 557 (756)
||+.||+|.+++. ..+.+++..++.++.||+.||+|||++ ||+||||||+|||+..+ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999997 356799999999999999999999999 99999999999998543 3599999999987
Q ss_pred cCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||......... .. .......
T Consensus 170 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~----~~~i~~~--- 238 (342)
T 2qr7_A 170 LRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EI----LARIGSG--- 238 (342)
T ss_dssp CBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HH----HHHHHHC---
T ss_pred CcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HH----HHHHccC---
Confidence 65432 2234567999999999999888999999999999999999999999743221111 00 0000000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...+...+.......+.+|+.+||..||++||++.+++++
T Consensus 239 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111112223344578999999999999999999999873
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=347.42 Aligned_cols=254 Identities=26% Similarity=0.320 Sum_probs=201.6
Q ss_pred CeeEEEEecccCceEEEEEEec-CC---CEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCce-eEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP-DG---QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR-LLV 480 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g---~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~-~LV 480 (756)
.|...+.||+|+||.||+|... ++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5777899999999999999843 33 3799998865333 2346789999999999999999999999876665 999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+++|+|.+++.. ....+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999975 456789999999999999999999999 999999999999999999999999999986543
Q ss_pred CC---CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 561 GD---MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 561 ~~---~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
.. ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+........ +. ..+....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~---------~~~~~~~ 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LT---------HFLAQGR 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HH---------HHHHTTC
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HH---------HHhhcCC
Confidence 21 1122345688999999999999999999999999999999996655432221100 00 0001111
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. ...+......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 246 ~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 246 R----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 11222334568999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=388.78 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=204.8
Q ss_pred HHhhCCeeEEE-EecccCceEEEEEEec---CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 402 ELATGGFSQAN-FLAEGGFGSVHRGVLP---DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 402 ~~~~~~y~~~~-~LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
.+...++.+.. .||+|+||.||+|.+. ++..||||+++.... .....|.+|+++|+.++|||||+++++|.. +.
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 34456677666 8999999999999853 566899999876533 345689999999999999999999999976 56
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.||||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 410 ~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp EEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred eEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 8999999999999999965 356799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 557 WQPDGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 557 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
........ ......+++.|+|||++.+..++.++|||||||+||||++ |+.||........ . .. +
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~----~~-----i 552 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M----AF-----I 552 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---H----HH-----H
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---H----HH-----H
Confidence 76433211 1122345689999999999999999999999999999998 9999975432110 0 00 0
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. ......+..+...+.+|+.+||..||++||++.+|++.|+.
T Consensus 553 ~~----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 553 EQ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp HT----TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred Hc----CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 11112333445679999999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.60 Aligned_cols=245 Identities=24% Similarity=0.319 Sum_probs=199.4
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC--cCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 468999999999999999999964 799999998875432 3345788999999999 899999999999999999999
Q ss_pred EEeecCCChhhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC--------------
Q 004395 481 YEYICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-------------- 544 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~--~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~-------------- 544 (756)
|||+++++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999996432 36799999999999999999999999 99999999999999844
Q ss_pred -----CcceeeccccceecCCCCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc
Q 004395 545 -----FEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQ 618 (756)
Q Consensus 545 -----~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~ 618 (756)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 478999999998765432 23589999999999775 567899999999999999999877632110
Q ss_pred chhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 619 CLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 619 ~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .+.....+. .+......+.+++.+||+.||++|||+.++++.
T Consensus 237 -~~----------~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -WH----------EIRQGRLPR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HH----------HHHTTCCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HH----------HHHcCCCCC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 00 001111111 222334568999999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=357.46 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=201.1
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEe--------c
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--------D 474 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--------~ 474 (756)
++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|+.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5899999999999999999996 5799999998765432 234578899999999999999999999987 3
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
+..|+||||+. ++|.+.+.. ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccC-CCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 46899999995 588777754 345799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCC---CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhh-hhh----
Q 004395 555 ARWQPDGD---MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTE-WAR---- 625 (756)
Q Consensus 555 A~~~~~~~---~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~-~~~---- 625 (756)
++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||............. ...
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98765322 222344678999999998876 568999999999999999999999997654322110000 000
Q ss_pred ---hhhhhhhhhhccCCccCCCCCh-h------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 ---PLLEEYAIDELVDPRLGNHYSE-H------EVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ---~~~~~~~i~~l~dp~l~~~~~~-~------~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+..................... . ....+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000000000000000 0 12357899999999999999999999884
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=357.05 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=202.0
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecC-----CCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPD-----GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
+..++|.+.+.||+|+||.||+|.... +..||||.+..... .....+.+|++++..++||||+++++++.+...
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 345689999999999999999998532 24699998875432 234468899999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999975 456799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 557 WQPDGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 557 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ... .+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----------~~~--~~ 263 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------VMK--AI 263 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------HHH--HH
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH----------HHH--HH
Confidence 76543211 1122346789999999999999999999999999999999 999996432210 000 00
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. ......+......+.+++.+||+.||++||++.++++.|+.
T Consensus 264 ~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 264 ND----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp HT----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HC----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00 00111222344578999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.57 Aligned_cols=262 Identities=28% Similarity=0.369 Sum_probs=199.4
Q ss_pred HHHHHhhCCeeEEEEecccCceEEEEEEec----CCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEE
Q 004395 399 AELELATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472 (756)
Q Consensus 399 ~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~ 472 (756)
.++.+..++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334556789999999999999999999843 355899998875432 23356899999999999999999999998
Q ss_pred ecCc-----eeEEEEeecCCChhhhhhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC
Q 004395 473 EDRR-----RLLVYEYICNGSLDSHLYG----CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (756)
Q Consensus 473 ~~~~-----~~LV~Ey~~ggsL~~~L~~----~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~ 543 (756)
+... .++||||+.+++|.+++.. .....+++..++.++.||+.||.|||+. ||+||||||+|||++.
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRD 182 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEECT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcC
Confidence 7653 4999999999999999843 2346799999999999999999999999 9999999999999999
Q ss_pred CCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchh
Q 004395 544 DFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 544 ~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~ 621 (756)
++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---- 258 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---- 258 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH----
Confidence 999999999999866543221 2233457889999999999999999999999999999999 8899865432211
Q ss_pred hhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 622 EWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 622 ~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.... ... ..+ ..+......+.+++.+||..||.+|||+.++++.|+.
T Consensus 259 --~~~~-----~~~-~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 259 --YDYL-----LHG-HRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp --HHHH-----HTT-CCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHH-----HcC-CCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0000 000 011 1222334578999999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=361.25 Aligned_cols=252 Identities=14% Similarity=0.122 Sum_probs=205.6
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEE------ecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC---CCCeeeEEEEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGV------LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ---HRNVVMLIGFC 471 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~------~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~---HpNIV~l~~~~ 471 (756)
++...++|.+.+.||+|+||.||+|. ..+++.||||++... ....+..|++++..++ |+||+.+++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 44566889999999999999999994 457899999988643 4557889999999997 89999999999
Q ss_pred EecCceeEEEEeecCCChhhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-----
Q 004395 472 IEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH----- 543 (756)
Q Consensus 472 ~~~~~~~LV~Ey~~ggsL~~~L~~~---~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~----- 543 (756)
...+..||||||+.+|+|.+++... ....+++..++.++.||+.||+|||+. ||+||||||+||||+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTCC
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999642 356799999999999999999999999 9999999999999998
Q ss_pred ------CCcceeeccccceecCCC-CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004395 544 ------DFEPLVGDFGLARWQPDG-DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKG 616 (756)
Q Consensus 544 ------~~~vkL~DFGlA~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 616 (756)
++.+||+|||+|+..... ........+||+.|+|||++.+..|+.++|||||||++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 899999999999765321 2223345679999999999999999999999999999999999999985322110
Q ss_pred ccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhhc
Q 004395 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSR-PRMSQVLRILEG 680 (756)
Q Consensus 617 ~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~R-PS~~eVL~~Le~ 680 (756)
. .+.. .+. .++ ....+.+++..|+..+|.+| |++.++.+.|+.
T Consensus 293 ~--------------~~~~----~~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 C--------------KPEG----LFR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp E--------------EECS----CCT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred e--------------eech----hcc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0 0011 111 111 23457789999999999999 578888887764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=349.20 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=207.6
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.+.|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++..++||||+++++++.+....|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35799999999999999999985 5789999998875543 345679999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++. .+++++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999984 46799999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ . ..+.....+.+.
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~------~~~~~~~~~~~~ 240 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------L------FLIPKNNPPTLE 240 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------H------HHHHHSCCCCCC
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH------H------HHhhcCCCCCCc
Confidence 2 22445799999999999999999999999999999999999999964332110 0 001111112222
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. .....+.+++.+||..||.+|||+.++++.
T Consensus 241 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 G----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp S----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred c----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2 233468899999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=360.03 Aligned_cols=246 Identities=28% Similarity=0.399 Sum_probs=201.1
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
+.|...+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+++|+.++||||+++++++.+....++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4699999999999999999994 57999999988754332 2346889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+. |+|.+++.. ...++++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9995 788888854 346799999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCcccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 562 DMGVETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||........ ... +.....
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~------~~~~~~ 270 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH------IAQNES 270 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH------HHHSCC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHH------HHhcCC
Confidence 3457999999999884 57789999999999999999999999964332110 000 011111
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+.. ........+.+++.+||+.||++|||+.++++.
T Consensus 271 ~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 112233468899999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.97 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=202.5
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEE--EEEEeccc-CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAV--AVKQHKLA-SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~V--AVK~~~~~-~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV 480 (756)
++|.+.+.||+|+||.||+|.. .+|..+ |+|.+... .......+.+|+++|.++ +||||+++++++.+.+..|+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 6899999999999999999995 456654 89987643 233456799999999999 899999999999999999999
Q ss_pred EEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc
Q 004395 481 YEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~ 546 (756)
|||+++++|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCCCe
Confidence 99999999999996432 35799999999999999999999999 9999999999999999999
Q ss_pred ceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhh
Q 004395 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 547 vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~ 625 (756)
+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 252 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HHH
Confidence 9999999997433211 1233457889999999999899999999999999999998 999996543211 000
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. +.. ......+......+.+++.+||..||.+|||+.++++.|+.
T Consensus 253 ~------~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 253 K------LPQ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp H------GGG----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H------hhc----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0 011 01111222344578999999999999999999999998875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=348.98 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=200.2
Q ss_pred CCeeEEEEecccCceEEEEEEecC----CCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEE-ecCceeE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCI-EDRRRLL 479 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~-~~~~~~L 479 (756)
.+|.+.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 479999999999999999998532 23689998765332 23457899999999999999999999865 4557899
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+|+|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999964 456789999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCC---CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 560 DGDM---GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 560 ~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
.... .......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||........ ... +..
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~------~~~------~~~ 247 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVY------LLQ 247 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH------HHH------HHT
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH------HHH------Hhc
Confidence 4321 12234567889999999999999999999999999999999 5556543322111 000 000
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.... ..+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 248 ~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 248 GRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0011 1122233568999999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=374.20 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=207.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+|+.++||||+++++++.+....|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3478999999999999999999954 79999999886432 2334578999999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+|+|.+++. ..+.+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999996 456799999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... .. ..+..
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~---------~~i~~ 230 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LF---------KKICD 230 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HH---------HHHHT
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HH---------HHHhc
Confidence 543 2345679999999999988766 789999999999999999999997543210 00 00111
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
... ..+......+.+|+.+||..||.+|||+.+++++
T Consensus 231 ~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 231 GIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 100 1122233468899999999999999999999973
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=373.65 Aligned_cols=194 Identities=24% Similarity=0.328 Sum_probs=155.1
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEec-----Cc
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RR 476 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~-----~~ 476 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36899999999999999999984 4789999998864322 2345788999999999999999999999543 46
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+||||+ +++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999997 789999986 456799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC--------------------------CcccccccCccccCcccc-ccCCCCchhhHHHHHHHHHHHHhC
Q 004395 557 WQPDGDM--------------------------GVETRVIGTFGYLAPEYA-QSGQITEKADVYSFGVVLVELVTG 605 (756)
Q Consensus 557 ~~~~~~~--------------------------~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSlGvvL~ELltG 605 (756)
....... ......+||+.|+|||++ .+..|+.++|||||||+||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 123456789999999976 567799999999999999999994
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.44 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=194.1
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+++|+.++||||+++++++.++...|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346899999999999999999984 57899999988654322 244678999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec-----CCCcceeeccccc
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-----HDFEPLVGDFGLA 555 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~-----~~~~vkL~DFGlA 555 (756)
|||+. |+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99995 699999974 45699999999999999999999999 999999999999994 4556999999999
Q ss_pred eecCCCCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh--hhhh-
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL--LEEY- 631 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~--~~~~- 631 (756)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||........ +....... ....
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTT
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCchhh
Confidence 87643321 23445689999999999874 589999999999999999999999975433211 11000000 0000
Q ss_pred -----hhhhccC--CccCCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 632 -----AIDELVD--PRLGNH-----YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 632 -----~i~~l~d--p~l~~~-----~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
....... +..... ........+.+|+.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 000000 00113356889999999999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.90 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=181.9
Q ss_pred CeeEE---EEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEE
Q 004395 407 GFSQA---NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 407 ~y~~~---~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~ 481 (756)
+|.+. +.||+|+||.||+|.. .+|+.||||++... ....+.+|+.++..+. ||||+++++++.+....|+||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 46654 7899999999999996 47899999988632 3456889999999997 999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC---cceeeccccceec
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---EPLVGDFGLARWQ 558 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~---~vkL~DFGlA~~~ 558 (756)
||+.+|+|.+++.. ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 86 ELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp CCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999974 46799999999999999999999999 999999999999998766 8999999999876
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ... +..+..
T Consensus 160 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~~~-----~~~i~~ 230 (325)
T 3kn6_A 160 PPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA---VEI-----MKKIKK 230 (325)
T ss_dssp CC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH---HHH-----HHHHTT
T ss_pred CCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH---HHH-----HHHHHc
Confidence 54332 234567899999999999999999999999999999999999999754322110000 000 011111
Q ss_pred Ccc--CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 639 PRL--GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 639 p~l--~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
... ...........+.+|+.+||..||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 111 00001123457899999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=383.20 Aligned_cols=255 Identities=28% Similarity=0.376 Sum_probs=211.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+++|..++||||+++++++.+....||
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 456899999999999999999995 47999999988543 23345568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.||+|.+++.......+++..++.++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999765556699999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ..... .+.. ...
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~------~i~~-~~~ 406 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVER------LVKE-VPE 406 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHH------HHHH-CCC
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHH------Hhhc-ccc
Confidence 443 234468999999999999999999999999999999999999999754322110 00000 0011 011
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
.++......+.+||.+||..||.+|| ++.+|+++
T Consensus 407 ----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 12233445789999999999999999 78898764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=365.79 Aligned_cols=254 Identities=21% Similarity=0.278 Sum_probs=193.5
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--------CcCchhHHHHHHHHHhcCCCCeeeEEEEEEe
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--------SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--------~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~ 473 (756)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4568999999999999999999995 568999999876432 122335889999999999999999999985
Q ss_pred cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC---cceee
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---EPLVG 550 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~---~vkL~ 550 (756)
....|+||||+.+|+|.+++. ....+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEEe
Confidence 456899999999999999986 456799999999999999999999999 999999999999997544 59999
Q ss_pred ccccceecCCCCCCcccccccCccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh
Q 004395 551 DFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS---GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 551 DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
|||+++...... ......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||........ +....
T Consensus 285 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i--- 357 (419)
T 3i6u_A 285 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI--- 357 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH---
T ss_pred ecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH---
Confidence 999998765432 2345679999999999853 6788999999999999999999999975432211 10000
Q ss_pred hhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 ~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.... .. ..+.. .......+.+++.+||+.||++|||+.+++++
T Consensus 358 -~~~~-~~-~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 -TSGK-YN-FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -HTTC-CC-CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -hcCC-CC-CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 00 00000 01123468899999999999999999999883
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.45 Aligned_cols=255 Identities=22% Similarity=0.281 Sum_probs=204.4
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEe--cCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--~~~~~L 479 (756)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+++++.++||||+++++++.+ ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 36899999999999999999995 4789999998875432 234568899999999999999999998854 567899
Q ss_pred EEEeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCc-----eEeeccCCCceeecCCCcceeecc
Q 004395 480 VYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGC-----IVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g-----IiHrDLKp~NILL~~~~~vkL~DF 552 (756)
||||+++++|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR----SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH----C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc----cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999999642 345699999999999999999999999 7 999999999999999999999999
Q ss_pred ccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
|+++...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ... .
T Consensus 161 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~------~ 227 (279)
T 2w5a_A 161 GLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAG------K 227 (279)
T ss_dssp CHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH------H
T ss_pred chheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH------HHH------H
Confidence 9998664332 12234578999999999999999999999999999999999999997543210 000 0
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+.....+ ..+......+.+++.+||+.||.+||++.+|++.+..
T Consensus 228 i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 228 IREGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred Hhhcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0110111 1222334568999999999999999999999997653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=353.25 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=200.8
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEe----
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE---- 473 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~---- 473 (756)
++....++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3445678999999999999999999995 578999999987543 3456799999999999 79999999999987
Q ss_pred --cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeec
Q 004395 474 --DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 474 --~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
....|+||||+.+++|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999999765556899999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCcccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhh
Q 004395 552 FGLARWQPDGDMGVETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626 (756)
Q Consensus 552 FGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 626 (756)
||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||........ +
T Consensus 173 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~------ 243 (326)
T 2x7f_A 173 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--L------ 243 (326)
T ss_dssp CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H------
T ss_pred CcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--H------
Confidence 99998654321 1233457999999999987 56789999999999999999999999964332110 0
Q ss_pred hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..+.....+.. ........+.+++.+||..||.+||++.++++
T Consensus 244 ----~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 ----FLIPRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ----HHHHHSCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HHhhcCccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00011111111 11223356889999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=364.49 Aligned_cols=268 Identities=23% Similarity=0.226 Sum_probs=210.4
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC--ceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR--RRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~--~~~LV 480 (756)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+++|+.++||||+++++++.+.. ..|+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 468999999999999999999954 69999999987543 234567889999999999999999999998765 67999
Q ss_pred EEeecCCChhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee----cCCCcceeeccccc
Q 004395 481 YEYICNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL----THDFEPLVGDFGLA 555 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~-~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL----~~~~~vkL~DFGlA 555 (756)
|||+.+|+|.+++.... ...+++..++.++.||+.||+|||+. ||+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999996532 23499999999999999999999999 99999999999999 78888999999999
Q ss_pred eecCCCCCCcccccccCccccCcccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQS--------GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .......
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~ 239 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence 8765432 2234679999999999865 56788999999999999999999999643322110 0000000
Q ss_pred hhhh---hh-----------hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 628 LEEY---AI-----------DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 628 ~~~~---~i-----------~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.... .+ ............+......+.+++.+||..||++||++.++++.++.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 0000 00 00000111123446677788999999999999999999999998765
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=345.59 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=199.1
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEe----cCcee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRRL 478 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~----~~~~~ 478 (756)
..|.+.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+|+.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4589999999999999999995 568899999876443 2234568899999999999999999999876 34589
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCc--eEeeccCCCceeec-CCCcceeeccccc
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLT-HDFEPLVGDFGLA 555 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g--IiHrDLKp~NILL~-~~~~vkL~DFGlA 555 (756)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. + |+||||||+|||++ .++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC----CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999974 36799999999999999999999999 7 99999999999998 7899999999999
Q ss_pred eecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
...... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||........ ...... ..
T Consensus 180 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~-----~~ 245 (290)
T 1t4h_A 180 TLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVT-----SG 245 (290)
T ss_dssp GGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHT-----TT
T ss_pred cccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHHh-----cc
Confidence 754432 234567999999999887 4589999999999999999999999965332111 000000 00
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..... .+......+.+++.+||+.||.+|||+.+++++
T Consensus 246 ~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 VKPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCccc----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00111 111223468999999999999999999999873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=356.72 Aligned_cols=266 Identities=24% Similarity=0.264 Sum_probs=198.6
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc-----CchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-----GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~-----~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
...++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+++++.++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999995 46899999988653221 23468899999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.++||||+. ++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFME-TDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCS-EEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCC-CCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999996 589888864 345789999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh--hhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL--EEYAI 633 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~--~~~~i 633 (756)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||........ +........ .....
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChhhh
Confidence 7654322 23456789999999998764 589999999999999999999999875432211 111000000 00000
Q ss_pred h------hccCCccCCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 D------ELVDPRLGNHY-----SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~------~l~dp~l~~~~-----~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. +.......... .......+.+|+.+||..||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000000000 02233578999999999999999999999884
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=344.33 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=205.0
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+++++.++||||+++++++.+....|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 368999999999999999999954 6889999987543 223346789999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+++|.+++.. .+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999974 35699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|..||........ ... +.. .+.
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~------~~~-~~~- 229 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HRR------IVN-VDL- 229 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH------HHT-TCC-
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HHH------Hhc-ccc-
Confidence 22 2345799999999999999999999999999999999999999964332110 000 000 011
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.++......+.+++.+||..||.+||++.++++
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 122233456889999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=363.26 Aligned_cols=266 Identities=24% Similarity=0.320 Sum_probs=205.2
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
..++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3468999999999999999999954 789999998875432 23457899999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ||+||||||+|||++.++.+||+|||++......
T Consensus 111 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred ECCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999974 357999999999999999999999841 7999999999999999999999999999754322
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhh------------------
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW------------------ 623 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~------------------ 623 (756)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 12345799999999999999999999999999999999999999975432211000000
Q ss_pred -----hh---h-hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 624 -----AR---P-LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 624 -----~~---~-~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. + ......+..+................+.+|+.+||+.||++|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 0 000000001111111111112234568899999999999999999999873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=368.71 Aligned_cols=199 Identities=24% Similarity=0.291 Sum_probs=168.3
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEec-----Cc
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RR 476 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~-----~~ 476 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999995 4689999998864322 2345788999999999999999999999876 56
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+||||+ +++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||+|+
T Consensus 105 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIA-DSDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecC-CcCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 89999998 579999996 456799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCC---------------------CcccccccCccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004395 557 WQPDGDM---------------------GVETRVIGTFGYLAPEYA-QSGQITEKADVYSFGVVLVELVTGRKAVD 610 (756)
Q Consensus 557 ~~~~~~~---------------------~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSlGvvL~ELltG~~Pf~ 610 (756)
....... ...+..+||+.|+|||++ .+..|+.++|||||||++|||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 7654321 123557899999999986 56679999999999999999998666553
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.76 Aligned_cols=247 Identities=23% Similarity=0.271 Sum_probs=194.1
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC---cCchhHHHHHHH-HHhcCCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEV-LSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~---~~~~~f~~Ev~i-L~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.++|.+.+.||+|+||.||+|... +++.||||++..... .....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999954 689999998865432 233456677776 467899999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.||+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999974 45789999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||....... ... .++..
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~---------~i~~~ 254 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYD---------NILNK 254 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHH---------HHHHS
T ss_pred cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHH---------HHHhc
Confidence 322 23345789999999999999999999999999999999999999996432210 000 01110
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVL 675 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL 675 (756)
. ..++......+.+|+.+||+.||.+||++.+.+
T Consensus 255 ~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 255 P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp C--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred c--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 0 012223345688999999999999999985433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=355.59 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=203.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
..++|.+.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999983 357799999886432 2334578999999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---CCcce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQ-----EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPL 548 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~-----~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~~~vk 548 (756)
.|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||+. ||+||||||+|||++. +..+|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999975422 4589999999999999999999999 9999999999999984 45699
Q ss_pred eeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhh
Q 004395 549 VGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARP 626 (756)
Q Consensus 549 L~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~ 626 (756)
|+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~-- 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VL-- 255 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HH--
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------HH--
Confidence 999999975433221 12234568999999999999999999999999999999998 999996543210 00
Q ss_pred hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. +.....+ ..+......+.+++.+||+.||.+||++.+|++.|+.
T Consensus 256 --~~--~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 256 --EF--VTSGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp --HH--HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HH--HhcCCCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 00 0000011 1222334568899999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.32 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=206.9
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe--cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCC------CeeeEEEEEEec
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL--PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR------NVVMLIGFCIED 474 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~Hp------NIV~l~~~~~~~ 474 (756)
...++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ......+.+|++++..++|+ +|+++++++.+.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3457999999999999999999985 36889999988643 23345688999999998765 499999999999
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-----------
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH----------- 543 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~----------- 543 (756)
+..|+||||+ +++|.+++......++++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCCcc
Confidence 9999999999 99999999876666899999999999999999999999 9999999999999987
Q ss_pred --------CCcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc
Q 004395 544 --------DFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPK 615 (756)
Q Consensus 544 --------~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 615 (756)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999875432 23457999999999999999999999999999999999999999755432
Q ss_pred cccchh-hhhhhhhhh-------------------------hhhhhccCCc-cCCCCChhHHHHHHHHHHHhcccCCCCC
Q 004395 616 GQQCLT-EWARPLLEE-------------------------YAIDELVDPR-LGNHYSEHEVYCMLHAASLCIRRDPHSR 668 (756)
Q Consensus 616 ~~~~l~-~~~~~~~~~-------------------------~~i~~l~dp~-l~~~~~~~~~~~l~~Li~~CL~~dP~~R 668 (756)
...... ....+.... ........+. ............+.+|+.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 211000 000000000 0000000000 0011233456789999999999999999
Q ss_pred CCHHHHHH
Q 004395 669 PRMSQVLR 676 (756)
Q Consensus 669 PS~~eVL~ 676 (756)
||+.|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=372.85 Aligned_cols=263 Identities=21% Similarity=0.262 Sum_probs=196.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC-----
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR----- 475 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~----- 475 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+|+.++||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999984 57899999988643 2233457889999999999999999999997653
Q ss_pred -ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 476 -RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 476 -~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
..||||||+. ++|.+.+. ..+++..+..++.||+.||+|||+. ||+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~-~~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCS-EEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCC-CCHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 4699999995 55766664 2489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hh--------hhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TE--------WAR 625 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~--------~~~ 625 (756)
|+...... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.......+... .. +..
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98665432 33557899999999999999999999999999999999999999975543211100 00 000
Q ss_pred hh---hhhh----------hhhhccCCccCCCC---ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 PL---LEEY----------AIDELVDPRLGNHY---SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ~~---~~~~----------~i~~l~dp~l~~~~---~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .... .+.......+.... .......+.+|+.+||..||++|||+.|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000 00000000000000 01124568999999999999999999999885
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=354.18 Aligned_cols=264 Identities=18% Similarity=0.280 Sum_probs=206.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCc-----------------hhHHHHHHHHHhcCCCCeee
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD-----------------HEFCSEVEVLSCAQHRNVVM 466 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~-----------------~~f~~Ev~iL~~L~HpNIV~ 466 (756)
..++|.+.+.||+|+||.||+|.. +|+.||||++........ ..+.+|++++..++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 347899999999999999999999 999999998764322211 67999999999999999999
Q ss_pred EEEEEEecCceeEEEEeecCCChhhh------hhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCce
Q 004395 467 LIGFCIEDRRRLLVYEYICNGSLDSH------LYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNI 539 (756)
Q Consensus 467 l~~~~~~~~~~~LV~Ey~~ggsL~~~------L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NI 539 (756)
+++++.+.+..|+||||+.+++|.++ +.......+++..++.++.||+.||.|||+ . ||+||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChHhE
Confidence 99999999999999999999999999 654446889999999999999999999999 8 999999999999
Q ss_pred eecCCCcceeeccccceecCCCCCCcccccccCccccCccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 004395 540 LLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG-QITE-KADVYSFGVVLVELVTGRKAVDLNRPKGQ 617 (756)
Q Consensus 540 LL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~-ksDVwSlGvvL~ELltG~~Pf~~~~~~~~ 617 (756)
|++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|..||........
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999999876443 23456799999999999887 6666 99999999999999999999975443111
Q ss_pred cchhhhhhhhhh-hhhhhhccCC---ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 618 QCLTEWARPLLE-EYAIDELVDP---RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 618 ~~l~~~~~~~~~-~~~i~~l~dp---~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
........... .........+ .............+.+++.+||..||.+|||+.++++
T Consensus 261 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 -LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000000 0000000000 0000011233457899999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.66 Aligned_cols=252 Identities=26% Similarity=0.363 Sum_probs=202.1
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
...++|.+.+.||+|+||.||+|... +|+.||||.+... .....+.+|+.++..++||||+++++++.+....|+||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999964 6999999988753 34567999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999863 356799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ . ..+.....+.+
T Consensus 179 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~------~~~~~~~~~~~ 245 (314)
T 3com_A 179 M-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------I------FMIPTNPPPTF 245 (314)
T ss_dssp B-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------H------HHHHHSCCCCC
T ss_pred c-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------H------HHHhcCCCccc
Confidence 2 123345799999999999999999999999999999999999999964332100 0 00011111111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..+......+.+++.+||..||.+|||+.++++
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112223456899999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.10 Aligned_cols=265 Identities=23% Similarity=0.358 Sum_probs=200.6
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcC--chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~--~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.++|.+.+.||+|+||.||+|... +|+.||||++....... ...+.+|+++++.++||||+++++++.+....|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 358999999999999999999954 68999999876543322 345789999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999998988765 446799999999999999999999999 9999999999999999999999999999865443
Q ss_pred CCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh-hhhhh-------hh-hhh
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT-EWARP-------LL-EEY 631 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~~~-------~~-~~~ 631 (756)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............ ..... .. ...
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 21 22345689999999999875 7899999999999999999999999755432111000 00000 00 000
Q ss_pred hhhhccCCccCCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 632 AIDELVDPRLGNHYS-----EHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 632 ~i~~l~dp~l~~~~~-----~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.......+......+ +.....+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 011111111111111 123457899999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=369.87 Aligned_cols=267 Identities=18% Similarity=0.231 Sum_probs=211.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC-CCeeeEEEEEEecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H-pNIV~l~~~~~~~~~~~LV~ 481 (756)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+..|++++..|+| ++|+.+..++.+....+|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 357899999999999999999995 579999999876543 23468899999999986 66777777888888899999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee---cCCCcceeeccccceec
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQ 558 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL---~~~~~vkL~DFGlA~~~ 558 (756)
||+ +++|.+++.. ....+++..++.|+.||+.||+|||++ ||+||||||+|||| +.++.+||+|||+++.+
T Consensus 83 e~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999 9999999974 356799999999999999999999999 99999999999999 68899999999999976
Q ss_pred CCCCCC------cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 559 PDGDMG------VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 559 ~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 543321 22356799999999999999999999999999999999999999976543322111111110000001
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcCcCcccc
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDTVIDTY 687 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~~~~~~~ 687 (756)
+..+. . .....+.+|+.+||..||++||++.+|++.|+.......+
T Consensus 237 ~~~l~-----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 237 IEALC-----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp HHHHH-----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHh-----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 11111 1 1234689999999999999999999999998865433333
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=344.31 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=199.7
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
+|.....||+|+||.||+|.. .+++.||||.+..........+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 344455899999999999995 5789999999876665566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-CCcceeeccccceecCCCCC
Q 004395 486 NGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 486 ggsL~~~L~~~-~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-~~~vkL~DFGlA~~~~~~~~ 563 (756)
+++|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999753 234577999999999999999999999 9999999999999987 89999999999987654321
Q ss_pred CcccccccCccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 564 GVETRVIGTFGYLAPEYAQSGQ--ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ .. .... .....+.
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~-~~~~-~~~~~~~- 246 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--------AM-FKVG-MFKVHPE- 246 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--------HH-HHHH-HHCCCCC-
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--------HH-Hhhc-ccccccc-
Confidence 223457899999999997643 88999999999999999999999963221100 00 0000 0011122
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+......+.+++.+||+.||++||++.++++
T Consensus 247 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 ---IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22334456889999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.60 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=188.8
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc-C-chhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-G-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~-~-~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
++..++|++.+.||+|+||.||+|.. .+|+.||||++...... . ...+..+...++.++||||+++++++.+.+..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 34567899999999999999999995 57999999988654222 1 223444555577889999999999999999999
Q ss_pred EEEEeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 479 LVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
+||||+. |+|.+++.. .....+++..++.++.|++.||.|||+++ ||+||||||+|||++.++.+||+|||+++
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL---SVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS---CCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 9999995 688887753 24578999999999999999999999863 89999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYA----QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
...... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.........
T Consensus 159 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------- 222 (290)
T 3fme_A 159 YLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-------------- 222 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--------------
T ss_pred cccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--------------
Confidence 665432 22334699999999996 5667899999999999999999999999643221110
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+...................+.+++.+||+.||++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 223 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00000001111111223456899999999999999999999977
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=348.61 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=200.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
..++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++..++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3468999999999999999999964 689999999877666667789999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999998864 345799999999999999999999999 99999999999999999999999999986322110
Q ss_pred CCcccccccCccccCcccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 563 MGVETRVIGTFGYLAPEYA-----QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l-----~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
.......||+.|+|||++ .+..++.++||||||+++|+|++|..||........ ... +....
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~------~~~~~ 238 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLK------IAKSD 238 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH------HHHSC
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHH------HhccC
Confidence 011235689999999988 467789999999999999999999999975432110 000 00000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+. ...+......+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 PPT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred Ccc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 010 1112233456889999999999999999999876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.89 Aligned_cols=265 Identities=24% Similarity=0.355 Sum_probs=188.0
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
+.+..++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++..++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 445678999999999999999999994 478999999876443 233457889999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhc------cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecc
Q 004395 479 LVYEYICNGSLDSHLYG------CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~------~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
+||||+.+++|.+++.. .....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEec
Confidence 99999999999999863 1346699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCC----CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh
Q 004395 553 GLARWQPDGDM----GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 553 GlA~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
|++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... .......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~ 243 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLTLQND 243 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHTSS
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHHhccC
Confidence 99986643221 11234579999999999876 56899999999999999999999999754432110 0000000
Q ss_pred hhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 628 ~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.. .......++. ........+.+++.+||+.||.+||++.++++
T Consensus 244 ~~-~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PP-SLETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CC-CTTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CC-ccccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 0000001111 11223346889999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.50 Aligned_cols=270 Identities=24% Similarity=0.386 Sum_probs=199.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHH--hcCCCCeeeEEEEEEe-----cCc
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLS--CAQHRNVVMLIGFCIE-----DRR 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~--~L~HpNIV~l~~~~~~-----~~~ 476 (756)
..++|.+.+.||+|+||.||+|.. +++.||||++... ....+..|.+++. .++||||+++++++.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 347899999999999999999987 7899999988643 2344555655544 5899999999986643 225
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccC-----ceEeeccCCCceeecCCCcceeec
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG-----CIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~-----gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
.|+||||+++|+|.+++.. ..+++..++.++.||+.||+|||+.+..+ ||+||||||+|||++.++.+||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 6899999999999999964 34589999999999999999999873221 799999999999999999999999
Q ss_pred cccceecCCCCC-------CcccccccCccccCcccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 004395 552 FGLARWQPDGDM-------GVETRVIGTFGYLAPEYAQS-------GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ 617 (756)
Q Consensus 552 FGlA~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~ 617 (756)
||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987653221 12224579999999999986 4567899999999999999999877743322211
Q ss_pred c-ch-hhh--hhhhhhhh---hhhhccCCccCCCC--ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 618 Q-CL-TEW--ARPLLEEY---AIDELVDPRLGNHY--SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 618 ~-~l-~~~--~~~~~~~~---~i~~l~dp~l~~~~--~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. .. ... ..+..... .......+.+.... .......+.+|+.+||..||++|||+.|+++.|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 1 00 000 00000000 01111122222211 22356679999999999999999999999999885
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=372.53 Aligned_cols=252 Identities=24% Similarity=0.295 Sum_probs=206.3
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+++|++++||||+++++++.+....|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4468999999999999999999954 79999999886432 3345679999999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee---cCCCcceeeccccce
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLAR 556 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL---~~~~~vkL~DFGlA~ 556 (756)
||||+.+|+|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999997 456799999999999999999999999 99999999999999 567899999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
.+.... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||........ + .... ...
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~--------~~i~-~~~ 243 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI--L--------KKVE-KGK 243 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H--------HHHH-HCC
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH--H--------HHHH-cCC
Confidence 765433 2345679999999999876 699999999999999999999999975432110 0 0000 000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. .............+.+|+.+||+.||.+|||+.+++++
T Consensus 244 ~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 244 Y--TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp C--CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C--CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 00001112334568899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=358.46 Aligned_cols=273 Identities=25% Similarity=0.306 Sum_probs=201.7
Q ss_pred ChHHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcC-----------chhHHHHHHHHHhcCCCCee
Q 004395 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-----------DHEFCSEVEVLSCAQHRNVV 465 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~-----------~~~f~~Ev~iL~~L~HpNIV 465 (756)
.+.++....++|.+.+.||+|+||.||+|...+|+.||||++....... ...+.+|+++|+.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567888899999999999999999999998789999999876433221 25789999999999999999
Q ss_pred eEEEEEEec-----CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCcee
Q 004395 466 MLIGFCIED-----RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 540 (756)
Q Consensus 466 ~l~~~~~~~-----~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NIL 540 (756)
++++++... ...|+||||+. |+|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChHHEE
Confidence 999998543 35799999995 788888864 455799999999999999999999999 9999999999999
Q ss_pred ecCCCcceeeccccceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 004395 541 LTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC 619 (756)
Q Consensus 541 L~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~ 619 (756)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999998544322 2344678999999999877 778999999999999999999999997543221100
Q ss_pred -hhhhhh-hhhh------hhhhhhccCCccCC-------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 620 -LTEWAR-PLLE------EYAIDELVDPRLGN-------HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 620 -l~~~~~-~~~~------~~~i~~l~dp~l~~-------~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...... +... .............. .........+.+|+.+||+.||.+|||+.+++++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000 0000 00000111000000 0111234568899999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=358.88 Aligned_cols=265 Identities=22% Similarity=0.255 Sum_probs=205.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcC--------CCCeeeEEEEEE--
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ--------HRNVVMLIGFCI-- 472 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~--------HpNIV~l~~~~~-- 472 (756)
..++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+++|+.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 457899999999999999999984 57899999998643 233457889999999985 788999999988
Q ss_pred --ecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-----
Q 004395 473 --EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----- 545 (756)
Q Consensus 473 --~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~----- 545 (756)
+....|+||||+ +++|.+++.......+++..++.++.||+.||.|||++| ||+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccchhhhh
Confidence 556789999999 778888776655578999999999999999999999964 799999999999999775
Q ss_pred --------------------------------------------cceeeccccceecCCCCCCcccccccCccccCcccc
Q 004395 546 --------------------------------------------EPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA 581 (756)
Q Consensus 546 --------------------------------------------~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l 581 (756)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876533 2345799999999999
Q ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh-------hh----hhh-hhcc----------CC
Q 004395 582 QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL-------EE----YAI-DELV----------DP 639 (756)
Q Consensus 582 ~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~-------~~----~~i-~~l~----------dp 639 (756)
.+..++.++|||||||+||||++|+.||................... .. ... .... ..
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999997544322110000000000 00 000 0000 00
Q ss_pred c---------cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 640 R---------LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 640 ~---------l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. .....+......+.+|+.+||+.||++|||+.|++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 0012345566789999999999999999999999873
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=361.04 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=197.3
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~------ 475 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 57899999999999999999995 5799999998854322 22356889999999999999999999998763
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8999999964 5799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hhhhh-hh---hh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TEWAR-PL---LE 629 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~-~~---~~ 629 (756)
+..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......+... ..... +. ..
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 876432 244678999999999877 7899999999999999999999999975443211100 00000 00 00
Q ss_pred -------hh---hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 -------EY---AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 -------~~---~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .+.......+ ..........+.+|+.+||..||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 0000000011 11122334578999999999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=345.77 Aligned_cols=256 Identities=26% Similarity=0.348 Sum_probs=197.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEec--CCC--EEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP--DGQ--AVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~--~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
..++|++.+.||+|+||.||+|.+. +++ .||||+++... ......+.+|+++++.++||||+++++++.+..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3468999999999999999999853 333 68999876442 233467899999999999999999999998754
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.++||||+.+++|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEccccccc
Confidence 89999999999999999752 35699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 557 WQPDGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 557 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~--------- 234 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------IL--------- 234 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH---------
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HH---------
Confidence 77543321 1223457889999999998889999999999999999999 999996543210 00
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+.........+......+.+++.+||..||.+|||+.++++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 281 (291)
T 1u46_A 235 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 281 (291)
T ss_dssp HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 01101111111222344578999999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=338.51 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=198.3
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
+..++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++.+....|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 34578999999999999999999964 79999999876432 234457889999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 88 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999999999974 35699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
.... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||....... .. .. +...
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~----~~--~~~~- 226 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------LF----KK--IRGG- 226 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH----HH--HHHC-
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HH----HH--hhcC-
Confidence 5432 2234568999999999988766 689999999999999999999996432110 00 00 0000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. ..+......+.+++.+||+.||++|||+.++++.
T Consensus 227 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 VF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 1122233568899999999999999999999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=363.28 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=193.1
Q ss_pred CeeEEEEecccCceEEEEEEec--CC--CEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEe-cCceeEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVLP--DG--QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRRRLLV 480 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~--~g--~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~-~~~~~LV 480 (756)
.|.+.+.||+|+||.||+|... ++ ..||||.++.... .....|.+|+.++++++||||++++++|.+ ++..|+|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 5888999999999999999853 22 3689998764332 334679999999999999999999998754 4578999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999964 446789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCC---cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 561 GDMG---VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 561 ~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
.... ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||........ . .. +...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~---~~------~~~~ 312 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---T---VY------LLQG 312 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---H---HH------HHTT
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---H---HH------HHcC
Confidence 3211 1233557889999999999999999999999999999999 6777764432211 0 00 0000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... ..+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 313 ~~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 313 RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011 1122234568999999999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=361.05 Aligned_cols=263 Identities=22% Similarity=0.292 Sum_probs=198.5
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEec-----
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED----- 474 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~----- 474 (756)
++...++|.+.+.||+|+||.||+|.. .+|+.||||++..... .+.+|+++|+.++||||++++++|...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 355678999999999999999999984 6799999998864432 234799999999999999999998543
Q ss_pred ---------------------------------CceeEEEEeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHH
Q 004395 475 ---------------------------------RRRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRY 519 (756)
Q Consensus 475 ---------------------------------~~~~LV~Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~y 519 (756)
...++||||+. |+|.+.+.. .....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 34889999996 688877753 256789999999999999999999
Q ss_pred HHhhcccCceEeeccCCCceeec-CCCcceeeccccceecCCCCCCcccccccCccccCccccccC-CCCchhhHHHHHH
Q 004395 520 LHEECRVGCIVHRDMRPNNILLT-HDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGV 597 (756)
Q Consensus 520 LH~~~~~~gIiHrDLKp~NILL~-~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGv 597 (756)
||+. ||+||||||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++|||||||
T Consensus 157 LH~~----gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 157 IHSL----GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHTT----TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHC----cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 9999 999999999999998 68999999999999765433 23445789999999998764 5899999999999
Q ss_pred HHHHHHhCCCCCCCCCcccccchhhhhh----hhhhhh-----hhhhccCCccC-----CCCChhHHHHHHHHHHHhccc
Q 004395 598 VLVELVTGRKAVDLNRPKGQQCLTEWAR----PLLEEY-----AIDELVDPRLG-----NHYSEHEVYCMLHAASLCIRR 663 (756)
Q Consensus 598 vL~ELltG~~Pf~~~~~~~~~~l~~~~~----~~~~~~-----~i~~l~dp~l~-----~~~~~~~~~~l~~Li~~CL~~ 663 (756)
++|||++|+.||.......+ +..... +..... ...+..-+... ..++......+.+|+.+||..
T Consensus 231 il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999999975443221 111100 000000 00000001110 012223445689999999999
Q ss_pred CCCCCCCHHHHHH
Q 004395 664 DPHSRPRMSQVLR 676 (756)
Q Consensus 664 dP~~RPS~~eVL~ 676 (756)
||.+|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=371.01 Aligned_cols=251 Identities=25% Similarity=0.292 Sum_probs=202.5
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc--CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~--~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+++|++++||||+++++++.+....|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 45799999999999999999995 47999999987543 2334567999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec---CCCcceeeccccceec
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT---HDFEPLVGDFGLARWQ 558 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~---~~~~vkL~DFGlA~~~ 558 (756)
|||.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999998864 35799999999999999999999999 999999999999995 4567999999999866
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||........ ..... ....
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~i~-~~~~- 239 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI----------LKRVE-TGKY- 239 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHHH-HTCC-
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------HHHHH-hCCC-
Confidence 4432 2344679999999999975 599999999999999999999999965432110 00000 0000
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.............+.+|+.+||..||.+|||+.+++++
T Consensus 240 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 -AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001112234568899999999999999999999984
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.88 Aligned_cols=258 Identities=19% Similarity=0.257 Sum_probs=202.1
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEe--cCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIE--DRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~--~~~~~LV 480 (756)
.++|++.+.||+|+||.||+|.. .+++.||||++.. .....+.+|+++|..++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999984 5789999998863 33567899999999997 9999999999988 6678999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-cceeeccccceecC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQP 559 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-~vkL~DFGlA~~~~ 559 (756)
|||+.+++|.+++. .+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999884 389999999999999999999999 999999999999999777 89999999998765
Q ss_pred CCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhh-------
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEY------- 631 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------- 631 (756)
.... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||......... +...........
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHH
Confidence 4432 234578999999999877 67899999999999999999999999543322111 111100000000
Q ss_pred -------hhhhccC--------CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 632 -------AIDELVD--------PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 632 -------~i~~l~d--------p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....+.. ..............+.+|+.+||+.||.+|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 000111112235678999999999999999999999883
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.32 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=205.8
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 468999999999999999999964 688999998764422 2345688999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+++|.+++.. ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998864 35799999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .. .+....
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~---------~~~~~~ 231 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YL---------RIKKNE 231 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH---------HHHTTC
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH---------HHhhcc
Confidence 322 23345799999999999998899999999999999999999999965432110 00 000000
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...+......+.+++.+||+.||++|||+.++++.
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01122333568899999999999999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=371.89 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=199.4
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.++|.+.+.||+|+||.||+|... ++..||||++.... ......+.+|+.+|+.++||||++++++|.+....|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999954 78999999886543 334567999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---CCcceeeccccceec
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQ 558 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~~~vkL~DFGlA~~~ 558 (756)
|||.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999998864 35799999999999999999999999 9999999999999976 455999999999876
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.... ......||+.|+|||++. +.|+.++|||||||++|+|++|..||........ .... .. ...
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i-~~---~~~-- 254 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI------LRKV-EK---GKY-- 254 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-HH---TCC--
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-Hh---CCC--
Confidence 5432 234567999999999986 5689999999999999999999999975432110 0000 00 000
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+...........+.+|+.+||+.||.+|||+.+++++
T Consensus 255 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 255 -TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00000111233568899999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=349.85 Aligned_cols=263 Identities=21% Similarity=0.328 Sum_probs=203.6
Q ss_pred CCCCChHHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCC--cCchhHHHHHHHHHhcC--CCCeeeEE
Q 004395 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQ--HRNVVMLI 468 (756)
Q Consensus 393 ~~~~s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~--HpNIV~l~ 468 (756)
...+.+..+.+..++|.+.+.||+|+||.||++...+++.||||++..... .....+.+|++++..++ ||||++++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 344555667777889999999999999999999988899999998865432 23457899999999997 59999999
Q ss_pred EEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcce
Q 004395 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548 (756)
Q Consensus 469 ~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vk 548 (756)
+++.+....|+||| +.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||+++ +.+|
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEET-TEEE
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEEC-CeEE
Confidence 99999999999999 468999999974 45799999999999999999999999 9999999999999964 8999
Q ss_pred eeccccceecCCCCCC-cccccccCccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004395 549 VGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQS-----------GQITEKADVYSFGVVLVELVTGRKAVDLNRPKG 616 (756)
Q Consensus 549 L~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 616 (756)
|+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence 9999999866543211 2234569999999999875 478899999999999999999999996432210
Q ss_pred ccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 617 ~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+....++.....++......+.+++.+||..||.+||++.++++.
T Consensus 247 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 --------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 01111222222222233334568899999999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=350.00 Aligned_cols=269 Identities=21% Similarity=0.244 Sum_probs=193.5
Q ss_pred HHHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc-
Q 004395 399 AELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR- 476 (756)
Q Consensus 399 ~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~- 476 (756)
.......++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+..|++.+..++||||++++++|.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34566678999999999999999999996 478999999876433 334467788999999999999999999976544
Q ss_pred ------eeEEEEeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHH--hhcccCceEeeccCCCceeecC-CC
Q 004395 477 ------RLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLH--EECRVGCIVHRDMRPNNILLTH-DF 545 (756)
Q Consensus 477 ------~~LV~Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH--~~~~~~gIiHrDLKp~NILL~~-~~ 545 (756)
.++||||+. ++|...+.. .....+++..++.++.|++.||.||| +. ||+||||||+|||++. ++
T Consensus 95 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~----~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV----NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp CTTCEEEEEEEECCS-CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT----CCBCSCCCGGGEEEETTTT
T ss_pred cccceeEEEEeeccc-ccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC----CeecCcCCHHHEEEeCCCC
Confidence 789999996 465554432 25667999999999999999999999 87 9999999999999997 89
Q ss_pred cceeeccccceecCCCCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh
Q 004395 546 EPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA 624 (756)
Q Consensus 546 ~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 624 (756)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +....
T Consensus 170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~ 245 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIV 245 (360)
T ss_dssp EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHH
Confidence 99999999998765433 23345789999999998664 489999999999999999999999976443211 11111
Q ss_pred hhhh--hhhhhhhcc---------C------CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 625 RPLL--EEYAIDELV---------D------PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 625 ~~~~--~~~~i~~l~---------d------p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.... ....+..+. . ..............+.+|+.+||+.||.+|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000000000 0 000011122245679999999999999999999999873
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=365.57 Aligned_cols=200 Identities=22% Similarity=0.272 Sum_probs=176.3
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc------CCCCeeeEEEEEEecCc
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA------QHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L------~HpNIV~l~~~~~~~~~ 476 (756)
...+|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|++++..+ .|+||+.+++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 456899999999999999999985 46899999988643 22345678899999887 56799999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc--ceeecccc
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE--PLVGDFGL 554 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~--vkL~DFGl 554 (756)
.|+||||+ +++|.+++.......+++..++.++.||+.||+|||+. ||+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999999 57999999876666799999999999999999999999 9999999999999999987 99999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNR 613 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 613 (756)
++..... .....||+.|+|||++.+..++.++|||||||+||||++|..||....
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9865432 234579999999999999999999999999999999999999997654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.31 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=207.2
Q ss_pred hHHHHHhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcC--------chhHHHHHHHHHhc-CCCCeeeE
Q 004395 398 YAELELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG--------DHEFCSEVEVLSCA-QHRNVVML 467 (756)
Q Consensus 398 ~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~--------~~~f~~Ev~iL~~L-~HpNIV~l 467 (756)
+.......++|.+.+.||+|+||.||+|... +|+.||||++....... ...+.+|+.++..+ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999964 79999999887543221 24578899999999 79999999
Q ss_pred EEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcc
Q 004395 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (756)
Q Consensus 468 ~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~v 547 (756)
++++......|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999974 35799999999999999999999999 99999999999999999999
Q ss_pred eeeccccceecCCCCCCcccccccCccccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 004395 548 LVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS------GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 548 kL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~ 621 (756)
||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||........ +
T Consensus 240 kl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~- 314 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM--L- 314 (365)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-
T ss_pred EEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--H-
Confidence 999999998765433 2345679999999999863 3588999999999999999999999964321100 0
Q ss_pred hhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 622 EWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 622 ~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
... . ........ .........+.+++.+||..||++|||+.++++.
T Consensus 315 ---~~i-~----~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 ---RMI-M----EGQYQFSS--PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ---HHH-H----HTCCCCCH--HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHH-H----hCCCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 0 00000000 0001123458899999999999999999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.70 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=204.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC---------cCchhHHHHHHHHHhcC-CCCeeeEEEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---------QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCI 472 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---------~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~ 472 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999999996 4789999999875431 11346788999999996 999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecc
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
+....++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999974 35799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCcccccccCccccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhh
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQ------SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 626 (756)
|++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||....... ....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~ 240 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRM 240 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------HHHH
Confidence 9998765433 233457899999999885 4568899999999999999999999996432110 0000
Q ss_pred hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
. . .. ...............+.+++.+||..||.+|||+.++++
T Consensus 241 ~-~----~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 I-M----SG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H-H----HT--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H-h----cC--CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 0 00 001111111234457899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=345.51 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=204.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEe--cCCCEEEEEEecccCC--cCchhHHHHHHHHHhc---CCCCeeeEEEEEE----
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL--PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCA---QHRNVVMLIGFCI---- 472 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L---~HpNIV~l~~~~~---- 472 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999996 4688999998764432 2344678888888777 8999999999987
Q ss_pred -ecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeec
Q 004395 473 -EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (756)
Q Consensus 473 -~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~D 551 (756)
.....++||||+. |+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999996 7999999876666799999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh--hh
Q 004395 552 FGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL--LE 629 (756)
Q Consensus 552 FGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~--~~ 629 (756)
||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ +....... ..
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~ 239 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPG 239 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCC
Confidence 99998654321 23346789999999999999999999999999999999999999975432211 00000000 00
Q ss_pred hhhhhh-------cc---CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 630 EYAIDE-------LV---DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 630 ~~~i~~-------l~---dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
...+.. .. .......+.......+.+|+.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00 000001112234456889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.96 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=197.8
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--------cCchhHHHHHHHHHhcCCCCeeeEEEEEEec
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--------QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--------~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~ 474 (756)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++|+.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 446899999999999999999995 4689999998764321 2234688999999999999999999998765
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc---ceeec
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGD 551 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~---vkL~D 551 (756)
. .|+||||+.+++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999986 456799999999999999999999999 9999999999999987665 99999
Q ss_pred cccceecCCCCCCcccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh
Q 004395 552 FGLARWQPDGDMGVETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL 628 (756)
Q Consensus 552 FGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 628 (756)
||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........ +... .
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~----~ 232 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ----I 232 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHH----H
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHH----H
Confidence 99998765432 233467999999999874 56789999999999999999999999975432211 1000 0
Q ss_pred hhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 629 ~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
...... ..+... ......+.+++.+||..||++||++.++++
T Consensus 233 ~~~~~~--~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccc--cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000000 000000 112346889999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.51 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=205.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC---cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
..++|.+.+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3468999999999999999999954 688999998764422 234568899999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998864 35799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..... .. ...
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~------~~-~~~ 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRI------KK-NEY 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH------HH-TCC
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHH------hc-CCC
Confidence 3322 2344679999999999999999999999999999999999999996533211 00000 00 011
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
. .+......+.+++.+||+.||++|||+.++++
T Consensus 259 ~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 S----IPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred C----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 12223346889999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=370.05 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=201.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-------------cCchhHHHHHHHHHhcCCCCeeeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-------------QGDHEFCSEVEVLSCAQHRNVVMLIG 469 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-------------~~~~~f~~Ev~iL~~L~HpNIV~l~~ 469 (756)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999995 4689999998764321 23457899999999999999999999
Q ss_pred EEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC---c
Q 004395 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---E 546 (756)
Q Consensus 470 ~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~---~ 546 (756)
+|.+....|+|||||.+|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999864 35799999999999999999999999 999999999999998876 6
Q ss_pred ceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhh
Q 004395 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP 626 (756)
Q Consensus 547 vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~ 626 (756)
+||+|||+++...... ......||+.|+|||++. +.|+.++|||||||++|+|++|..||........ +. .
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----~ 258 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI--IK----K 258 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----H
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----H
Confidence 9999999998775432 234567999999999987 4689999999999999999999999975432110 00 0
Q ss_pred hhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 627 ~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. . ..... +...........+.+|+.+||..||.+|||+.|+++.
T Consensus 259 i-~----~~~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 V-E----KGKYY--FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp H-H----HCCCC--CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H-H----cCCCC--CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0 00000 0000001223468899999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=373.90 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=207.9
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++|..++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 46899999999999999999996 479999999886432 23446788999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 481 YEYICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~--~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
|||+.||+|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+||||+.+|.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999997533 45799999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ........ ... .
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i-----~~~--~ 409 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRV-----LEQ--A 409 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHH-----HHC--C
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHH-----hhc--c
Confidence 54432 23446899999999999999999999999999999999999999975432111 01111100 010 0
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRM-----SQVLR 676 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~-----~eVL~ 676 (756)
..++......+.+|+.+||..||.+||++ .+|++
T Consensus 410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11223344578899999999999999975 56654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=367.37 Aligned_cols=241 Identities=15% Similarity=0.157 Sum_probs=190.5
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHH---HHHhcCCCCeeeEE-------EE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVE---VLSCAQHRNVVMLI-------GF 470 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~---iL~~L~HpNIV~l~-------~~ 470 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .......|.+|++ +|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35799999999999999999995 57999999998743 2234467889994 55556799999998 77
Q ss_pred EEecCc-----------------eeEEEEeecCCChhhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhhcccCc
Q 004395 471 CIEDRR-----------------RLLVYEYICNGSLDSHLYGCH-----QEPLEWSARQKIAVGAARGLRYLHEECRVGC 528 (756)
Q Consensus 471 ~~~~~~-----------------~~LV~Ey~~ggsL~~~L~~~~-----~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g 528 (756)
+.+.+. .||||||+ +|+|.+++.... ...+++..++.|+.||+.||+|||++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ 226 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----G 226 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----C
Confidence 765542 78999999 789999996421 12344588889999999999999999 9
Q ss_pred eEeeccCCCceeecCCCcceeeccccceecCCCCCCcccccccCccccCccccccC-----------CCCchhhHHHHHH
Q 004395 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG-----------QITEKADVYSFGV 597 (756)
Q Consensus 529 IiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDVwSlGv 597 (756)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999986432 2345567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 598 VLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 598 vL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
+||||++|+.||......... ..+.. . .. .....+.+|+.+||..||++|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~---------------~~~~~-~-~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS---------------EWIFR-S-CK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS---------------GGGGS-S-CC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch---------------hhhhh-h-cc----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999644322110 00000 0 01 22346889999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=382.73 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=199.7
Q ss_pred CeeE-EEEecccCceEEEEEEe---cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 407 GFSQ-ANFLAEGGFGSVHRGVL---PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 407 ~y~~-~~~LG~G~fG~Vy~a~~---~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
.+.+ .+.||+|+||.||+|.+ .+++.||||+++.... .....|.+|+++|..++|||||+++++|.. +..+||
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 3444 34899999999999974 3567899999875433 234679999999999999999999999964 568999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||+.+|+|.+++.. ...+++..++.|+.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++.+..
T Consensus 448 ~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 999999999999963 46799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 561 GDM--GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 561 ~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
... .......||+.|+|||++.+..++.++|||||||+||||++ |+.||........ ...+
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~----------------~~~i 585 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----------------TAML 585 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------HHHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHH
Confidence 331 12233457889999999999999999999999999999998 9999965432110 0000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
........+......+.+|+..||+.||++||++.+|++.|+.
T Consensus 586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111112233445678999999999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=360.08 Aligned_cols=253 Identities=12% Similarity=0.055 Sum_probs=184.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC---cCchhHHHHHHHHHhc--CCCCeeeEE-------EEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCA--QHRNVVMLI-------GFCI 472 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L--~HpNIV~l~-------~~~~ 472 (756)
..|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999995 4789999999876543 2234577886555555 599988865 5554
Q ss_pred ecC-----------------ceeEEEEeecCCChhhhhhccCCCCCCHHHH------HHHHHHHHHHHHHHHhhcccCce
Q 004395 473 EDR-----------------RRLLVYEYICNGSLDSHLYGCHQEPLEWSAR------QKIAVGAARGLRYLHEECRVGCI 529 (756)
Q Consensus 473 ~~~-----------------~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~------~~ia~qIa~aL~yLH~~~~~~gI 529 (756)
..+ ..||||||+. |+|.+++... ...+++..+ +.++.||+.||+|||++ ||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSK----GL 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----TE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC----CC
Confidence 332 3799999997 9999999753 234455566 78889999999999999 99
Q ss_pred EeeccCCCceeecCCCcceeeccccceecCCCCCCcccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCC
Q 004395 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRK 607 (756)
Q Consensus 530 iHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~ 607 (756)
+||||||+||||+.++.+||+|||+|+..... .....+|+.|+|||++.+ ..++.++|||||||+||||++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999866432 224567799999999987 779999999999999999999999
Q ss_pred CCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 608 AVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 608 Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
||....+..... +..... .......+...........+.+|+.+||+.||++|||+.++++
T Consensus 292 Pf~~~~~~~~~~---~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGS---WKRPSL-----RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTC---CCBCCT-----TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccc---hhhhhh-----hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 997654321111 100000 0000111111111234457899999999999999999999976
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=361.05 Aligned_cols=259 Identities=24% Similarity=0.271 Sum_probs=196.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC------cee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------RRL 478 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~------~~~ 478 (756)
.+|.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+|+++|+.++||||++++++|.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4699999999999999999996 469999999876432 23447999999999999999999986432 367
Q ss_pred EEEEeecCCChhhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC-Ccceeeccccc
Q 004395 479 LVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLA 555 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~--~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~-~~vkL~DFGlA 555 (756)
+||||+. ++|.+.+.. .....+++..++.++.||+.||+|||+. ||+||||||+||||+.+ +.+||+|||++
T Consensus 130 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 9999995 567666542 2457899999999999999999999999 99999999999999965 56899999999
Q ss_pred eecCCCCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh--hhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL--EEYA 632 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~--~~~~ 632 (756)
+....... .....||+.|+|||++.+. .|+.++|||||||+||||++|+.||.......+ +......+- ....
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQ 280 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 97654332 2346799999999998764 799999999999999999999999975432211 111111000 0000
Q ss_pred hhh-------ccCCccCC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 633 IDE-------LVDPRLGN-----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 633 i~~-------l~dp~l~~-----~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+.. +..+.+.. .+.......+.+|+.+||..||.+|||+.|++++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000 11111100 0122334578999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.90 Aligned_cols=265 Identities=23% Similarity=0.269 Sum_probs=201.5
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEec-----Cce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~-----~~~ 477 (756)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+++|..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999995 47889999988743322 235788999999999999999999999765 368
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999985 699998853 4699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--CcccccccCccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh-hhh-hhhhh---
Q 004395 558 QPDGDM--GVETRVIGTFGYLAPEYAQ-SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT-EWA-RPLLE--- 629 (756)
Q Consensus 558 ~~~~~~--~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~-~~~~~--- 629 (756)
...... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||............ ... .+...
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 653321 1224467999999999865 455899999999999999999999999765432221000 000 00000
Q ss_pred ------hhh-hhhccCCcc--CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 ------EYA-IDELVDPRL--GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 ------~~~-i~~l~dp~l--~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
... ...+..+.. ...........+.+|+.+||..||.+|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000000 000011233568899999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=347.70 Aligned_cols=264 Identities=23% Similarity=0.299 Sum_probs=195.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEE----------
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI---------- 472 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~---------- 472 (756)
..++|.+.+.||+|+||.||+|... +|+.||||++..........+.+|+++++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3578999999999999999999965 58999999887665555678999999999999999999999874
Q ss_pred ----ecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec-CCCcc
Q 004395 473 ----EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-HDFEP 547 (756)
Q Consensus 473 ----~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~-~~~~v 547 (756)
+....|+||||+. |+|.+++. .+++++..++.++.||+.||+|||+. ||+||||||+|||++ .++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCeE
Confidence 3467899999996 79999984 46799999999999999999999999 999999999999997 56799
Q ss_pred eeeccccceecCCCC--CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh
Q 004395 548 LVGDFGLARWQPDGD--MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA 624 (756)
Q Consensus 548 kL~DFGlA~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~ 624 (756)
||+|||+++...... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||........ +....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLIL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 999999998654321 112234567999999998865 7789999999999999999999999975443211 00000
Q ss_pred h--hhhhhhhhhh------------ccCCcc-CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 625 R--PLLEEYAIDE------------LVDPRL-GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 625 ~--~~~~~~~i~~------------l~dp~l-~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. +........+ ...+.. ...........+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 0000000000 000000 000111234568999999999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=341.18 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=200.3
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC----CcCchhHHHHHHHHHhcCCCCeeeEEEEEE--ecCce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCI--EDRRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~----~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~--~~~~~ 477 (756)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999995 578999999886432 234467999999999999999999999984 45578
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|+||||+.++ |.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999655 87888766677899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC-CCcccccccCccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 558 QPDGD-MGVETRVIGTFGYLAPEYAQSGQ--ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 558 ~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
..... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ..... +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~------i~ 226 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFEN------IG 226 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH------HH
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHH------Hh
Confidence 65322 12223456999999999997654 378999999999999999999999743211 00000 00
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .. ..+......+.+++.+||..||.+|||+.++++.
T Consensus 227 ~~-~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 KG-SY----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HC-CC----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cC-CC----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 01 1122334568899999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=350.19 Aligned_cols=263 Identities=19% Similarity=0.298 Sum_probs=203.8
Q ss_pred hHHHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 398 YAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 398 ~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
..++++..++|.+.+.||+|+||.||+|.... .||+|+++... ......|.+|+.+++.++||||+++++++.+..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34455667899999999999999999998743 49999876543 233456889999999999999999999999999
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..++||||+.+++|.+++.. ....+++..++.++.||+.||+|||+. ||+||||||+|||++ ++.+||+|||++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999964 345799999999999999999999999 999999999999998 689999999998
Q ss_pred eecCCCC----CCcccccccCccccCcccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhh
Q 004395 556 RWQPDGD----MGVETRVIGTFGYLAPEYAQS---------GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTE 622 (756)
Q Consensus 556 ~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~---------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~ 622 (756)
+...... ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----- 251 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI----- 251 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-----
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----
Confidence 7543211 112233468999999999864 4578999999999999999999999975432110
Q ss_pred hhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcCcC
Q 004395 623 WARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGDTV 683 (756)
Q Consensus 623 ~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~~~ 683 (756)
... +.....+... .......+.+++.+||..||++|||+.++++.|+....
T Consensus 252 -~~~------~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 252 -IWQ------MGTGMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp -HHH------HHTTCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred -HHH------hccCCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 000 0111111111 11122358899999999999999999999999986543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.03 Aligned_cols=262 Identities=21% Similarity=0.259 Sum_probs=192.8
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~------ 475 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999984 4789999998865322 23356889999999999999999999998665
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..|+||||+. ++|.+++. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999995 68888885 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hh--------hhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LT--------EWARP 626 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~--------~~~~~ 626 (756)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .. .+...
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 8654322 2344679999999999999999999999999999999999999997543221100 00 00000
Q ss_pred h---hhh----------hhhhhccCCccCCCC---ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 627 L---LEE----------YAIDELVDPRLGNHY---SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 627 ~---~~~----------~~i~~l~dp~l~~~~---~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+ ... ..+..+......... .......+.+|+.+||..||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 000 000000000000000 11235678999999999999999999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=382.19 Aligned_cols=250 Identities=20% Similarity=0.253 Sum_probs=207.0
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCce
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~ 477 (756)
...++|.+.+.||+|+||.||+|.. .+++.||||+++.. .......+..|..+|..+ +||||+.+++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3457899999999999999999995 46899999988643 234456788899999987 699999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
||||||+.||+|.+++.. .+.+++..++.++.||+.||+|||+. |||||||||+||||+.++.+||+|||+|+.
T Consensus 418 ~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999974 35799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
...... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ +..++
T Consensus 492 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~---------------~~~i~ 555 (674)
T 3pfq_A 492 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---------------FQSIM 555 (674)
T ss_dssp CCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---------------HHHHH
T ss_pred cccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH---------------HHHHH
Confidence 443322 34557899999999999999999999999999999999999999975432110 01111
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRM-----SQVLR 676 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~-----~eVL~ 676 (756)
... ..++......+.+||.+||..||++||++ .+|++
T Consensus 556 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 556 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111 12333445678999999999999999997 66665
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=346.60 Aligned_cols=264 Identities=20% Similarity=0.284 Sum_probs=204.5
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec-CC-CEEEEEEecccCCcCchhHHHHHHHHHhcCCCC------eeeEEEEEEec
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP-DG-QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN------VVMLIGFCIED 474 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g-~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN------IV~l~~~~~~~ 474 (756)
...++|.+.+.||+|+||.||+|... ++ +.||||++... ......+.+|+.+++.++|+| ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 34579999999999999999999953 44 78999998643 233456888999999997765 99999999999
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee-------------
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL------------- 541 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL------------- 541 (756)
...|+||||+ +++|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecccccccccccc
Confidence 9999999999 78888888765557899999999999999999999999 99999999999999
Q ss_pred ------cCCCcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc
Q 004395 542 ------THDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPK 615 (756)
Q Consensus 542 ------~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 615 (756)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 67889999999999875433 23457999999999999999999999999999999999999999754432
Q ss_pred cccchh-hhhhhhhhh-------------------------hhhhhccCCc-cCCCCChhHHHHHHHHHHHhcccCCCCC
Q 004395 616 GQQCLT-EWARPLLEE-------------------------YAIDELVDPR-LGNHYSEHEVYCMLHAASLCIRRDPHSR 668 (756)
Q Consensus 616 ~~~~l~-~~~~~~~~~-------------------------~~i~~l~dp~-l~~~~~~~~~~~l~~Li~~CL~~dP~~R 668 (756)
...... ....+.... ........+. ............+.+|+.+||..||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 111000 000000000 0000000000 0011223445678999999999999999
Q ss_pred CCHHHHHH
Q 004395 669 PRMSQVLR 676 (756)
Q Consensus 669 PS~~eVL~ 676 (756)
||+.++++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=355.74 Aligned_cols=260 Identities=23% Similarity=0.291 Sum_probs=196.3
Q ss_pred hCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc------ee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR------RL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~------~~ 478 (756)
..+|.+.+.||+|+||.||+|....+..||+|++..... ...+|+++|+.++||||++++++|..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457999999999999999999987666799997754322 23379999999999999999999976543 78
Q ss_pred EEEEeecCCChhhhhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec-CCCcceeeccccc
Q 004395 479 LVYEYICNGSLDSHLY--GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-HDFEPLVGDFGLA 555 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~--~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~-~~~~vkL~DFGlA 555 (756)
+||||+.++ |...+. ......+++..++.++.||+.||+|||+. ||+||||||+||||+ .++.+||+|||+|
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 999999654 443332 22457899999999999999999999999 999999999999999 7999999999999
Q ss_pred eecCCCCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh----hhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR----PLLEE 630 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----~~~~~ 630 (756)
+....... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.......+ +..... +....
T Consensus 190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQ 265 (394)
T ss_dssp EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 97654432 2346789999999998764 589999999999999999999999976543211 111110 00000
Q ss_pred hh--hhhccC---CccC-----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 631 YA--IDELVD---PRLG-----NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 631 ~~--i~~l~d---p~l~-----~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. ...... +... ..+.......+.+|+.+||..||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 000000 0000 01122234578999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=345.38 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=193.6
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC------cCchhHHHHHHHHHhc----CCCCeeeEE
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS------QGDHEFCSEVEVLSCA----QHRNVVMLI 468 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~------~~~~~f~~Ev~iL~~L----~HpNIV~l~ 468 (756)
+.+...++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3456678999999999999999999985 5789999999865432 1234567799999999 899999999
Q ss_pred EEEEecCceeEEEEe-ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec-CCCc
Q 004395 469 GFCIEDRRRLLVYEY-ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-HDFE 546 (756)
Q Consensus 469 ~~~~~~~~~~LV~Ey-~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~-~~~~ 546 (756)
+++.+.+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCCe
Confidence 999999999999999 789999999974 35799999999999999999999999 999999999999999 8899
Q ss_pred ceeeccccceecCCCCCCcccccccCccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh
Q 004395 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQIT-EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 547 vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~ 625 (756)
+||+|||+++...... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||.....
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------- 244 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------- 244 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence 9999999998775432 3445699999999999876664 599999999999999999999953210
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. ... .. .++......+.+++.+||+.||++|||+.++++.
T Consensus 245 -~-----~~~--~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 -I-----LEA--EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -H-----HHT--CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -H-----hhh--cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 00 1122334568899999999999999999999884
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=338.05 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=194.6
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEe----------
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE---------- 473 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~---------- 473 (756)
.++|++.+.||+|+||.||+|.. .+|+.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45799999999999999999995 47999999988642 2334678899999999999999999998865
Q ss_pred ---cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceee
Q 004395 474 ---DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (756)
Q Consensus 474 ---~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~ 550 (756)
....|+||||+.+++|.+++.. ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEEe
Confidence 4568999999999999999975 345688899999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCC-------------CCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004395 551 DFGLARWQPDGD-------------MGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKG 616 (756)
Q Consensus 551 DFGlA~~~~~~~-------------~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 616 (756)
|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~- 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER- 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence 999998654321 1122345689999999999764 78999999999999999998 44311000
Q ss_pred ccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 617 QQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 617 ~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .... +.. ....+...++......+.+++.+||+.||.+|||+.++++.
T Consensus 235 ----~~----~~~~--~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 ----VN----ILKK--LRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ----HH----HHHH--HHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----HH----HHHh--ccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00 0000 000 11122223444455678999999999999999999999883
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=359.51 Aligned_cols=261 Identities=24% Similarity=0.283 Sum_probs=184.4
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEec------C
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------R 475 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~------~ 475 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|+.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999984 5799999998864322 2345688999999999999999999999754 4
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..|+||||+ +++|.+++. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999998 899999885 35799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hhhhh-hh---hh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TEWAR-PL---LE 629 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~-~~---~~ 629 (756)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......+... ..... +. ..
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865432 245679999999999877 7789999999999999999999999975543221100 00000 00 00
Q ss_pred ---hhhhh---hccCCccCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 ---EYAID---ELVDPRLGNH---YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 ---~~~i~---~l~dp~l~~~---~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..... ..+....... ........+.+|+.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 0000000000 001223468899999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=351.78 Aligned_cols=202 Identities=23% Similarity=0.251 Sum_probs=174.7
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CC-----CeeeEEEEEEec
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HR-----NVVMLIGFCIED 474 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-Hp-----NIV~l~~~~~~~ 474 (756)
+...++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+..|+.++..+. |+ +|+.+++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34567999999999999999999995 47889999998732 223456778999998885 55 499999999999
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--hcccCceEeeccCCCceeec--CCCcceee
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE--ECRVGCIVHRDMRPNNILLT--HDFEPLVG 550 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~--~~~~~gIiHrDLKp~NILL~--~~~~vkL~ 550 (756)
...||||||+ +++|.+++.......+++..++.++.||+.||.|||. . ||+||||||+||||+ .++.+||+
T Consensus 129 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~----~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL----SIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTT----CEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCC----CEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999 5699999987665779999999999999999999994 5 899999999999995 47889999
Q ss_pred ccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004395 551 DFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNR 613 (756)
Q Consensus 551 DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 613 (756)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999876542 234679999999999999999999999999999999999999997544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=358.28 Aligned_cols=201 Identities=24% Similarity=0.362 Sum_probs=156.1
Q ss_pred CCeeE-EEEecccCceEEEEEEec---CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEe--cCceeE
Q 004395 406 GGFSQ-ANFLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLL 479 (756)
Q Consensus 406 ~~y~~-~~~LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--~~~~~L 479 (756)
+.|.+ +++||+|+||.||+|... +++.||||++... .....+.+|+++|+.++||||+++++++.. ....|+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34665 457999999999999954 5789999987643 334578899999999999999999999964 668899
Q ss_pred EEEeecCCChhhhhhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceee----cCCCcce
Q 004395 480 VYEYICNGSLDSHLYGC-------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL----THDFEPL 548 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~-------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL----~~~~~vk 548 (756)
||||+ +++|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||| +.++.+|
T Consensus 98 v~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 98 LFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 99998 56888877421 223599999999999999999999999 99999999999999 7789999
Q ss_pred eeccccceecCCCC--CCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004395 549 VGDFGLARWQPDGD--MGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNR 613 (756)
Q Consensus 549 L~DFGlA~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 613 (756)
|+|||+|+...... .......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999998765322 122345679999999999987 458999999999999999999999996543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=348.15 Aligned_cols=266 Identities=22% Similarity=0.283 Sum_probs=199.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEec-----Cc
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RR 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~-----~~ 476 (756)
..++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+++|+.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999954 789999998864332 2234688999999999999999999998764 67
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999995 799998864 5799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCC---------cccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh-hhhh
Q 004395 557 WQPDGDMG---------VETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT-EWAR 625 (756)
Q Consensus 557 ~~~~~~~~---------~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~~ 625 (756)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 76532211 1223578999999998754 77899999999999999999999999754322110000 0000
Q ss_pred -h-------hhhhhhhhhccC--CccCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 -P-------LLEEYAIDELVD--PRLGN----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 -~-------~~~~~~i~~l~d--p~l~~----~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+ ........+... +.... .........+.+|+.+||..||++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000000000000 00000 0011234568899999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.41 Aligned_cols=258 Identities=23% Similarity=0.294 Sum_probs=197.1
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCce---
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR--- 477 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~--- 477 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 346899999999999999999995 47899999988754322 245788999999999999999999999887655
Q ss_pred ---eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 478 ---LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 478 ---~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
|+||||+. ++|.+++. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999995 78888773 3599999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh--------
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR-------- 625 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~-------- 625 (756)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.....
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTE 264 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCcHH
Confidence 9865432 234578999999999887 7889999999999999999999999975432211 000000
Q ss_pred ---hh---hhhhhhhhccCCccCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 ---PL---LEEYAIDELVDPRLGNH---YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 ---~~---~~~~~i~~l~dp~l~~~---~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. ........+ ....... ........+.+|+.+||+.||++|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSL-PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHS-CCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhcc-CCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 000000000 0000000 011234578999999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=379.51 Aligned_cols=258 Identities=25% Similarity=0.354 Sum_probs=205.4
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec----CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~ 475 (756)
.++..++|.+.+.||+|+||.||+|... .+..||||.+..... .....|.+|+.+++.++||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4455678999999999999999999853 256799998765432 23357999999999999999999999985 45
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
..|+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecCCC
Confidence 68999999999999999975 345799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
+..............+|+.|+|||++.+..++.++|||||||++|||++ |..||........ . . .+.
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~------~----~--~i~ 606 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------I----G--RIE 606 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------H----H--HHH
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH------H----H--HHH
Confidence 8765544333344567889999999999999999999999999999997 9999975432110 0 0 001
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..... ..+...+..+.+++.+||..||++|||+.+|++.|+.
T Consensus 607 ~~~~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 607 NGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp HTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 10011 1223344578999999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.06 Aligned_cols=265 Identities=19% Similarity=0.258 Sum_probs=202.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-----------CCCeeeEEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-----------HRNVVMLIGFC 471 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-----------HpNIV~l~~~~ 471 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++... ......+.+|++++.++. ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 346899999999999999999995 57899999988632 223456888999999886 89999999999
Q ss_pred EecC----ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec-----
Q 004395 472 IEDR----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT----- 542 (756)
Q Consensus 472 ~~~~----~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~----- 542 (756)
.... ..++||||+ +++|.+++.......+++..++.++.||+.||+|||+++ ||+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChHHeEEeccCCC
Confidence 8654 789999999 999999998766677999999999999999999999953 799999999999994
Q ss_pred -CCCcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 004395 543 -HDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT 621 (756)
Q Consensus 543 -~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~ 621 (756)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4457999999999876542 23457899999999999999999999999999999999999999754321110000
Q ss_pred hhhhhhhh-----------hhhh-h------hccCC-------------ccCCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 004395 622 EWARPLLE-----------EYAI-D------ELVDP-------------RLGNHYSEHEVYCMLHAASLCIRRDPHSRPR 670 (756)
Q Consensus 622 ~~~~~~~~-----------~~~i-~------~l~dp-------------~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS 670 (756)
........ .... . ..... .....++......+.+||.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 00000000 0000 0 00000 0011244566778999999999999999999
Q ss_pred HHHHHHH
Q 004395 671 MSQVLRI 677 (756)
Q Consensus 671 ~~eVL~~ 677 (756)
+.|++++
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.87 Aligned_cols=252 Identities=25% Similarity=0.291 Sum_probs=202.6
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 44578999999999999999999964 78999999886443 2345679999999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC---Ccceeeccccce
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD---FEPLVGDFGLAR 556 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~---~~vkL~DFGlA~ 556 (756)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999998864 35799999999999999999999999 99999999999999764 469999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ..... . ...
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~----~~~ 238 (287)
T 2wei_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRV-E----TGK 238 (287)
T ss_dssp TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-H----HCC
T ss_pred eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHH-H----cCC
Confidence 664432 2234568999999999875 48999999999999999999999996543210 00000 0 000
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..... .........+.+++.+||..||.+|||+.++++
T Consensus 239 ~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 YAFDL--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCS--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCc--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000 000122346889999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.55 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=175.6
Q ss_pred hhCCeeEEE-EecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHH-HHHHhcCCCCeeeEEEEEEe----cCc
Q 004395 404 ATGGFSQAN-FLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEV-EVLSCAQHRNVVMLIGFCIE----DRR 476 (756)
Q Consensus 404 ~~~~y~~~~-~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev-~iL~~L~HpNIV~l~~~~~~----~~~ 476 (756)
..++|.+.+ .||+|+||.||+|... +|+.||||++... .....|+ ..+..+.||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 356899955 6999999999999964 7999999987632 2233333 34667789999999999976 445
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---CCcceeeccc
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFG 553 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~~~vkL~DFG 553 (756)
.++||||+.+|+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 89999999999999999866566899999999999999999999999 9999999999999976 4559999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... . ........
T Consensus 177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~----~~~~~~~~ 247 (336)
T 3fhr_A 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--P----GMKRRIRL 247 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--h----hHHHhhhc
Confidence 998665332 23456899999999999899999999999999999999999999644322110 0 00000000
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.. ..............+.+|+.+||..||.+|||+.++++
T Consensus 248 ~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 248 GQ---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cc---cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00111111233456889999999999999999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=345.59 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=202.0
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc------CchhHHHHHHHHHhcC--CCCeeeEEEE
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQ--HRNVVMLIGF 470 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~------~~~~f~~Ev~iL~~L~--HpNIV~l~~~ 470 (756)
+.+...++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+++.+. ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3455678999999999999999999984 57899999988654322 2346778999999996 5999999999
Q ss_pred EEecCceeEEEEeecC-CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec-CCCcce
Q 004395 471 CIEDRRRLLVYEYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-HDFEPL 548 (756)
Q Consensus 471 ~~~~~~~~LV~Ey~~g-gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~-~~~~vk 548 (756)
+.+.+..++||||+.+ ++|.+++.. ...+++..++.++.||+.||+|||+. ||+||||||+|||++ +++.+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCCEE
Confidence 9999999999999976 899999974 46799999999999999999999999 999999999999999 789999
Q ss_pred eeccccceecCCCCCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhh
Q 004395 549 VGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627 (756)
Q Consensus 549 L~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~ 627 (756)
|+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~ 255 (320)
T 3a99_A 191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------I 255 (320)
T ss_dssp ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H
T ss_pred EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------h
Confidence 99999998765432 234569999999999987665 6889999999999999999999953210 0
Q ss_pred hhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 ~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
... ... +.......+.+++.+||..||++|||+.+|++.
T Consensus 256 -----~~~--~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 -----IRG--QVF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -----HHC--CCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----hcc--ccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 001 112223468899999999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.61 Aligned_cols=257 Identities=23% Similarity=0.300 Sum_probs=197.3
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCc-----
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR----- 476 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~----- 476 (756)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999995 47999999988654322 23568899999999999999999999987654
Q ss_pred -eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 477 -RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 477 -~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
.|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999995 78888874 3599999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh---------
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR--------- 625 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~--------- 625 (756)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.....
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEF 247 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 865332 234578999999999877 6789999999999999999999999975442211 000000
Q ss_pred --hhhh---hhhhhhc---cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 626 --PLLE---EYAIDEL---VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 626 --~~~~---~~~i~~l---~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.... ...+..+ ..+.+ ..........+.+++.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0000000 00011 11222345678999999999999999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.51 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=180.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHH-HHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVE-VLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~-iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 447899999999999999999996 4799999998875432 22345666666 66778999999999999999999999
Q ss_pred EEeecCCChhhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 481 YEYICNGSLDSHLYG---CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~---~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
|||+. ++|.+++.. .....+++..++.++.|++.||.|||+.+ ||+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH---SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC---CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99996 588777742 23678999999999999999999999863 799999999999999999999999999986
Q ss_pred cCCCCCCcccccccCccccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYA----QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
..... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||......... +. . +
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~----~------~ 242 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-LT----Q------V 242 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------C----C------C
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-HH----H------H
Confidence 64432 22334699999999998 4567899999999999999999999999753221110 00 0 0
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.....+.+...........+.+++.+||..||.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000111111112233457899999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=352.98 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=189.9
Q ss_pred hCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEEEe
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.+.|...+.||+|+||+||.+...+|+.||||++... ....+.+|+++|..+ +||||+++++++.+....||||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 3467778999999999998776678999999987643 234678999999886 899999999999999999999999
Q ss_pred ecCCChhhhhhccCCCC-----CCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC-------------C
Q 004395 484 ICNGSLDSHLYGCHQEP-----LEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-------------F 545 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~-----L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~-------------~ 545 (756)
| +|+|.+++....... ..+..++.++.||+.||+|||+. ||+||||||+|||++.+ +
T Consensus 91 ~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 91 C-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp C-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred C-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCce
Confidence 9 579999997432211 12334678999999999999999 99999999999999754 4
Q ss_pred cceeeccccceecCCCCCC---cccccccCccccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 004395 546 EPLVGDFGLARWQPDGDMG---VETRVIGTFGYLAPEYAQS-------GQITEKADVYSFGVVLVELVT-GRKAVDLNRP 614 (756)
Q Consensus 546 ~vkL~DFGlA~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 614 (756)
.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999977653321 1234579999999999975 678999999999999999999 9999964322
Q ss_pred ccccchhhhhhhhhhhhhhhhcc-CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 615 KGQQCLTEWARPLLEEYAIDELV-DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 615 ~~~~~l~~~~~~~~~~~~i~~l~-dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
... ..+.... .+.............+.+++.+||+.||.+|||+.+|+++
T Consensus 246 ~~~-------------~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RES-------------NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHH-------------HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHH-------------HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 110 0001111 1111122234566789999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=333.59 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=180.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcC--chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~--~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
..++|.+.+.||+|+||.||+|... +|+.||||++....... ...+..+..++..++||||+++++++.+....|+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3468999999999999999999964 79999999887543221 22344455678888999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|||+ ++.+..++. .....+++..++.++.||+.||.|||+ . ||+||||||+|||++.++.+||+|||++....
T Consensus 103 ~e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKH----GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHH----CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhC----CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9998 555555443 345679999999999999999999998 5 89999999999999999999999999997654
Q ss_pred CCCCCcccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...... .
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~-----~ 244 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-----VLTKVL-----Q 244 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHHH-----H
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-----HHHHHh-----c
Confidence 432 223456999999999984 56789999999999999999999999974322100 000000 0
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
. ..+.+. ........+.+++.+||..||.+||++.++++
T Consensus 245 ~-~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 245 E-EPPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp S-CCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c-CCCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 011111 11123346889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=347.94 Aligned_cols=252 Identities=24% Similarity=0.288 Sum_probs=189.6
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
+...+|.+.+.||+|+||.||.....+|+.||||++.... ...+.+|+++|+.+ +||||+++++++.+....||||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3445799999999999999765555689999999886432 33467899999999 7999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---C--Ccceeeccccce
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---D--FEPLVGDFGLAR 556 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~--~~vkL~DFGlA~ 556 (756)
||| +|+|.+++... ...+.+..++.++.||+.||.|||+. ||+||||||+||||+. + ..+||+|||+|+
T Consensus 98 E~~-~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELC-AATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECC-SEEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECC-CCCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 998 57999999753 33455556789999999999999999 9999999999999953 2 357799999998
Q ss_pred ecCCCCC--CcccccccCccccCccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhh
Q 004395 557 WQPDGDM--GVETRVIGTFGYLAPEYAQ---SGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEE 630 (756)
Q Consensus 557 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 630 (756)
....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||........ ....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~-- 242 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILL-- 242 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHT--
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHh--
Confidence 7654321 2234567999999999997 4667889999999999999999 9999854321100 0000
Q ss_pred hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 631 ~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...... ...........+.+|+.+||+.||.+|||+.+|+++
T Consensus 243 ---~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 243 ---GACSLD--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ---TCCCCT--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---ccCCcc--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 000000 011122344567899999999999999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=367.23 Aligned_cols=240 Identities=22% Similarity=0.289 Sum_probs=192.7
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEec--CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc--
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLP--DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR-- 476 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~-- 476 (756)
+...++|.+.+.||+|+||.||+|... +|+.||||++..... .....|.+|+++|..++||||++++++|...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 345689999999999999999999964 689999998764322 233568899999999999999999999998766
Q ss_pred ---eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 477 ---RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 477 ---~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
.||||||+.|++|.+++.. .+++..++.++.||+.||.|||++ ||+||||||+|||++.+ .+||+|||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEecc
Confidence 7999999999999987742 799999999999999999999999 99999999999999886 89999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
+++..... ....||+.|+|||++.++. +.++|||||||+||+|++|..||........
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------- 284 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------- 284 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------
T ss_pred cchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------
Confidence 99876543 3457999999999997654 8999999999999999999988753211000
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhh
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR-MSQVLRILE 679 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-~~eVL~~Le 679 (756)
. ...........+.+++.+||+.||.+||+ ++++...|.
T Consensus 285 ---~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 ---P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ---C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 00000112246889999999999999995 555555443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.17 Aligned_cols=228 Identities=18% Similarity=0.244 Sum_probs=181.4
Q ss_pred hCCeeEE-EEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHH-HhcCCCCeeeEEEEEEe----cCce
Q 004395 405 TGGFSQA-NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFCIE----DRRR 477 (756)
Q Consensus 405 ~~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL-~~L~HpNIV~l~~~~~~----~~~~ 477 (756)
.++|.+. +.||+|+||.||+|.. .+++.||||++.. ...+.+|++++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567777 7899999999999995 5789999998853 34678899988 55689999999999987 6778
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---CCcceeecccc
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGL 554 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~~~vkL~DFGl 554 (756)
|+||||+.+|+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999876666899999999999999999999999 9999999999999998 78999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
+.... +..++.++|||||||++|||++|+.||......... . ... .
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~----~~~-----~ 212 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--P----GMK-----T 212 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------C----CSC-----C
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--H----HHH-----H
Confidence 87542 244678999999999999999999999644321100 0 000 0
Q ss_pred hccCCccCCCCC----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 635 ELVDPRLGNHYS----EHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~l~~~~~----~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+.... ...+ ......+.+++.+||+.||.+|||+.+++++
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0011 1234568999999999999999999999873
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=315.99 Aligned_cols=231 Identities=14% Similarity=0.092 Sum_probs=183.5
Q ss_pred HhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcC---chhHHHHHHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~---~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
+..++|.+.+.||+|+||.||+|... +|+.||||++....... ...|.+|+.++..++||||+++++++.+++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34578999999999999999999964 58999999987554332 257899999999999999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
+||||+.|++|.+++.. + .....+..++.||+.||+|||++ ||+||||||+|||++.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999999942 3 35567889999999999999999 99999999999999999999997443
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
|++ .++.++|||||||++|||+||+.||............ ...... ....
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--~~~~~~-----~~~~ 224 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--ERDTAG-----QPIE 224 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--CBCTTS-----CBCC
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--HHHhcc-----CCCC
Confidence 333 3689999999999999999999999765443211000 000000 0000
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...........+.+++.+||+.||++| |+.++++.|+.
T Consensus 225 ---~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 225 ---PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp ---HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred ---hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 000111233468999999999999999 99999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=339.80 Aligned_cols=240 Identities=15% Similarity=0.162 Sum_probs=182.8
Q ss_pred CCeeEEEEecccCceEEEEEE-ecCCCEEEEEEecccCC---cCchhHHHHHHHHHhcCC-CCe----------------
Q 004395 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQH-RNV---------------- 464 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~---~~~~~f~~Ev~iL~~L~H-pNI---------------- 464 (756)
..|...+.||+|+||.||+|. ..+|+.||||++..... ...+.|.+|+.++..+.| +|+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 468889999999999999999 45799999998874333 235679999999999987 221
Q ss_pred -----eeEEEEEEe-----cCceeEEEEeecCCChhhhhh-----ccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCce
Q 004395 465 -----VMLIGFCIE-----DRRRLLVYEYICNGSLDSHLY-----GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529 (756)
Q Consensus 465 -----V~l~~~~~~-----~~~~~LV~Ey~~ggsL~~~L~-----~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gI 529 (756)
..++.++.. ....+++|+++ +++|.+++. ......+++..++.++.||+.||+|||++ ||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~i 232 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GL 232 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----Cc
Confidence 112122222 12457777765 899999984 22355688899999999999999999999 99
Q ss_pred EeeccCCCceeecCCCcceeeccccceecCCCCCCcccccccCccccCcccc----------ccCCCCchhhHHHHHHHH
Q 004395 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYA----------QSGQITEKADVYSFGVVL 599 (756)
Q Consensus 530 iHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l----------~~~~~s~ksDVwSlGvvL 599 (756)
+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999865432 344567 999999999 556688999999999999
Q ss_pred HHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 600 VELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 600 ~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
|||++|+.||........ ........ ..+ +..+.+|+.+||+.||++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~---------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG---------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC---------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh---------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999965432111 00111100 112 246899999999999999999998865
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=359.16 Aligned_cols=258 Identities=27% Similarity=0.358 Sum_probs=199.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC-CcCchhHHHHHHHHHhcCCCCeeeEEEEEEe------cCce
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE------DRRR 477 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~-~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~------~~~~ 477 (756)
++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++|..++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999995 578999999876532 2234568999999999999999999999765 6778
Q ss_pred eEEEEeecCCChhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc---ceeeccc
Q 004395 478 LLVYEYICNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDFG 553 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~-~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~---vkL~DFG 553 (756)
|+||||+.+|+|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999997532 34699999999999999999999999 9999999999999997765 8999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|..........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccch
Confidence 998765443 234567999999999999999999999999999999999999999643211 1111111110000
Q ss_pred hhcc------------CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHH
Q 004395 634 DELV------------DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQV 674 (756)
Q Consensus 634 ~~l~------------dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eV 674 (756)
.... ...............+.+++.+||..||++|||+.++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000 0011123445577889999999999999999999774
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=322.43 Aligned_cols=243 Identities=15% Similarity=0.156 Sum_probs=188.8
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCC--------cCchhHHHHHHHHHhcC---------CCCeee
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--------QGDHEFCSEVEVLSCAQ---------HRNVVM 466 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~--------~~~~~f~~Ev~iL~~L~---------HpNIV~ 466 (756)
..++|.+.+.||+|+||.||+|.. +|+.||||++..... .....+.+|+.+|+.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 456799999999999999999998 789999999875432 22367899999999886 888888
Q ss_pred EEEEEE------------------------------ecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHH
Q 004395 467 LIGFCI------------------------------EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARG 516 (756)
Q Consensus 467 l~~~~~------------------------------~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~a 516 (756)
+.+++. +....||||||+.+|++.+.+. ...+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHH
Confidence 888754 2678999999999998777773 3578999999999999999
Q ss_pred HHHHH-hhcccCceEeeccCCCceeecCCC--------------------cceeeccccceecCCCCCCcccccccCccc
Q 004395 517 LRYLH-EECRVGCIVHRDMRPNNILLTHDF--------------------EPLVGDFGLARWQPDGDMGVETRVIGTFGY 575 (756)
Q Consensus 517 L~yLH-~~~~~~gIiHrDLKp~NILL~~~~--------------------~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y 575 (756)
|+||| +. ||+||||||+||||+.++ .+||+|||+|+..... ..+||+.|
T Consensus 174 L~~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 99999 88 999999999999999887 8999999999876432 35799999
Q ss_pred cCccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc-cCCccCCCCChhHHHHH
Q 004395 576 LAPEYAQSGQITEKADVYSFGVV-LVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL-VDPRLGNHYSEHEVYCM 653 (756)
Q Consensus 576 ~APE~l~~~~~s~ksDVwSlGvv-L~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l-~dp~l~~~~~~~~~~~l 653 (756)
+|||++.+.. +.++||||||++ .+++++|..||.. ..|....... ..... ................+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDK-MLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHH-HHHTCCCSSCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHh-hhhhhccCcccchhhhhhcCHHH
Confidence 9999998766 899999998777 7788889988731 0111111110 01010 11111111233566789
Q ss_pred HHHHHHhcccCCCCCCCHHHHH-H
Q 004395 654 LHAASLCIRRDPHSRPRMSQVL-R 676 (756)
Q Consensus 654 ~~Li~~CL~~dP~~RPS~~eVL-~ 676 (756)
.+|+.+||+.| |+.|++ +
T Consensus 313 ~dli~~~L~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLLCQ 331 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHHHH
T ss_pred HHHHHHHhccC-----CHHHHHhc
Confidence 99999999976 999998 5
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=301.19 Aligned_cols=186 Identities=18% Similarity=0.109 Sum_probs=132.5
Q ss_pred EecccCceEEEEEE-ecCCCEEEEEEecccCC----------cCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEE
Q 004395 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS----------QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 413 ~LG~G~fG~Vy~a~-~~~g~~VAVK~~~~~~~----------~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV 480 (756)
.++.|++|.+..+. .-.|+.||+|.+..... ...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777776655 34688999998764321 1224699999999999 699999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
||||+|++|.++|. ..++++.. +|+.||+.||+|||++ |||||||||+||||+.+|.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999997 45677754 5889999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAV 609 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf 609 (756)
.. ......+||+.|||||++.+ .+..++|+||+|+++++|.+|..++
T Consensus 392 ~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 33 23456789999999999975 4677899999999988887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=267.38 Aligned_cols=184 Identities=15% Similarity=0.168 Sum_probs=146.2
Q ss_pred eEEEEecccCceEEEEEEecCCCEEEEEEecccCCcC--------chhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 409 SQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--------DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~--------~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
...+.||+|+||.||+|.. .++.+|+|+........ .+.|.+|+++|++++||||+.+..++......|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 67889999765432211 23478999999999999999666666677788999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
|||++|++|.+++.. ++.++.|++.||.|||++ ||+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999963 568999999999999999 9999999999999998 999999999998754
Q ss_pred CCCC------cccccccCccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 004395 561 GDMG------VETRVIGTFGYLAPEYAQS--GQITEKADVYSFGVVLVELVTGRKAV 609 (756)
Q Consensus 561 ~~~~------~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf 609 (756)
.... ......||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3211 1235789999999999987 67888999999999999888877765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=222.01 Aligned_cols=150 Identities=15% Similarity=0.035 Sum_probs=120.6
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCc------------------CchhHHHHHHHHHhcCCC
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ------------------GDHEFCSEVEVLSCAQHR 462 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~------------------~~~~f~~Ev~iL~~L~Hp 462 (756)
+......|.+.+.||+|+||.||+|...+|+.||||.++..... ....+.+|+++|+.++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 34445678888999999999999999977999999988643221 13458899999999994
Q ss_pred CeeeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec
Q 004395 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (756)
Q Consensus 463 NIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~ 542 (756)
+.+++++. .+..|+||||++|++|.+ +.. .....++.|++.||.|||+. ||+||||||+|||++
T Consensus 164 --~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 --LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVS 227 (282)
T ss_dssp --SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE
T ss_pred --CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEEE
Confidence 55555443 356799999999999998 421 23457999999999999999 999999999999999
Q ss_pred CCCcceeeccccceecCCCCCCcccccccCccccCccccc
Q 004395 543 HDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ 582 (756)
Q Consensus 543 ~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 582 (756)
++.+||+|||+|+. +..|+|||++.
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999973 44578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=188.73 Aligned_cols=137 Identities=20% Similarity=0.139 Sum_probs=107.9
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCE--EEEEEecccCCcC------------------------chhHHHHHHHHHhc
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQA--VAVKQHKLASSQG------------------------DHEFCSEVEVLSCA 459 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~--VAVK~~~~~~~~~------------------------~~~f~~Ev~iL~~L 459 (756)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 377899999999999999997 78999 9999865432110 12578899999999
Q ss_pred CCCCe--eeEEEEEEecCceeEEEEeecC-C----ChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hhcccCceEe
Q 004395 460 QHRNV--VMLIGFCIEDRRRLLVYEYICN-G----SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH-EECRVGCIVH 531 (756)
Q Consensus 460 ~HpNI--V~l~~~~~~~~~~~LV~Ey~~g-g----sL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH-~~~~~~gIiH 531 (756)
.|+|| +.++++ ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. ||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~----givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA----ELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS----CEEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC----CEEe
Confidence 88754 455543 357999999942 4 66655432 234567889999999999999 88 9999
Q ss_pred eccCCCceeecCCCcceeeccccceec
Q 004395 532 RDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 532 rDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999988 9999999999854
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=3.8e-17 Score=180.27 Aligned_cols=136 Identities=13% Similarity=0.126 Sum_probs=102.7
Q ss_pred CeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCc-----C---------chh--------HHHHHHHHHhcCCCCe
Q 004395 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ-----G---------DHE--------FCSEVEVLSCAQHRNV 464 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~-----~---------~~~--------f~~Ev~iL~~L~HpNI 464 (756)
-|.+...||.|+||.||+|...+|+.||||+++..... . ... ...|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 49999999999999999999889999999987643110 0 001 2346667777755444
Q ss_pred --eeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec
Q 004395 465 --VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (756)
Q Consensus 465 --V~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~ 542 (756)
...+++ ...+|||||+.|++|..+.. . .....++.||+.+|.|||+. |||||||||.|||++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH----GLIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEe
Confidence 233332 23489999999988876542 1 13457889999999999998 999999999999998
Q ss_pred CCCc----------ceeeccccceec
Q 004395 543 HDFE----------PLVGDFGLARWQ 558 (756)
Q Consensus 543 ~~~~----------vkL~DFGlA~~~ 558 (756)
+++. +.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 8773 889999988754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=3.2e-12 Score=132.14 Aligned_cols=145 Identities=13% Similarity=0.014 Sum_probs=115.6
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.-.+|.+...++.|+++.||++... +..+++|............+.+|+++|+.+. +..++++++++.+.+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3467999999999999999999854 6889999876533233456999999999995 6788899999998889999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc--------------------------------------
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC-------------------------------------- 524 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~-------------------------------------- 524 (756)
|++|.+|.+.+. +......++.+++++|+.||...
T Consensus 91 ~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999987642 11223578899999999999810
Q ss_pred -----------------ccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 525 -----------------RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 525 -----------------~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
...+++|+|++|.|||+++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01369999999999999876666799998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=3.1e-11 Score=123.47 Aligned_cols=138 Identities=18% Similarity=0.061 Sum_probs=103.7
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC--eeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN--IV~l~~~~~~~~~~~LV~Ey 483 (756)
.+|.+..+.+.|..+.||++...+|..+++|..... ....+..|+++++.+.+.+ ++++++++..++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 355554444466679999998777888999986543 3356889999999996544 56789988888889999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcc--------------------------------------
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR-------------------------------------- 525 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~-------------------------------------- 525 (756)
++|.+|. ... .. ...++.++++.|..||....
T Consensus 97 i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9998884 211 11 23677888888888886420
Q ss_pred ----------------cCceEeeccCCCceeecCCCcceeeccccce
Q 004395 526 ----------------VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 526 ----------------~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
..+++|+|++|.|||++.++.+.|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=5e-10 Score=121.47 Aligned_cols=144 Identities=17% Similarity=0.225 Sum_probs=108.6
Q ss_pred eEEEEecccCceEEEEEEecCCCEEEEEEec--ccC-CcCchhHHHHHHHHHhcC--CCCeeeEEEEEEec---CceeEE
Q 004395 409 SQANFLAEGGFGSVHRGVLPDGQAVAVKQHK--LAS-SQGDHEFCSEVEVLSCAQ--HRNVVMLIGFCIED---RRRLLV 480 (756)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~--~~~-~~~~~~f~~Ev~iL~~L~--HpNIV~l~~~~~~~---~~~~LV 480 (756)
...+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.|. +..+++++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999988754 578888655 322 123457889999999997 45688999998776 458999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc------------------------------------
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC------------------------------------ 524 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~------------------------------------ 524 (756)
|||++|..+.+.. ...++...+..++.++++.|+.||...
T Consensus 120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999988885432 134778888999999999999999731
Q ss_pred ------------------ccCceEeeccCCCceeecCCCc--ceeecccccee
Q 004395 525 ------------------RVGCIVHRDMRPNNILLTHDFE--PLVGDFGLARW 557 (756)
Q Consensus 525 ------------------~~~gIiHrDLKp~NILL~~~~~--vkL~DFGlA~~ 557 (756)
...+++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 0137999999999999997753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=4.7e-10 Score=118.96 Aligned_cols=183 Identities=19% Similarity=0.176 Sum_probs=124.0
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCC--eeeEEEEEEecC---ceeEEEEeec
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRN--VVMLIGFCIEDR---RRLLVYEYIC 485 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpN--IV~l~~~~~~~~---~~~LV~Ey~~ 485 (756)
+.++.|.+..||+.. ..+++|+.... .....+.+|+++|+.+. +.. ++.++.+..... ..|+||++++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458999999999863 45888875422 23457889999999884 333 456665554433 3489999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc-----------------------------------------
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----------------------------------------- 524 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~----------------------------------------- 524 (756)
|.+|.+... ..++...+..++.+++..|+.||...
T Consensus 100 G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 100 GVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 998876443 24778888899999999999999610
Q ss_pred -------------ccCceEeeccCCCceeecC--CCcceeeccccceecCCCCCCcccccccCccc---cCcccccc---
Q 004395 525 -------------RVGCIVHRDMRPNNILLTH--DFEPLVGDFGLARWQPDGDMGVETRVIGTFGY---LAPEYAQS--- 583 (756)
Q Consensus 525 -------------~~~gIiHrDLKp~NILL~~--~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y---~APE~l~~--- 583 (756)
....++|+|++|.|||++. ++.+.|+||+.+..... . ........+ ..|+....
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~----~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-D----NDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-T----HHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-H----HHHHHHHhhccccCHHHHHHHHH
Confidence 0125899999999999998 45678999999875321 1 011111111 22221110
Q ss_pred --CC---------CCchhhHHHHHHHHHHHHhCCCCC
Q 004395 584 --GQ---------ITEKADVYSFGVVLVELVTGRKAV 609 (756)
Q Consensus 584 --~~---------~s~ksDVwSlGvvL~ELltG~~Pf 609 (756)
+. .....+.|++|.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 122368999999999999998776
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=98.50 E-value=1.5e-07 Score=87.96 Aligned_cols=131 Identities=17% Similarity=0.236 Sum_probs=100.1
Q ss_pred ccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhh
Q 004395 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (756)
Q Consensus 20 ~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (756)
-++|+|++|.+.. +..|+.||+.-.-+.|..|+||+|++...... ++. +. ...+...+..+.
T Consensus 5 ~~~ILv~~D~s~~-s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~--~~~----~~-----------~~~~~~~~~~~~ 66 (146)
T 3s3t_A 5 YTNILVPVDSSDA-AQAAFTEAVNIAQRHQANLTALYVVDDSAYHT--PAL----DP-----------VLSELLDAEAAH 66 (146)
T ss_dssp CCEEEEECCSSHH-HHHHHHHHHHHHHHHTCEEEEEEEEECCCCCC--GGG----HH-----------HHHHHHHHHHHH
T ss_pred cceEEEEcCCCHH-HHHHHHHHHHHHHhcCCEEEEEEEecCccccc--ccc----cc-----------ccHHHHHHHHHH
Confidence 4789999999865 89999999998777899999999988654321 110 00 111222333444
Q ss_pred HHHHHHHHhhhcCCCCc-eEEEEEEeCCCCchhhH-HhhhccceEEEeccccch---------hhhhhhhccceeEEEEe
Q 004395 100 CSQMILQLHDVYDPNKI-NFKIKIVSGSPCGAVAA-EAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMK 168 (756)
Q Consensus 100 ~~~~~~~l~~~~~~~~v-~~~~~v~~g~~~~~v~~-eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~ 168 (756)
..+.+.++...++..|| +++..+..|.|...|+. .|++.+|..||++.|=+. .-.+++.+.+|-|.+++
T Consensus 67 ~~~~l~~~~~~~~~~g~~~~~~~~~~g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvV~ 146 (146)
T 3s3t_A 67 AKDAMRQRQQFVATTSAPNLKTEISYGIPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAPCNVIVIR 146 (146)
T ss_dssp HHHHHHHHHHHHTTSSCCCCEEEEEEECHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCSSEEEEEC
T ss_pred HHHHHHHHHHHHHhcCCcceEEEEecCChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCCCCEEEeC
Confidence 45778888888888899 99999999999989999 899999999999987322 24589999999998875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.4e-06 Score=89.81 Aligned_cols=141 Identities=17% Similarity=0.058 Sum_probs=100.7
Q ss_pred CCeeEEEEecccCce-EEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFG-SVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG-~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.+|+.. .+..|..| .||+.... ++..+.+|+.... ....+.+|..+|+.|. +--+.++++++.+.+..|+|||
T Consensus 25 ~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 445543 34445554 68988754 5677889975432 3456888999999885 3347789999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc--------------------------------------
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC-------------------------------------- 524 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~-------------------------------------- 524 (756)
+++|.++.+.... .......++.+++..|+.||...
T Consensus 101 ~l~G~~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 9999888766532 11233456667777777777531
Q ss_pred ----------------ccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 525 ----------------RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 525 ----------------~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
....++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01138999999999999988777799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.4e-06 Score=92.72 Aligned_cols=137 Identities=20% Similarity=0.156 Sum_probs=98.7
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCC---CeeeEEEEEE-ecCceeEEEEeecC
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR---NVVMLIGFCI-EDRRRLLVYEYICN 486 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~Hp---NIV~l~~~~~-~~~~~~LV~Ey~~g 486 (756)
...++.|....||+. |..+++|+.. .......+.+|+++|..|.+. .|++.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999987 5668888742 222345788999999999752 3667777774 44567899999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC------------------------------------------ 524 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~------------------------------------------ 524 (756)
.+|.+... ..++......++.++++.|+.||...
T Consensus 98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88876432 13456666677777777777777531
Q ss_pred --------------ccCceEeeccCCCceeecC---CCc-ceeecccccee
Q 004395 525 --------------RVGCIVHRDMRPNNILLTH---DFE-PLVGDFGLARW 557 (756)
Q Consensus 525 --------------~~~gIiHrDLKp~NILL~~---~~~-vkL~DFGlA~~ 557 (756)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1125799999999999987 455 47999998864
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=98.40 E-value=3e-07 Score=85.11 Aligned_cols=127 Identities=14% Similarity=0.158 Sum_probs=96.1
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhc-cCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchh-h
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHV-VQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDIT-D 98 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~-~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 98 (756)
++|+|++|.+.. +..|+.||+.-. -+.|..|+||+|++..... ++. +. ...+...++. +
T Consensus 2 ~~ILv~~D~s~~-s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~----~~~---~~-----------~~~~~~~~~~~~ 62 (138)
T 3idf_A 2 KKLLFAIDDTEA-CERAAQYILDMFGKDADCTLTLIHVKPEFMLY----GEA---VL-----------AAYDEIEMKEEE 62 (138)
T ss_dssp EEEEEECCSSHH-HHHHHHHHHHHHTTCTTEEEEEEEEECCCCCC----HHH---HH-----------HHHHHHHHHHHH
T ss_pred ceEEEEeCCCHH-HHHHHHHHHHHhccCCCCEEEEEEEecCCCcc----ccc---cc-----------CcHHHHHHHHHH
Confidence 689999999865 899999999998 8899999999998864322 110 00 0012223333 4
Q ss_pred hHHHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccchh--------hhhhhhccceeEEEEe
Q 004395 99 SCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE--------EKCCMEELQCNIVVMK 168 (756)
Q Consensus 99 ~~~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~--------~~~~~~~l~C~i~~~~ 168 (756)
...+.+.++...++..+++++..+..|.|...|+..|+ +|..||++.|=+.. -.+++.+.+|.|.+++
T Consensus 63 ~~~~~l~~~~~~~~~~g~~~~~~v~~g~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~ 138 (138)
T 3idf_A 63 KAKLLTQKFSTFFTEKGINPFVVIKEGEPVEMVLEEAK--DYNLLIIGSSENSFLNKIFASHQDDFIQKAPIPVLIVK 138 (138)
T ss_dssp HHHHHHHHHHHHHHTTTCCCEEEEEESCHHHHHHHHHT--TCSEEEEECCTTSTTSSCCCCTTCHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHHHHHHHCCCCeEEEEecCChHHHHHHHHh--cCCEEEEeCCCcchHHHHhCcHHHHHHhcCCCCEEEeC
Confidence 44577888888888899999999999998888888888 99999999983221 2478889999988874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.2e-06 Score=94.51 Aligned_cols=83 Identities=8% Similarity=-0.057 Sum_probs=59.6
Q ss_pred eEEEEe-cccCceEEEEEEec-------CCCEEEEEEecccC---CcCchhHHHHHHHHHhcC-C--CCeeeEEEEEEec
Q 004395 409 SQANFL-AEGGFGSVHRGVLP-------DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQ-H--RNVVMLIGFCIED 474 (756)
Q Consensus 409 ~~~~~L-G~G~fG~Vy~a~~~-------~g~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~-H--pNIV~l~~~~~~~ 474 (756)
...+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+|+.|. + -.+++++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88999999998754 26778898754332 112356889999999885 3 3577888887665
Q ss_pred ---CceeEEEEeecCCChhh
Q 004395 475 ---RRRLLVYEYICNGSLDS 491 (756)
Q Consensus 475 ---~~~~LV~Ey~~ggsL~~ 491 (756)
+..|+||||++|..|.+
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCB
T ss_pred CccCCceEEEEecCCCChhh
Confidence 35689999998877654
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=8.3e-07 Score=82.53 Aligned_cols=130 Identities=15% Similarity=0.261 Sum_probs=90.6
Q ss_pred ccEEEEEEeCCCC-cchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhh
Q 004395 20 AEKVVVAVKASKE-IPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITD 98 (756)
Q Consensus 20 ~~~v~v~~d~~~~-~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (756)
+++|+|++|.+.. .+..|+.||+.-.-+.|..|+||+|++..... .++ + ... ........+
T Consensus 1 ~k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~---~~~----~---~~~--------~~~~~~~~~ 62 (143)
T 3fdx_A 1 SNAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYY---ASL----G---MAY--------TAELPGMDE 62 (143)
T ss_dssp CCEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC----------------------------------CHHH
T ss_pred CCEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCccc---ccc----c---ccc--------cchhhhHHH
Confidence 3789999999853 38999999998877789999999998864321 111 0 000 000111222
Q ss_pred hHHHHHHHHhhhcCC---CCceEEEEEEeCCCCchhhHHhhhccceEEEeccccchh---------hhhhhhccceeEEE
Q 004395 99 SCSQMILQLHDVYDP---NKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVV 166 (756)
Q Consensus 99 ~~~~~~~~l~~~~~~---~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~---------~~~~~~~l~C~i~~ 166 (756)
...+....|..+++. ++++++..+..|.|...|+..|++.++..||++.| +.. -.+++.+.+|-|.+
T Consensus 63 ~~~~~~~~l~~~~~~~~~~~~~v~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~~~~Gs~~~~v~~~~~~pVlv 141 (143)
T 3fdx_A 63 LREGSETQLKEIAKKFSIPEDRMHFHVAEGSPKDKILALAKSLPADLVIIASH-RPDITTYLLGSNAAAVVRHAECSVLV 141 (143)
T ss_dssp HHHHHHHHHHHHHTTSCCCGGGEEEEEEESCHHHHHHHHHHHTTCSEEEEESS-CTTCCSCSSCHHHHHHHHHCSSEEEE
T ss_pred HHHHHHHHHHHHHHHcCCCCCceEEEEEecChHHHHHHHHHHhCCCEEEEeCC-CCCCeeeeeccHHHHHHHhCCCCEEE
Confidence 223555566666665 45678999999998888888899999999999998 543 35889999999988
Q ss_pred Ee
Q 004395 167 MK 168 (756)
Q Consensus 167 ~~ 168 (756)
++
T Consensus 142 v~ 143 (143)
T 3fdx_A 142 VR 143 (143)
T ss_dssp EC
T ss_pred eC
Confidence 74
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.38 E-value=4.9e-07 Score=86.20 Aligned_cols=146 Identities=13% Similarity=0.153 Sum_probs=97.8
Q ss_pred ccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCC-cccccccccccccCCccccccccccccccchhh
Q 004395 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGR-RFWVFPRFAGDCASGHRKSFSGTISEQRGDITD 98 (756)
Q Consensus 20 ~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (756)
-++|+|++|.+.. +..|+.||+.-.-+.|..|+||+|++...... ...+|... +.+.. .. ..+...+...+..+
T Consensus 5 ~~~ILv~vD~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~-~~~~~--~~-~~~~~~~~~~~~~~ 79 (162)
T 1mjh_A 5 YKKILYPTDFSET-AEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLG-VAGLN--KS-VEEFENELKNKLTE 79 (162)
T ss_dssp CCEEEEECCSCHH-HHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC---------------------CHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHH-HHHHHHHHHHHHhhcCCeEEEEEEecCcccccccccccccc-ccccc--cc-hhhhHHHHHHHHHH
Confidence 3789999999866 89999999998888899999999987530000 00011000 00000 00 00001112223333
Q ss_pred hHHHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEEec
Q 004395 99 SCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMKR 169 (756)
Q Consensus 99 ~~~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~~ 169 (756)
...+.+..+...++..||+++..+..|.|...|+..|++.++..||++.|=+. --.+++.+..|-|.+++.
T Consensus 80 ~~~~~l~~~~~~~~~~g~~~~~~v~~G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~~pVlvv~~ 159 (162)
T 1mjh_A 80 EAKNKMENIKKELEDVGFKVKDIIVVGIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSNKPVLVVKR 159 (162)
T ss_dssp HHHHHHHHHHHHHHHTTCEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCCSCEEEECC
T ss_pred HHHHHHHHHHHHHHHcCCceEEEEcCCCHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCCCCEEEEeC
Confidence 44566777777777789999999999998888888899999999999988322 245899999999999985
Q ss_pred C
Q 004395 170 S 170 (756)
Q Consensus 170 ~ 170 (756)
.
T Consensus 160 ~ 160 (162)
T 1mjh_A 160 K 160 (162)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.35 E-value=8.2e-07 Score=85.54 Aligned_cols=134 Identities=10% Similarity=0.057 Sum_probs=93.5
Q ss_pred CCCccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEE--EEecCCCCCCcccccccccccccCCcccccccccccccc
Q 004395 17 SDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLL--VVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRG 94 (756)
Q Consensus 17 ~~~~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll--~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 94 (756)
....++|+|++|.|.. +..|+.||+.-.- .|..|+|| +|++..... .+++. + .. +...
T Consensus 14 ~~~~~~ILv~vD~s~~-s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~---~~~~~--~-----~~--------~~~~ 73 (163)
T 1tq8_A 14 LSAYKTVVVGTDGSDS-SMRAVDRAAQIAG-ADAKLIIASAYLPQHEDAR---AADIL--K-----DE--------SYKV 73 (163)
T ss_dssp CCCCCEEEEECCSSHH-HHHHHHHHHHHHT-TTSEEEEEEECCC------------------------------------
T ss_pred cccCCEEEEEcCCCHH-HHHHHHHHHHHhC-CCCEEEEEEeeeccCcccc---ccccc--c-----cH--------HHHH
Confidence 3345899999999865 8999999999877 89999999 887643210 11110 0 00 1111
Q ss_pred chhhhHHHHHHHHhhhcCCCCce-EEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeE
Q 004395 95 DITDSCSQMILQLHDVYDPNKIN-FKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNI 164 (756)
Q Consensus 95 ~~~~~~~~~~~~l~~~~~~~~v~-~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i 164 (756)
+..+...+.+..+.+.++..+|. ++..+..|.|...|+..|++.+|..||++.+=+. .-.+++.+.+|.|
T Consensus 74 ~~~~~~~~~l~~~~~~~~~~gv~~v~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSva~~vl~~a~~PV 153 (163)
T 1tq8_A 74 TGTAPIYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAKVDV 153 (163)
T ss_dssp --CCTHHHHHHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCeEEEEEecCCHHHHHHHHHHhcCCCEEEECCCCCCcccceeeccHHHHHHHhCCCCE
Confidence 22333456777777777778998 9999999998888888899999999999998332 2348899999999
Q ss_pred EEEecC
Q 004395 165 VVMKRS 170 (756)
Q Consensus 165 ~~~~~~ 170 (756)
.+++..
T Consensus 154 lvV~~~ 159 (163)
T 1tq8_A 154 LIVHTT 159 (163)
T ss_dssp EEECCC
T ss_pred EEEeCC
Confidence 999843
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=98.26 E-value=1.2e-06 Score=84.26 Aligned_cols=142 Identities=11% Similarity=0.087 Sum_probs=95.6
Q ss_pred ccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhh
Q 004395 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (756)
Q Consensus 20 ~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (756)
-++|+|++|.+.. +..|+.||+.-.-+.|..|+||+|++........-+++.... . .. ....+...+..+.
T Consensus 5 ~~~ILv~vD~s~~-s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~---~--~~---~~~~~~~~~~~~~ 75 (170)
T 2dum_A 5 FRKVLFPTDFSEG-AYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYD---N--AE---IELKDIKEKLKEE 75 (170)
T ss_dssp CSEEEEECCSSHH-HHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC--------------------CCTTSHHHHHHH
T ss_pred cceEEEEecCCHH-HHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccc---c--cc---ccHHHHHHHHHHH
Confidence 3789999999866 889999999988888999999999875321100001100000 0 00 0001112223333
Q ss_pred HHHHHHHHhhhcCCCCceEEE--EEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEEe
Q 004395 100 CSQMILQLHDVYDPNKINFKI--KIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMK 168 (756)
Q Consensus 100 ~~~~~~~l~~~~~~~~v~~~~--~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~ 168 (756)
..+.+..+.+.++..+|+++. .+..|.+...|+..|++.+|..||++.|=+. --.+++.+..|-|.+++
T Consensus 76 ~~~~l~~~~~~~~~~g~~~~~~~~~~~g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~~PVlvv~ 155 (170)
T 2dum_A 76 ASRKLQEKAEEVKRAFRAKNVRTIIRFGIPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTKKPVLIIK 155 (170)
T ss_dssp HHHHHHHHHHHHHHHTTCSEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHHHHHHcCCceeeeeEEecCChHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCCCCEEEEc
Confidence 345566666666666888887 8899998888888899999999999998332 23488999999999998
Q ss_pred cC
Q 004395 169 RS 170 (756)
Q Consensus 169 ~~ 170 (756)
..
T Consensus 156 ~~ 157 (170)
T 2dum_A 156 EV 157 (170)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=98.25 E-value=8.5e-07 Score=84.06 Aligned_cols=130 Identities=8% Similarity=0.134 Sum_probs=96.0
Q ss_pred CccEEEEEEe--CCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccch
Q 004395 19 VAEKVVVAVK--ASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDI 96 (756)
Q Consensus 19 ~~~~v~v~~d--~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (756)
.-++|+|++| .+.. +..|+.||+.-.-+.|..|+||+|++..... ++. + ...+...+.
T Consensus 14 ~~~~ILv~vD~~~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~----~~~---~------------~~~~~~~~~ 73 (156)
T 3fg9_A 14 VYRRILLTVDEDDNTS-SERAFRYATTLAHDYDVPLGICSVLESEDIN----IFD---S------------LTPSKIQAK 73 (156)
T ss_dssp CCC-EEEECCSCCCHH-HHHHHHHHHHHHHHHTCCEEEEEEECCCCTT----CCC---S------------SHHHHHHHH
T ss_pred cCceEEEEECCCCCHH-HHHHHHHHHHHHHhcCCEEEEEEEEeCCCcc----ccc---c------------CCHHHHHHH
Confidence 3489999999 8755 8999999999877789999999998864321 110 0 001222233
Q ss_pred hhhHHHHHHHHhhhcCCCCc-eEEEEEEe-CCCCchhhHH-hhhccceEEEeccccch--------hhhhhhhccceeEE
Q 004395 97 TDSCSQMILQLHDVYDPNKI-NFKIKIVS-GSPCGAVAAE-AKKAQAGWVVLDKQLKH--------EEKCCMEELQCNIV 165 (756)
Q Consensus 97 ~~~~~~~~~~l~~~~~~~~v-~~~~~v~~-g~~~~~v~~e-ak~~~a~wvVld~~~k~--------~~~~~~~~l~C~i~ 165 (756)
.+...+.+.++.+.++..|| .++..+.. |.|...|+.. |++.+|..||++.|=+. .-.+++.+.+|-|.
T Consensus 74 ~~~~~~~l~~~~~~~~~~g~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~Gs~~~~vl~~a~~PVl 153 (156)
T 3fg9_A 74 RKHVEDVVAEYVQLAEQRGVNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAGAIGPRLARKAPISVI 153 (156)
T ss_dssp HHHHHHHHHHHHHHHHHHTCSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCSCHHHHHHHHCSSEEE
T ss_pred HHHHHHHHHHHHHHHHHcCCCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeecchHHHHHHhCCCCEE
Confidence 33345667777777777799 59999999 9999999999 99999999999998332 23588999999998
Q ss_pred EEe
Q 004395 166 VMK 168 (756)
Q Consensus 166 ~~~ 168 (756)
+++
T Consensus 154 vV~ 156 (156)
T 3fg9_A 154 VVR 156 (156)
T ss_dssp EEC
T ss_pred EeC
Confidence 874
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=98.24 E-value=7.2e-07 Score=83.21 Aligned_cols=133 Identities=17% Similarity=0.196 Sum_probs=96.1
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++|+|++|.|.. +..|+.||+.-.-+.|..|+||+|++..... .+++... .. ....+...+..+..
T Consensus 3 ~~ILv~vD~s~~-s~~al~~A~~la~~~~a~l~ll~v~~~~~~~---~~~~~~~------~~----~~~~~~~~~~~~~~ 68 (147)
T 3hgm_A 3 NRIMVPVDGSKG-AVKALEKGVGLQQLTGAELYILCVFKHHSLL---EASLSMA------RP----EQLDIPDDALKDYA 68 (147)
T ss_dssp SEEEEECCSBHH-HHHHHHHHHHHHHHHCCEEEEEEEECCHHHH---HHTBSSC------CC----GGGCCCTTHHHHHH
T ss_pred ceEEEEeCCCHH-HHHHHHHHHHHHHhcCCEEEEEEEecCcccc---ccccccc------Ch----hhhhhHHHHHHHHH
Confidence 689999999865 8999999999877789999999998853211 1111000 00 01112223333444
Q ss_pred HHHHHHHhhhcCCCCceE---EEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEE
Q 004395 101 SQMILQLHDVYDPNKINF---KIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVM 167 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~~---~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~ 167 (756)
.+.+.++...++..+|.+ +..+..|.|...|+.+|++.+|..||++.|=+. .-.+++.+.+|-|.++
T Consensus 69 ~~~l~~~~~~~~~~g~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvV 147 (147)
T 3hgm_A 69 TEIAVQAKTRATELGVPADKVRAFVKGGRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAHCPVLVV 147 (147)
T ss_dssp HHHHHHHHHHHHHTTCCGGGEEEEEEESCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCSSCEEEC
T ss_pred HHHHHHHHHHHHhcCCCccceEEEEecCCHHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCCCCEEEC
Confidence 567777777777789888 999999998888988899999999999988322 2458899999988764
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.22 E-value=2.1e-06 Score=83.03 Aligned_cols=141 Identities=20% Similarity=0.271 Sum_probs=93.2
Q ss_pred CccEEEEEEeCCCC--------cchhhHhHHhhhccC---CCCeEEEEEEecCCCCCCcccccccccccccCCccccccc
Q 004395 19 VAEKVVVAVKASKE--------IPRTALVWALTHVVQ---PGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSG 87 (756)
Q Consensus 19 ~~~~v~v~~d~~~~--------~~~~a~~wal~~~~~---~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (756)
..++|+|++|.+.. .+..||.||+....+ .|..|+||+|++....+ +.++ .+ ... ...
T Consensus 4 ~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~--~~~~---~~----~~~--~~~ 72 (175)
T 2gm3_A 4 EPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDG--FDDV---DS----IYA--SPE 72 (175)
T ss_dssp -CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC---------------C----CCC--SHH
T ss_pred CccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeeccccc--cccc---cc----ccC--CHH
Confidence 35899999999861 489999999997765 47799999998643211 0000 00 000 000
Q ss_pred cccccccchhhhHHHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhh
Q 004395 88 TISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCME 158 (756)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~ 158 (756)
...+...+..+...+.+..+...+...+|.++..+..|.|...|+..|++.+|..|||+.|=+. .-.+++.
T Consensus 73 ~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~ 152 (175)
T 2gm3_A 73 DFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVK 152 (175)
T ss_dssp HHHHHTTSHHHHHHHHHHHHHHHHHHHTCEEEEEEEESCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHCCCceEEEEecCCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHh
Confidence 1111112222223355666666666679999999999998888888899999999999998332 2358999
Q ss_pred ccceeEEEEecC
Q 004395 159 ELQCNIVVMKRS 170 (756)
Q Consensus 159 ~l~C~i~~~~~~ 170 (756)
+..|-|.+++..
T Consensus 153 ~a~~pVlvv~~~ 164 (175)
T 2gm3_A 153 HAECPVMTIKRN 164 (175)
T ss_dssp HCSSCEEEEECC
T ss_pred CCCCCEEEEcCC
Confidence 999999999843
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=1.8e-06 Score=80.94 Aligned_cols=134 Identities=14% Similarity=0.177 Sum_probs=88.3
Q ss_pred ccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhh
Q 004395 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (756)
Q Consensus 20 ~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (756)
-++|+|++|.+.. +..|+.||+.-.-+.|..|+||+|++........++ +.. .....+...+..+.
T Consensus 6 ~~~ILv~vD~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~-----~~~--------~~~~~~~~~~~~~~ 71 (150)
T 3tnj_A 6 YHHILLAVDFSSE-DSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYG-----TAI--------PLDTETTYDAMLDV 71 (150)
T ss_dssp CSEEEEECCCSTT-HHHHHHHHHHHHHHHTCEEEEEEEEC--------CT-----TCC--------CSSSCCCHHHHHHH
T ss_pred cceEEEEeCCCHH-HHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccc-----ccc--------CcCHHHHHHHHHHH
Confidence 3789999999866 899999999987778999999999876432100011 000 00111222222333
Q ss_pred HHHHHHHHhhhcCCCCce-EEEEEEeCCCCchhhHHhhhccceEEEeccccchh--------hhhhhhccceeEEEEecC
Q 004395 100 CSQMILQLHDVYDPNKIN-FKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE--------EKCCMEELQCNIVVMKRS 170 (756)
Q Consensus 100 ~~~~~~~l~~~~~~~~v~-~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~--------~~~~~~~l~C~i~~~~~~ 170 (756)
..+.+..+..-+ ++. ++..+..|.|...|+..|++.+|..||++.|=+.. -.+++.+..|-|.+++..
T Consensus 72 ~~~~l~~~~~~~---~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~~~ 148 (150)
T 3tnj_A 72 EKQKLSQIGNTL---GIDPAHRWLVWGEPREEIIRIAEQENVDLIVVGSHGRHGLALLLGSTANSVLHYAKCDVLAVRLR 148 (150)
T ss_dssp HHHHHHHHHHHH---TCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEEEC--------CCCHHHHHHHHCSSEEEEEECC
T ss_pred HHHHHHHHHHHc---CCCcceEEEecCCHHHHHHHHHHHcCCCEEEEecCCCCCcCeEecchHHHHHHhCCCCEEEEeCC
Confidence 334444443333 666 57788899998889888999999999999883322 357889999999999853
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.16 E-value=7.7e-06 Score=75.62 Aligned_cols=131 Identities=12% Similarity=0.041 Sum_probs=92.0
Q ss_pred ccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEe-cC-CCCCCcccccccccccccCCccccccccccccccchh
Q 004395 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVV-PS-HSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDIT 97 (756)
Q Consensus 20 ~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (756)
-++|+|++|.+.. +..|+.||+.-.-+.|..|+||+|+ +. ...+ .+++ .+... . .+...++.
T Consensus 4 ~~~ILv~~D~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~--~~~~---~~~~~-------~---~~~~~~~~ 67 (138)
T 1q77_A 4 MKVLLVLTDAYSD-CEKAITYAVNFSEKLGAELDILAVLEDVYNLER--ANVT---FGLPF-------P---PEIKEESK 67 (138)
T ss_dssp CEEEEEEESTTCC-CHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHH--HHHH---HCCCC-------C---THHHHHHH
T ss_pred ccEEEEEccCCHh-HHHHHHHHHHHHHHcCCeEEEEEEecccccccc--cccc---cCCCC-------C---hHHHHHHH
Confidence 4789999999866 8999999999887889999999998 52 0000 0111 00000 0 01112223
Q ss_pred hhHHHHHHHHhhh--cCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccchhhhhhhhccceeEEEEe
Q 004395 98 DSCSQMILQLHDV--YDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMK 168 (756)
Q Consensus 98 ~~~~~~~~~l~~~--~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~~~~~~~~l~C~i~~~~ 168 (756)
+...+.+..+ +. ....+ +++..+..|.|...|+..|++.+|..||++.|=+.--.+++.+..|-|.+++
T Consensus 68 ~~~~~~l~~~-~~~~~~~~~-~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~g~sv~~~vl~~a~~PVlvv~ 138 (138)
T 1q77_A 68 KRIERRLREV-WEKLTGSTE-IPGVEYRIGPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGLNLASLIVK 138 (138)
T ss_dssp HHHHHHHHHH-HHHHHSCCC-CCCEEEECSCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHSSSEEEECC
T ss_pred HHHHHHHHHH-HHHhhccCC-cceEEEEcCCHHHHHHHHHHhcCCCEEEEeCCCCchHHHHHHhCCCceEeeC
Confidence 3334566666 55 35567 7777888999888888889999999999999844456689999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.5e-05 Score=87.48 Aligned_cols=75 Identities=13% Similarity=0.005 Sum_probs=51.0
Q ss_pred EEEecccCceEEEEEEec-CCCEEEEEEecccCC-------cCchhHHHHHHHHHhcCC--C-CeeeEEEEEEecCceeE
Q 004395 411 ANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-------QGDHEFCSEVEVLSCAQH--R-NVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~-------~~~~~f~~Ev~iL~~L~H--p-NIV~l~~~~~~~~~~~L 479 (756)
.+.||.|.++.||++... +++.|+||....... .....+..|.++|..+.. + .+++++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999753 568899997543211 123457889999988742 3 34566654 3455789
Q ss_pred EEEeecCC
Q 004395 480 VYEYICNG 487 (756)
Q Consensus 480 V~Ey~~gg 487 (756)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=3.3e-06 Score=80.55 Aligned_cols=120 Identities=12% Similarity=0.097 Sum_probs=90.1
Q ss_pred ccEEEEEEeC-CCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhh
Q 004395 20 AEKVVVAVKA-SKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITD 98 (756)
Q Consensus 20 ~~~v~v~~d~-~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (756)
-++|+|++|. +.. +..|+.||+.-.-+.|..|+||+|++..... . .+..+
T Consensus 24 ~~~ILv~vD~~s~~-s~~al~~A~~la~~~~a~l~llhV~~~~~~~--------------------------~--~~~~~ 74 (155)
T 3dlo_A 24 YMPIVVAVDKKSDR-AERVLRFAAEEARLRGVPVYVVHSLPGGGRT--------------------------K--DEDII 74 (155)
T ss_dssp CCCEEEECCSSSHH-HHHHHHHHHHHHHHHTCCEEEEEEECCSTTS--------------------------C--HHHHH
T ss_pred cCeEEEEECCCCHH-HHHHHHHHHHHHHhcCCEEEEEEEEcCCCcc--------------------------c--HHHHH
Confidence 4889999999 754 8999999999877789999999998742100 0 11222
Q ss_pred hHHHHHHHHhhhcCCCCceEEEEE--EeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEE
Q 004395 99 SCSQMILQLHDVYDPNKINFKIKI--VSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVM 167 (756)
Q Consensus 99 ~~~~~~~~l~~~~~~~~v~~~~~v--~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~ 167 (756)
...+.+..+.+.++..++.+++.+ ..|.|...|+..|++.+|..||++.+=+. .-.+.+.+..|-|.++
T Consensus 75 ~~~~~l~~~~~~~~~~g~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~~PVLvV 154 (155)
T 3dlo_A 75 EAKETLSWAVSIIRKEGAEGEEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKANKPVICI 154 (155)
T ss_dssp HHHHHHHHHHHHHHHTTCCEEEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCSSCEEEE
T ss_pred HHHHHHHHHHHHHHhcCCCceEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCCCCEEEe
Confidence 234566666666666788777664 44998888888899999999999988322 2348899999999987
Q ss_pred e
Q 004395 168 K 168 (756)
Q Consensus 168 ~ 168 (756)
|
T Consensus 155 r 155 (155)
T 3dlo_A 155 K 155 (155)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.09 E-value=7.3e-06 Score=75.94 Aligned_cols=129 Identities=14% Similarity=0.155 Sum_probs=87.1
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++|+|++|.+.. +..|+.||+.-.-+.|..|+||+|.+..... +.++ .. . ...+...+..+..
T Consensus 3 ~~ILv~~D~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~--~~~~---~~----~-------~~~~~~~~~~~~~ 65 (141)
T 1jmv_A 3 KHILVAVDLSEE-SPILLKKAVGIAKRHDAKLSIIHVDVNFSDL--YTGL---ID----V-------NMSSMQDRISTET 65 (141)
T ss_dssp SEEEEEECCSTT-HHHHHHHHHHHHHHHTCEEEEEEEEECCGGG--CCCC---EE----H-------HHHHHTTCCCCHH
T ss_pred ceEEEEecCchh-hHHHHHHHHHHHHhcCCEEEEEEEecCchhh--hccc---cc----c-------chHHHHHHHHHHH
Confidence 689999999866 8999999999877789999999998532110 0011 00 0 0001111112222
Q ss_pred HHHHHHHhhhcCCCCceE-EEEEEeCCCCchhhHHhhhccceEEEeccccchh-------hhhhhhccceeEEEEecC
Q 004395 101 SQMILQLHDVYDPNKINF-KIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE-------EKCCMEELQCNIVVMKRS 170 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~~-~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~-------~~~~~~~l~C~i~~~~~~ 170 (756)
.+.+..+ ++..++.+ +..+..|.|...|+..|++.+|..||++.| +.. -.+++.+.+|-|.+++..
T Consensus 66 ~~~l~~~---~~~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~lgs~~~~vl~~~~~pVlvv~~~ 139 (141)
T 1jmv_A 66 QKALLDL---AESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHH-QDFWSKLMSSTRQVMNTIKIDMLVVPLR 139 (141)
T ss_dssp HHHHHHH---HHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEEC-CCCHHHHHHHHHHHHTTCCSEEEEEECC
T ss_pred HHHHHHH---HHHcCCCceEEEEecCCHHHHHHHHHHhcCCCEEEEeCC-CchhhhhcchHHHHHhcCCCCEEEeeCC
Confidence 2333333 33336665 577788998888888899999999999999 643 347889999999999843
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=98.05 E-value=3.5e-06 Score=77.93 Aligned_cols=125 Identities=12% Similarity=0.195 Sum_probs=85.7
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++|+|++|.+.. +..|+.||+.-.-+.|..|+||+|++.... +|. +. .. + +...+..+..
T Consensus 3 ~~ILv~~D~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~-----~~~---~~----~~----~---~~~~~~~~~~ 62 (137)
T 2z08_A 3 KTILLAYDGSEH-ARRAAEVAKAEAEAHGARLIVVHAYEPVPD-----YLG---EP----FF----E---EALRRRLERA 62 (137)
T ss_dssp SEEEEECCSSHH-HHHHHHHHHHHHHHHTCEEEEEEEECC---------------------------------CHHHHHH
T ss_pred ceEEEEeCCCHH-HHHHHHHHHHHHhhcCCEEEEEEEecCCCc-----ccc---cc----ch----H---HHHHHHHHHH
Confidence 689999999865 889999999987777999999999874211 110 00 00 0 1112222223
Q ss_pred HHHHHHHhhhcCCCCc-eEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEEe
Q 004395 101 SQMILQLHDVYDPNKI-NFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMK 168 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v-~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~ 168 (756)
.+.+..+... .|+ .++..+..|.|...|+..|++.++..||++.|=+. .-.+++.+.+|-|.+++
T Consensus 63 ~~~l~~~~~~---~g~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~ 137 (137)
T 2z08_A 63 EGVLEEARAL---TGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAPCPVLLVR 137 (137)
T ss_dssp HHHHHHHHHH---HCCCGGGEEEEESSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHH---cCCCccEEEEEecCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCCCCEEEeC
Confidence 3444444433 577 77888889998888888899999999999988322 24488999999998874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=2.3e-05 Score=83.14 Aligned_cols=141 Identities=14% Similarity=0.163 Sum_probs=81.1
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC--CCeeeEEE------EEEecCceeEEEE
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH--RNVVMLIG------FCIEDRRRLLVYE 482 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H--pNIV~l~~------~~~~~~~~~LV~E 482 (756)
...|+.|..+.||+....+| .+++|+... ....+..|+.++..|.. -.+++++. +....+..++||+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45576677899999987555 488998764 12344456666665531 12333332 1234567899999
Q ss_pred eecCCChh--------------hhhhcc-C----C-------CCCCHHHH------------------------------
Q 004395 483 YICNGSLD--------------SHLYGC-H----Q-------EPLEWSAR------------------------------ 506 (756)
Q Consensus 483 y~~ggsL~--------------~~L~~~-~----~-------~~L~~~~~------------------------------ 506 (756)
|++|..+. ..++.. . . ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99886553 011111 0 0 00122211
Q ss_pred -HHHHHHHHHHHHHHHh--------h-cccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 507 -QKIAVGAARGLRYLHE--------E-CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 507 -~~ia~qIa~aL~yLH~--------~-~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
..+...+..++.+|+. . ....+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445667763 1 012379999999999999888899999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.8e-05 Score=80.41 Aligned_cols=81 Identities=19% Similarity=0.090 Sum_probs=61.8
Q ss_pred hCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC---CCeeeEEEEEEecCceeEEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH---RNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H---pNIV~l~~~~~~~~~~~LV~ 481 (756)
.....-...+|.|..+.||+....+|+.|.+|+...........|..|++.|+.|.- --+++++++. ..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 356777889999999999999999999999997654444444568899999998852 2355666553 348999
Q ss_pred EeecCCCh
Q 004395 482 EYICNGSL 489 (756)
Q Consensus 482 Ey~~ggsL 489 (756)
||+.++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99977654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=9e-05 Score=79.27 Aligned_cols=139 Identities=17% Similarity=0.142 Sum_probs=92.4
Q ss_pred EEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC---CCCeeeEEEEEEecCceeEEEEeecC
Q 004395 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~---HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
..+.|+.|.+..+|+... ++..+++|+.... ....|..|++.|+.|. ...+++.+.++...+..++||||++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356799999999999886 4678889976532 2456889999999884 35688999998888889999999988
Q ss_pred CChhh-----------hhhccCC-C-------------------CCCHHHHH---HHHH----------------HHHHH
Q 004395 487 GSLDS-----------HLYGCHQ-E-------------------PLEWSARQ---KIAV----------------GAARG 516 (756)
Q Consensus 487 gsL~~-----------~L~~~~~-~-------------------~L~~~~~~---~ia~----------------qIa~a 516 (756)
..+.. .|+.... . .-+|.... ++.. .++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76521 1222111 0 01344321 1111 11111
Q ss_pred H-HHHHhhcccCceEeeccCCCceeecCCCcceeeccc
Q 004395 517 L-RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (756)
Q Consensus 517 L-~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFG 553 (756)
+ ..|......+.++|+|+.+.|+|++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 2232212234799999999999999887 8899984
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=97.74 E-value=2.7e-05 Score=81.59 Aligned_cols=131 Identities=9% Similarity=0.173 Sum_probs=96.5
Q ss_pred ccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhh
Q 004395 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (756)
Q Consensus 20 ~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (756)
-++|+|++|.+.. +..|+.||+.-.-+.|..|+||+|++....+ ++ ..+ . ...+...+..+.
T Consensus 22 ~~~ILv~vD~s~~-s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~----~~--~~~----~-------~~~~~~~~~~~~ 83 (294)
T 3loq_A 22 SNAMLLPTDLSEN-SFKVLEYLGDFKKVGVEEIGVLFVINLTKLS----TV--SGG----I-------DIDHYIDEMSEK 83 (294)
T ss_dssp TCEEEEECCSCTG-GGGGGGGHHHHHHTTCCEEEEECCEECTTC-----------C----C-------CTTHHHHHHHHH
T ss_pred hccEEEecCCCHH-HHHHHHHHHHHHhhcCCEEEEEEEecCcccc----cc--ccc----c-------cHHHHHHHHHHH
Confidence 3799999999865 8999999999888889999999998864322 11 000 0 111222233344
Q ss_pred HHHHHHHHhhhcCCCCceEEE-EEE-eCCCCchhhHHhhhccceEEEeccccchh---------hhhhhhccceeEEEEe
Q 004395 100 CSQMILQLHDVYDPNKINFKI-KIV-SGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVMK 168 (756)
Q Consensus 100 ~~~~~~~l~~~~~~~~v~~~~-~v~-~g~~~~~v~~eak~~~a~wvVld~~~k~~---------~~~~~~~l~C~i~~~~ 168 (756)
..+.+..+.+.+...+|.++. .++ .|.+...| .|++.+|..||++++=+.. ..+++.+..|.|.+++
T Consensus 84 ~~~~l~~~~~~~~~~g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~~PVlvv~ 161 (294)
T 3loq_A 84 AEEVLPEVAQKIEAAGIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSKVPVYIFK 161 (294)
T ss_dssp HHHHHHHHHHHHHHTTCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHHHHHHcCCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCCCCEEEec
Confidence 456777787777778999998 888 89887777 8999999999999884332 3478899999999998
Q ss_pred cC
Q 004395 169 RS 170 (756)
Q Consensus 169 ~~ 170 (756)
..
T Consensus 162 ~~ 163 (294)
T 3loq_A 162 HD 163 (294)
T ss_dssp CC
T ss_pred Cc
Confidence 54
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=4.9e-05 Score=80.33 Aligned_cols=132 Identities=14% Similarity=0.165 Sum_probs=91.4
Q ss_pred CCccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchh
Q 004395 18 DVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDIT 97 (756)
Q Consensus 18 ~~~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (756)
...++|+|++|.+.. +..|+.||+.-.-+.|..|+||+|++....+ |.. + .. . .+...+..
T Consensus 17 ~~~~~ILv~~D~s~~-s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~---~~~----~----~~----~---~~~~~~~~ 77 (309)
T 3cis_A 17 NSSLGIIVGIDDSPA-AQVAVRWAARDAELRKIPLTLVHAVSPEVAT---WLE----V----PL----P---PGVLRWQQ 77 (309)
T ss_dssp -CTTEEEEECCSSHH-HHHHHHHHHHHHHHHTCCEEEEEECCCCCCC---TTC----C----CC----C---HHHHHHHH
T ss_pred CCCCeEEEEECCCHH-HHHHHHHHHHHHHhcCCcEEEEEEecCcccc---ccc----C----CC----C---chhhHHHH
Confidence 345899999999865 8899999999877789999999998732211 211 0 00 0 01111122
Q ss_pred hhHHHHHHHHhhhcCC-----CCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhcccee
Q 004395 98 DSCSQMILQLHDVYDP-----NKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCN 163 (756)
Q Consensus 98 ~~~~~~~~~l~~~~~~-----~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~ 163 (756)
+...+.+.++.+.++. +++.++..+..|.+...|+..|+ ++..||++.+-+. ...+++.+..|.
T Consensus 78 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~~P 155 (309)
T 3cis_A 78 DHGRHLIDDALKVVEQASLRAGPPTVHSEIVPAAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAHCP 155 (309)
T ss_dssp HHHHHHHHHHHHHHHHHCSSSCCSCEEEEEESSCHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHCSSC
T ss_pred HHHHHHHHHHHHHHHHhcccCCCceEEEEEecCCHHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhCCCC
Confidence 2223455555554443 38999999999998888887787 8999999988332 245899999999
Q ss_pred EEEEecC
Q 004395 164 IVVMKRS 170 (756)
Q Consensus 164 i~~~~~~ 170 (756)
|.+++..
T Consensus 156 Vlvv~~~ 162 (309)
T 3cis_A 156 VVIIHDE 162 (309)
T ss_dssp EEEECTT
T ss_pred EEEEcCC
Confidence 9999844
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00018 Score=79.58 Aligned_cols=76 Identities=16% Similarity=0.237 Sum_probs=48.2
Q ss_pred CceEeeccCCCceeecCCCcceeeccccceecCCCCCCccccccc--CccccCccccccC---CCCchhhHHHHHHHHHH
Q 004395 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG--TFGYLAPEYAQSG---QITEKADVYSFGVVLVE 601 (756)
Q Consensus 527 ~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~G--t~~Y~APE~l~~~---~~s~ksDVwSlGvvL~E 601 (756)
..++|+|++|.|||++.++ +.|+||+.+.+-... .... ...+ ...|++|+..... .-....++..+...+|+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 3799999999999998876 999999998753211 0000 0111 2346666655321 11234566678888888
Q ss_pred HHhC
Q 004395 602 LVTG 605 (756)
Q Consensus 602 LltG 605 (756)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00025 Score=74.99 Aligned_cols=157 Identities=12% Similarity=0.054 Sum_probs=87.8
Q ss_pred ChHHHHHhhCCeeE-----EEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC--eeeEEE
Q 004395 397 SYAELELATGGFSQ-----ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIG 469 (756)
Q Consensus 397 s~~~l~~~~~~y~~-----~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN--IV~l~~ 469 (756)
+..++......|.+ .+.|+.|....+|+....+| .+++|+.... .....+..|+.++..|...+ +++++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444444444543 45677888899999987666 5788876642 22345677888887774222 233332
Q ss_pred E------EEecCceeEEEEeecCCChhh--------------hhhccC---CCC----C---CHHHHHH-----------
Q 004395 470 F------CIEDRRRLLVYEYICNGSLDS--------------HLYGCH---QEP----L---EWSARQK----------- 508 (756)
Q Consensus 470 ~------~~~~~~~~LV~Ey~~ggsL~~--------------~L~~~~---~~~----L---~~~~~~~----------- 508 (756)
. ....+..+++|+|++|..+.. .++... ..+ . .|...+.
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 122456789999998765421 011110 000 1 1221110
Q ss_pred -HHHHHHHHHHHHHhhc---ccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 509 -IAVGAARGLRYLHEEC---RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 509 -ia~qIa~aL~yLH~~~---~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
+...+...+++++... ...+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0112444566665431 12379999999999999987666899998875
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=97.56 E-value=7.3e-05 Score=78.97 Aligned_cols=135 Identities=15% Similarity=0.177 Sum_probs=96.8
Q ss_pred ccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhh
Q 004395 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (756)
Q Consensus 20 ~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (756)
-++|+|++|.|.. +..|+.||+.-.-+.|-.|+||+|++..... ..++ .+ .........+..+.
T Consensus 7 ~k~ILv~~D~s~~-s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~--~~~~---~~----------~~~~~~~~~~~~~~ 70 (319)
T 3olq_A 7 YQNLLVVIDPNQD-DQPALRRAVYIVQRNGGRIKAFLPVYDLSYD--MTTL---LS----------PDERNAMRKGVINQ 70 (319)
T ss_dssp SCEEEEECCTTCS-CCHHHHHHHHHHHHHCCEEEEEEEECCGGGG--CTTT---SC----------HHHHHHHHHHHHHH
T ss_pred cceEEEEECCCcc-cHHHHHHHHHHHHHcCCeEEEEEEecccchh--hccc---cC----------hhhHHHHHHHHHHH
Confidence 3789999999976 8999999999877778899999998642211 0000 00 00111111222233
Q ss_pred HHHHHHHHhhhcCCCCceEEEEEE-eCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEEec
Q 004395 100 CSQMILQLHDVYDPNKINFKIKIV-SGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMKR 169 (756)
Q Consensus 100 ~~~~~~~l~~~~~~~~v~~~~~v~-~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~~ 169 (756)
..+.+..+.+.+...+|.++..+. .|.+...|+.+|++.+|..||++.+-+. .....+.+..|-|.+++.
T Consensus 71 ~~~~l~~~~~~~~~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~~PVlvv~~ 150 (319)
T 3olq_A 71 KTAWIKQQARYYLEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCPAPVWMVKD 150 (319)
T ss_dssp HHHHHHHHHHHHHHTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCSSCEEEEES
T ss_pred HHHHHHHHHHHHhhcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCCCCEEEecC
Confidence 345666676666678999999999 8999888888899999999999988432 345789999999999985
Q ss_pred C
Q 004395 170 S 170 (756)
Q Consensus 170 ~ 170 (756)
.
T Consensus 151 ~ 151 (319)
T 3olq_A 151 K 151 (319)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00015 Score=75.90 Aligned_cols=116 Identities=20% Similarity=0.258 Sum_probs=90.4
Q ss_pred CCccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchh
Q 004395 18 DVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDIT 97 (756)
Q Consensus 18 ~~~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (756)
...++|+|++|.+.. +..|+.||+.-.-..|..|+||+|.+...
T Consensus 168 ~~~~~Ilv~~d~s~~-s~~al~~a~~la~~~~~~l~ll~v~~~~~----------------------------------- 211 (294)
T 3loq_A 168 SLFDRVLVAYDFSKW-ADRALEYAKFVVKKTGGELHIIHVSEDGD----------------------------------- 211 (294)
T ss_dssp CTTSEEEEECCSSHH-HHHHHHHHHHHHHHHTCEEEEEEECSSSC-----------------------------------
T ss_pred ccCCEEEEEECCCHH-HHHHHHHHHHHhhhcCCEEEEEEEccCch-----------------------------------
Confidence 345899999999865 89999999988777889999999976411
Q ss_pred hhHHHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEEe
Q 004395 98 DSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMK 168 (756)
Q Consensus 98 ~~~~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~ 168 (756)
..+.+..+.+.++..++.++..+..|.+...|...|++.+|..||++.+=+. .-++.+.+.+|.+.+++
T Consensus 212 --~~~~l~~~~~~l~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pvLvv~ 289 (294)
T 3loq_A 212 --KTADLRVMEEVIGAEGIEVHVHIESGTPHKAILAKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSPVPVFVCK 289 (294)
T ss_dssp --CHHHHHHHHHHHHHTTCCEEEEEECSCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCSSCEEEEC
T ss_pred --HHHHHHHHHHHHHHcCCcEEEEEecCCHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCCCCEEEEC
Confidence 0233445555555568889999999988878888899999999999998322 23578899999999998
Q ss_pred cCc
Q 004395 169 RSQ 171 (756)
Q Consensus 169 ~~~ 171 (756)
...
T Consensus 290 ~~~ 292 (294)
T 3loq_A 290 RGD 292 (294)
T ss_dssp SCT
T ss_pred CCC
Confidence 653
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=8.4e-05 Score=76.55 Aligned_cols=136 Identities=11% Similarity=0.092 Sum_probs=93.4
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCcccccccccccc----ccch
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQ----RGDI 96 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 96 (756)
++|+|++|.+.. +..|+.||+.-.-+.|..|+||+|++..... +.++ .+ .... .+.+.+. ..+.
T Consensus 1 k~ILv~vD~s~~-s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~--~~~~---~~-----~~~~-~~~~~~~~~~~~~~~ 68 (268)
T 3ab8_A 1 MRILLATDGSPQ-ARGAEALAEWLAYKLSAPLTVLFVVDTRLAR--IPEL---LD-----FGAL-TVPVPVLRTELERAL 68 (268)
T ss_dssp CCEEEECCSCGG-GHHHHHHHHHHHHHHTCCEEEEEEEEHHHHT--HHHH---C-------------CHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHH-HHHHHHHHHHHHHHhCCcEEEEEEeccCCcc--cccc---cC-----chHH-HHHHHHHHHHHHHHH
Confidence 479999999865 8999999999877788999999998743211 0010 00 0000 0011000 2223
Q ss_pred hhhHHHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch-h---------hhhhhhccceeEEE
Q 004395 97 TDSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH-E---------EKCCMEELQCNIVV 166 (756)
Q Consensus 97 ~~~~~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~-~---------~~~~~~~l~C~i~~ 166 (756)
.+...+.+..+...++..+|.++..+..|.|...|+.. +.+|..||++.|-+. . -.+++.+.+|-|.+
T Consensus 69 ~~~~~~~l~~~~~~~~~~g~~~~~~~~~g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~~PVlv 146 (268)
T 3ab8_A 69 ALRGEAVLERVRQSALAAGVAVEAVLEEGVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASPVPVLL 146 (268)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCEEEEEEEECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCSSCEEE
T ss_pred HHHHHHHHHHHHHHHHhCCCCeEEEEecCCHHHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCCCCEEE
Confidence 33345677777777777899999999999988777755 889999999988433 2 35899999999999
Q ss_pred EecC
Q 004395 167 MKRS 170 (756)
Q Consensus 167 ~~~~ 170 (756)
++..
T Consensus 147 v~~~ 150 (268)
T 3ab8_A 147 APGE 150 (268)
T ss_dssp ECSS
T ss_pred ECCC
Confidence 9844
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00026 Score=73.96 Aligned_cols=129 Identities=13% Similarity=0.156 Sum_probs=88.3
Q ss_pred CccEEEEEEeCCCC------cchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCcccccccccccc
Q 004395 19 VAEKVVVAVKASKE------IPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQ 92 (756)
Q Consensus 19 ~~~~v~v~~d~~~~------~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (756)
..++|+|++|.+.. ++..|+.||+.-.-..|..|+||+|++..... +.. . .. +.
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~---~~~-----------~-----~~-~~ 192 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLS---SAD-----------P-----TF-QL 192 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC----------------------------CH-HH
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCcccc---ccC-----------c-----hh-HH
Confidence 45899999999976 37999999999877789999999998854322 000 0 00 11
Q ss_pred ccchhhhHHHHHHHHhhhcCCCCc-eEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccce
Q 004395 93 RGDITDSCSQMILQLHDVYDPNKI-NFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQC 162 (756)
Q Consensus 93 ~~~~~~~~~~~~~~l~~~~~~~~v-~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C 162 (756)
..+..+...+.+..+..- .++ .+...+..|.|...|...|++.+|..||++.|=+. --.+.+.+.+|
T Consensus 193 ~~~~~~~~~~~l~~~~~~---~g~~~~~~~v~~g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~~ 269 (290)
T 3mt0_A 193 SETIEARYREACRTFQAE---YGFSDEQLHIEEGPADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLES 269 (290)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTCCTTTEEEEESCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHHHH---cCCCcceEEEeccCHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCCC
Confidence 122222222333333333 366 36678889988888888899999999999988322 23588999999
Q ss_pred eEEEEecC
Q 004395 163 NIVVMKRS 170 (756)
Q Consensus 163 ~i~~~~~~ 170 (756)
-+.+++..
T Consensus 270 pVLvv~~~ 277 (290)
T 3mt0_A 270 DVLVLKPD 277 (290)
T ss_dssp EEEEECCH
T ss_pred CEEEECCC
Confidence 99999854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00072 Score=75.34 Aligned_cols=73 Identities=15% Similarity=0.134 Sum_probs=51.5
Q ss_pred EEEecccCceEEEEEEecC--------CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCe-eeEEEEEEecCceeEEE
Q 004395 411 ANFLAEGGFGSVHRGVLPD--------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~--------g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNI-V~l~~~~~~~~~~~LV~ 481 (756)
.+.|+.|....+|++...+ +..+.+|+.... .....+..|..++..|...++ +++++.+.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678889899999998653 578999977421 121566789999998863334 677776542 3899
Q ss_pred EeecCCCh
Q 004395 482 EYICNGSL 489 (756)
Q Consensus 482 Ey~~ggsL 489 (756)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99976554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00097 Score=70.95 Aligned_cols=141 Identities=14% Similarity=0.066 Sum_probs=73.5
Q ss_pred EEecccCceE-EEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC--CCeeeEEEEEEecCceeEEEEeecCCC
Q 004395 412 NFLAEGGFGS-VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDRRRLLVYEYICNGS 488 (756)
Q Consensus 412 ~~LG~G~fG~-Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H--pNIV~l~~~~~~~~~~~LV~Ey~~ggs 488 (756)
+.|+.|+... +|+....+|..+++|...... ...+..|+.++..|.. -.+++++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 3465554444 667665446777777543221 1345567777777742 3356777764333 378999997666
Q ss_pred hhhhhhcc---------------------CC---CCCCHHHHH-------H-H------------HHHHHHHHHHHHhh-
Q 004395 489 LDSHLYGC---------------------HQ---EPLEWSARQ-------K-I------------AVGAARGLRYLHEE- 523 (756)
Q Consensus 489 L~~~L~~~---------------------~~---~~L~~~~~~-------~-i------------a~qIa~aL~yLH~~- 523 (756)
+.+.+... .. ..+...... . + ...+...+..|...
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 64433210 00 011111100 0 0 00111222333211
Q ss_pred -cccCceEeeccCCCceeecCC----Ccceeecccccee
Q 004395 524 -CRVGCIVHRDMRPNNILLTHD----FEPLVGDFGLARW 557 (756)
Q Consensus 524 -~~~~gIiHrDLKp~NILL~~~----~~vkL~DFGlA~~ 557 (756)
.....++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 112379999999999999875 6789999999874
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00029 Score=73.65 Aligned_cols=113 Identities=13% Similarity=0.133 Sum_probs=88.1
Q ss_pred ccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhh
Q 004395 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (756)
Q Consensus 20 ~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (756)
-++|+|++|.+.. +..|+.||+.-.-+.|-.|+||+|+++ +.
T Consensus 7 ~~~ILv~~D~s~~-s~~al~~A~~la~~~~a~l~ll~v~~~------------------------------~~------- 48 (290)
T 3mt0_A 7 IRSILVVIEPDQL-EGLALKRAQLIAGVTQSHLHLLVCEKR------------------------------RD------- 48 (290)
T ss_dssp CCEEEEECCSSCS-CCHHHHHHHHHHHHHCCEEEEEEECSS------------------------------SC-------
T ss_pred hceEEEEeCCCcc-chHHHHHHHHHHHhcCCeEEEEEeeCc------------------------------HH-------
Confidence 3789999999866 899999999987778889999999762 00
Q ss_pred HHHHHHHHhhhcCCCCceEEEEEEe-CCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEEec
Q 004395 100 CSQMILQLHDVYDPNKINFKIKIVS-GSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMKR 169 (756)
Q Consensus 100 ~~~~~~~l~~~~~~~~v~~~~~v~~-g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~~ 169 (756)
..+.+.++.+.+...+|.++..+.. |.+...|+.+|+..++..||++++-+. .....+.+..|-|.+++.
T Consensus 49 ~~~~l~~~~~~~~~~~~~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~~PVlvv~~ 128 (290)
T 3mt0_A 49 HSAALNDLAQELREEGYSVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAPCPVLMTKT 128 (290)
T ss_dssp CHHHHHHHHHHHHHTTCCEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCSSCEEEECC
T ss_pred HHHHHHHHHHHHhhCCCeEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCCCCEEEecC
Confidence 0233444444445679999999984 777778888899999999999988332 235789999999999984
Q ss_pred C
Q 004395 170 S 170 (756)
Q Consensus 170 ~ 170 (756)
.
T Consensus 129 ~ 129 (290)
T 3mt0_A 129 A 129 (290)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00043 Score=73.02 Aligned_cols=125 Identities=11% Similarity=0.118 Sum_probs=86.0
Q ss_pred ccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhh
Q 004395 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (756)
Q Consensus 20 ~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (756)
.++|+|++|.+.. +..||.||+.-.-+.|..|+||+|.+..... ++ . .... .++.+.
T Consensus 171 ~~~Ilv~~D~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~----~~-----------~---~~~~----~~~~~~ 227 (309)
T 3cis_A 171 QAPVLVGVDGSSA-SELATAIAFDEASRRNVDLVALHAWSDVDVS----EW-----------P---GIDW----PATQSM 227 (309)
T ss_dssp CCCEEEECCSSHH-HHHHHHHHHHHHHHTTCCEEEEEESCSSCCT----TC-----------S---SCCH----HHHHHH
T ss_pred CCeEEEEeCCChH-HHHHHHHHHHHHHhcCCEEEEEEEeeccccc----CC-----------C---cccH----HHHHHH
Confidence 4789999999865 8889999998877788999999997642210 00 0 0000 111222
Q ss_pred HHHHHHHHhhhcCC--CCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEEe
Q 004395 100 CSQMILQLHDVYDP--NKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMK 168 (756)
Q Consensus 100 ~~~~~~~l~~~~~~--~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~ 168 (756)
..+.+..+...+.. .+|.++..+..|.|...|+..|+ +|..|||+.+=+. --.+.+.+.+|-+.+++
T Consensus 228 ~~~~l~~~~~~~~~~~~~~~~~~~~~~g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~~pVlvv~ 305 (309)
T 3cis_A 228 AEQVLAERLAGWQERYPNVAITRVVVRDQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLARTPVIVAR 305 (309)
T ss_dssp HHHHHHHHHTTHHHHCTTSCEEEEEESSCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHHHHHhhCCCCcEEEEEEcCCHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCCCCEEEeC
Confidence 22333333222221 58999999999988888887787 9999999998222 24578999999999998
Q ss_pred c
Q 004395 169 R 169 (756)
Q Consensus 169 ~ 169 (756)
.
T Consensus 306 ~ 306 (309)
T 3cis_A 306 E 306 (309)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00046 Score=72.53 Aligned_cols=138 Identities=13% Similarity=0.032 Sum_probs=77.6
Q ss_pred EEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCe-eeEEEEEEecCceeEEEEee-cCCC
Q 004395 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYI-CNGS 488 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNI-V~l~~~~~~~~~~~LV~Ey~-~ggs 488 (756)
.+.|+.|....+|+. ..+++|+..... .......+|+.+++.+...++ +++++++ ...-++|+||+ .|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 567989999999998 458888765432 222334678888887753233 4666553 44458999999 6655
Q ss_pred hhhh------------------hhccCC---CCCCH-HHHHHHHH--------------HHHHHHHHHH----hhcccCc
Q 004395 489 LDSH------------------LYGCHQ---EPLEW-SARQKIAV--------------GAARGLRYLH----EECRVGC 528 (756)
Q Consensus 489 L~~~------------------L~~~~~---~~L~~-~~~~~ia~--------------qIa~aL~yLH----~~~~~~g 528 (756)
|... ++.... ..... .....+.. .+...+..|. .......
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5321 111000 00111 11111111 1111111111 1112236
Q ss_pred eEeeccCCCceeecCCCcceeecccccee
Q 004395 529 IVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 529 IiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
++|+|+.+.||| ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998863
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00062 Score=71.77 Aligned_cols=135 Identities=15% Similarity=0.133 Sum_probs=89.2
Q ss_pred CccEEEEEEeCCCC------cchhhHhHHhhhccCC--CCeEEEEEEecCCCCCCcccccccccccccCCcccccccccc
Q 004395 19 VAEKVVVAVKASKE------IPRTALVWALTHVVQP--GDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTIS 90 (756)
Q Consensus 19 ~~~~v~v~~d~~~~------~~~~a~~wal~~~~~~--gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (756)
..++|+|++|.+.+ .+..|+.||+.-.-.. |..|+||+|.+...... +. .. . .....
T Consensus 155 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~--~~---~~-------~---~~~~~ 219 (319)
T 3olq_A 155 EYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINI--AI---EL-------P---DFDPN 219 (319)
T ss_dssp TTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSC--CT---TC-------T---TCCHH
T ss_pred cCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhh--hc---cC-------C---cccHH
Confidence 45899999999986 5789999998865554 89999999987643220 00 00 0 00111
Q ss_pred ccccchhhhHHHHHHHHhhhcCCCCc-eEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhcc
Q 004395 91 EQRGDITDSCSQMILQLHDVYDPNKI-NFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEEL 160 (756)
Q Consensus 91 ~~~~~~~~~~~~~~~~l~~~~~~~~v-~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l 160 (756)
+...+..+...+.+..+ .+..++ .++..|..|.|...|...|++.+|..||++.|=+. --.+.+.+.
T Consensus 220 ~~~~~~~~~~~~~l~~~---~~~~~~~~~~~~v~~g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~ 296 (319)
T 3olq_A 220 LYNNALRGQHLIAMKEL---RQKFSIPEEKTHVKEGLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHI 296 (319)
T ss_dssp HHHHHHHHHHHHHHHHH---HHHTTCCGGGEEEEESCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHH---HHHhCCCcccEEEecCCcHHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhC
Confidence 12222222223333333 333344 35667788998778888899999999999998322 234889999
Q ss_pred ceeEEEEecCc
Q 004395 161 QCNIVVMKRSQ 171 (756)
Q Consensus 161 ~C~i~~~~~~~ 171 (756)
+|-|.+++...
T Consensus 297 ~~pVLvv~~~~ 307 (319)
T 3olq_A 297 KCDLLAIKPDG 307 (319)
T ss_dssp CSEEEEECCTT
T ss_pred CCCEEEECCCC
Confidence 99999998543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0017 Score=70.18 Aligned_cols=74 Identities=14% Similarity=0.052 Sum_probs=46.0
Q ss_pred EEEecccCceEEEEEEecC---------CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC-eeeEEEEEEecCceeEE
Q 004395 411 ANFLAEGGFGSVHRGVLPD---------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~---------g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN-IV~l~~~~~~~~~~~LV 480 (756)
...|+.|..-.+|+....+ +..+++|+..... ........|.+++..|...+ ++++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888888999988643 2688888765322 11223567888888885334 45677654 2 3789
Q ss_pred EEeecCCCh
Q 004395 481 YEYICNGSL 489 (756)
Q Consensus 481 ~Ey~~ggsL 489 (756)
|||++|.+|
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0026 Score=67.16 Aligned_cols=142 Identities=14% Similarity=0.075 Sum_probs=82.5
Q ss_pred EEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC--eeeEEEE-----EEecCceeEEEEee
Q 004395 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIGF-----CIEDRRRLLVYEYI 484 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN--IV~l~~~-----~~~~~~~~LV~Ey~ 484 (756)
..|+ |....||+....+|+.+++|...... .....+..|..++..|...+ +++++.. ...++..++||+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4577 88889999887778789999876331 23456777888888774222 3444432 12245568899999
Q ss_pred cCCChhh-----h---------hhcc----C---CCCCCHHHH----HHH---------------HHHHHHHHHHHHhhc
Q 004395 485 CNGSLDS-----H---------LYGC----H---QEPLEWSAR----QKI---------------AVGAARGLRYLHEEC 524 (756)
Q Consensus 485 ~ggsL~~-----~---------L~~~----~---~~~L~~~~~----~~i---------------a~qIa~aL~yLH~~~ 524 (756)
+|..+.. . ++.. . ...+.+... ..+ ...+-..++.+....
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 7755421 0 1110 0 011222211 001 111112233333221
Q ss_pred ---ccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 525 ---RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 525 ---~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223689999999999998 4 889999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0052 Score=69.08 Aligned_cols=74 Identities=8% Similarity=-0.037 Sum_probs=49.6
Q ss_pred EEEecccCceEEEEEEecC-CCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCe-eeEEEEEEecCceeEEEEeecCCC
Q 004395 411 ANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYICNGS 488 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~-g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNI-V~l~~~~~~~~~~~LV~Ey~~ggs 488 (756)
.+.|+.|-...+|+....+ +..+.+|+..... .......+|..+|..|...++ +++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4578888899999998754 4788898764322 222223689999999975555 57777763 2 35999998755
Q ss_pred h
Q 004395 489 L 489 (756)
Q Consensus 489 L 489 (756)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0033 Score=68.97 Aligned_cols=140 Identities=17% Similarity=0.169 Sum_probs=84.6
Q ss_pred EEecccCceEEEEEEec--------CCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEEE
Q 004395 412 NFLAEGGFGSVHRGVLP--------DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~--------~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~E 482 (756)
+.|..|-...+|+.... ++..|.+|+... .......+.+|.++++.|. +.-.+++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666888889998864 247899997532 2234556778999998885 3334677777643 39999
Q ss_pred eecCCChhhh-----------------hhccC---CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 004395 483 YICNGSLDSH-----------------LYGCH---QEPLE--WSARQKIAVGAAR-------------------GLRYLH 521 (756)
Q Consensus 483 y~~ggsL~~~-----------------L~~~~---~~~L~--~~~~~~ia~qIa~-------------------aL~yLH 521 (756)
|++|.+|..- |+... ..... +..+.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9988665421 11110 11122 3455555544322 234443
Q ss_pred hh----cccCceEeeccCCCceeecCC----Ccceeeccccce
Q 004395 522 EE----CRVGCIVHRDMRPNNILLTHD----FEPLVGDFGLAR 556 (756)
Q Consensus 522 ~~----~~~~gIiHrDLKp~NILL~~~----~~vkL~DFGlA~ 556 (756)
+. .....++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 32 122369999999999999877 789999998875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0083 Score=60.65 Aligned_cols=99 Identities=16% Similarity=0.099 Sum_probs=65.1
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCcc
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~~ 566 (756)
-+|.+.|.. .+.++++.++|.++.|.+.+|.-+-... .-..+=+.|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~---~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRR---QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcc---cCCceecCCcceEEecCCceeccc-cccc----------
Confidence 368888865 5789999999999999999987762110 111233457899999999887753 1110
Q ss_pred cccccCccccCccccccCCCCchhhHHHHHHHHHHHHh
Q 004395 567 TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT 604 (756)
Q Consensus 567 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt 604 (756)
.....+.|||... ...+.+.=|||||++||.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1223467888764 345788999999999999886
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.003 Score=64.74 Aligned_cols=111 Identities=10% Similarity=0.099 Sum_probs=82.4
Q ss_pred CccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhh
Q 004395 19 VAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITD 98 (756)
Q Consensus 19 ~~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (756)
..++|+|++|.+.. +..|+.||..-.-..|..|+||+|.+.. +
T Consensus 153 ~~~~ilv~~d~s~~-~~~al~~a~~la~~~~a~l~ll~v~~~~-----------------------------~------- 195 (268)
T 3ab8_A 153 ELEGALLGYDASES-AVRALHALAPLARALGLGVRVVSVHEDP-----------------------------A------- 195 (268)
T ss_dssp CCCEEEEECCSCHH-HHHHHHHHHHHHHHHTCCEEEEEECSSH-----------------------------H-------
T ss_pred CCCEEEEEECCCHH-HHHHHHHHHHhhhcCCCEEEEEEEcCcH-----------------------------H-------
Confidence 45799999999866 7889999887655567789999996531 0
Q ss_pred hHHHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch-----hhhhhhhccceeEEEEe
Q 004395 99 SCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH-----EEKCCMEELQCNIVVMK 168 (756)
Q Consensus 99 ~~~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~-----~~~~~~~~l~C~i~~~~ 168 (756)
...+.+..+...++..+|.++..+..|.+...|...|++. ..||++..+++ --.+.+.+.+|-+.+++
T Consensus 196 ~~~~~l~~~~~~l~~~~~~~~~~~~~g~~~~~i~~~a~~~--dliV~G~~~~~~~~Gs~~~~vl~~~~~pvlvv~ 268 (268)
T 3ab8_A 196 RAEAWALEAEAYLRDHGVEASALVLGGDAADHLLRLQGPG--DLLALGAPVRRLVFGSTAERVIRNAQGPVLTAR 268 (268)
T ss_dssp HHHHHHHHHHHHHHHTTCCEEEEEECSCHHHHHHHHCCTT--EEEEEECCCSCCSSCCHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHHHHHHHcCCceEEEEeCCChHHHHHHHHHhC--CEEEECCcccccEeccHHHHHHhcCCCCEEEeC
Confidence 0123344455555556899999999998888888778877 99999984333 34678999999998874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.027 Score=60.35 Aligned_cols=72 Identities=10% Similarity=0.097 Sum_probs=46.0
Q ss_pred EEEecccC--ceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC---CCCeeeEEEE------EEecCceeE
Q 004395 411 ANFLAEGG--FGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ---HRNVVMLIGF------CIEDRRRLL 479 (756)
Q Consensus 411 ~~~LG~G~--fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~---HpNIV~l~~~------~~~~~~~~L 479 (756)
.+.|..|+ ...||+....+| .+++|+...... ..|+.++..|. -|+++..+.. ....+..++
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~ 98 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKII 98 (339)
T ss_dssp EEEETTTSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEE
T ss_pred eEEeeccCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEE
Confidence 44554333 678999987777 899997664331 35666666653 2334554432 233567799
Q ss_pred EEEeecCCCh
Q 004395 480 VYEYICNGSL 489 (756)
Q Consensus 480 V~Ey~~ggsL 489 (756)
||+|++|..+
T Consensus 99 l~~~i~G~~~ 108 (339)
T 3i1a_A 99 AYPFIHAPNG 108 (339)
T ss_dssp EEECCCCCBT
T ss_pred EEeccCCCcC
Confidence 9999988766
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.14 E-value=0.036 Score=61.57 Aligned_cols=140 Identities=14% Similarity=0.053 Sum_probs=86.5
Q ss_pred EEEecccCceEEEEEEecC--------CCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEE
Q 004395 411 ANFLAEGGFGSVHRGVLPD--------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~--------g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~ 481 (756)
.+.|..|-...+|+....+ +..|.+++..... .......+|..+++.|. +.-.+++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778888999988653 5789998754332 22234568999988885 333456665442 37899
Q ss_pred EeecCCChhhh-----------------hhc--c---------CCCCCCHHHHHHHHHHH-------------------H
Q 004395 482 EYICNGSLDSH-----------------LYG--C---------HQEPLEWSARQKIAVGA-------------------A 514 (756)
Q Consensus 482 Ey~~ggsL~~~-----------------L~~--~---------~~~~L~~~~~~~ia~qI-------------------a 514 (756)
||++|.+|..- |+. . ...+.-+..+.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99988664210 010 0 11122244444443322 2
Q ss_pred HHHHHHHhhc--------------------ccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 515 RGLRYLHEEC--------------------RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 515 ~aL~yLH~~~--------------------~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
..+.+|.+.. ....++|+|+.+.||+ +.++.+.|+||..|.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 2334443221 1236999999999999 788899999998875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.93 E-value=1.5 Score=47.80 Aligned_cols=29 Identities=28% Similarity=0.448 Sum_probs=24.7
Q ss_pred ceEeeccCCCceee------cCCCcceeeccccce
Q 004395 528 CIVHRDMRPNNILL------THDFEPLVGDFGLAR 556 (756)
Q Consensus 528 gIiHrDLKp~NILL------~~~~~vkL~DFGlA~ 556 (756)
.++|+|+.+.|||+ +++..++++||-+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 47899999999999 456779999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.29 E-value=2.7 Score=42.06 Aligned_cols=116 Identities=9% Similarity=0.098 Sum_probs=79.6
Q ss_pred CCCCeeeEEEEEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCce
Q 004395 460 QHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 539 (756)
Q Consensus 460 ~HpNIV~l~~~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NI 539 (756)
.||+.+.. .+-.+.+.+.+.|+.- .+...+-. -..++...+++++.+|+....+++.. +|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~r------~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRTR------YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGSS------EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcCc------eEEEEecceE
Confidence 58988877 4556666666666653 32322221 13578899999999999888666644 7888999999
Q ss_pred eecCCCcceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004395 540 LLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVD 610 (756)
Q Consensus 540 LL~~~~~vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~ 610 (756)
+++.++.++++-.|+-.. ++|. .++...=+-.+=|++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999987766422 2221 11222233467789999999988774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 756 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 6e-65
Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 21/284 (7%)
Query: 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA 459
+ E+ G + + G FG+V++G AV + + Q F +EV VL
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 460 QHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRY 519
+H N+++ +G+ + +V ++ SL HL+ + E IA A+G+ Y
Sbjct: 62 RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDY 119
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE-TRVIGTFGYLAP 578
LH + I+HRD++ NNI L D +GDFGLA + + ++ G+ ++AP
Sbjct: 120 LHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 579 EYAQ---SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635
E + + ++DVY+FG+VL EL+TG+ + Q L +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL---- 231
Query: 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
++ ++ + M + C+++ RP Q+L +E
Sbjct: 232 ---SKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-63
Identities = 72/268 (26%), Positives = 108/268 (40%), Gaps = 25/268 (9%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VAVK K S F +E ++ QH+ +V L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ ++ EY+ NGSL L L + +A A G+ ++ E +HRD
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
+R NIL++ + DFGLAR D + + APE G T K+DV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 594 SFGVVLVELVTGRKAV--DLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVY 651
SFG++L E+VT + + P+ Q L R + + +EL
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ------------- 241
Query: 652 CMLHAASLCIRRDPHSRPRMSQVLRILE 679
LC + P RP + +LE
Sbjct: 242 ----LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 9e-62
Identities = 68/305 (22%), Positives = 118/305 (38%), Gaps = 37/305 (12%)
Query: 401 LELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSC 458
+EL F + + L G G V + P G +A K L E++VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 459 AQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLR 518
+V G D + E++ GSLD L + K+++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 118
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAP 578
YL E+ + I+HRD++P+NIL+ E + DFG++ D +GT Y++P
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172
Query: 579 EYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQ-------------------- 618
E Q + ++D++S G+ LVE+ GR + K +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 619 ---CLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAA----SLCIRRDPHSRPRM 671
L+ + AI EL+D + + + C+ ++P R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 672 SQVLR 676
Q++
Sbjct: 293 KQLMV 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 4e-60
Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 27/288 (9%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ +G FG V RG G+ VAVK + +E+ +H N++ I +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 474 DR----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC- 528
D + LV +Y +GSL +L ++ + K+A+ A GL +LH E
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 529 ---IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE---TRVIGTFGYLAPEYAQ 582
I HRD++ NIL+ + + D GLA ++ +GT Y+APE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 583 S------GQITEKADVYSFGVVLVELVTGRK----AVDLNRPKGQQCLTEWARPLLEEYA 632
+ ++AD+Y+ G+V E+ D P ++ + + +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 633 IDELVDPRLGNHYSEHEV-YCMLHAASLCIRRDPHSRPRMSQVLRILE 679
++ + P + N + E M C + +R ++ + L
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 7e-60
Identities = 65/266 (24%), Positives = 107/266 (40%), Gaps = 21/266 (7%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ G FG VH G + VA+K + + + +F E EV+ H +V L G C+E
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
LV+E++ +G L + + + + G+ YL E C ++HRD
Sbjct: 72 QAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRD 126
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
+ N L+ + V DFG+ R+ D T + +PE + + K+DV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 594 SFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCM 653
SFGV++ E+ + K NR + I S H +
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVV-----------EDISTGFRLYKPRLASTH----V 231
Query: 654 LHAASLCIRRDPHSRPRMSQVLRILE 679
+ C + P RP S++LR L
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-59
Identities = 56/268 (20%), Positives = 99/268 (36%), Gaps = 25/268 (9%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VA+K K S + EF E +V+ H +V L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
R ++ EY+ NG L ++L + + ++ + YL + +HRD
Sbjct: 71 QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQ----FLHRD 125
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVY 593
+ N L+ V DFGL+R+ D + + PE + + K+D++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 594 SFGVVLVELVTGRKAV--DLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVY 651
+FGV++ E+ + K + + + + R A +++
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT------------- 232
Query: 652 CMLHAASLCIRRDPHSRPRMSQVLRILE 679
C RP +L +
Sbjct: 233 ----IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 4e-58
Identities = 64/288 (22%), Positives = 120/288 (41%), Gaps = 21/288 (7%)
Query: 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCS 451
P +Y + E+ + + L G +G V+ GV VAVK K + + + EF
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLK 62
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV 511
E V+ +H N+V L+G C + ++ E++ G+L +L C+++ + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG 571
+ + YL ++ +HRD+ N L+ + V DFGL+R
Sbjct: 123 QISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 572 TFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEY 631
+ APE + + K+DV++FGV+L E+ T + P ++
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------------PGIDLS 223
Query: 632 AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+ EL++ E + C + +P RP +++ + E
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 9e-58
Identities = 64/267 (23%), Positives = 108/267 (40%), Gaps = 27/267 (10%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ +G FG V G G VAVK + + F +E V++ +H N+V L+G +E
Sbjct: 15 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 474 DRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
++ L +V EY+ GSL +L + L K ++ + YL VHR
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHR 127
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADV 592
D+ N+L++ D V DFGL + + + APE + + + K+DV
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 593 YSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYC 652
+SFG++L E+ + + P + L + + + Y +
Sbjct: 184 WSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGY------KMDAPDGCPPA---- 228
Query: 653 MLHAASLCIRRDPHSRPRMSQVLRILE 679
+ C D RP Q+ LE
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-57
Identities = 73/290 (25%), Positives = 107/290 (36%), Gaps = 22/290 (7%)
Query: 391 KPPRW-FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEF 449
KP + E+ L +G FG V G VA+K K + F
Sbjct: 1 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAF 59
Query: 450 CSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKI 509
E +V+ +H +V L E+ +V EY+ GSL L G + L +
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
A A G+ Y+ VHRD+R NIL+ + V DFGLAR D +
Sbjct: 119 AAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174
Query: 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 629
+ APE A G+ T K+DV+SFG++L EL T + +
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---------- 224
Query: 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
++ E + C R++P RP + LE
Sbjct: 225 -DQVERGYRMPCPPECPES----LHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (497), Expect = 2e-57
Identities = 65/302 (21%), Positives = 118/302 (39%), Gaps = 38/302 (12%)
Query: 396 FSYAELELATGGFSQA---------NFLAEGGFGSVHRGVLP----DGQAVAVKQ-HKLA 441
F++ + A F++ + G FG V G L VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 442 SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPL 501
+ + +F SE ++ H NV+ L G + +++ E++ NGSLD +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQF 125
Query: 502 EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
+ G A G++YL + VHRD+ NIL+ + V DFGL+R+ D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 562 DMGVETR----VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ 617
+ APE Q + T +DV+S+G+V+ E+++ + RP
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWD 236
Query: 618 QCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677
+ + ++Y + + C ++D + RP+ Q++
Sbjct: 237 MTNQDVINAIEQDYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 678 LE 679
L+
Sbjct: 287 LD 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 6e-56
Identities = 67/289 (23%), Positives = 111/289 (38%), Gaps = 32/289 (11%)
Query: 400 ELELATGGFSQANF-LAEGGFGSVHRGVL---PDGQAVAVKQHKLASSQGD-HEFCSEVE 454
+L L A+ L G FGSV +GV VA+K K + + D E E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 455 VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA 514
++ + +V LIG C + +LV E G L L G +E + S ++ +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVS 119
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR--VIGT 572
G++YL E+ VHRD+ N+LL + + DFGL++ D R
Sbjct: 120 MGMKYLEEKN----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 573 FGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKA--VDLNRPKGQQCLTEWARPLLEE 630
+ APE + + ++DV+S+GV + E ++ + + P+ + + R
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 235
Query: 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
EL S C RP V + +
Sbjct: 236 ECPPELYA-----------------LMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-55
Identities = 72/293 (24%), Positives = 114/293 (38%), Gaps = 43/293 (14%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDHE-FCSEVEVLS-CAQHRNVV 465
L G FG V VAVK K ++ + E SE++VLS H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH----------------QEPLEWSARQKI 509
L+G C L++ EY C G L + L + L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETR 568
+ A+G+ +L + +HRD+ NILLTH + DFGLAR + D + V+
Sbjct: 151 SYQVAKGMAFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 569 VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL 628
++APE + T ++DV+S+G+ L EL + + P +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---------- 256
Query: 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681
+++ EH M C DP RP Q+++++E
Sbjct: 257 ----FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-55
Identities = 67/275 (24%), Positives = 111/275 (40%), Gaps = 29/275 (10%)
Query: 414 LAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLI 468
+ G FG V+ G L D AVK + G+ +F +E ++ H NV+ L+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 469 GFCIE-DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
G C+ + L+V Y+ +G L + + A+G+++L +
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 149
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG---VETRVIGTFGYLAPEYAQSG 584
VHRD+ N +L F V DFGLAR D + +T ++A E Q+
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 585 QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644
+ T K+DV+SFGV+L EL+T P + LL+ L+ P +
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGR---RLLQP---EY 258
Query: 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+ + C RP S+++ +
Sbjct: 259 CPDP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (472), Expect = 1e-53
Identities = 66/276 (23%), Positives = 111/276 (40%), Gaps = 33/276 (11%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRN 463
FS + G FG+V+ + + + VA+K+ + Q + + EV L +H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+ G + + LV EY + D H++PL+ + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
++HRD++ NILL+ +GDFG A +GT ++APE +
Sbjct: 135 ----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILA 185
Query: 584 ---GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640
GQ K DV+S G+ +EL + + Y I + P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------------YHIAQNESPA 233
Query: 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
L + + + C+++ P RP +L+
Sbjct: 234 LQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-53
Identities = 64/267 (23%), Positives = 108/267 (40%), Gaps = 30/267 (11%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +G FG+V+ +A+K +L + +H+ EVE+ S +H N++ L G
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+ + R L+ EY G++ L + A L Y H + +
Sbjct: 74 YFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKR----V 127
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEK 589
+HRD++P N+LL E + DFG + P T + GT YL PE + EK
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHDEK 184
Query: 590 ADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649
D++S GV+ E + G+ + N + + R E+ + V
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQET-----YKRISRVEFTFPDFVTEGA-------- 231
Query: 650 VYCMLHAASLCIRRDPHSRPRMSQVLR 676
S ++ +P RP + +VL
Sbjct: 232 ----RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-53
Identities = 58/287 (20%), Positives = 110/287 (38%), Gaps = 28/287 (9%)
Query: 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQ-----AVAVKQHKLASSQGD-HEFCSEVEV 455
E+ ++ + G FG V++G+L VA+K K ++ +F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR 515
+ H N++ L G + + +++ EY+ NG+ + G A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV--IGTF 573
G++YL VHRD+ NIL+ + V DFGL+R D T
Sbjct: 122 GMKYLANMN----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 574 GYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633
+ APE + T +DV+SFG+V+ E++T + + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------V 222
Query: 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680
+ ++ + C +++ RP+ + ++ IL+
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-53
Identities = 61/275 (22%), Positives = 106/275 (38%), Gaps = 33/275 (12%)
Query: 414 LAEGGFGSVHRGVLPD---GQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQHRNVVMLI 468
L G FG+V +G + VAVK K ++ E +E V+ + +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G C + +LV E G L+ +L ++ ++ + G++YL E
Sbjct: 75 GICEAESW-MLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---- 127
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR--VIGTFGYLAPEYAQSGQI 586
VHRD+ N+LL + DFGL++ + + + + APE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 587 TEKADVYSFGVVLVELVTGRKA--VDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644
+ K+DV+SFGV++ E + + + + L + R E+ D
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD------ 241
Query: 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+LC D +RP + V L
Sbjct: 242 -----------LMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (464), Expect = 1e-52
Identities = 69/315 (21%), Positives = 111/315 (35%), Gaps = 53/315 (16%)
Query: 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQGDH-EF 449
LE + EG FG V + P VAVK K +S +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 450 CSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC------------- 496
E +++ + N+V L+G C + L++EY+ G L+ L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 497 ---------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
PL + + IA A G+ YL E VHRD+ N L+ +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVV 179
Query: 548 LVGDFGLARWQPDGD-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR 606
+ DFGL+R D + ++ PE + T ++DV+++GVVL E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 607 KA--VDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRD 664
+ + + + E EL + LC +
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNILACPENCPLELYN-----------------LMRLCWSKL 282
Query: 665 PHSRPRMSQVLRILE 679
P RP + RIL+
Sbjct: 283 PADRPSFCSIHRILQ 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 66/296 (22%), Positives = 104/296 (35%), Gaps = 48/296 (16%)
Query: 414 LAEGGFGSVHRGVLPD------GQAVAVKQHKLASSQGDHE-FCSEVEVLS-CAQHRNVV 465
L G FG V VAVK K + + E SE+++++ H N+V
Sbjct: 45 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 104
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQ---------------------EPLEWS 504
L+G C L++EY C G L ++L + L +
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 505 ARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDM 563
A A+G+ +L + VHRD+ N+L+TH + DFGLAR D +
Sbjct: 165 DLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 564 GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW 623
V ++APE G T K+DV+S+G++L E+ + P
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN----- 275
Query: 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+L+ + + C D RP + L
Sbjct: 276 ---------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-52
Identities = 61/271 (22%), Positives = 105/271 (38%), Gaps = 25/271 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGF 470
+ G +G + DG+ + K+ S SEV +L +H N+V
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 471 CIE--DRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
I+ + +V EY G L S + ++ L+ ++ L+ H
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131
Query: 527 G-CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
G ++HRD++P N+ L +GDFGLAR + D +GT Y++PE
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFVGTPYYMSPEQMNRMS 190
Query: 586 ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645
EK+D++S G +L EL K I E R+ Y
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------------GKIREGKFRRIPYRY 238
Query: 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
S+ E+ ++ + + + RP + ++L
Sbjct: 239 SD-ELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-51
Identities = 62/269 (23%), Positives = 110/269 (40%), Gaps = 26/269 (9%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG V++ + A K S + ++ E+++L+ H N+V L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ ++ E+ G++D+ + + PL S Q + L YLH+ I+HR
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDN----KIIHR 134
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ-----IT 587
D++ NIL T D + + DFG++ + IGT ++APE
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 588 EKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSE 647
KADV+S G+ L+E+ P +L + A E + +S
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMR----------VLLKIAKSEPPTLAQPSRWSS 243
Query: 648 HEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
L C+ ++ +R SQ+L+
Sbjct: 244 -NFKDFL---KKCLEKNVDARWTTSQLLQ 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-51
Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 34/273 (12%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ G F +V++G+ + VA + + + F E E+L QH N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 471 CIEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ +LV E + +G+L ++L + ++ + +GL++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 527 GCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
I+HRD++ +NI +T +GD GLA + VIGT ++APE + +
Sbjct: 134 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYE-EK 188
Query: 586 ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ--QCLTEWARPLLEEYAIDELVDPRLGN 643
E DVY+FG+ ++E+ T + Q + +T +P D++ P +
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS----FDKVAIPEV-- 242
Query: 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
CIR++ R + +L
Sbjct: 243 ----------KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-51
Identities = 71/293 (24%), Positives = 112/293 (38%), Gaps = 44/293 (15%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDG---QAVAVKQHKLASSQGDH-EFCSEVEVLS-CAQHR 462
+ + EG FG V + + A+K+ K +S+ DH +F E+EVL H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQK 508
N++ L+G C L EY +G+L L L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 509 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
A ARG+ YL ++ +HRD+ NIL+ ++ + DFGL+R Q T
Sbjct: 132 FAADVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TM 185
Query: 569 VIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKA--VDLNRPKGQQCLTEWARP 626
++A E T +DV+S+GV+L E+V+ + + + L + R
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245
Query: 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
DE+ D C R P+ RP +Q+L L
Sbjct: 246 EKPLNCDDEVYD-----------------LMRQCWREKPYERPSFAQILVSLN 281
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 3e-50
Identities = 52/264 (19%), Positives = 104/264 (39%), Gaps = 23/264 (8%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G G+V+ + + GQ VA++Q L +E+ V+ ++ N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+V EY+ GSL + + ++ + + L +LH ++HR
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN----QVIHR 140
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADV 592
D++ +NILL D + DFG + + ++GT ++APE K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 593 YSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYC 652
+S G++ +E++ G P L A + + + S
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRA----------LYLIATNGTPELQNPEKLSAI---- 245
Query: 653 MLHAASLCIRRDPHSRPRMSQVLR 676
+ C+ D R ++L+
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-50
Identities = 63/271 (23%), Positives = 107/271 (39%), Gaps = 26/271 (9%)
Query: 414 LAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLI 468
+ EG FG VH+G+ AVA+K K +S E F E + H ++V LI
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G + ++ E G L S L L+ ++ A + L YL +
Sbjct: 75 GVI-TENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKR---- 128
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
VHRD+ N+L++ + +GDFGL+R+ D ++ ++APE + T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEH 648
+DV+ FGV + E++ +P + I+ + +
Sbjct: 189 ASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIG------RIENGERLPMPPNCPPT 237
Query: 649 EVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+ + C DP RPR +++ L
Sbjct: 238 ----LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-50
Identities = 60/267 (22%), Positives = 97/267 (36%), Gaps = 24/267 (8%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGFC 471
L EG +G V V +AVAVK + + E E+ + H NVV G
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
E + L EY G L + + Q+ G+ YLH I H
Sbjct: 73 REGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITH 126
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGTFGYLAPEYAQSGQI-TEK 589
RD++P N+LL + DFGLA + + + ++ GT Y+APE + + E
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 590 ADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649
DV+S G+VL ++ G D Q ++
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQ----------EYSDWKEKKTYLNPWKKIDSAP 236
Query: 650 VYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ + + +P +R + + +
Sbjct: 237 LALLHK----ILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-49
Identities = 67/278 (24%), Positives = 101/278 (36%), Gaps = 35/278 (12%)
Query: 414 LAEGGFGSVHRGVLP----DGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FG V RG +VAVK L+ + +F EV + HRN++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
L G + + +V E GSL HQ + AV A G+ YL +
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESK--- 130
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD--MGVETRVIGTFGYLAPEYAQSG 584
+HRD+ N+LL +GDFGL R P D ++ F + APE ++
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 585 QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ---QCLTEWARPLLEEYAIDELVDPRL 641
+ +D + FGV L E+ T + + Q + E R E ++ +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN--- 246
Query: 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
C P RP + L
Sbjct: 247 --------------VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-48
Identities = 58/281 (20%), Positives = 112/281 (39%), Gaps = 32/281 (11%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQ----AVAVKQ-HKLASSQGDHEFCSEVEVLSCAQH 461
F + L G FG+V++G+ +P+G+ VA+K+ + S + + E E V++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
+V L+G C+ +L + + + G L + H++ + V A+G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFGYLAPEY 580
+ +VHRD+ N+L+ + DFGLA+ + ++A E
Sbjct: 129 DRR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 581 AQSGQITEKADVYSFGVVLVELVTGRKAV--DLNRPKGQQCLTEWARPLLEEYAIDELVD 638
T ++DV+S+GV + EL+T + + L + R ++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244
Query: 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
C D SRP+ +++
Sbjct: 245 -----------------IMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 5e-48
Identities = 74/313 (23%), Positives = 131/313 (41%), Gaps = 45/313 (14%)
Query: 393 PRWFSYAEL------ELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQ-HK 439
P +FS A++ E+A + + L +G FG V+ GV VA+K ++
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 440 LASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQ- 498
AS + EF +E V+ +VV L+G + + L++ E + G L S+L
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 499 -------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551
P S ++A A G+ YL+ VHRD+ N ++ DF +GD
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGD 176
Query: 552 FGLARWQPDGD-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKA-- 608
FG+ R + D + + +++PE + G T +DV+SFGVVL E+ T +
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 236
Query: 609 VDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSR 668
L+ + + + E + D L + +C + +P R
Sbjct: 237 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFE-----------------LMRMCWQYNPKMR 279
Query: 669 PRMSQVLRILEGD 681
P +++ ++ +
Sbjct: 280 PSFLEIISSIKEE 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 5e-46
Identities = 54/271 (19%), Positives = 92/271 (33%), Gaps = 28/271 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L EG F +V L + A+K + E +V+S H V L
Sbjct: 16 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+D + Y NG L ++ + + + L YLH + I
Sbjct: 76 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGKG----I 129
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
+HRD++P NILL D + DFG A+ P+ +GT Y++PE +
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEH 648
+D+++ G ++ +LV G + + + EY E P+
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDFPEKFFPKA------- 237
Query: 649 EVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+ D R ++
Sbjct: 238 -----RDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 6e-46
Identities = 69/290 (23%), Positives = 113/290 (38%), Gaps = 42/290 (14%)
Query: 414 LAEGGFGSVHRGV------LPDGQAVAVKQHKLASSQGDH-EFCSEVEVLS-CAQHRNVV 465
L G FG V + VAVK K ++ +H SE+++L H NVV
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLYGC--------------HQEPLEWSARQKIA 510
L+G C + L ++ E+ G+L ++L +++ L +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRV 569
A+G+ +L +HRD+ NILL+ + DFGLAR D D +
Sbjct: 141 FQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 570 IGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLE 629
++APE T ++DV+SFGV+L E+ + P + E L+
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCRRLK 251
Query: 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
E R ++ + M C +P RP S+++ L
Sbjct: 252 -----EGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 165 bits (418), Expect = 8e-46
Identities = 64/340 (18%), Positives = 116/340 (34%), Gaps = 29/340 (8%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG VHR G A K E++ +S +H +V L
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+D +++YE++ G L + H + + +GL ++HE VH
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN----NYVHL 148
Query: 533 DMRPNNILLTHDFEPLV--GDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKA 590
D++P NI+ T + DFGL T GT + APE A+ +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYT 206
Query: 591 DVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEV 650
D++S GV+ L++G G+ ++ +D+ +
Sbjct: 207 DMWSVGVLSYILLSGLSPFG-----GENDDETLRNVKSCDWNMDDSAFSGISED------ 255
Query: 651 YCMLHAASLCIRRDPHSRPRMSQVLR---ILEGDTVIDTYMSTPGYDVGSRSGRIWVEQQ 707
+ DP++R + Q L + G+ R ++ +
Sbjct: 256 --GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD---SIKTK 310
Query: 708 QHQQQQLPYSGPLMNEALEGFGRKLPLDSLKAAFWERDKA 747
+ ++ + S++ AFW+R +A
Sbjct: 311 YDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEA 350
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-45
Identities = 74/293 (25%), Positives = 114/293 (38%), Gaps = 48/293 (16%)
Query: 414 LAEGGFGSVHRGVLP--------DGQAVAVKQHKLASSQGDH-EFCSEVEVLS-CAQHRN 463
L EG FG V VAVK K +++ D + SE+E++ +H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKI 509
++ L+G C +D ++ EY G+L +L +E L
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
A ARG+ YL + +HRD+ N+L+T D + DFGLAR D +T
Sbjct: 141 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 570 I-GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ--QCLTEWARP 626
++APE T ++DV+SFGV+L E+ T + P + + L E R
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 256
Query: 627 LLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+EL C P RP Q++ L+
Sbjct: 257 DKPSNCTNELYM-----------------MMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 4e-44
Identities = 51/266 (19%), Positives = 93/266 (34%), Gaps = 23/266 (8%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG VHR V G+ K + +E+ +++ H ++ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ +L+ E++ G L + + + A GL+++HE IVH
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS----IVHL 151
Query: 533 DMRPNNILLTHDFEPLV--GDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKA 590
D++P NI+ V DFGLA ++ T + APE +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYT 209
Query: 591 DVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEV 650
D+++ GV+ L++G G+ L ++ DE +
Sbjct: 210 DMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEFDEDAFSSVSPE------ 258
Query: 651 YCMLHAASLCIRRDPHSRPRMSQVLR 676
++++P R + L
Sbjct: 259 --AKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 3e-43
Identities = 48/276 (17%), Positives = 94/276 (34%), Gaps = 26/276 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ G FG ++ G + G+ VA+K + + + E ++ Q + I +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ ++ + SL+ L+ +A + Y+H + +HR
Sbjct: 73 AEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN----FIHR 127
Query: 533 DMRPNNILLT---HDFEPLVGDFGLARWQPDGDMGVE------TRVIGTFGYLAPEYAQS 583
D++P+N L+ + DFGLA+ D + GT Y +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 584 GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643
+ + + D+ S G VL+ G + ++ E I+ L
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK----- 242
Query: 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
Y E L+ C +P S + ++
Sbjct: 243 GYPS-EFATYLNF---CRSLRFDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 2e-42
Identities = 62/285 (21%), Positives = 111/285 (38%), Gaps = 28/285 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGFC 471
L G F V + VA+K + +G +E+ VL +H N+V L
Sbjct: 17 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 76
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
L+ + + G L + + ++ ++YLH+ IVH
Sbjct: 77 ESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL----GIVH 130
Query: 532 RDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
RD++P N+L D + ++ DFGL++ + G + + GT GY+APE ++
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLAQKPYSK 188
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEH 648
D +S GV+ L+ G P + + +L+ + D + S+
Sbjct: 189 AVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKA---EYEFDSPYWDDISDS 239
Query: 649 EVYCMLHAASLCIRRDPHSRPRMSQVLR--ILEGDTVIDTYMSTP 691
+ H + +DP R Q L+ + GDT +D +
Sbjct: 240 AKDFIRH----LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-42
Identities = 55/266 (20%), Positives = 95/266 (35%), Gaps = 24/266 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG VHR V + K K+ + E+ +L+ A+HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
++++E+I + + L L++LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHSHN----IGHF 126
Query: 533 DMRPNNILLTHDFEPLV--GDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKA 590
D+RP NI+ + +FG AR GD + Y APE Q ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 591 DVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEV 650
D++S G ++ L++G + + EY DE + E
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQI-----IENIMNAEYTFDEEAFKEISI-----EA 234
Query: 651 YCMLHAASLCIRRDPHSRPRMSQVLR 676
+ + ++ SR S+ L+
Sbjct: 235 MDFV---DRLLVKERKSRMTASEALQ 257
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 61/284 (21%), Positives = 106/284 (37%), Gaps = 27/284 (9%)
Query: 414 LAEGGFGSVHRG--VLPDGQAVAVKQHKLASSQGDHEFCSEVEV-----LSCAQHRNVVM 466
+ EG +G V + + G+ VA+K+ ++ + + + EV L +H NVV
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 467 LIGFCIEDRRRLLVYEYI----CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
L C R + + L ++L + + + + RGL +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ 582
+VHRD++P NIL+T + + DFGLAR T V+ T Y APE
Sbjct: 135 HR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVLL 188
Query: 583 SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ--QCLTEWARPLLEEYAIDELVDPR 640
D++S G + E+ + + Q + L P E++ D + +
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 641 LGNHYSEHEVYCMLHAAS--------LCIRRDPHSRPRMSQVLR 676
+ S + + C+ +P R L
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (385), Expect = 3e-41
Identities = 61/274 (22%), Positives = 103/274 (37%), Gaps = 31/274 (11%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQ--- 460
FS + GGFG V+ D G+ A+K ++ QG+ +E +LS
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520
+V + + + + + G L HL + + A GL ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHM 123
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEY 580
H +V+RD++P NILL + D GLA +GT GY+APE
Sbjct: 124 HNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEV 176
Query: 581 AQSGQ-ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639
Q G AD +S G +L +L+ G ++ K + + +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----------AV 226
Query: 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQ 673
L + +S E+ +L ++RD + R
Sbjct: 227 ELPDSFSP-ELRSLLEG---LLQRDVNRRLGCLG 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-41
Identities = 66/268 (24%), Positives = 98/268 (36%), Gaps = 29/268 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCSEVEVLSCA-QHRNVVMLI 468
L +G FG V Q A+K K D + E VLS A +H + +
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
V EY+ G L H+ CH + S A GL++LH +
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---- 123
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
IV+RD++ +NILL D + DFG+ + GD GT Y+APE +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNH 182
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEH 648
D +SFGV+L E++ G+ + P + E D
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD---------- 232
Query: 649 EVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+L R+P R + +R
Sbjct: 233 ----LLVK---LFVREPEKRLGVRGDIR 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (376), Expect = 9e-41
Identities = 41/278 (14%), Positives = 86/278 (30%), Gaps = 28/278 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ EG FG + G L + Q VA+K + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
++ ++ + G L A ++ +HE+ +V+R
Sbjct: 71 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVYR 125
Query: 533 DMRPNNILLTHDFEPLVG-----DFGLARWQPDGDMGVETR------VIGTFGYLAPEYA 581
D++P+N L+ DFG+ ++ D + GT Y++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 582 QSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641
+ + + D+ + G V + + G + + E + + EL
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA--- 242
Query: 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679
+ E E Y +H + P + +
Sbjct: 243 --GFPE-EFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (372), Expect = 2e-40
Identities = 60/277 (21%), Positives = 116/277 (41%), Gaps = 30/277 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRNVVMLIG 469
L GG VH L + VAVK + ++ F E + + H +V +
Sbjct: 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74
Query: 470 FCIEDRRRL----LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
+ +V EY+ +L ++ + P+ ++ A + L + H+
Sbjct: 75 TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG- 131
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD--MGVETRVIGTFGYLAPEYAQS 583
I+HRD++P NI+++ V DFG+AR D + VIGT YL+PE A+
Sbjct: 132 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 584 GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643
+ ++DVYS G VL E++TG + P + ++ ++ + P +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----------VAYQHVREDPIPPSARH 238
Query: 644 HYSEHEVYCMLHAASLCIRRDPHSRPR-MSQVLRILE 679
++ ++ + ++P +R + +++ L
Sbjct: 239 EGLSADLDAVVLK---ALAKNPENRYQTAAEMRADLV 272
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 147 bits (372), Expect = 2e-40
Identities = 52/277 (18%), Positives = 102/277 (36%), Gaps = 20/277 (7%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
+ EG +G V++ G+ A+K+ +L E+ +L +H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+R +LV+E++ + LE + + G+ Y H+ ++H
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR----VLH 123
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKAD 591
RD++P N+L+ + E + DFGLAR ++ + S + + D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 592 VYSFGVVLVELVTGRKAVDLNRPKGQ-QCLTEWARPLLEEYAIDELVDPRLGNHYSEHEV 650
++S G + E+V G Q + + + P+ +++ +E
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 651 YCMLH--------AASL---CIRRDPHSRPRMSQVLR 676
L ++ DP+ R Q L
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 146 bits (370), Expect = 5e-40
Identities = 59/280 (21%), Positives = 96/280 (34%), Gaps = 38/280 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---------FCSEVEVLS-CAQHR 462
L G V R + P + AVK + EV++L + H
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
N++ L + LV++ + G L +L + L +KI + LH+
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHK 128
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQ 582
IVHRD++P NILL D + DFG + G+ V GT YLAPE +
Sbjct: 129 LN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIE 182
Query: 583 SGQ------ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636
++ D++S GV++ L+ G + +
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF-------- 234
Query: 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
+ YS+ + S + P R + L
Sbjct: 235 -GSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 60/283 (21%), Positives = 110/283 (38%), Gaps = 25/283 (8%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-----FCSEVEVLSCAQHRNVV 465
+FL EG F +V++ Q VA+K+ KL + E+++L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
L+ LV++++ + + L S + + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
I+HRD++PNN+LL + + DFGLA+ T + T Y APE +
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGAR 176
Query: 586 -ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ------QCLTEWARPLLEEYAIDELVD 638
D+++ G +L EL+ + + Q T + ++ + V
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 639 PRLGNHYSEHEVYCMLHAASL-----CIRRDPHSRPRMSQVLR 676
+ H ++ L +P +R +Q L+
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 52/284 (18%), Positives = 98/284 (34%), Gaps = 20/284 (7%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQHRNV 464
F + + EG +G V++ G+ VA+K+ +L + E+ +L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
V L+ + + LV+E+ + L + + + +GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
++HRD++P N+L+ + + DFGLAR V+ +
Sbjct: 123 ----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 585 QITEKADVYSFGVVLVELVTGR--------KAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636
+ D++S G + E+VT R + E P + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 637 VDPRLGNHYSEHEVYCMLHAA----SLCIRRDPHSRPRMSQVLR 676
P+ V + S + DP+ R L
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-39
Identities = 56/285 (19%), Positives = 108/285 (37%), Gaps = 24/285 (8%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIG 469
+++ EG +G V + VA+K+ Q + E+++L +H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ Y+ + + LY + L RGL+Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA----N 129
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLAR--WQPDGDMGVETRVIGTFGYLAPEYAQSGQI 586
++HRD++P+N+LL + + DFGLAR G T + T Y APE + +
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 587 -TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645
T+ D++S G +L E+++ R Q + ++ +++ + N+
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 646 SEHEVYCMLHAASL--------------CIRRDPHSRPRMSQVLR 676
+ L + +PH R + Q L
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 62/289 (21%), Positives = 101/289 (34%), Gaps = 41/289 (14%)
Query: 408 FSQANF---------LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH------EFCS 451
F Q N L G F V + G A K K ++ +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV 511
EV +L QH NV+ L +L+ E + G L +E L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLK 120
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLARWQPDGDMGVET 567
G+ YLH I H D++P NI+L P + DFGLA G+
Sbjct: 121 QILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 174
Query: 568 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPL 627
+ GT ++APE + +AD++S GV+ L++G + + L
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---------L 225
Query: 628 LEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
A++ + ++ S + + +DP R + L+
Sbjct: 226 ANVSAVNYEFEDEYFSNTSA-LAKDFIRR---LLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (360), Expect = 2e-38
Identities = 59/264 (22%), Positives = 99/264 (37%), Gaps = 31/264 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L G FG VH +G+ A+K + + E +LS H ++ + G
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+ ++ ++ +Y G L Q A+ A L YLH + I
Sbjct: 72 TFQDAQQIFMIMDY-IEGGELFSLLRKSQRFPNPVAK-FYAAEVCLALEYLHSKD----I 125
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEK 589
++RD++P NILL + + DFG A++ PD V + GT Y+APE + +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 590 ADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649
D +SFG+++ E++ G + A + +++ D
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD----------- 230
Query: 650 VYCMLHAASLCIRRDPHSRPRMSQ 673
S I RD R Q
Sbjct: 231 ------LLSRLITRDLSQRLGNLQ 248
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 51/272 (18%), Positives = 97/272 (35%), Gaps = 29/272 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLS-CAQHRNVVMLIGFC 471
L G G V + + A+K + + EVE+ +Q ++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 472 ----IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ L+V E + G L S + + +I ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 131
Query: 528 CIVHRDMRPNNILLTHDFEPLV---GDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
I HRD++P N+L T + DFG A+ + T T Y+APE
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPE 188
Query: 585 QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644
+ + D++S GV++ L+ G P + + + + P
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
EV ++ ++ +P R +++ +
Sbjct: 243 EVSEEVKMLIRN---LLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 54/274 (19%), Positives = 92/274 (33%), Gaps = 42/274 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE------FCSEVEVLS--CAQHRNV 464
L GGFGSV+ G+ + D VA+K + E EV +L + V
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
+ L+ + +L+ E D + + L+ + +R+ H
Sbjct: 72 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 129
Query: 525 RVGCIVHRDMRPNNILLTHD-FEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQS 583
++HRD++ NIL+ + E + DFG D T GT Y PE+ +
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRY 183
Query: 584 GQ-ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642
+ A V+S G++L ++V G P + + E
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFFRQRVSSECQH---- 233
Query: 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676
C+ P RP ++
Sbjct: 234 -------------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 59/290 (20%), Positives = 100/290 (34%), Gaps = 30/290 (10%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
++ + G FG V++ L D G+ VA+K+ Q E++++ H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 467 LIGFCIEDRRR------LLVYEYICNGSLDSHL-YGCHQEPLEWSARQKIAVGAARGLRY 519
L F + LV +Y+ Y ++ L + R L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDGDMGVETRVIGTFGYLAP 578
+H I HRD++P N+LL D L + DFG A+ G+ + + +
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRYYRAPE 192
Query: 579 EYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQ---------QCLTEWARPLLE 629
+ T DV+S G VL EL+ G+ + Q E R +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 630 EYAIDELVDPRLGNHYSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLR 676
Y + + A +L + P +R +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 61/293 (20%), Positives = 105/293 (35%), Gaps = 36/293 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGF 470
+ +G FG V + GQ VA+K+ + + + E+++L +H NVV LI
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 471 CIEDRRR--------LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
C LV+++ + S +++ GL Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW---QPDGDMGVETRVIGTFGYLAPE 579
I+HRDM+ N+L+T D + DFGLAR + T + T Y PE
Sbjct: 136 NK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 580 YAQSGQ-ITEKADVYSFGVVLVELVTGRKAVDLNRP--------KGQQCLTEWARPLLEE 630
+ D++ G ++ E+ T + N + +T P ++
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 631 YAIDELVDPRLGNHYSEHEVYCML----HAASL---CIRRDPHSRPRMSQVLR 676
Y + E ++ G + +A L + DP R L
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 52/279 (18%), Positives = 100/279 (35%), Gaps = 22/279 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ EG +G+V + + VA+K+ +L E+ +L +H+N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
D++ LV+E+ + L+ + +GL + H ++
Sbjct: 70 LHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN----VL 123
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKA 590
HRD++P N+L+ + E + +FGLAR V+ + + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 591 DVYSFGVVLVELVTGRKAVDLNRPKGQQC---LTEWARPLLEEYA-----IDELVDPRLG 642
D++S G + EL + + Q P E++ D P
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 643 NHYSEHEVYCMLHAASL-----CIRRDPHSRPRMSQVLR 676
S V L+A ++ +P R + L+
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-32
Identities = 55/318 (17%), Positives = 114/318 (35%), Gaps = 48/318 (15%)
Query: 391 KPPRWFSYAELELATGGFSQANF-----LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ 444
+P ++ Y + G +Q ++ L G + V + + + + V VK K +
Sbjct: 17 RPREYWDYESHVVEWG--NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK 74
Query: 445 GDHEFCSEVEVLS-CAQHRNVVMLIGFCIEDRRRL--LVYEYICNGSLDSHLYGCHQEPL 501
+ E+++L N++ L + R LV+E++ N + L
Sbjct: 75 ---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTL 126
Query: 502 EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPD 560
+ + L Y H I+HRD++P+N+++ H+ L + D+GLA +
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 561 GDMGVETRVIGTFGYLAPEYAQSGQ-ITEKADVYSFGVVLVELVTGR-----------KA 608
G + + + PE Q D++S G +L ++ + +
Sbjct: 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240
Query: 609 VDLNRPKGQQCLTEWAR-------PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASL-- 659
V + + G + L ++ P + +SE++ A
Sbjct: 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 300
Query: 660 -CIRRDPHSRPRMSQVLR 676
+R D SR + +
Sbjct: 301 KLLRYDHQSRLTAREAME 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (318), Expect = 2e-32
Identities = 55/260 (21%), Positives = 92/260 (35%), Gaps = 31/260 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L G FG V G A+K K+ + +E +L +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
++ +V EY+ G + SHL + A YLH +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLD----L 162
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEK 589
++RD++P N+L+ V DFG A+ G + GT LAPE S +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 590 ADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHE 649
D ++ GV++ E+ G +A ++ Y R +H+S +
Sbjct: 219 VDWWALGVLIYEMAAGYPPF-------------FADQPIQIYEKIVSGKVRFPSHFSS-D 264
Query: 650 VYCMLHAASLCIRRDPHSRP 669
+ +L ++ D R
Sbjct: 265 LKDLLRN---LLQVDLTKRF 281
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 5e-32
Identities = 49/197 (24%), Positives = 71/197 (36%), Gaps = 11/197 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +G FG V G+ A+K + + +E VL +H + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
R V EY G L HL E A + L +
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYLHSRD-V 126
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEK 589
V+RD++ N++L D + DFGL + D GT YLAPE +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 590 ADVYSFGVVLVELVTGR 606
D + GVV+ E++ GR
Sbjct: 186 VDWWGLGVVMYEMMCGR 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 6e-32
Identities = 57/282 (20%), Positives = 96/282 (34%), Gaps = 26/282 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ G +G+V V G VA+K+ S E+ +L +H NV+ L+
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
D ++ G E L Q + +GLRY+H +
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII-- 143
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITE 588
HRD++P N+ + D E + DFGLAR Q D +M V+ + + T+
Sbjct: 144 --HRDLKPGNLAVNEDCELKILDFGLAR-QADSEM--TGYVVTRWYRAPEVILNWMRYTQ 198
Query: 589 KADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEH 648
D++S G ++ E++TG+ + Q + L N+
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 649 EVYCMLHAASL--------------CIRRDPHSRPRMSQVLR 676
AS+ + D R + L
Sbjct: 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 57/271 (21%), Positives = 103/271 (38%), Gaps = 30/271 (11%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQHR-NV 464
L G +G V G+ A+K K A+ ++ +E +VL + +
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
V L + + L+ +YI G L +HL + + L
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEIVLALEHLH 146
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
++G I++RD++ NILL + ++ DFGL++ + GT Y+AP+ + G
Sbjct: 147 KLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 585 Q--ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642
+ D +S GV++ EL+TG ++ K E +R +L+ +P
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS-------EPPYP 256
Query: 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQ 673
S + + +DP R
Sbjct: 257 QEMSALAKDLIQR----LLMKDPKKRLGCGP 283
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 8e-30
Identities = 59/297 (19%), Positives = 100/297 (33%), Gaps = 45/297 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ G G V + VA+K+ + E+ ++ C H+N++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 471 CI------EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
E + LV E + + + G+++LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSAG 139
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSG 584
+ HRD++P+NI++ D + DFGLAR M T + T Y APE
Sbjct: 140 II----HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGM 193
Query: 585 QITEKADVYSFGVVLVELVTGR----------------KAVDLNRPKGQQCLTEWAR--- 625
E D++S G ++ E+V + + + P+ + L R
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 626 ---PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLR 676
P +L L SEH A L + DP R + L+
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-27
Identities = 59/287 (20%), Positives = 106/287 (36%), Gaps = 36/287 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGF 470
+ G +GSV G VAVK+ H E+ +L +H NV+ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 471 C-----IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
+E+ + + ++ L++ + L Q + RGL+Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQ 585
+ HRD++P+N+ + D E + DFGLAR D + V +
Sbjct: 143 I----HRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMH 195
Query: 586 ITEKADVYSFGVVLVELVTGR-------------KAVDLNRPKGQQCLTEWARPLLEEYA 632
+ D++S G ++ EL+TGR + L G + L + + Y
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 633 IDELVDPRLGNHYSEHEVYCMLHAASL---CIRRDPHSRPRMSQVLR 676
P++ +++ + A L + D R +Q L
Sbjct: 256 QSLTQMPKM--NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.0 bits (245), Expect = 6e-23
Identities = 38/210 (18%), Positives = 70/210 (33%), Gaps = 21/210 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G F +V + + VA+K + E+++L +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 473 EDRRRLLVYEYICNGSL--------------DSHLYGCHQEPLEWSARQKIAVGAARGLR 518
+LL + + + + + ++I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 519 YLHEECRVGCIVHRDMRPNNILLT-HDFEPLVGDFGLARW-QPDGDMGVETRVIGTFGYL 576
Y+H C I+H D++P N+L+ D + +A T I T Y
Sbjct: 140 YMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 577 APEYAQSGQITEKADVYSFGVVLVELVTGR 606
+PE AD++S ++ EL+TG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.3 bits (218), Expect = 1e-20
Identities = 24/153 (15%), Positives = 45/153 (29%), Gaps = 20/153 (13%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASS----------QGDHEFCSEVEVLSCAQHRN 463
+ EG +V VK HK+ + GD F + + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+ L G + Y + N L + + ++ + +
Sbjct: 68 LQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
IVH D+ N+L+ + + DF +
Sbjct: 123 ----GIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 756 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.34 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 98.81 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 98.71 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.61 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 98.34 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 98.34 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.88 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.32 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.17 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-51 Score=436.84 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=220.2
Q ss_pred hHHHHHhhCCeeEEEEecccCceEEEEEEec-CCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 398 YAELELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 398 ~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
+..+++..++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....+.|.+|+++|++++|||||+++++|.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3445667789999999999999999999964 6899999988754 3445679999999999999999999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|||||||++|+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+|+
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999999876778899999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
..............|++.|+|||++.+..|+.++|||||||++|||++|..||........ +.+.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~---------------~~~~ 228 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYEL 228 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---------------HHHH
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH---------------HHHH
Confidence 7665544444456689999999999999999999999999999999997777643222110 0011
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+........+...+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111222333445678999999999999999999999998875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=430.16 Aligned_cols=259 Identities=26% Similarity=0.368 Sum_probs=213.9
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
+++..++|++.+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|+++|++++|||||++++++.+ +..|+|
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 45566799999999999999999999988899999998754 3445679999999999999999999998865 567999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
||||++|+|.+++......++++..++.|+.||++||.|||++ +|+||||||+||||++++.+||+|||+|+....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999988655555799999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
..........||+.|+|||++.++.++.++|||||||+||||+||..|+........ ... .+.....+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-----~~~------~i~~~~~~- 229 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQ------NLERGYRM- 229 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHH------HHHTTCCC-
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-----HHH------HHHhcCCC-
Confidence 544444556799999999999999999999999999999999997665533221100 000 01111111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+...+..+.+|+.+||+.||++||||++|++.|+.
T Consensus 230 ---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 ---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1223344578999999999999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=425.15 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=200.1
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
++|++.+.||+|+||.||+|.+.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..|+||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 589999999999999999999988899999998753 3445689999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999865 456799999999999999999999999 99999999999999999999999999998776554444
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHY 645 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~ 645 (756)
.....||+.|+|||++.+..|+.++|||||||++|||+|+..|+...... .+.... +..-.. ...
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----~~~~~~------i~~~~~----~~~ 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVED------ISTGFR----LYK 223 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----HHHHHH------HHHTCC----CCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----HHHHHH------HHhcCC----CCC
Confidence 44567999999999999999999999999999999999965444322211 000100 011111 112
Q ss_pred ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 646 SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 646 ~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+......+.+|+.+||+.||++||||++|++.|+.
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 22334578999999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=425.44 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=204.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999995 5799999999865432 3345799999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC-
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD- 562 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~- 562 (756)
|.+|+|.+++. ..+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999996 456899999999999999999999999 99999999999999999999999999999765332
Q ss_pred CCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.......+||+.|+|||++.+..+ +.++|||||||+||||+||+.||......... ...+ .....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~-------------~~~~~ 224 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW-------------KEKKT 224 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH-------------HTTCT
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH-------------hcCCC
Confidence 223445789999999999988776 57899999999999999999999754322111 0000 00000
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
...........+.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111223456889999999999999999999876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=426.78 Aligned_cols=249 Identities=21% Similarity=0.337 Sum_probs=210.1
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++|+.++|||||+++++|.+++..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999994 579999999987666566678999999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
+||+|.+++.. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999998853 4699999999999999999999999 999999999999999999999999999997754332
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....+||+.|+|||++.+..|+.++|||||||++|||+||+.||........ +. .... .. .+. ..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~----~~~~----~~--~~~--~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY----LIAT----NG--TPE--LQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHH----HC--SCC--CS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HH----HHHh----CC--CCC--CC
Confidence 33456799999999999999999999999999999999999999964432111 00 0000 00 111 11
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+......+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22334557899999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=427.47 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=204.7
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
++..++|.+.+.||+|+||.||+|++. ..||||+++... ....+.|.+|+++|++++|||||++++++.+ ...+|
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 455678999999999999999999864 359999986543 3344679999999999999999999998754 56899
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|||||++|+|.+++.. ....+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+...
T Consensus 81 v~Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999975 346799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCC-CCcccccccCccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 560 DGD-MGVETRVIGTFGYLAPEYAQS---GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 560 ~~~-~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
... ........||+.|||||++.+ ..|+.++|||||||+||||+||+.||......... .... ...
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~----~~~ 225 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMV----GRG 225 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHH----HHT
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHH----hcC
Confidence 432 223345679999999999864 45899999999999999999999999754322110 0000 011
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...+.+ ...+...+..+.+|+.+||..||++||||.+|++.|+.
T Consensus 226 ~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 226 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111111 11223344578999999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=418.32 Aligned_cols=245 Identities=25% Similarity=0.394 Sum_probs=207.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++++.||+|+||.||+|.. .+|+.||+|++... .......+.+|+++|+.++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4799999999999999999996 47899999987532 2344567899999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
|||.+|+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999973 45799999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
. .....||+.|+|||++.+..|+.++|||||||+||||++|+.||........ + ..+....
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~-------------~~i~~~~- 220 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--Y-------------KRISRVE- 220 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H-------------HHHHTTC-
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH--H-------------HHHHcCC-
Confidence 2 3456799999999999999999999999999999999999999965432110 0 0000110
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
..++......+.+|+.+||+.||++|||+.|+++
T Consensus 221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1122334457889999999999999999999987
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=421.94 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=208.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
+.|++++.||+|+||.||+|.. .+|+.||||++........+.|.+|+++|++++|||||++++++.+++..|||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4699999999999999999995 579999999988766666778999999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~ 564 (756)
++|+|.+++.. ..+++++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 99999998864 346799999999999999999999999 99999999999999999999999999998653221 1
Q ss_pred cccccccCccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 565 VETRVIGTFGYLAPEYAQ-----SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
......||+.|+|||++. +..|+.++|||||||+||||+||+.||........ +... .....+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i----------~~~~~~ 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKI----------AKSEPP 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHH----------HHSCCC
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHH----------HcCCCC
Confidence 223467999999999984 46689999999999999999999999975432211 1100 000001
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
. ...+......+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 T--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1122334457899999999999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=414.36 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=214.5
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeec
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~ 485 (756)
++|++.+.||+|+||.||+|++++++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999999888899999987543 345689999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCCc
Q 004395 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (756)
Q Consensus 486 ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~~ 565 (756)
+|+|.+++.. ....+++..+++++.|+++||+|||+. ||+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999999765 456789999999999999999999999 99999999999999999999999999998766554444
Q ss_pred ccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCC
Q 004395 566 ETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNH 644 (756)
Q Consensus 566 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~ 644 (756)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||........ .. .+..-. ...
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~------~~------~i~~~~----~~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AE------HIAQGL----RLY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------HH------HHHTTC----CCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH------HH------HHHhCC----CCC
Confidence 455679999999999999999999999999999999998 8999975432110 00 011111 112
Q ss_pred CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 645 YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 645 ~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+......+.+|+.+||+.||++|||+++|++.|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 223344578999999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=432.76 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=207.3
Q ss_pred HhhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
+..++|++.+.||+|+||+||+|.. .+|+.||+|+++.... .....+.+|+.+|+.++|||||+++++|.+....|||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4567899999999999999999995 5799999999875433 3345789999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
||||+||+|.+++.. .+.+++..+..++.||+.||.|||+ + ||+||||||+||||+.++.+||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH----CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC----CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999974 3579999999999999999999996 5 89999999999999999999999999998654
Q ss_pred CCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhh-hhh------------
Q 004395 560 DGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW-ARP------------ 626 (756)
Q Consensus 560 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~-~~~------------ 626 (756)
+. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.............. ...
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 32 23456899999999999999999999999999999999999999975432211000000 000
Q ss_pred -------------hhh-hhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 627 -------------LLE-EYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 627 -------------~~~-~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
... .......................+.+|+.+||..||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000 000000000000000111123468899999999999999999999873
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=419.85 Aligned_cols=259 Identities=27% Similarity=0.369 Sum_probs=206.9
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++..++|++++.||+|+||.||+|.+.+++.||||+++.. ....+.|.+|+.+|++++|||||+++++|.+ +..++||
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 3445789999999999999999999888889999998744 3445689999999999999999999999854 5689999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
|||++|+|..++.......+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+|+.....
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999999998765566799999999999999999999999 9999999999999999999999999999877655
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.........||+.|+|||++.++.++.++|||||||+||||++|..|+........ .... +.. ..
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-----~~~~------i~~----~~ 231 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQ------VER----GY 231 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHH------HHT----TC
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-----HHHH------HHh----cC
Confidence 44444556799999999999999999999999999999999997766643322110 0000 011 11
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
....+......+.++|.+||+.||++||++++|++.|+..
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 1123334455789999999999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=418.87 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=194.5
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEe--cCceeEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLV 480 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--~~~~~LV 480 (756)
++|++.+.||+|+||.||+|.. .+|+.||||++..... .....|.+|+++|++++|||||++++++.+ +..+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999995 5799999998865432 223568899999999999999999999865 4568999
Q ss_pred EEeecCCChhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhcc-cCceEeeccCCCceeecCCCcceeecccccee
Q 004395 481 YEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECR-VGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~--~~~~L~~~~~~~ia~qIa~aL~yLH~~~~-~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
||||++|+|.+++... ....+++..++.++.||+.||.|||+... ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998542 45689999999999999999999998710 11399999999999999999999999999997
Q ss_pred cCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
..... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||....... .... +....
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~------i~~~~ 230 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGK------IREGK 230 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHH------HHHTC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HHHH------HHcCC
Confidence 65432 23345789999999999999999999999999999999999999996433210 0000 11111
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+. .+......+.+|+.+||+.||.+|||+.|+++
T Consensus 231 ~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 22233456899999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-49 Score=422.03 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=198.0
Q ss_pred hCCeeEEEEecccCceEEEEEEec-CC---CEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP-DG---QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g---~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.++|++.+.||+|+||.||+|... +| ..||||.+..... ...+.|.+|+++|++++|||||+++|+|.+++..|+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 457899999999999999999964 33 3688998764433 334579999999999999999999999999999999
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|||||++|+|.+++.. ..+.+++..++.++.||++||.|||++ +|+||||||+||||+.++.+||+|||+|+...
T Consensus 105 v~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998864 456799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC----cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 560 DGDMG----VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 560 ~~~~~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
..... ......||+.|+|||++.++.|+.++|||||||+||||+| |+.||....... . ... +.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~------~----~~~--i~ 247 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------V----INA--IE 247 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H----HHH--HH
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH------H----HHH--HH
Confidence 43211 1223468999999999999999999999999999999998 899996543210 0 000 01
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. ......+...+..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 248 ~----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 248 Q----DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp T----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred c----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 11112233445678999999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=423.90 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=208.1
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecC-C-----CEEEEEEeccc-CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPD-G-----QAVAVKQHKLA-SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE 473 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g-----~~VAVK~~~~~-~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~ 473 (756)
++..++|.+.+.||+|+||.||+|.... + ..||+|.+... .......|.+|+.+|.++ +|||||+++++|.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3455789999999999999999998532 2 36999987643 334456799999999998 89999999999999
Q ss_pred cCceeEEEEeecCCChhhhhhccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEee
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGCH---------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~~---------------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHr 532 (756)
.+..|||||||++|+|.++|.... ...+++..++.++.||+.||+|||++ +||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~IiHR 188 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHR 188 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEET
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----Ceeec
Confidence 999999999999999999996532 24589999999999999999999999 99999
Q ss_pred ccCCCceeecCCCcceeeccccceecCCCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 004395 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVD 610 (756)
Q Consensus 533 DLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~ 610 (756)
||||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999866543322 2335678999999999999999999999999999999998 899997
Q ss_pred CCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 004395 611 LNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILE 679 (756)
Q Consensus 611 ~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le 679 (756)
....... +. .++........+...+..+.+||.+||+.||++|||++||+++|.
T Consensus 269 ~~~~~~~--~~-------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDAN--FY-------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHH--HH-------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHH--HH-------------HHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 5432211 11 001111111223344567899999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=414.86 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=207.4
Q ss_pred hCCeeEEEE-ecccCceEEEEEEec---CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 405 TGGFSQANF-LAEGGFGSVHRGVLP---DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 405 ~~~y~~~~~-LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.++|.+.+. ||+|+||.||+|.+. ++..||||+++.... ...+.|.+|+++|++++|||||+++++|.+ +..||
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 457888885 999999999999853 455899999875433 334679999999999999999999999865 56899
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
|||||++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+...
T Consensus 86 vmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998854 456799999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCC--CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhc
Q 004395 560 DGDM--GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDEL 636 (756)
Q Consensus 560 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l 636 (756)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||........ .. . +..-
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~------~~-~-----i~~~ 228 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MA-F-----IEQG 228 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH------HH-H-----HHTT
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH------HH-H-----HHcC
Confidence 4332 12234568999999999999999999999999999999998 9999975432110 00 0 1111
Q ss_pred cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 637 VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 637 ~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.. ...+...+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus 229 ~~----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 229 KR----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp CC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 12233445678999999999999999999999998873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-48 Score=421.70 Aligned_cols=252 Identities=19% Similarity=0.261 Sum_probs=210.5
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
++|++++.||+|+||.||+|.. .+|+.||||++..........+.+|+++|++|+|||||+++++|.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4799999999999999999995 579999999987655445567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec--CCCcceeeccccceecCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT--HDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~--~~~~vkL~DFGlA~~~~~~~ 562 (756)
.||+|.+++.. ...++++..++.|+.||+.||.|||++ ||+||||||+||||+ .++.+||+|||+|+......
T Consensus 109 ~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999988754 345799999999999999999999999 999999999999997 67899999999999876543
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
......||+.|+|||++.+..|+.++|||||||+||||+||+.||........ + .. +.. ....+.
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~--------~~--i~~-~~~~~~ 248 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--L--------QN--VKR-CDWEFD 248 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--H--------HH--HHH-CCCCCC
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--H--------HH--HHh-CCCCCC
Confidence 34556799999999999999999999999999999999999999964432110 0 00 000 011111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..........+.+||.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22223344578999999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=413.26 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=201.8
Q ss_pred hhCCeeEEEEecccCceEEEEEEecCC-----CEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVLPDG-----QAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g-----~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
..+.|++.++||+|+||.||+|.+.+. ..||||++...... ....|.+|+++|++++|||||+++|+|.+....
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 346799999999999999999996432 37999988654332 334699999999999999999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
++|||||.+++|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999988764 456799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 558 QPDGDM--GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 558 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
...... .......||+.|+|||++.++.++.++|||||||+||||++|..|+........ . ..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-----~----------~~ 224 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----V----------MK 224 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----H----------HH
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-----H----------HH
Confidence 654322 122345689999999999999999999999999999999997666543322110 0 00
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+........+...+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus 225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 111111222334455678999999999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=411.07 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=197.9
Q ss_pred CCe-eEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEe----cCce
Q 004395 406 GGF-SQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRR 477 (756)
Q Consensus 406 ~~y-~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~----~~~~ 477 (756)
++| ++.+.||+|+||+||+|.. .+++.||+|++.... ......|.+|+++|++++|||||+++++|.+ +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 345 6778899999999999995 478999999876543 2234568999999999999999999999875 3457
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCc--eEeeccCCCceeec-CCCcceeecccc
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLT-HDFEPLVGDFGL 554 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g--IiHrDLKp~NILL~-~~~~vkL~DFGl 554 (756)
|||||||++|+|.+++.. ...+++..++.++.||+.||+|||++ + |+||||||+||||+ .++.+||+|||+
T Consensus 88 ~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~----~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHC----CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 999999999999999974 46799999999999999999999998 7 99999999999996 578999999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
|+..... .....+||+.|+|||++.+ .|+.++|||||||+||||++|+.||........ +. ... ..
T Consensus 162 a~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~---~~i-----~~ 227 (270)
T d1t4ha_ 162 ATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RRV-----TS 227 (270)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HHH-----TT
T ss_pred ceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HH---HHH-----Hc
Confidence 9864332 2346789999999999875 699999999999999999999999964332111 00 000 00
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
....+. ++......+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 GVKPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TCCCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcc----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 001111 11222346889999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-49 Score=421.45 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=193.0
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
..+.|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|+.++|||||++++++.+++..||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456799999999999999999995 4799999998865432 23456889999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec---CCCcceeeccccceec
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT---HDFEPLVGDFGLARWQ 558 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~---~~~~vkL~DFGlA~~~ 558 (756)
|||+||+|.+++. ..+.+++..+..++.||+.||+|||++ ||+||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997 456899999999999999999999999 999999999999994 5789999999999866
Q ss_pred CCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccC
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVD 638 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~d 638 (756)
.... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ .... ... .
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i-----~~~--~ 225 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQI-----LKA--E 225 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHH-----HTT--C
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHH-----hcc--C
Confidence 5433 23456799999999999999999999999999999999999999964332110 0000 000 1
Q ss_pred CccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 639 PRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 639 p~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..+........+..+.+|+.+||..||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111112223344578999999999999999999999884
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=417.95 Aligned_cols=249 Identities=20% Similarity=0.273 Sum_probs=205.1
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++++.||+|+||.||+|.. .+|+.||||++... .......+.+|+++|++++||||++++++|.+++..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4799999999999999999995 57999999987642 2334567999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
|||+||+|.+++.. .+.+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999873 46799999999999999999999999 9999999999999999999999999999977543
Q ss_pred C-CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 D-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
. .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||........ + ..+....
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~-------------~~i~~~~ 226 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI--F-------------QKIIKLE 226 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-------------HHHHTTC
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH--H-------------HHHHcCC
Confidence 2 2234456899999999999999999999999999999999999999975432110 0 0001100
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..++......+.+||.+||+.||++|||++|++..
T Consensus 227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 01222334568899999999999999999997653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-48 Score=423.08 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=209.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~ 484 (756)
++|.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5899999999999999999995 579999999987665555667899999999999999999999999999999999999
Q ss_pred cCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC--CCcceeeccccceecCCCC
Q 004395 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH--DFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 485 ~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~--~~~vkL~DFGlA~~~~~~~ 562 (756)
.||+|.+++.. ..+.+++..++.++.||+.||.|||++ |||||||||+||||+. ++.+||+|||+|+......
T Consensus 106 ~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999864 346799999999999999999999999 9999999999999964 6789999999999775433
Q ss_pred CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccC
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLG 642 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~ 642 (756)
......||+.|||||++.+..|+.++|||||||++|||++|+.||........ + ... .. ....+.
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~----~~i------~~-~~~~~~ 245 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--L----RNV------KS-CDWNMD 245 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHH------HH-TCCCSC
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH--H----HHH------Hh-CCCCCC
Confidence 34457899999999999999999999999999999999999999965432110 0 000 00 001111
Q ss_pred CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 643 NHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 643 ~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..........+.+||.+||..||++|||+.|++++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112334568899999999999999999999884
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=410.51 Aligned_cols=246 Identities=25% Similarity=0.338 Sum_probs=197.6
Q ss_pred EEecccCceEEEEEEec---CCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEeecC
Q 004395 412 NFLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (756)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~---~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey~~g 486 (756)
+.||+|+||.||+|.+. +++.||||+++..... ..+.|.+|+++|++++|||||+++++|.+ +..|||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999853 3568999998644322 24579999999999999999999999965 567999999999
Q ss_pred CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCCC--
Q 004395 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG-- 564 (756)
Q Consensus 487 gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~~-- 564 (756)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+........
T Consensus 92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999973 56799999999999999999999999 9999999999999999999999999999976543321
Q ss_pred cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCC
Q 004395 565 VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGN 643 (756)
Q Consensus 565 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~ 643 (756)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ... . +.. ....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~------~~~-~-----i~~----~~~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTA-M-----LEK----GERM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHH-H-----HHT----TCCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH------HHH-H-----HHc----CCCC
Confidence 2234578999999999999999999999999999999998 899997543211 000 0 011 1111
Q ss_pred CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 644 HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 644 ~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+...+..+.+|+.+||+.||++|||+++|++.|+.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 2233445678999999999999999999999998863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-48 Score=416.49 Aligned_cols=244 Identities=28% Similarity=0.403 Sum_probs=201.6
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc---CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~---~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
.|+.++.||+|+||.||+|.. .+|+.||||++...... ....|.+|+++|++++|||||++++++.+++..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 599999999999999999994 57899999998754432 23468899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
||.+|+|..++. ..+++++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp CCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999977665 356899999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcccccccCccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCC
Q 004395 563 MGVETRVIGTFGYLAPEYAQS---GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDP 639 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp 639 (756)
.....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||........ + . .+.....+
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~--------~--~i~~~~~~ 232 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L--------Y--HIAQNESP 232 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H--------H--HHHHSCCC
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--H--------H--HHHhCCCC
Confidence 234679999999999864 5689999999999999999999999964322100 0 0 00111111
Q ss_pred ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 640 RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 640 ~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.+ .+......+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 11223456899999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=408.87 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=206.2
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC------cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS------QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~------~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
.++|++++.||+|+||.||+|.. .+|+.||||++..... ...+.|.+|+++|++++|||||+++++|.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999995 5799999998764322 1245799999999999999999999999999999
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC----cceeeccc
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFG 553 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~----~vkL~DFG 553 (756)
|||||||.+|+|.+++.. .+.+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999974 35799999999999999999999999 999999999999998876 48999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
+|+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||........ +.. +
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~----------i 228 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN----------V 228 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH----------H
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--HHH----------H
Confidence 999775443 23456799999999999999999999999999999999999999975432110 000 0
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
... ...+...........+.+||.+||..||++|||+.|+++
T Consensus 229 ~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 229 SAV-NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HTT-CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Hhc-CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000011123346889999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=408.29 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=198.3
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEecC----CCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEEEEecCc
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~ 476 (756)
++..++|++.+.||+|+||.||+|.... +..||||.++..... ....|.+|+++|++++|||||+++++|. ++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 3456789999999999999999998532 357889987654333 3456999999999999999999999996 467
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp CEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhhe
Confidence 8999999999999998764 456799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDE 635 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~ 635 (756)
..............||+.|+|||++.+..|+.++|||||||++|||+| |.+||........ + .. +..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~--------~~--i~~ 224 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--I--------GR--IEN 224 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H--------HH--HHT
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--H--------HH--HHc
Confidence 765544444455678999999999999999999999999999999998 8999875443211 0 00 011
Q ss_pred ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 636 LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 636 l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
-..+ ..+...+..+.+||.+||..||++|||+.||++.|+.
T Consensus 225 ~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 225 GERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0111 2233445679999999999999999999999998863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=407.14 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=201.9
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCC----EEEEEEeccc-CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQ----AVAVKQHKLA-SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~VAVK~~~~~-~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~L 479 (756)
.+|++++.||+|+||.||+|.+ .+|+ +||+|.++.. .....+.|.+|+++|++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 4699999999999999999985 3454 6888887643 334566899999999999999999999999864 5788
Q ss_pred EEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecC
Q 004395 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~ 559 (756)
+|||+.+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+...
T Consensus 88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998865 467899999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCC-cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 560 DGDMG-VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 560 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
..... ......||+.|+|||++.++.|+.++|||||||+||||+| |..||........ . ... ..
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~----~~i-----~~-- 228 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SIL-----EK-- 228 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---H----HHH-----HH--
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---H----HHH-----Hc--
Confidence 43322 2234568999999999999999999999999999999998 7888865432110 0 000 01
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
......+...+..+.+|+.+||+.||.+|||+.||++.|+.
T Consensus 229 --~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 229 --GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp --TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 11112233445678999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=408.96 Aligned_cols=249 Identities=23% Similarity=0.286 Sum_probs=208.5
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEE
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
-++|.+++.||+|+||.||+|.. .+|+.||||+++.. .......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35799999999999999999995 58999999988643 233456789999999999999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
||||.||+|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999974 46799999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... +....... ...
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----------~~~~i~~~---~~~ 223 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------LFELILME---EIR 223 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----------HHHHHHHC---CCC
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----------HHHHHhcC---CCC
Confidence 32 23455789999999999999999999999999999999999999997543211 00100000 111
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~~ 677 (756)
++......+.+||.+||+.||.+||+ +.+++++
T Consensus 224 ----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 22334456889999999999999995 7888763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=402.32 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=200.1
Q ss_pred HhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEe-cCceeEEE
Q 004395 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRRRLLVY 481 (756)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~-~~~~~LV~ 481 (756)
+..++|++++.||+|+||.||+|.+ .|+.||||+++. ....+.|.+|+++|++++||||++++|+|.+ .+.+|+||
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 4456899999999999999999998 578999998864 3345679999999999999999999999865 45689999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+++|+|.++|.......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999999765455699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.....+|+.|+|||++.++.++.++|||||||++|||+| |+.||....... +... +..-..+
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~---------i~~~~~~- 219 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR---------VEKGYKM- 219 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH---------HTTTCCC-
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH---------HHcCCCC-
Confidence 234568999999999999999999999999999999998 677776432211 0000 1111112
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+......+.+|+.+||..||.+||||.+|++.|+.
T Consensus 220 ---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 220 ---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 2333444578999999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-47 Score=406.85 Aligned_cols=263 Identities=26% Similarity=0.364 Sum_probs=212.9
Q ss_pred hHHHHHhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCCc-CchhHHHHHHHHHhcCCCCeeeEEEE
Q 004395 398 YAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGF 470 (756)
Q Consensus 398 ~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L~HpNIV~l~~~ 470 (756)
+.+++...++|++.+.||+|+||.||+|++. +++.||||+++..... ....|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4566777889999999999999999999853 4578999998754333 34579999999999999999999999
Q ss_pred EEecCceeEEEEeecCCChhhhhhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCc
Q 004395 471 CIEDRRRLLVYEYICNGSLDSHLYGCH----------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGC 528 (756)
Q Consensus 471 ~~~~~~~~LV~Ey~~ggsL~~~L~~~~----------------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~g 528 (756)
|.+....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~ 160 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----K 160 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----C
Confidence 999999999999999999999996421 23589999999999999999999999 9
Q ss_pred eEeeccCCCceeecCCCcceeeccccceecCCCC-CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCC-
Q 004395 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR- 606 (756)
Q Consensus 529 IiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~- 606 (756)
||||||||+||||+.++.+||+|||+|+...... ........||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 9999999999999999999999999998654432 22334567899999999999999999999999999999999996
Q ss_pred CCCCCCCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 607 KAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 607 ~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
+||........ . ..+.+.. ....+...+..+.+|+.+||+.||++||||.||++.|+.
T Consensus 241 ~p~~~~~~~e~------~---------~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~ 298 (301)
T d1lufa_ 241 QPYYGMAHEEV------I---------YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298 (301)
T ss_dssp CTTTTSCHHHH------H---------HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHH------H---------HHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 56654322110 0 0111111 112233445578999999999999999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-47 Score=406.07 Aligned_cols=245 Identities=24% Similarity=0.327 Sum_probs=206.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++++.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4799999999999999999995 57999999988632 2344567999999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
|||.||+|..++. ....+++..++.++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999887 456789999999999999999999999 9999999999999999999999999999976543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
....+||+.|+|||++.+..|+.++|||||||+||||+||+.||........ . ..+....
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~---------~~i~~~~- 217 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------Y---------EKILNAE- 217 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H---------HHHHHCC-
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------H---------HHHHcCC-
Confidence 2456899999999999999999999999999999999999999975432110 0 0000000
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLRI 677 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~~ 677 (756)
..++......+.+++.+||..||.+|| |+++++++
T Consensus 218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 112223345688999999999999996 88998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.3e-47 Score=396.84 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=200.9
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcC---chhHHHHHHHHHhcCCCCeeeEEEEEEecCc---
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR--- 476 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~---~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~--- 476 (756)
..++|++.+.||+|+||.||+|.. .+|+.||||+++...... ...|.+|+++|+.++|||||++++++.....
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 357899999999999999999994 579999999987543322 3468999999999999999999999987543
Q ss_pred -eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 477 -RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 477 -~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
.|||||||+|++|.+++.. .+++++..++.++.||+.||+|||++ ||+||||||+||||+.++.++|+|||++
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhh
Confidence 7999999999999998864 46799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC--CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhh
Q 004395 556 RWQPDGD--MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAI 633 (756)
Q Consensus 556 ~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i 633 (756)
....... .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||....+... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~----- 227 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHV----- 227 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHH-----
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHH-----
Confidence 8654332 2233456899999999999999999999999999999999999999975432110 00000
Q ss_pred hhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhh
Q 004395 634 DELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRP-RMSQVLRILE 679 (756)
Q Consensus 634 ~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RP-S~~eVL~~Le 679 (756)
.. .+..........+..+.+++.+||+.||++|| |+++++..|.
T Consensus 228 ~~--~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 228 RE--DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HC--CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred hc--CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 00 01111111223345689999999999999999 8999988765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=401.18 Aligned_cols=265 Identities=23% Similarity=0.295 Sum_probs=201.8
Q ss_pred ChHHHHHhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEE
Q 004395 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLI 468 (756)
Q Consensus 397 s~~~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~ 468 (756)
....+++..++|++.+.||+|+||.||+|... +++.||||+++.... .....+..|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34556677789999999999999999999842 356899998865432 2345688888888877 689999999
Q ss_pred EEEEec-CceeEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeec
Q 004395 469 GFCIED-RRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533 (756)
Q Consensus 469 ~~~~~~-~~~~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrD 533 (756)
+++.+. ...++|||||++|+|.+++.... ...+++..++.++.||+.||.|||++ +|||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrD 159 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRD 159 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCc
Confidence 998764 46899999999999999996432 34689999999999999999999999 999999
Q ss_pred cCCCceeecCCCcceeeccccceecCCCC-CCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 004395 534 MRPNNILLTHDFEPLVGDFGLARWQPDGD-MGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR-KAVDL 611 (756)
Q Consensus 534 LKp~NILL~~~~~vkL~DFGlA~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~-~Pf~~ 611 (756)
|||+||||++++.+||+|||+|+...... ........||+.|+|||++.++.++.++|||||||++|||+||. .||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765433 22334567999999999999999999999999999999999975 56754
Q ss_pred CCcccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 612 NRPKGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 612 ~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
...... + ... +..-..+ ..+......+.+++.+||+.||++|||+.||+++|+.
T Consensus 240 ~~~~~~--~----~~~-----~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 240 VKIDEE--F----CRR-----LKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp CCCSHH--H----HHH-----HHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHH--H----HHH-----HhcCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 322110 0 000 1111111 1223344568999999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-46 Score=393.24 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=206.4
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcC---------chhHHHHHHHHHhcC-CCCeeeEEEEEEec
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---------DHEFCSEVEVLSCAQ-HRNVVMLIGFCIED 474 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~---------~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~ 474 (756)
++|++.+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999995 579999999986543221 135889999999997 99999999999999
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
+..|||||||++|+|.++|.. .+++++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999974 45799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCcccccccCccccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQS------GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLL 628 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~ 628 (756)
++...... ......||+.|+|||++.+ ..++.++||||+||+||||++|+.||........ ....
T Consensus 157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------~~~i- 227 (277)
T d1phka_ 157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LRMI- 227 (277)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-
T ss_pred eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH------HHHH-
Confidence 99876543 2345679999999998853 4578899999999999999999999975432110 0000
Q ss_pred hhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 629 EEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 629 ~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
... ...............+.+|+.+||..||.+|||+.||+++
T Consensus 228 ----~~~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 ----MSG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ----HHT--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----HhC--CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 0111111223445678999999999999999999999763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=396.83 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=197.4
Q ss_pred hCCeeEEEEecccCceEEEEEEec--CC--CEEEEEEecccC---CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCce
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLP--DG--QAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~--~g--~~VAVK~~~~~~---~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~ 477 (756)
.++|++.+.||+|+||.||+|.+. ++ ..||||+++... ....+.|.+|+++|++++|||||+++|+|.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 367999999999999999999853 23 378999876432 2234579999999999999999999999975 567
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccccee
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~ 557 (756)
++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999998865 345799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCC--cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 558 QPDGDMG--VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 558 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
....... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||........ +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---------------~~ 225 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---------------LH 225 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---------------HH
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---------------HH
Confidence 7544321 2234568889999999999999999999999999999998 8999964332110 01
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+.........+...+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus 226 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 226 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111111112233444578999999999999999999999998874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-46 Score=408.39 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=201.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHH---HHHHHhcCCCCeeeEEEEEEecCcee
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSE---VEVLSCAQHRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~E---v~iL~~L~HpNIV~l~~~~~~~~~~~ 478 (756)
++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+| +++++.++|||||+++++|.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5899999999999999999995 47999999987532 12233345555 55666678999999999999999999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
||||||+||+|.++|.. ...+++..++.++.||+.||+|||++ |||||||||+||||+.+|.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999974 46789999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhcc
Q 004395 559 PDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELV 637 (756)
Q Consensus 559 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~ 637 (756)
.... .....||+.|+|||++.. ..|+.++|||||||+||||+||+.||..........+. ....
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------------~~~~ 222 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------RMTL 222 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH------------HHSS
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------Hhcc
Confidence 5543 345679999999999864 56899999999999999999999999754432211000 0000
Q ss_pred CCccCCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 004395 638 DPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLRI 677 (756)
Q Consensus 638 dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~~ 677 (756)
.. ....+......+.+||.+||..||++||| +++++++
T Consensus 223 ~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 TM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred cC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 10 11122234456899999999999999999 6888764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=400.65 Aligned_cols=253 Identities=21% Similarity=0.259 Sum_probs=206.4
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
..++|.+++.||+|+||+||+|.. .+|+.||||+++... .....+.+|+++|+.++|||||++++++.+++.+|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 357899999999999999999995 478999999987543 233468899999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCC--CcceeeccccceecCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD--FEPLVGDFGLARWQPD 560 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~--~~vkL~DFGlA~~~~~ 560 (756)
||.||+|.+++.. ....+++..++.++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999964 345799999999999999999999999 99999999999999854 5799999999987654
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.. ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||........ + ..... .. ..
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--~----~~i~~----~~---~~ 221 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--I----ENIMN----AE---YT 221 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H----HHHHH----TC---CC
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--H----HHHHh----CC---CC
Confidence 33 23456799999999999999999999999999999999999999975432110 0 00000 00 00
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
+...........+.+|+.+||..||.+|||+.|++++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000001123468899999999999999999999883
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=403.07 Aligned_cols=251 Identities=20% Similarity=0.217 Sum_probs=201.2
Q ss_pred hCCeeEEE-EecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEe----cCce
Q 004395 405 TGGFSQAN-FLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE----DRRR 477 (756)
Q Consensus 405 ~~~y~~~~-~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~----~~~~ 477 (756)
.++|.+.. .||+|+||.||+|.. .+|+.||||+++. ...+.+|++++.++ +|||||+++++|.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35798875 699999999999995 6799999998753 34688899987655 89999999999876 4568
Q ss_pred eEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC---CCcceeecccc
Q 004395 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGL 554 (756)
Q Consensus 478 ~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~---~~~vkL~DFGl 554 (756)
|||||||+||+|.++|.......+++..++.++.||+.||+|||+. ||+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc----CCccccccccccccccccccccccccccce
Confidence 9999999999999999865567899999999999999999999999 9999999999999985 56799999999
Q ss_pred ceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 555 ARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 555 A~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
|+...... ......||+.|+|||++.+..|+.++|||||||+||+|+||+.||......... .. + ..
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--~~----~-----~~ 227 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PG----M-----KT 227 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--HH----H-----HH
Confidence 99776543 234567999999999999999999999999999999999999999654322110 00 0 00
Q ss_pred hccCCc--cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 635 ELVDPR--LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~--l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.+.... +...........+.+|+.+||+.||++|||+.|++++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000000 0011112334568999999999999999999999883
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-46 Score=405.92 Aligned_cols=244 Identities=22% Similarity=0.246 Sum_probs=205.3
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++|++++.||+|+||.||+|.. .+|+.||||++... .......+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4799999999999999999995 57999999987532 2334467899999999999999999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~ 561 (756)
||+.+|+|..++.. .+.+++..++.++.||+.||.|||++ |||||||||+||||+.+|.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999974 35799999999999999999999999 9999999999999999999999999999976543
Q ss_pred CCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCcc
Q 004395 562 DMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPRL 641 (756)
Q Consensus 562 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~l 641 (756)
.....||+.|||||++.+..|+.++|||||||+||||+||+.||........ + .. +... ...
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~--------~~--i~~~-~~~- 256 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--Y--------EK--IVSG-KVR- 256 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H--------HH--HHHC-CCC-
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH--H--------HH--HhcC-CCC-
Confidence 2456799999999999999999999999999999999999999965432100 0 00 0000 111
Q ss_pred CCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 004395 642 GNHYSEHEVYCMLHAASLCIRRDPHSRP-----RMSQVLR 676 (756)
Q Consensus 642 ~~~~~~~~~~~l~~Li~~CL~~dP~~RP-----S~~eVL~ 676 (756)
.+......+.+|+.+||..||.+|+ |++++++
T Consensus 257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1223345688999999999999994 8999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=399.07 Aligned_cols=261 Identities=27% Similarity=0.379 Sum_probs=211.3
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEe------cCCCEEEEEEecccCCc-CchhHHHHHHHHHhc-CCCCeeeEEEEEE
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~~~~~~~~-~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~ 472 (756)
+++..++|++.+.||+|+||.||+|++ .+++.||||+++..... ....|.+|+.+++.+ +|||||+++++|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 455667999999999999999999984 34678999998754432 344689999999999 6999999999999
Q ss_pred ecCceeEEEEeecCCChhhhhhccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCC
Q 004395 473 EDRRRLLVYEYICNGSLDSHLYGCH----------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (756)
Q Consensus 473 ~~~~~~LV~Ey~~ggsL~~~L~~~~----------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp 536 (756)
+....|+|||||++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----~ivHrDLKp 173 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAA 173 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----Ceeeccccc
Confidence 9999999999999999999996432 23689999999999999999999999 999999999
Q ss_pred CceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCc
Q 004395 537 NNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTG-RKAVDLNRP 614 (756)
Q Consensus 537 ~NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG-~~Pf~~~~~ 614 (756)
+|||++.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|+ .+||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997765432 233446799999999999999999999999999999999995 554543322
Q ss_pred ccccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 615 KGQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 615 ~~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
... +. .++........+...+..+.+||.+||+.||.+||||.+|++.|+.
T Consensus 254 ~~~--~~-------------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 254 DSK--FY-------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp SHH--HH-------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH--HH-------------HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 00 0111111112223344578999999999999999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=393.85 Aligned_cols=259 Identities=24% Similarity=0.250 Sum_probs=196.5
Q ss_pred EEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc-----CchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 410 QANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-----GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~-----~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
.+++||+|+||+||+|.. .+|+.||||+++..... ....+.+|+++|+.++|||||++++++.+++..||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 467899999999999995 57999999988654322 234689999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.++++..++. ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 98877766654 456799999999999999999999999 999999999999999999999999999987654332
Q ss_pred CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhh----hhhh----hhhh
Q 004395 564 GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARP----LLEE----YAID 634 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~----~~~~----~~i~ 634 (756)
.....+||+.|+|||++.+ ..|+.++|||||||++|||+||..||.......+ +...... .... ....
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSSTTSST
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HHHHHHhcCCCChhhccchhccc
Confidence 2344679999999998865 4679999999999999999999999975433211 0000000 0000 0000
Q ss_pred hccCCccCCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 635 ELVDPRLGNHY-----SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 635 ~l~dp~l~~~~-----~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
....-...... .......+.+|+.+||+.||++|||+.|+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000000000 01223568899999999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=397.77 Aligned_cols=259 Identities=28% Similarity=0.360 Sum_probs=206.2
Q ss_pred HHhhCCeeEEEEecccCceEEEEEEec--------CCCEEEEEEecccCC-cCchhHHHHHHHHHhc-CCCCeeeEEEEE
Q 004395 402 ELATGGFSQANFLAEGGFGSVHRGVLP--------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (756)
Q Consensus 402 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~ 471 (756)
++..++|.+++.||+|+||.||+|+.. ++..||||+++.... ....++.+|+..+.++ +|||||+++++|
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 345578999999999999999999842 234799998865443 2346788999999888 799999999999
Q ss_pred EecCceeEEEEeecCCChhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCC
Q 004395 472 IEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (756)
Q Consensus 472 ~~~~~~~LV~Ey~~ggsL~~~L~~~~--------------~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~ 537 (756)
.++...++|||||++|+|.++|.... ...+++..++.++.||+.||+|||+. +||||||||+
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp~ 164 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAAR 164 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeeccc
Confidence 99999999999999999999996432 34689999999999999999999999 9999999999
Q ss_pred ceeecCCCcceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 004395 538 NILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVT-GRKAVDLNRPK 615 (756)
Q Consensus 538 NILL~~~~~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~ 615 (756)
|||++.++.+||+|||+++....... .......||+.|+|||.+.++.|+.++|||||||++|||++ |..||......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999987654332 22344678999999999999999999999999999999998 68888643321
Q ss_pred cccchhhhhhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 616 GQQCLTEWARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 616 ~~~~l~~~~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. +. .. +.. ......+...+..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 245 ~---~~----~~-----i~~----~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 245 E---LF----KL-----LKE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp H---HH----HH-----HHT----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HH----HH-----HHc----CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 0 00 00 111 11112233344578999999999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=396.33 Aligned_cols=269 Identities=23% Similarity=0.312 Sum_probs=201.9
Q ss_pred hCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHH--HHhcCCCCeeeEEEEEEecC----cee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV--LSCAQHRNVVMLIGFCIEDR----RRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~i--L~~L~HpNIV~l~~~~~~~~----~~~ 478 (756)
.+.|.+.+.||+|+||.||+|++ +|+.||||+++.. ....+..|.++ +..++|||||+++++|.+.+ ..|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 35788999999999999999997 6899999988643 23345555554 45789999999999998765 579
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc----ccCceEeeccCCCceeecCCCcceeecccc
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~----~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
+|||||++|+|.++|.. ..++|..++.++.|++.||.|||..+ ...||+||||||+||||+.++.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999964 46999999999999999999999732 122899999999999999999999999999
Q ss_pred ceecCCCCC---CcccccccCccccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh----
Q 004395 555 ARWQPDGDM---GVETRVIGTFGYLAPEYAQSGQ------ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT---- 621 (756)
Q Consensus 555 A~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~------~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~---- 621 (756)
++....... .......||+.|+|||++.+.. ++.++|||||||+||||+||..||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 997654332 1233567999999999987643 577999999999999999999888543322111110
Q ss_pred hhhhhhhhhhhhhhccCCccCCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 622 EWARPLLEEYAIDELVDPRLGNHY-SEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 622 ~~~~~~~~~~~i~~l~dp~l~~~~-~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
................+|.+.... .......+.+|+.+||+.||++|||+.||++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 011111111112222233322222 22355678999999999999999999999998873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=396.97 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=202.0
Q ss_pred CCeeEEEEecccCceEEEEEEec-CCC--EEEEEEeccc-CCcCchhHHHHHHHHHhc-CCCCeeeEEEEEEecCceeEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLP-DGQ--AVAVKQHKLA-SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~--~VAVK~~~~~-~~~~~~~f~~Ev~iL~~L-~HpNIV~l~~~~~~~~~~~LV 480 (756)
++|++.+.||+|+||.||+|.+. +|. .||||.+... .....+.|.+|+++|+++ +|||||+++++|.+++..|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67999999999999999999964 454 4778876543 334556799999999999 699999999999999999999
Q ss_pred EEeecCCChhhhhhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCc
Q 004395 481 YEYICNGSLDSHLYGC--------------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~--------------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~ 546 (756)
|||+++|+|.++|+.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCCc
Confidence 9999999999999643 246799999999999999999999999 9999999999999999999
Q ss_pred ceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCcccccchhhhhh
Q 004395 547 PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRK-AVDLNRPKGQQCLTEWAR 625 (756)
Q Consensus 547 vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~-Pf~~~~~~~~~~l~~~~~ 625 (756)
+||+|||+|+...... ......||..|+|||.+.++.|+.++|||||||++|||++|.. ||....... +. .
T Consensus 166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~---~ 237 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---E 237 (309)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---H
T ss_pred eEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HH---H
Confidence 9999999998654322 1234568999999999999999999999999999999999765 564332110 00 0
Q ss_pred hhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 626 PLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 626 ~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
. +.. ......+...+..+.+||.+||+.||++||||.+|++.|+.
T Consensus 238 ~------i~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 238 K------LPQ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp H------GGG----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H------HHh----cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0 011 11112233445679999999999999999999999998875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=393.95 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=200.3
Q ss_pred EEEEecccCceEEEEEEecC--C--CEEEEEEeccc-CCcCchhHHHHHHHHHhcCCCCeeeEEEEEEec-CceeEEEEe
Q 004395 410 QANFLAEGGFGSVHRGVLPD--G--QAVAVKQHKLA-SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-RRRLLVYEY 483 (756)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~--g--~~VAVK~~~~~-~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~-~~~~LV~Ey 483 (756)
+.++||+|+||+||+|.+.+ + ..||||+++.. .......|.+|+++|++++||||++++|++.+. ...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 35789999999999999643 2 36899988643 333446799999999999999999999998764 578999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
|++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred eecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999875 456788999999999999999999999 999999999999999999999999999997654332
Q ss_pred C---cccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 564 G---VETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 564 ~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
. ......||+.|+|||++.++.++.++||||||++||||+||..||........ +..... .. ..+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-----~~~~i~-----~g-~~~- 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLL-----QG-RRL- 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHH-----TT-CCC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-----HHHHHH-----cC-CCC-
Confidence 1 22345789999999999999999999999999999999998888754322111 111100 00 011
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
..+......+.+|+.+||+.||++||+|.||++.|+.
T Consensus 254 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~ 290 (311)
T d1r0pa_ 254 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122334568999999999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=390.59 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=202.8
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|++++.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+++|++++|||||++++++.++...|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999995 6799999999865432 345679999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+. +++.+++.......+++..++.++.||+.||+|||+. |||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 984 5666666555677899999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCcccccccCccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh----hhh----hhhhh
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQ-ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR----PLL----EEYAI 633 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----~~~----~~~~i 633 (756)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||........ +..... +.. .....
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhccccccc
Confidence 2334567999999999887655 57999999999999999999999975432211 000000 000 00000
Q ss_pred hhccCC--ccCCC----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 634 DELVDP--RLGNH----YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 634 ~~l~dp--~l~~~----~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...... ..... ........+.+|+.+||..||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 00000 011223568899999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=399.05 Aligned_cols=247 Identities=24% Similarity=0.326 Sum_probs=204.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEeccc---CCcCchhHHHHHHHHH-hcCCCCeeeEEEEEEecCceeEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLS-CAQHRNVVMLIGFCIEDRRRLLV 480 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~---~~~~~~~f~~Ev~iL~-~L~HpNIV~l~~~~~~~~~~~LV 480 (756)
++|.+++.||+|+||+||+|.. .+|+.||||+++.. .......+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999995 47999999998643 2334456777887765 68999999999999999999999
Q ss_pred EEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCC
Q 004395 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 481 ~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~ 560 (756)
||||++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999974 45789999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhhhccCCc
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAIDELVDPR 640 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~~l~dp~ 640 (756)
.. .......||+.|+|||++.+..|+.++|||||||++|||+||+.||........ .... . ...+.
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~----------~~~i--~-~~~~~ 221 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----------FHSI--R-MDNPF 221 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------HHHH--H-HCCCC
T ss_pred cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH----------HHHH--H-cCCCC
Confidence 32 233456799999999999999999999999999999999999999975432110 0000 0 01121
Q ss_pred cCCCCChhHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 004395 641 LGNHYSEHEVYCMLHAASLCIRRDPHSRPRMS-QVLR 676 (756)
Q Consensus 641 l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~-eVL~ 676 (756)
++......+.+|+.+||..||++||++. ++++
T Consensus 222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2233345689999999999999999985 6654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=389.54 Aligned_cols=240 Identities=22% Similarity=0.310 Sum_probs=197.9
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc------CchhHHHHHHHHHhcC--CCCeeeEEEEEEecC
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQ--HRNVVMLIGFCIEDR 475 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~------~~~~f~~Ev~iL~~L~--HpNIV~l~~~~~~~~ 475 (756)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999995 57999999988643221 2234778999999997 899999999999999
Q ss_pred ceeEEEEeecC-CChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-CCcceeeccc
Q 004395 476 RRLLVYEYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFG 553 (756)
Q Consensus 476 ~~~LV~Ey~~g-gsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-~~~vkL~DFG 553 (756)
..|+||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECccc
Confidence 99999999976 577777763 46799999999999999999999999 9999999999999985 4799999999
Q ss_pred cceecCCCCCCcccccccCccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhh
Q 004395 554 LARWQPDGDMGVETRVIGTFGYLAPEYAQSGQI-TEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYA 632 (756)
Q Consensus 554 lA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 632 (756)
+|+..... ......||+.|+|||++.+..+ +.++|||||||+||||+||+.||..... ..
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~---- 217 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------II---- 217 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HH----
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hh----
Confidence 99876443 2345789999999999987665 6789999999999999999999953210 00
Q ss_pred hhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 633 IDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 633 i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.. ...+ +...+..+.+|+.+||..||++|||+.|+++
T Consensus 218 -~~--~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 218 -RG--QVFF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -HC--CCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hc--ccCC----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 0111 1223346889999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-45 Score=386.05 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=201.7
Q ss_pred CCeeEEEEecccCceEEEEEEecCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~Ey 483 (756)
++|.+++.||+|+||+||+|..++|+.||||++.... ......+.+|+.+|++++|||||+++++|.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999998899999999986543 23356799999999999999999999999999999999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~~ 563 (756)
+.++.+..+.. ..+.+++..+..++.||+.||+|||+. +||||||||+||||+.++.+||+|||+|........
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 97666665554 457899999999999999999999999 999999999999999999999999999987654332
Q ss_pred CcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh----hhhh----hhhhh
Q 004395 564 GVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR----PLLE----EYAID 634 (756)
Q Consensus 564 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----~~~~----~~~i~ 634 (756)
......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ +..... +... .....
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhhh
Confidence 2344568999999999865 4568999999999999999999999975432211 110000 0000 00000
Q ss_pred hc------cCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 635 EL------VDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 635 ~l------~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
.. ..+.............+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011011112223457889999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=393.99 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=210.5
Q ss_pred HHHhhCCeeEEEEecccCceEEEEEEec------CCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEe
Q 004395 401 LELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (756)
Q Consensus 401 l~~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~ 473 (756)
+++..++|.+.+.||+|+||.||+|.+. +++.||||+++.... .....|.+|++++++++|||||+++++|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4555679999999999999999999853 357899998864332 233468999999999999999999999999
Q ss_pred cCceeEEEEeecCCChhhhhhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC
Q 004395 474 DRRRLLVYEYICNGSLDSHLYGC--------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (756)
Q Consensus 474 ~~~~~LV~Ey~~ggsL~~~L~~~--------~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~ 545 (756)
....++||||+.+|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||||+.++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecCCc
Confidence 99999999999999999998532 224579999999999999999999999 999999999999999999
Q ss_pred cceeeccccceecCCCCC-CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcccccchhhh
Q 004395 546 EPLVGDFGLARWQPDGDM-GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGR-KAVDLNRPKGQQCLTEW 623 (756)
Q Consensus 546 ~vkL~DFGlA~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~-~Pf~~~~~~~~~~l~~~ 623 (756)
.+||+|||+|+....... .......||+.|+|||.+.++.++.++|||||||+||||+||. .||...... +.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~ 244 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QV 244 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------HH
Confidence 999999999986644322 2233456899999999999999999999999999999999985 666433211 00
Q ss_pred hhhhhhhhhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 624 ARPLLEEYAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 624 ~~~~~~~~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
. ..+.+.. ....+...+..+.+++.+||+.||++||||.+|++.|+..
T Consensus 245 ~---------~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 245 L---------RFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp H---------HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred H---------HHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 0 1111111 1112233445799999999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=385.05 Aligned_cols=266 Identities=23% Similarity=0.271 Sum_probs=199.7
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cC-CCEEEEEEecccC--CcCchhHHHHHHHHHhc---CCCCeeeEEEEEEe----
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PD-GQAVAVKQHKLAS--SQGDHEFCSEVEVLSCA---QHRNVVMLIGFCIE---- 473 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~-g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L---~HpNIV~l~~~~~~---- 473 (756)
.++|++++.||+|+||+||+|.. .+ ++.||||+++... ......+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999995 34 6789999876542 23344677888887766 79999999999864
Q ss_pred -cCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecc
Q 004395 474 -DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (756)
Q Consensus 474 -~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DF 552 (756)
....+++|||+.++++.... ......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecch
Confidence 34679999999776665443 33567899999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hhhhh-hhhhh
Q 004395 553 GLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL-TEWAR-PLLEE 630 (756)
Q Consensus 553 GlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l-~~~~~-~~~~~ 630 (756)
|+++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||........... ..... +....
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9998654322 33456799999999999999999999999999999999999999975543211000 00000 00000
Q ss_pred ----hhhhh----ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 631 ----YAIDE----LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 631 ----~~i~~----l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
..... .........+.......+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000000111222334568899999999999999999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-43 Score=375.36 Aligned_cols=258 Identities=17% Similarity=0.211 Sum_probs=199.6
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCC-eeeEEEEEEecCceeEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDRRRLLVYEY 483 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpN-IV~l~~~~~~~~~~~LV~Ey 483 (756)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+..|+++++.++|+| |+.+.+++.++...++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999995 578999999877543 3346889999999998765 55566667788888999999
Q ss_pred ecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeec---CCCcceeeccccceecCC
Q 004395 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT---HDFEPLVGDFGLARWQPD 560 (756)
Q Consensus 484 ~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~---~~~~vkL~DFGlA~~~~~ 560 (756)
+ +++|.+.+.. ..+.+++..++.++.|++.||+|||++ ||+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 8 7777776654 456899999999999999999999999 999999999999975 456799999999998754
Q ss_pred CCC------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 561 GDM------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 561 ~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 332 12345679999999999999999999999999999999999999997554332211110000000000001
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEG 680 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~ 680 (756)
.+.. ..+..+.+++..||+.||++||++.++.+.|+.
T Consensus 239 -----~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 239 -----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -----HHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred -----Hhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1111 223468899999999999999999999888875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-43 Score=373.90 Aligned_cols=261 Identities=16% Similarity=0.172 Sum_probs=208.5
Q ss_pred hhCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC-CCeeeEEEEEEecCceeEEE
Q 004395 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H-pNIV~l~~~~~~~~~~~LV~ 481 (756)
..++|++++.||+|+||.||+|+. .+|+.||||++... .....+.+|++++..|+| +||+.+++++.++...++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 357899999999999999999995 47899999987543 234568899999999975 89999999999999999999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecC-----CCcceeeccccce
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-----DFEPLVGDFGLAR 556 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~-----~~~vkL~DFGlA~ 556 (756)
||+ +++|.+++.. ....+++..+..++.|++.||+|||+. ||+||||||+|||++. ++.+||+|||+|+
T Consensus 81 e~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 81 DLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 998 8999998865 456799999999999999999999999 9999999999999974 5789999999999
Q ss_pred ecCCCCC------CcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhh
Q 004395 557 WQPDGDM------GVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEE 630 (756)
Q Consensus 557 ~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 630 (756)
.+..... ......+||+.|||||++.+..++.++|||||||++|||+||..||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 7654321 1233467999999999999999999999999999999999999999754433221111100000000
Q ss_pred hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcC
Q 004395 631 YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRILEGD 681 (756)
Q Consensus 631 ~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~Le~~ 681 (756)
....++ ... .+..+.+++..|+..+|++||+++.+.+.|+..
T Consensus 235 ~~~~~l-----~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 235 TPLREL-----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp SCHHHH-----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CChHHh-----cCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 011111 111 234688999999999999999999998888753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=379.52 Aligned_cols=266 Identities=23% Similarity=0.284 Sum_probs=196.5
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccC--CcCchhHHHHHHHHHhcCCCCeeeEEEEEEe--------c
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--------D 474 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~--~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~--------~ 474 (756)
++|++++.||+|+||+||+|.. .+|+.||||++.... ......+.+|+++|+.++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999995 589999999875442 3345678999999999999999999999865 3
Q ss_pred CceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeecccc
Q 004395 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (756)
Q Consensus 475 ~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGl 554 (756)
...|+||||+.++.+..... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeecce
Confidence 45799999997776665443 556799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCC---CCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh-hhhhhhhh
Q 004395 555 ARWQPDGD---MGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT-EWARPLLE 629 (756)
Q Consensus 555 A~~~~~~~---~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~-~~~~~~~~ 629 (756)
++.+.... .......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||............ ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98765432 1223346799999999998764 6899999999999999999999999754332111000 00000000
Q ss_pred h-------hhhhhccCCccCCCCCh-h------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 E-------YAIDELVDPRLGNHYSE-H------EVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 ~-------~~i~~l~dp~l~~~~~~-~------~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. ................. . ....+.+|+.+||..||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 00000000000000000 0 12356789999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=381.15 Aligned_cols=259 Identities=23% Similarity=0.276 Sum_probs=195.4
Q ss_pred CeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCeeeEEEEEEec------CceeE
Q 004395 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------RRRLL 479 (756)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~------~~~~L 479 (756)
+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|+++|++++||||++++++|... ..+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 699999999999999999995 5799999999875432 234799999999999999999998643 24789
Q ss_pred EEEeecCCChhhhhh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-cceeecccccee
Q 004395 480 VYEYICNGSLDSHLY-GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARW 557 (756)
Q Consensus 480 V~Ey~~ggsL~~~L~-~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-~vkL~DFGlA~~ 557 (756)
|||||.++.+..+.. ......+++..++.++.||+.||+|||++ ||+||||||+||||+.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999996554443332 22566899999999999999999999999 999999999999999775 899999999987
Q ss_pred cCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhh----hh---hh
Q 004395 558 QPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWAR----PL---LE 629 (756)
Q Consensus 558 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~----~~---~~ 629 (756)
..... .....+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||.......+ +..... +. ..
T Consensus 173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHH
T ss_pred ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhh
Confidence 75443 2344679999999998765 5789999999999999999999999975443211 111100 00 00
Q ss_pred hh-------hhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 630 EY-------AIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 630 ~~-------~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. .....................+.+|+.+||..||++|||+.|+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000000011122334568899999999999999999999873
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=384.28 Aligned_cols=266 Identities=22% Similarity=0.273 Sum_probs=197.9
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC-cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC----cee
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR----RRL 478 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~-~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~----~~~ 478 (756)
+.+|++++.||+|+||+||+|.. .+|+.||||++..... .....+.+|+++|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999984 6899999999864432 23457889999999999999999999997653 235
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceec
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~ 558 (756)
++++|+.+|+|.+++.. +.+++..++.++.||+.||+|||++ |||||||||+||||++++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55666779999999963 4699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--CcccccccCccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhh--hhhhhhh--
Q 004395 559 PDGDM--GVETRVIGTFGYLAPEYAQ-SGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWA--RPLLEEY-- 631 (756)
Q Consensus 559 ~~~~~--~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~--~~~~~~~-- 631 (756)
..... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||............... .+.....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 54321 2234567999999999984 456789999999999999999999999755432211100000 0000000
Q ss_pred ----hh-hhc-cCCccCC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 632 ----AI-DEL-VDPRLGN----HYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 632 ----~i-~~l-~dp~l~~----~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
.. ... ..+.... .........+.+|+.+||..||++|||+.|+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000 0000000 0011223468899999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=366.84 Aligned_cols=265 Identities=18% Similarity=0.211 Sum_probs=205.6
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecCceeEEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~~~~LV~E 482 (756)
++|++++.||+|+||+||+|+. .+|+.||||+++.... .....+.+|+.+|+.++||||++++++|.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999995 5789999999865433 234578999999999999999999999999999999999
Q ss_pred eecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccceecCCCC
Q 004395 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (756)
Q Consensus 483 y~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~~~~~~~ 562 (756)
|+.+++|..++. ..+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998888776 567889999999999999999999999 99999999999999999999999999999775433
Q ss_pred CCcccccccCccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch--hhhhhhhh-hh----hhhh
Q 004395 563 MGVETRVIGTFGYLAPEYAQSGQ-ITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCL--TEWARPLL-EE----YAID 634 (756)
Q Consensus 563 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l--~~~~~~~~-~~----~~i~ 634 (756)
. ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||........... ........ .. ....
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2 233456788999999987665 68999999999999999999999754332221100 00000000 00 0000
Q ss_pred h------ccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 635 E------LVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 635 ~------l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. .................+.+|+.+||+.||.+|||++|+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000111222334568899999999999999999999873
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=380.61 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=195.4
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~~------ 475 (756)
.++|++++.||+|+||+||+|.. .+|+.||||+++.... .....+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 57899999999999999999995 5799999999875332 22356889999999999999999999998655
Q ss_pred ceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccc
Q 004395 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (756)
Q Consensus 476 ~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA 555 (756)
.+|+||||+ +.+|..++. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccce
Confidence 469999998 777877764 35799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCcccccccCccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhh---------h-
Q 004395 556 RWQPDGDMGVETRVIGTFGYLAPEYAQS-GQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEW---------A- 624 (756)
Q Consensus 556 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~---------~- 624 (756)
+..... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. .
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 876543 245679999999999876 4568999999999999999999999975532211100000 0
Q ss_pred --hhhhhh---hhhhhccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 625 --RPLLEE---YAIDELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 625 --~~~~~~---~~i~~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
...... ..+.+.....+ ..........+.+|+.+||..||++|||+.|+|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00001101100 11112234567899999999999999999999984
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-42 Score=370.08 Aligned_cols=257 Identities=18% Similarity=0.265 Sum_probs=198.1
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEec--CceeEEE
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIED--RRRLLVY 481 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~--~~~~LV~ 481 (756)
++|++++.||+|+||+||+|+. .+|+.||||+++.. ....+.+|+++|+.++ ||||++++++|... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999995 57999999998643 3467889999999996 99999999999844 4689999
Q ss_pred EeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCC-cceeeccccceecCC
Q 004395 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQPD 560 (756)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~-~vkL~DFGlA~~~~~ 560 (756)
|||.+++|..+. +.+++..++.++.||+.||.|||++ ||+||||||+||||+.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997764 3699999999999999999999999 999999999999998755 689999999997755
Q ss_pred CCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh--hhh-hhhh----hhh-
Q 004395 561 GDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT--EWA-RPLL----EEY- 631 (756)
Q Consensus 561 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~--~~~-~~~~----~~~- 631 (756)
.. .....+||+.|+|||.+.+. .++.++|||||||++|||++|+.||............ ... .+.. ...
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 43 23456799999999998764 5799999999999999999999999754432111000 000 0000 000
Q ss_pred -----hhhhccCC--------ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 004395 632 -----AIDELVDP--------RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMSQVLR 676 (756)
Q Consensus 632 -----~i~~l~dp--------~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~ 676 (756)
........ .............+.+||.+||..||++|||++|+|+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 0001111223456889999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=376.90 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=204.0
Q ss_pred CCeeEEEEecccCceEEEEEEe----cCCCEEEEEEecccC----CcCchhHHHHHHHHHhcCC-CCeeeEEEEEEecCc
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRR 476 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~~~~~~----~~~~~~f~~Ev~iL~~L~H-pNIV~l~~~~~~~~~ 476 (756)
++|++++.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999984 258999999876432 2345678899999999976 899999999999999
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.++||||+.+|+|.+++.. .+.+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999974 45678899999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCCcccccccCccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhhhhhhhhhhhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSG--QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLTEWARPLLEEYAID 634 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~i~ 634 (756)
.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||......... ...... ...
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~-----~~~ 250 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRR-----ILK 250 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHH-----HHH
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHh-----ccc
Confidence 8765544445567899999999998764 4688999999999999999999999765433211 110000 000
Q ss_pred hccCCccCCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 004395 635 ELVDPRLGNHYSEHEVYCMLHAASLCIRRDPHSRPR-----MSQVLR 676 (756)
Q Consensus 635 ~l~dp~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS-----~~eVL~ 676 (756)
..+ .++......+.+|+.+||..||++||| ++|+++
T Consensus 251 --~~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 --SEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --CCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --CCC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011 122334457899999999999999994 788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=369.50 Aligned_cols=262 Identities=23% Similarity=0.261 Sum_probs=195.1
Q ss_pred hCCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCc--CchhHHHHHHHHHhcCCCCeeeEEEEEEec-----Cc
Q 004395 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RR 476 (756)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~--~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~-----~~ 476 (756)
.++|++++.||+|+||+||+|.. .+|+.||||++...... ....+.+|+++|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999994 57999999998754322 234688999999999999999999998643 34
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.+++|+|+.+|+|.+++. .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchhc
Confidence 577788888999999994 45799999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCCcccccccCccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh-hh-hhhhh-----
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSG-QITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQCLT-EW-ARPLL----- 628 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l~-~~-~~~~~----- 628 (756)
.... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||............ .. ..+..
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 5533 23446789999999987665 4689999999999999999999999754322110000 00 00000
Q ss_pred ----hhhhhhhccCCccCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 629 ----EEYAIDELVDPRLGNH---YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 629 ----~~~~i~~l~dp~l~~~---~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
................ ........+.+||.+||..||.+|||+.|+|++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000000000 001223467899999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=367.41 Aligned_cols=261 Identities=21% Similarity=0.259 Sum_probs=189.5
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCC--cCchhHHHHHHHHHhcCCCCeeeEEEEEEec------Cc
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------RR 476 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~--~~~~~f~~Ev~iL~~L~HpNIV~l~~~~~~~------~~ 476 (756)
++|++++.||+|+||+||+|.. .+|+.||||++..... .....+.+|+.+|++++|||||+++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6899999999999999999995 4799999999875432 2334688999999999999999999999643 57
Q ss_pred eeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 477 ~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.|+|||||.+ +|.+.+. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhhh
Confidence 8999999955 5555553 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hh--------hhhhhh
Q 004395 557 WQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC-LT--------EWARPL 627 (756)
Q Consensus 557 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-l~--------~~~~~~ 627 (756)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......... .. .+....
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 665432 3345679999999999999999999999999999999999999996543221100 00 000000
Q ss_pred h---hhh----------hhhhccCCccCCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 004395 628 L---EEY----------AIDELVDPRLGNH---YSEHEVYCMLHAASLCIRRDPHSRPRMSQVLRI 677 (756)
Q Consensus 628 ~---~~~----------~i~~l~dp~l~~~---~~~~~~~~l~~Li~~CL~~dP~~RPS~~eVL~~ 677 (756)
. ... ............. ........+.+|+.+||..||++|||++|||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000 0000010011111 112245678899999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.5e-37 Score=330.14 Aligned_cols=263 Identities=18% Similarity=0.208 Sum_probs=192.2
Q ss_pred CCeeEEEEecccCceEEEEEEe-cCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-----------CCCeeeEEEEEEe
Q 004395 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-----------HRNVVMLIGFCIE 473 (756)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-----------HpNIV~l~~~~~~ 473 (756)
++|++++.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|+.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999995 579999999987432 22356788999988875 5789999998865
Q ss_pred c--CceeEEEEeecCCCh-hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hcccCceEeeccCCCceeecCCCc---
Q 004395 474 D--RRRLLVYEYICNGSL-DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFE--- 546 (756)
Q Consensus 474 ~--~~~~LV~Ey~~ggsL-~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~-~~~~~gIiHrDLKp~NILL~~~~~--- 546 (756)
. ...+++|+++..+.. ...........+++..+..++.||+.||+|||+ . ||+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~----~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC----GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT----CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc----CcccccCChhHeeeeccCcccc
Confidence 3 456677777655543 333344466789999999999999999999998 6 8999999999999987654
Q ss_pred ---ceeeccccceecCCCCCCcccccccCccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc----
Q 004395 547 ---PLVGDFGLARWQPDGDMGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAVDLNRPKGQQC---- 619 (756)
Q Consensus 547 ---vkL~DFGlA~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~---- 619 (756)
++++|||.+....... ...+||+.|+|||++.+..|+.++||||+||++++|++|+.||..........
T Consensus 168 ~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 8999999998664332 34679999999999999999999999999999999999999996433211100
Q ss_pred hhhhhhh-------hhhhhh-hhhcc---------CC----------ccCCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 004395 620 LTEWARP-------LLEEYA-IDELV---------DP----------RLGNHYSEHEVYCMLHAASLCIRRDPHSRPRMS 672 (756)
Q Consensus 620 l~~~~~~-------~~~~~~-i~~l~---------dp----------~l~~~~~~~~~~~l~~Li~~CL~~dP~~RPS~~ 672 (756)
+...... ...... ..... .. .............+.+|+.+||..||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0000000 000000 00000 00 001123455677899999999999999999999
Q ss_pred HHHHH
Q 004395 673 QVLRI 677 (756)
Q Consensus 673 eVL~~ 677 (756)
|+|++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.8e-23 Score=206.07 Aligned_cols=164 Identities=16% Similarity=0.088 Sum_probs=121.7
Q ss_pred eeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcC------------------chhHHHHHHHHHhcCCCCeeeEEE
Q 004395 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG------------------DHEFCSEVEVLSCAQHRNVVMLIG 469 (756)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~------------------~~~f~~Ev~iL~~L~HpNIV~l~~ 469 (756)
+.+++.||+|+||.||+|...+|+.||||+++...... ...+..|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999998899999999875422110 112456888999999999999887
Q ss_pred EEEecCceeEEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCccee
Q 004395 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (756)
Q Consensus 470 ~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL 549 (756)
+. ..+++|||+.+..+.. ++...+..++.|++.+|+|||+. ||+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCC-CEEE
Confidence 63 2489999997765543 23344678999999999999999 99999999999999865 5889
Q ss_pred eccccceecCCCCCCcccccccCccccC------ccccccCCCCchhhHHHHHHHH
Q 004395 550 GDFGLARWQPDGDMGVETRVIGTFGYLA------PEYAQSGQITEKADVYSFGVVL 599 (756)
Q Consensus 550 ~DFGlA~~~~~~~~~~~~~~~Gt~~Y~A------PE~l~~~~~s~ksDVwSlGvvL 599 (756)
+|||+|+....+.. ..|.. .+++ ...|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~---------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGW---------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTH---------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCc---------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999986543321 01111 1112 36678899999975443
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.34 E-value=5.5e-13 Score=127.88 Aligned_cols=141 Identities=21% Similarity=0.312 Sum_probs=102.4
Q ss_pred ccEEEEEEeCCCC--------cchhhHhHHhhhccCCCCe---EEEEEEecCCCCCCcccccccccccccCCcccccccc
Q 004395 20 AEKVVVAVKASKE--------IPRTALVWALTHVVQPGDC---ITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGT 88 (756)
Q Consensus 20 ~~~v~v~~d~~~~--------~~~~a~~wal~~~~~~gd~---~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (756)
+.|||||||.|.. -|+.|+.|||.|+++.||+ |+|++|.+....+ +.+ ....... .+.
T Consensus 1 p~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~---~~~--~~~~~~~------~~~ 69 (171)
T d2gm3a1 1 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDG---FDD--VDSIYAS------PED 69 (171)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC---------------CCCCS------HHH
T ss_pred CCEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccc---ccc--ccccccC------HHH
Confidence 3689999998852 4899999999999999996 6677766543322 111 1111100 112
Q ss_pred ccccccchhhhHHHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhc
Q 004395 89 ISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEE 159 (756)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~ 159 (756)
..+...+..+...+++.++.+.|+..++.++..|+.|.|...|..+|++.++.+|||+.|=+. .-.||+++
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~ 149 (171)
T d2gm3a1 70 FRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKH 149 (171)
T ss_dssp HHHHTTSHHHHHHHHHHHHHHHHHHHTCEEEEEEEESCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhcCCceEEEEEeCChHHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhC
Confidence 233444455556788999999999999999999999999888988899999999999998332 23499999
Q ss_pred cceeEEEEecCc
Q 004395 160 LQCNIVVMKRSQ 171 (756)
Q Consensus 160 l~C~i~~~~~~~ 171 (756)
..|.|+++++..
T Consensus 150 ~~cpVlvV~~~~ 161 (171)
T d2gm3a1 150 AECPVMTIKRNA 161 (171)
T ss_dssp CSSCEEEEECCG
T ss_pred CCCCEEEEeCCC
Confidence 999999999664
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=98.81 E-value=2.3e-09 Score=100.42 Aligned_cols=146 Identities=16% Similarity=0.205 Sum_probs=100.0
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++|+|++|.|.. +.+|+.||+...-+.|..|+||+|++....... ..++... +...... .......+....+.+..
T Consensus 4 ~~ILvavD~s~~-s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~-~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~ 79 (160)
T d1mjha_ 4 KKILYPTDFSET-AEIALKHVKAFKTLKAEEVILLHVIDEREIKKR-DIFSLLL-GVAGLNK-SVEEFENELKNKLTEEA 79 (160)
T ss_dssp CEEEEECCSCHH-HHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC--------------------CHHHHHHHHHHHHHHH
T ss_pred CeEEEEECCCHH-HHHHHHHHHHHHHhcCCEEEEEEeccccccccc-ccccccc-cccccch-hHHHHHHHHHHHHHHHH
Confidence 689999998765 899999999999999999999999876543311 0110000 1111111 00111112222233333
Q ss_pred HHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEEecC
Q 004395 101 SQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMKRS 170 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~~~~ 170 (756)
.+.+.++...++..+|.++..+..|.|...|+..|++.+|..||++.|=+. .-.+++.+.+|.|.++|+.
T Consensus 80 ~~~l~~~~~~~~~~gv~~~~~~~~G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~~pVlvV~~~ 158 (160)
T d1mjha_ 80 KNKMENIKKELEDVGFKVKDIIVVGIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSNKPVLVVKRK 158 (160)
T ss_dssp HHHHHHHHHHHHHTTCEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCCSCEEEECCC
T ss_pred HHHHHHHHHHHHhcCCeEEEEEEeccHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCCCCEEEEcCC
Confidence 466677777777789999999999998888888899999999999987322 3459999999999999964
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.71 E-value=1.1e-08 Score=94.05 Aligned_cols=132 Identities=13% Similarity=0.122 Sum_probs=89.2
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++++|++|.|.. +..|+.||+.-..+.++.++|+++.+.......... .. ..+......+..
T Consensus 6 k~ILv~vD~s~~-s~~al~~A~~la~~~~~~~~~~~~~~~~~~~~~~~~---------~~--------~~~~~~~~~~~~ 67 (147)
T d1tq8a_ 6 KTVVVGTDGSDS-SMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADI---------LK--------DESYKVTGTAPI 67 (147)
T ss_dssp CEEEEECCSSHH-HHHHHHHHHHHHTTTSEEEEEEECCC-------------------------------------CCTH
T ss_pred CEEEEEECCCHH-HHHHHHHHHHHHhcCCCEEEEEEEeccccccccccc---------ch--------hhhHHHHHHHHH
Confidence 789999999865 999999999866555455555555543322211000 00 011122223334
Q ss_pred HHHHHHHhhhcCCCCce-EEEEEEeCCCCchhhHHhhhccceEEEeccccchh---------hhhhhhccceeEEEEecC
Q 004395 101 SQMILQLHDVYDPNKIN-FKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVMKRS 170 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~-~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~---------~~~~~~~l~C~i~~~~~~ 170 (756)
.+.+.++.+.+...++. +++.+..|.+...|..+|++.++..||++++-+.. -.+++++.+|.|.++|.+
T Consensus 68 ~~~l~~~~~~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~~pVlvV~~~ 147 (147)
T d1tq8a_ 68 YEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAKVDVLIVHTT 147 (147)
T ss_dssp HHHHHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTTCEEEEECCC
T ss_pred HHHHHHHHHHHHHcCCCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCCCCEEEEecC
Confidence 57788888888776665 89999999998888888999999999999985432 238999999999999853
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.61 E-value=1.2e-07 Score=94.92 Aligned_cols=149 Identities=15% Similarity=0.048 Sum_probs=106.6
Q ss_pred HHHHhhCCeeEEEEecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCcee
Q 004395 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRL 478 (756)
Q Consensus 400 ~l~~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~ 478 (756)
++...-..|+..+..+.+....||+... +++.+.||+...........+.+|+.+|..|. +--+++++.++.+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555567888777655555678998875 55677888776555555667889999998885 334678888888888999
Q ss_pred EEEEeecCCChhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 004395 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC---------------------------------- 524 (756)
Q Consensus 479 LV~Ey~~ggsL~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~~~---------------------------------- 524 (756)
+||++++|.++.+.... . .....++.++++.|+.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~---~----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED---E----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTT---C----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEecccccccccccc---c----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999988887654421 0 112334556666666666431
Q ss_pred ---------------------ccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 525 ---------------------RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 525 ---------------------~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
...+++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01148999999999999987767799999875
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=98.34 E-value=3.2e-07 Score=82.78 Aligned_cols=125 Identities=12% Similarity=0.147 Sum_probs=87.0
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++|+|++|.|.. +..|+.||+...-+.|..|+||+|++..... .+. ....+...+..+..
T Consensus 2 k~Ilv~~D~s~~-s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~---~~~----------------~~~~~~~~~~~~~~ 61 (135)
T d2z3va1 2 KTILLAYDGSEH-ARRAAEVAKAEAEAHGARLIVVHAYEPVPDY---LGE----------------PFFEEALRRRLERA 61 (135)
T ss_dssp CEEEEECCSSHH-HHHHHHHHHHHHHHHTCEEEEEEEECCCCTT---CCT----------------THHHHHHHHHHHHH
T ss_pred CEEEEEECCCHH-HHHHHHHHHHHHHHcCCEEEEEEEecCCccc---ccc----------------chhHHHHHHHHHHH
Confidence 689999998865 9999999999988999999999998753221 110 01112222223333
Q ss_pred HHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch---------hhhhhhhccceeEEEE
Q 004395 101 SQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVM 167 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~---------~~~~~~~~l~C~i~~~ 167 (756)
.+.+.++.+.+.-. .++..+..|.|...|+..|++.++..||++.|-+. ...||+.+.+|.|.++
T Consensus 62 ~~~l~~~~~~~~~~--~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~~pVlvV 135 (135)
T d2z3va1 62 EGVLEEARALTGVP--KEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAPCPVLLV 135 (135)
T ss_dssp HHHHHHHHHHHCCC--GGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCSSCEEEE
T ss_pred HHHHHHHHHhcCCC--eEEEEEEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCCCCEEeC
Confidence 34555555444222 23455677998878887899999999999988433 3449999999999875
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=98.34 E-value=6.4e-07 Score=81.05 Aligned_cols=130 Identities=15% Similarity=0.162 Sum_probs=87.1
Q ss_pred cEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchhhhH
Q 004395 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (756)
Q Consensus 21 ~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (756)
++|+|++|.+.. +..|+.||....-+.|+.|++|+|++..... .+ ++.. ....+......+..
T Consensus 3 k~ILv~vD~s~~-s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~---~~-----~~~~--------~~~~~~~~~~~~~~ 65 (140)
T d1jmva_ 3 KHILVAVDLSEE-SPILLKKAVGIAKRHDAKLSIIHVDVNFSDL---YT-----GLID--------VNMSSMQDRISTET 65 (140)
T ss_dssp SEEEEEECCSTT-HHHHHHHHHHHHHHHTCEEEEEEEEECCGGG---CC-----CCEE--------HHHHHHTTCCCCHH
T ss_pred CeEEEEECCCHH-HHHHHHHHHHHHHHcCCeEEEEEEeeecccc---cc-----cccc--------cchHHHHHHHHHHH
Confidence 689999999976 8999999999988899999999998764322 11 1100 01111122222222
Q ss_pred HHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccch------hhhhhhhccceeEEEEec
Q 004395 101 SQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH------EEKCCMEELQCNIVVMKR 169 (756)
Q Consensus 101 ~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~------~~~~~~~~l~C~i~~~~~ 169 (756)
.+.+.++..-.+.+ ..+..+..|.+...|..+|++.+|..||++.|-+. ...+++.++.|.|.+++.
T Consensus 66 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~lgs~~~~li~~~~~pVliVp~ 138 (140)
T d1jmva_ 66 QKALLDLAESVDYP--ISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSKLMSSTRQVMNTIKIDMLVVPL 138 (140)
T ss_dssp HHHHHHHHHHSSSC--CCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHHHHHHHHHHHTTCCSEEEEEEC
T ss_pred HHHHHHHHHhcCCc--eEEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCCcccHHHHHHhccCCCEEEEec
Confidence 23333333332222 23455667888888888899999999999987322 244999999999999984
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=98.26 E-value=3e-07 Score=82.87 Aligned_cols=137 Identities=10% Similarity=0.016 Sum_probs=98.8
Q ss_pred CCccEEEEEEeCCCCcchhhHhHHhhhccCCCCeEEEEEEecCCCCCCcccccccccccccCCccccccccccccccchh
Q 004395 18 DVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDIT 97 (756)
Q Consensus 18 ~~~~~v~v~~d~~~~~~~~a~~wal~~~~~~gd~~~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (756)
+-.++++|++|.|.. |..||.||....-+-|..|+||+|+...... ..+ ...-. .....+...+..
T Consensus 2 ~~mk~ILv~~D~S~~-s~~al~~A~~~a~~~~a~l~llhv~~~~~~~---~~~---~~~~~-------~~~~~~~~e~~~ 67 (138)
T d1q77a_ 2 NAMKVLLVLTDAYSD-CEKAITYAVNFSEKLGAELDILAVLEDVYNL---ERA---NVTFG-------LPFPPEIKEESK 67 (138)
T ss_dssp CCCEEEEEEESTTCC-CHHHHHHHHHHHTTTCCEEEEEEECHHHHHH---HHH---HHHHC-------CCCCTHHHHHHH
T ss_pred CCCCEEEEEEeCCHH-HHHHHHHHHHhhhhccceEEEEEEccCcccc---ccc---ccccc-------cchhhhhhhhhh
Confidence 456899999999976 9999999999999999999999998642211 110 00000 001223333344
Q ss_pred hhHHHHHHHHhhhcCCCCceEEEEEEeCCCCchhhHHhhhccceEEEeccccchhhhhhhhccceeEEEEe
Q 004395 98 DSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMK 168 (756)
Q Consensus 98 ~~~~~~~~~l~~~~~~~~v~~~~~v~~g~~~~~v~~eak~~~a~wvVld~~~k~~~~~~~~~l~C~i~~~~ 168 (756)
+...+.+..+.+-++..+++++..|..|.|...|...|++.++..||++.|=+.--+..+...+|-..++|
T Consensus 68 ~~~~~~l~~~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~g~~~~~livk 138 (138)
T d1q77a_ 68 KRIERRLREVWEKLTGSTEIPGVEYRIGPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGLNLASLIVK 138 (138)
T ss_dssp HHHHHHHHHHHHHHHSCCCCCCEEEECSCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHSSSEEEECC
T ss_pred hhccccchhhcccccccceeEEEeeecchhHHHHHHhhhhccCCEEEEecCCCcHHHHHhcCCCCCEEEeC
Confidence 44445566666666678999999999999999999889999999999999976666677777777665543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.08 E-value=1.2e-05 Score=79.48 Aligned_cols=131 Identities=19% Similarity=0.072 Sum_probs=88.3
Q ss_pred EecccC-ceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCC--CCeeeEEEEEEecCceeEEEEeecCCCh
Q 004395 413 FLAEGG-FGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (756)
Q Consensus 413 ~LG~G~-fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~H--pNIV~l~~~~~~~~~~~LV~Ey~~ggsL 489 (756)
.+..|. .+.||+....++..+.+|..... ....+..|+.+|+.|.. -.+++++.++.+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344454 36799999878888889975533 23457889998887753 3367888888888899999999988776
Q ss_pred hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 004395 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE----------------------------------------------- 522 (756)
Q Consensus 490 ~~~L~~~~~~~L~~~~~~~ia~qIa~aL~yLH~----------------------------------------------- 522 (756)
.+.. +.. ..++.+++..|+-||.
T Consensus 94 ~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 4321 110 1112233333333332
Q ss_pred ----hc---ccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 523 ----EC---RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 523 ----~~---~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.. ....++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 11248999999999999987777899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.45 E-value=0.00022 Score=75.85 Aligned_cols=77 Identities=14% Similarity=0.056 Sum_probs=50.1
Q ss_pred EEEecccCceEEEEEEec-CCCEEEEEEecc----cC---CcCchhHHHHHHHHHhcC-C--CCeeeEEEEEEecCceeE
Q 004395 411 ANFLAEGGFGSVHRGVLP-DGQAVAVKQHKL----AS---SQGDHEFCSEVEVLSCAQ-H--RNVVMLIGFCIEDRRRLL 479 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~-~g~~VAVK~~~~----~~---~~~~~~f~~Ev~iL~~L~-H--pNIV~l~~~~~~~~~~~L 479 (756)
.+.||.|....||+.... +++.|+||.-.. .. .........|+++|..+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 456899999999999854 467899996332 11 112334567888888763 2 346677765 4456689
Q ss_pred EEEeecCCCh
Q 004395 480 VYEYICNGSL 489 (756)
Q Consensus 480 V~Ey~~ggsL 489 (756)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.88 E-value=0.0008 Score=69.29 Aligned_cols=134 Identities=13% Similarity=0.091 Sum_probs=78.4
Q ss_pred eEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCee--eEE-----EEEEecCceeEEEEeecCCChhh-
Q 004395 420 GSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVV--MLI-----GFCIEDRRRLLVYEYICNGSLDS- 491 (756)
Q Consensus 420 G~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNIV--~l~-----~~~~~~~~~~LV~Ey~~ggsL~~- 491 (756)
-.||++...+|+.|++|+.+.. .....++..|.+.+..|...+|. ..+ ..+..++..+.+++++.|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999989999999987644 23456788899988887532221 111 12334566789999987644321
Q ss_pred ---h-------h---hc----c---CCCCCCHH-------------------HHHHHHHHHHHHHHHHHhhc---ccCce
Q 004395 492 ---H-------L---YG----C---HQEPLEWS-------------------ARQKIAVGAARGLRYLHEEC---RVGCI 529 (756)
Q Consensus 492 ---~-------L---~~----~---~~~~L~~~-------------------~~~~ia~qIa~aL~yLH~~~---~~~gI 529 (756)
. + +. . ....+++. ....+...+...++.+.... ...++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0 00 0 01111111 11112222233333333321 23479
Q ss_pred EeeccCCCceeecCCCcceeeccccce
Q 004395 530 VHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 530 iHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
||+|+.+.|||++++ ..++||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999743 4589999886
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.32 E-value=0.0086 Score=62.91 Aligned_cols=74 Identities=14% Similarity=0.088 Sum_probs=51.0
Q ss_pred EEEecccCceEEEEEEecC--------CCEEEEEEecccCCcCchhHHHHHHHHHhcC-CCCeeeEEEEEEecCceeEEE
Q 004395 411 ANFLAEGGFGSVHRGVLPD--------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVY 481 (756)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~--------g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~-HpNIV~l~~~~~~~~~~~LV~ 481 (756)
++.|+.|-.=.+|++..++ ...|.+++.- . ........+|..+++.+. +.-.+++++++.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4578888888999988644 3457777654 2 333445668999999885 4334578887743 6899
Q ss_pred EeecCCChh
Q 004395 482 EYICNGSLD 490 (756)
Q Consensus 482 Ey~~ggsL~ 490 (756)
||++|.+|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.17 E-value=0.005 Score=62.29 Aligned_cols=158 Identities=11% Similarity=0.002 Sum_probs=83.3
Q ss_pred CChHHHHHhhCCeeEEEE-----ecccCceEEEEEEecCCCEEEEEEecccCCcCchhHHHHHHHHHhcCCCCe-----e
Q 004395 396 FSYAELELATGGFSQANF-----LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-----V 465 (756)
Q Consensus 396 ~s~~~l~~~~~~y~~~~~-----LG~G~fG~Vy~a~~~~g~~VAVK~~~~~~~~~~~~f~~Ev~iL~~L~HpNI-----V 465 (756)
++-.+++....+|.++++ |..|---+.|+....+|+ +++|+..... ...++..|++++..|...++ +
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 345667766777766433 445666778998876665 8899875432 33456667777777643222 1
Q ss_pred eEE---EEEEecCceeEEEEeecCCChhhh--------------hhcc---C----CCCCCHH-----------------
Q 004395 466 MLI---GFCIEDRRRLLVYEYICNGSLDSH--------------LYGC---H----QEPLEWS----------------- 504 (756)
Q Consensus 466 ~l~---~~~~~~~~~~LV~Ey~~ggsL~~~--------------L~~~---~----~~~L~~~----------------- 504 (756)
... .+..-......++.++.+...... ++.. . .......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 011223445666777655433211 0000 0 0000000
Q ss_pred -HHHHHHHHHHHHHHHHHhhcccCceEeeccCCCceeecCCCcceeeccccce
Q 004395 505 -ARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (756)
Q Consensus 505 -~~~~ia~qIa~aL~yLH~~~~~~gIiHrDLKp~NILL~~~~~vkL~DFGlA~ 556 (756)
.....+..+...+.-.+...-+.|+||+|+.++|||++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1112222223333333322223389999999999999988777899999875
|